data_1mnl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mnl _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.311 0.577 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CB ' ' HE2' ' A' ' 44' ' ' LYS . 6.8 p90 -165.2 150.07 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 10.4 pt-20 -171.02 132.37 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 21.5 pt -83.63 -177.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.266 -0.897 . . . . 0.0 110.486 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.641 ' CD1' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -121.63 -154.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.577 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -138.77 50.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.837 -1.164 . . . . 0.0 111.53 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.577 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 19.2 tt 40.44 51.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.159 0.98 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.676 ' N ' HG22 ' A' ' 12' ' ' THR . . . -139.51 -65.43 0.04 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 46.2 Cg_endo -82.4 -58.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.83 1.437 . . . . 0.0 111.275 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 6' ' ' ILE . 2.6 m-30 -54.33 -22.07 11.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.834 -1.166 . . . . 0.0 109.687 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.676 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -69.12 -61.26 1.87 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.577 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -55.3 -25.09 32.11 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.676 0.751 . . . . 0.0 110.001 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -80.72 -44.1 19.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.797 0.808 . . . . 0.0 109.871 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -46.82 -47.21 21.1 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.479 0.656 . . . . 0.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -64.74 -51.13 54.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -67.73 -79.74 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.24 . . . . 0.0 110.592 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -33.84 -62.55 0.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.447 0.641 . . . . 0.0 111.1 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -44.39 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.411 -0.806 . . . . 0.0 109.917 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 26.2 t -41.62 -25.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.553 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' ALA . 2.6 t70 -87.66 -70.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.983 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.58 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . 4.1 tt0 -61.88 -37.4 84.45 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.32 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -58.79 -53.22 60.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.938 -1.101 . . . . 0.0 108.778 177.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 10.0 t-20 -68.68 -47.05 67.46 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.36 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -57.1 -35.84 69.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 110.322 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -68.63 -21.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.0 110.005 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 121.5 10.47 6.54 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 18.0 mm-40 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 109.562 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.606 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.406 0.622 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -136.94 52.12 1.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 109.943 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 13.9 p90 -169.7 123.11 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.881 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' N ' ' A' ' 65' ' ' SER . 1.8 t-20 -155.14 -65.06 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -0.937 . . . . 0.0 110.71 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -69.14 -98.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.954 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.3 t -161.84 172.35 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.687 -1.258 . . . . 0.0 111.719 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -120.17 113.22 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.602 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -120.49 -59.92 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.92 -1.113 . . . . 0.0 110.707 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.1 Cg_endo -82.73 47.65 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.091 1.048 . . . . 0.0 111.081 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 38' ' ' ILE . 27.8 p -84.18 122.18 28.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -123.23 164.15 19.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 111.25 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.23 137.46 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.864 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HE2' ' CB ' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -145.58 134.2 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.069 -1.019 . . . . 0.0 110.291 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 46' ' ' ILE . 15.7 m -126.75 155.11 43.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.517 ' N ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.529 ' CE2' ' HE3' ' A' ' 43' ' ' LYS . 35.4 t80 -113.76 104.1 11.87 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.386 -1.067 . . . . 0.0 110.019 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 20.2 pt-20 -119.52 175.99 5.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.455 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.648 ' CD1' ' CG2' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -153.51 162.75 40.96 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.573 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.6 tt0 -126.22 120.98 31.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.61 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 2.3 tp -118.66 71.5 0.85 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 109.566 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -70.16 110.97 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.59 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 29.1 m -159.74 -165.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.601 -0.687 . . . . 0.0 109.795 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.584 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.5 t80 -138.93 130.02 26.68 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.053 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -124.05 -131.4 0.26 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.632 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 79.8 p -81.73 -28.93 33.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.237 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.88 18.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.602 -0.686 . . . . 0.0 109.655 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.8 ttmm -105.18 73.63 1.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.57 HD13 ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.77 64.54 8.63 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 177.25 -127.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.517 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' CD ' ' HG3' ' A' ' 59' ' ' GLN . 14.0 ttm180 -132.46 127.02 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.49 -1.381 . . . . 0.0 111.987 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.64 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -83.79 102.75 12.54 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -86.55 172.83 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.497 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.648 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -168.51 131.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.877 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -122.25 159.73 26.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' ASP . 2.3 mt-10 -152.59 108.51 3.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.829 -1.169 . . . . 0.0 111.785 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.069 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.519 ' CA ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 tp -171.2 -169.44 0.74 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.954 -1.092 . . . . 0.0 109.791 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.659 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -170.69 166.16 8.04 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.3 mtt-85 -145.91 143.7 29.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.724 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 2.5 m-85 -115.22 73.81 0.85 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -159.71 -164.9 1.41 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.911 -1.118 . . . . 0.0 111.759 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.594 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 70.79 52.06 16.86 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.392 -3.483 . . . . 0.0 104.392 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.2 Cg_endo -64.46 -174.14 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.714 1.902 . . . . 0.0 112.742 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 1.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.105 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.161 0.505 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -161.77 149.0 14.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -177.18 159.23 1.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.45 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.452 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 3.1 pt -95.03 -175.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.621 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.7 -165.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.217 -0.927 . . . . 0.0 110.468 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.536 ' O ' HG21 ' A' ' 8' ' ' ILE . 24.1 t70 -139.94 51.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.074 -1.016 . . . . 0.0 111.167 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 7' ' ' ASP . 4.6 tt 39.52 40.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.836 0.827 . . . . 0.0 110.098 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.538 ' N ' HG22 ' A' ' 12' ' ' THR . . . -147.25 -65.9 0.01 OUTLIER Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' THR . 44.7 Cg_endo -75.13 -85.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.61 1.321 . . . . 0.0 111.386 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.621 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 66.2 m-85 -39.05 -27.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.398 -0.814 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.556 ' CB ' HG23 ' A' ' 38' ' ' ILE . 18.6 p -60.47 -58.31 9.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.076 -1.015 . . . . 0.0 108.648 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.7 pt20 -59.15 -15.97 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.446 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -76.19 -60.04 2.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 110.065 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 pp -43.68 -34.81 1.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.409 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -62.51 -54.43 34.2 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -72.96 -66.45 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -1.022 . . . . 0.0 110.131 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 21' ' ' ASP . 2.0 m-30 -40.5 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.484 0.659 . . . . 0.0 110.44 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -39.92 -68.2 0.19 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.808 -0.558 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 16' ' ' GLY . 4.1 t -41.98 -26.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.104 -0.997 . . . . 0.0 110.024 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 18' ' ' PHE . 6.0 m-20 -95.3 -66.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 14.6 mm-40 -59.08 -26.83 64.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.825 -1.172 . . . . 0.0 109.23 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -76.79 -61.54 1.94 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 25.3 t-20 -54.22 -43.12 70.53 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.615 -1.234 . . . . 0.0 107.815 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 18.5 tptp -56.28 -59.21 5.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.211 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.545 ' CD1' ' O ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -55.32 -20.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.629 0.728 . . . . 0.0 109.622 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 81.13 60.72 2.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -1.14 . . . . 0.0 109.892 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.031 0.443 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -36.5 90.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.751 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' LEU . 7.7 t80 165.82 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 0.0 109.617 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -155.66 -64.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.94 -1.1 . . . . 0.0 111.382 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.624 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -69.52 -99.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 111.453 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 13.9 t -159.22 172.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.536 -1.352 . . . . 0.0 111.727 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.567 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -127.79 99.08 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.626 . . . . 0.0 110.01 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -108.49 -54.76 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.488 -0.758 . . . . 0.0 110.159 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 41.7 Cg_endo -84.88 51.37 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.412 1.217 . . . . 0.0 111.306 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.482 ' O ' HD13 ' A' ' 6' ' ' ILE . 21.9 t -104.42 106.37 16.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.526 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 10.2 mtt -96.96 157.08 16.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.056 -1.028 . . . . 0.0 110.158 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.591 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 2.6 tmtt? -137.11 154.71 50.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 110.978 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 13.3 tttt -160.33 158.9 30.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.627 -0.671 . . . . 0.0 109.603 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.573 HG22 ' CD1' ' A' ' 56' ' ' TYR . 21.4 m -159.48 151.05 20.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.561 ' N ' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 76' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 121.976 0.764 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 45' ' ' THR . 2.4 m-85 -116.95 173.48 6.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 122.133 -0.628 . . . . 0.0 109.898 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER 178.72 130.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.499 -0.751 . . . . 0.0 109.206 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 73' ' ' ILE . 3.4 p90 -150.6 171.73 16.65 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.1 -1.44 . . . . 0.0 113.606 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.526 ' CG ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -124.34 112.35 16.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.544 ' CD2' ' HE3' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -104.36 68.28 0.87 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 109.67 -178.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -69.81 109.7 4.56 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.547 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 34.8 m -159.41 -162.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.574 0.702 . . . . 0.0 109.634 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.624 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -137.94 124.6 20.96 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -122.86 -127.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.477 -0.765 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 t -84.57 -52.56 6.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.019 -1.051 . . . . 0.0 109.389 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -128.65 30.23 5.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.359 -0.838 . . . . 0.0 109.256 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -125.46 80.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.703 0.763 . . . . 0.0 110.046 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.581 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 6.3 mp -90.07 59.66 4.58 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 p90 176.98 -142.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.407 -0.808 . . . . 0.0 109.581 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 4.8 ttm180 -113.26 140.77 47.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.531 -1.356 . . . . 0.0 112.236 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' CB ' HD21 ' A' ' 60' ' ' LEU . . . -99.44 103.45 15.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' HB3' ' N ' ' A' ' 86' ' ' ARG . 9.9 t70 -77.24 157.58 30.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.769 -1.207 . . . . 0.0 109.927 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -162.62 101.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.672 0.748 . . . . 0.0 109.156 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -113.37 134.96 54.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ASP . 18.4 mt-10 -157.9 136.53 11.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.936 -1.102 . . . . 0.0 111.28 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.555 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.227 -0.92 . . . . 0.0 109.826 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -170.47 160.43 7.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 0.0 109.514 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.559 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -156.02 175.21 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.04 -1.038 . . . . 0.0 110.399 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.539 ' N ' ' HB3' ' A' ' 72' ' ' ASP . 6.0 mtt180 -157.5 131.67 8.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.0 110.704 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 84.2 m-85 -107.98 64.92 0.63 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -152.63 -158.76 0.93 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.998 -1.064 . . . . 0.0 111.148 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.17 52.82 29.53 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 104.876 -3.29 . . . . 0.0 104.876 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -65.64 -171.78 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.728 1.909 . . . . 0.0 112.585 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.139 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.336 0.588 . . . . 2.8300000000000001 110.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 23.5 p90 -79.99 167.96 19.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 4.4800000000000004 110.225 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.86 119.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 2.7200000000000002 110.167 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.523 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 1.2 pt -80.35 -176.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.219 -0.926 . . . . 1.9399999999999999 110.396 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.21 -164.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.287 -0.883 . . . . 2.9500000000000002 109.881 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 42.2 t0 -144.35 61.77 1.34 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 3.5 111.592 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 14.0 tt 40.53 45.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.002 0.906 . . . . 2.2599999999999998 109.953 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 12' ' ' THR . . . -138.41 -65.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 120.138 -1.03 . . . . 1.04 111.434 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 43.6 Cg_endo -82.17 -72.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.596 1.314 . . . . 1.05 111.416 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.609 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 1.9 m-30 -44.5 -32.05 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 109.583 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.533 HG21 ' CD1' ' A' ' 38' ' ' ILE . 25.0 p -57.59 -57.69 11.59 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.52 -1.289 . . . . 1.4399999999999999 107.52 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -72.99 -17.67 61.43 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.749 0.785 . . . . 2.77 109.455 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.523 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 2.7 t-20 -79.4 -58.65 3.1 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.643 0.735 . . . . 2.1000000000000001 109.371 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 19' ' ' ALA . 2.6 tp -42.04 -56.13 2.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.212 -0.662 . . . . 2.6000000000000001 109.212 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -49.53 -57.48 9.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.67000000000000004 109.535 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -68.75 -77.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.129 . . . . 2.9500000000000002 110.665 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 3.3 m-85 -37.77 -72.57 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.418 0.628 . . . . 2.8500000000000001 111.221 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -41.42 -69.23 0.14 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 1.1699999999999999 110.342 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 55.4 t -42.34 -27.95 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 2.04 110.356 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' LYS . 2.2 m-20 -93.49 -62.54 1.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.233 -0.917 . . . . 1.9099999999999999 110.353 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 2.0 mt-10 -61.96 -31.57 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.008 -1.057 . . . . 2.1699999999999999 109.81 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -75.42 -59.59 2.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.181 -1.044 . . . . 1.6399999999999999 108.181 178.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 36.8 t-20 -53.25 -46.56 69.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.223 -1.399 . . . . 2.27 107.223 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 13.7 tttt -58.2 -48.56 79.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.867 -1.16 . . . . 3.3300000000000001 107.867 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.586 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -48.46 -26.54 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.527 -0.916 . . . . 2.2799999999999998 108.527 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 27.89 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.223 -1.551 . . . . 1.01 109.223 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 24.8 tp60 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.431 -1.041 . . . . 2.73 109.671 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.324 0.583 . . . . 3.0699999999999998 109.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -144.9 50.65 1.25 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.345 -0.847 . . . . 1.27 109.769 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.522 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 9.6 t80 -179.88 74.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 4.2999999999999998 110.279 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.32 -45.86 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 2.9100000000000001 110.561 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -69.24 -94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 3.96 111.002 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 23.1 t -158.55 172.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.694 -1.254 . . . . 1.6399999999999999 111.622 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.542 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -134.39 85.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.675 -0.641 . . . . 2.29 109.361 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -103.25 -54.22 0.12 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 3.6299999999999999 110.817 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.9 Cg_endo -83.5 52.15 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.335 1.177 . . . . 0.60999999999999999 110.324 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' A' ' 6' ' ' ILE . 21.2 p -104.03 113.1 26.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.835 . . . . 2.0800000000000001 110.408 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.523 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 8.3 mtm -113.91 176.97 4.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.846 . . . . 2.6499999999999999 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.23 159.32 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.027 . . . . 2.1400000000000001 110.985 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -154.17 128.59 9.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.503 -0.748 . . . . 2.9500000000000002 109.93 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.0 m -118.57 148.84 42.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 1.26 110.084 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.527 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.404 -0.962 . . . . 2.4700000000000002 108.404 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.527 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 110.625 -0.99 . . . . 0.80000000000000004 110.625 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' GLU . 36.6 t80 -156.84 92.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -1.057 . . . . 4.21 110.418 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.7 pt-20 -126.47 171.83 10.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 2.6299999999999999 108.85 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 1.7 p90 -163.05 166.02 24.11 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 117.876 -1.53 . . . . 2.4199999999999999 113.419 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 70' ' ' ARG . 92.6 mt-30 -119.82 107.53 13.27 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.742 -1.207 . . . . 2.1699999999999999 107.742 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.568 HD11 ' CD2' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -105.77 73.72 1.02 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.289 -0.882 . . . . 1.3700000000000001 109.14 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -69.61 112.34 6.03 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.031 -1.1 . . . . 2.4300000000000002 108.031 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' CG1' ' A' ' 38' ' ' ILE . 22.7 m -157.84 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.769 0.795 . . . . 1.1200000000000001 109.496 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.631 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.5 t80 -149.19 129.47 13.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 1.8400000000000001 109.272 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HB2' ' N ' ' A' ' 34' ' ' PHE . . . -123.53 -118.09 0.29 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 1.29 109.685 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -102.15 -25.21 13.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.754 -1.216 . . . . 1.75 108.804 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.8 16.19 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 1.99 109.603 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -113.93 78.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 2.02 110.338 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.631 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 10.9 mt -86.16 63.19 7.88 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.501 -0.926 . . . . 2.2999999999999998 108.501 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 176.06 -122.69 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.539 -0.864 . . . . 2.3100000000000001 109.912 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.522 ' CZ ' ' HG2' ' A' ' 59' ' ' GLN . 5.9 tmm_? -133.73 144.61 49.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.166 -1.583 . . . . 2.3999999999999999 112.416 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -92.08 92.33 8.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.241 -1.763 . . . . 1.1499999999999999 106.241 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 4.7 t0 -80.99 82.96 6.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.011 . . . . 1.73 110.741 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.628 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -76.19 138.92 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.692 -0.803 . . . . 1.75 109.577 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -131.54 121.65 24.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 1.5900000000000001 109.518 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 83' ' ' LYS . 1.1 mt-10 -151.81 119.16 5.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.937 -1.102 . . . . 2.2999999999999998 110.477 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.462 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.2 t0 . . . . . 0 C--N 1.303 -1.416 0 O-C-N 121.17 -0.956 . . . . 2.2599999999999998 109.895 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 75' ' ' GLU . 10.8 mtpt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.325 -0.62 . . . . 3.9300000000000002 109.325 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD1' HD12 ' A' ' 26' ' ' ILE . 9.0 tp -170.1 179.12 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 2.9500000000000002 110.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.586 ' CD2' ' CG1' ' A' ' 26' ' ' ILE . 1.2 pt? -153.68 -179.19 7.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 1.8 110.509 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.538 ' C ' ' CD2' ' A' ' 87' ' ' PHE . 3.0 mtt180 -134.66 -177.06 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 3.1899999999999999 110.49 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.586 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 69.4 m-85 -154.17 62.6 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.055 -0.72 . . . . 0.97999999999999998 109.055 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 3.0 m-80 -152.37 -157.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 2.48 111.488 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 66.71 52.59 33.01 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 104.855 -3.298 . . . . 1.4199999999999999 104.855 -176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.0 Cg_endo -67.77 -171.17 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 124.499 1.789 . . . . 2.1499999999999999 111.899 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.524 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 31.6 m . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 117.945 -1.026 . . . . 2.29 110.4 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.267 0.555 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 42.2 p-90 -150.58 142.32 23.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.156 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 21.2 mt-10 -158.36 -176.99 6.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.42 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.568 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -133.38 168.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -148.66 -170.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.7 OUTLIER 174.5 143.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.03 -1.044 . . . . 0.0 111.319 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CA ' HG23 ' A' ' 12' ' ' THR . 2.7 tp 43.06 25.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.317 0.58 . . . . 0.0 110.636 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.528 ' N ' HG22 ' A' ' 12' ' ' THR . . . -127.75 -103.21 1.19 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.311 -1.423 . . . . 0.0 112.421 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.533 ' CG ' HG22 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -81.66 -64.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.844 1.696 . . . . 0.0 111.984 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.711 ' CD1' ' CZ ' ' A' ' 58' ' ' TYR . 2.2 m-85 -42.91 -25.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.578 HG23 ' CA ' ' A' ' 8' ' ' ILE . 2.6 p -69.59 -62.08 1.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.573 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.8 tt0 -66.64 -18.0 65.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 109.357 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 15' ' ' LEU . 1.7 m-80 -79.21 -60.83 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.664 -0.647 . . . . 0.0 110.053 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -39.91 -50.66 2.48 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.425 0.631 . . . . 0.0 109.39 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -53.32 -57.31 15.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' PHE . 6.0 tttp -69.36 -69.25 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -1.175 . . . . 0.0 110.62 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-30 -38.72 -63.33 0.52 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.996 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -44.19 -72.79 0.05 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.589 -0.694 . . . . 0.0 110.273 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 11.0 t -40.74 -26.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 0.0 110.616 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.5 m-20 -92.19 -70.92 0.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.943 -1.098 . . . . 0.0 109.783 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 73' ' ' ILE . 8.9 mm-40 -56.42 -34.61 66.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.911 -1.118 . . . . 0.0 109.52 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.2 tt0 -67.17 -56.63 9.1 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.9 m120 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.914 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -55.35 -51.07 67.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.489 -0.757 . . . . 0.0 109.757 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -62.91 -16.57 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.469 -0.77 . . . . 0.0 110.021 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 115.26 50.89 0.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.32 -1.106 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.813 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -112.83 52.88 0.77 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.262 -0.899 . . . . 0.0 110.094 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.64 98.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 12.1 t-20 -134.2 -64.83 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.935 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -70.41 -106.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 111.237 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 11.0 t -158.85 173.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.485 -1.384 . . . . 0.0 111.829 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.563 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -120.9 132.53 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.596 0.712 . . . . 0.0 110.259 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.613 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -136.63 -61.54 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.536 -0.727 . . . . 0.0 109.709 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.0 Cg_endo -81.48 46.16 2.17 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.062 1.033 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 22.9 p -80.34 80.18 6.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.078 -1.014 . . . . 0.0 109.098 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.485 ' O ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -83.18 138.13 33.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.131 -0.981 . . . . 0.0 111.066 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.38 157.61 17.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.801 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 4.5 mttt -160.09 103.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -0.78 . . . . 0.0 109.214 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.549 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.4 m -124.27 153.89 41.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.866 -1.146 . . . . 0.0 111.213 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.549 ' N ' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 76' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -150.35 86.74 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.267 -1.137 . . . . 0.0 111.153 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 7.1 pt-20 -95.16 149.27 21.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CZ ' ' CD1' ' A' ' 11' ' ' PHE . 2.3 t80 -144.97 139.64 27.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.914 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 28.2 mt-30 -99.19 107.03 19.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.674 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 25.0 tp -98.92 62.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.591 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 1.4 t80 -71.9 104.86 3.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.779 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 33.6 m -161.64 -165.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.7 t80 -131.26 134.6 46.57 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.248 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 35' ' ' ASN . . . -130.68 -132.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.331 -0.856 . . . . 0.0 109.977 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.0 -29.73 13.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.595 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -136.18 3.88 2.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.427 -0.796 . . . . 0.0 110.12 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.539 ' O ' ' CD ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -113.19 100.7 8.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 63' ' ' TYR . 6.8 mp -100.88 59.31 0.92 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.366 -0.834 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.24 -115.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.012 . . . . 0.0 110.156 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 38.9 ttp85 -124.35 157.83 34.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.332 -1.48 . . . . 0.0 112.807 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -118.37 91.88 3.68 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 30.5 t0 -69.15 81.27 0.34 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 110.906 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.549 ' CD1' ' HG3' ' A' ' 22' ' ' GLU . 2.6 mm -68.38 114.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.394 -0.817 . . . . 0.0 108.903 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.478 ' C ' ' CG ' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -118.36 118.17 31.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.372 -0.83 . . . . 0.0 110.675 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' CG ' ' C ' ' A' ' 74' ' ' SER . 40.3 mt-10 -153.38 120.19 5.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.031 -1.043 . . . . 0.0 110.794 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.153 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 83' ' ' LYS . 7.4 tp -169.97 -174.13 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 110.221 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.652 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -165.43 179.1 6.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 110.645 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mtt85 -142.84 128.65 19.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.652 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 4.5 m-85 -104.77 85.13 2.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -153.59 -156.98 0.74 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.734 -1.229 . . . . 0.0 110.784 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.05 51.49 6.88 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.1 Cg_endo -66.49 138.64 50.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.459 1.768 . . . . 0.0 111.203 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.323 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.289 0.566 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.55 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -132.37 178.16 7.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 43' ' ' LYS . 1.1 tt0 176.99 119.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.767 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 16.4 pt -75.59 178.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.248 -0.908 . . . . 0.0 110.829 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.57 ' HB ' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -92.84 -164.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.328 -0.857 . . . . 0.0 110.712 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.55 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 39.6 t0 -156.75 46.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.797 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 17.9 tt 40.27 37.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.656 0.741 . . . . 0.0 109.83 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 12' ' ' THR . . . -143.52 -65.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.207 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' THR . 46.1 Cg_endo -78.7 -79.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.665 1.35 . . . . 0.0 111.427 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.598 ' CE1' ' HB2' ' A' ' 43' ' ' LYS . 97.1 m-85 -40.19 -29.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' N ' ' A' ' 9' ' ' GLY . 16.9 p -61.15 -59.11 5.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -67.35 -12.36 59.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 16.4 m120 -84.61 -69.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 4.0 pp -42.04 -28.22 0.17 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.695 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' ASN . . . -74.66 -46.15 19.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -80.87 -41.89 22.39 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.201 -1.176 . . . . 0.0 110.253 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -35.85 82.46 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.595 0.712 . . . . 0.0 109.916 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -65.87 -71.79 0.18 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 21' ' ' ASP . 7.5 p -34.52 -33.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.775 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 19' ' ' ALA . 87.1 m-20 -93.15 -73.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 6.9 mm-40 -57.2 -23.42 47.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.107 . . . . 0.0 110.206 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.581 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 1.4 tt0 -80.93 -63.36 1.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 49.1 m-20 -52.23 -46.89 65.9 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -55.35 -50.67 69.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.553 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -50.18 -24.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.7 0.762 . . . . 0.0 109.05 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.04 36.12 1.06 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.503 -0.998 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.235 0.541 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.6 57.81 0.77 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.534 ' CA ' ' HB3' ' A' ' 64' ' ' ALA . 2.4 t80 -158.5 109.69 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -152.02 -70.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.923 . . . . 0.0 111.281 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -69.47 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.926 -1.109 . . . . 0.0 111.265 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' HG21 ' A' ' 62' ' ' VAL . 4.6 t -160.57 156.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.443 -1.411 . . . . 0.0 112.273 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.535 ' CD1' HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -106.12 140.74 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.713 0.768 . . . . 0.0 109.546 178.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.566 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.47 -61.92 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.679 -0.638 . . . . 0.0 110.09 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 52.1 Cg_endo -77.91 39.95 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.307 1.161 . . . . 0.0 111.687 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.522 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 85.3 m -93.49 148.45 22.07 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.938 -1.101 . . . . 0.0 109.945 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.494 ' O ' ' O ' ' A' ' 59' ' ' GLN . 5.2 mtm -138.48 161.93 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.028 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 2.7 tmtt? -152.03 131.72 13.16 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.955 -1.091 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -148.81 130.54 15.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.884 . . . . 0.0 110.348 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.579 HG21 ' N ' ' A' ' 46' ' ' ILE . 1.5 m -108.21 154.09 22.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.977 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.579 ' N ' HG21 ' A' ' 45' ' ' THR . 12.9 pt . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.483 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.57 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.3 t80 -160.85 107.73 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.786 -0.832 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' LYS . 6.9 pt-20 -117.74 142.84 46.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.233 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.646 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -144.35 170.64 15.62 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.027 -1.469 . . . . 0.0 113.425 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HB2' ' NE ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -135.11 128.72 32.69 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.646 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -128.8 85.61 2.35 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 109.104 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 1.8 t80 -77.52 108.94 11.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' VAL . 1.3 p -153.46 173.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.0 t80 -128.57 127.23 41.91 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.765 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -127.67 -126.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.856 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.588 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -96.96 -40.21 9.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.45 31.94 4.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 109.861 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' CE ' HG12 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -143.85 92.23 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.753 0.787 . . . . 0.0 109.357 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 1.6 mp -100.58 63.58 1.09 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.715 -0.616 . . . . 0.0 110.761 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 168.86 -109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.034 -1.041 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 1.4 ttp-105 -130.4 141.52 50.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.906 -1.121 . . . . 0.0 112.779 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.625 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.26 113.41 26.79 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 3.1 t70 -93.35 168.69 10.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.076 . . . . 0.0 111.34 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.639 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 4.3 tp -158.99 116.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.473 ' C ' ' CG ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -126.69 131.51 51.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.92 -1.113 . . . . 0.0 109.814 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 16.1 mt-10 -149.82 132.05 15.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.93 -1.106 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.168 -0.958 . . . . 0.0 110.079 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 21.0 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -170.73 151.29 3.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 110.832 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.568 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -136.1 175.93 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.42 -0.8 . . . . 0.0 109.506 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.5 mtm180 -147.79 178.75 8.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.042 -1.036 . . . . 0.0 110.949 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 1.9 m-85 -155.63 84.26 1.04 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -153.42 -154.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 62.34 53.39 42.39 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.8 Cg_endo -64.43 154.78 69.75 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.582 1.833 . . . . 0.0 111.549 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.188 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.27 0.557 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.469 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 28.1 p90 -107.65 155.37 20.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.888 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.525 ' HG2' ' CD ' ' A' ' 43' ' ' LYS . 12.3 pt-20 -177.34 137.76 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 42' ' ' MET . 4.9 pt -89.3 -178.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.597 HG13 ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -125.73 -147.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.18 -0.95 . . . . 0.0 109.656 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -134.79 -152.12 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.76 -1.213 . . . . 0.0 110.295 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.0 tt -104.35 39.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 12' ' ' THR . . . -144.69 -63.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.272 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 41.9 Cg_endo -68.72 -93.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.293 1.154 . . . . 0.0 112.498 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.597 ' CG ' HG13 ' A' ' 6' ' ' ILE . 2.7 m-85 -43.33 -26.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 0.0 111.013 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.553 ' CB ' HG23 ' A' ' 38' ' ' ILE . 22.4 p -54.41 -56.34 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.825 -1.172 . . . . 0.0 108.391 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' A' ' 12' ' ' THR . 7.4 tt0 -58.24 -22.43 52.17 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.762 0.791 . . . . 0.0 109.233 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 5.4 t-20 -72.26 -56.81 4.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.538 0.685 . . . . 0.0 109.801 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -42.32 -56.09 3.1 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.588 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -51.41 -38.38 41.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -79.81 -80.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -1.056 . . . . 0.0 110.676 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CD2' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -37.59 -36.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.283 0.563 . . . . 0.0 111.004 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -66.71 -69.6 0.3 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.393 -0.817 . . . . 0.0 109.738 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 19' ' ' ALA . 9.5 t -39.35 -27.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 110.198 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 19' ' ' ALA . 5.6 m-20 -93.32 -69.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 110.122 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.567 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 6.3 mp0 -57.27 -32.51 66.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.502 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -69.68 -59.88 2.67 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.8 m120 -55.94 -44.71 78.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -52.8 63.02 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.453 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -54.51 -22.48 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.489 -0.757 . . . . 0.0 109.711 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 120.43 19.83 3.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 50.9 mm-40 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.946 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.233 0.54 . . . . 0.0 110.055 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -147.3 53.58 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 110.065 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.522 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 22.5 t80 -175.64 97.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 12.2 t-20 -129.68 -52.55 1.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -69.72 -99.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 111.183 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.3 t -161.46 173.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.558 -1.339 . . . . 0.0 111.825 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.573 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -126.92 121.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.437 0.637 . . . . 0.0 109.576 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.594 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -129.36 -58.27 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.467 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.2 Cg_endo -84.91 45.68 1.7 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.178 1.094 . . . . 0.0 110.965 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.5 ' HB3' HG12 ' A' ' 38' ' ' ILE . 24.0 p -80.06 88.6 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 109.496 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.462 ' HA ' HG21 ' A' ' 5' ' ' ILE . 17.0 mtm -88.93 135.38 33.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.426 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CD ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.428 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' GLU . 19.5 mttt -142.97 121.09 12.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.592 HG21 ' N ' ' A' ' 46' ' ' ILE . 5.7 m -125.87 150.12 48.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.592 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' O ' ' CG2' ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -159.45 88.39 0.86 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.967 . . . . 0.0 110.565 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' LYS . 12.6 pt-20 -87.99 155.45 19.82 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 2.6 t80 -142.24 124.98 15.93 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.493 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.49 ' HA ' ' CD ' ' A' ' 70' ' ' ARG . 10.7 mt-30 -96.78 96.22 8.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 7.8 tp -97.04 69.32 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 108.978 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -72.96 110.45 7.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.096 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 22.9 m -160.96 -163.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.589 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.0 t80 -140.72 130.05 23.75 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.85 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . . . -125.44 -116.31 0.28 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.409 -0.807 . . . . 0.0 109.945 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -46.32 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.25 -1.42 5.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 110.021 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' CE ' HG22 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -94.53 92.32 7.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.781 . . . . 0.0 109.734 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.589 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 10.1 mt -96.35 61.92 2.05 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.657 ' N ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 167.59 -113.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.019 . . . . 0.0 110.473 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.25 149.61 52.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.43 -1.419 . . . . 0.0 113.626 -178.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -101.89 92.66 4.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -70.78 79.84 0.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.903 . . . . 0.0 110.64 -177.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.515 ' CD1' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -68.59 107.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.54 0.686 . . . . 0.0 109.571 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -103.18 114.86 29.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.472 -0.768 . . . . 0.0 110.31 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 74' ' ' SER . 11.3 mt-10 -145.94 112.04 5.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.072 -1.018 . . . . 0.0 110.748 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.8 m-20 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.997 . . . . 0.0 109.513 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HA ' ' CG ' ' A' ' 75' ' ' GLU . 16.1 mtmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.8 tp -169.88 -172.07 1.3 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.152 -0.968 . . . . 0.0 109.979 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -150.94 -179.72 7.53 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 72' ' ' ASP . 21.1 mtm180 -146.01 126.78 14.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.127 . . . . 0.0 111.55 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 2.6 m-85 -104.77 89.6 3.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.419 -0.801 . . . . 0.0 108.933 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.587 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.44 -143.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.52 -1.362 . . . . 0.0 111.268 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 51.37 50.33 41.46 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.2 Cg_endo -68.91 158.02 59.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.332 1.701 . . . . 0.0 111.111 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.339 -179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.227 0.537 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -133.41 169.11 17.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.464 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 6.5 tp10 -168.28 116.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 20.9 pt -110.14 144.15 18.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.988 -1.07 . . . . 0.0 111.512 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.38 -175.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 172.74 34.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.655 -1.278 . . . . 0.0 112.145 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 7' ' ' ASP . 6.7 tp 177.92 18.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.502 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.47 -64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.524 -1.798 . . . . 0.0 111.906 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.517 ' HG3' ' CG2' ' A' ' 6' ' ' ILE . 46.3 Cg_endo -74.66 -86.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.69 1.363 . . . . 0.0 112.199 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 43' ' ' LYS . 3.9 m-85 -45.78 -22.43 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.555 HG21 ' CD1' ' A' ' 38' ' ' ILE . 27.6 p -66.14 -59.89 3.33 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.972 -1.08 . . . . 0.0 109.177 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.484 ' N ' ' OG1' ' A' ' 12' ' ' THR . 29.1 tt0 -72.15 -19.89 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.495 0.664 . . . . 0.0 109.924 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 8.2 m120 -79.25 -51.38 9.53 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.0 109.294 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 16' ' ' GLY . 1.6 tt -44.98 -55.55 5.41 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.4 0.619 . . . . 0.0 109.521 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -52.31 -55.37 22.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' PHE . 4.3 mttm -69.89 -79.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -1.124 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -33.03 -66.64 0.14 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.451 0.643 . . . . 0.0 111.232 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -42.35 -70.28 0.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.601 -0.687 . . . . 0.0 109.849 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 24.8 t -43.62 -25.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.214 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 19' ' ' ALA . 7.6 t0 -91.18 -69.48 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.23 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.553 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 77.4 mm-40 -59.55 -34.86 73.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.767 -1.208 . . . . 0.0 109.345 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.57 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -66.6 -54.75 20.04 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 109.017 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.5 m120 -64.7 -43.7 92.64 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.041 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.1 tttm -57.65 -46.0 84.78 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 5.6 tp -64.26 -17.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.466 -0.771 . . . . 0.0 110.016 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.45 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 112.98 37.47 1.37 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB3' ' OE2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.134 . . . . 0.0 110.066 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.55 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.275 0.559 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.7 55.5 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 110.458 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 5.5 p90 -177.33 119.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.103 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.414 ' HB3' ' C ' ' A' ' 64' ' ' ALA . 45.6 t30 -157.37 -56.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.818 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -69.29 -97.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 9.7 t -160.14 172.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.659 -1.276 . . . . 0.0 111.476 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.566 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -127.17 121.1 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.687 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.545 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.5 ttm180 -130.91 -57.37 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 110.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.9 Cg_endo -86.5 45.19 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.07 1.037 . . . . 0.0 110.965 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.514 ' SG ' ' CD1' ' A' ' 38' ' ' ILE . 22.1 p -85.11 79.27 9.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.487 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.521 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 2.8 mtp -82.47 163.0 21.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.171 -0.956 . . . . 0.0 110.685 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 3.4 ttpp -138.51 140.86 39.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.211 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 57' ' ' GLU . 6.0 ttmm -142.75 128.79 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.605 HG21 ' O ' ' A' ' 55' ' ' GLY . 1.4 m -114.44 160.26 19.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 110.213 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.54 ' N ' HG21 ' A' ' 45' ' ' THR . 1.3 tt . . . . . 0 C--N 1.306 -1.283 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.605 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 1.2 t80 -161.25 91.44 0.86 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.842 -0.799 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.3 mt-10 -123.87 -179.44 4.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.646 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -164.08 167.01 20.81 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.557 -1.257 . . . . 0.0 112.943 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 49.6 mt-30 -120.72 107.89 13.32 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' A' ' 58' ' ' TYR . 1.3 tp -98.6 71.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.027 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -72.78 111.48 7.96 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.628 0.728 . . . . 0.0 109.082 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.579 ' CG2' ' CE ' ' A' ' 67' ' ' LYS . 17.2 m -160.1 -163.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.2 t80 -138.85 126.88 22.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.714 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HB2' ' CA ' ' A' ' 34' ' ' PHE . . . -122.58 -130.41 0.27 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.461 -0.774 . . . . 0.0 109.886 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.55 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.87 -18.51 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 25.4 t70 -151.02 38.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.579 ' CE ' ' CG2' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -150.31 88.69 1.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.553 0.692 . . . . 0.0 109.514 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 7.7 mt -92.44 60.04 3.51 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.618 -0.676 . . . . 0.0 109.596 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 170.45 -122.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.188 -0.945 . . . . 0.0 109.851 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 2.6 tmm_? -122.53 147.88 45.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.21 -1.556 . . . . 0.0 113.246 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -102.05 98.09 8.33 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -68.78 152.37 45.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 110.133 -177.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.646 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.77 127.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.555 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 34.2 t -129.98 155.34 46.26 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.222 -0.923 . . . . 0.0 109.24 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 76' ' ' ASP . 3.5 mp0 -156.33 116.79 3.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.607 -1.308 . . . . 0.0 112.46 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 75' ' ' GLU . 2.7 p30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.412 0.625 . . . . 0.0 111.643 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 ' CD1' HD12 ' A' ' 26' ' ' ILE . 9.8 tp -171.22 179.51 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 0.0 109.864 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -170.03 167.5 8.9 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.035 -1.041 . . . . 0.0 110.455 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.566 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 1.1 mtt180 -143.44 -174.86 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.58 ' CE2' HD13 ' A' ' 85' ' ' LEU . 10.7 m-85 -155.01 83.52 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.584 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -168.68 -164.06 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.503 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 86.82 54.83 2.54 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 39.5 Cg_endo -63.21 144.68 92.37 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 124.407 1.741 . . . . 0.0 111.472 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.465 HG13 ' OH ' ' A' ' 61' ' ' TYR . 4.7 m . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.309 0.576 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 m-90 -83.28 -176.81 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 5' ' ' ILE . 20.7 tp10 174.31 163.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -139.29 173.43 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.931 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.581 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 1.2 pp -136.82 -159.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 6' ' ' ILE . 1.7 t70 -113.21 -143.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 109.617 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.519 ' HA ' HG23 ' A' ' 12' ' ' THR . 0.8 OUTLIER -108.38 38.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 12' ' ' THR . . . -129.91 -56.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.702 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.5 Cg_endo -75.7 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 122.963 0.98 . . . . 0.0 111.853 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.7 ' CE1' ' CD2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -40.4 -34.96 0.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.136 -0.978 . . . . 0.0 110.447 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.534 ' CG2' ' CD1' ' A' ' 38' ' ' ILE . 44.5 p -50.19 -54.22 22.38 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.4 OUTLIER -63.78 -25.98 68.43 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.751 0.786 . . . . 0.0 109.36 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 11.6 m120 -72.26 -52.4 16.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 0.0 109.86 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -42.9 -58.4 2.41 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.257 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.593 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -45.72 -45.97 13.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -83.52 -80.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.053 . . . . 0.0 111.154 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 2.5 m-85 -35.69 -29.58 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 111.592 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -84.02 -72.49 0.46 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 24.3 t -43.64 -26.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 109.833 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -86.64 -62.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.667 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' HB2' HD12 ' A' ' 85' ' ' LEU . 25.3 mm-40 -62.12 -43.21 99.32 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.464 -1.294 . . . . 0.0 108.998 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.616 ' N ' HD12 ' A' ' 85' ' ' LEU . 55.4 mt-10 -58.83 -51.86 68.2 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 108.877 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.0 t-20 -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.383 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -57.66 -42.11 82.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.966 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.529 HG21 ' O ' ' A' ' 23' ' ' GLU . 4.2 tp -69.57 -16.48 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.393 -0.817 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.07 52.72 0.26 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.434 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.297 -1.12 . . . . 0.0 109.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.227 0.537 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.527 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -130.04 52.5 2.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.751 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.527 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 38.9 t80 -163.85 112.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.415 -0.803 . . . . 0.0 110.015 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.4 -55.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.546 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.571 ' HD2' ' CG ' ' A' ' 63' ' ' TYR . 17.6 mttt -69.46 -103.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 111.049 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 9.2 t -159.59 172.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.755 -1.216 . . . . 0.0 111.536 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.57 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -128.65 129.12 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.615 -0.678 . . . . 0.0 109.846 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.593 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -132.1 -58.13 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.375 -0.828 . . . . 0.0 110.057 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 44.9 Cg_endo -87.44 46.42 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.174 1.091 . . . . 0.0 110.81 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 22.6 p -87.46 111.61 21.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.462 ' HB3' ' CE ' ' A' ' 44' ' ' LYS . 27.1 mtm -109.66 179.81 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.703 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CE ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -152.54 142.38 22.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 110.107 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HE3' ' N ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -137.96 105.69 5.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.772 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.604 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.9 m -124.17 154.19 40.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.604 ' N ' HG21 ' A' ' 45' ' ' THR . 25.8 pt . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.577 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' GLU . 86.5 t80 -152.29 90.83 1.54 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.259 -1.142 . . . . 0.0 110.809 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.9 tt0 -112.08 159.61 18.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CD2' ' CE1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.35 169.16 25.22 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 117.859 -1.536 . . . . 0.0 113.45 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 13.3 mt-30 -137.93 120.97 16.67 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -121.98 83.85 2.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 109.436 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -75.18 110.32 9.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 35.6 m -160.33 -161.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.462 -0.774 . . . . 0.0 109.697 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.638 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.0 t80 -135.09 135.2 41.04 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.506 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . . . -133.15 -127.74 0.18 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -40.01 9.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.992 . . . . 0.0 108.982 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.453 ' OD1' HG21 ' A' ' 33' ' ' THR . 2.5 p30 -127.67 -2.39 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' NZ ' HD22 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -104.5 88.87 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.638 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -100.25 60.9 1.05 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 108.788 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 88' ' ' ASN . 0.3 OUTLIER 172.3 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 7.3 ttp180 -152.94 156.27 38.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.972 -1.705 . . . . 0.0 112.643 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.618 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -119.2 115.52 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' OD1' ' NH1' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -93.07 166.34 12.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.992 -1.067 . . . . 0.0 110.235 -178.064 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.583 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.69 114.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.618 -0.676 . . . . 0.0 109.179 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -109.84 144.57 38.11 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.3 mt-10 -167.72 104.17 0.5 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.694 -1.254 . . . . 0.0 111.726 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 16.1 p-10 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.657 0.741 . . . . 0.0 112.149 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 6.8 mttt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -170.86 -169.56 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.528 -1.357 . . . . 0.0 111.75 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -170.37 175.95 4.63 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.52 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 13.0 mtt180 -150.35 152.15 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.614 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 13.4 m-85 -103.69 97.39 7.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 1.5 t-20 -66.79 125.86 27.19 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . -8.09 99.35 0.01 OUTLIER Glycine 0 N--CA 1.503 3.108 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.448 ' C ' ' HB2' ' A' ' 68' ' ' LEU . 47.3 Cg_endo -74.95 79.07 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.553 . . . . 0.0 109.941 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.541 ' N ' ' HB2' ' A' ' 68' ' ' LEU . 2.1 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.239 -0.913 . . . . 0.0 110.336 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.284 0.564 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 4.8 p90 -115.77 177.81 4.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.51 121.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.206 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 18.4 pt -85.17 170.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.075 -1.016 . . . . 0.0 110.499 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.603 ' CG2' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -89.4 -166.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.256 -0.902 . . . . 0.0 110.509 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.56 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 4.3 m-20 -137.16 49.56 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.141 -0.975 . . . . 0.0 110.705 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 5.1 tt 39.9 46.01 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.963 0.887 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG22 ' A' ' 12' ' ' THR . . . -156.1 -62.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.346 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.1 Cg_endo -72.7 -84.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 0.0 111.535 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.603 ' CD2' ' CG2' ' A' ' 6' ' ' ILE . 6.3 m-85 -41.42 -29.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.243 -0.911 . . . . 0.0 110.568 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.54 ' HA ' HG22 ' A' ' 38' ' ' ILE . 11.4 p -55.33 -58.0 9.52 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.535 ' N ' ' OG1' ' A' ' 12' ' ' THR . 9.6 mt-30 -68.19 -17.7 64.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.694 0.759 . . . . 0.0 109.394 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 17' ' ' LYS . 7.2 t-20 -80.82 -57.28 3.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.55 0.69 . . . . 0.0 109.352 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -39.14 -46.49 1.45 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.562 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -65.24 -40.45 96.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -77.44 -69.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -1.054 . . . . 0.0 110.241 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 1.7 m-30 -40.86 -47.3 2.91 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.686 0.755 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -57.69 -77.56 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.526 -0.734 . . . . 0.0 110.01 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 21' ' ' ASP . 7.0 p -38.33 -27.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.0 110.967 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.11 -77.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.915 -1.115 . . . . 0.0 110.213 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.1 mm-40 -56.06 -36.31 67.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.671 -1.268 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 30.6 tt0 -64.77 -52.37 57.28 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 18.8 t-20 -66.64 -44.19 82.62 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.015 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.8 ttmt -59.72 -41.72 91.46 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.127 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 5.4 tp -69.39 -17.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.389 -0.819 . . . . 0.0 110.194 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . 115.58 52.13 0.4 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.524 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 36.5 mm-40 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.122 . . . . 0.0 109.736 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.29 0.567 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -129.98 52.71 1.98 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 6.3 p90 -172.7 62.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 -26.16 11.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.102 -0.999 . . . . 0.0 111.218 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.587 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -96.39 -89.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 10.0 t -160.29 172.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.482 -1.386 . . . . 0.0 111.342 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.556 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -135.6 82.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.573 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.569 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -102.04 -58.02 0.1 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.026 -1.046 . . . . 0.0 111.494 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' O ' ' HB3' ' A' ' 61' ' ' TYR . 39.3 Cg_endo -79.19 48.04 2.7 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.292 1.154 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 6' ' ' ILE . 20.8 p -104.74 121.62 43.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.799 -1.188 . . . . 0.0 109.789 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLN . 2.3 mpt? -117.65 157.66 26.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.111 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.53 129.8 46.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 110.215 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 57' ' ' GLU . 15.0 mttm -130.93 125.43 33.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.697 HG21 ' O ' ' A' ' 55' ' ' GLY . 21.1 m -125.1 164.65 19.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.984 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.697 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.542 ' CD2' ' OG1' ' A' ' 45' ' ' THR . 13.7 t80 -162.2 109.51 1.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.902 -0.764 . . . . 0.0 110.617 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -126.04 177.85 6.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.351 -0.843 . . . . 0.0 108.831 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.653 ' CD1' ' CG2' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -165.38 175.18 9.34 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.168 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.521 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.8 tt0 -127.69 125.06 39.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.625 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 21.1 tp -119.52 67.62 0.81 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.726 -1.234 . . . . 0.0 109.842 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.574 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 2.5 t80 -69.5 108.78 3.93 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 34.9 m -160.42 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 68' ' ' LEU . 1.4 t80 -154.2 117.34 4.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.971 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' CB ' ' NZ ' ' A' ' 67' ' ' LYS . . . -104.46 -102.62 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.559 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.512 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 22.9 t -120.03 -26.74 5.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.75 5.62 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.959 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.571 ' NZ ' ' CB ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -109.07 86.35 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 110.109 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.642 ' CD1' ' CE1' ' A' ' 63' ' ' TYR . 1.2 tp -88.78 61.96 6.21 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.717 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.0 OUTLIER 169.73 -113.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.0 110.213 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 17.5 ttm180 -127.0 146.21 50.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.557 -1.34 . . . . 0.0 112.963 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -106.59 102.42 11.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.523 ' O ' ' CA ' ' A' ' 85' ' ' LEU . 5.3 t70 -84.68 154.88 22.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.653 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -156.18 142.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' HD11 ' A' ' 73' ' ' ILE . 1.1 t -128.49 159.2 36.2 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -167.65 105.04 0.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.677 -1.264 . . . . 0.0 111.917 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' GLU . 56.9 p-10 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -171.2 -167.78 0.57 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.585 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -170.81 172.4 5.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.295 -0.878 . . . . 0.0 109.704 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 19.6 mtp180 -148.51 178.6 8.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.909 -1.12 . . . . 0.0 111.244 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CE2' HD13 ' A' ' 85' ' ' LEU . 3.2 m-85 -155.36 80.86 1.05 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -155.79 -163.31 1.47 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.765 -1.209 . . . . 0.0 111.209 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 77.74 53.21 5.08 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.14 119.66 6.93 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.834 1.965 . . . . 0.0 111.697 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.232 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.531 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 7.5 p90 -159.36 165.58 32.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -0.901 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 43' ' ' LYS . 8.2 pt-20 -172.94 158.71 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.05 171.81 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.163 -0.96 . . . . 0.0 110.44 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.601 HG13 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -150.84 -176.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.868 -0.52 . . . . 0.0 109.784 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.547 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 1.8 p30 -179.32 126.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CA ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER 43.21 25.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.691 -0.631 . . . . 0.0 110.13 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 12' ' ' THR . . . -118.02 -107.63 2.38 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.161 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . 48.7 Cg_endo -80.65 -72.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.72 1.613 . . . . 0.0 112.752 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.601 ' CD1' HG13 ' A' ' 6' ' ' ILE . 59.6 m-85 -40.09 -27.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.286 -0.883 . . . . 0.0 109.9 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 13' ' ' GLN . 2.1 p -65.69 -61.81 1.87 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.582 ' N ' ' OG1' ' A' ' 12' ' ' THR . 5.3 mt-30 -59.89 -26.35 65.83 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.924 0.868 . . . . 0.0 108.767 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 1.7 t-20 -74.45 -47.0 36.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.604 0.716 . . . . 0.0 109.202 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.577 ' CD2' ' CD2' ' A' ' 60' ' ' LEU . 3.4 tm? -44.03 -70.4 0.11 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -44.27 -37.39 4.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 18.1 mttp -71.24 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -40.54 -41.3 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.579 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -59.63 -68.27 0.3 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.438 -0.789 . . . . 0.0 109.316 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 23.3 t -38.5 -28.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.479 -0.763 . . . . 0.0 110.288 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.17 -73.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 110.341 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 14.0 mm-40 -54.86 -27.98 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.897 -1.127 . . . . 0.0 109.827 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -76.76 -61.11 2.08 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 6.6 m-20 -51.76 -47.17 64.22 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 20.7 mmmt -55.25 -51.69 65.8 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -51.77 -22.39 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.101 178.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.2 67.41 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.213 -1.169 . . . . 0.0 110.304 -179.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.329 0.585 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -154.35 62.32 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.1 t80 176.94 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.315 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -117.12 -56.37 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 110.734 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -69.51 -101.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.019 -1.051 . . . . 0.0 111.263 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 2.4 t -163.43 174.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.696 -1.253 . . . . 0.0 111.527 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.585 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -121.36 112.16 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.739 -0.601 . . . . 0.0 109.768 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.595 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -119.23 -57.07 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.1 Cg_endo -86.93 48.29 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.901 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' CB ' HD13 ' A' ' 60' ' ' LEU . 23.6 p -96.41 122.13 38.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' GLN . 12.1 mtm -121.1 165.14 15.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -143.17 144.5 32.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 18.5 mttt -148.43 157.44 43.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 1.6 m -149.1 152.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.567 ' N ' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.564 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.495 2.595 0 CA-C-O 121.736 0.631 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -157.84 107.42 2.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.705 -0.88 . . . . 0.0 110.234 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' LYS . 17.1 pt-20 -117.14 134.65 54.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.664 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.41 164.22 26.18 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.49 -1.284 . . . . 0.0 112.534 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 11.5 mt-30 -132.12 124.12 28.5 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.664 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 1.8 tp -120.69 78.15 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.747 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -73.28 113.0 9.86 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 69' ' ' PHE . 32.9 m -159.63 -162.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 2.8 t80 -136.01 141.58 44.37 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 63' ' ' TYR . . . -138.98 -115.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.845 . . . . 0.0 110.043 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -111.8 -39.0 4.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.268 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 3.5 p-10 -127.54 -0.98 6.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.602 -0.687 . . . . 0.0 109.641 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' CE ' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -106.25 97.68 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 109.736 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.567 ' HG ' ' CZ ' ' A' ' 63' ' ' TYR . 6.5 mp -100.2 60.09 1.03 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.428 -0.795 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 168.17 -115.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 110.237 -179.233 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 3.1 ttm180 -122.46 145.35 48.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.184 -1.572 . . . . 0.0 113.142 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.37 108.31 19.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' CB ' ' CG ' ' A' ' 86' ' ' ARG . 1.4 t70 -90.33 162.37 15.19 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.917 -1.114 . . . . 0.0 111.247 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.598 ' HB ' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.78 101.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.26 150.52 22.01 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.656 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -169.06 119.9 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.104 -0.998 . . . . 0.0 110.675 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.452 ' C ' ' HA2' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.584 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 3.8 tt -171.25 163.65 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.17 . . . . 0.0 110.516 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.6 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -149.43 160.86 43.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.596 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.55 ' CG ' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -150.53 147.9 28.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 111.269 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -124.7 89.82 3.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.598 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.52 -146.43 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.685 -1.26 . . . . 0.0 110.929 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 60.35 52.8 50.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -67.01 136.6 41.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.408 1.741 . . . . 0.0 111.253 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.279 -179.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.279 0.562 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -66.3 -176.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 174.78 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.937 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 1.1 pp -89.37 167.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 120.979 -1.076 . . . . 0.0 110.324 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.645 ' CG2' ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -115.11 -160.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.995 -1.065 . . . . 0.0 110.672 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 40.3 t0 -135.46 52.74 2.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.844 -1.16 . . . . 0.0 112.123 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 29.8 pt 39.83 46.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.168 0.985 . . . . 0.0 110.314 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 12' ' ' THR . . . -134.02 -69.15 0.07 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.785 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.28 -63.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.845 1.445 . . . . 0.0 111.28 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.645 ' CD1' ' CG2' ' A' ' 6' ' ' ILE . 3.5 m-85 -47.39 -36.02 9.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.025 -1.047 . . . . 0.0 109.212 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.656 HG22 ' N ' ' A' ' 9' ' ' GLY . 1.7 p -52.3 -57.66 9.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.602 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.87 -15.97 62.62 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.059 179.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 5.7 m120 -82.82 -68.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.271 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 3.0 pp -40.93 -28.76 0.09 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.456 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -71.42 -53.34 10.35 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -76.58 -42.49 42.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -1.127 . . . . 0.0 110.837 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' ALA . 7.6 m-85 -63.63 -64.86 0.78 Allowed 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.44 -0.788 . . . . 0.0 110.065 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -44.42 -66.22 0.42 Allowed 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.625 -0.672 . . . . 0.0 110.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 30.5 m -42.43 -26.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 120.961 -1.087 . . . . 0.0 110.149 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -94.77 -69.86 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 22.7 mm-40 -55.37 -35.01 64.79 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.247 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -69.69 -59.66 2.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.057 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 61.7 t-20 -51.38 -45.32 62.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -54.46 46.67 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.703 -0.799 . . . . 0.0 108.965 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -57.06 -19.1 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.636 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.66 70.91 1.33 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 32' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.336 0.589 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.97 50.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.633 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 6.5 p90 -162.85 123.0 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.74 -59.26 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.992 -1.068 . . . . 0.0 111.314 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HG3' ' CD2' ' A' ' 63' ' ' TYR . 1.1 mmmt -69.09 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.993 -1.067 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.4 t -161.13 173.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.7 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.599 HG13 HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -123.96 103.35 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.959 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.638 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -101.74 -60.48 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.953 -1.092 . . . . 0.0 110.185 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.638 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.4 Cg_endo -86.76 54.43 3.07 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.176 1.092 . . . . 0.0 110.336 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.516 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 4.5 t -102.67 110.55 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.518 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 2.0 mtt -113.75 175.75 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 110.628 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 2.3 ttpt -147.68 120.7 8.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -114.78 160.98 18.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.568 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.1 m -163.53 153.42 15.21 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.87 -1.144 . . . . 0.0 110.364 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.568 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.515 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -152.87 110.21 3.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.427 -1.043 . . . . 0.0 111.018 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.0 pm0 -124.8 124.46 42.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.51 169.67 10.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.566 -1.334 . . . . 0.0 113.267 -177.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 6.7 mp0 -133.66 123.08 24.39 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -121.24 72.59 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 0.0 109.888 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -68.23 107.13 2.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.579 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 34.8 m -158.29 -160.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.346 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.633 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.0 t80 -140.99 129.24 22.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.515 -0.741 . . . . 0.0 109.932 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 34' ' ' PHE . . . -122.0 -130.27 0.27 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 66' ' ' ASP . 1.0 OUTLIER -86.49 -18.76 30.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 108.744 178.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 9.6 p-10 -162.4 23.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.565 -0.71 . . . . 0.0 109.735 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.592 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -117.07 71.47 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.384 -0.823 . . . . 0.0 110.32 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.633 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 4.6 mt -81.73 52.6 1.95 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -168.62 -153.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.547 -0.721 . . . . 0.0 109.81 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 17.3 ttm180 -106.52 119.64 39.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 111.321 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.616 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -80.6 107.19 13.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t70 -87.64 160.37 18.18 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.602 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.73 112.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.905 0.86 . . . . 0.0 109.745 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.485 ' CB ' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.12 144.17 31.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.005 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.58 105.75 2.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.461 -1.399 . . . . 0.0 112.335 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' CG ' ' A' ' 83' ' ' LYS . 1.7 p-10 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.521 0.677 . . . . 0.0 111.03 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' CG ' ' OD1' ' A' ' 76' ' ' ASP . 79.4 mttt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -171.17 -172.99 1.19 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 110.605 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.3 167.67 8.36 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.646 -0.659 . . . . 0.0 109.329 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.9 mtm180 -143.45 -176.21 4.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.933 -1.105 . . . . 0.0 111.198 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.593 ' CE1' HD13 ' A' ' 85' ' ' LEU . 17.3 m-85 -155.98 66.79 0.6 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -154.16 -161.41 1.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.81 -1.182 . . . . 0.0 111.624 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 73.05 54.7 6.82 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -176.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.1 Cg_endo -62.57 177.12 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.82 1.958 . . . . 0.0 112.065 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG11 ' OH ' ' A' ' 61' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.196 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.12 0.486 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 7.0 p-90 -144.03 169.27 18.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.783 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 177.28 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.063 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' CG2' ' HG3' ' A' ' 42' ' ' MET . 6.9 pt -69.89 -172.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.605 HG13 ' CG ' ' A' ' 11' ' ' PHE . 1.1 mm -131.1 -138.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 38' ' ' ILE . 19.3 m-20 -142.07 -146.83 0.2 Allowed 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.791 -1.193 . . . . 0.0 110.221 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.477 ' C ' HG23 ' A' ' 12' ' ' THR . 19.5 tt -113.62 47.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.622 ' N ' HG22 ' A' ' 12' ' ' THR . . . -157.39 -60.9 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.357 -1.402 . . . . 0.0 111.777 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 38.6 Cg_endo -64.92 -68.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.527 1.277 . . . . 0.0 112.527 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.605 ' CG ' HG13 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -65.36 -23.53 67.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.483 -1.385 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 9' ' ' GLY . 10.0 p -48.62 -53.36 18.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -64.02 -29.78 70.9 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.072 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.0 m-80 -66.02 -58.73 4.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.605 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 9.0 tp -41.03 -66.99 0.28 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.568 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -43.46 -29.31 1.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' ASN . 70.5 mmtt -88.67 -82.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 110.418 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -41.6 -27.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.486 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.558 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -81.2 -70.5 0.53 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.4 p -41.57 -25.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.324 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ALA . 59.3 t0 -92.7 -72.5 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.085 -1.01 . . . . 0.0 110.516 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -57.83 -28.96 64.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.452 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.3 tt0 -72.43 -58.97 2.97 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.5 m120 -54.14 -51.82 63.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -51.45 -48.62 62.69 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.456 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.572 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -53.75 -20.44 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.529 0.68 . . . . 0.0 109.294 178.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.68 22.86 5.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 1.5 tp60 . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.443 -1.033 . . . . 0.0 109.664 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.37 0.605 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -155.35 49.67 0.55 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.302 -0.874 . . . . 0.0 110.088 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.568 ' CD1' ' HA2' ' A' ' 16' ' ' GLY . 43.5 p90 179.65 55.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.471 -0.768 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 20.9 t-20 -85.77 -54.24 4.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.454 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -69.54 -105.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.021 -1.049 . . . . 0.0 110.962 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.7 t -161.06 172.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.53 -1.356 . . . . 0.0 111.775 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.561 ' CG1' HG21 ' A' ' 12' ' ' THR . 1.2 pp -121.37 97.62 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.601 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -96.04 -55.56 0.21 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.863 -1.148 . . . . 0.0 109.866 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.2 Cg_endo -86.87 54.18 2.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.554 1.292 . . . . 0.0 110.362 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 7.5 t -91.25 92.94 8.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -90.68 126.4 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.155 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -123.63 155.78 37.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.555 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 1.4 ptpp? -164.54 173.5 11.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.594 HG21 ' N ' ' A' ' 46' ' ' ILE . 18.4 m -157.86 158.07 34.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.594 ' N ' HG21 ' A' ' 45' ' ' THR . 6.8 pt . . . . . 0 C--N 1.299 -1.605 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.568 ' CD1' HG22 ' A' ' 45' ' ' THR . 11.3 m-85 -115.65 -179.19 3.58 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.82 -0.812 . . . . 0.0 110.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 56' ' ' TYR . 7.4 pt-20 171.34 137.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.652 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -151.06 171.78 16.79 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 117.432 -1.707 . . . . 0.0 113.974 -178.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt-30 -129.24 124.82 35.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.652 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 23.7 tp -117.67 71.76 0.83 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.871 -1.143 . . . . 0.0 109.83 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.582 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -69.53 107.01 3.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 38' ' ' ILE . 13.0 m -158.2 -160.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.343 -0.848 . . . . 0.0 109.685 -177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -141.32 139.1 33.53 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.473 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB2' ' N ' ' A' ' 34' ' ' PHE . . . -132.98 -113.08 0.22 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.374 -0.829 . . . . 0.0 109.508 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -30.6 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.125 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -143.18 12.82 1.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.652 -0.655 . . . . 0.0 109.51 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HE3' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.16 87.71 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.525 -0.735 . . . . 0.0 110.03 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.562 HD22 ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -93.57 63.21 3.42 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.657 -0.652 . . . . 0.0 109.773 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.62 -118.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.573 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 48.0 ttp85 -123.76 146.08 48.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.402 -1.436 . . . . 0.0 112.807 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.624 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -109.48 106.56 16.36 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 6.1 t70 -84.74 159.88 20.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 110.753 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.613 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -160.11 119.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.503 0.668 . . . . 0.0 109.577 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -108.75 153.39 23.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.046 . . . . 0.0 109.528 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -152.19 104.75 2.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.641 -1.287 . . . . 0.0 112.206 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 76' ' ' ASP . 3.2 p30 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.499 0.666 . . . . 0.0 111.494 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 10.5 tp -171.17 178.72 3.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.353 -0.842 . . . . 0.0 109.639 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.588 HD22 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -154.58 167.99 28.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.558 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 6.5 mtt-85 -139.48 -177.7 5.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.772 -1.205 . . . . 0.0 111.45 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CZ ' HD22 ' A' ' 85' ' ' LEU . 11.0 m-85 -156.19 82.89 0.99 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.669 -0.644 . . . . 0.0 109.399 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -161.21 -164.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.615 -1.303 . . . . 0.0 111.371 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.555 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 80.6 53.72 3.95 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.2 Cg_endo -60.09 149.67 83.37 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.828 1.962 . . . . 0.0 111.828 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.109 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.341 0.591 . . . . 2.79 110.2 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 65.3 p-90 -115.53 152.59 32.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 4.46 110.202 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' CD ' ' CD ' ' A' ' 43' ' ' LYS . 3.8 pt-20 -163.69 134.08 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.92 . . . . 2.7000000000000002 110.177 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 16.7 pt -82.34 175.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.055 -1.028 . . . . 1.8999999999999999 110.491 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.638 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.35 -162.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.251 -0.906 . . . . 2.9199999999999999 109.881 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -136.36 50.17 2.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.14 . . . . 2.73 111.515 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 11.5 tt 40.18 43.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.936 0.874 . . . . 2.2200000000000002 110.043 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 12' ' ' THR . . . -132.81 -62.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.295 -0.955 . . . . 1.02 110.804 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.9 Cg_endo -86.34 -61.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.503 1.265 . . . . 1.04 110.896 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.638 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 3.1 m-85 -50.06 -31.89 14.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.993 -1.067 . . . . 1.8300000000000001 109.387 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.538 HG21 ' CD1' ' A' ' 38' ' ' ILE . 7.2 p -60.2 -58.67 7.53 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.124 -1.436 . . . . 1.4099999999999999 107.124 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.9 tt0 -66.73 -19.47 65.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.766 0.793 . . . . 2.7200000000000002 109.18 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.504 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 9.9 t-20 -78.19 -56.43 4.47 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.502 0.668 . . . . 2.0899999999999999 109.547 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 67' ' ' LYS . 7.1 tp -41.55 -66.13 0.37 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.402 0.62 . . . . 2.6299999999999999 109.357 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.67 -43.61 16.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.323 -1.511 . . . . 0.67000000000000004 109.323 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -69.64 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -1.16 . . . . 2.8900000000000001 110.939 -179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -37.69 -53.71 1.23 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.414 0.626 . . . . 2.8599999999999999 111.238 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.9 -70.06 0.12 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.475 -0.766 . . . . 1.1599999999999999 110.001 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 16.2 t -42.77 -26.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.032 . . . . 2.0099999999999998 110.358 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -91.9 -66.28 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.8100000000000001 109.896 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 2.3 mm-40 -60.16 -41.09 92.06 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.581 -1.247 . . . . 2.1699999999999999 108.981 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -61.46 -53.22 59.3 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.6799999999999999 108.711 178.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 27.4 t-20 -61.86 -46.58 88.82 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.687 -1.205 . . . . 2.2799999999999998 107.824 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -56.92 -48.18 78.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 3.2799999999999998 109.842 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -60.85 -20.18 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.925 -0.71 . . . . 2.2599999999999998 109.844 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 122.67 28.54 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.572 -1.411 . . . . 0.98999999999999999 109.572 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.521 ' CG ' ' OE2' ' A' ' 23' ' ' GLU . 8.6 tp60 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.152 . . . . 2.75 110.019 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.544 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 2.7 mp . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 3.0 110.026 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -140.44 52.43 1.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.298 -0.876 . . . . 1.25 109.848 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 38.4 p90 -167.86 129.08 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.83 . . . . 4.25 110.036 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' HB2' ' N ' ' A' ' 65' ' ' SER . 7.7 t30 -153.67 -64.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 2.8500000000000001 110.678 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.632 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.98 -94.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.964 . . . . 3.8799999999999999 111.329 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 24.4 t -157.97 172.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.693 -1.254 . . . . 1.6000000000000001 111.822 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.546 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -129.22 86.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.201 -0.666 . . . . 2.27 109.201 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -102.73 -52.14 0.14 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 3.6000000000000001 110.533 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.3 Cg_endo -85.59 52.8 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.53 1.279 . . . . 0.60999999999999999 110.789 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 6' ' ' ILE . 21.5 p -104.2 120.39 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 2.0699999999999998 109.781 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.49 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 14.7 mtm -119.04 178.02 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 2.6000000000000001 110.631 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -138.61 151.58 47.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 2.1099999999999999 110.461 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.519 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 1.9 mttt -148.39 106.21 3.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.362 -0.837 . . . . 2.9100000000000001 109.889 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.534 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.6 m -112.8 152.55 29.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 1.26 110.173 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.534 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 106.769 -1.567 . . . . 2.4300000000000002 106.769 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 110.172 -1.171 . . . . 0.79000000000000004 110.172 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.564 ' CZ ' ' HE3' ' A' ' 43' ' ' LYS . 7.5 t80 -150.53 98.31 2.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.29 -1.124 . . . . 3.9300000000000002 110.87 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 15.8 pt-20 -120.0 174.01 6.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 2.5299999999999998 108.914 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.636 ' CD1' ' CG2' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -159.6 177.64 10.69 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 117.952 -1.499 . . . . 2.2400000000000002 113.45 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.52 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -135.45 117.24 15.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.589 -1.263 . . . . 2.1800000000000002 107.589 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.591 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 2.2 tp -116.0 72.41 0.81 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 1.3700000000000001 109.513 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -69.63 111.74 5.64 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.117 -1.068 . . . . 2.1899999999999999 108.117 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' CG1' ' A' ' 38' ' ' ILE . 34.6 m -158.13 -158.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.789 0.804 . . . . 1.1100000000000001 109.813 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.0 t80 -143.61 126.21 15.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.699 -0.626 . . . . 1.8100000000000001 109.535 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . . . -121.44 -136.45 0.32 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.393 -0.817 . . . . 1.29 109.884 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -87.34 -25.73 23.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 1.72 108.964 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 15.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 1.78 109.567 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -118.29 79.2 1.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 2.0 110.11 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mp -89.73 57.67 3.98 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.622 -0.881 . . . . 2.2599999999999998 108.622 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -173.09 -121.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.074 -1.05 . . . . 2.27 110.023 -178.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.521 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 30.5 ttm180 -133.84 124.76 27.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.325 -1.484 . . . . 2.4300000000000002 112.215 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -81.79 103.35 11.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.984 -1.487 . . . . 1.1299999999999999 106.984 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.45 156.04 19.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 1.75 110.15 -178.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.636 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -159.22 141.74 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.513 -0.742 . . . . 1.75 109.863 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.504 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -127.96 153.32 46.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.238 -0.914 . . . . 1.55 109.049 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -157.67 106.42 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.635 -1.291 . . . . 2.2999999999999998 111.772 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' GLU . 1.4 p30 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.502 0.667 . . . . 1.74 111.224 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 mttt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.395 -0.965 . . . . 3.8399999999999999 108.395 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 26' ' ' ILE . 10.0 tp -171.25 179.74 2.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.318 -0.864 . . . . 2.9399999999999999 109.338 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.555 HD13 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -155.65 172.28 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.103 -0.998 . . . . 1.76 110.094 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.533 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 3.9 mtt180 -142.33 -176.67 4.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -0.894 . . . . 3.0600000000000001 110.905 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 23' ' ' GLU . 48.5 m-85 -154.93 64.63 0.65 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.95999999999999996 108.954 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.87 -157.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 2.5 111.26 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.46 52.5 30.33 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.193 -3.163 . . . . 1.3999999999999999 105.193 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.4 Cg_endo -67.55 -175.03 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.582 1.833 . . . . 2.1400000000000001 111.933 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.52 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 31.1 m . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 117.966 -1.016 . . . . 2.25 110.387 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 45' ' ' THR . 6.2 mt-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.523 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 51.2 p-90 -118.59 169.98 9.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.807 -1.183 . . . . 0.0 110.036 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 1.4 tt0 175.79 115.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 15.2 pt -82.77 -176.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.601 HG23 ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -116.39 -165.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.089 -1.007 . . . . 0.0 110.543 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.552 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 25.3 m-20 -136.66 49.99 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.945 -1.097 . . . . 0.0 111.461 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 19.5 tt 39.7 42.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.575 ' N ' HG22 ' A' ' 12' ' ' THR . . . -145.47 -68.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.975 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' O ' ' CG ' ' A' ' 13' ' ' GLN . 43.8 Cg_endo -73.77 -84.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.689 1.363 . . . . 0.0 111.392 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.601 ' CG ' HG23 ' A' ' 6' ' ' ILE . 24.7 m-85 -39.68 -31.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.012 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 9' ' ' GLY . 11.7 p -55.97 -56.89 15.28 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.85 -1.156 . . . . 0.0 108.21 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.516 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -57.34 -17.83 14.24 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.41 179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.507 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.7 OUTLIER -79.86 -60.56 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.702 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.2 pp -41.57 -30.68 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.66 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.41 -49.28 20.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' PHE . 10.4 tptt -71.62 -69.36 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -1.05 . . . . 0.0 110.21 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-85 -39.75 -62.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.483 0.659 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.12 -72.45 0.06 Allowed 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 15.7 t -38.52 -26.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.756 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 19' ' ' ALA . 9.4 m-20 -95.09 -70.73 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 110.26 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 1.8 mt-10 -57.96 -26.87 62.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.579 -1.249 . . . . 0.0 109.062 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 87' ' ' PHE . 1.9 tt0 -74.34 -58.91 2.99 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' GLN . 1.7 m-80 -56.81 -44.73 82.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.461 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.94 -52.68 63.28 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.793 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 7.3 tp -63.68 -12.87 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.264 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.64 59.48 0.43 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 109.991 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.515 ' CD1' ' OD1' ' A' ' 35' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.501 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -135.13 55.27 1.9 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 11.3 p90 -174.4 60.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.886 . . . . 0.0 110.262 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.515 ' OD1' ' CD1' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -90.1 -56.05 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -69.63 -106.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.079 . . . . 0.0 111.115 -178.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 6.1 t -160.03 173.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.732 -1.23 . . . . 0.0 111.431 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.576 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -120.53 118.07 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.498 -0.751 . . . . 0.0 110.162 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -123.49 -56.87 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.896 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.4 Cg_endo -87.33 48.89 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.212 1.111 . . . . 0.0 110.354 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . 2.7 t -91.27 128.81 37.24 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.537 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 14.2 mtm -122.96 162.98 21.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -145.19 115.87 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.481 -0.762 . . . . 0.0 109.237 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 1.3 mttp -124.93 152.12 44.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.034 -1.041 . . . . 0.0 110.313 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.551 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.3 m -147.41 152.51 38.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.551 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -155.37 104.37 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 110.113 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 2.1 pt-20 -105.15 152.31 22.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 60' ' ' LEU . 13.5 t80 -128.27 148.74 50.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.644 -1.285 . . . . 0.0 112.673 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 21.9 mt-30 -134.41 109.9 9.07 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -116.0 71.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.973 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -72.98 108.44 5.89 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.684 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 33.6 m -159.86 -159.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.593 -0.692 . . . . 0.0 109.371 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 3.6 t80 -135.69 142.07 45.04 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.527 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.536 ' CB ' ' HE3' ' A' ' 67' ' ' LYS . . . -137.08 -118.99 0.15 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -99.42 -28.97 13.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.018 -1.051 . . . . 0.0 109.222 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -148.99 18.28 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.736 0.779 . . . . 0.0 109.143 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' CD ' HG22 ' A' ' 62' ' ' VAL . 7.0 ttmt -109.18 79.15 1.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.511 0.672 . . . . 0.0 110.104 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.7 mp -85.89 57.59 4.56 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 109.263 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.52 -124.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.529 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 7.6 ttm180 -127.19 144.42 51.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.199 -1.563 . . . . 0.0 113.486 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.529 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -112.39 111.59 22.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -99.04 170.06 8.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.774 -1.204 . . . . 0.0 110.369 -177.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.568 HG21 ' CB ' ' A' ' 58' ' ' TYR . 3.1 tp -151.62 113.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.768 0.794 . . . . 0.0 109.237 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 21.9 t -97.85 151.45 20.21 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.08 . . . . 0.0 109.5 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.8 110.08 4.4 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.387 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.417 -0.802 . . . . 0.0 111.218 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 74' ' ' SER . 11.8 tttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 4.7 tp -171.18 -170.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.969 -1.082 . . . . 0.0 110.037 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -171.21 -179.96 2.83 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.229 -0.92 . . . . 0.0 110.695 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.569 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 5.8 ptm85 -170.25 112.8 0.45 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.125 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.629 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 6.8 m-85 -90.85 86.66 6.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.525 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.599 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -160.78 -171.34 3.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.818 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . 91.9 59.65 1.31 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 37.1 Cg_endo -59.43 125.16 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.502 1.791 . . . . 0.0 112.116 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' OH ' ' A' ' 61' ' ' TYR . 2.6 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.211 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.214 0.53 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 29.6 p90 -154.22 146.85 24.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 48.4 mt-10 -157.6 -174.54 4.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -121.85 171.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 110.035 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.635 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -81.1 -164.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.329 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 16.1 t0 -147.43 46.7 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.439 -0.788 . . . . 0.0 110.658 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.554 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 2.9 tt 39.88 40.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.657 0.741 . . . . 0.0 109.84 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' HG22 ' A' ' 12' ' ' THR . . . -146.54 -61.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.628 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 11' ' ' PHE . 43.4 Cg_endo -83.87 -77.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.574 1.302 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.635 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 86.1 m-85 -39.89 -35.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 110.284 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 13' ' ' GLN . 9.7 p -61.61 -59.95 4.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.537 ' N ' ' OG1' ' A' ' 12' ' ' THR . 35.5 tt0 -66.73 -15.27 63.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.52 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.57 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 43.8 m-20 -78.4 -57.72 3.63 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.548 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -42.31 -50.73 4.98 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.581 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -51.64 -56.34 16.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -67.4 -77.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -1.081 . . . . 0.0 110.696 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 14' ' ' ASN . 16.8 m-30 -33.69 -63.99 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.569 0.699 . . . . 0.0 111.355 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -42.2 -71.89 0.07 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 12.5 t -39.86 -27.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 1.6 t70 -92.3 -71.0 0.67 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' CB ' HD12 ' A' ' 73' ' ' ILE . 2.8 pt-20 -54.35 -29.01 46.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.38 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.3 tt0 -72.53 -60.18 2.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -59.3 -39.14 82.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.306 -1.358 . . . . 0.0 107.916 178.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -60.46 -48.94 79.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.552 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.37 -32.74 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.417 -0.802 . . . . 0.0 110.606 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 140.41 42.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.496 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.376 -1.073 . . . . 0.0 108.889 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.873 0.844 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.525 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -163.44 42.79 0.11 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.552 0.692 . . . . 0.0 109.789 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 31.0 p90 -174.42 99.23 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.687 -0.633 . . . . 0.0 109.895 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.445 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 5.8 t-20 -141.58 -52.42 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.903 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.576 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -70.51 -98.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.0 111.494 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 1.1 t -161.83 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.798 -1.189 . . . . 0.0 111.051 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.587 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -140.59 123.96 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.565 0.698 . . . . 0.0 109.709 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 mtt180 -140.7 -56.59 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.6 Cg_endo -83.52 42.48 1.25 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.17 1.089 . . . . 0.0 111.712 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' O ' HG22 ' A' ' 6' ' ' ILE . 20.5 p -103.22 129.62 50.21 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 109.333 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -121.74 163.22 19.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.0 111.035 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -117.89 155.19 30.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.752 . . . . 0.0 109.958 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 27.0 mttt -159.79 118.64 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 1.8 m -119.72 148.83 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.553 ' N ' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 0.8 OUTLIER -162.44 107.68 1.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.682 -0.893 . . . . 0.0 109.936 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 1.1 pp20? -126.87 177.26 6.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -161.96 171.89 16.89 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.216 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.51 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 26.8 mt-30 -130.28 125.29 34.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.662 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -121.49 75.11 1.16 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.842 -1.161 . . . . 0.0 109.738 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.516 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 2.1 t80 -74.11 111.04 8.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.141 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.609 ' CG2' ' CE ' ' A' ' 67' ' ' LYS . 17.7 m -159.0 -154.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.784 0.802 . . . . 0.0 109.068 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 68' ' ' LEU . 1.8 t80 -139.68 134.81 32.48 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.299 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -130.16 -126.65 0.21 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.361 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -103.14 -34.12 8.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.082 -1.011 . . . . 0.0 110.113 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 8.1 p-10 -132.65 0.83 3.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.609 ' CE ' ' CG2' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -114.38 104.09 11.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.845 . . . . 0.0 109.622 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 63' ' ' TYR . 10.2 mt -100.58 66.61 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.461 -0.774 . . . . 0.0 109.852 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 167.68 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 31.4 ttm180 -121.26 148.09 44.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.127 -1.608 . . . . 0.0 112.909 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -113.93 107.52 15.81 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 13.8 t70 -88.57 165.92 14.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.957 -1.089 . . . . 0.0 110.639 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 58' ' ' TYR . 3.2 tp -165.29 112.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.639 0.733 . . . . 0.0 109.301 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.5 p -108.76 162.44 14.17 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.652 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -170.12 117.72 0.56 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.781 . . . . 0.0 109.792 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.443 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.217 0.532 . . . . 0.0 110.222 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 5.0 tp -170.47 123.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -125.16 167.85 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.211 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 60.1 mtm180 -157.88 119.26 3.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.964 -1.085 . . . . 0.0 111.993 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 12.8 m-85 -107.43 71.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.71 -161.81 1.33 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.384 -1.326 . . . . 0.0 111.406 -179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.44 52.0 6.32 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 105.345 -3.102 . . . . 0.0 105.345 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.03 158.21 35.37 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.807 1.951 . . . . 0.0 112.08 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.282 -179.67 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 45' ' ' THR . 4.7 pm0 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.532 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 26.4 p-90 -143.02 149.57 38.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 43' ' ' LYS . 34.8 mt-10 -152.77 136.73 16.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 110.656 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -79.28 -174.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 110.664 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -114.2 -167.96 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.341 -0.849 . . . . 0.0 110.297 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 33.9 t70 -137.12 49.27 2.04 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 111.16 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.542 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 17.8 tt 38.74 33.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.615 0.722 . . . . 0.0 109.911 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 12' ' ' THR . . . -138.11 -59.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.686 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.88 -56.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.511 1.269 . . . . 0.0 111.57 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 9.2 m-85 -61.78 -27.21 68.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.959 -1.088 . . . . 0.0 109.695 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' N ' ' A' ' 9' ' ' GLY . 10.8 p -65.44 -59.85 3.57 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.206 -0.934 . . . . 0.0 108.789 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 44.6 tt0 -59.67 -20.38 55.8 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.763 0.792 . . . . 0.0 109.175 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -71.26 -56.22 6.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.748 0.785 . . . . 0.0 109.248 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 5.7 tt -43.1 -64.25 0.67 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 15' ' ' LEU . . . -41.11 -44.67 3.75 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.82 -79.78 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -1.167 . . . . 0.0 110.643 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -36.99 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.423 0.63 . . . . 0.0 111.086 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -77.4 -74.69 0.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 14.1 t -36.74 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.618 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' ALA . 34.9 t70 -93.05 -79.28 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 2.5 mt-10 -49.36 -25.8 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.805 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 11.6 tt0 -77.52 -63.18 1.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 4.3 m120 -49.53 -48.43 48.3 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -55.01 -51.55 65.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.95 -25.13 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.442 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.85 21.7 5.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.428 -1.042 . . . . 0.0 109.657 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.54 0.686 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.537 ' HA ' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -161.24 54.02 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.619 -0.675 . . . . 0.0 109.577 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 2.6 p90 -161.53 32.56 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -18.04 20.83 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.802 -1.186 . . . . 0.0 109.09 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.716 ' HB3' ' CA ' ' A' ' 64' ' ' ALA 0.357 0.0 OUTLIER -66.55 -141.24 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 -178.124 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.636 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -161.12 -176.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 113.877 -1.511 . . . . 0.0 106.963 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.58 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.61 121.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.379 -1.451 . . . . 0.0 110.96 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.595 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -125.78 -57.16 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 110.126 179.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.8 Cg_endo -85.31 47.81 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.203 1.107 . . . . 0.0 110.89 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -85.38 129.77 34.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.867 . . . . 0.0 109.525 178.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 41.3 mtm -133.31 161.95 33.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.882 -1.136 . . . . 0.0 110.785 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 10.4 ttpt -129.12 156.31 44.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -159.17 113.67 2.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.112 -0.993 . . . . 0.0 110.571 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 ' N ' ' A' ' 46' ' ' ILE . 18.3 m -122.13 154.27 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.526 ' N ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HA ' HG22 ' A' ' 45' ' ' THR . 13.6 t80 -120.77 100.4 7.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.403 -1.057 . . . . 0.0 110.286 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 50.9 tt0 -123.05 173.83 7.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.352 -0.843 . . . . 0.0 109.225 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.637 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -162.36 173.37 14.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.081 -1.447 . . . . 0.0 113.179 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 2.6 pt20 -128.7 124.27 35.23 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -118.11 72.58 0.87 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 108.593 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.572 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -71.56 106.42 4.0 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.567 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.572 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 17.8 m -163.52 -144.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.696 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 22.7 t80 -135.03 161.57 34.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.716 ' CA ' ' HB3' ' A' ' 36' ' ' LYS . . . -136.56 -140.31 0.16 Allowed 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.946 0.794 . . . . 0.0 108.924 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 24.3 t -86.91 -1.62 57.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.66 33.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.592 -0.693 . . . . 0.0 109.72 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.98 93.87 3.59 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.836 . . . . 0.0 109.701 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.651 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 1.4 mm? -88.46 74.8 8.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.602 ' CG ' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 171.52 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.571 -1.33 . . . . 0.0 110.59 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' HD3' ' CB ' ' A' ' 59' ' ' GLN . 34.2 ttm180 -139.12 147.69 42.25 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.56 -1.338 . . . . 0.0 112.598 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.617 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.57 103.07 12.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 176.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -83.99 161.34 20.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 110.197 -178.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.604 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -163.01 108.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 121.939 0.875 . . . . 0.0 109.9 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 1.3 t -107.26 156.35 18.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 108.633 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 74' ' ' SER . 29.9 mt-10 -155.07 104.57 2.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.569 -1.332 . . . . 0.0 112.13 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 75' ' ' GLU . 1.6 p30 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.488 -0.758 . . . . 0.0 111.091 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -171.09 146.58 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.031 . . . . 0.0 110.304 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.597 ' CD2' ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -137.62 158.34 44.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.9 . . . . 0.0 109.59 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -142.8 147.71 35.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.947 -1.096 . . . . 0.0 111.009 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.597 ' CZ ' ' CD2' ' A' ' 85' ' ' LEU . 8.9 m-85 -119.55 85.56 2.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 109.348 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -168.94 -167.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.635 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 85.96 56.41 2.33 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.0 Cg_endo -61.87 151.37 81.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.508 1.794 . . . . 0.0 111.689 -176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.45 HG11 ' OH ' ' A' ' 61' ' ' TYR . 22.5 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 67.4 mm-40 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.2 p-90 -137.2 161.0 37.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.512 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 1.6 pm0 -172.47 173.03 4.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.588 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.7 173.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.588 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -112.17 -153.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.532 -0.73 . . . . 0.0 109.717 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -141.04 48.06 1.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.865 -1.147 . . . . 0.0 111.439 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 15.6 pt 40.17 36.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.932 0.873 . . . . 0.0 109.883 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.548 ' N ' HG22 ' A' ' 12' ' ' THR . . . -132.51 -59.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.954 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 43.8 Cg_endo -85.73 -66.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.596 1.314 . . . . 0.0 110.947 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.705 ' CE2' ' CE1' ' A' ' 58' ' ' TYR . 1.1 m-85 -47.42 -32.36 4.96 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.137 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 9' ' ' GLY . 23.6 p -59.9 -57.42 12.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.504 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.21 -26.13 68.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.549 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.495 ' OD1' ' CE2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -76.83 -49.9 14.71 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.481 0.658 . . . . 0.0 109.832 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 2.4 tm? -42.94 -63.7 0.75 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.392 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' N ' HD11 ' A' ' 15' ' ' LEU . . . -49.05 -41.84 30.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 20' ' ' VAL . 11.1 tptp -68.99 -68.52 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -1.16 . . . . 0.0 110.593 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CE2' ' OD1' ' A' ' 14' ' ' ASN . 18.0 m-30 -54.9 -36.11 64.84 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -58.68 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.815 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 9.6 p -38.41 -27.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -87.17 -75.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.866 -1.146 . . . . 0.0 110.107 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.561 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.4 mm-40 -59.47 -36.98 77.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 4.0 tt0 -62.62 -49.45 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.038 -1.039 . . . . 0.0 109.251 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 33.9 t-20 -70.63 -45.33 65.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 30.6 mmtt -58.61 -38.68 78.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 110.052 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 5.3 tp -71.68 -15.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.0 110.08 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 105.53 54.63 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 46.2 tp60 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.36 -1.082 . . . . 0.0 109.661 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.329 0.585 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -146.15 53.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 22.4 p90 178.98 114.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.82 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.28 -48.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.0 110.834 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.91 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 111.197 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 17.0 t -158.31 172.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.633 -1.292 . . . . 0.0 111.361 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -133.26 99.94 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.757 . . . . 0.0 110.012 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.574 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.81 -54.18 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 110.492 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.584 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.1 Cg_endo -85.06 50.28 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.491 1.258 . . . . 0.0 111.362 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . 16.5 p -81.35 137.27 35.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' GLN . 6.2 mtp -130.95 169.29 16.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 110.959 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -151.92 138.65 18.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 109.946 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.497 ' HG2' ' N ' ' A' ' 45' ' ' THR . 8.3 ttmm -137.93 163.47 31.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.679 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.58 HG22 ' CD2' ' A' ' 56' ' ' TYR . 5.1 m -163.25 148.67 11.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.075 -1.016 . . . . 0.0 110.879 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.531 ' N ' HG21 ' A' ' 45' ' ' THR . 25.3 pt . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' ' CG1' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CD2' HG22 ' A' ' 45' ' ' THR . 0.2 OUTLIER -157.42 97.77 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' CG ' ' HB3' ' A' ' 44' ' ' LYS . 4.3 pm0 -92.86 165.52 12.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.064 -1.022 . . . . 0.0 109.513 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.705 ' CE1' ' CE2' ' A' ' 11' ' ' PHE . 72.4 t80 -137.09 136.81 38.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.164 -0.96 . . . . 0.0 111.283 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.534 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 18.0 mt-30 -135.15 106.82 6.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 2.9 tp -119.41 80.16 1.53 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.01 -1.056 . . . . 0.0 110.076 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -74.4 110.37 8.64 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 29.3 m -160.33 -158.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.596 0.712 . . . . 0.0 109.656 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -140.82 133.99 29.5 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.67 -0.644 . . . . 0.0 109.474 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 34' ' ' PHE . . . -130.16 -124.4 0.21 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.738 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 t -97.73 -17.94 19.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.195 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.41 20.78 0.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.792 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.533 ' CD ' HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -118.61 81.03 1.62 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -0.791 . . . . 0.0 110.188 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.567 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -84.94 57.6 4.52 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.575 -0.703 . . . . 0.0 109.855 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.89 -117.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 110.368 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.534 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 21.5 ttp180 -122.96 148.26 45.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.158 -1.589 . . . . 0.0 113.122 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' A' ' 58' ' ' TYR . . . -109.94 105.35 14.48 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 66.2 m-20 -85.2 163.69 18.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.804 -1.185 . . . . 0.0 110.718 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.614 ' HB ' ' CD2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -160.12 103.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -93.71 157.48 16.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.824 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.46 96.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.867 -1.146 . . . . 0.0 111.465 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' CG ' ' HE2' ' A' ' 83' ' ' LYS . 11.6 p-10 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.37 -167.74 0.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.095 -1.003 . . . . 0.0 109.979 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.596 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -171.25 171.74 5.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.211 -0.93 . . . . 0.0 109.757 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.542 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 30.3 mtt180 -144.77 175.41 10.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.002 -1.062 . . . . 0.0 110.986 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.596 ' CE2' HD13 ' A' ' 85' ' ' LEU . 1.9 m-85 -151.63 69.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.519 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.606 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -155.06 -156.1 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.282 . . . . 0.0 111.105 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 87.68 52.79 2.89 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 106.711 -2.556 . . . . 0.0 106.711 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 39.6 Cg_endo -63.9 140.84 75.2 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.236 1.651 . . . . 0.0 111.276 -177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.343 -179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.213 0.53 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 3' ' ' TRP . 5.9 p90 -124.18 170.4 10.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 110.318 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 176.66 111.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.105 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -92.32 178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.379 -0.825 . . . . 0.0 110.594 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -116.86 -166.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.65 41.46 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.15 . . . . 0.0 111.155 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 38' ' ' ILE . 4.1 mt 57.18 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.02 0.914 . . . . 0.0 110.291 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.544 ' N ' HG22 ' A' ' 12' ' ' THR . . . -153.5 -63.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 44.0 Cg_endo -75.87 -76.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.59 1.31 . . . . 0.0 111.631 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 6' ' ' ILE . 3.2 m-85 -48.91 -26.65 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.023 -1.048 . . . . 0.0 110.46 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.56 ' CB ' HG23 ' A' ' 38' ' ' ILE . 26.9 p -57.6 -57.77 11.26 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.943 -1.098 . . . . 0.0 108.26 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.1 mm-40 -63.2 -24.8 68.04 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.77 0.795 . . . . 0.0 109.206 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' LEU . 4.6 t30 -72.14 -56.3 5.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.487 0.66 . . . . 0.0 109.37 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.573 ' HA ' ' CD2' ' A' ' 18' ' ' PHE . 3.2 tm? -42.66 -71.72 0.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.66 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -40.73 -37.82 1.4 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.7 mttp -76.78 -83.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -1.093 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.575 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -45.43 -28.33 0.87 Allowed 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.587 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -63.55 -72.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 10.4 p -41.72 -25.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.512 ' N ' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -89.52 -70.8 0.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 110.112 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.566 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.5 mm-40 -59.9 -38.5 82.46 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.718 -1.239 . . . . 0.0 109.324 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.2 tt0 -63.58 -51.84 63.56 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.235 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 27.8 t-20 -67.15 -44.52 79.59 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.163 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -43.11 92.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.42 -0.8 . . . . 0.0 110.092 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -66.6 -21.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 118.6 36.02 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 3.0 mm-40 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.324 0.583 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -154.24 49.05 0.62 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.776 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 12' ' ' THR . 3.4 t80 179.8 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.547 -0.721 . . . . 0.0 110.228 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -154.22 -48.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 110.579 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.586 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 1.3 mmpt? -69.61 -100.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 24.7 t -157.89 171.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.605 -1.309 . . . . 0.0 111.669 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.56 HG23 ' CB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -135.41 92.93 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.682 -0.636 . . . . 0.0 109.829 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.563 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -105.1 -53.26 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.635 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.5 Cg_endo -84.7 50.78 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.538 1.283 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 38' ' ' ILE . 20.6 p -104.12 118.32 36.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLN . 66.4 mtm -126.66 175.6 7.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.514 ' NZ ' ' OG1' ' A' ' 45' ' ' THR . 10.9 tmtt? -152.71 140.68 20.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.038 -1.039 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' GLU . 13.6 mttt -137.93 121.99 17.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 0.0 109.778 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.577 HG22 ' CG ' ' A' ' 56' ' ' TYR . 6.5 m -108.42 154.12 22.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.896 . . . . 0.0 110.746 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' N ' HG21 ' A' ' 45' ' ' THR . 3.0 tt . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.577 ' CG ' HG22 ' A' ' 45' ' ' THR . 18.4 m-85 -133.25 119.36 19.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.987 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -124.31 163.75 21.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 0.0 109.623 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -157.54 165.89 34.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.448 -1.301 . . . . 0.0 112.681 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.519 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 5.5 pt20 -124.47 120.41 31.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.635 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 2.9 tp -114.43 67.77 0.69 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 1.7 t80 -68.79 108.65 3.51 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 27.4 m -159.56 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.596 0.712 . . . . 0.0 109.585 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 1.9 t80 -148.46 130.94 15.75 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.951 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB2' ' CA ' ' A' ' 34' ' ' PHE . . . -126.83 -123.74 0.24 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.829 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.0 p -91.53 -32.84 15.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.056 . . . . 0.0 109.551 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.36 14.26 1.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.587 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . 4.7 ttmt -107.98 78.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.756 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.571 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -89.94 68.53 7.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.624 -0.673 . . . . 0.0 109.287 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 173.31 -119.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.28 -0.887 . . . . 0.0 109.863 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' HD3' ' CB ' ' A' ' 59' ' ' GLN . 16.4 ttm180 -135.32 124.93 25.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.571 -1.33 . . . . 0.0 111.702 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.44 104.27 12.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 32.6 t70 -89.39 157.1 18.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 110.167 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.601 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.09 117.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t -116.66 144.98 43.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.011 -1.056 . . . . 0.0 111.085 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -129.43 159.85 34.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.068 -1.02 . . . . 0.0 111.732 -178.672 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.36 0.6 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 tp -171.32 128.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.197 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -130.31 171.96 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.981 -1.075 . . . . 0.0 111.099 -179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.552 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -146.45 -179.0 6.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.851 . . . . 0.0 110.564 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.575 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 5.2 m-85 -153.44 67.6 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.528 -0.732 . . . . 0.0 109.199 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.06 -158.7 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.72 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.622 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.06 48.9 44.33 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 44.5 Cg_endo -69.03 -173.79 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.446 1.761 . . . . 0.0 111.823 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.523 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 27.4 m . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.311 0.577 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HA ' ' HG3' ' A' ' 44' ' ' LYS . 59.0 p-90 -119.35 -176.5 3.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.476 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER 176.33 112.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 110.105 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 ' CE ' ' A' ' 42' ' ' MET . 1.2 pp -85.68 -179.06 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 110.638 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.649 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -135.24 -161.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.989 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -127.17 -157.11 0.79 Allowed 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.988 -1.07 . . . . 0.0 109.505 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.55 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -101.08 36.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' N ' HG22 ' A' ' 12' ' ' THR . . . -128.4 -57.42 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.906 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.6 Cg_endo -82.51 -77.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.369 1.194 . . . . 0.0 111.253 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.649 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 2.0 m-85 -43.63 -29.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.937 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 24.3 p -62.15 -58.91 6.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -62.47 -15.54 50.42 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.259 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LEU . 1.2 t30 -83.14 -59.13 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.624 0.726 . . . . 0.0 110.052 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.3 pp -42.57 -31.54 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.649 -0.657 . . . . 0.0 109.704 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.96 -56.64 5.7 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -69.63 -67.15 0.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -1.142 . . . . 0.0 110.525 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.05 -49.27 1.73 Allowed 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.468 0.651 . . . . 0.0 110.424 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.632 ' N ' ' CD1' ' A' ' 18' ' ' PHE . . . -53.74 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.834 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' CG ' ' A' ' 24' ' ' ASN . 2.7 t -37.86 -26.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.46 -0.775 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.7 m-20 -89.76 -73.51 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.616 -1.303 . . . . 0.0 110.039 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.58 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 1.8 mt-10 -59.13 -32.91 70.29 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.255 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HG3' ' CZ ' ' A' ' 87' ' ' PHE . 2.3 tt0 -63.69 -56.65 14.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 108.339 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 2.3 m120 -62.57 -47.11 85.29 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.757 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.92 -41.19 74.19 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.404 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 4.9 tp -72.62 -10.91 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.835 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.47 51.31 1.33 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 11.2 tp60 . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.487 -1.008 . . . . 0.0 109.346 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.61 ' N ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.29 0.567 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -41.86 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 110.68 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 32' ' ' LEU . 1.6 t80 164.12 115.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 109.203 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.515 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -165.34 -59.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.394 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.516 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 3.8 tppp? -69.54 -103.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.982 -1.074 . . . . 0.0 111.139 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 15.8 t -158.59 172.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.213 . . . . 0.0 111.524 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -123.8 117.49 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.521 0.677 . . . . 0.0 109.797 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.548 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -124.3 -56.27 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.582 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.6 Cg_endo -86.61 48.14 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.174 1.091 . . . . 0.0 110.537 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -89.18 117.87 28.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 109.675 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.518 ' CE ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -127.57 179.6 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 110.641 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -158.11 134.77 9.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 109.773 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 2.4 tttt -141.34 122.81 15.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 17.9 m -101.65 150.47 23.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.9 . . . . 0.0 109.68 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.527 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -123.32 108.3 12.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.545 -0.973 . . . . 0.0 110.028 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 3.0 mp0 -114.73 163.62 15.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.842 . . . . 0.0 108.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.63 ' CE1' ' O ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -150.8 163.48 38.51 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.916 -179.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.526 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 26.8 mt-30 -128.11 121.84 30.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.625 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -116.33 69.57 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.355 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -70.88 109.37 4.99 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.505 -0.747 . . . . 0.0 109.27 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -161.51 -163.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.516 ' CD1' ' CB ' ' A' ' 36' ' ' LYS . 2.5 t80 -135.19 138.01 43.23 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.887 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -135.21 -136.22 0.16 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.421 -0.799 . . . . 0.0 110.102 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -82.82 -37.61 24.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.801 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -138.15 7.42 2.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' O ' ' CD ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -105.44 94.82 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.837 0.827 . . . . 0.0 109.737 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.515 HD21 ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -101.31 64.53 1.02 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.364 -0.835 . . . . 0.0 108.775 178.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 173.08 -123.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.305 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 36.8 ttp180 -130.44 122.71 28.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.526 -1.359 . . . . 0.0 111.944 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -83.01 106.31 14.72 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 22.6 t70 -88.89 170.96 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.762 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.618 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -169.94 119.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.565 -0.709 . . . . 0.0 110.17 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -110.89 156.71 20.78 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.016 -1.052 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.5 111.81 4.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.489 -1.382 . . . . 0.0 112.138 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.216 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' SER . 13.7 mtmm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 1.5 tt -171.9 130.81 0.65 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 0.0 109.829 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.601 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -117.1 168.28 10.42 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.0 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 10.8 mtt180 -137.04 -172.07 3.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.488 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.602 ' CZ ' ' HG3' ' A' ' 23' ' ' GLU . 60.1 m-85 -158.32 64.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -154.31 -160.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.728 -1.233 . . . . 0.0 111.71 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.19 50.88 30.7 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -177.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.7 Cg_endo -67.95 -173.86 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 124.564 1.823 . . . . 0.0 111.851 -176.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.526 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 25.0 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.38 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.154 0.502 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.551 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 2.9 p-90 -131.97 170.84 14.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.8 tp10 178.67 160.47 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.731 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.67 173.3 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.039 -1.038 . . . . 0.0 110.444 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.581 HG22 ' CG ' ' A' ' 11' ' ' PHE . 1.2 pp -103.84 -160.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.503 -0.748 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 12.9 p30 -132.0 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.977 -1.077 . . . . 0.0 111.644 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 14.9 tt 41.14 46.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.974 0.892 . . . . 0.0 109.909 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.544 ' N ' HG22 ' A' ' 12' ' ' THR . . . -133.66 -62.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD2' ' CD1' ' A' ' 6' ' ' ILE . 44.1 Cg_endo -84.01 -68.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.733 1.386 . . . . 0.0 111.062 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 43' ' ' LYS . 3.2 m-85 -44.58 -29.52 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.4 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 17.5 p -64.43 -58.77 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.508 ' N ' ' OG1' ' A' ' 12' ' ' THR . 3.8 tt0 -65.74 -26.72 67.86 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.844 0.831 . . . . 0.0 109.052 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.486 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 1.2 t30 -74.12 -55.16 6.42 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.584 0.707 . . . . 0.0 109.495 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 2.7 tt -37.99 -53.9 1.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.394 0.616 . . . . 0.0 109.924 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -56.04 -46.59 84.4 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.5 tttp -73.15 -72.46 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -1.185 . . . . 0.0 111.016 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CD1' ' ND2' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -39.88 -48.08 2.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.593 0.711 . . . . 0.0 110.868 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -55.34 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.712 -0.618 . . . . 0.0 110.604 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 15.0 m -43.89 -23.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 120.952 -1.092 . . . . 0.0 110.546 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -88.73 -73.78 0.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.072 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.558 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.6 mm-40 -57.69 -37.53 73.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.693 -1.255 . . . . 0.0 109.232 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -64.71 -50.06 68.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.974 -1.078 . . . . 0.0 109.155 178.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 55.1 t-20 -66.02 -46.53 77.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.573 -1.329 . . . . 0.0 107.739 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 4.2 tttp -59.4 -41.54 89.69 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.032 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -73.77 -12.93 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.05 81.44 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.526 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.426 ' C ' ' OG1' ' A' ' 33' ' ' THR . 16.6 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.553 0.692 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -164.13 51.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.781 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -176.19 123.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.363 -0.836 . . . . 0.0 109.833 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -158.67 -58.86 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.042 -1.036 . . . . 0.0 111.318 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.647 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.61 -97.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.957 -1.09 . . . . 0.0 111.38 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 6.7 t -160.48 173.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.521 -1.362 . . . . 0.0 111.617 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.568 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -126.79 109.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.795 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.596 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -117.24 -59.4 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.999 . . . . 0.0 110.926 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.6 Cg_endo -83.98 46.84 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.117 1.062 . . . . 0.0 111.119 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' CG1' ' A' ' 6' ' ' ILE . 18.6 p -88.97 98.0 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.509 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -97.52 -177.58 3.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 0.0 111.013 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -161.86 155.78 21.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.708 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.1 OUTLIER -170.68 126.96 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 110.817 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 19.2 m -112.58 152.11 29.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.548 ' N ' HG21 ' A' ' 45' ' ' THR . 2.1 mt . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' CG2' ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.494 2.521 0 CA-C-O 121.845 0.691 . . . . 0.0 111.992 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CG ' ' OG1' ' A' ' 45' ' ' THR . 2.0 t80 -126.91 102.06 6.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.146 -0.62 . . . . 0.0 109.808 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.5 pt-20 -104.08 152.23 22.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 109.558 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.642 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -141.94 154.93 45.43 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.14 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.506 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 6.1 pt20 -126.05 125.24 42.28 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.642 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 1.2 tp -121.44 69.54 0.92 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.919 -1.113 . . . . 0.0 109.179 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.557 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 23.0 t80 -69.21 110.52 4.62 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 31.2 m -159.5 -161.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -142.56 126.62 17.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 34' ' ' PHE . . . -119.95 -131.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.632 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 85.1 p -85.69 -25.29 26.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.007 -1.058 . . . . 0.0 109.175 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.59 17.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.1 ttmm -110.7 74.5 0.88 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.053 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mt -85.73 66.48 9.66 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 175.31 -119.92 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.455 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.563 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 19.6 ttp85 -137.73 125.65 22.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.55 -1.344 . . . . 0.0 111.918 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.69 110.71 17.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 1.5 t70 -92.03 165.58 13.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 111.032 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.603 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.78 118.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.28 142.06 51.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.861 -1.15 . . . . 0.0 110.771 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ASP . 21.7 mt-10 -152.99 132.29 12.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.315 -0.866 . . . . 0.0 109.824 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 0.0 110.723 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -172.2 155.8 3.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.971 -1.081 . . . . 0.0 109.602 -179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.583 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -142.72 166.24 25.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 11.1 mmt180 -135.32 -174.08 3.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 111.168 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CZ ' HD13 ' A' ' 85' ' ' LEU . 20.6 m-85 -157.69 61.08 0.48 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -152.27 -157.0 0.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 111.765 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.62 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 68.91 49.3 42.71 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -68.69 -169.26 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 124.436 1.756 . . . . 0.0 112.009 -176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 19.0 m . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.285 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.186 0.517 . . . . 2.7200000000000002 110.279 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.1 p90 -125.19 156.51 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 4.4400000000000004 110.214 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.519 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 5.6 pt-20 -166.36 129.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 2.4300000000000002 110.183 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.488 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 10.8 pt -75.45 176.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.18 -0.95 . . . . 1.8500000000000001 110.42 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.642 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -111.15 -162.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 2.9399999999999999 109.891 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -137.48 49.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.853 -1.154 . . . . 2.3399999999999999 111.597 -179.173 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 10.6 tt 40.08 43.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.826 0.822 . . . . 2.1299999999999999 110.038 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG22 ' A' ' 12' ' ' THR . . . -133.04 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.061 -1.066 . . . . 1.03 110.933 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.7 Cg_endo -86.35 -59.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.558 1.294 . . . . 1.01 111.131 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.642 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 m-30 -52.28 -32.7 38.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.957 -1.09 . . . . 2.0 109.318 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 38' ' ' ILE . 8.5 p -59.19 -57.91 10.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.113 -1.439 . . . . 1.29 107.113 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.532 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -66.8 -18.47 65.39 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.672 0.749 . . . . 2.6400000000000001 109.141 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.506 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 13.6 t-20 -78.02 -63.73 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 2.0299999999999998 109.833 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -40.22 -63.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.328 0.585 . . . . 2.5600000000000001 109.573 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -46.16 -46.18 15.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.246 -1.542 . . . . 0.57999999999999996 109.246 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -70.78 -84.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 3.1200000000000001 110.538 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' ALA . 2.5 m-85 -38.71 -64.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.401 0.619 . . . . 3.2599999999999998 111.045 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -43.37 -70.61 0.1 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.602 -0.686 . . . . 1.1299999999999999 109.919 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 42.4 t -40.89 -27.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.353 -0.842 . . . . 1.97 110.46 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -92.6 -66.27 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 1.72 110.336 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.536 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 2.4 mt-10 -60.82 -31.66 71.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.045 -1.062 . . . . 1.95 109.874 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -73.69 -60.19 2.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.891 -1.151 . . . . 1.6100000000000001 107.891 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.5 t-20 -52.02 -48.57 64.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.228 -1.397 . . . . 2.1899999999999999 107.228 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 42.5 tttt -56.85 -47.26 80.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.954 -1.128 . . . . 3.1600000000000001 107.954 177.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.542 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -50.48 -24.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.56 -0.904 . . . . 1.9199999999999999 108.56 178.609 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.67 24.99 2.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.384 -1.486 . . . . 0.87 109.384 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 34.6 tp60 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 2.6400000000000001 109.79 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.266 0.555 . . . . 2.71 109.961 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -146.9 50.12 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.266 -0.896 . . . . 1.21 109.91 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.517 ' N ' ' HB3' ' A' ' 64' ' ' ALA . 11.3 t80 174.96 79.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.73 . . . . 4.4199999999999999 109.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -120.94 -44.36 2.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.97 110.627 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.598 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.91 -96.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 3.8599999999999999 110.955 -179.406 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 28.1 t -157.57 171.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.621 -1.3 . . . . 1.27 111.679 -179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.543 ' CD1' HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.88 88.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.168 -0.678 . . . . 2.2200000000000002 109.168 179.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -105.02 -53.55 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.979 -1.075 . . . . 3.5699999999999998 110.979 -179.274 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.6 Cg_endo -84.02 50.92 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.395 1.208 . . . . 0.63 110.941 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 21.0 p -103.52 120.82 41.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.399 -0.813 . . . . 1.9299999999999999 109.807 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.488 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 27.5 mtm -119.03 177.29 4.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 2.4900000000000002 110.649 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -140.62 154.28 46.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.229 -0.919 . . . . 1.9199999999999999 110.41 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -151.75 100.63 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.144 -0.973 . . . . 2.8500000000000001 110.354 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 ' OG1' ' CE ' ' A' ' 43' ' ' LYS . 2.0 m -97.88 148.88 22.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 1.29 110.265 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.359 -0.978 . . . . 2.27 108.359 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 110.611 -0.996 . . . . 0.81000000000000005 110.611 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' GLU . 3.7 t80 -155.85 78.02 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.554 -0.968 . . . . 3.0800000000000001 110.231 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 14.9 pt-20 -99.35 167.39 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 2.4300000000000002 109.0 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -162.44 170.63 18.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.996 -1.481 . . . . 2.0099999999999998 112.977 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.519 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -133.82 123.76 25.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.787 -1.19 . . . . 2.3700000000000001 107.787 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.593 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -121.07 74.78 1.11 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.034 -1.041 . . . . 1.3400000000000001 109.399 -179.06 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -69.25 112.28 5.73 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.198 -1.038 . . . . 2.0600000000000001 108.198 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG22 ' CD ' ' A' ' 67' ' ' LYS . 33.2 m -158.19 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.779 0.799 . . . . 1.3 109.851 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.63 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.4 t80 -147.28 130.44 16.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.141 -0.688 . . . . 1.76 109.141 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 34' ' ' PHE . . . -124.17 -126.07 0.25 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.388 -0.82 . . . . 1.26 109.721 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 t -95.15 -24.71 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.912 -1.117 . . . . 1.8 108.726 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.02 18.4 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.503 0.668 . . . . 1.52 109.446 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.3 ttmm -115.23 78.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 2.0099999999999998 110.229 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.63 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 9.0 mt -88.17 64.86 7.89 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.895 -0.78 . . . . 2.3500000000000001 108.895 178.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 178.7 -123.83 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.047 -1.061 . . . . 2.2599999999999998 110.534 -179.085 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 25.3 ttm180 -131.02 123.63 29.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.328 -1.483 . . . . 2.1600000000000001 112.194 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -80.48 107.9 13.66 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.651 -1.611 . . . . 1.1499999999999999 106.651 176.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 1.8 t70 -89.64 162.2 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.002 -1.061 . . . . 1.71 110.404 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.583 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.2 110.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.73 0.776 . . . . 1.6299999999999999 109.294 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -110.71 122.47 47.89 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.247 -0.908 . . . . 1.5700000000000001 109.955 -179.211 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 83' ' ' LYS . 22.9 mt-10 -144.96 122.86 11.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 2.02 110.066 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 2.1400000000000001 110.104 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.526 ' CG ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.976 -0.75 . . . . 3.6899999999999999 108.976 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 11.8 tp -170.59 173.95 5.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.145 . . . . 2.6800000000000002 110.423 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.542 ' CD2' ' CG1' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -154.01 171.64 18.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 1.53 109.928 179.487 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.543 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 10.6 mtt180 -140.08 -177.9 5.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 3.25 110.989 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 23.7 m-85 -153.27 63.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.706 -0.621 . . . . 0.87 109.398 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -153.3 -156.5 0.7 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.194 . . . . 2.3599999999999999 111.388 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.98 52.32 29.07 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 105.323 -3.111 . . . . 1.4399999999999999 105.323 -177.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.6 Cg_endo -68.33 -178.02 1.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 124.598 1.841 . . . . 2.23 111.938 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 30.1 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.966 -1.016 . . . . 2.27 110.45 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.56 178.18 8.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -1.129 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' CB ' ' HE2' ' A' ' 44' ' ' LYS . 6.8 p90 -165.2 150.07 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 10.4 pt-20 -171.02 132.37 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 21.5 pt -83.63 -177.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.266 -0.897 . . . . 0.0 110.486 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.641 ' CD1' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -121.63 -154.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.577 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -138.77 50.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.837 -1.164 . . . . 0.0 111.53 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.577 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 19.2 tt 40.44 51.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.159 0.98 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.676 ' N ' HG22 ' A' ' 12' ' ' THR . . . -139.51 -65.43 0.04 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 46.2 Cg_endo -82.4 -58.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.83 1.437 . . . . 0.0 111.275 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 6' ' ' ILE . 2.6 m-30 -54.33 -22.07 11.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.834 -1.166 . . . . 0.0 109.687 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.676 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -69.12 -61.26 1.87 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.577 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -55.3 -25.09 32.11 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.676 0.751 . . . . 0.0 110.001 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -80.72 -44.1 19.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.797 0.808 . . . . 0.0 109.871 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -46.82 -47.21 21.1 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.479 0.656 . . . . 0.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -64.74 -51.13 54.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -67.73 -79.74 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.24 . . . . 0.0 110.592 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -33.84 -62.55 0.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.447 0.641 . . . . 0.0 111.1 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -44.39 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.411 -0.806 . . . . 0.0 109.917 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 26.2 t -41.62 -25.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.553 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' ALA . 2.6 t70 -87.66 -70.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.983 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.58 ' HB3' ' CD1' ' A' ' 85' ' ' LEU . 4.1 tt0 -61.88 -37.4 84.45 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.32 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -58.79 -53.22 60.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.938 -1.101 . . . . 0.0 108.778 177.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 10.0 t-20 -68.68 -47.05 67.46 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.36 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -57.1 -35.84 69.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 110.322 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -68.63 -21.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.0 110.005 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 121.5 10.47 6.54 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 18.0 mm-40 -107.73 58.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 109.562 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 30' ' ' GLY . 33.1 p90 -82.61 12.75 4.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 31' ' ' ARG . . . -42.06 -66.86 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -145.57 -162.48 1.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.749 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.606 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.28 -177.78 1.19 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.186 -0.946 . . . . 0.0 109.74 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -136.94 52.12 1.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 109.943 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 13.9 p90 -169.7 123.11 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.881 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' N ' ' A' ' 65' ' ' SER . 1.8 t-20 -155.14 -65.06 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -0.937 . . . . 0.0 110.71 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -69.14 -98.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.954 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.3 t -161.84 172.35 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.687 -1.258 . . . . 0.0 111.719 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -120.17 113.22 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.602 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -120.49 -59.92 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.92 -1.113 . . . . 0.0 110.707 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.1 Cg_endo -82.73 47.65 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.091 1.048 . . . . 0.0 111.081 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 38' ' ' ILE . 27.8 p -84.18 122.18 28.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -123.23 164.15 19.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 111.25 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.23 137.46 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.864 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HE2' ' CB ' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -145.58 134.2 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.069 -1.019 . . . . 0.0 110.291 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 46' ' ' ILE . 15.7 m -126.75 155.11 43.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.517 ' N ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -116.27 56.1 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CE2' ' HA ' ' A' ' 49' ' ' ASN . 10.8 p90 -103.79 -179.3 3.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.686 0.755 . . . . 0.0 111.598 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -69.2 -100.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.648 -0.657 . . . . 0.0 110.089 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 8.4 t30 -178.89 -43.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.884 -1.135 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 50' ' ' GLU . 22.9 tt0 -154.98 17.47 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.809 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 -29.83 2.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.468 -0.77 . . . . 0.0 109.832 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 8.3 pt-20 -170.63 178.33 3.64 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.456 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 77' ' ' TYR . 16.3 mm -125.45 126.71 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.527 -0.733 . . . . 0.0 109.412 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -100.46 -59.63 1.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.076 -1.015 . . . . 0.0 112.509 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . . . -142.73 127.67 3.23 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.253 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.529 ' CE2' ' HE3' ' A' ' 43' ' ' LYS . 35.4 t80 -113.76 104.1 11.87 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.386 -1.067 . . . . 0.0 110.019 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 20.2 pt-20 -119.52 175.99 5.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.455 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.648 ' CD1' ' CG2' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -153.51 162.75 40.96 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.573 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.6 tt0 -126.22 120.98 31.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.61 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 2.3 tp -118.66 71.5 0.85 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 109.566 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -70.16 110.97 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.59 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 29.1 m -159.74 -165.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.601 -0.687 . . . . 0.0 109.795 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.584 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.5 t80 -138.93 130.02 26.68 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.053 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -124.05 -131.4 0.26 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.632 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 79.8 p -81.73 -28.93 33.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.237 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.88 18.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.602 -0.686 . . . . 0.0 109.655 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.8 ttmm -105.18 73.63 1.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.57 HD13 ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.77 64.54 8.63 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 177.25 -127.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.517 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' CD ' ' HG3' ' A' ' 59' ' ' GLN . 14.0 ttm180 -132.46 127.02 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.49 -1.381 . . . . 0.0 111.987 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.64 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -83.79 102.75 12.54 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -86.55 172.83 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.497 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.648 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -168.51 131.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.877 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.6 OUTLIER -122.25 159.73 26.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 2.3 mt-10 -152.59 108.51 3.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.829 -1.169 . . . . 0.0 111.785 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.563 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -42.62 168.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.569 ' CE2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -158.19 -56.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.594 -1.316 . . . . 0.0 111.281 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 9.0 tptp -134.55 -37.16 0.85 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.934 -1.104 . . . . 0.0 109.342 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.702 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 17.6 m -75.25 -62.29 1.61 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.702 ' HB3' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 151.58 47.52 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.577 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' CA ' ' HA ' ' A' ' 76' ' ' ASP . . . -62.75 -137.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 8.2 ptm85 -172.43 172.56 4.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.403 -1.645 . . . . 0.0 111.082 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' O ' HD11 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -99.09 127.7 45.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.519 ' CA ' ' OE2' ' A' ' 22' ' ' GLU . 7.3 tp -171.2 -169.44 0.74 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.954 -1.092 . . . . 0.0 109.791 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.659 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -170.69 166.16 8.04 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.3 mtt-85 -145.91 143.7 29.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.724 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.659 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 2.5 m-85 -115.22 73.81 0.85 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -159.71 -164.9 1.41 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.911 -1.118 . . . . 0.0 111.759 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.594 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 70.79 52.06 16.86 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.392 -3.483 . . . . 0.0 104.392 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.2 Cg_endo -64.46 -174.14 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.714 1.902 . . . . 0.0 112.742 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 1.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.105 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.56 173.79 10.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 110.209 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -161.77 149.0 14.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -177.18 159.23 1.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.45 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 3.1 pt -95.03 -175.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.621 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.7 -165.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.217 -0.927 . . . . 0.0 110.468 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.536 ' O ' HG21 ' A' ' 8' ' ' ILE . 24.1 t70 -139.94 51.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.074 -1.016 . . . . 0.0 111.167 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 7' ' ' ASP . 4.6 tt 39.52 40.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.836 0.827 . . . . 0.0 110.098 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.538 ' N ' HG22 ' A' ' 12' ' ' THR . . . -147.25 -65.9 0.01 OUTLIER Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' THR . 44.7 Cg_endo -75.13 -85.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.61 1.321 . . . . 0.0 111.386 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.621 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 66.2 m-85 -39.05 -27.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.398 -0.814 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.556 ' CB ' HG23 ' A' ' 38' ' ' ILE . 18.6 p -60.47 -58.31 9.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.076 -1.015 . . . . 0.0 108.648 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.7 pt20 -59.15 -15.97 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.446 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -76.19 -60.04 2.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 110.065 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 pp -43.68 -34.81 1.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.409 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -62.51 -54.43 34.2 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -72.96 -66.45 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -1.022 . . . . 0.0 110.131 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 21' ' ' ASP . 2.0 m-30 -40.5 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.484 0.659 . . . . 0.0 110.44 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -39.92 -68.2 0.19 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.808 -0.558 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 16' ' ' GLY . 4.1 t -41.98 -26.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.104 -0.997 . . . . 0.0 110.024 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 18' ' ' PHE . 6.0 m-20 -95.3 -66.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.537 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 14.6 mm-40 -59.08 -26.83 64.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.825 -1.172 . . . . 0.0 109.23 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -76.79 -61.54 1.94 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 25.3 t-20 -54.22 -43.12 70.53 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.615 -1.234 . . . . 0.0 107.815 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 18.5 tptp -56.28 -59.21 5.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.211 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.545 ' CD1' ' O ' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -55.32 -20.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.629 0.728 . . . . 0.0 109.622 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 81.13 60.72 2.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -119.35 -45.88 2.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -1.14 . . . . 0.0 109.892 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -140.34 -73.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.392 -0.818 . . . . 0.0 110.066 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.41 43.27 7.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -117.92 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -170.53 50.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -36.5 90.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.751 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' LEU . 7.7 t80 165.82 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 0.0 109.617 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -155.66 -64.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.94 -1.1 . . . . 0.0 111.382 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.624 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -69.52 -99.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 111.453 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 13.9 t -159.22 172.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.536 -1.352 . . . . 0.0 111.727 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.567 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -127.79 99.08 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.626 . . . . 0.0 110.01 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -108.49 -54.76 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.488 -0.758 . . . . 0.0 110.159 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 41.7 Cg_endo -84.88 51.37 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.412 1.217 . . . . 0.0 111.306 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.482 ' O ' HD13 ' A' ' 6' ' ' ILE . 21.9 t -104.42 106.37 16.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.526 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 10.2 mtt -96.96 157.08 16.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.056 -1.028 . . . . 0.0 110.158 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.591 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 2.6 tmtt? -137.11 154.71 50.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 110.978 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 13.3 tttt -160.33 158.9 30.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.627 -0.671 . . . . 0.0 109.603 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.573 HG22 ' CD1' ' A' ' 56' ' ' TYR . 21.4 m -159.48 151.05 20.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -118.48 62.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.483 ' CD1' ' OE2' ' A' ' 48' ' ' GLU . 12.3 p90 -68.1 -157.1 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.567 0.699 . . . . 0.0 111.215 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 52' ' ' GLU . 3.1 pm0 -66.88 -164.86 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.32 1.057 . . . . 0.0 111.884 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.459 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 16.0 t-20 -168.83 -36.72 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 -43.63 3.2 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.761 -0.587 . . . . 0.0 109.462 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 26.6 ttt85 -173.5 20.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.536 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 48' ' ' GLU . 12.8 pt-20 -147.85 120.86 8.8 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.137 -1.602 . . . . 0.0 111.926 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.644 ' CG2' ' CG ' ' A' ' 77' ' ' TYR . 7.8 mt -68.33 138.83 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -104.78 -77.27 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.118 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 76' ' ' ASP . . . -171.12 174.97 44.88 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.878 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 45' ' ' THR . 2.4 m-85 -116.95 173.48 6.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 122.133 -0.628 . . . . 0.0 109.898 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER 178.72 130.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.499 -0.751 . . . . 0.0 109.206 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 73' ' ' ILE . 3.4 p90 -150.6 171.73 16.65 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.1 -1.44 . . . . 0.0 113.606 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' CG ' ' HB2' ' A' ' 42' ' ' MET . 0.0 OUTLIER -124.34 112.35 16.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.544 ' CD2' ' HE3' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -104.36 68.28 0.87 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 109.67 -178.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -69.81 109.7 4.56 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.547 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 34.8 m -159.41 -162.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.574 0.702 . . . . 0.0 109.634 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.624 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -137.94 124.6 20.96 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -122.86 -127.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.477 -0.765 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 t -84.57 -52.56 6.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.019 -1.051 . . . . 0.0 109.389 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 29' ' ' TYR . 7.0 t0 -128.65 30.23 5.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.359 -0.838 . . . . 0.0 109.256 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -125.46 80.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.703 0.763 . . . . 0.0 110.046 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.581 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 6.3 mp -90.07 59.66 4.58 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 p90 176.98 -142.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.407 -0.808 . . . . 0.0 109.581 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 4.8 ttm180 -113.26 140.77 47.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.531 -1.356 . . . . 0.0 112.236 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' CB ' HD21 ' A' ' 60' ' ' LEU . . . -99.44 103.45 15.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' HB3' ' N ' ' A' ' 86' ' ' ARG . 9.9 t70 -77.24 157.58 30.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.769 -1.207 . . . . 0.0 109.927 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -162.62 101.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.672 0.748 . . . . 0.0 109.156 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -113.37 134.96 54.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 mt-10 -157.9 136.53 11.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.936 -1.102 . . . . 0.0 111.28 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.638 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -60.13 -144.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.227 -0.92 . . . . 0.0 109.826 178.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.644 ' CG ' ' CG2' ' A' ' 53' ' ' ILE . 6.2 t80 -161.26 -56.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.68 -1.262 . . . . 0.0 111.36 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 1.7 ttmm -74.49 -58.43 3.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.113 -0.992 . . . . 0.0 109.722 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 52.6 m -93.75 9.52 36.77 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.137 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' C ' ' A' ' 81' ' ' GLY . 27.3 mmm-85 59.65 15.85 4.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.472 -0.768 . . . . 0.0 109.755 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.638 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . 4.09 -72.37 0.0 OUTLIER Glycine 0 N--CA 1.499 2.882 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.58 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 80' ' ' ARG . 3.2 mtt180 -161.07 -174.64 4.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.768 -1.43 . . . . 0.0 111.515 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -170.47 160.43 7.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 0.0 109.514 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.559 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -156.02 175.21 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.04 -1.038 . . . . 0.0 110.399 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.539 ' N ' ' HB3' ' A' ' 72' ' ' ASP . 6.0 mtt180 -157.5 131.67 8.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.0 110.704 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 84.2 m-85 -107.98 64.92 0.63 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -152.63 -158.76 0.93 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.998 -1.064 . . . . 0.0 111.148 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.17 52.82 29.53 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 104.876 -3.29 . . . . 0.0 104.876 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -65.64 -171.78 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.728 1.909 . . . . 0.0 112.585 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.139 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.58 -1.408 . . . . 4.0700000000000003 109.58 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' HG2' ' C ' ' A' ' 1' ' ' GLY . 3.4 mt-10 -137.34 129.92 29.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 2.8300000000000001 110.218 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 23.5 p90 -79.99 167.96 19.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 4.4800000000000004 110.225 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.86 119.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 2.7200000000000002 110.167 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 1.2 pt -80.35 -176.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.219 -0.926 . . . . 1.9399999999999999 110.396 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.609 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.21 -164.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.287 -0.883 . . . . 2.9500000000000002 109.881 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 42.2 t0 -144.35 61.77 1.34 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 3.5 111.592 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 14.0 tt 40.53 45.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.002 0.906 . . . . 2.2599999999999998 109.953 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 12' ' ' THR . . . -138.41 -65.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 120.138 -1.03 . . . . 1.04 111.434 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 43.6 Cg_endo -82.17 -72.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.596 1.314 . . . . 1.05 111.416 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.609 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 1.9 m-30 -44.5 -32.05 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 109.583 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.533 HG21 ' CD1' ' A' ' 38' ' ' ILE . 25.0 p -57.59 -57.69 11.59 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.52 -1.289 . . . . 1.4399999999999999 107.52 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -72.99 -17.67 61.43 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.749 0.785 . . . . 2.77 109.455 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 2.7 t-20 -79.4 -58.65 3.1 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.643 0.735 . . . . 2.1000000000000001 109.371 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 19' ' ' ALA . 2.6 tp -42.04 -56.13 2.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.212 -0.662 . . . . 2.6000000000000001 109.212 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -49.53 -57.48 9.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.67000000000000004 109.535 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -68.75 -77.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.129 . . . . 2.9500000000000002 110.665 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 3.3 m-85 -37.77 -72.57 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.418 0.628 . . . . 2.8500000000000001 111.221 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' CB ' HD13 ' A' ' 15' ' ' LEU . . . -41.42 -69.23 0.14 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 1.1699999999999999 110.342 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 55.4 t -42.34 -27.95 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 2.04 110.356 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' LYS . 2.2 m-20 -93.49 -62.54 1.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.233 -0.917 . . . . 1.9099999999999999 110.353 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 2.0 mt-10 -61.96 -31.57 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.008 -1.057 . . . . 2.1699999999999999 109.81 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -75.42 -59.59 2.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.181 -1.044 . . . . 1.6399999999999999 108.181 178.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 36.8 t-20 -53.25 -46.56 69.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.223 -1.399 . . . . 2.27 107.223 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 13.7 tttt -58.2 -48.56 79.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.867 -1.16 . . . . 3.3300000000000001 107.867 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.586 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -48.46 -26.54 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.527 -0.916 . . . . 2.2799999999999998 108.527 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 27.89 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.223 -1.551 . . . . 1.01 109.223 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 24.8 tp60 -128.91 68.52 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -1.041 . . . . 2.73 109.671 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.503 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 35.1 p90 -90.45 23.62 2.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 5.8099999999999996 109.766 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -40.44 -55.74 3.05 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.893 -1.283 . . . . 2.5899999999999999 109.893 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.511 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 13.1 mtt180 -161.07 -89.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -1.178 . . . . 4.1399999999999997 110.001 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 3.4 mp -133.26 -178.2 4.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.313 -0.867 . . . . 3.0699999999999998 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -144.9 50.65 1.25 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.345 -0.847 . . . . 1.27 109.769 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.522 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 9.6 t80 -179.88 74.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 4.2999999999999998 110.279 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.32 -45.86 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 2.9100000000000001 110.561 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -69.24 -94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 3.96 111.002 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 23.1 t -158.55 172.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.694 -1.254 . . . . 1.6399999999999999 111.622 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.542 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -134.39 85.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.675 -0.641 . . . . 2.29 109.361 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -103.25 -54.22 0.12 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 3.6299999999999999 110.817 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.9 Cg_endo -83.5 52.15 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.335 1.177 . . . . 0.60999999999999999 110.324 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' A' ' 6' ' ' ILE . 21.2 p -104.03 113.1 26.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.835 . . . . 2.0800000000000001 110.408 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.523 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 8.3 mtm -113.91 176.97 4.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.846 . . . . 2.6499999999999999 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.23 159.32 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.027 . . . . 2.1400000000000001 110.985 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -154.17 128.59 9.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.503 -0.748 . . . . 2.9500000000000002 109.93 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.0 m -118.57 148.84 42.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 1.26 110.084 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.527 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -115.51 43.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.404 -0.962 . . . . 2.4700000000000002 108.404 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.88 -176.82 6.08 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.624 -0.672 . . . . 3.1299999999999999 110.915 -178.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' CG ' ' HG2' ' A' ' 52' ' ' GLU . 9.7 tp10 -69.4 -101.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 4.0099999999999998 109.648 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.4 -59.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.773 -1.204 . . . . 4.8799999999999999 110.637 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -146.84 12.24 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 4.3799999999999999 110.059 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -122.7 -22.58 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.352 -0.842 . . . . 5.7800000000000002 109.828 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' HG2' ' CG ' ' A' ' 48' ' ' GLU . 15.4 pt-20 -170.14 -163.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.111 -1.036 . . . . 3.2799999999999998 111.107 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.638 ' CG1' ' CG ' ' A' ' 77' ' ' TYR . 9.9 tp -131.57 157.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.742 -0.599 . . . . 2.5600000000000001 109.539 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 2.9 tttt -136.36 -64.56 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.917 -1.115 . . . . 3.3700000000000001 111.572 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.527 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -134.21 164.19 24.54 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.631 -1.747 . . . . 0.80000000000000004 110.625 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' GLU . 36.6 t80 -156.84 92.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -1.057 . . . . 4.21 110.418 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.7 pt-20 -126.47 171.83 10.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 2.6299999999999999 108.85 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 1.7 p90 -163.05 166.02 24.11 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 117.876 -1.53 . . . . 2.4199999999999999 113.419 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 70' ' ' ARG . 92.6 mt-30 -119.82 107.53 13.27 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.742 -1.207 . . . . 2.1699999999999999 107.742 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.568 HD11 ' CD2' ' A' ' 11' ' ' PHE . 0.4 OUTLIER -105.77 73.72 1.02 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.289 -0.882 . . . . 1.3700000000000001 109.14 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -69.61 112.34 6.03 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.031 -1.1 . . . . 2.4300000000000002 108.031 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' CG1' ' A' ' 38' ' ' ILE . 22.7 m -157.84 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.769 0.795 . . . . 1.1200000000000001 109.496 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.631 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.5 t80 -149.19 129.47 13.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 1.8400000000000001 109.272 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' HB2' ' N ' ' A' ' 34' ' ' PHE . . . -123.53 -118.09 0.29 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 1.29 109.685 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -102.15 -25.21 13.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.754 -1.216 . . . . 1.75 108.804 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.8 16.19 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 1.99 109.603 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -113.93 78.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 2.02 110.338 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.631 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 10.9 mt -86.16 63.19 7.88 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.501 -0.926 . . . . 2.2999999999999998 108.501 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 176.06 -122.69 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.539 -0.864 . . . . 2.3100000000000001 109.912 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.522 ' CZ ' ' HG2' ' A' ' 59' ' ' GLN . 5.9 tmm_? -133.73 144.61 49.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.166 -1.583 . . . . 2.3999999999999999 112.416 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -92.08 92.33 8.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.241 -1.763 . . . . 1.1499999999999999 106.241 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 4.7 t0 -80.99 82.96 6.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.011 . . . . 1.73 110.741 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.628 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -76.19 138.92 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.692 -0.803 . . . . 1.75 109.577 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -131.54 121.65 24.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 1.5900000000000001 109.518 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 1.1 mt-10 -151.81 119.16 5.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.937 -1.102 . . . . 2.2999999999999998 110.477 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.567 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 3.2 t0 -61.33 -137.83 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.17 -0.956 . . . . 2.2599999999999998 109.895 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.638 ' CG ' ' CG1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.21 -60.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 3.3999999999999999 110.76 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 tttt -87.06 -55.23 3.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.184 -0.948 . . . . 4.5800000000000001 109.587 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 1.81 18.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.309 -0.869 . . . . 4.0999999999999996 109.602 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 81' ' ' GLY . 12.9 mmt85 55.3 29.07 12.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.335 -0.853 . . . . 7.0599999999999996 109.935 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -24.92 -70.49 0.03 OUTLIER Glycine 0 N--CA 1.501 3.03 0 CA-C-N 116.216 -0.447 . . . . 2.9900000000000002 112.102 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -162.97 -178.08 5.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.653 -1.498 . . . . 5.75 111.212 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 75' ' ' GLU . 10.8 mtpt -148.58 105.29 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.655 -0.653 . . . . 3.9300000000000002 109.325 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.45 ' CD1' HD12 ' A' ' 26' ' ' ILE . 9.0 tp -170.1 179.12 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 2.9500000000000002 110.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.586 ' CD2' ' CG1' ' A' ' 26' ' ' ILE . 1.2 pt? -153.68 -179.19 7.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 1.8 110.509 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.538 ' C ' ' CD2' ' A' ' 87' ' ' PHE . 3.0 mtt180 -134.66 -177.06 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 3.1899999999999999 110.49 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.586 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 69.4 m-85 -154.17 62.6 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.055 -0.72 . . . . 0.97999999999999998 109.055 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 3.0 m-80 -152.37 -157.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 2.48 111.488 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 66.71 52.59 33.01 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 104.855 -3.298 . . . . 1.4199999999999999 104.855 -176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.0 Cg_endo -67.77 -171.17 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 124.499 1.789 . . . . 2.1499999999999999 111.899 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.524 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 31.6 m . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 117.945 -1.026 . . . . 2.29 110.4 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.32 159.71 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 0.0 110.245 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 42.2 p-90 -150.58 142.32 23.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.156 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 21.2 mt-10 -158.36 -176.99 6.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.42 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.568 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -133.38 168.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.574 HG13 ' CD2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -148.66 -170.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.7 OUTLIER 174.5 143.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.03 -1.044 . . . . 0.0 111.319 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.578 ' CA ' HG23 ' A' ' 12' ' ' THR . 2.7 tp 43.06 25.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.317 0.58 . . . . 0.0 110.636 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.528 ' N ' HG22 ' A' ' 12' ' ' THR . . . -127.75 -103.21 1.19 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.311 -1.423 . . . . 0.0 112.421 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.533 ' CG ' HG22 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -81.66 -64.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.844 1.696 . . . . 0.0 111.984 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.711 ' CD1' ' CZ ' ' A' ' 58' ' ' TYR . 2.2 m-85 -42.91 -25.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.578 HG23 ' CA ' ' A' ' 8' ' ' ILE . 2.6 p -69.59 -62.08 1.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.573 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.8 tt0 -66.64 -18.0 65.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 109.357 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 15' ' ' LEU . 1.7 m-80 -79.21 -60.83 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.664 -0.647 . . . . 0.0 110.053 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -39.91 -50.66 2.48 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.425 0.631 . . . . 0.0 109.39 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -53.32 -57.31 15.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' PHE . 6.0 tttp -69.36 -69.25 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -1.175 . . . . 0.0 110.62 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-30 -38.72 -63.33 0.52 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.996 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -44.19 -72.79 0.05 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.589 -0.694 . . . . 0.0 110.273 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 11.0 t -40.74 -26.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 0.0 110.616 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.5 m-20 -92.19 -70.92 0.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.943 -1.098 . . . . 0.0 109.783 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 73' ' ' ILE . 8.9 mm-40 -56.42 -34.61 66.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.911 -1.118 . . . . 0.0 109.52 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 1.2 tt0 -67.17 -56.63 9.1 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.9 m120 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.914 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -55.35 -51.07 67.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.489 -0.757 . . . . 0.0 109.757 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -62.91 -16.57 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.469 -0.77 . . . . 0.0 110.021 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 115.26 50.89 0.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -152.16 78.18 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -1.106 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 30' ' ' GLY . 29.4 p90 -107.66 29.14 7.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.57 -53.95 4.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -168.53 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -1.135 . . . . 0.0 109.897 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -146.34 153.13 40.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 109.813 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -112.83 52.88 0.77 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.262 -0.899 . . . . 0.0 110.094 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.64 98.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 12.1 t-20 -134.2 -64.83 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.935 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -70.41 -106.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 111.237 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 11.0 t -158.85 173.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.485 -1.384 . . . . 0.0 111.829 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.563 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -120.9 132.53 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.596 0.712 . . . . 0.0 110.259 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.613 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -136.63 -61.54 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.536 -0.727 . . . . 0.0 109.709 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.0 Cg_endo -81.48 46.16 2.17 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.062 1.033 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 22.9 p -80.34 80.18 6.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.078 -1.014 . . . . 0.0 109.098 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.485 ' O ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -83.18 138.13 33.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.131 -0.981 . . . . 0.0 111.066 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.38 157.61 17.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.801 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 4.5 mttt -160.09 103.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -0.78 . . . . 0.0 109.214 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.549 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.4 m -124.27 153.89 41.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.866 -1.146 . . . . 0.0 111.213 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.549 ' N ' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -128.74 60.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.585 ' CD2' ' OE1' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -88.57 -153.55 0.25 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.933 0.873 . . . . 0.0 112.528 -177.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -68.55 -145.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.759 0.79 . . . . 0.0 111.891 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.607 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -113.79 -49.26 2.88 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -167.99 25.66 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -31.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.144 -1.022 . . . . 0.0 112.005 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 1.7 mt-10 -107.89 -156.6 0.59 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.511 -1.368 . . . . 0.0 111.919 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.666 ' CG2' ' CG ' ' A' ' 77' ' ' TYR . 30.4 mm -152.91 131.28 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -119.89 -65.9 1.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.715 -1.241 . . . . 0.0 111.815 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 76' ' ' ASP . . . -144.01 164.68 27.49 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.164 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -150.35 86.74 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.267 -1.137 . . . . 0.0 111.153 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 7.1 pt-20 -95.16 149.27 21.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CZ ' ' CD1' ' A' ' 11' ' ' PHE . 2.3 t80 -144.97 139.64 27.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.914 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 28.2 mt-30 -99.19 107.03 19.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.674 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 25.0 tp -98.92 62.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.591 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 1.4 t80 -71.9 104.86 3.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.779 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 33.6 m -161.64 -165.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.588 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.7 t80 -131.26 134.6 46.57 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.248 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 35' ' ' ASN . . . -130.68 -132.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.331 -0.856 . . . . 0.0 109.977 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.0 -29.73 13.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.595 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -136.18 3.88 2.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.427 -0.796 . . . . 0.0 110.12 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' O ' ' CD ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -113.19 100.7 8.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 63' ' ' TYR . 6.8 mp -100.88 59.31 0.92 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.366 -0.834 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.24 -115.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.012 . . . . 0.0 110.156 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 38.9 ttp85 -124.35 157.83 34.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.332 -1.48 . . . . 0.0 112.807 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -118.37 91.88 3.68 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 30.5 t0 -69.15 81.27 0.34 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 110.906 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.549 ' CD1' ' HG3' ' A' ' 22' ' ' GLU . 2.6 mm -68.38 114.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.394 -0.817 . . . . 0.0 108.903 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.478 ' C ' ' CG ' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -118.36 118.17 31.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.372 -0.83 . . . . 0.0 110.675 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' CG ' ' C ' ' A' ' 74' ' ' SER . 40.3 mt-10 -153.38 120.19 5.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.031 -1.043 . . . . 0.0 110.794 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.541 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 5.4 t0 -72.4 -140.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.153 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.666 ' CG ' ' CG2' ' A' ' 53' ' ' ILE . 0.3 OUTLIER 179.72 -65.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.965 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 5.7 tttt -77.68 -55.79 5.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 0.0 109.169 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -72.26 -6.23 41.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.362 -0.836 . . . . 0.0 109.012 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER 63.02 27.43 15.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.334 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -33.03 -78.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 5.4 mtt85 -170.16 -168.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.657 -1.496 . . . . 0.0 111.436 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -149.43 104.16 3.35 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 83' ' ' LYS . 7.4 tp -169.97 -174.13 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 110.221 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.652 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -165.43 179.1 6.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 110.645 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mtt85 -142.84 128.65 19.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.652 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 4.5 m-85 -104.77 85.13 2.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -153.59 -156.98 0.74 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.734 -1.229 . . . . 0.0 110.784 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.05 51.49 6.88 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.1 Cg_endo -66.49 138.64 50.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.459 1.768 . . . . 0.0 111.203 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.323 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -154.06 161.41 41.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.268 -1.137 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.55 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -132.37 178.16 7.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 43' ' ' LYS . 1.1 tt0 176.99 119.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.767 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 16.4 pt -75.59 178.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.248 -0.908 . . . . 0.0 110.829 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.57 ' HB ' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -92.84 -164.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.328 -0.857 . . . . 0.0 110.712 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.55 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 39.6 t0 -156.75 46.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.797 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.55 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 17.9 tt 40.27 37.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.656 0.741 . . . . 0.0 109.83 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 12' ' ' THR . . . -143.52 -65.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.207 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' THR . 46.1 Cg_endo -78.7 -79.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.665 1.35 . . . . 0.0 111.427 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.598 ' CE1' ' HB2' ' A' ' 43' ' ' LYS . 97.1 m-85 -40.19 -29.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' N ' ' A' ' 9' ' ' GLY . 16.9 p -61.15 -59.11 5.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -67.35 -12.36 59.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 16.4 m120 -84.61 -69.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 4.0 pp -42.04 -28.22 0.17 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.695 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 14' ' ' ASN . . . -74.66 -46.15 19.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -80.87 -41.89 22.39 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.201 -1.176 . . . . 0.0 110.253 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -35.85 82.46 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.595 0.712 . . . . 0.0 109.916 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -65.87 -71.79 0.18 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 21' ' ' ASP . 7.5 p -34.52 -33.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.775 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 19' ' ' ALA . 87.1 m-20 -93.15 -73.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 6.9 mm-40 -57.2 -23.42 47.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.107 . . . . 0.0 110.206 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.581 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 1.4 tt0 -80.93 -63.36 1.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 49.1 m-20 -52.23 -46.89 65.9 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -55.35 -50.67 69.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.553 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -50.18 -24.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.7 0.762 . . . . 0.0 109.05 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.04 36.12 1.06 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -139.26 73.51 1.43 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.503 -0.998 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 46.8 t80 -92.95 25.47 3.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.414 -0.804 . . . . 0.0 109.697 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.7 -66.47 0.65 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 35.6 mtp180 -161.67 -91.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -1.206 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.6 OUTLIER -138.06 159.39 42.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.91 . . . . 0.0 110.062 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.6 57.81 0.77 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.534 ' CA ' ' HB3' ' A' ' 64' ' ' ALA . 2.4 t80 -158.5 109.69 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -152.02 -70.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.923 . . . . 0.0 111.281 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -69.47 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.926 -1.109 . . . . 0.0 111.265 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' HG21 ' A' ' 62' ' ' VAL . 4.6 t -160.57 156.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.443 -1.411 . . . . 0.0 112.273 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.535 ' CD1' HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -106.12 140.74 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.713 0.768 . . . . 0.0 109.546 178.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.566 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.47 -61.92 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.679 -0.638 . . . . 0.0 110.09 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 52.1 Cg_endo -77.91 39.95 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.307 1.161 . . . . 0.0 111.687 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.522 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 85.3 m -93.49 148.45 22.07 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.938 -1.101 . . . . 0.0 109.945 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.494 ' O ' ' O ' ' A' ' 59' ' ' GLN . 5.2 mtm -138.48 161.93 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.028 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 2.7 tmtt? -152.03 131.72 13.16 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.955 -1.091 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -148.81 130.54 15.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.884 . . . . 0.0 110.348 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.579 HG21 ' N ' ' A' ' 46' ' ' ILE . 1.5 m -108.21 154.09 22.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.977 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.579 ' N ' HG21 ' A' ' 45' ' ' THR . 12.9 pt -120.67 41.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.547 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -69.93 -148.27 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 122.12 0.962 . . . . 0.0 111.673 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.2 pt-20 -69.12 -153.0 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.962 0.887 . . . . 0.0 112.608 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 3.5 t30 -156.35 -35.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.303 0.573 . . . . 0.0 109.574 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.46 -29.94 1.17 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 51' ' ' ARG . 4.0 ppt_? -171.37 20.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.739 -1.225 . . . . 0.0 112.089 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 5.1 mt-10 -114.97 -147.13 0.41 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.974 -1.079 . . . . 0.0 110.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG12 ' CG ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -170.66 140.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' TYR . 7.7 mttt -131.64 -78.12 0.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 112.091 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' O ' HG21 ' A' ' 45' ' ' THR . . . -163.14 -163.62 16.25 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 117.757 -2.163 . . . . 0.0 111.326 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.57 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.3 t80 -160.85 107.73 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.786 -0.832 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' LYS . 6.9 pt-20 -117.74 142.84 46.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.233 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.646 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -144.35 170.64 15.62 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.027 -1.469 . . . . 0.0 113.425 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.513 ' HB2' ' NE ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -135.11 128.72 32.69 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.646 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -128.8 85.61 2.35 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 109.104 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 1.8 t80 -77.52 108.94 11.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 37' ' ' VAL . 1.3 p -153.46 173.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.0 t80 -128.57 127.23 41.91 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.765 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -127.67 -126.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.856 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.588 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -96.96 -40.21 9.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.45 31.94 4.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 109.861 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' CE ' HG12 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -143.85 92.23 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.753 0.787 . . . . 0.0 109.357 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 1.6 mp -100.58 63.58 1.09 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.715 -0.616 . . . . 0.0 110.761 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 168.86 -109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.034 -1.041 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 1.4 ttp-105 -130.4 141.52 50.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.906 -1.121 . . . . 0.0 112.779 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.625 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.26 113.41 26.79 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 3.1 t70 -93.35 168.69 10.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.076 . . . . 0.0 111.34 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.639 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 4.3 tp -158.99 116.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.473 ' C ' ' CG ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -126.69 131.51 51.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.92 -1.113 . . . . 0.0 109.814 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 16.1 mt-10 -149.82 132.05 15.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.93 -1.106 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -74.87 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.168 -0.958 . . . . 0.0 110.079 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.58 ' CG ' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -173.08 -46.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.586 -1.321 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -66.39 -61.56 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.128 . . . . 0.0 108.123 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 11.5 t -90.86 14.33 13.98 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 81' ' ' GLY . 30.0 mmt180 48.53 42.42 18.79 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.513 0.673 . . . . 0.0 109.227 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -33.35 -79.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 3.6 mtm180 -171.12 -160.73 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.677 -1.484 . . . . 0.0 112.446 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.484 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 21.0 mttt -148.35 139.8 23.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -170.73 151.29 3.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 110.832 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.568 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -136.1 175.93 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.42 -0.8 . . . . 0.0 109.506 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.5 mtm180 -147.79 178.75 8.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.042 -1.036 . . . . 0.0 110.949 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 1.9 m-85 -155.63 84.26 1.04 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.596 ' O ' ' CG ' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -153.42 -154.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 62.34 53.39 42.39 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.8 Cg_endo -64.43 154.78 69.75 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.582 1.833 . . . . 0.0 111.549 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.188 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' C ' ' CG ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' CG ' ' C ' ' A' ' 1' ' ' GLY . 21.7 mt-10 -148.98 130.98 15.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.262 -1.14 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.469 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 28.1 p90 -107.65 155.37 20.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.888 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.525 ' HG2' ' CD ' ' A' ' 43' ' ' LYS . 12.3 pt-20 -177.34 137.76 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 42' ' ' MET . 4.9 pt -89.3 -178.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.597 HG13 ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -125.73 -147.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.18 -0.95 . . . . 0.0 109.656 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -134.79 -152.12 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.76 -1.213 . . . . 0.0 110.295 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HA ' HG23 ' A' ' 12' ' ' THR . 2.0 tt -104.35 39.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 12' ' ' THR . . . -144.69 -63.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.272 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 41.9 Cg_endo -68.72 -93.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.293 1.154 . . . . 0.0 112.498 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.597 ' CG ' HG13 ' A' ' 6' ' ' ILE . 2.7 m-85 -43.33 -26.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 0.0 111.013 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.553 ' CB ' HG23 ' A' ' 38' ' ' ILE . 22.4 p -54.41 -56.34 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.825 -1.172 . . . . 0.0 108.391 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' A' ' 12' ' ' THR . 7.4 tt0 -58.24 -22.43 52.17 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.762 0.791 . . . . 0.0 109.233 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 5.4 t-20 -72.26 -56.81 4.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.538 0.685 . . . . 0.0 109.801 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -42.32 -56.09 3.1 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.588 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.589 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -51.41 -38.38 41.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -79.81 -80.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -1.056 . . . . 0.0 110.676 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CD2' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -37.59 -36.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.283 0.563 . . . . 0.0 111.004 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -66.71 -69.6 0.3 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.393 -0.817 . . . . 0.0 109.738 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 19' ' ' ALA . 9.5 t -39.35 -27.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 110.198 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 19' ' ' ALA . 5.6 m-20 -93.32 -69.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 110.122 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.567 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 6.3 mp0 -57.27 -32.51 66.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.502 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -69.68 -59.88 2.67 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 29' ' ' TYR . 1.8 m120 -55.94 -44.71 78.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -52.8 63.02 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.453 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -54.51 -22.48 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.489 -0.757 . . . . 0.0 109.711 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 120.43 19.83 3.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 50.9 mm-40 -114.88 60.44 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.946 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 61.2 t80 -84.16 13.8 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -43.35 -53.04 5.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.453 ' HG2' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.26 -147.2 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.06 -174.23 0.59 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -147.3 53.58 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 110.065 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.522 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 22.5 t80 -175.64 97.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 12.2 t-20 -129.68 -52.55 1.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -69.72 -99.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 111.183 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.3 t -161.46 173.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.558 -1.339 . . . . 0.0 111.825 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.573 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -126.92 121.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.437 0.637 . . . . 0.0 109.576 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.594 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -129.36 -58.27 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.467 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.2 Cg_endo -84.91 45.68 1.7 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.178 1.094 . . . . 0.0 110.965 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.5 ' HB3' HG12 ' A' ' 38' ' ' ILE . 24.0 p -80.06 88.6 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 109.496 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.462 ' HA ' HG21 ' A' ' 5' ' ' ILE . 17.0 mtm -88.93 135.38 33.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.426 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' CD ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.428 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' GLU . 19.5 mttt -142.97 121.09 12.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.649 ' CG2' ' CD2' ' A' ' 47' ' ' TYR . 5.7 m -125.87 150.12 48.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.592 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER -115.4 45.11 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.649 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 2.9 m-30 -75.61 176.64 7.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -99.65 -77.9 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.528 -0.732 . . . . 0.0 109.446 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.615 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 1.3 t30 87.78 -18.97 0.25 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.656 0.741 . . . . 0.0 109.28 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 0.2 43.19 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.516 ' CB ' ' OE1' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -170.19 -29.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.888 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' CD ' ' HD3' ' A' ' 78' ' ' LYS . 15.3 pt-20 -169.05 -166.18 0.61 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.95 -1.094 . . . . 0.0 111.108 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.601 ' CG2' ' CD2' ' A' ' 77' ' ' TYR . 39.9 mm -117.47 113.83 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.632 -0.667 . . . . 0.0 109.556 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.7 OUTLIER -80.86 -75.77 0.26 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.302 -0.874 . . . . 0.0 111.969 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 47' ' ' TYR . . . -153.33 -177.61 27.04 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 118.006 -2.045 . . . . 0.0 111.163 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.573 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -159.45 88.39 0.86 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.967 . . . . 0.0 110.565 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' LYS . 12.6 pt-20 -87.99 155.45 19.82 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 2.6 t80 -142.24 124.98 15.93 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.493 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.49 ' HA ' ' CD ' ' A' ' 70' ' ' ARG . 10.7 mt-30 -96.78 96.22 8.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 7.8 tp -97.04 69.32 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 108.978 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -72.96 110.45 7.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.096 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 22.9 m -160.96 -163.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.0 t80 -140.72 130.05 23.75 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.85 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . . . -125.44 -116.31 0.28 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.409 -0.807 . . . . 0.0 109.945 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -46.32 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.25 -1.42 5.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 110.021 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' CE ' HG22 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -94.53 92.32 7.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.781 . . . . 0.0 109.734 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.589 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 10.1 mt -96.35 61.92 2.05 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.657 ' N ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 167.59 -113.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.019 . . . . 0.0 110.473 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.25 149.61 52.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.43 -1.419 . . . . 0.0 113.626 -178.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -101.89 92.66 4.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -70.78 79.84 0.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.903 . . . . 0.0 110.64 -177.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.515 ' CD1' ' HG2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -68.59 107.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.54 0.686 . . . . 0.0 109.571 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -103.18 114.86 29.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.472 -0.768 . . . . 0.0 110.31 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 74' ' ' SER . 11.3 mt-10 -145.94 112.04 5.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.072 -1.018 . . . . 0.0 110.748 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.532 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 3.8 m-20 -81.99 -149.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.997 . . . . 0.0 109.513 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.601 ' CD2' ' CG2' ' A' ' 53' ' ' ILE . 1.1 t80 -176.4 -58.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.348 -1.47 . . . . 0.0 111.091 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -66.37 -58.46 5.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.928 -1.107 . . . . 0.0 108.584 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.43 2.15 29.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 81' ' ' GLY . 26.6 mmt180 55.71 38.8 30.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.571 -0.706 . . . . 0.0 109.743 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -37.73 -85.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 81' ' ' GLY . 1.1 mtt180 -155.21 -169.14 3.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.892 -1.358 . . . . 0.0 111.753 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HA ' ' CG ' ' A' ' 75' ' ' GLU . 16.1 mtmt -151.21 97.33 2.42 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 74' ' ' SER . 7.8 tp -169.88 -172.07 1.3 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.152 -0.968 . . . . 0.0 109.979 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.638 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -150.94 -179.72 7.53 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 72' ' ' ASP . 21.1 mtm180 -146.01 126.78 14.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.127 . . . . 0.0 111.55 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 2.6 m-85 -104.77 89.6 3.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.419 -0.801 . . . . 0.0 108.933 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.587 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.44 -143.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.52 -1.362 . . . . 0.0 111.268 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 51.37 50.33 41.46 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.2 Cg_endo -68.91 158.02 59.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.332 1.701 . . . . 0.0 111.111 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.339 -179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.13 178.84 6.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -133.41 169.11 17.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.464 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 6.5 tp10 -168.28 116.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 20.9 pt -110.14 144.15 18.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.988 -1.07 . . . . 0.0 111.512 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.38 -175.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 172.74 34.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.655 -1.278 . . . . 0.0 112.145 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 7' ' ' ASP . 6.7 tp 177.92 18.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.502 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.47 -64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.524 -1.798 . . . . 0.0 111.906 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' HG3' ' CG2' ' A' ' 6' ' ' ILE . 46.3 Cg_endo -74.66 -86.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.69 1.363 . . . . 0.0 112.199 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 43' ' ' LYS . 3.9 m-85 -45.78 -22.43 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.555 HG21 ' CD1' ' A' ' 38' ' ' ILE . 27.6 p -66.14 -59.89 3.33 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.972 -1.08 . . . . 0.0 109.177 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' N ' ' OG1' ' A' ' 12' ' ' THR . 29.1 tt0 -72.15 -19.89 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.495 0.664 . . . . 0.0 109.924 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 8.2 m120 -79.25 -51.38 9.53 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.0 109.294 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 16' ' ' GLY . 1.6 tt -44.98 -55.55 5.41 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.4 0.619 . . . . 0.0 109.521 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -52.31 -55.37 22.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' PHE . 4.3 mttm -69.89 -79.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -1.124 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -33.03 -66.64 0.14 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.451 0.643 . . . . 0.0 111.232 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -42.35 -70.28 0.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.601 -0.687 . . . . 0.0 109.849 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 24.8 t -43.62 -25.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.214 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 19' ' ' ALA . 7.6 t0 -91.18 -69.48 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.23 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.553 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 77.4 mm-40 -59.55 -34.86 73.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.767 -1.208 . . . . 0.0 109.345 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.57 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -66.6 -54.75 20.04 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 109.017 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.5 m120 -64.7 -43.7 92.64 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.041 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.1 tttm -57.65 -46.0 84.78 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 5.6 tp -64.26 -17.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.466 -0.771 . . . . 0.0 110.016 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.45 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 112.98 37.47 1.37 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB3' ' OE2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -138.99 72.09 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.134 . . . . 0.0 110.066 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 29' ' ' TYR . 41.8 p90 -109.72 30.75 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.857 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.41 -48.53 5.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 72.2 mtt-85 -157.76 -89.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.55 ' CD1' ' CB ' ' A' ' 65' ' ' SER . 0.8 OUTLIER -141.0 152.57 45.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.919 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.7 55.5 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 110.458 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 5.5 p90 -177.33 119.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.103 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.414 ' HB3' ' C ' ' A' ' 64' ' ' ALA . 45.6 t30 -157.37 -56.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.818 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -69.29 -97.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 9.7 t -160.14 172.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.659 -1.276 . . . . 0.0 111.476 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.566 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -127.17 121.1 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.687 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.545 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.5 ttm180 -130.91 -57.37 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 110.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.9 Cg_endo -86.5 45.19 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.07 1.037 . . . . 0.0 110.965 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.514 ' SG ' ' CD1' ' A' ' 38' ' ' ILE . 22.1 p -85.11 79.27 9.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.487 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.521 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 2.8 mtp -82.47 163.0 21.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.171 -0.956 . . . . 0.0 110.685 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 3.4 ttpp -138.51 140.86 39.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.211 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 57' ' ' GLU . 6.0 ttmm -142.75 128.79 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.605 HG21 ' O ' ' A' ' 55' ' ' GLY . 1.4 m -114.44 160.26 19.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 110.213 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.54 ' N ' HG21 ' A' ' 45' ' ' THR . 1.3 tt -131.5 82.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.601 ' CE1' HG22 ' A' ' 45' ' ' THR . 23.7 m-85 -68.78 -164.75 0.05 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.537 ' N ' ' HB2' ' A' ' 54' ' ' LYS . 2.5 tp10 -66.99 -99.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.758 -0.589 . . . . 0.0 110.032 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.517 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 2.8 m120 -127.83 -78.05 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.694 -1.254 . . . . 0.0 109.748 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.73 18.78 1.15 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -145.13 -29.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.143 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 2.7 mm-40 -118.54 -159.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -126.04 169.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 48' ' ' GLU . 18.0 tttt -156.97 -49.56 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.801 -1.187 . . . . 0.0 113.245 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.605 ' O ' HG21 ' A' ' 45' ' ' THR . . . -143.08 172.17 24.68 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 117.54 -2.267 . . . . 0.0 111.277 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 1.2 t80 -161.25 91.44 0.86 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.842 -0.799 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.3 mt-10 -123.87 -179.44 4.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.646 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -164.08 167.01 20.81 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.557 -1.257 . . . . 0.0 112.943 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 49.6 mt-30 -120.72 107.89 13.32 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' A' ' 58' ' ' TYR . 1.3 tp -98.6 71.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.027 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -72.78 111.48 7.96 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.628 0.728 . . . . 0.0 109.082 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.579 ' CG2' ' CE ' ' A' ' 67' ' ' LYS . 17.2 m -160.1 -163.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.2 t80 -138.85 126.88 22.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.714 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' HB2' ' CA ' ' A' ' 34' ' ' PHE . . . -122.58 -130.41 0.27 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.461 -0.774 . . . . 0.0 109.886 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.55 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.87 -18.51 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 25.4 t70 -151.02 38.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.579 ' CE ' ' CG2' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -150.31 88.69 1.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.553 0.692 . . . . 0.0 109.514 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 7.7 mt -92.44 60.04 3.51 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.618 -0.676 . . . . 0.0 109.596 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 170.45 -122.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.188 -0.945 . . . . 0.0 109.851 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 2.6 tmm_? -122.53 147.88 45.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.21 -1.556 . . . . 0.0 113.246 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -102.05 98.09 8.33 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -68.78 152.37 45.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 110.133 -177.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.646 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.77 127.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.555 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 34.2 t -129.98 155.34 46.26 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.222 -0.923 . . . . 0.0 109.24 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.5 mp0 -156.33 116.79 3.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.607 -1.308 . . . . 0.0 112.46 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.625 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 2.7 p30 -39.89 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.412 0.625 . . . . 0.0 111.643 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.577 ' CE1' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.93 -61.42 0.23 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 178.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HB2' ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -126.42 -38.94 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.271 -0.893 . . . . 0.0 108.653 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.562 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 37.3 p -90.87 30.16 1.24 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 39.98 57.92 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.643 . . . . 0.0 111.49 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.625 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -53.4 -108.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -173.82 155.64 2.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.498 -1.59 . . . . 0.0 112.094 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -103.17 126.54 50.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.482 ' CD1' HD12 ' A' ' 26' ' ' ILE . 9.8 tp -171.22 179.51 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 0.0 109.864 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -170.03 167.5 8.9 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.035 -1.041 . . . . 0.0 110.455 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.566 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 1.1 mtt180 -143.44 -174.86 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.58 ' CE2' HD13 ' A' ' 85' ' ' LEU . 10.7 m-85 -155.01 83.52 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.584 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -168.68 -164.06 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.503 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 86.82 54.83 2.54 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 39.5 Cg_endo -63.21 144.68 92.37 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 124.407 1.741 . . . . 0.0 111.472 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.465 HG13 ' OH ' ' A' ' 61' ' ' TYR . 4.7 m . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 0.5 OUTLIER 175.83 178.21 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -1.146 . . . . 0.0 110.168 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 m-90 -83.28 -176.81 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 5' ' ' ILE . 20.7 tp10 174.31 163.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -139.29 173.43 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.931 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.581 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 1.2 pp -136.82 -159.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 6' ' ' ILE . 1.7 t70 -113.21 -143.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 109.617 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.519 ' HA ' HG23 ' A' ' 12' ' ' THR . 0.8 OUTLIER -108.38 38.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 12' ' ' THR . . . -129.91 -56.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.702 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.5 Cg_endo -75.7 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 122.963 0.98 . . . . 0.0 111.853 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.7 ' CE1' ' CD2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -40.4 -34.96 0.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.136 -0.978 . . . . 0.0 110.447 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.534 ' CG2' ' CD1' ' A' ' 38' ' ' ILE . 44.5 p -50.19 -54.22 22.38 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.4 OUTLIER -63.78 -25.98 68.43 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.751 0.786 . . . . 0.0 109.36 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 11.6 m120 -72.26 -52.4 16.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 0.0 109.86 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -42.9 -58.4 2.41 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.257 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.593 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -45.72 -45.97 13.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -83.52 -80.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.053 . . . . 0.0 111.154 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 2.5 m-85 -35.69 -29.58 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 111.592 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -84.02 -72.49 0.46 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 24.3 t -43.64 -26.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 109.833 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -86.64 -62.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.667 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' HB2' HD12 ' A' ' 85' ' ' LEU . 25.3 mm-40 -62.12 -43.21 99.32 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.464 -1.294 . . . . 0.0 108.998 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' N ' HD12 ' A' ' 85' ' ' LEU . 55.4 mt-10 -58.83 -51.86 68.2 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 108.877 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 35.0 t-20 -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.383 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -57.66 -42.11 82.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.966 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.529 HG21 ' O ' ' A' ' 23' ' ' GLU . 4.2 tp -69.57 -16.48 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.393 -0.817 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.07 52.72 0.26 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.434 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -158.34 81.83 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -1.12 . . . . 0.0 109.878 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 39.4 p90 -105.5 29.18 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.15 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -41.16 -51.73 4.27 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HB3' ' CD2' ' A' ' 32' ' ' LEU . 7.6 mtm180 -179.62 -81.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -141.49 164.68 29.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.44 -0.787 . . . . 0.0 109.782 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.527 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -130.04 52.5 2.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.751 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.527 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 38.9 t80 -163.85 112.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.415 -0.803 . . . . 0.0 110.015 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -150.4 -55.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.546 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.571 ' HD2' ' CG ' ' A' ' 63' ' ' TYR . 17.6 mttt -69.46 -103.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 111.049 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 9.2 t -159.59 172.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.755 -1.216 . . . . 0.0 111.536 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.57 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -128.65 129.12 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.615 -0.678 . . . . 0.0 109.846 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.593 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -132.1 -58.13 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.375 -0.828 . . . . 0.0 110.057 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 44.9 Cg_endo -87.44 46.42 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.174 1.091 . . . . 0.0 110.81 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 22.6 p -87.46 111.61 21.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.462 ' HB3' ' CE ' ' A' ' 44' ' ' LYS . 27.1 mtm -109.66 179.81 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.703 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' CE ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -152.54 142.38 22.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 110.107 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.489 ' HE3' ' N ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -137.96 105.69 5.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.772 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.604 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.9 m -124.17 154.19 40.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.604 ' N ' HG21 ' A' ' 45' ' ' THR . 25.8 pt -122.2 39.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -75.75 -150.19 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.274 1.035 . . . . 0.0 111.696 -178.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.4 pt-20 -68.73 -155.99 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.077 0.941 . . . . 0.0 112.745 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.583 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 1.7 m-20 -155.99 -35.41 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.433 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HG3' ' HG2' ' A' ' 51' ' ' ARG . 15.7 pt-20 -131.29 -30.78 1.69 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 110.819 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG2' ' HG3' ' A' ' 50' ' ' GLU . 1.6 ptt85 -171.31 18.57 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.719 -1.238 . . . . 0.0 112.358 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 40.3 mm-40 -111.71 -148.33 0.43 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.836 -1.165 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG12 ' CG ' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -171.15 142.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 77' ' ' TYR . 1.8 mtmt -141.3 -75.09 0.31 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.754 -1.216 . . . . 0.0 112.463 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.577 ' O ' HG21 ' A' ' 45' ' ' THR . . . -141.06 167.61 25.62 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' GLU . 86.5 t80 -152.29 90.83 1.54 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.259 -1.142 . . . . 0.0 110.809 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.9 tt0 -112.08 159.61 18.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.7 ' CD2' ' CE1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.35 169.16 25.22 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 117.859 -1.536 . . . . 0.0 113.45 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 13.3 mt-30 -137.93 120.97 16.67 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.641 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -121.98 83.85 2.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 109.436 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -75.18 110.32 9.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 35.6 m -160.33 -161.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.462 -0.774 . . . . 0.0 109.697 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.638 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.0 t80 -135.09 135.2 41.04 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.506 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . . . -133.15 -127.74 0.18 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -40.01 9.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.992 . . . . 0.0 108.982 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.453 ' OD1' HG21 ' A' ' 33' ' ' THR . 2.5 p30 -127.67 -2.39 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' NZ ' HD22 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -104.5 88.87 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.638 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -100.25 60.9 1.05 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 108.788 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CD2' ' HB3' ' A' ' 88' ' ' ASN . 0.3 OUTLIER 172.3 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 7.3 ttp180 -152.94 156.27 38.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.972 -1.705 . . . . 0.0 112.643 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.618 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -119.2 115.52 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' OD1' ' NH1' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -93.07 166.34 12.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.992 -1.067 . . . . 0.0 110.235 -178.064 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.69 114.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.618 -0.676 . . . . 0.0 109.179 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -109.84 144.57 38.11 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.3 mt-10 -167.72 104.17 0.5 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.694 -1.254 . . . . 0.0 111.726 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.582 ' HB3' ' CA ' ' A' ' 81' ' ' GLY . 16.1 p-10 -61.8 -148.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.657 0.741 . . . . 0.0 112.149 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.569 ' CG ' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 175.97 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.389 0.614 . . . . 0.0 109.505 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.3 ttpt -119.85 -32.12 4.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 109.06 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -69.48 -15.98 63.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 79' ' ' THR . 7.6 mmt180 74.02 104.11 0.07 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.23 1.014 . . . . 0.0 110.343 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.582 ' CA ' ' HB3' ' A' ' 76' ' ' ASP . . . -143.01 -95.09 0.21 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -171.6 -157.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.408 -1.643 . . . . 0.0 112.041 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 6.8 mttt -146.8 117.74 7.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -170.86 -169.56 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.528 -1.357 . . . . 0.0 111.75 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -170.37 175.95 4.63 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.52 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 13.0 mtt180 -150.35 152.15 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.614 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 13.4 m-85 -103.69 97.39 7.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 1.5 t-20 -66.79 125.86 27.19 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . -8.09 99.35 0.01 OUTLIER Glycine 0 N--CA 1.503 3.108 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.448 ' C ' ' HB2' ' A' ' 68' ' ' LEU . 47.3 Cg_endo -74.95 79.07 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.553 . . . . 0.0 109.941 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.541 ' N ' ' HB2' ' A' ' 68' ' ' LEU . 2.1 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.239 -0.913 . . . . 0.0 110.336 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -123.87 162.13 23.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.356 -1.085 . . . . 0.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 4.8 p90 -115.77 177.81 4.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.51 121.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.206 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 18.4 pt -85.17 170.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.075 -1.016 . . . . 0.0 110.499 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.603 ' CG2' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -89.4 -166.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.256 -0.902 . . . . 0.0 110.509 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.56 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 4.3 m-20 -137.16 49.56 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.141 -0.975 . . . . 0.0 110.705 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 5.1 tt 39.9 46.01 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.963 0.887 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG22 ' A' ' 12' ' ' THR . . . -156.1 -62.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.346 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.1 Cg_endo -72.7 -84.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 0.0 111.535 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.603 ' CD2' ' CG2' ' A' ' 6' ' ' ILE . 6.3 m-85 -41.42 -29.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.243 -0.911 . . . . 0.0 110.568 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.54 ' HA ' HG22 ' A' ' 38' ' ' ILE . 11.4 p -55.33 -58.0 9.52 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.535 ' N ' ' OG1' ' A' ' 12' ' ' THR . 9.6 mt-30 -68.19 -17.7 64.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.694 0.759 . . . . 0.0 109.394 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 17' ' ' LYS . 7.2 t-20 -80.82 -57.28 3.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.55 0.69 . . . . 0.0 109.352 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -39.14 -46.49 1.45 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.562 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -65.24 -40.45 96.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -77.44 -69.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -1.054 . . . . 0.0 110.241 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 1.7 m-30 -40.86 -47.3 2.91 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.686 0.755 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -57.69 -77.56 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.526 -0.734 . . . . 0.0 110.01 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG11 ' N ' ' A' ' 21' ' ' ASP . 7.0 p -38.33 -27.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.0 110.967 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.11 -77.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.915 -1.115 . . . . 0.0 110.213 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.1 mm-40 -56.06 -36.31 67.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.671 -1.268 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 30.6 tt0 -64.77 -52.37 57.28 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.578 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 18.8 t-20 -66.64 -44.19 82.62 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.015 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.8 ttmt -59.72 -41.72 91.46 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.127 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 5.4 tp -69.39 -17.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.389 -0.819 . . . . 0.0 110.194 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . 115.58 52.13 0.4 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.524 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 36.5 mm-40 -156.36 82.32 0.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.122 . . . . 0.0 109.736 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 50.9 p90 -104.02 30.37 5.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.889 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 31' ' ' ARG . . . -38.67 -48.81 2.43 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 171.37 -82.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -1.235 . . . . 0.0 110.341 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -131.91 158.89 40.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.521 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -129.98 52.71 1.98 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.559 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 6.3 p90 -172.7 62.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 -26.16 11.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.102 -0.999 . . . . 0.0 111.218 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.587 ' HG2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -96.39 -89.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 10.0 t -160.29 172.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.482 -1.386 . . . . 0.0 111.342 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.556 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -135.6 82.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.573 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.569 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -102.04 -58.02 0.1 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.026 -1.046 . . . . 0.0 111.494 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' O ' ' HB3' ' A' ' 61' ' ' TYR . 39.3 Cg_endo -79.19 48.04 2.7 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.292 1.154 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 6' ' ' ILE . 20.8 p -104.74 121.62 43.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.799 -1.188 . . . . 0.0 109.789 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLN . 2.3 mpt? -117.65 157.66 26.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.111 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.53 129.8 46.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 110.215 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 57' ' ' GLU . 15.0 mttm -130.93 125.43 33.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.697 HG21 ' O ' ' A' ' 55' ' ' GLY . 21.1 m -125.1 164.65 19.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.984 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -127.55 51.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 2' ' ' GLU . 3.8 p90 -69.47 -159.79 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.989 0.899 . . . . 0.0 111.322 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.589 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -67.46 -147.47 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.693 0.758 . . . . 0.0 112.237 -178.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.589 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 1.1 t30 -156.75 -35.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.592 -0.692 . . . . 0.0 109.827 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.52 -31.75 1.78 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.293 -0.879 . . . . 0.0 110.796 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.97 20.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.801 -1.187 . . . . 0.0 112.222 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' C ' ' HB3' ' A' ' 48' ' ' GLU . 13.1 mt-10 -111.92 -151.27 0.48 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 0.0 110.516 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.637 ' CG2' ' CG ' ' A' ' 77' ' ' TYR . 1.2 mp -164.19 132.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -123.72 -76.51 0.59 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.557 -1.34 . . . . 0.0 113.095 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.697 ' O ' HG21 ' A' ' 45' ' ' THR . . . -155.43 -174.09 24.9 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.303 -1.903 . . . . 0.0 109.913 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.542 ' CD2' ' OG1' ' A' ' 45' ' ' THR . 13.7 t80 -162.2 109.51 1.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.902 -0.764 . . . . 0.0 110.617 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -126.04 177.85 6.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.351 -0.843 . . . . 0.0 108.831 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.653 ' CD1' ' CG2' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -165.38 175.18 9.34 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.168 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.521 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.8 tt0 -127.69 125.06 39.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.625 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 21.1 tp -119.52 67.62 0.81 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.726 -1.234 . . . . 0.0 109.842 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.574 ' HB3' ' O ' ' A' ' 40' ' ' PRO . 2.5 t80 -69.5 108.78 3.93 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 34.9 m -160.42 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.642 ' CE1' ' CD1' ' A' ' 68' ' ' LEU . 1.4 t80 -154.2 117.34 4.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.971 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' CB ' ' NZ ' ' A' ' 67' ' ' LYS . . . -104.46 -102.62 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.559 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.512 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 22.9 t -120.03 -26.74 5.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.75 5.62 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.959 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' NZ ' ' CB ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -109.07 86.35 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 110.109 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.642 ' CD1' ' CE1' ' A' ' 63' ' ' TYR . 1.2 tp -88.78 61.96 6.21 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.717 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.0 OUTLIER 169.73 -113.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.0 110.213 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 17.5 ttm180 -127.0 146.21 50.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.557 -1.34 . . . . 0.0 112.963 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -106.59 102.42 11.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.523 ' O ' ' CA ' ' A' ' 85' ' ' LEU . 5.3 t70 -84.68 154.88 22.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.653 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -156.18 142.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' HD11 ' A' ' 73' ' ' ILE . 1.1 t -128.49 159.2 36.2 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -167.65 105.04 0.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.677 -1.264 . . . . 0.0 111.917 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.602 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 56.9 p-10 -55.56 -165.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.637 ' CG ' ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -160.61 -53.34 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.496 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.1 tptm -135.11 -39.78 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.133 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.596 ' C ' ' HG3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.7 -61.71 1.88 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.596 ' HG3' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 152.06 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.794 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -21.19 -96.42 0.01 OUTLIER Glycine 0 N--CA 1.505 3.271 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 1.5 mtt180 -165.12 -165.29 0.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.946 -1.326 . . . . 0.0 110.786 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -166.76 88.73 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -171.2 -167.78 0.57 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.585 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -170.81 172.4 5.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.295 -0.878 . . . . 0.0 109.704 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 19.6 mtp180 -148.51 178.6 8.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.909 -1.12 . . . . 0.0 111.244 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CE2' HD13 ' A' ' 85' ' ' LEU . 3.2 m-85 -155.36 80.86 1.05 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -155.79 -163.31 1.47 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.765 -1.209 . . . . 0.0 111.209 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 77.74 53.21 5.08 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.14 119.66 6.93 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.834 1.965 . . . . 0.0 111.697 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.232 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' N ' ' ND2' ' A' ' 49' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -172.5 170.01 5.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -1.168 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 7.5 p90 -159.36 165.58 32.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -0.901 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' CD ' ' HD2' ' A' ' 43' ' ' LYS . 8.2 pt-20 -172.94 158.71 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.578 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.05 171.81 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.163 -0.96 . . . . 0.0 110.44 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.601 HG13 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -150.84 -176.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.868 -0.52 . . . . 0.0 109.784 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.547 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 1.8 p30 -179.32 126.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CA ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER 43.21 25.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.691 -0.631 . . . . 0.0 110.13 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 12' ' ' THR . . . -118.02 -107.63 2.38 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.161 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . 48.7 Cg_endo -80.65 -72.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.72 1.613 . . . . 0.0 112.752 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.601 ' CD1' HG13 ' A' ' 6' ' ' ILE . 59.6 m-85 -40.09 -27.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.286 -0.883 . . . . 0.0 109.9 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 13' ' ' GLN . 2.1 p -65.69 -61.81 1.87 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.582 ' N ' ' OG1' ' A' ' 12' ' ' THR . 5.3 mt-30 -59.89 -26.35 65.83 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.924 0.868 . . . . 0.0 108.767 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 1.7 t-20 -74.45 -47.0 36.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.604 0.716 . . . . 0.0 109.202 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.577 ' CD2' ' CD2' ' A' ' 60' ' ' LEU . 3.4 tm? -44.03 -70.4 0.11 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -44.27 -37.39 4.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 18.1 mttp -71.24 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -40.54 -41.3 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.579 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -59.63 -68.27 0.3 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.438 -0.789 . . . . 0.0 109.316 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 23.3 t -38.5 -28.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.479 -0.763 . . . . 0.0 110.288 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.17 -73.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 110.341 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 14.0 mm-40 -54.86 -27.98 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.897 -1.127 . . . . 0.0 109.827 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -76.76 -61.11 2.08 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 6.6 m-20 -51.76 -47.17 64.22 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 20.7 mmmt -55.25 -51.69 65.8 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -51.77 -22.39 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.101 178.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.2 67.41 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -127.49 -71.64 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -1.169 . . . . 0.0 110.304 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -102.25 -75.37 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 24' ' ' ASN . . . 100.8 36.41 3.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 72.1 mtt180 -153.56 -82.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -1.18 . . . . 0.0 110.437 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 31' ' ' ARG . 7.0 mt -131.08 166.17 21.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.905 . . . . 0.0 110.38 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.53 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -154.35 62.32 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.1 t80 176.94 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.315 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -117.12 -56.37 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 110.734 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.596 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -69.51 -101.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.019 -1.051 . . . . 0.0 111.263 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 2.4 t -163.43 174.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.696 -1.253 . . . . 0.0 111.527 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.585 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -121.36 112.16 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.739 -0.601 . . . . 0.0 109.768 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.595 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -119.23 -57.07 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.1 Cg_endo -86.93 48.29 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.901 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' CB ' HD13 ' A' ' 60' ' ' LEU . 23.6 p -96.41 122.13 38.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' GLN . 12.1 mtm -121.1 165.14 15.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -143.17 144.5 32.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 18.5 mttt -148.43 157.44 43.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 56' ' ' TYR . 1.6 m -149.1 152.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.567 ' N ' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -122.39 43.91 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER -72.74 -147.27 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.06 0.933 . . . . 0.0 111.721 -178.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.587 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.2 pt-20 -68.54 -153.9 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 122.043 0.925 . . . . 0.0 112.724 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.587 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 10.5 m120 -157.16 -36.04 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.538 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -137.71 -27.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 111.252 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.34 23.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.685 -1.259 . . . . 0.0 111.83 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 1.3 mt-10 -121.67 -147.11 0.38 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.109 . . . . 0.0 110.445 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 77' ' ' TYR . 0.2 OUTLIER -170.94 145.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -137.89 -76.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.556 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' HG21 ' A' ' 45' ' ' THR . . . -158.82 -173.12 26.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 118.12 -1.991 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -157.84 107.42 2.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.705 -0.88 . . . . 0.0 110.234 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' LYS . 17.1 pt-20 -117.14 134.65 54.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.664 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.41 164.22 26.18 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.49 -1.284 . . . . 0.0 112.534 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 11.5 mt-30 -132.12 124.12 28.5 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.664 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 1.8 tp -120.69 78.15 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.747 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -73.28 113.0 9.86 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 69' ' ' PHE . 32.9 m -159.63 -162.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 2.8 t80 -136.01 141.58 44.37 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 63' ' ' TYR . . . -138.98 -115.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.845 . . . . 0.0 110.043 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -111.8 -39.0 4.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.268 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.481 ' HB3' ' CE1' ' A' ' 29' ' ' TYR . 3.5 p-10 -127.54 -0.98 6.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.602 -0.687 . . . . 0.0 109.641 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' CE ' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -106.25 97.68 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 109.736 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.567 ' HG ' ' CZ ' ' A' ' 63' ' ' TYR . 6.5 mp -100.2 60.09 1.03 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.428 -0.795 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 168.17 -115.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 110.237 -179.233 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 3.1 ttm180 -122.46 145.35 48.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.184 -1.572 . . . . 0.0 113.142 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.37 108.31 19.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' CB ' ' CG ' ' A' ' 86' ' ' ARG . 1.4 t70 -90.33 162.37 15.19 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.917 -1.114 . . . . 0.0 111.247 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.598 ' HB ' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.78 101.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.26 150.52 22.01 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.656 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.06 119.9 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.104 -0.998 . . . . 0.0 110.675 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.604 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -61.47 -152.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.584 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -166.37 -50.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.864 -1.148 . . . . 0.0 110.928 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' CA ' HG21 ' A' ' 53' ' ' ILE . 11.1 ttmt -67.8 -57.91 5.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.095 . . . . 0.0 108.521 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.474 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 86.2 m -99.06 10.81 40.7 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 81' ' ' GLY . 24.3 mmt85 58.88 18.49 6.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.536 -0.727 . . . . 0.0 109.789 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.604 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -0.36 -69.68 0.0 OUTLIER Glycine 0 N--CA 1.501 3.03 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.315 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -170.05 -173.14 1.47 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.736 -1.449 . . . . 0.0 111.371 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -146.23 137.2 24.38 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 3.8 tt -171.25 163.65 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.17 . . . . 0.0 110.516 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -149.43 160.86 43.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.596 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.55 ' CG ' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -150.53 147.9 28.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 111.269 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -124.7 89.82 3.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.598 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.52 -146.43 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.685 -1.26 . . . . 0.0 110.929 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 60.35 52.8 50.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -67.01 136.6 41.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.408 1.741 . . . . 0.0 111.253 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.279 -179.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER 173.6 148.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -1.149 . . . . 0.0 110.413 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -66.3 -176.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 174.78 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.937 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 1.1 pp -89.37 167.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 120.979 -1.076 . . . . 0.0 110.324 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.645 ' CG2' ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -115.11 -160.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.995 -1.065 . . . . 0.0 110.672 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 40.3 t0 -135.46 52.74 2.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.844 -1.16 . . . . 0.0 112.123 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 29.8 pt 39.83 46.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.168 0.985 . . . . 0.0 110.314 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 12' ' ' THR . . . -134.02 -69.15 0.07 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.785 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.28 -63.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.845 1.445 . . . . 0.0 111.28 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.645 ' CD1' ' CG2' ' A' ' 6' ' ' ILE . 3.5 m-85 -47.39 -36.02 9.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.025 -1.047 . . . . 0.0 109.212 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.656 HG22 ' N ' ' A' ' 9' ' ' GLY . 1.7 p -52.3 -57.66 9.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.602 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.87 -15.97 62.62 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.059 179.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 5.7 m120 -82.82 -68.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.271 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 3.0 pp -40.93 -28.76 0.09 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.456 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -71.42 -53.34 10.35 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -76.58 -42.49 42.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -1.127 . . . . 0.0 110.837 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' ALA . 7.6 m-85 -63.63 -64.86 0.78 Allowed 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.44 -0.788 . . . . 0.0 110.065 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -44.42 -66.22 0.42 Allowed 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.625 -0.672 . . . . 0.0 110.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 30.5 m -42.43 -26.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 120.961 -1.087 . . . . 0.0 110.149 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -94.77 -69.86 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 22.7 mm-40 -55.37 -35.01 64.79 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.247 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -69.69 -59.66 2.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.057 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 61.7 t-20 -51.38 -45.32 62.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -54.46 46.67 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.703 -0.799 . . . . 0.0 108.965 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -57.06 -19.1 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.636 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.66 70.91 1.33 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.48 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -126.74 -74.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.75 -71.36 0.76 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.12 18.01 9.63 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -135.96 -140.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -1.159 . . . . 0.0 110.287 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 32' ' ' LEU . 2.7 mm? -83.24 152.38 25.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.295 -0.878 . . . . 0.0 110.799 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.97 50.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.633 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 6.5 p90 -162.85 123.0 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.74 -59.26 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.992 -1.068 . . . . 0.0 111.314 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HG3' ' CD2' ' A' ' 63' ' ' TYR . 1.1 mmmt -69.09 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.993 -1.067 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.4 t -161.13 173.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.7 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.599 HG13 HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -123.96 103.35 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.959 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.638 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -101.74 -60.48 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.953 -1.092 . . . . 0.0 110.185 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.638 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.4 Cg_endo -86.76 54.43 3.07 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.176 1.092 . . . . 0.0 110.336 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.516 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 4.5 t -102.67 110.55 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.518 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 2.0 mtt -113.75 175.75 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 110.628 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 2.3 ttpt -147.68 120.7 8.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -114.78 160.98 18.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.568 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.1 m -163.53 153.42 15.21 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.87 -1.144 . . . . 0.0 110.364 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.568 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER -122.13 41.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.61 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -81.81 -144.42 0.06 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.02 0.914 . . . . 0.0 111.92 -177.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 47' ' ' TYR . 2.0 pt-20 -68.81 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.291 1.043 . . . . 0.0 112.939 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 3.1 p30 -163.47 -46.41 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HB3' ' CD ' ' A' ' 51' ' ' ARG . 2.7 mp0 -107.53 -41.11 5.14 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.508 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' CD ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -171.88 14.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.758 -1.214 . . . . 0.0 112.828 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 12.3 pt-20 -105.71 -145.39 0.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.511 -1.368 . . . . 0.0 110.494 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.643 ' CG2' ' CG ' ' A' ' 77' ' ' TYR . 0.7 OUTLIER -170.06 143.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -139.38 -76.89 0.35 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.799 -1.188 . . . . 0.0 112.551 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.515 ' O ' HG21 ' A' ' 45' ' ' THR . . . -144.98 175.1 24.77 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.409 -1.853 . . . . 0.0 110.735 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -152.87 110.21 3.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.427 -1.043 . . . . 0.0 111.018 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.0 pm0 -124.8 124.46 42.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -122.51 169.67 10.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.566 -1.334 . . . . 0.0 113.267 -177.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 6.7 mp0 -133.66 123.08 24.39 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.621 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -121.24 72.59 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 0.0 109.888 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -68.23 107.13 2.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.579 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 34.8 m -158.29 -160.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.346 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.633 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.0 t80 -140.99 129.24 22.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.515 -0.741 . . . . 0.0 109.932 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 34' ' ' PHE . . . -122.0 -130.27 0.27 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 66' ' ' ASP . 1.0 OUTLIER -86.49 -18.76 30.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 108.744 178.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 9.6 p-10 -162.4 23.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.565 -0.71 . . . . 0.0 109.735 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.592 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -117.07 71.47 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.384 -0.823 . . . . 0.0 110.32 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.633 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 4.6 mt -81.73 52.6 1.95 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -168.62 -153.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.547 -0.721 . . . . 0.0 109.81 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 17.3 ttm180 -106.52 119.64 39.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 111.321 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.616 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -80.6 107.19 13.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t70 -87.64 160.37 18.18 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.602 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.73 112.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.905 0.86 . . . . 0.0 109.745 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' CB ' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -103.12 144.17 31.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.005 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.5 mt-10 -153.58 105.75 2.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.461 -1.399 . . . . 0.0 112.335 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.626 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 1.7 p-10 -50.66 173.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.521 0.677 . . . . 0.0 111.03 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.643 ' CG ' ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.17 -72.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.138 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.0 tppt? -120.2 -34.34 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 79' ' ' THR . 3.2 m -90.43 9.33 29.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.364 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 66.33 55.38 0.86 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.496 -0.752 . . . . 0.0 111.057 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.626 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -51.33 -99.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -158.21 -165.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.279 . . . . 0.0 111.052 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 79.4 mttt -158.18 97.93 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -171.17 -172.99 1.19 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 110.605 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.3 167.67 8.36 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.646 -0.659 . . . . 0.0 109.329 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.9 mtm180 -143.45 -176.21 4.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.933 -1.105 . . . . 0.0 111.198 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.593 ' CE1' HD13 ' A' ' 85' ' ' LEU . 17.3 m-85 -155.98 66.79 0.6 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -154.16 -161.41 1.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.81 -1.182 . . . . 0.0 111.624 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 73.05 54.7 6.82 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -176.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.1 Cg_endo -62.57 177.12 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.82 1.958 . . . . 0.0 112.065 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG11 ' OH ' ' A' ' 61' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.196 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER 71.29 -148.55 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.318 -1.107 . . . . 0.0 110.128 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.555 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 7.0 p-90 -144.03 169.27 18.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.783 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 177.28 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.063 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' CG2' ' HG3' ' A' ' 42' ' ' MET . 6.9 pt -69.89 -172.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.605 HG13 ' CG ' ' A' ' 11' ' ' PHE . 1.1 mm -131.1 -138.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' HD12 ' A' ' 38' ' ' ILE . 19.3 m-20 -142.07 -146.83 0.2 Allowed 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.791 -1.193 . . . . 0.0 110.221 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.477 ' C ' HG23 ' A' ' 12' ' ' THR . 19.5 tt -113.62 47.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.622 ' N ' HG22 ' A' ' 12' ' ' THR . . . -157.39 -60.9 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.357 -1.402 . . . . 0.0 111.777 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 38.6 Cg_endo -64.92 -68.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.527 1.277 . . . . 0.0 112.527 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.605 ' CG ' HG13 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -65.36 -23.53 67.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.483 -1.385 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 9' ' ' GLY . 10.0 p -48.62 -53.36 18.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -64.02 -29.78 70.9 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.072 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 17' ' ' LYS . 2.0 m-80 -66.02 -58.73 4.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.605 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . 9.0 tp -41.03 -66.99 0.28 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.568 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -43.46 -29.31 1.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' ASN . 70.5 mmtt -88.67 -82.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 110.418 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -41.6 -27.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.486 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.558 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -81.2 -70.5 0.53 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.4 p -41.57 -25.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.324 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ALA . 59.3 t0 -92.7 -72.5 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.085 -1.01 . . . . 0.0 110.516 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 0.8 OUTLIER -57.83 -28.96 64.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.452 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.3 tt0 -72.43 -58.97 2.97 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 29' ' ' TYR . 1.5 m120 -54.14 -51.82 63.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -51.45 -48.62 62.69 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.456 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -53.75 -20.44 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.529 0.68 . . . . 0.0 109.294 178.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.68 22.86 5.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 1.5 tp60 -120.96 65.19 0.86 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.443 -1.033 . . . . 0.0 109.664 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 7.0 t80 -89.98 23.11 2.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.439 -0.788 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.69 -58.71 1.75 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -168.32 -96.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -1.229 . . . . 0.0 110.5 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 1.9 mp -112.11 -175.39 2.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -155.35 49.67 0.55 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.302 -0.874 . . . . 0.0 110.088 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.568 ' CD1' ' HA2' ' A' ' 16' ' ' GLY . 43.5 p90 179.65 55.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.471 -0.768 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 20.9 t-20 -85.77 -54.24 4.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.454 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -69.54 -105.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.021 -1.049 . . . . 0.0 110.962 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 3.7 t -161.06 172.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.53 -1.356 . . . . 0.0 111.775 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.561 ' CG1' HG21 ' A' ' 12' ' ' THR . 1.2 pp -121.37 97.62 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.601 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -96.04 -55.56 0.21 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.863 -1.148 . . . . 0.0 109.866 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.2 Cg_endo -86.87 54.18 2.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.554 1.292 . . . . 0.0 110.362 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 7.5 t -91.25 92.94 8.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -90.68 126.4 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.155 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -123.63 155.78 37.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.555 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 1.4 ptpp? -164.54 173.5 11.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.594 HG21 ' N ' ' A' ' 46' ' ' ILE . 18.4 m -157.86 158.07 34.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.594 ' N ' HG21 ' A' ' 45' ' ' THR . 6.8 pt -118.74 48.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.581 ' CE2' ' OH ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -116.45 164.07 15.1 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -178.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -90.43 -125.87 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.884 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 170.96 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.865 -1.147 . . . . 0.0 110.553 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.446 ' OE2' ' HB3' ' A' ' 49' ' ' ASN . 14.8 mp0 -129.26 -3.23 4.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -128.83 -30.94 2.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.288 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 17.2 pt-20 -170.28 -165.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.584 HG22 ' CD1' ' A' ' 77' ' ' TYR . 7.6 tt -152.6 107.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.731 0.776 . . . . 0.0 109.566 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -82.77 -76.43 0.27 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.86 -1.15 . . . . 0.0 112.103 -178.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 77' ' ' TYR . . . -172.28 173.22 45.23 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 117.772 -2.156 . . . . 0.0 111.237 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.581 ' OH ' ' CE2' ' A' ' 47' ' ' TYR . 11.3 m-85 -115.65 -179.19 3.58 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.82 -0.812 . . . . 0.0 110.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 56' ' ' TYR . 7.4 pt-20 171.34 137.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.652 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -151.06 171.78 16.79 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 117.432 -1.707 . . . . 0.0 113.974 -178.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt-30 -129.24 124.82 35.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.652 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 23.7 tp -117.67 71.76 0.83 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.871 -1.143 . . . . 0.0 109.83 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.582 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -69.53 107.01 3.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 38' ' ' ILE . 13.0 m -158.2 -160.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.343 -0.848 . . . . 0.0 109.685 -177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -141.32 139.1 33.53 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.473 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB2' ' N ' ' A' ' 34' ' ' PHE . . . -132.98 -113.08 0.22 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.374 -0.829 . . . . 0.0 109.508 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -30.6 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.125 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -143.18 12.82 1.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.652 -0.655 . . . . 0.0 109.51 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HE3' ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -111.16 87.71 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.525 -0.735 . . . . 0.0 110.03 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.562 HD22 ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -93.57 63.21 3.42 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.657 -0.652 . . . . 0.0 109.773 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.62 -118.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.573 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 48.0 ttp85 -123.76 146.08 48.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.402 -1.436 . . . . 0.0 112.807 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.624 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -109.48 106.56 16.36 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 6.1 t70 -84.74 159.88 20.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 110.753 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.613 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -160.11 119.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.503 0.668 . . . . 0.0 109.577 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.502 ' HB3' ' CB ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -108.75 153.39 23.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.046 . . . . 0.0 109.528 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 2.5 mt-10 -152.19 104.75 2.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.641 -1.287 . . . . 0.0 112.206 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 3.2 p30 -63.96 170.51 3.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.499 0.666 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.584 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -149.03 -75.14 0.17 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.563 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 10.9 tttm -117.26 -34.4 4.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.307 -0.871 . . . . 0.0 108.871 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 79' ' ' THR . 4.5 m -87.91 12.32 13.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.483 -0.76 . . . . 0.0 109.159 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 79' ' ' THR . 0.7 OUTLIER 59.57 55.29 4.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.732 -0.605 . . . . 0.0 111.411 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.624 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -53.71 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.514 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 1.7 mtm-85 -155.65 -169.45 3.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.235 . . . . 0.0 110.715 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -162.29 82.22 0.54 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 10.5 tp -171.17 178.72 3.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.353 -0.842 . . . . 0.0 109.639 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.588 HD22 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -154.58 167.99 28.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 6.5 mtt-85 -139.48 -177.7 5.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.772 -1.205 . . . . 0.0 111.45 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.588 ' CZ ' HD22 ' A' ' 85' ' ' LEU . 11.0 m-85 -156.19 82.89 0.99 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.669 -0.644 . . . . 0.0 109.399 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -161.21 -164.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.615 -1.303 . . . . 0.0 111.371 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.555 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 80.6 53.72 3.95 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.2 Cg_endo -60.09 149.67 83.37 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.828 1.962 . . . . 0.0 111.828 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.109 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' C ' ' HG2' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.561 -1.416 . . . . 4.0199999999999996 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' HG2' ' C ' ' A' ' 1' ' ' GLY . 13.6 mm-40 -136.19 135.99 39.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -1.146 . . . . 2.79 110.2 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 65.3 p-90 -115.53 152.59 32.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 4.46 110.202 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' CD ' ' CD ' ' A' ' 43' ' ' LYS . 3.8 pt-20 -163.69 134.08 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.92 . . . . 2.7000000000000002 110.177 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 16.7 pt -82.34 175.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.055 -1.028 . . . . 1.8999999999999999 110.491 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.638 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.35 -162.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.251 -0.906 . . . . 2.9199999999999999 109.881 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -136.36 50.17 2.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.14 . . . . 2.73 111.515 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 11.5 tt 40.18 43.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.936 0.874 . . . . 2.2200000000000002 110.043 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG22 ' A' ' 12' ' ' THR . . . -132.81 -62.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.295 -0.955 . . . . 1.02 110.804 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.9 Cg_endo -86.34 -61.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.503 1.265 . . . . 1.04 110.896 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.638 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 3.1 m-85 -50.06 -31.89 14.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.993 -1.067 . . . . 1.8300000000000001 109.387 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.538 HG21 ' CD1' ' A' ' 38' ' ' ILE . 7.2 p -60.2 -58.67 7.53 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.124 -1.436 . . . . 1.4099999999999999 107.124 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.9 tt0 -66.73 -19.47 65.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.766 0.793 . . . . 2.7200000000000002 109.18 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.504 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 9.9 t-20 -78.19 -56.43 4.47 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.502 0.668 . . . . 2.0899999999999999 109.547 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD12 ' CE ' ' A' ' 67' ' ' LYS . 7.1 tp -41.55 -66.13 0.37 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.402 0.62 . . . . 2.6299999999999999 109.357 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.67 -43.61 16.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.323 -1.511 . . . . 0.67000000000000004 109.323 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -69.64 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -1.16 . . . . 2.8900000000000001 110.939 -179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -37.69 -53.71 1.23 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.414 0.626 . . . . 2.8599999999999999 111.238 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.9 -70.06 0.12 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.475 -0.766 . . . . 1.1599999999999999 110.001 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 16.2 t -42.77 -26.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.032 . . . . 2.0099999999999998 110.358 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -91.9 -66.28 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.8100000000000001 109.896 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 2.3 mm-40 -60.16 -41.09 92.06 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.581 -1.247 . . . . 2.1699999999999999 108.981 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -61.46 -53.22 59.3 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.6799999999999999 108.711 178.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.572 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 27.4 t-20 -61.86 -46.58 88.82 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.687 -1.205 . . . . 2.2799999999999998 107.824 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -56.92 -48.18 78.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 3.2799999999999998 109.842 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -60.85 -20.18 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.925 -0.71 . . . . 2.2599999999999998 109.844 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 122.67 28.54 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.572 -1.411 . . . . 0.98999999999999999 109.572 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.521 ' CG ' ' OE2' ' A' ' 23' ' ' GLU . 8.6 tp60 -126.77 65.95 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.152 . . . . 2.75 110.019 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.572 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 37.4 p90 -88.14 19.15 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 5.7000000000000002 109.961 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.52 -62.62 2.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 2.54 109.594 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 2.9 mtt180 -168.04 -88.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -1.212 . . . . 4.0099999999999998 109.989 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.544 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 2.7 mp -121.83 -177.65 3.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 3.0 110.026 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -140.44 52.43 1.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.298 -0.876 . . . . 1.25 109.848 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 38.4 p90 -167.86 129.08 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.83 . . . . 4.25 110.036 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' HB2' ' N ' ' A' ' 65' ' ' SER . 7.7 t30 -153.67 -64.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 2.8500000000000001 110.678 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.632 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.98 -94.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.964 . . . . 3.8799999999999999 111.329 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 24.4 t -157.97 172.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.693 -1.254 . . . . 1.6000000000000001 111.822 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.546 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -129.22 86.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.201 -0.666 . . . . 2.27 109.201 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.531 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -102.73 -52.14 0.14 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 3.6000000000000001 110.533 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.3 Cg_endo -85.59 52.8 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.53 1.279 . . . . 0.60999999999999999 110.789 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 6' ' ' ILE . 21.5 p -104.2 120.39 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 2.0699999999999998 109.781 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.49 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 14.7 mtm -119.04 178.02 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 2.6000000000000001 110.631 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -138.61 151.58 47.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 2.1099999999999999 110.461 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.519 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 1.9 mttt -148.39 106.21 3.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.362 -0.837 . . . . 2.9100000000000001 109.889 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.567 HG23 ' CG ' ' A' ' 47' ' ' TYR . 2.6 m -112.8 152.55 29.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 1.26 110.173 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.534 ' N ' HG21 ' A' ' 45' ' ' THR . 0.8 OUTLIER -120.36 41.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.769 -1.567 . . . . 2.4300000000000002 106.769 178.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.576 ' CD2' ' OE2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -81.88 -153.09 0.1 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.402 1.096 . . . . 3.1099999999999999 112.462 -177.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.576 ' OE2' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -68.84 -164.52 0.05 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.38 1.086 . . . . 3.6499999999999999 112.84 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 13.1 t30 -126.91 -41.12 1.83 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.893 -1.151 . . . . 4.79 107.893 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 16.4 tt0 -175.28 28.63 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.84 -0.538 . . . . 4.3200000000000003 109.637 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -171.05 -24.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.927 -1.108 . . . . 5.6699999999999999 112.62 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 22.9 pm0 -115.07 -146.23 0.4 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.272 -1.518 . . . . 2.8799999999999999 111.61 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CD1' ' CE1' ' A' ' 77' ' ' TYR . 10.7 tt -169.42 143.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 109.633 -0.506 . . . . 2.54 109.633 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -139.52 -73.88 0.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.647 -1.221 . . . . 3.3100000000000001 112.752 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 45' ' ' THR . . . -149.57 173.67 29.3 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.263 -1.923 . . . . 0.79000000000000004 110.172 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.564 ' CZ ' ' HE3' ' A' ' 43' ' ' LYS . 7.5 t80 -150.53 98.31 2.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.29 -1.124 . . . . 3.9300000000000002 110.87 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 15.8 pt-20 -120.0 174.01 6.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 2.5299999999999998 108.914 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.636 ' CD1' ' CG2' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -159.6 177.64 10.69 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 117.952 -1.499 . . . . 2.2400000000000002 113.45 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.52 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -135.45 117.24 15.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.589 -1.263 . . . . 2.1800000000000002 107.589 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.591 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 2.2 tp -116.0 72.41 0.81 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 1.3700000000000001 109.513 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.574 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -69.63 111.74 5.64 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.117 -1.068 . . . . 2.1899999999999999 108.117 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' CG1' ' A' ' 38' ' ' ILE . 34.6 m -158.13 -158.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.789 0.804 . . . . 1.1100000000000001 109.813 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.0 t80 -143.61 126.21 15.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.699 -0.626 . . . . 1.8100000000000001 109.535 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 67' ' ' LYS . . . -121.44 -136.45 0.32 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.393 -0.817 . . . . 1.29 109.884 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -87.34 -25.73 23.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 1.72 108.964 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 15.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 1.78 109.567 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -118.29 79.2 1.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 2.0 110.11 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mp -89.73 57.67 3.98 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.622 -0.881 . . . . 2.2599999999999998 108.622 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -173.09 -121.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.074 -1.05 . . . . 2.27 110.023 -178.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.521 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 30.5 ttm180 -133.84 124.76 27.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.325 -1.484 . . . . 2.4300000000000002 112.215 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -81.79 103.35 11.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.984 -1.487 . . . . 1.1299999999999999 106.984 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' ' CA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.45 156.04 19.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 1.75 110.15 -178.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.636 ' CG2' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -159.22 141.74 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.513 -0.742 . . . . 1.75 109.863 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.504 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -127.96 153.32 46.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.238 -0.914 . . . . 1.55 109.049 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -157.67 106.42 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.635 -1.291 . . . . 2.2999999999999998 111.772 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 1.4 p30 -48.79 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.502 0.667 . . . . 1.74 111.224 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.636 ' CE1' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.31 -38.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 3.4500000000000002 109.487 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 1.5 ttpt -150.55 -42.92 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.939 -0.763 . . . . 4.4699999999999998 108.939 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -90.98 18.02 7.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.816 -0.809 . . . . 4.0099999999999998 108.816 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' CD ' ' N ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER 58.43 52.33 7.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 6.8899999999999997 110.823 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.585 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -44.72 -93.06 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.215 -1.554 . . . . 2.9900000000000002 109.215 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -161.33 -167.44 1.76 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.169 -1.194 . . . . 5.7000000000000002 110.796 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -165.25 86.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.395 -0.965 . . . . 3.8399999999999999 108.395 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.519 ' CD1' HG12 ' A' ' 26' ' ' ILE . 10.0 tp -171.25 179.74 2.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.318 -0.864 . . . . 2.9399999999999999 109.338 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.555 HD13 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -155.65 172.28 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.103 -0.998 . . . . 1.76 110.094 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.533 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 3.9 mtt180 -142.33 -176.67 4.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -0.894 . . . . 3.0600000000000001 110.905 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 23' ' ' GLU . 48.5 m-85 -154.93 64.63 0.65 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.95999999999999996 108.954 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.87 -157.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 2.5 111.26 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.46 52.5 30.33 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.193 -3.163 . . . . 1.3999999999999999 105.193 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.4 Cg_endo -67.55 -175.03 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.582 1.833 . . . . 2.1400000000000001 111.933 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.52 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 31.1 m . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 117.966 -1.016 . . . . 2.25 110.387 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.63 ' CA ' ' CE1' ' A' ' 47' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 6.2 mt-10 63.05 -121.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -1.157 . . . . 0.0 109.823 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.523 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 51.2 p-90 -118.59 169.98 9.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.807 -1.183 . . . . 0.0 110.036 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 1.4 tt0 175.79 115.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 15.2 pt -82.77 -176.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.601 HG23 ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -116.39 -165.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.089 -1.007 . . . . 0.0 110.543 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.552 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 25.3 m-20 -136.66 49.99 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.945 -1.097 . . . . 0.0 111.461 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 19.5 tt 39.7 42.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.575 ' N ' HG22 ' A' ' 12' ' ' THR . . . -145.47 -68.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.975 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' O ' ' CG ' ' A' ' 13' ' ' GLN . 43.8 Cg_endo -73.77 -84.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.689 1.363 . . . . 0.0 111.392 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.601 ' CG ' HG23 ' A' ' 6' ' ' ILE . 24.7 m-85 -39.68 -31.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.012 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 9' ' ' GLY . 11.7 p -55.97 -56.89 15.28 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.85 -1.156 . . . . 0.0 108.21 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.516 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -57.34 -17.83 14.24 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.41 179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' N ' ' HG3' ' A' ' 13' ' ' GLN . 0.7 OUTLIER -79.86 -60.56 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.702 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.2 pp -41.57 -30.68 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.66 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.41 -49.28 20.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' PHE . 10.4 tptt -71.62 -69.36 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -1.05 . . . . 0.0 110.21 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-85 -39.75 -62.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.483 0.659 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.12 -72.45 0.06 Allowed 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 15.7 t -38.52 -26.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.756 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 19' ' ' ALA . 9.4 m-20 -95.09 -70.73 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 110.26 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 1.8 mt-10 -57.96 -26.87 62.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.579 -1.249 . . . . 0.0 109.062 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 87' ' ' PHE . 1.9 tt0 -74.34 -58.91 2.99 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' GLN . 1.7 m-80 -56.81 -44.73 82.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.461 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.94 -52.68 63.28 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.793 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 7.3 tp -63.68 -12.87 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.264 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.64 59.48 0.43 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -159.12 80.29 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 109.991 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.446 ' O ' ' C ' ' A' ' 30' ' ' GLY . 51.7 p90 -103.73 28.07 6.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -41.56 -53.41 4.32 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 173.02 -69.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -1.209 . . . . 0.0 110.427 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.515 ' CD1' ' OD1' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -135.2 164.76 26.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.324 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.501 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -135.13 55.27 1.9 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 11.3 p90 -174.4 60.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.886 . . . . 0.0 110.262 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.515 ' OD1' ' CD1' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -90.1 -56.05 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -69.63 -106.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.079 . . . . 0.0 111.115 -178.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 6.1 t -160.03 173.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.732 -1.23 . . . . 0.0 111.431 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.576 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -120.53 118.07 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.498 -0.751 . . . . 0.0 110.162 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -123.49 -56.87 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.896 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.4 Cg_endo -87.33 48.89 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.212 1.111 . . . . 0.0 110.354 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . 2.7 t -91.27 128.81 37.24 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.537 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 14.2 mtm -122.96 162.98 21.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -145.19 115.87 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.481 -0.762 . . . . 0.0 109.237 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 1.3 mttp -124.93 152.12 44.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.034 -1.041 . . . . 0.0 110.313 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.551 HG21 ' N ' ' A' ' 46' ' ' ILE . 2.3 m -147.41 152.51 38.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -122.81 41.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.63 ' CE1' ' CA ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -83.07 -143.35 0.07 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.929 0.871 . . . . 0.0 111.704 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.614 ' N ' ' CG ' ' A' ' 47' ' ' TYR . 3.0 pt-20 -65.96 -163.97 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 112.62 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 2.1 p-10 -159.89 -46.35 0.05 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -115.66 -36.54 4.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.855 -0.528 . . . . 0.0 111.029 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -171.89 20.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.721 -1.237 . . . . 0.0 112.344 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.589 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 7.5 pt-20 -117.53 -142.16 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.748 -1.22 . . . . 0.0 110.583 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG12 ' CD1' ' A' ' 77' ' ' TYR . 7.7 tp -172.52 156.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 2.7 mttt -153.28 -73.01 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.081 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' HG21 ' A' ' 45' ' ' THR . . . -149.42 175.21 28.71 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.612 -1.756 . . . . 0.0 110.224 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -155.37 104.37 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 110.113 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 2.1 pt-20 -105.15 152.31 22.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.617 ' CZ ' ' HB2' ' A' ' 60' ' ' LEU . 13.5 t80 -128.27 148.74 50.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.644 -1.285 . . . . 0.0 112.673 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 21.9 mt-30 -134.41 109.9 9.07 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -116.0 71.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.973 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.585 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -72.98 108.44 5.89 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.684 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 33.6 m -159.86 -159.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.593 -0.692 . . . . 0.0 109.371 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 3.6 t80 -135.69 142.07 45.04 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.527 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.536 ' CB ' ' HE3' ' A' ' 67' ' ' LYS . . . -137.08 -118.99 0.15 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -99.42 -28.97 13.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.018 -1.051 . . . . 0.0 109.222 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -148.99 18.28 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.736 0.779 . . . . 0.0 109.143 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' CD ' HG22 ' A' ' 62' ' ' VAL . 7.0 ttmt -109.18 79.15 1.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.511 0.672 . . . . 0.0 110.104 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 5.7 mp -85.89 57.59 4.56 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 109.263 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.52 -124.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.529 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 7.6 ttm180 -127.19 144.42 51.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.199 -1.563 . . . . 0.0 113.486 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.529 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -112.39 111.59 22.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -99.04 170.06 8.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.774 -1.204 . . . . 0.0 110.369 -177.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.568 HG21 ' CB ' ' A' ' 58' ' ' TYR . 3.1 tp -151.62 113.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.768 0.794 . . . . 0.0 109.237 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 21.9 t -97.85 151.45 20.21 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.08 . . . . 0.0 109.5 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -148.8 110.08 4.4 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.387 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.53 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -54.0 156.88 2.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.417 -0.802 . . . . 0.0 111.218 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.58 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -148.13 -68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.114 -0.991 . . . . 0.0 108.801 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 39.0 tttm -124.9 -37.2 2.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 2.1 t -75.69 -2.84 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 80' ' ' ARG . 5.7 mmm180 73.62 46.03 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.094 0.473 . . . . 0.0 111.206 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -63.4 -130.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.511 ' CD ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -174.04 174.16 3.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.419 -1.636 . . . . 0.0 111.518 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 74' ' ' SER . 11.8 tttt -103.08 125.63 49.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HB2' ' CD ' ' A' ' 82' ' ' ARG . 4.7 tp -171.18 -170.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.969 -1.082 . . . . 0.0 110.037 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -171.21 -179.96 2.83 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.229 -0.92 . . . . 0.0 110.695 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.569 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 5.8 ptm85 -170.25 112.8 0.45 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.125 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.629 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 6.8 m-85 -90.85 86.66 6.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.525 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.599 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -160.78 -171.34 3.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.818 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . 91.9 59.65 1.31 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 37.1 Cg_endo -59.43 125.16 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.502 1.791 . . . . 0.0 112.116 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' OH ' ' A' ' 61' ' ' TYR . 2.6 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.211 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.46 162.46 18.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -1.144 . . . . 0.0 110.206 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 29.6 p90 -154.22 146.85 24.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 48.4 mt-10 -157.6 -174.54 4.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -121.85 171.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 110.035 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.635 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -81.1 -164.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.329 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 16.1 t0 -147.43 46.7 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.439 -0.788 . . . . 0.0 110.658 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.554 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 2.9 tt 39.88 40.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.657 0.741 . . . . 0.0 109.84 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' N ' HG22 ' A' ' 12' ' ' THR . . . -146.54 -61.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.628 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 11' ' ' PHE . 43.4 Cg_endo -83.87 -77.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.574 1.302 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.635 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 86.1 m-85 -39.89 -35.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 110.284 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 13' ' ' GLN . 9.7 p -61.61 -59.95 4.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' N ' ' OG1' ' A' ' 12' ' ' THR . 35.5 tt0 -66.73 -15.27 63.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.52 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.57 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 43.8 m-20 -78.4 -57.72 3.63 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.548 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -42.31 -50.73 4.98 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.581 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -51.64 -56.34 16.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -67.4 -77.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -1.081 . . . . 0.0 110.696 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 14' ' ' ASN . 16.8 m-30 -33.69 -63.99 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.569 0.699 . . . . 0.0 111.355 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -42.2 -71.89 0.07 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 12.5 t -39.86 -27.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 1.6 t70 -92.3 -71.0 0.67 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' CB ' HD12 ' A' ' 73' ' ' ILE . 2.8 pt-20 -54.35 -29.01 46.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.38 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.3 tt0 -72.53 -60.18 2.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -59.3 -39.14 82.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.306 -1.358 . . . . 0.0 107.916 178.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -60.46 -48.94 79.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.552 ' CG1' HD23 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.37 -32.74 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.417 -0.802 . . . . 0.0 110.606 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 140.41 42.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -149.67 79.49 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -1.073 . . . . 0.0 108.889 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 31' ' ' ARG . 20.3 p90 -83.27 17.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 110.811 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 31' ' ' ARG . . . -43.1 -25.71 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER 76.84 -4.93 2.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.722 -0.87 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 31' ' ' ARG . 15.2 mt -121.08 130.04 53.59 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.525 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -163.44 42.79 0.11 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.552 0.692 . . . . 0.0 109.789 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 31.0 p90 -174.42 99.23 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.687 -0.633 . . . . 0.0 109.895 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.445 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 5.8 t-20 -141.58 -52.42 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.903 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.576 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -70.51 -98.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.0 111.494 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 1.1 t -161.83 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.798 -1.189 . . . . 0.0 111.051 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -140.59 123.96 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.565 0.698 . . . . 0.0 109.709 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.551 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 mtt180 -140.7 -56.59 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.6 Cg_endo -83.52 42.48 1.25 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.17 1.089 . . . . 0.0 111.712 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' O ' HG22 ' A' ' 6' ' ' ILE . 20.5 p -103.22 129.62 50.21 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 109.333 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -121.74 163.22 19.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.0 111.035 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -117.89 155.19 30.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.752 . . . . 0.0 109.958 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 27.0 mttt -159.79 118.64 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.58 HG23 ' CD1' ' A' ' 47' ' ' TYR . 1.8 m -119.72 148.83 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.553 ' N ' HG21 ' A' ' 45' ' ' THR . 0.0 OUTLIER -109.02 48.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.58 ' CD1' HG23 ' A' ' 45' ' ' THR . 0.1 OUTLIER -107.42 169.55 8.51 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.486 -0.759 . . . . 0.0 110.884 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 2.8 tp10 -74.33 -102.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 109.802 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.2 OUTLIER 179.64 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.016 . . . . 0.0 110.288 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -149.23 12.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 109.864 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.44 -25.01 4.85 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 48' ' ' GLU . 12.1 pt-20 -170.11 179.94 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.92 . . . . 0.0 110.956 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' CG ' ' A' ' 77' ' ' TYR . 1.8 tp -138.3 116.07 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.444 -0.785 . . . . 0.0 109.353 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -94.72 -71.6 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.075 -1.015 . . . . 0.0 112.157 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 45' ' ' THR . . . -149.3 -176.62 22.7 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.481 -1.819 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 0.8 OUTLIER -162.44 107.68 1.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.682 -0.893 . . . . 0.0 109.936 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 1.1 pp20? -126.87 177.26 6.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -161.96 171.89 16.89 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.216 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.51 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 26.8 mt-30 -130.28 125.29 34.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.662 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -121.49 75.11 1.16 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.842 -1.161 . . . . 0.0 109.738 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.516 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 2.1 t80 -74.11 111.04 8.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.141 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.609 ' CG2' ' CE ' ' A' ' 67' ' ' LYS . 17.7 m -159.0 -154.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.784 0.802 . . . . 0.0 109.068 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 68' ' ' LEU . 1.8 t80 -139.68 134.81 32.48 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.299 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -130.16 -126.65 0.21 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.361 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -103.14 -34.12 8.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.082 -1.011 . . . . 0.0 110.113 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 8.1 p-10 -132.65 0.83 3.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.609 ' CE ' ' CG2' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -114.38 104.09 11.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.845 . . . . 0.0 109.622 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 63' ' ' TYR . 10.2 mt -100.58 66.61 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.461 -0.774 . . . . 0.0 109.852 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 167.68 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 31.4 ttm180 -121.26 148.09 44.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.127 -1.608 . . . . 0.0 112.909 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -113.93 107.52 15.81 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 13.8 t70 -88.57 165.92 14.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.957 -1.089 . . . . 0.0 110.639 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 58' ' ' TYR . 3.2 tp -165.29 112.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.639 0.733 . . . . 0.0 109.301 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.5 p -108.76 162.44 14.17 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.652 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -170.12 117.72 0.56 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.781 . . . . 0.0 109.792 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.586 ' CB ' ' HB2' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -58.33 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.443 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CG ' ' CG1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -167.81 -59.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.931 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -54.22 -46.62 72.57 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -107.35 -8.39 16.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER 56.41 31.68 19.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.572 -0.705 . . . . 0.0 110.324 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' ARG . . . -126.42 80.66 0.36 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.23 -1.462 . . . . 0.0 111.548 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.586 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 21.3 mtt180 -170.09 78.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.924 . . . . 0.0 108.644 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -100.65 146.98 26.5 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.222 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 5.0 tp -170.47 123.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.626 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -125.16 167.85 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.211 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 60.1 mtm180 -157.88 119.26 3.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.964 -1.085 . . . . 0.0 111.993 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 12.8 m-85 -107.43 71.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.71 -161.81 1.33 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.384 -1.326 . . . . 0.0 111.406 -179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.44 52.0 6.32 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 105.345 -3.102 . . . . 0.0 105.345 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.03 158.21 35.37 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.807 1.951 . . . . 0.0 112.08 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.282 -179.67 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 47' ' ' TYR . 4.7 pm0 -148.71 176.57 10.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -1.158 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.532 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 26.4 p-90 -143.02 149.57 38.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 43' ' ' LYS . 34.8 mt-10 -152.77 136.73 16.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 110.656 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -79.28 -174.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 110.664 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -114.2 -167.96 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.341 -0.849 . . . . 0.0 110.297 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 33.9 t70 -137.12 49.27 2.04 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 111.16 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.542 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 17.8 tt 38.74 33.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.615 0.722 . . . . 0.0 109.911 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 12' ' ' THR . . . -138.11 -59.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.686 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.88 -56.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.511 1.269 . . . . 0.0 111.57 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 9.2 m-85 -61.78 -27.21 68.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.959 -1.088 . . . . 0.0 109.695 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' N ' ' A' ' 9' ' ' GLY . 10.8 p -65.44 -59.85 3.57 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.206 -0.934 . . . . 0.0 108.789 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 44.6 tt0 -59.67 -20.38 55.8 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.763 0.792 . . . . 0.0 109.175 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -71.26 -56.22 6.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.748 0.785 . . . . 0.0 109.248 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.54 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 5.7 tt -43.1 -64.25 0.67 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 15' ' ' LEU . . . -41.11 -44.67 3.75 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.82 -79.78 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -1.167 . . . . 0.0 110.643 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -36.99 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.423 0.63 . . . . 0.0 111.086 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -77.4 -74.69 0.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 14.1 t -36.74 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.618 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' ALA . 34.9 t70 -93.05 -79.28 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 2.5 mt-10 -49.36 -25.8 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.805 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 11.6 tt0 -77.52 -63.18 1.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 29' ' ' TYR . 4.3 m120 -49.53 -48.43 48.3 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -55.01 -51.55 65.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -49.95 -25.13 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.442 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.85 21.7 5.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -113.44 62.12 0.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.428 -1.042 . . . . 0.0 109.657 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.52 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 34.4 p90 -88.8 22.7 2.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.865 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -36.67 -49.56 1.37 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 3.2 mtp180 -178.52 -83.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -1.214 . . . . 0.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 1.7 mp -123.47 -179.44 4.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 110.524 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.537 ' HA ' ' CB ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -161.24 54.02 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.619 -0.675 . . . . 0.0 109.577 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 2.6 p90 -161.53 32.56 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -18.04 20.83 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.802 -1.186 . . . . 0.0 109.09 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.716 ' HB3' ' CA ' ' A' ' 64' ' ' ALA 0.357 0.0 OUTLIER -66.55 -141.24 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 -178.124 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.636 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -161.12 -176.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 113.877 -1.511 . . . . 0.0 106.963 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.58 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.61 121.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.379 -1.451 . . . . 0.0 110.96 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.595 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -125.78 -57.16 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 110.126 179.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.8 Cg_endo -85.31 47.81 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.203 1.107 . . . . 0.0 110.89 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -85.38 129.77 34.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.867 . . . . 0.0 109.525 178.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 41.3 mtm -133.31 161.95 33.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.882 -1.136 . . . . 0.0 110.785 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 10.4 ttpt -129.12 156.31 44.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -159.17 113.67 2.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.112 -0.993 . . . . 0.0 110.571 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 ' N ' ' A' ' 46' ' ' ILE . 18.3 m -122.13 154.27 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' N ' HG21 ' A' ' 45' ' ' THR . 0.3 OUTLIER -122.76 64.3 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 32.1 p90 -101.96 -179.31 3.97 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.688 0.756 . . . . 0.0 111.67 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.523 ' CB ' ' HG2' ' A' ' 52' ' ' GLU . 46.1 tp10 -68.94 -97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.649 -0.657 . . . . 0.0 109.974 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.468 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -162.22 -61.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.984 -1.073 . . . . 0.0 110.786 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 14.61 0.69 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.795 . . . . 0.0 109.52 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -22.95 5.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.5 -0.75 . . . . 0.0 109.665 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.523 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 6.6 pt-20 -163.97 169.05 18.56 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.58 ' HB ' ' CD1' ' A' ' 77' ' ' TYR . 18.0 mm -122.6 134.53 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -105.58 -57.24 2.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.096 -1.002 . . . . 0.0 112.203 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 45' ' ' THR . . . -147.43 130.23 3.48 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.843 -1.646 . . . . 0.0 110.003 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HA ' HG22 ' A' ' 45' ' ' THR . 13.6 t80 -120.77 100.4 7.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.403 -1.057 . . . . 0.0 110.286 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 50.9 tt0 -123.05 173.83 7.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.352 -0.843 . . . . 0.0 109.225 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.637 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -162.36 173.37 14.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.081 -1.447 . . . . 0.0 113.179 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 2.6 pt20 -128.7 124.27 35.23 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -118.11 72.58 0.87 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 108.593 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.572 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 0.7 OUTLIER -71.56 106.42 4.0 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.567 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.572 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 17.8 m -163.52 -144.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.696 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 22.7 t80 -135.03 161.57 34.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.716 ' CA ' ' HB3' ' A' ' 36' ' ' LYS . . . -136.56 -140.31 0.16 Allowed 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.946 0.794 . . . . 0.0 108.924 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 24.3 t -86.91 -1.62 57.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.66 33.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.592 -0.693 . . . . 0.0 109.72 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.98 93.87 3.59 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.836 . . . . 0.0 109.701 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.651 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 1.4 mm? -88.46 74.8 8.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.602 ' CG ' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 171.52 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.571 -1.33 . . . . 0.0 110.59 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' HD3' ' CB ' ' A' ' 59' ' ' GLN . 34.2 ttm180 -139.12 147.69 42.25 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.56 -1.338 . . . . 0.0 112.598 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.617 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.57 103.07 12.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 176.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -83.99 161.34 20.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 110.197 -178.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.604 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -163.01 108.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 121.939 0.875 . . . . 0.0 109.9 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 1.3 t -107.26 156.35 18.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 108.633 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 29.9 mt-10 -155.07 104.57 2.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.569 -1.332 . . . . 0.0 112.13 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.552 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 1.6 p30 -40.05 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.488 -0.758 . . . . 0.0 111.091 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.58 ' CD1' ' HB ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.86 -75.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 178.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 31.8 tptt -115.88 -35.04 4.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 108.988 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.525 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 1.2 p -86.13 7.29 25.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 0.0 109.237 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER 66.45 51.7 1.14 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.623 -0.673 . . . . 0.0 111.013 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 76' ' ' ASP . . . -60.46 -117.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 10.7 ptm85 -173.52 158.09 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.422 -1.634 . . . . 0.0 112.133 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -103.33 118.23 36.3 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -171.09 146.58 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.031 . . . . 0.0 110.304 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.597 ' CD2' ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -137.62 158.34 44.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.9 . . . . 0.0 109.59 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -142.8 147.71 35.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.947 -1.096 . . . . 0.0 111.009 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.597 ' CZ ' ' CD2' ' A' ' 85' ' ' LEU . 8.9 m-85 -119.55 85.56 2.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 109.348 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -168.94 -167.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.635 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 85.96 56.41 2.33 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.0 Cg_endo -61.87 151.37 81.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.508 1.794 . . . . 0.0 111.689 -176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.45 HG11 ' OH ' ' A' ' 61' ' ' TYR . 22.5 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 67.4 mm-40 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -1.133 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.2 p-90 -137.2 161.0 37.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.512 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 1.6 pm0 -172.47 173.03 4.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.588 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.7 173.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.588 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -112.17 -153.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.532 -0.73 . . . . 0.0 109.717 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -141.04 48.06 1.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.865 -1.147 . . . . 0.0 111.439 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 15.6 pt 40.17 36.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.932 0.873 . . . . 0.0 109.883 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.548 ' N ' HG22 ' A' ' 12' ' ' THR . . . -132.51 -59.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.954 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 43.8 Cg_endo -85.73 -66.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.596 1.314 . . . . 0.0 110.947 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.705 ' CE2' ' CE1' ' A' ' 58' ' ' TYR . 1.1 m-85 -47.42 -32.36 4.96 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.137 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 9' ' ' GLY . 23.6 p -59.9 -57.42 12.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.504 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.21 -26.13 68.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.549 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.495 ' OD1' ' CE2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -76.83 -49.9 14.71 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.481 0.658 . . . . 0.0 109.832 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 2.4 tm? -42.94 -63.7 0.75 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.392 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' N ' HD11 ' A' ' 15' ' ' LEU . . . -49.05 -41.84 30.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 20' ' ' VAL . 11.1 tptp -68.99 -68.52 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -1.16 . . . . 0.0 110.593 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CE2' ' OD1' ' A' ' 14' ' ' ASN . 18.0 m-30 -54.9 -36.11 64.84 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -58.68 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.815 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 9.6 p -38.41 -27.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -87.17 -75.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.866 -1.146 . . . . 0.0 110.107 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.561 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.4 mm-40 -59.47 -36.98 77.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 4.0 tt0 -62.62 -49.45 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.038 -1.039 . . . . 0.0 109.251 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.628 ' ND2' ' CG ' ' A' ' 29' ' ' TYR . 33.9 t-20 -70.63 -45.33 65.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 30.6 mmtt -58.61 -38.68 78.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 110.052 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 5.3 tp -71.68 -15.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.0 110.08 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 105.53 54.63 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 46.2 tp60 -170.2 88.81 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -1.082 . . . . 0.0 109.661 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.628 ' CG ' ' ND2' ' A' ' 24' ' ' ASN . 35.3 p90 -142.83 51.03 1.43 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.09 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -39.24 -29.4 0.11 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER 174.15 -67.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -1.152 . . . . 0.0 110.016 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 2.2 mp -132.62 177.62 7.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.126 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -146.15 53.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 22.4 p90 178.98 114.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.82 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.28 -48.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.0 110.834 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.91 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 111.197 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 17.0 t -158.31 172.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.633 -1.292 . . . . 0.0 111.361 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.568 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -133.26 99.94 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.757 . . . . 0.0 110.012 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.574 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.81 -54.18 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 110.492 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.584 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.1 Cg_endo -85.06 50.28 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.491 1.258 . . . . 0.0 111.362 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . 16.5 p -81.35 137.27 35.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' GLN . 6.2 mtp -130.95 169.29 16.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 110.959 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -151.92 138.65 18.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 109.946 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' HG2' ' N ' ' A' ' 45' ' ' THR . 8.3 ttmm -137.93 163.47 31.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.679 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.58 HG22 ' CD2' ' A' ' 56' ' ' TYR . 5.1 m -163.25 148.67 11.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.075 -1.016 . . . . 0.0 110.879 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.531 ' N ' HG21 ' A' ' 45' ' ' THR . 25.3 pt -118.87 40.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.577 ' CD2' ' OE2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -75.45 -160.09 0.12 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.102 0.953 . . . . 0.0 112.406 -177.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HG2' ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.76 -144.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.615 0.721 . . . . 0.0 111.816 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.602 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -118.41 -40.82 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -174.79 26.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -157.83 -29.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.05 . . . . 0.0 111.832 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.573 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -109.61 -155.34 0.56 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.445 -1.409 . . . . 0.0 111.988 -178.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.645 ' CG2' ' CG ' ' A' ' 77' ' ' TYR . 37.5 mm -151.92 135.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' TYR . 1.7 mptt -130.97 -65.52 0.78 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.849 -1.157 . . . . 0.0 112.044 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' ' CG1' ' A' ' 46' ' ' ILE . . . -141.04 171.07 24.31 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.064 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.58 ' CD2' HG22 ' A' ' 45' ' ' THR . 0.2 OUTLIER -157.42 97.77 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' CG ' ' HB3' ' A' ' 44' ' ' LYS . 4.3 pm0 -92.86 165.52 12.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.064 -1.022 . . . . 0.0 109.513 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.705 ' CE1' ' CE2' ' A' ' 11' ' ' PHE . 72.4 t80 -137.09 136.81 38.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.164 -0.96 . . . . 0.0 111.283 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.534 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 18.0 mt-30 -135.15 106.82 6.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 2.9 tp -119.41 80.16 1.53 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.01 -1.056 . . . . 0.0 110.076 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.584 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -74.4 110.37 8.64 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 29.3 m -160.33 -158.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.596 0.712 . . . . 0.0 109.656 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -140.82 133.99 29.5 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.67 -0.644 . . . . 0.0 109.474 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 34' ' ' PHE . . . -130.16 -124.4 0.21 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.738 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 t -97.73 -17.94 19.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.195 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.41 20.78 0.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.792 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.533 ' CD ' HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -118.61 81.03 1.62 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -0.791 . . . . 0.0 110.188 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.567 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -84.94 57.6 4.52 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.575 -0.703 . . . . 0.0 109.855 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.89 -117.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 110.368 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.534 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 21.5 ttp180 -122.96 148.26 45.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.158 -1.589 . . . . 0.0 113.122 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' A' ' 58' ' ' TYR . . . -109.94 105.35 14.48 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 66.2 m-20 -85.2 163.69 18.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.804 -1.185 . . . . 0.0 110.718 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.614 ' HB ' ' CD2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -160.12 103.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -93.71 157.48 16.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.824 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' CA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -161.46 96.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.867 -1.146 . . . . 0.0 111.465 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 11.6 p-10 -57.21 173.21 0.25 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 111.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.645 ' CG ' ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -157.65 -73.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.485 -0.759 . . . . 0.0 109.312 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 15.8 tptt -119.0 -33.12 4.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 0.0 109.087 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -89.26 6.46 40.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 109.579 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 79' ' ' THR . 27.5 mmm-85 67.75 52.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 110.975 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -57.12 -106.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mtm180 -170.05 148.68 3.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.886 -1.361 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HE2' ' CG ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -109.41 95.66 5.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.853 . . . . 0.0 108.796 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.37 -167.74 0.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.095 -1.003 . . . . 0.0 109.979 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.596 HD13 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -171.25 171.74 5.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.211 -0.93 . . . . 0.0 109.757 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 30.3 mtt180 -144.77 175.41 10.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.002 -1.062 . . . . 0.0 110.986 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.596 ' CE2' HD13 ' A' ' 85' ' ' LEU . 1.9 m-85 -151.63 69.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.519 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.606 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -155.06 -156.1 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.282 . . . . 0.0 111.105 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 87.68 52.79 2.89 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 106.711 -2.556 . . . . 0.0 106.711 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 39.6 Cg_endo -63.9 140.84 75.2 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.236 1.651 . . . . 0.0 111.276 -177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.343 -179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.489 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -86.87 161.78 18.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.262 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 3' ' ' TRP . 5.9 p90 -124.18 170.4 10.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 110.318 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 176.66 111.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.105 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -92.32 178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.379 -0.825 . . . . 0.0 110.594 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -116.86 -166.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.65 41.46 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.15 . . . . 0.0 111.155 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 38' ' ' ILE . 4.1 mt 57.18 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.02 0.914 . . . . 0.0 110.291 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.544 ' N ' HG22 ' A' ' 12' ' ' THR . . . -153.5 -63.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 44.0 Cg_endo -75.87 -76.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.59 1.31 . . . . 0.0 111.631 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 6' ' ' ILE . 3.2 m-85 -48.91 -26.65 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.023 -1.048 . . . . 0.0 110.46 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.56 ' CB ' HG23 ' A' ' 38' ' ' ILE . 26.9 p -57.6 -57.77 11.26 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.943 -1.098 . . . . 0.0 108.26 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.1 mm-40 -63.2 -24.8 68.04 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.77 0.795 . . . . 0.0 109.206 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' LEU . 4.6 t30 -72.14 -56.3 5.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.487 0.66 . . . . 0.0 109.37 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.573 ' HA ' ' CD2' ' A' ' 18' ' ' PHE . 3.2 tm? -42.66 -71.72 0.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.66 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' N ' ' CD1' ' A' ' 15' ' ' LEU . . . -40.73 -37.82 1.4 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.7 mttp -76.78 -83.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -1.093 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.575 ' CE1' HD11 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -45.43 -28.33 0.87 Allowed 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.587 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -63.55 -72.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 10.4 p -41.72 -25.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.512 ' N ' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -89.52 -70.8 0.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 110.112 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.566 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.5 mm-40 -59.9 -38.5 82.46 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.718 -1.239 . . . . 0.0 109.324 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.2 tt0 -63.58 -51.84 63.56 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.235 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t-20 -67.15 -44.52 79.59 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.163 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -43.11 92.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.42 -0.8 . . . . 0.0 110.092 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -66.6 -21.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' HG21 ' A' ' 26' ' ' ILE . . . 118.6 36.02 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 3.0 mm-40 -134.58 71.55 1.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 24' ' ' ASN . 5.7 t80 -100.66 28.53 5.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.956 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.64 -39.55 0.85 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 2.4 mmt180 169.65 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -1.078 . . . . 0.0 110.015 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 HD13 ' HD2' ' A' ' 31' ' ' ARG . 1.3 mp -120.64 -177.73 3.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.054 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -154.24 49.05 0.62 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.776 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 12' ' ' THR . 3.4 t80 179.8 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.547 -0.721 . . . . 0.0 110.228 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -154.22 -48.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 110.579 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.586 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 1.3 mmpt? -69.61 -100.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 24.7 t -157.89 171.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.605 -1.309 . . . . 0.0 111.669 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.56 HG23 ' CB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -135.41 92.93 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.682 -0.636 . . . . 0.0 109.829 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.563 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -105.1 -53.26 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.635 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.5 Cg_endo -84.7 50.78 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.538 1.283 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 38' ' ' ILE . 20.6 p -104.12 118.32 36.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLN . 66.4 mtm -126.66 175.6 7.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.514 ' NZ ' ' OG1' ' A' ' 45' ' ' THR . 10.9 tmtt? -152.71 140.68 20.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.038 -1.039 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' GLU . 13.6 mttt -137.93 121.99 17.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 0.0 109.778 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.577 HG22 ' CG ' ' A' ' 56' ' ' TYR . 6.5 m -108.42 154.12 22.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.896 . . . . 0.0 110.746 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.588 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 3.0 tt -118.68 102.07 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 2' ' ' GLU . 8.7 p90 -110.21 -173.93 2.37 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.281 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.544 ' HB3' ' C ' ' A' ' 52' ' ' GLU . 16.7 pm0 -69.62 -141.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.01 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 17.8 t30 -141.03 -40.64 0.4 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.741 0.782 . . . . 0.0 109.161 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' GLU . 2.4 tm-20 178.72 32.4 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -165.05 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 111.855 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' C ' ' HB3' ' A' ' 48' ' ' GLU . 24.1 pt-20 -129.09 -152.1 0.5 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.447 -1.408 . . . . 0.0 111.02 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.585 ' HB ' ' CE1' ' A' ' 77' ' ' TYR . 4.0 mt -160.01 125.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.77 -0.581 . . . . 0.0 109.552 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 18.8 mttm -91.08 -77.5 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 112.036 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . . . -178.49 179.23 48.71 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.059 -2.019 . . . . 0.0 110.085 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.577 ' CG ' HG22 ' A' ' 45' ' ' THR . 18.4 m-85 -133.25 119.36 19.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.987 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -124.31 163.75 21.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 0.0 109.623 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -157.54 165.89 34.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.448 -1.301 . . . . 0.0 112.681 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.519 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 5.5 pt20 -124.47 120.41 31.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.635 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 2.9 tp -114.43 67.77 0.69 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.546 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 1.7 t80 -68.79 108.65 3.51 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 27.4 m -159.56 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.596 0.712 . . . . 0.0 109.585 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 1.9 t80 -148.46 130.94 15.75 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.951 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB2' ' CA ' ' A' ' 34' ' ' PHE . . . -126.83 -123.74 0.24 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.829 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.0 p -91.53 -32.84 15.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.056 . . . . 0.0 109.551 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.36 14.26 1.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.587 ' HA ' ' CE1' ' A' ' 69' ' ' PHE . 4.7 ttmt -107.98 78.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.756 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.571 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -89.94 68.53 7.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.624 -0.673 . . . . 0.0 109.287 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 173.31 -119.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.28 -0.887 . . . . 0.0 109.863 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' HD3' ' CB ' ' A' ' 59' ' ' GLN . 16.4 ttm180 -135.32 124.93 25.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.571 -1.33 . . . . 0.0 111.702 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.44 104.27 12.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 32.6 t70 -89.39 157.1 18.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 110.167 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.601 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.09 117.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 2.1 t -116.66 144.98 43.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.011 -1.056 . . . . 0.0 111.085 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -129.43 159.85 34.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 39.8 m-20 -128.23 -161.09 1.07 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.068 -1.02 . . . . 0.0 111.732 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 5.3 t80 166.06 -52.62 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 11.0 tmtt? -87.37 -47.99 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 79.1 p -69.26 -48.7 61.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.626 ' HB3' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 167.38 88.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 176.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' C ' ' A' ' 76' ' ' ASP . . . -29.95 109.92 0.03 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -157.61 175.86 13.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.696 -0.884 . . . . 0.0 108.864 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -130.57 151.77 50.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 tp -171.32 128.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.197 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -130.31 171.96 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.981 -1.075 . . . . 0.0 111.099 -179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.552 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -146.45 -179.0 6.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.851 . . . . 0.0 110.564 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.575 ' CE1' ' HG3' ' A' ' 23' ' ' GLU . 5.2 m-85 -153.44 67.6 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.528 -0.732 . . . . 0.0 109.199 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.06 -158.7 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.72 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.622 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.06 48.9 44.33 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 44.5 Cg_endo -69.03 -173.79 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.446 1.761 . . . . 0.0 111.823 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.523 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 27.4 m . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -176.07 171.67 2.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -1.157 . . . . 0.0 110.335 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HA ' ' HG3' ' A' ' 44' ' ' LYS . 59.0 p-90 -119.35 -176.5 3.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.476 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER 176.33 112.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 110.105 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG23 ' CE ' ' A' ' 42' ' ' MET . 1.2 pp -85.68 -179.06 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 110.638 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.649 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -135.24 -161.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.989 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -127.17 -157.11 0.79 Allowed 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.988 -1.07 . . . . 0.0 109.505 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.55 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -101.08 36.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' N ' HG22 ' A' ' 12' ' ' THR . . . -128.4 -57.42 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.906 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.6 Cg_endo -82.51 -77.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.369 1.194 . . . . 0.0 111.253 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.649 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 2.0 m-85 -43.63 -29.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.937 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 24.3 p -62.15 -58.91 6.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -62.47 -15.54 50.42 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.259 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 15' ' ' LEU . 1.2 t30 -83.14 -59.13 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.624 0.726 . . . . 0.0 110.052 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.3 pp -42.57 -31.54 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.649 -0.657 . . . . 0.0 109.704 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.96 -56.64 5.7 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -69.63 -67.15 0.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -1.142 . . . . 0.0 110.525 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.05 -49.27 1.73 Allowed 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.468 0.651 . . . . 0.0 110.424 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.632 ' N ' ' CD1' ' A' ' 18' ' ' PHE . . . -53.74 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.834 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' CG ' ' A' ' 24' ' ' ASN . 2.7 t -37.86 -26.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.46 -0.775 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.7 m-20 -89.76 -73.51 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.616 -1.303 . . . . 0.0 110.039 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.58 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 1.8 mt-10 -59.13 -32.91 70.29 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.255 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HG3' ' CZ ' ' A' ' 87' ' ' PHE . 2.3 tt0 -63.69 -56.65 14.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 108.339 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 29' ' ' TYR . 2.3 m120 -62.57 -47.11 85.29 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.757 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.92 -41.19 74.19 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.404 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 22' ' ' GLU . 4.9 tp -72.62 -10.91 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.835 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.47 51.31 1.33 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 11.2 tp60 -170.18 90.46 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.487 -1.008 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 31' ' ' ARG . 1.4 t80 -69.35 -33.79 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.883 . . . . 0.0 110.23 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 41.6 27.12 0.29 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 4.1 mtt180 64.52 -143.76 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 110.323 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.61 ' N ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -86.68 75.32 9.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.33 -0.856 . . . . 0.0 110.831 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.536 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -41.86 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 110.68 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 32' ' ' LEU . 1.6 t80 164.12 115.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 109.203 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.515 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -165.34 -59.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.394 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' O ' ' CG2' ' A' ' 37' ' ' VAL . 3.8 tppp? -69.54 -103.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.982 -1.074 . . . . 0.0 111.139 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 15.8 t -158.59 172.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.213 . . . . 0.0 111.524 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -123.8 117.49 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.521 0.677 . . . . 0.0 109.797 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.548 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -124.3 -56.27 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.582 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.6 Cg_endo -86.61 48.14 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.174 1.091 . . . . 0.0 110.537 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -89.18 117.87 28.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 109.675 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.518 ' CE ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -127.57 179.6 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 110.641 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -158.11 134.77 9.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 109.773 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 2.4 tttt -141.34 122.81 15.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 17.9 m -101.65 150.47 23.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.9 . . . . 0.0 109.68 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -107.21 45.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -110.3 169.78 8.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.487 0.66 . . . . 0.0 111.095 -178.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.537 ' CB ' ' HG2' ' A' ' 52' ' ' GLU . 20.5 tp10 -86.44 -89.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.559 -0.713 . . . . 0.0 109.792 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.494 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 3.2 t-20 -175.99 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.414 -0.804 . . . . 0.0 110.492 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 14.09 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.839 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -23.8 3.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 110.109 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.537 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 7.3 pt-20 -168.45 79.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.028 -1.045 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.586 HG23 ' CD2' ' A' ' 77' ' ' TYR . 2.8 mp -68.97 86.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.502 -0.749 . . . . 0.0 109.084 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -56.26 -71.19 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 45' ' ' THR . . . -161.83 162.76 34.3 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.477 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -123.32 108.3 12.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.545 -0.973 . . . . 0.0 110.028 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 74' ' ' SER . 3.0 mp0 -114.73 163.62 15.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.842 . . . . 0.0 108.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.63 ' CE1' ' O ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -150.8 163.48 38.51 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.916 -179.408 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 26.8 mt-30 -128.11 121.84 30.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.625 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -116.33 69.57 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.355 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.582 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -70.88 109.37 4.99 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.505 -0.747 . . . . 0.0 109.27 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 18.3 m -161.51 -163.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.516 ' CD1' ' CB ' ' A' ' 36' ' ' LYS . 2.5 t80 -135.19 138.01 43.23 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.887 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.538 ' HB3' ' CA ' ' A' ' 34' ' ' PHE . . . -135.21 -136.22 0.16 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.421 -0.799 . . . . 0.0 110.102 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -82.82 -37.61 24.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.801 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -138.15 7.42 2.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' O ' ' CD ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -105.44 94.82 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.837 0.827 . . . . 0.0 109.737 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.515 HD21 ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -101.31 64.53 1.02 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.364 -0.835 . . . . 0.0 108.775 178.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 173.08 -123.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.305 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 36.8 ttp180 -130.44 122.71 28.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.526 -1.359 . . . . 0.0 111.944 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -83.01 106.31 14.72 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 22.6 t70 -88.89 170.96 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.762 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.618 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -169.94 119.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.565 -0.709 . . . . 0.0 110.17 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -110.89 156.71 20.78 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.016 -1.052 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -148.5 111.81 4.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.489 -1.382 . . . . 0.0 112.138 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.541 ' HA ' ' CA ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -48.66 150.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.216 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CD2' HG23 ' A' ' 53' ' ' ILE . 1.7 t80 -147.88 -73.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.933 -1.105 . . . . 0.0 109.932 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 9.7 tmtt? -109.91 -38.17 5.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.791 -1.193 . . . . 0.0 109.547 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.539 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 1.2 m -86.23 8.44 21.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 108.815 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER 65.55 49.27 1.84 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.665 -0.647 . . . . 0.0 111.044 179.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 76' ' ' ASP . . . -62.25 -125.26 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptp180 -173.76 168.01 4.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.397 -1.649 . . . . 0.0 111.9 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' SER . 13.7 mtmm -100.36 120.13 39.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 1.5 tt -171.9 130.81 0.65 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 0.0 109.829 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.601 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -117.1 168.28 10.42 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.0 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 10.8 mtt180 -137.04 -172.07 3.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.488 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.602 ' CZ ' ' HG3' ' A' ' 23' ' ' GLU . 60.1 m-85 -158.32 64.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -154.31 -160.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.728 -1.233 . . . . 0.0 111.71 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.19 50.88 30.7 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -177.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.7 Cg_endo -67.95 -173.86 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 124.564 1.823 . . . . 0.0 111.851 -176.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.526 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 25.0 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.38 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -168.05 157.57 9.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -1.194 . . . . 0.0 110.366 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.551 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 2.9 p-90 -131.97 170.84 14.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.8 tp10 178.67 160.47 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.731 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.576 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.67 173.3 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.039 -1.038 . . . . 0.0 110.444 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.581 HG22 ' CG ' ' A' ' 11' ' ' PHE . 1.2 pp -103.84 -160.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.503 -0.748 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 12.9 p30 -132.0 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.977 -1.077 . . . . 0.0 111.644 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 14.9 tt 41.14 46.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.974 0.892 . . . . 0.0 109.909 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.544 ' N ' HG22 ' A' ' 12' ' ' THR . . . -133.66 -62.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD2' ' CD1' ' A' ' 6' ' ' ILE . 44.1 Cg_endo -84.01 -68.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.733 1.386 . . . . 0.0 111.062 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 43' ' ' LYS . 3.2 m-85 -44.58 -29.52 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.4 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 17.5 p -64.43 -58.77 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.508 ' N ' ' OG1' ' A' ' 12' ' ' THR . 3.8 tt0 -65.74 -26.72 67.86 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.844 0.831 . . . . 0.0 109.052 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.486 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 1.2 t30 -74.12 -55.16 6.42 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.584 0.707 . . . . 0.0 109.495 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 2.7 tt -37.99 -53.9 1.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.394 0.616 . . . . 0.0 109.924 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 15' ' ' LEU . . . -56.04 -46.59 84.4 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 20' ' ' VAL . 3.5 tttp -73.15 -72.46 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -1.185 . . . . 0.0 111.016 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CD1' ' ND2' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -39.88 -48.08 2.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.593 0.711 . . . . 0.0 110.868 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -55.34 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.712 -0.618 . . . . 0.0 110.604 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 15.0 m -43.89 -23.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 120.952 -1.092 . . . . 0.0 110.546 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -88.73 -73.78 0.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.072 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.558 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 20.6 mm-40 -57.69 -37.53 73.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.693 -1.255 . . . . 0.0 109.232 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -64.71 -50.06 68.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.974 -1.078 . . . . 0.0 109.155 178.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 55.1 t-20 -66.02 -46.53 77.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.573 -1.329 . . . . 0.0 107.739 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 4.2 tttp -59.4 -41.54 89.69 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.032 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -73.77 -12.93 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.05 81.44 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -140.47 -72.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.171 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.492 ' N ' ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.26 -23.25 7.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.937 . . . . 0.0 110.138 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 24' ' ' ASN . . . 40.37 28.85 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.514 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 1.8 mtt-85 -141.91 -68.29 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -1.197 . . . . 0.0 110.586 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 31' ' ' ARG . 16.6 mt -138.2 160.35 39.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 110.702 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -164.13 51.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.781 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -176.19 123.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.363 -0.836 . . . . 0.0 109.833 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -158.67 -58.86 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.042 -1.036 . . . . 0.0 111.318 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.647 ' CD ' ' CE2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.61 -97.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.957 -1.09 . . . . 0.0 111.38 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 6.7 t -160.48 173.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.521 -1.362 . . . . 0.0 111.617 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.568 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -126.79 109.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.795 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.596 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -117.24 -59.4 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.999 . . . . 0.0 110.926 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.6 Cg_endo -83.98 46.84 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.117 1.062 . . . . 0.0 111.119 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' CG1' ' A' ' 6' ' ' ILE . 18.6 p -88.97 98.0 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.509 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -97.52 -177.58 3.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 0.0 111.013 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -161.86 155.78 21.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.708 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.1 OUTLIER -170.68 126.96 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 110.817 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 56' ' ' TYR . 19.2 m -112.58 152.11 29.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.548 ' N ' HG21 ' A' ' 45' ' ' THR . 2.1 mt -123.37 126.25 72.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.546 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 11.1 p90 -149.36 162.62 39.71 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.399 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 6.9 tp10 -69.58 -129.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.211 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER 166.41 -19.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.842 -1.161 . . . . 0.0 110.908 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.42 21.65 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.058 . . . . 0.0 109.755 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.33 -32.2 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.934 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.2 pt-20 -171.31 -161.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.623 -1.298 . . . . 0.0 112.449 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.643 ' CG1' ' CD2' ' A' ' 77' ' ' TYR . 9.8 tp -123.27 157.12 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.9 -63.48 1.45 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.344 -1.473 . . . . 0.0 113.227 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' CG2' ' A' ' 45' ' ' THR . . . -170.52 166.63 39.83 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 117.409 -2.329 . . . . 0.0 111.992 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' CG ' ' OG1' ' A' ' 45' ' ' THR . 2.0 t80 -126.91 102.06 6.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.146 -0.62 . . . . 0.0 109.808 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.5 pt-20 -104.08 152.23 22.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 109.558 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.642 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -141.94 154.93 45.43 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.14 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.506 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 6.1 pt20 -126.05 125.24 42.28 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.642 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 1.2 tp -121.44 69.54 0.92 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.919 -1.113 . . . . 0.0 109.179 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.557 ' O ' ' CG1' ' A' ' 62' ' ' VAL . 23.0 t80 -69.21 110.52 4.62 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' CG1' ' O ' ' A' ' 61' ' ' TYR . 31.2 m -159.5 -161.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -142.56 126.62 17.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 34' ' ' PHE . . . -119.95 -131.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.632 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.516 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 85.1 p -85.69 -25.29 26.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.007 -1.058 . . . . 0.0 109.175 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.59 17.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.1 ttmm -110.7 74.5 0.88 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.053 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mt -85.73 66.48 9.66 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 175.31 -119.92 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.455 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.563 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 19.6 ttp85 -137.73 125.65 22.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.55 -1.344 . . . . 0.0 111.918 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.69 110.71 17.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 86' ' ' ARG . 1.5 t70 -92.03 165.58 13.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 111.032 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.603 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.78 118.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.28 142.06 51.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.861 -1.15 . . . . 0.0 110.771 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 21.7 mt-10 -152.99 132.29 12.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.315 -0.866 . . . . 0.0 109.824 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.611 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -58.07 -154.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 0.0 110.723 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.643 ' CD2' ' CG1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -160.75 -48.7 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.032 -1.043 . . . . 0.0 111.301 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.544 ' CG ' ' N ' ' A' ' 79' ' ' THR . 8.2 pttp -52.47 -42.0 63.84 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.029 -1.044 . . . . 0.0 108.52 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 11.8 t -135.22 14.3 3.52 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 82' ' ' ARG . 2.6 mmm180 67.21 14.65 9.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.754 -0.591 . . . . 0.0 109.443 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . 11.17 -75.72 0.0 OUTLIER Glycine 0 N--CA 1.5 2.956 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.553 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -153.22 -171.8 4.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.845 -1.385 . . . . 0.0 111.44 -178.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -144.13 144.8 31.75 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -172.2 155.8 3.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.971 -1.081 . . . . 0.0 109.602 -179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.583 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -142.72 166.24 25.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 11.1 mmt180 -135.32 -174.08 3.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 111.168 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CZ ' HD13 ' A' ' 85' ' ' LEU . 20.6 m-85 -157.69 61.08 0.48 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -152.27 -157.0 0.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 111.765 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.62 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 68.91 49.3 42.71 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -68.69 -169.26 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 124.436 1.756 . . . . 0.0 112.009 -176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 19.0 m . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.285 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.484 -1.446 . . . . 3.79 109.484 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -136.72 151.07 48.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -1.191 . . . . 2.7200000000000002 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.1 p90 -125.19 156.51 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 4.4400000000000004 110.214 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.519 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 5.6 pt-20 -166.36 129.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 2.4300000000000002 110.183 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.488 ' CG2' ' HG2' ' A' ' 42' ' ' MET . 10.8 pt -75.45 176.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.18 -0.95 . . . . 1.8500000000000001 110.42 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.642 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -111.15 -162.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 2.9399999999999999 109.891 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.532 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -137.48 49.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.853 -1.154 . . . . 2.3399999999999999 111.597 -179.173 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 7' ' ' ASP . 10.6 tt 40.08 43.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.826 0.822 . . . . 2.1299999999999999 110.038 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG22 ' A' ' 12' ' ' THR . . . -133.04 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.061 -1.066 . . . . 1.03 110.933 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.7 Cg_endo -86.35 -59.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.558 1.294 . . . . 1.01 111.131 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.642 ' CD2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 m-30 -52.28 -32.7 38.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.957 -1.09 . . . . 2.0 109.318 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 38' ' ' ILE . 8.5 p -59.19 -57.91 10.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.113 -1.439 . . . . 1.29 107.113 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -66.8 -18.47 65.39 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.672 0.749 . . . . 2.6400000000000001 109.141 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.506 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 13.6 t-20 -78.02 -63.73 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 2.0299999999999998 109.833 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -40.22 -63.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.328 0.585 . . . . 2.5600000000000001 109.573 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -46.16 -46.18 15.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.246 -1.542 . . . . 0.57999999999999996 109.246 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -70.78 -84.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 3.1200000000000001 110.538 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' ALA . 2.5 m-85 -38.71 -64.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.401 0.619 . . . . 3.2599999999999998 111.045 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -43.37 -70.61 0.1 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.602 -0.686 . . . . 1.1299999999999999 109.919 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 42.4 t -40.89 -27.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.353 -0.842 . . . . 1.97 110.46 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -92.6 -66.27 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 1.72 110.336 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.536 ' HB2' ' CD1' ' A' ' 85' ' ' LEU . 2.4 mt-10 -60.82 -31.66 71.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.045 -1.062 . . . . 1.95 109.874 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -73.69 -60.19 2.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.891 -1.151 . . . . 1.6100000000000001 107.891 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.5 t-20 -52.02 -48.57 64.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.228 -1.397 . . . . 2.1899999999999999 107.228 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 42.5 tttt -56.85 -47.26 80.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.954 -1.128 . . . . 3.1600000000000001 107.954 177.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.542 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -50.48 -24.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.56 -0.904 . . . . 1.9199999999999999 108.56 178.609 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.67 24.99 2.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.384 -1.486 . . . . 0.87 109.384 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 34.6 tp60 -125.47 66.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 2.6400000000000001 109.79 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 38.5 p90 -90.76 22.69 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 5.7699999999999996 109.831 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -41.32 -55.55 3.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.818 -1.313 . . . . 2.5299999999999998 109.818 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 9.4 mtt180 -162.6 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -1.208 . . . . 3.96 110.069 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 ' CD1' ' HB3' ' A' ' 31' ' ' ARG . 3.9 mp -126.9 -177.31 3.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 2.71 109.961 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -146.9 50.12 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.266 -0.896 . . . . 1.21 109.91 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.517 ' N ' ' HB3' ' A' ' 64' ' ' ALA . 11.3 t80 174.96 79.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.73 . . . . 4.4199999999999999 109.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -120.94 -44.36 2.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.97 110.627 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' CD ' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -68.91 -96.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 3.8599999999999999 110.955 -179.406 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 38' ' ' ILE . 28.1 t -157.57 171.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.621 -1.3 . . . . 1.27 111.679 -179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.543 ' CD1' HG21 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.88 88.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.168 -0.678 . . . . 2.2200000000000002 109.168 179.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -105.02 -53.55 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.979 -1.075 . . . . 3.5699999999999998 110.979 -179.274 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.6 Cg_endo -84.02 50.92 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.395 1.208 . . . . 0.63 110.941 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 21.0 p -103.52 120.82 41.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.399 -0.813 . . . . 1.9299999999999999 109.807 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.488 ' HG2' ' CG2' ' A' ' 5' ' ' ILE . 27.5 mtm -119.03 177.29 4.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 2.4900000000000002 110.649 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -140.62 154.28 46.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.229 -0.919 . . . . 1.9199999999999999 110.41 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -151.75 100.63 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.144 -0.973 . . . . 2.8500000000000001 110.354 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 ' OG1' ' CE ' ' A' ' 43' ' ' LYS . 2.0 m -97.88 148.88 22.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 1.29 110.265 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -114.39 43.39 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.359 -0.978 . . . . 2.27 108.359 178.79 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' HA ' ' CB ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -82.12 -177.13 6.5 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.495 0.664 . . . . 3.0800000000000001 110.987 -178.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.524 ' CB ' ' HG3' ' A' ' 52' ' ' GLU . 2.2 tp10 -69.38 -101.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 3.5800000000000001 109.789 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 65.1 t30 -176.1 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.751 -1.218 . . . . 4.8600000000000003 110.938 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -149.19 14.15 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 4.4800000000000004 110.079 -179.684 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.88 -27.83 3.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.421 -0.799 . . . . 5.7800000000000002 109.626 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 48' ' ' GLU . 2.9 pt-20 -170.58 -165.17 0.43 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.046 -1.061 . . . . 2.8199999999999998 111.269 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.627 ' CG1' ' CG ' ' A' ' 77' ' ' TYR . 9.6 tp -126.47 152.7 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.658 -0.651 . . . . 2.6699999999999999 109.54 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.86 -65.93 0.77 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.999 -1.063 . . . . 3.2999999999999998 111.705 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.2 173.91 21.43 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.689 -1.72 . . . . 0.81000000000000005 110.611 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' GLU . 3.7 t80 -155.85 78.02 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.554 -0.968 . . . . 3.0800000000000001 110.231 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 14.9 pt-20 -99.35 167.39 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 2.4300000000000002 109.0 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -162.44 170.63 18.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.996 -1.481 . . . . 2.0099999999999998 112.977 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.519 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -133.82 123.76 25.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.787 -1.19 . . . . 2.3700000000000001 107.787 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -121.07 74.78 1.11 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.034 -1.041 . . . . 1.3400000000000001 109.399 -179.06 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -69.25 112.28 5.73 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.198 -1.038 . . . . 2.0600000000000001 108.198 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG22 ' CD ' ' A' ' 67' ' ' LYS . 33.2 m -158.19 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.779 0.799 . . . . 1.3 109.851 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.63 ' CE1' ' CD2' ' A' ' 68' ' ' LEU . 2.4 t80 -147.28 130.44 16.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.141 -0.688 . . . . 1.76 109.141 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 34' ' ' PHE . . . -124.17 -126.07 0.25 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.388 -0.82 . . . . 1.26 109.721 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 t -95.15 -24.71 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.912 -1.117 . . . . 1.8 108.726 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.02 18.4 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.503 0.668 . . . . 1.52 109.446 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 69' ' ' PHE . 1.3 ttmm -115.23 78.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 2.0099999999999998 110.229 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.63 ' CD2' ' CE1' ' A' ' 63' ' ' TYR . 9.0 mt -88.17 64.86 7.89 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.895 -0.78 . . . . 2.3500000000000001 108.895 178.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CZ ' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 178.7 -123.83 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.047 -1.061 . . . . 2.2599999999999998 110.534 -179.085 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 25.3 ttm180 -131.02 123.63 29.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.328 -1.483 . . . . 2.1600000000000001 112.194 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -80.48 107.9 13.66 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.651 -1.611 . . . . 1.1499999999999999 106.651 176.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 1.8 t70 -89.64 162.2 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.002 -1.061 . . . . 1.71 110.404 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.583 HG21 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.2 110.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.73 0.776 . . . . 1.6299999999999999 109.294 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -110.71 122.47 47.89 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.247 -0.908 . . . . 1.5700000000000001 109.955 -179.211 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 83' ' ' LYS . 22.9 mt-10 -144.96 122.86 11.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 2.02 110.066 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.578 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER -60.88 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 2.1400000000000001 110.104 179.694 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.627 ' CG ' ' CG1' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -171.28 -60.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.85 -1.157 . . . . 2.8700000000000001 110.715 -179.699 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 12.9 tttt -83.48 -56.7 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 4.4699999999999998 109.596 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.82 0.54 23.45 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.333 -0.854 . . . . 3.8799999999999999 109.619 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 81' ' ' GLY . 9.1 mmt85 57.01 28.54 14.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 6.6399999999999997 109.916 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.578 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -24.29 -70.25 0.02 OUTLIER Glycine 0 N--CA 1.502 3.071 0 CA-C-N 116.104 -0.498 . . . . 2.5800000000000001 112.287 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -168.49 -172.52 1.7 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.591 -1.535 . . . . 5.46 111.831 -179.196 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' CG ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -149.93 125.63 10.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.976 -0.75 . . . . 3.6899999999999999 108.976 179.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 11.8 tp -170.59 173.95 5.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.145 . . . . 2.6800000000000002 110.423 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.542 ' CD2' ' CG1' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -154.01 171.64 18.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 1.53 109.928 179.487 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.543 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 10.6 mtt180 -140.08 -177.9 5.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 3.25 110.989 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 23.7 m-85 -153.27 63.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.706 -0.621 . . . . 0.87 109.398 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -153.3 -156.5 0.7 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.194 . . . . 2.3599999999999999 111.388 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.98 52.32 29.07 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 105.323 -3.111 . . . . 1.4399999999999999 105.323 -177.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.6 Cg_endo -68.33 -178.02 1.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 124.598 1.841 . . . . 2.23 111.938 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG1' ' OH ' ' A' ' 61' ' ' TYR . 30.1 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.966 -1.016 . . . . 2.27 110.45 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.311 0.577 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CB ' ' HE2' ' A' ' 44' ' ' LYS . 6.8 p90 -165.2 150.07 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 10.4 pt-20 -171.02 132.37 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' CG ' ' A' ' 42' ' ' MET . 21.5 pt -83.63 -177.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.266 -0.897 . . . . 0.0 110.486 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.768 HD11 ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -121.63 -154.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -138.77 50.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.837 -1.164 . . . . 0.0 111.53 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.623 ' C ' HG21 ' A' ' 12' ' ' THR . 19.2 tt 40.44 51.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.159 0.98 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -139.51 -65.43 0.04 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 46.2 Cg_endo -82.4 -58.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.83 1.437 . . . . 0.0 111.275 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 6' ' ' ILE . 2.6 m-30 -54.33 -22.07 11.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.834 -1.166 . . . . 0.0 109.687 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.893 HG22 ' CG1' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.12 -61.26 1.87 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.577 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -55.3 -25.09 32.11 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.676 0.751 . . . . 0.0 110.001 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -80.72 -44.1 19.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.797 0.808 . . . . 0.0 109.871 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.04 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -46.82 -47.21 21.1 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.479 0.656 . . . . 0.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 1.04 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -64.74 -51.13 54.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -67.73 -79.74 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.24 . . . . 0.0 110.592 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -33.84 -62.55 0.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.447 0.641 . . . . 0.0 111.1 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.39 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.411 -0.806 . . . . 0.0 109.917 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 26.2 t -41.62 -25.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.553 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' ALA . 2.6 t70 -87.66 -70.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.983 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.001 ' HB3' HD13 ' A' ' 85' ' ' LEU . 4.1 tt0 -61.88 -37.4 84.45 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.32 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 1.054 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -58.79 -53.22 60.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.938 -1.101 . . . . 0.0 108.778 177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 10.0 t-20 -68.68 -47.05 67.46 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.36 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -57.1 -35.84 69.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 110.322 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.054 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -68.63 -21.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.0 110.005 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.5 10.47 6.54 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 18.0 mm-40 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 109.562 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.864 HD13 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.406 0.622 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.572 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -136.94 52.12 1.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 109.943 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 13.9 p90 -169.7 123.11 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.881 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HB2' ' N ' ' A' ' 65' ' ' SER . 1.8 t-20 -155.14 -65.06 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -0.937 . . . . 0.0 110.71 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.82 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -69.14 -98.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.954 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.84 172.35 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.687 -1.258 . . . . 0.0 111.719 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.893 ' CG1' HG22 ' A' ' 12' ' ' THR . 0.3 OUTLIER -120.17 113.22 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -120.49 -59.92 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.92 -1.113 . . . . 0.0 110.707 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.1 Cg_endo -82.73 47.65 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.091 1.048 . . . . 0.0 111.081 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.563 ' HB3' HD13 ' A' ' 38' ' ' ILE . 27.8 p -84.18 122.18 28.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.751 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -123.23 164.15 19.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 111.25 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.23 137.46 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.864 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.527 ' HE2' ' CB ' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -145.58 134.2 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.069 -1.019 . . . . 0.0 110.291 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 55' ' ' GLY . 15.7 m -126.75 155.11 43.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.459 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.722 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.535 ' CE2' ' HE3' ' A' ' 43' ' ' LYS . 35.4 t80 -113.76 104.1 11.87 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.386 -1.067 . . . . 0.0 110.019 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.2 pt-20 -119.52 175.99 5.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.455 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.872 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -153.51 162.75 40.96 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.573 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.6 tt0 -126.22 120.98 31.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' LEU . 2.3 tp -118.66 71.5 0.85 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 109.566 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -70.16 110.97 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.803 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.1 m -159.74 -165.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.601 -0.687 . . . . 0.0 109.795 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.961 ' CE1' HD12 ' A' ' 68' ' ' LEU . 2.5 t80 -138.93 130.02 26.68 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.053 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -124.05 -131.4 0.26 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.632 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.542 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 79.8 p -81.73 -28.93 33.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.237 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.88 18.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.602 -0.686 . . . . 0.0 109.655 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.803 ' CD ' HG23 ' A' ' 62' ' ' VAL . 1.8 ttmm -105.18 73.63 1.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.961 HD12 ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.77 64.54 8.63 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 177.25 -127.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.517 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 14.0 ttm180 -132.46 127.02 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.49 -1.381 . . . . 0.0 111.987 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.668 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -83.79 102.75 12.54 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -86.55 172.83 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.497 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.872 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -168.51 131.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.877 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.511 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -122.25 159.73 26.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' ASP . 2.3 mt-10 -152.59 108.51 3.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.829 -1.169 . . . . 0.0 111.785 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.069 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.3 tp -171.2 -169.44 0.74 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.954 -1.092 . . . . 0.0 109.791 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' HB3' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.69 166.16 8.04 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.3 mtt-85 -145.91 143.7 29.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.724 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.964 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.5 m-85 -115.22 73.81 0.85 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -159.71 -164.9 1.41 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.911 -1.118 . . . . 0.0 111.759 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.594 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 70.79 52.06 16.86 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.392 -3.483 . . . . 0.0 104.392 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.2 Cg_endo -64.46 -174.14 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.714 1.902 . . . . 0.0 112.742 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 1.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.105 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.161 0.505 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -161.77 149.0 14.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -177.18 159.23 1.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.45 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.452 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 3.1 pt -95.03 -175.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.621 HG21 ' CB ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.7 -165.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.217 -0.927 . . . . 0.0 110.468 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 8' ' ' ILE . 24.1 t70 -139.94 51.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.074 -1.016 . . . . 0.0 111.167 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 8' ' ' ILE . 4.6 tt 39.52 40.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.836 0.827 . . . . 0.0 110.098 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.505 ' N ' HG21 ' A' ' 12' ' ' THR . . . -147.25 -65.9 0.01 OUTLIER Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' THR . 44.7 Cg_endo -75.13 -85.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.61 1.321 . . . . 0.0 111.386 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.621 ' CB ' HG21 ' A' ' 6' ' ' ILE . 66.2 m-85 -39.05 -27.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.398 -0.814 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.822 HG22 ' CG2' ' A' ' 38' ' ' ILE . 18.6 p -60.47 -58.31 9.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.076 -1.015 . . . . 0.0 108.648 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.7 pt20 -59.15 -15.97 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.446 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -76.19 -60.04 2.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 110.065 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 pp -43.68 -34.81 1.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.409 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -62.51 -54.43 34.2 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -72.96 -66.45 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -1.022 . . . . 0.0 110.131 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 21' ' ' ASP . 2.0 m-30 -40.5 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.484 0.659 . . . . 0.0 110.44 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -39.92 -68.2 0.19 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.808 -0.558 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t -41.98 -26.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.104 -0.997 . . . . 0.0 110.024 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 18' ' ' PHE . 6.0 m-20 -95.3 -66.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.826 ' CG ' HD11 ' A' ' 73' ' ' ILE . 14.6 mm-40 -59.08 -26.83 64.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.825 -1.172 . . . . 0.0 109.23 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -76.79 -61.54 1.94 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 25.3 t-20 -54.22 -43.12 70.53 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.615 -1.234 . . . . 0.0 107.815 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 18.5 tptp -56.28 -59.21 5.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.211 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -55.32 -20.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.629 0.728 . . . . 0.0 109.622 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 60.72 2.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -1.14 . . . . 0.0 109.892 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.031 0.443 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -36.5 90.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.751 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' LEU . 7.7 t80 165.82 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 0.0 109.617 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -155.66 -64.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.94 -1.1 . . . . 0.0 111.382 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.52 -99.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 111.453 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 36' ' ' LYS . 13.9 t -159.22 172.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.536 -1.352 . . . . 0.0 111.727 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.822 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -127.79 99.08 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.626 . . . . 0.0 110.01 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.549 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -108.49 -54.76 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.488 -0.758 . . . . 0.0 110.159 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 41.7 Cg_endo -84.88 51.37 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.412 1.217 . . . . 0.0 111.306 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.9 t -104.42 106.37 16.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.536 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 10.2 mtt -96.96 157.08 16.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.056 -1.028 . . . . 0.0 110.158 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 2.6 tmtt? -137.11 154.71 50.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 110.978 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 13.3 tttt -160.33 158.9 30.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.627 -0.671 . . . . 0.0 109.603 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.4 m -159.48 151.05 20.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.96 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 121.976 0.764 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CD2' ' OG1' ' A' ' 45' ' ' THR . 2.4 m-85 -116.95 173.48 6.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 122.133 -0.628 . . . . 0.0 109.898 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 178.72 130.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.499 -0.751 . . . . 0.0 109.206 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' HB ' ' A' ' 73' ' ' ILE . 3.4 p90 -150.6 171.73 16.65 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.1 -1.44 . . . . 0.0 113.606 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.537 ' HB3' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -124.34 112.35 16.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -104.36 68.28 0.87 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 109.67 -178.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.852 ' OH ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.81 109.7 4.56 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG23 ' HD3' ' A' ' 67' ' ' LYS . 34.8 m -159.41 -162.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.574 0.702 . . . . 0.0 109.634 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.624 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -137.94 124.6 20.96 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -122.86 -127.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.477 -0.765 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.543 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 t -84.57 -52.56 6.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.019 -1.051 . . . . 0.0 109.389 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -128.65 30.23 5.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.359 -0.838 . . . . 0.0 109.256 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.752 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -125.46 80.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.703 0.763 . . . . 0.0 110.046 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 6.3 mp -90.07 59.66 4.58 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 p90 176.98 -142.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.407 -0.808 . . . . 0.0 109.581 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.537 ' NH1' ' HB3' ' A' ' 59' ' ' GLN . 4.8 ttm180 -113.26 140.77 47.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.531 -1.356 . . . . 0.0 112.236 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -99.44 103.45 15.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' N ' ' A' ' 86' ' ' ARG . 9.9 t70 -77.24 157.58 30.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.769 -1.207 . . . . 0.0 109.927 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.826 HD11 ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -162.62 101.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.672 0.748 . . . . 0.0 109.156 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -113.37 134.96 54.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 74' ' ' SER . 18.4 mt-10 -157.9 136.53 11.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.936 -1.102 . . . . 0.0 111.28 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.63 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.227 -0.92 . . . . 0.0 109.826 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -170.47 160.43 7.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 0.0 109.514 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.02 175.21 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.04 -1.038 . . . . 0.0 110.399 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 72' ' ' ASP . 6.0 mtt180 -157.5 131.67 8.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.0 110.704 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 84.2 m-85 -107.98 64.92 0.63 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -152.63 -158.76 0.93 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.998 -1.064 . . . . 0.0 111.148 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.17 52.82 29.53 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 104.876 -3.29 . . . . 0.0 104.876 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -65.64 -171.78 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.728 1.909 . . . . 0.0 112.585 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.852 HG13 ' OH ' ' A' ' 61' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.139 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.336 0.588 . . . . 2.8300000000000001 110.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 23.5 p90 -79.99 167.96 19.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 3.6000000000000001 110.225 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.86 119.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 2.7200000000000002 110.167 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG22 ' CG ' ' A' ' 42' ' ' MET . 1.2 pt -80.35 -176.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.219 -0.926 . . . . 1.3700000000000001 110.396 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.739 HD12 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.21 -164.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.287 -0.883 . . . . 2.4300000000000002 109.881 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 8' ' ' ILE . 42.2 t0 -144.35 61.77 1.34 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 3.5 111.592 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.69 ' C ' HG21 ' A' ' 12' ' ' THR . 14.0 tt 40.53 45.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.002 0.906 . . . . 1.76 109.953 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -138.41 -65.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 120.138 -1.03 . . . . 0.85999999999999999 111.434 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.6 Cg_endo -82.17 -72.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.596 1.314 . . . . 0.93999999999999995 111.416 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.739 ' CD2' HD12 ' A' ' 6' ' ' ILE . 1.9 m-30 -44.5 -32.05 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 1.53 109.583 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.733 HG22 HG21 ' A' ' 38' ' ' ILE . 25.0 p -57.59 -57.69 11.59 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.52 -1.289 . . . . 0.90000000000000002 107.52 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -72.99 -17.67 61.43 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.749 0.785 . . . . 2.3599999999999999 109.455 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.545 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 2.7 t-20 -79.4 -58.65 3.1 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.643 0.735 . . . . 1.5600000000000001 109.371 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.839 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 2.6 tp -42.04 -56.13 2.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.212 -0.662 . . . . 2.0499999999999998 109.212 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -49.53 -57.48 9.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.57999999999999996 109.535 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -68.75 -77.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.129 . . . . 2.4500000000000002 110.665 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 3.3 m-85 -37.77 -72.57 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.418 0.628 . . . . 2.2799999999999998 111.221 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -41.42 -69.23 0.14 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.56000000000000005 110.342 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 55.4 t -42.34 -27.95 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 1.4299999999999999 110.356 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' LYS . 2.2 m-20 -93.49 -62.54 1.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.233 -0.917 . . . . 1.9099999999999999 110.353 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.0 mt-10 -61.96 -31.57 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.008 -1.057 . . . . 2.1699999999999999 109.81 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.575 ' OE2' ' CD2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -75.42 -59.59 2.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.181 -1.044 . . . . 1.6399999999999999 108.181 178.104 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 36.8 t-20 -53.25 -46.56 69.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.223 -1.399 . . . . 2.27 107.223 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 13.7 tttt -58.2 -48.56 79.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.867 -1.16 . . . . 2.8799999999999999 107.867 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.604 HD11 ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -48.46 -26.54 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.527 -0.916 . . . . 1.6299999999999999 108.527 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 27.89 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.223 -1.551 . . . . 1.01 109.223 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 24.8 tp60 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.431 -1.041 . . . . 2.3500000000000001 109.671 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 32' ' ' LEU . 3.4 mp . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.324 0.583 . . . . 2.6000000000000001 109.873 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.621 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -144.9 50.65 1.25 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.345 -0.847 . . . . 0.94999999999999996 109.769 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.622 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 9.6 t80 -179.88 74.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 3.48 110.279 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.32 -45.86 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 2.52 110.561 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 3.5099999999999998 111.002 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LYS . 23.1 t -158.55 172.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.694 -1.254 . . . . 1.1200000000000001 111.622 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.39 85.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.675 -0.641 . . . . 1.6599999999999999 109.361 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -103.25 -54.22 0.12 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 3.0299999999999998 110.817 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.9 Cg_endo -83.5 52.15 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.335 1.177 . . . . 0.56999999999999995 110.324 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.552 ' C ' HD11 ' A' ' 6' ' ' ILE . 21.2 p -104.03 113.1 26.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.835 . . . . 1.6399999999999999 110.408 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.813 ' CG ' HG22 ' A' ' 5' ' ' ILE . 8.3 mtm -113.91 176.97 4.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.846 . . . . 2.1000000000000001 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.23 159.32 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.027 . . . . 1.6299999999999999 110.985 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -154.17 128.59 9.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.503 -0.748 . . . . 2.5099999999999998 109.93 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -118.57 148.84 42.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.62 110.084 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.525 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.404 -0.962 . . . . 2.0 108.404 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.9 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 110.625 -0.99 . . . . 0.60999999999999999 110.625 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' GLU . 36.6 t80 -156.84 92.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -1.057 . . . . 3.9100000000000001 110.418 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.7 pt-20 -126.47 171.83 10.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 2.6299999999999999 108.85 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 1.7 p90 -163.05 166.02 24.11 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 117.876 -1.53 . . . . 1.8200000000000001 113.419 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 70' ' ' ARG . 92.6 mt-30 -119.82 107.53 13.27 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.742 -1.207 . . . . 2.1699999999999999 107.742 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.714 HD21 HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -105.77 73.72 1.02 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.289 -0.882 . . . . 0.70999999999999996 109.14 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 1.08 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -69.61 112.34 6.03 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.031 -1.1 . . . . 1.73 108.031 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.621 HG23 ' CD ' ' A' ' 67' ' ' LYS . 22.7 m -157.84 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.769 0.795 . . . . 0.41999999999999998 109.496 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.658 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.5 t80 -149.19 129.47 13.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 1.28 109.272 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.622 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -123.53 -118.09 0.29 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.77000000000000002 109.685 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -102.15 -25.21 13.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.754 -1.216 . . . . 1.4099999999999999 108.804 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.8 16.19 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 1.99 109.603 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.832 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -113.93 78.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 1.3700000000000001 110.338 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.9 mt -86.16 63.19 7.88 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.501 -0.926 . . . . 1.79 108.501 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 176.06 -122.69 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.539 -0.864 . . . . 1.8799999999999999 109.912 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 5.9 tmm_? -133.73 144.61 49.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.166 -1.583 . . . . 1.8799999999999999 112.416 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -92.08 92.33 8.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.241 -1.763 . . . . 0.47999999999999998 106.241 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 4.7 t0 -80.99 82.96 6.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.011 . . . . 1.73 110.741 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -76.19 138.92 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.692 -0.803 . . . . 1.1799999999999999 109.577 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -131.54 121.65 24.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 1.26 109.518 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HG2' ' HG2' ' A' ' 83' ' ' LYS . 1.1 mt-10 -151.81 119.16 5.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.937 -1.102 . . . . 2.2999999999999998 110.477 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.554 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.2 t0 . . . . . 0 C--N 1.303 -1.416 0 O-C-N 121.17 -0.956 . . . . 2.2599999999999998 109.895 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.47 ' HG2' ' HG2' ' A' ' 75' ' ' GLU . 10.8 mtpt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.325 -0.62 . . . . 3.5299999999999998 109.325 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.0 tp -170.1 179.12 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 2.4100000000000001 110.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 1.2 pt? -153.68 -179.19 7.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 1.24 110.509 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.538 ' C ' ' CD2' ' A' ' 87' ' ' PHE . 3.0 mtt180 -134.66 -177.06 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 2.71 110.49 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 69.4 m-85 -154.17 62.6 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.055 -0.72 . . . . 0.76000000000000001 109.055 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 3.0 m-80 -152.37 -157.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 1.9099999999999999 111.488 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 66.71 52.59 33.01 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 104.855 -3.298 . . . . 1.21 104.855 -176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.0 Cg_endo -67.77 -171.17 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 124.499 1.789 . . . . 2.1499999999999999 111.899 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.08 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.6 m . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 117.945 -1.026 . . . . 2.29 110.4 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.267 0.555 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 42.2 p-90 -150.58 142.32 23.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.156 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 21.2 mt-10 -158.36 -176.99 6.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.42 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.039 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -133.38 168.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.039 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -148.66 -170.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.7 OUTLIER 174.5 143.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.03 -1.044 . . . . 0.0 111.319 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.7 tp 43.06 25.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.317 0.58 . . . . 0.0 110.636 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.625 ' N ' HG21 ' A' ' 12' ' ' THR . . . -127.75 -103.21 1.19 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.311 -1.423 . . . . 0.0 112.421 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.723 ' CG ' HG21 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -81.66 -64.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.844 1.696 . . . . 0.0 111.984 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.711 ' CD1' ' CZ ' ' A' ' 58' ' ' TYR . 2.2 m-85 -42.91 -25.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 38' ' ' ILE . 2.6 p -69.59 -62.08 1.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.573 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.8 tt0 -66.64 -18.0 65.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 109.357 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.7 m-80 -79.21 -60.83 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.664 -0.647 . . . . 0.0 110.053 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -39.91 -50.66 2.48 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.425 0.631 . . . . 0.0 109.39 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -53.32 -57.31 15.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' PHE . 6.0 tttp -69.36 -69.25 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -1.175 . . . . 0.0 110.62 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-30 -38.72 -63.33 0.52 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.996 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -44.19 -72.79 0.05 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.589 -0.694 . . . . 0.0 110.273 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 11.0 t -40.74 -26.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 0.0 110.616 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.5 m-20 -92.19 -70.92 0.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.943 -1.098 . . . . 0.0 109.783 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.863 ' CB ' HD13 ' A' ' 85' ' ' LEU . 8.9 mm-40 -56.42 -34.61 66.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.911 -1.118 . . . . 0.0 109.52 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.801 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -67.17 -56.63 9.1 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.9 m120 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.914 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -55.35 -51.07 67.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.489 -0.757 . . . . 0.0 109.757 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -62.91 -16.57 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.469 -0.77 . . . . 0.0 110.021 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.26 50.89 0.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.32 -1.106 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.813 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.917 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -112.83 52.88 0.77 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.262 -0.899 . . . . 0.0 110.094 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.64 98.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.1 t-20 -134.2 -64.83 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.935 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -70.41 -106.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 111.237 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 36' ' ' LYS . 11.0 t -158.85 173.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.485 -1.384 . . . . 0.0 111.829 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.9 132.53 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.596 0.712 . . . . 0.0 110.259 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.629 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -136.63 -61.54 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.536 -0.727 . . . . 0.0 109.709 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.0 Cg_endo -81.48 46.16 2.17 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.062 1.033 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.855 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.9 p -80.34 80.18 6.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.078 -1.014 . . . . 0.0 109.098 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.509 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -83.18 138.13 33.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.131 -0.981 . . . . 0.0 111.066 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.38 157.61 17.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.801 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 4.5 mttt -160.09 103.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -0.78 . . . . 0.0 109.214 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.4 m -124.27 153.89 41.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.866 -1.146 . . . . 0.0 111.213 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.846 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -150.35 86.74 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.267 -1.137 . . . . 0.0 111.153 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 7.1 pt-20 -95.16 149.27 21.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CZ ' ' CD1' ' A' ' 11' ' ' PHE . 2.3 t80 -144.97 139.64 27.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.914 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 28.2 mt-30 -99.19 107.03 19.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 25.0 tp -98.92 62.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.605 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.4 t80 -71.9 104.86 3.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.779 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG23 ' CE ' ' A' ' 67' ' ' LYS . 33.6 m -161.64 -165.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.7 t80 -131.26 134.6 46.57 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.248 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -130.68 -132.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.331 -0.856 . . . . 0.0 109.977 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.0 -29.73 13.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.595 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -136.18 3.88 2.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.427 -0.796 . . . . 0.0 110.12 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.634 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -113.19 100.7 8.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.582 ' HG ' ' CE2' ' A' ' 63' ' ' TYR . 6.8 mp -100.88 59.31 0.92 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.366 -0.834 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.24 -115.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.012 . . . . 0.0 110.156 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.9 ttp85 -124.35 157.83 34.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.332 -1.48 . . . . 0.0 112.807 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -118.37 91.88 3.68 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 30.5 t0 -69.15 81.27 0.34 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 110.906 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 22' ' ' GLU . 2.6 mm -68.38 114.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.394 -0.817 . . . . 0.0 108.903 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -118.36 118.17 31.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.372 -0.83 . . . . 0.0 110.675 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 40.3 mt-10 -153.38 120.19 5.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.031 -1.043 . . . . 0.0 110.794 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.153 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.4 tp -169.97 -174.13 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 110.221 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.981 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -165.43 179.1 6.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 110.645 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mtt85 -142.84 128.65 19.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.981 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 4.5 m-85 -104.77 85.13 2.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.635 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -153.59 -156.98 0.74 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.734 -1.229 . . . . 0.0 110.784 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.05 51.49 6.88 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.1 Cg_endo -66.49 138.64 50.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.459 1.768 . . . . 0.0 111.203 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.2 m . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.323 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.289 0.566 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -132.37 178.16 7.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 43' ' ' LYS . 1.1 tt0 176.99 119.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.767 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 16.4 pt -75.59 178.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.248 -0.908 . . . . 0.0 110.829 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.706 HG13 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.84 -164.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.328 -0.857 . . . . 0.0 110.712 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.699 ' O ' HG22 ' A' ' 8' ' ' ILE . 39.6 t0 -156.75 46.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.797 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 7' ' ' ASP . 17.9 tt 40.27 37.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.656 0.741 . . . . 0.0 109.83 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -143.52 -65.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.207 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 46.1 Cg_endo -78.7 -79.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.665 1.35 . . . . 0.0 111.427 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 43' ' ' LYS . 97.1 m-85 -40.19 -29.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.04 HG22 HD12 ' A' ' 38' ' ' ILE . 16.9 p -61.15 -59.11 5.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -67.35 -12.36 59.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 16.4 m120 -84.61 -69.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.0 pp -42.04 -28.22 0.17 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.695 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -74.66 -46.15 19.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -80.87 -41.89 22.39 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.201 -1.176 . . . . 0.0 110.253 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -35.85 82.46 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.595 0.712 . . . . 0.0 109.916 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -65.87 -71.79 0.18 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.5 p -34.52 -33.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.775 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 19' ' ' ALA . 87.1 m-20 -93.15 -73.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.079 ' HB2' HD13 ' A' ' 85' ' ' LEU . 6.9 mm-40 -57.2 -23.42 47.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.107 . . . . 0.0 110.206 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 1.4 tt0 -80.93 -63.36 1.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 49.1 m-20 -52.23 -46.89 65.9 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 11.0 ttpt -55.35 -50.67 69.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -50.18 -24.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.7 0.762 . . . . 0.0 109.05 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.04 36.12 1.06 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.503 -0.998 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.235 0.541 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -116.6 57.81 0.77 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 2.4 t80 -158.5 109.69 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -152.02 -70.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.923 . . . . 0.0 111.281 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -69.47 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.926 -1.109 . . . . 0.0 111.265 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 36' ' ' LYS . 4.6 t -160.57 156.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.443 -1.411 . . . . 0.0 112.273 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.04 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -106.12 140.74 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.713 0.768 . . . . 0.0 109.546 178.505 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.585 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.47 -61.92 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.679 -0.638 . . . . 0.0 110.09 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 52.1 Cg_endo -77.91 39.95 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.307 1.161 . . . . 0.0 111.687 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.635 ' HB3' HG21 ' A' ' 6' ' ' ILE . 85.3 m -93.49 148.45 22.07 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.938 -1.101 . . . . 0.0 109.945 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.512 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 5.2 mtm -138.48 161.93 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.028 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 2.7 tmtt? -152.03 131.72 13.16 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.955 -1.091 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -148.81 130.54 15.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.884 . . . . 0.0 110.348 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.5 m -108.21 154.09 22.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.977 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 46' ' ' ILE . 12.9 pt . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.483 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.3 t80 -160.85 107.73 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.786 -0.832 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.9 pt-20 -117.74 142.84 46.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.233 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -144.35 170.64 15.62 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.027 -1.469 . . . . 0.0 113.425 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -135.11 128.72 32.69 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.925 HD23 ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.8 85.61 2.35 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 109.104 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 1.8 t80 -77.52 108.94 11.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.624 HG11 HD21 ' A' ' 60' ' ' LEU . 1.3 p -153.46 173.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.0 t80 -128.57 127.23 41.91 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.765 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -127.67 -126.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.856 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.607 ' OG ' HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -96.96 -40.21 9.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.45 31.94 4.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 109.861 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -143.85 92.23 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.753 0.787 . . . . 0.0 109.357 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 68' ' ' LEU . 1.6 mp -100.58 63.58 1.09 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.715 -0.616 . . . . 0.0 110.761 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 168.86 -109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.034 -1.041 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 1.4 ttp-105 -130.4 141.52 50.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.906 -1.121 . . . . 0.0 112.779 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.925 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -107.26 113.41 26.79 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 3.1 t70 -93.35 168.69 10.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.076 . . . . 0.0 111.34 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 58' ' ' TYR . 4.3 tp -158.99 116.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -126.69 131.51 51.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.92 -1.113 . . . . 0.0 109.814 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 16.1 mt-10 -149.82 132.05 15.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.93 -1.106 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.168 -0.958 . . . . 0.0 110.079 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 21.0 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -170.73 151.29 3.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 110.832 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.079 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -136.1 175.93 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.42 -0.8 . . . . 0.0 109.506 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.5 mtm180 -147.79 178.75 8.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.042 -1.036 . . . . 0.0 110.949 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.787 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -155.63 84.26 1.04 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.622 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -153.42 -154.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 62.34 53.39 42.39 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.58 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.8 Cg_endo -64.43 154.78 69.75 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.582 1.833 . . . . 0.0 111.549 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.188 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.27 0.557 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 28.1 p90 -107.65 155.37 20.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.888 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.546 ' HG2' ' CD ' ' A' ' 43' ' ' LYS . 12.3 pt-20 -177.34 137.76 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.712 ' C ' HD13 ' A' ' 6' ' ' ILE . 4.9 pt -89.3 -178.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.712 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -125.73 -147.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.18 -0.95 . . . . 0.0 109.656 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -134.79 -152.12 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.76 -1.213 . . . . 0.0 110.295 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.774 ' C ' HG21 ' A' ' 12' ' ' THR . 2.0 tt -104.35 39.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.606 ' N ' HG21 ' A' ' 12' ' ' THR . . . -144.69 -63.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.272 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 6' ' ' ILE . 41.9 Cg_endo -68.72 -93.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.293 1.154 . . . . 0.0 112.498 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.696 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.7 m-85 -43.33 -26.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 0.0 111.013 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.047 HG22 HD12 ' A' ' 38' ' ' ILE . 22.4 p -54.41 -56.34 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.825 -1.172 . . . . 0.0 108.391 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' A' ' 12' ' ' THR . 7.4 tt0 -58.24 -22.43 52.17 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.762 0.791 . . . . 0.0 109.233 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 5.4 t-20 -72.26 -56.81 4.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.538 0.685 . . . . 0.0 109.801 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -42.32 -56.09 3.1 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.588 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.973 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.41 -38.38 41.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -79.81 -80.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -1.056 . . . . 0.0 110.676 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CD2' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -37.59 -36.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.283 0.563 . . . . 0.0 111.004 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.695 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -66.71 -69.6 0.3 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.393 -0.817 . . . . 0.0 109.738 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 19' ' ' ALA . 9.5 t -39.35 -27.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 110.198 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 19' ' ' ALA . 5.6 m-20 -93.32 -69.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 110.122 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.839 ' CB ' HD13 ' A' ' 85' ' ' LEU . 6.3 mp0 -57.27 -32.51 66.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.502 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.98 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -69.68 -59.88 2.67 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 23.4 m-20 -55.94 -44.71 78.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -52.8 63.02 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.453 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.98 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -54.51 -22.48 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.489 -0.757 . . . . 0.0 109.711 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 19.83 3.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 50.9 mm-40 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.946 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.233 0.54 . . . . 0.0 110.055 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.668 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -147.3 53.58 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 110.065 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 22.5 t80 -175.64 97.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.2 t-20 -129.68 -52.55 1.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.824 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -69.72 -99.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 111.183 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.46 173.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.558 -1.339 . . . . 0.0 111.825 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.047 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -126.92 121.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.437 0.637 . . . . 0.0 109.576 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.605 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -129.36 -58.27 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.467 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.2 Cg_endo -84.91 45.68 1.7 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.178 1.094 . . . . 0.0 110.965 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.752 ' SG ' HD11 ' A' ' 38' ' ' ILE . 24.0 p -80.06 88.6 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 109.496 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 5' ' ' ILE . 17.0 mtm -88.93 135.38 33.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.426 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CD ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.428 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' GLU . 19.5 mttt -142.97 121.09 12.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 5.7 m -125.87 150.12 48.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -159.45 88.39 0.86 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.967 . . . . 0.0 110.565 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' LYS . 12.6 pt-20 -87.99 155.45 19.82 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 60' ' ' LEU . 2.6 t80 -142.24 124.98 15.93 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.493 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 70' ' ' ARG . 10.7 mt-30 -96.78 96.22 8.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.903 ' CD2' HD23 ' A' ' 15' ' ' LEU . 7.8 tp -97.04 69.32 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 108.978 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -72.96 110.45 7.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.096 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.609 HG13 ' C ' ' A' ' 61' ' ' TYR . 22.9 m -160.96 -163.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.744 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.72 130.05 23.75 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.85 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 36' ' ' LYS . . . -125.44 -116.31 0.28 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.409 -0.807 . . . . 0.0 109.945 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -46.32 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.25 -1.42 5.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 110.021 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -94.53 92.32 7.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.781 . . . . 0.0 109.734 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.744 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.1 mt -96.35 61.92 2.05 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.657 ' N ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 167.59 -113.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.019 . . . . 0.0 110.473 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.25 149.61 52.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.43 -1.419 . . . . 0.0 113.626 -178.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -101.89 92.66 4.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -70.78 79.84 0.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.903 . . . . 0.0 110.64 -177.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -68.59 107.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.54 0.686 . . . . 0.0 109.571 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -103.18 114.86 29.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.472 -0.768 . . . . 0.0 110.31 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HG23 ' A' ' 73' ' ' ILE . 11.3 mt-10 -145.94 112.04 5.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.072 -1.018 . . . . 0.0 110.748 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.583 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.8 m-20 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.997 . . . . 0.0 109.513 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 16.1 mtmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.8 tp -169.88 -172.07 1.3 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.152 -0.968 . . . . 0.0 109.979 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.963 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -150.94 -179.72 7.53 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 72' ' ' ASP . 21.1 mtm180 -146.01 126.78 14.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.127 . . . . 0.0 111.55 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.6 m-85 -104.77 89.6 3.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.419 -0.801 . . . . 0.0 108.933 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.614 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 1.5 m120 -153.44 -143.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.52 -1.362 . . . . 0.0 111.268 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 51.37 50.33 41.46 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.2 Cg_endo -68.91 158.02 59.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.332 1.701 . . . . 0.0 111.111 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.5 m . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.227 0.537 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -133.41 169.11 17.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.464 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 6.5 tp10 -168.28 116.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.916 HG22 ' HG2' ' A' ' 42' ' ' MET . 20.9 pt -110.14 144.15 18.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.988 -1.07 . . . . 0.0 111.512 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.805 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.38 -175.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.639 ' HA ' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER 172.74 34.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.655 -1.278 . . . . 0.0 112.145 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 7' ' ' ASP . 6.7 tp 177.92 18.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.502 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -158.47 -64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.524 -1.798 . . . . 0.0 111.906 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.747 ' HG3' HG21 ' A' ' 6' ' ' ILE . 46.3 Cg_endo -74.66 -86.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.69 1.363 . . . . 0.0 112.199 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.652 ' HD2' HD12 ' A' ' 60' ' ' LEU . 3.9 m-85 -45.78 -22.43 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.961 HG22 HD12 ' A' ' 38' ' ' ILE . 27.6 p -66.14 -59.89 3.33 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.972 -1.08 . . . . 0.0 109.177 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.484 ' N ' ' OG1' ' A' ' 12' ' ' THR . 29.1 tt0 -72.15 -19.89 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.495 0.664 . . . . 0.0 109.924 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 8.2 m120 -79.25 -51.38 9.53 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.0 109.294 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.0 HD12 HD21 ' A' ' 60' ' ' LEU . 1.6 tt -44.98 -55.55 5.41 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.4 0.619 . . . . 0.0 109.521 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.985 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -52.31 -55.37 22.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' PHE . 4.3 mttm -69.89 -79.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -1.124 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -33.03 -66.64 0.14 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.451 0.643 . . . . 0.0 111.232 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -42.35 -70.28 0.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.601 -0.687 . . . . 0.0 109.849 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 24.8 t -43.62 -25.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.214 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 19' ' ' ALA . 7.6 t0 -91.18 -69.48 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.23 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.071 ' CB ' HD13 ' A' ' 85' ' ' LEU . 77.4 mm-40 -59.55 -34.86 73.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.767 -1.208 . . . . 0.0 109.345 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.913 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -66.6 -54.75 20.04 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 109.017 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.5 m120 -64.7 -43.7 92.64 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.041 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.1 tttm -57.65 -46.0 84.78 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.913 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -64.26 -17.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.466 -0.771 . . . . 0.0 110.016 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.98 37.47 1.37 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.464 ' HB3' ' OE2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.134 . . . . 0.0 110.066 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.989 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.275 0.559 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.7 55.5 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 110.458 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 5.5 p90 -177.33 119.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.103 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB3' ' C ' ' A' ' 64' ' ' ALA . 45.6 t30 -157.37 -56.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.818 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.29 -97.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.7 t -160.14 172.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.659 -1.276 . . . . 0.0 111.476 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.971 HD11 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.17 121.1 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.687 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.557 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.5 ttm180 -130.91 -57.37 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 110.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.9 Cg_endo -86.5 45.19 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.07 1.037 . . . . 0.0 110.965 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.971 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.1 p -85.11 79.27 9.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.487 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.916 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.8 mtp -82.47 163.0 21.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.171 -0.956 . . . . 0.0 110.685 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 3.4 ttpp -138.51 140.86 39.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.211 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 57' ' ' GLU . 6.0 ttmm -142.75 128.79 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.854 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.4 m -114.44 160.26 19.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 110.213 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.786 ' O ' HG23 ' A' ' 46' ' ' ILE . 1.3 tt . . . . . 0 C--N 1.306 -1.283 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.854 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 1.2 t80 -161.25 91.44 0.86 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.842 -0.799 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.3 mt-10 -123.87 -179.44 4.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -164.08 167.01 20.81 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.557 -1.257 . . . . 0.0 112.943 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 49.6 mt-30 -120.72 107.89 13.32 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 15' ' ' LEU . 1.3 tp -98.6 71.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.027 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.606 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -72.78 111.48 7.96 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.628 0.728 . . . . 0.0 109.082 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 15' ' ' LEU . 17.2 m -160.1 -163.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.574 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.2 t80 -138.85 126.88 22.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.714 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -122.58 -130.41 0.27 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.461 -0.774 . . . . 0.0 109.886 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.573 ' CB ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.87 -18.51 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 25.4 t70 -151.02 38.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.891 ' HE2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -150.31 88.69 1.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.553 0.692 . . . . 0.0 109.514 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 7.7 mt -92.44 60.04 3.51 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.618 -0.676 . . . . 0.0 109.596 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 170.45 -122.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.188 -0.945 . . . . 0.0 109.851 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 2.6 tmm_? -122.53 147.88 45.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.21 -1.556 . . . . 0.0 113.246 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 86' ' ' ARG . . . -102.05 98.09 8.33 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -68.78 152.37 45.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 110.133 -177.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.77 127.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 34.2 t -129.98 155.34 46.26 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.222 -0.923 . . . . 0.0 109.24 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' OE2' HG23 ' A' ' 73' ' ' ILE . 3.5 mp0 -156.33 116.79 3.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.607 -1.308 . . . . 0.0 112.46 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 75' ' ' GLU . 2.7 p30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.412 0.625 . . . . 0.0 111.643 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.8 tp -171.22 179.51 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 0.0 109.864 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.071 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.03 167.5 8.9 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.035 -1.041 . . . . 0.0 110.455 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.566 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 1.1 mtt180 -143.44 -174.86 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 10.7 m-85 -155.01 83.52 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.606 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -168.68 -164.06 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.503 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 86.82 54.83 2.54 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 39.5 Cg_endo -63.21 144.68 92.37 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 124.407 1.741 . . . . 0.0 111.472 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' H ' HG13 ' A' ' 91' ' ' VAL . 4.7 m . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.309 0.576 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 m-90 -83.28 -176.81 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HG2' ' CE ' ' A' ' 43' ' ' LYS . 20.7 tp10 174.31 163.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -139.29 173.43 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.931 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 7' ' ' ASP . 1.2 pp -136.82 -159.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 t70 -113.21 -143.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 109.617 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.823 ' C ' HG21 ' A' ' 12' ' ' THR . 0.8 OUTLIER -108.38 38.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.647 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -129.91 -56.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.702 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.5 Cg_endo -75.7 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 122.963 0.98 . . . . 0.0 111.853 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.7 ' CE1' ' CD2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -40.4 -34.96 0.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.136 -0.978 . . . . 0.0 110.447 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.133 HG22 HD12 ' A' ' 38' ' ' ILE . 44.5 p -50.19 -54.22 22.38 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.4 OUTLIER -63.78 -25.98 68.43 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.751 0.786 . . . . 0.0 109.36 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 11.6 m120 -72.26 -52.4 16.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 0.0 109.86 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -42.9 -58.4 2.41 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.257 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 1.02 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -45.72 -45.97 13.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -83.52 -80.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.053 . . . . 0.0 111.154 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 2.5 m-85 -35.69 -29.58 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 111.592 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.787 ' HB1' ' OE1' ' A' ' 23' ' ' GLU . . . -84.02 -72.49 0.46 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.749 HG23 ' OG1' ' A' ' 33' ' ' THR . 24.3 t -43.64 -26.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 109.833 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -86.64 -62.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.667 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.067 ' HB2' HD13 ' A' ' 85' ' ' LEU . 25.3 mm-40 -62.12 -43.21 99.32 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.464 -1.294 . . . . 0.0 108.998 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.888 ' CD ' HG21 ' A' ' 33' ' ' THR . 55.4 mt-10 -58.83 -51.86 68.2 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 108.877 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.0 t-20 -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.383 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -57.66 -42.11 82.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.966 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.2 tp -69.57 -16.48 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.393 -0.817 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.07 52.72 0.26 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.422 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.297 -1.12 . . . . 0.0 109.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' HA ' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.227 0.537 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.888 HG21 ' CD ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -130.04 52.5 2.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.751 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.522 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 38.9 t80 -163.85 112.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.415 -0.803 . . . . 0.0 110.015 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.9 t-20 -150.4 -55.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.546 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.749 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.6 mttt -69.46 -103.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 111.049 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.2 t -159.59 172.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.755 -1.216 . . . . 0.0 111.536 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.133 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.65 129.12 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.615 -0.678 . . . . 0.0 109.846 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -132.1 -58.13 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.375 -0.828 . . . . 0.0 110.057 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 44.9 Cg_endo -87.44 46.42 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.174 1.091 . . . . 0.0 110.81 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 1.001 ' HB2' HD12 ' A' ' 60' ' ' LEU . 22.6 p -87.46 111.61 21.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.482 ' HB3' ' CE ' ' A' ' 44' ' ' LYS . 27.1 mtm -109.66 179.81 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.703 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' CE ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -152.54 142.38 22.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 110.107 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -137.96 105.69 5.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.772 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.9 m -124.17 154.19 40.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 46' ' ' ILE . 25.8 pt . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' GLU . 86.5 t80 -152.29 90.83 1.54 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.259 -1.142 . . . . 0.0 110.809 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.9 tt0 -112.08 159.61 18.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.704 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -156.35 169.16 25.22 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 117.859 -1.536 . . . . 0.0 113.45 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 13.3 mt-30 -137.93 120.97 16.67 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -121.98 83.85 2.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 109.436 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.65 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -75.18 110.32 9.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.756 HG23 ' HD3' ' A' ' 67' ' ' LYS . 35.6 m -160.33 -161.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.462 -0.774 . . . . 0.0 109.697 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 1.109 ' CE1' HD22 ' A' ' 68' ' ' LEU . 2.0 t80 -135.09 135.2 41.04 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.506 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -133.15 -127.74 0.18 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -40.01 9.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.992 . . . . 0.0 108.982 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' OD1' HG22 ' A' ' 33' ' ' THR . 2.5 p30 -127.67 -2.39 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -104.5 88.87 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.109 HD22 ' CE1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -100.25 60.9 1.05 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 108.788 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER 172.3 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 7.3 ttp180 -152.94 156.27 38.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.972 -1.705 . . . . 0.0 112.643 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -119.2 115.52 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' OD1' ' NH1' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -93.07 166.34 12.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.992 -1.067 . . . . 0.0 110.235 -178.064 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.704 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.69 114.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.618 -0.676 . . . . 0.0 109.179 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -109.84 144.57 38.11 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 83' ' ' LYS . 3.3 mt-10 -167.72 104.17 0.5 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.694 -1.254 . . . . 0.0 111.726 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.598 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 16.1 p-10 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.657 0.741 . . . . 0.0 112.149 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.785 ' C ' HD23 ' A' ' 84' ' ' LEU . 6.8 mttt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.785 HD23 ' C ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -170.86 -169.56 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.528 -1.357 . . . . 0.0 111.75 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.37 175.95 4.63 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 13.0 mtt180 -150.35 152.15 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 13.4 m-85 -103.69 97.39 7.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 1.5 t-20 -66.79 125.86 27.19 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . -8.09 99.35 0.01 OUTLIER Glycine 0 N--CA 1.503 3.108 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.45 ' C ' ' HB2' ' A' ' 68' ' ' LEU . 47.3 Cg_endo -74.95 79.07 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.553 . . . . 0.0 109.941 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 68' ' ' LEU . 2.1 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.239 -0.913 . . . . 0.0 110.336 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.284 0.564 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CB ' ' HG2' ' A' ' 44' ' ' LYS . 4.8 p90 -115.77 177.81 4.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.51 121.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.206 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 18.4 pt -85.17 170.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.075 -1.016 . . . . 0.0 110.499 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.777 HG22 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -89.4 -166.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.256 -0.902 . . . . 0.0 110.509 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 m-20 -137.16 49.56 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.141 -0.975 . . . . 0.0 110.705 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 7' ' ' ASP . 5.1 tt 39.9 46.01 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.963 0.887 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -156.1 -62.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.346 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.1 Cg_endo -72.7 -84.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 0.0 111.535 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.777 ' CD2' HG22 ' A' ' 6' ' ' ILE . 6.3 m-85 -41.42 -29.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.243 -0.911 . . . . 0.0 110.568 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.599 ' HA ' HG21 ' A' ' 38' ' ' ILE . 11.4 p -55.33 -58.0 9.52 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.535 ' N ' ' OG1' ' A' ' 12' ' ' THR . 9.6 mt-30 -68.19 -17.7 64.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.694 0.759 . . . . 0.0 109.394 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.555 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 7.2 t-20 -80.82 -57.28 3.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.55 0.69 . . . . 0.0 109.352 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -39.14 -46.49 1.45 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 1.011 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -65.24 -40.45 96.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.74 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.44 -69.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -1.054 . . . . 0.0 110.241 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 1.7 m-30 -40.86 -47.3 2.91 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.686 0.755 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -57.69 -77.56 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.526 -0.734 . . . . 0.0 110.01 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.0 p -38.33 -27.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.0 110.967 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.11 -77.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.915 -1.115 . . . . 0.0 110.213 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.1 mm-40 -56.06 -36.31 67.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.671 -1.268 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.812 ' O ' HG22 ' A' ' 26' ' ' ILE . 30.6 tt0 -64.77 -52.37 57.28 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 18.8 t-20 -66.64 -44.19 82.62 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.015 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.8 ttmt -59.72 -41.72 91.46 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.127 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.4 tp -69.39 -17.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.389 -0.819 . . . . 0.0 110.194 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . 115.58 52.13 0.4 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 36.5 mm-40 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.122 . . . . 0.0 109.736 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.914 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.29 0.567 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.723 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -129.98 52.71 1.98 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.835 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 6.3 p90 -172.7 62.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -106.06 -26.16 11.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.102 -0.999 . . . . 0.0 111.218 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.761 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -96.39 -89.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 36' ' ' LYS . 10.0 t -160.29 172.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.482 -1.386 . . . . 0.0 111.342 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -135.6 82.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.573 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.577 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -102.04 -58.02 0.1 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.026 -1.046 . . . . 0.0 111.494 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 61' ' ' TYR . 39.3 Cg_endo -79.19 48.04 2.7 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.292 1.154 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . 20.8 p -104.74 121.62 43.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.799 -1.188 . . . . 0.0 109.789 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 2.3 mpt? -117.65 157.66 26.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.111 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.53 129.8 46.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 110.215 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 15.0 mttm -130.93 125.43 33.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.1 m -125.1 164.65 19.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.984 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.491 ' N ' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.73 ' HA ' HG23 ' A' ' 45' ' ' THR . 13.7 t80 -162.2 109.51 1.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.902 -0.764 . . . . 0.0 110.617 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -126.04 177.85 6.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.351 -0.843 . . . . 0.0 108.831 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 1.089 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -165.38 175.18 9.34 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.168 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.517 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.8 tt0 -127.69 125.06 39.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 41' ' ' CYS . 21.1 tp -119.52 67.62 0.81 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.726 -1.234 . . . . 0.0 109.842 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 2.5 t80 -69.5 108.78 3.93 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 15' ' ' LEU . 34.9 m -160.42 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.695 ' CE1' HD12 ' A' ' 68' ' ' LEU . 1.4 t80 -154.2 117.34 4.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.971 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.91 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -104.46 -102.62 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.559 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.512 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 22.9 t -120.03 -26.74 5.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.75 5.62 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.959 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.91 ' NZ ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -109.07 86.35 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 110.109 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 63' ' ' TYR . 1.2 tp -88.78 61.96 6.21 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.717 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 169.73 -113.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.0 110.213 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 17.5 ttm180 -127.0 146.21 50.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.557 -1.34 . . . . 0.0 112.963 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -106.59 102.42 11.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.3 t70 -84.68 154.88 22.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.089 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -156.18 142.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.842 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.1 t -128.49 159.2 36.2 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -167.65 105.04 0.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.677 -1.264 . . . . 0.0 111.917 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' GLU . 56.9 p-10 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -171.2 -167.78 0.57 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.81 172.4 5.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.295 -0.878 . . . . 0.0 109.704 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 19.6 mtp180 -148.51 178.6 8.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.909 -1.12 . . . . 0.0 111.244 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 3.2 m-85 -155.36 80.86 1.05 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -155.79 -163.31 1.47 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.765 -1.209 . . . . 0.0 111.209 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 77.74 53.21 5.08 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.14 119.66 6.93 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.834 1.965 . . . . 0.0 111.697 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.449 ' H ' HG12 ' A' ' 91' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.531 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 7.5 p90 -159.36 165.58 32.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -0.901 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 43' ' ' LYS . 8.2 pt-20 -172.94 158.71 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.823 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.05 171.81 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.163 -0.96 . . . . 0.0 110.44 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.823 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -150.84 -176.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.868 -0.52 . . . . 0.0 109.784 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.78 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.8 p30 -179.32 126.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER 43.21 25.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.691 -0.631 . . . . 0.0 110.13 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.66 ' N ' HG21 ' A' ' 12' ' ' THR . . . -118.02 -107.63 2.38 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.161 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . 48.7 Cg_endo -80.65 -72.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.72 1.613 . . . . 0.0 112.752 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 6' ' ' ILE . 59.6 m-85 -40.09 -27.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.286 -0.883 . . . . 0.0 109.9 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.829 HG22 HG21 ' A' ' 38' ' ' ILE . 2.1 p -65.69 -61.81 1.87 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.582 ' N ' ' OG1' ' A' ' 12' ' ' THR . 5.3 mt-30 -59.89 -26.35 65.83 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.924 0.868 . . . . 0.0 108.767 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 1.7 t-20 -74.45 -47.0 36.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.604 0.716 . . . . 0.0 109.202 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 60' ' ' LEU . 3.4 tm? -44.03 -70.4 0.11 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . . . -44.27 -37.39 4.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 18.1 mttp -71.24 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -40.54 -41.3 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.579 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -59.63 -68.27 0.3 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.438 -0.789 . . . . 0.0 109.316 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' GLY . 23.3 t -38.5 -28.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.479 -0.763 . . . . 0.0 110.288 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.17 -73.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 110.341 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 14.0 mm-40 -54.86 -27.98 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.897 -1.127 . . . . 0.0 109.827 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -76.76 -61.11 2.08 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 6.6 m-20 -51.76 -47.17 64.22 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 20.7 mmmt -55.25 -51.69 65.8 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.653 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -51.77 -22.39 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.101 178.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.2 67.41 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.213 -1.169 . . . . 0.0 110.304 -179.898 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.329 0.585 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.533 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -154.35 62.32 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.1 t80 176.94 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.315 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 t-20 -117.12 -56.37 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 110.734 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.51 -101.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.019 -1.051 . . . . 0.0 111.263 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' LYS . 2.4 t -163.43 174.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.696 -1.253 . . . . 0.0 111.527 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.004 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -121.36 112.16 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.739 -0.601 . . . . 0.0 109.768 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.604 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -119.23 -57.07 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.1 Cg_endo -86.93 48.29 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.901 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 60' ' ' LEU . 23.6 p -96.41 122.13 38.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' GLN . 12.1 mtm -121.1 165.14 15.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -143.17 144.5 32.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLU . 18.5 mttt -148.43 157.44 43.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.6 m -149.1 152.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.564 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.881 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.495 2.595 0 CA-C-O 121.736 0.631 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -157.84 107.42 2.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.705 -0.88 . . . . 0.0 110.234 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' LYS . 17.1 pt-20 -117.14 134.65 54.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.41 164.22 26.18 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.49 -1.284 . . . . 0.0 112.534 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 11.5 mt-30 -132.12 124.12 28.5 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.004 HD11 ' CD1' ' A' ' 38' ' ' ILE . 1.8 tp -120.69 78.15 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.747 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -73.28 113.0 9.86 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 38' ' ' ILE . 32.9 m -159.63 -162.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 2.8 t80 -136.01 141.58 44.37 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -138.98 -115.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.845 . . . . 0.0 110.043 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -111.8 -39.0 4.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.268 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 3.5 p-10 -127.54 -0.98 6.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.602 -0.687 . . . . 0.0 109.641 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -106.25 97.68 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 109.736 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' CZ ' ' A' ' 63' ' ' TYR . 6.5 mp -100.2 60.09 1.03 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.428 -0.795 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 168.17 -115.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 110.237 -179.233 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 3.1 ttm180 -122.46 145.35 48.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.184 -1.572 . . . . 0.0 113.142 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.37 108.31 19.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' CB ' ' HG3' ' A' ' 86' ' ' ARG . 1.4 t70 -90.33 162.37 15.19 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.917 -1.114 . . . . 0.0 111.247 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -155.78 101.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.26 150.52 22.01 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.656 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -169.06 119.9 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.104 -0.998 . . . . 0.0 110.675 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' C ' ' HA2' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.584 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.8 tt -171.25 163.65 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.17 . . . . 0.0 110.516 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -149.43 160.86 43.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.596 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HG3' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -150.53 147.9 28.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 111.269 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.932 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -124.7 89.82 3.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.638 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 2.1 m120 -153.52 -146.43 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.685 -1.26 . . . . 0.0 110.929 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 60.35 52.8 50.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -67.01 136.6 41.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.408 1.741 . . . . 0.0 111.253 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.279 -179.756 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.279 0.562 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -66.3 -176.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 174.78 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.937 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.965 HG22 ' HG2' ' A' ' 42' ' ' MET . 1.1 pp -89.37 167.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 120.979 -1.076 . . . . 0.0 110.324 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.149 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -115.11 -160.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.995 -1.065 . . . . 0.0 110.672 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 40.3 t0 -135.46 52.74 2.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.844 -1.16 . . . . 0.0 112.123 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.908 HG22 ' O ' ' A' ' 38' ' ' ILE . 29.8 pt 39.83 46.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.168 0.985 . . . . 0.0 110.314 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -134.02 -69.15 0.07 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.785 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 45.7 Cg_endo -79.28 -63.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.845 1.445 . . . . 0.0 111.28 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.149 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.5 m-85 -47.39 -36.02 9.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.025 -1.047 . . . . 0.0 109.212 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.909 HG22 HG13 ' A' ' 38' ' ' ILE . 1.7 p -52.3 -57.66 9.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.602 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -64.87 -15.97 62.62 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.059 179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.56 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 5.7 m120 -82.82 -68.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.271 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 3.0 pp -40.93 -28.76 0.09 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.456 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 20' ' ' VAL . . . -71.42 -53.34 10.35 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -76.58 -42.49 42.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -1.127 . . . . 0.0 110.837 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' ALA . 7.6 m-85 -63.63 -64.86 0.78 Allowed 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.44 -0.788 . . . . 0.0 110.065 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.42 -66.22 0.42 Allowed 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.625 -0.672 . . . . 0.0 110.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 16' ' ' GLY . 30.5 m -42.43 -26.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 120.961 -1.087 . . . . 0.0 110.149 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -94.77 -69.86 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.969 ' HB2' HD13 ' A' ' 85' ' ' LEU . 22.7 mm-40 -55.37 -35.01 64.79 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.247 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -69.69 -59.66 2.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.057 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 61.7 t-20 -51.38 -45.32 62.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -54.46 46.67 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.703 -0.799 . . . . 0.0 108.965 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -57.06 -19.1 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.636 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.66 70.91 1.33 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 32' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.336 0.589 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.97 50.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.633 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.552 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 6.5 p90 -162.85 123.0 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.74 -59.26 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.992 -1.068 . . . . 0.0 111.314 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 mmmt -69.09 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.993 -1.067 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.4 t -161.13 173.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.7 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -123.96 103.35 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.959 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.652 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -101.74 -60.48 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.953 -1.092 . . . . 0.0 110.185 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.4 Cg_endo -86.76 54.43 3.07 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.176 1.092 . . . . 0.0 110.336 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 1.071 ' SG ' HD12 ' A' ' 60' ' ' LEU . 4.5 t -102.67 110.55 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.965 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.0 mtt -113.75 175.75 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 110.628 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 2.3 ttpt -147.68 120.7 8.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -114.78 160.98 18.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.1 m -163.53 153.42 15.21 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.87 -1.144 . . . . 0.0 110.364 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -152.87 110.21 3.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.427 -1.043 . . . . 0.0 111.018 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.0 pm0 -124.8 124.46 42.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.51 169.67 10.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.566 -1.334 . . . . 0.0 113.267 -177.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' HB3' ' NE ' ' A' ' 70' ' ' ARG . 6.7 mp0 -133.66 123.08 24.39 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.071 HD12 ' SG ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -121.24 72.59 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 0.0 109.888 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.621 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -68.23 107.13 2.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.8 m -158.29 -160.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.346 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.99 129.24 22.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.515 -0.741 . . . . 0.0 109.932 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -122.0 -130.27 0.27 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 -18.76 30.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 108.744 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 9.6 p-10 -162.4 23.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.565 -0.71 . . . . 0.0 109.735 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -117.07 71.47 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.384 -0.823 . . . . 0.0 110.32 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.876 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 4.6 mt -81.73 52.6 1.95 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -168.62 -153.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.547 -0.721 . . . . 0.0 109.81 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 ttm180 -106.52 119.64 39.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 111.321 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.753 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -80.6 107.19 13.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t70 -87.64 160.37 18.18 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.732 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.73 112.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.905 0.86 . . . . 0.0 109.745 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -103.12 144.17 31.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.005 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.58 105.75 2.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.461 -1.399 . . . . 0.0 112.335 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' CG ' ' A' ' 83' ' ' LYS . 1.7 p-10 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.521 0.677 . . . . 0.0 111.03 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' CG ' ' OD1' ' A' ' 76' ' ' ASP . 79.4 mttt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -171.17 -172.99 1.19 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 110.605 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.969 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -170.3 167.67 8.36 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.646 -0.659 . . . . 0.0 109.329 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.9 mtm180 -143.45 -176.21 4.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.933 -1.105 . . . . 0.0 111.198 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.843 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 17.3 m-85 -155.98 66.79 0.6 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -154.16 -161.41 1.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.81 -1.182 . . . . 0.0 111.624 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 73.05 54.7 6.82 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -176.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.1 Cg_endo -62.57 177.12 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.82 1.958 . . . . 0.0 112.065 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.461 HG13 ' OH ' ' A' ' 61' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.196 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.12 0.486 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.526 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 7.0 p-90 -144.03 169.27 18.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.783 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 177.28 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.063 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.0 HG22 ' HG3' ' A' ' 42' ' ' MET . 6.9 pt -69.89 -172.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mm -131.1 -138.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.535 ' O ' HD11 ' A' ' 38' ' ' ILE . 19.3 m-20 -142.07 -146.83 0.2 Allowed 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.791 -1.193 . . . . 0.0 110.221 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt -113.62 47.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.611 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -157.39 -60.9 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.357 -1.402 . . . . 0.0 111.777 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.815 ' HG2' HG22 ' A' ' 6' ' ' ILE . 38.6 Cg_endo -64.92 -68.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.527 1.277 . . . . 0.0 112.527 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.659 ' HD1' HG21 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -65.36 -23.53 67.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.483 -1.385 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' N ' ' A' ' 9' ' ' GLY . 10.0 p -48.62 -53.36 18.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.4 tp60 -64.02 -29.78 70.9 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.072 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 3.8 m120 -66.02 -58.73 4.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.605 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.833 HD13 ' CD2' ' A' ' 60' ' ' LEU . 9.0 tp -41.03 -66.99 0.28 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -43.46 -29.31 1.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 20' ' ' VAL . 70.5 mmtt -88.67 -82.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 110.418 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -41.6 -27.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.486 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 15' ' ' LEU . . . -81.2 -70.5 0.53 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 17' ' ' LYS . 4.4 p -41.57 -25.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.324 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ALA . 59.3 t0 -92.7 -72.5 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.085 -1.01 . . . . 0.0 110.516 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.974 ' HB2' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -57.83 -28.96 64.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.452 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.3 tt0 -72.43 -58.97 2.97 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 17.0 m-20 -54.14 -51.82 63.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -51.45 -48.62 62.69 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.456 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.054 HD11 HD11 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -53.75 -20.44 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.529 0.68 . . . . 0.0 109.294 178.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.68 22.86 5.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 1.5 tp60 . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.443 -1.033 . . . . 0.0 109.664 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.37 0.605 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -155.35 49.67 0.55 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.302 -0.874 . . . . 0.0 110.088 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.669 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 43.5 p90 179.65 55.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.471 -0.768 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 20.9 t-20 -85.77 -54.24 4.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.454 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.806 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.54 -105.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.021 -1.049 . . . . 0.0 110.962 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.7 t -161.06 172.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.53 -1.356 . . . . 0.0 111.775 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.56 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.2 pp -121.37 97.62 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.611 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -96.04 -55.56 0.21 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.863 -1.148 . . . . 0.0 109.866 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.2 Cg_endo -86.87 54.18 2.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.554 1.292 . . . . 0.0 110.362 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 60' ' ' LEU . 7.5 t -91.25 92.94 8.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 1.0 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -90.68 126.4 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.155 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -123.63 155.78 37.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 1.4 ptpp? -164.54 173.5 11.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.4 m -157.86 158.07 34.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 46' ' ' ILE . 6.8 pt . . . . . 0 C--N 1.299 -1.605 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HA ' HG23 ' A' ' 45' ' ' THR . 11.3 m-85 -115.65 -179.19 3.58 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.82 -0.812 . . . . 0.0 110.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 7.4 pt-20 171.34 137.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.807 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -151.06 171.78 16.79 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 117.432 -1.707 . . . . 0.0 113.974 -178.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.553 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt-30 -129.24 124.82 35.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.833 ' CD2' HD13 ' A' ' 15' ' ' LEU . 23.7 tp -117.67 71.76 0.83 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.871 -1.143 . . . . 0.0 109.83 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -69.53 107.01 3.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' CD ' ' A' ' 67' ' ' LYS . 13.0 m -158.2 -160.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.343 -0.848 . . . . 0.0 109.685 -177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -141.32 139.1 33.53 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.473 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.669 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -132.98 -113.08 0.22 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.374 -0.829 . . . . 0.0 109.508 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -30.6 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.125 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -143.18 12.82 1.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.652 -0.655 . . . . 0.0 109.51 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HZ3' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.16 87.71 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.525 -0.735 . . . . 0.0 110.03 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 1.5 mt -93.57 63.21 3.42 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.657 -0.652 . . . . 0.0 109.773 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.62 -118.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.573 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 48.0 ttp85 -123.76 146.08 48.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.402 -1.436 . . . . 0.0 112.807 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -109.48 106.56 16.36 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 6.1 t70 -84.74 159.88 20.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 110.753 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.807 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -160.11 119.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.503 0.668 . . . . 0.0 109.577 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -108.75 153.39 23.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.046 . . . . 0.0 109.528 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -152.19 104.75 2.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.641 -1.287 . . . . 0.0 112.206 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 76' ' ' ASP . 3.2 p30 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.499 0.666 . . . . 0.0 111.494 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 HD11 ' A' ' 26' ' ' ILE . 10.5 tp -171.17 178.72 3.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.353 -0.842 . . . . 0.0 109.639 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.974 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -154.58 167.99 28.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.558 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 6.5 mtt-85 -139.48 -177.7 5.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.772 -1.205 . . . . 0.0 111.45 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.693 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 11.0 m-85 -156.19 82.89 0.99 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.669 -0.644 . . . . 0.0 109.399 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -161.21 -164.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.615 -1.303 . . . . 0.0 111.371 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.555 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 80.6 53.72 3.95 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.2 Cg_endo -60.09 149.67 83.37 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.828 1.962 . . . . 0.0 111.828 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 91' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.109 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.341 0.591 . . . . 2.79 110.2 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -115.53 152.59 32.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 3.5800000000000001 110.202 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 3.8 pt-20 -163.69 134.08 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.92 . . . . 2.7000000000000002 110.177 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' A' ' 42' ' ' MET . 16.7 pt -82.34 175.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.055 -1.028 . . . . 1.3600000000000001 110.491 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.083 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.35 -162.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.251 -0.906 . . . . 2.4100000000000001 109.881 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -136.36 50.17 2.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.14 . . . . 2.4300000000000002 111.515 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 7' ' ' ASP . 11.5 tt 40.18 43.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.936 0.874 . . . . 1.72 110.043 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.81 -62.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.295 -0.955 . . . . 0.84999999999999998 110.804 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.9 Cg_endo -86.34 -61.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.503 1.265 . . . . 0.93000000000000005 110.896 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.1 m-85 -50.06 -31.89 14.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.993 -1.067 . . . . 1.3899999999999999 109.387 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.716 HG22 ' CG2' ' A' ' 38' ' ' ILE . 7.2 p -60.2 -58.67 7.53 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.124 -1.436 . . . . 0.89000000000000001 107.124 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.9 tt0 -66.73 -19.47 65.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.766 0.793 . . . . 2.3100000000000001 109.18 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 9.9 t-20 -78.19 -56.43 4.47 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.502 0.668 . . . . 1.55 109.547 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 60' ' ' LEU . 7.1 tp -41.55 -66.13 0.37 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.402 0.62 . . . . 2.0800000000000001 109.357 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.67 -43.61 16.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.323 -1.511 . . . . 0.56999999999999995 109.323 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -69.64 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -1.16 . . . . 2.3999999999999999 110.939 -179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.1 m-85 -37.69 -53.71 1.23 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.414 0.626 . . . . 2.25 111.238 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.667 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -43.9 -70.06 0.12 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.475 -0.766 . . . . 0.55000000000000004 110.001 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 32' ' ' LEU . 16.2 t -42.77 -26.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.032 . . . . 1.3999999999999999 110.358 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -91.9 -66.28 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.8100000000000001 109.896 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.109 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.3 mm-40 -60.16 -41.09 92.06 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.581 -1.247 . . . . 2.1699999999999999 108.981 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.827 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -61.46 -53.22 59.3 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.6799999999999999 108.711 178.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 27.4 t-20 -61.86 -46.58 88.82 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.687 -1.205 . . . . 2.2799999999999998 107.824 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -56.92 -48.18 78.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 2.8199999999999998 109.842 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -60.85 -20.18 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.925 -0.71 . . . . 1.6000000000000001 109.844 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.67 28.54 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.572 -1.411 . . . . 0.98999999999999999 109.572 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.521 ' CG ' ' OE2' ' A' ' 23' ' ' GLU . 8.6 tp60 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.152 . . . . 2.3100000000000001 110.019 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' VAL . 2.7 mp . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 2.5499999999999998 110.026 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.667 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -140.44 52.43 1.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.298 -0.876 . . . . 0.93000000000000005 109.848 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 32' ' ' LEU . 38.4 p90 -167.86 129.08 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.83 . . . . 3.4399999999999999 110.036 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB2' ' N ' ' A' ' 65' ' ' SER . 7.7 t30 -153.67 -64.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 2.46 110.678 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.98 -94.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.964 . . . . 3.4399999999999999 111.329 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.4 t -157.97 172.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.693 -1.254 . . . . 1.1000000000000001 111.822 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.716 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -129.22 86.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.201 -0.666 . . . . 1.6399999999999999 109.201 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -102.73 -52.14 0.14 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 3.02 110.533 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.3 Cg_endo -85.59 52.8 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.53 1.279 . . . . 0.56999999999999995 110.789 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.5 p -104.2 120.39 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 1.6200000000000001 109.781 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.854 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.7 mtm -119.04 178.02 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 2.0600000000000001 110.631 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -138.61 151.58 47.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 1.6100000000000001 110.461 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 1.9 mttt -148.39 106.21 3.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.362 -0.837 . . . . 2.48 109.889 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.6 m -112.8 152.55 29.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.62 110.173 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 106.769 -1.567 . . . . 1.96 106.769 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.803 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 110.172 -1.171 . . . . 0.59999999999999998 110.172 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CZ ' ' HE3' ' A' ' 43' ' ' LYS . 7.5 t80 -150.53 98.31 2.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.29 -1.124 . . . . 3.8300000000000001 110.87 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 15.8 pt-20 -120.0 174.01 6.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 2.5299999999999998 108.914 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 1.107 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -159.6 177.64 10.69 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 117.952 -1.499 . . . . 1.79 113.45 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -135.45 117.24 15.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.589 -1.263 . . . . 2.1400000000000001 107.589 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 41' ' ' CYS . 2.2 tp -116.0 72.41 0.81 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.69999999999999996 109.513 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 1.061 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.63 111.74 5.64 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.117 -1.068 . . . . 1.6100000000000001 108.117 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.697 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.6 m -158.13 -158.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.789 0.804 . . . . 0.41999999999999998 109.813 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.0 t80 -143.61 126.21 15.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.699 -0.626 . . . . 1.26 109.535 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -121.44 -136.45 0.32 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.393 -0.817 . . . . 0.75 109.884 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -87.34 -25.73 23.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 1.3899999999999999 108.964 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 15.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 1.78 109.567 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.912 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -118.29 79.2 1.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.3600000000000001 110.11 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mp -89.73 57.67 3.98 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.622 -0.881 . . . . 1.75 108.622 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -173.09 -121.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.074 -1.05 . . . . 1.8500000000000001 110.023 -178.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 30.5 ttm180 -133.84 124.76 27.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.325 -1.484 . . . . 1.9099999999999999 112.215 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -81.79 103.35 11.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.984 -1.487 . . . . 0.46999999999999997 106.984 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.45 156.04 19.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 1.75 110.15 -178.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.107 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -159.22 141.74 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.513 -0.742 . . . . 1.1699999999999999 109.863 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -127.96 153.32 46.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.238 -0.914 . . . . 1.23 109.049 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -157.67 106.42 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.635 -1.291 . . . . 2.2999999999999998 111.772 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' GLU . 1.4 p30 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.502 0.667 . . . . 1.74 111.224 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 mttt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.395 -0.965 . . . . 3.4500000000000002 108.395 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.643 HD11 HG12 ' A' ' 26' ' ' ILE . 10.0 tp -171.25 179.74 2.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.318 -0.864 . . . . 2.4199999999999999 109.338 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.109 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -155.65 172.28 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.103 -0.998 . . . . 1.22 110.094 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.533 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 3.9 mtt180 -142.33 -176.67 4.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -0.894 . . . . 2.6200000000000001 110.905 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 48.5 m-85 -154.93 64.63 0.65 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.73999999999999999 108.954 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.87 -157.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 1.9299999999999999 111.26 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.46 52.5 30.33 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.193 -3.163 . . . . 1.21 105.193 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.4 Cg_endo -67.55 -175.03 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.582 1.833 . . . . 2.1400000000000001 111.933 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.061 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.1 m . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 117.966 -1.016 . . . . 2.25 110.387 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 45' ' ' THR . 6.2 mt-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.512 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 51.2 p-90 -118.59 169.98 9.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.807 -1.183 . . . . 0.0 110.036 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 1.4 tt0 175.79 115.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 42' ' ' MET . 15.2 pt -82.77 -176.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.742 HG21 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -116.39 -165.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.089 -1.007 . . . . 0.0 110.543 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.658 ' O ' HG22 ' A' ' 8' ' ' ILE . 25.3 m-20 -136.66 49.99 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.945 -1.097 . . . . 0.0 111.461 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt 39.7 42.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.455 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -145.47 -68.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.975 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 43.8 Cg_endo -73.77 -84.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.689 1.363 . . . . 0.0 111.392 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 24.7 m-85 -39.68 -31.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.012 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.029 HG22 HD12 ' A' ' 38' ' ' ILE . 11.7 p -55.97 -56.89 15.28 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.85 -1.156 . . . . 0.0 108.21 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.516 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -57.34 -17.83 14.24 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.41 179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.57 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -79.86 -60.56 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.702 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 12' ' ' THR . 1.2 pp -41.57 -30.68 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.66 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.41 -49.28 20.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' PHE . 10.4 tptt -71.62 -69.36 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -1.05 . . . . 0.0 110.21 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-85 -39.75 -62.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.483 0.659 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.12 -72.45 0.06 Allowed 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 15.7 t -38.52 -26.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.756 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 19' ' ' ALA . 9.4 m-20 -95.09 -70.73 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 110.26 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.822 ' CD ' HD11 ' A' ' 73' ' ' ILE . 1.8 mt-10 -57.96 -26.87 62.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.579 -1.249 . . . . 0.0 109.062 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.9 tt0 -74.34 -58.91 2.99 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.1 m120 -56.81 -44.73 82.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.461 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.94 -52.68 63.28 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.793 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 85' ' ' LEU . 7.3 tp -63.68 -12.87 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.264 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.64 59.48 0.43 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 109.991 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.637 HD11 ' OD1' ' A' ' 35' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -135.13 55.27 1.9 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 11.3 p90 -174.4 60.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.886 . . . . 0.0 110.262 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.637 ' OD1' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -90.1 -56.05 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.63 -106.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.079 . . . . 0.0 111.115 -178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.1 t -160.03 173.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.732 -1.23 . . . . 0.0 111.431 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.029 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.53 118.07 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.498 -0.751 . . . . 0.0 110.162 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.607 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -123.49 -56.87 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.896 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.4 Cg_endo -87.33 48.89 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.212 1.111 . . . . 0.0 110.354 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 6' ' ' ILE . 2.7 t -91.27 128.81 37.24 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.537 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.2 mtm -122.96 162.98 21.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -145.19 115.87 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.481 -0.762 . . . . 0.0 109.237 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 1.3 mttp -124.93 152.12 44.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.034 -1.041 . . . . 0.0 110.313 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.3 m -147.41 152.51 38.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -155.37 104.37 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 110.113 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 44' ' ' LYS . 2.1 pt-20 -105.15 152.31 22.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CB ' HG22 ' A' ' 73' ' ' ILE . 13.5 t80 -128.27 148.74 50.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.644 -1.285 . . . . 0.0 112.673 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.489 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 21.9 mt-30 -134.41 109.9 9.07 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -116.0 71.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.973 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.62 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -72.98 108.44 5.89 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.684 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 61' ' ' TYR . 33.6 m -159.86 -159.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.593 -0.692 . . . . 0.0 109.371 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 3.6 t80 -135.69 142.07 45.04 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.527 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -137.08 -118.99 0.15 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -99.42 -28.97 13.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.018 -1.051 . . . . 0.0 109.222 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -148.99 18.28 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.736 0.779 . . . . 0.0 109.143 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.64 ' NZ ' HD13 ' A' ' 15' ' ' LEU . 7.0 ttmt -109.18 79.15 1.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.511 0.672 . . . . 0.0 110.104 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.7 mp -85.89 57.59 4.56 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 109.263 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.52 -124.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 7.6 ttm180 -127.19 144.42 51.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.199 -1.563 . . . . 0.0 113.486 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -112.39 111.59 22.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -99.04 170.06 8.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.774 -1.204 . . . . 0.0 110.369 -177.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.85 HD12 ' O ' ' A' ' 84' ' ' LEU . 3.1 tp -151.62 113.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.768 0.794 . . . . 0.0 109.237 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 21.9 t -97.85 151.45 20.21 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.08 . . . . 0.0 109.5 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.8 110.08 4.4 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.387 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.417 -0.802 . . . . 0.0 111.218 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 74' ' ' SER . 11.8 tttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.85 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.7 tp -171.18 -170.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.969 -1.082 . . . . 0.0 110.037 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -171.21 -179.96 2.83 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.229 -0.92 . . . . 0.0 110.695 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 5.8 ptm85 -170.25 112.8 0.45 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.125 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.72 ' HE2' HG21 ' A' ' 26' ' ' ILE . 6.8 m-85 -90.85 86.66 6.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.525 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.619 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -160.78 -171.34 3.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.818 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . 91.9 59.65 1.31 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 37.1 Cg_endo -59.43 125.16 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.502 1.791 . . . . 0.0 112.116 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 2.6 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.211 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.214 0.53 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 29.6 p90 -154.22 146.85 24.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 48.4 mt-10 -157.6 -174.54 4.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' CG1' HD13 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -121.85 171.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 110.035 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.941 HG13 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -81.1 -164.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.329 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.1 t0 -147.43 46.7 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.439 -0.788 . . . . 0.0 110.658 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.9 tt 39.88 40.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.657 0.741 . . . . 0.0 109.84 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -146.54 -61.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.628 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.4 Cg_endo -83.87 -77.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.574 1.302 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.737 ' CG ' HG22 ' A' ' 6' ' ' ILE . 86.1 m-85 -39.89 -35.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 110.284 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 1.06 HG22 HD12 ' A' ' 38' ' ' ILE . 9.7 p -61.61 -59.95 4.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.537 ' N ' ' OG1' ' A' ' 12' ' ' THR . 35.5 tt0 -66.73 -15.27 63.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.52 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 43.8 m-20 -78.4 -57.72 3.63 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.548 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -42.31 -50.73 4.98 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 1.021 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.64 -56.34 16.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -67.4 -77.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -1.081 . . . . 0.0 110.696 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 14' ' ' ASN . 16.8 m-30 -33.69 -63.99 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.569 0.699 . . . . 0.0 111.355 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 33' ' ' THR . . . -42.2 -71.89 0.07 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 12.5 t -39.86 -27.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 1.6 t70 -92.3 -71.0 0.67 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 2.8 pt-20 -54.35 -29.01 46.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.38 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -72.53 -60.18 2.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -59.3 -39.14 82.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.306 -1.358 . . . . 0.0 107.916 178.132 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -60.46 -48.94 79.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.37 -32.74 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.417 -0.802 . . . . 0.0 110.606 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.41 42.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.493 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.376 -1.073 . . . . 0.0 108.889 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.873 0.844 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.755 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -163.44 42.79 0.11 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.552 0.692 . . . . 0.0 109.789 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 31.0 p90 -174.42 99.23 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.687 -0.633 . . . . 0.0 109.895 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.8 t-20 -141.58 -52.42 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.903 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -70.51 -98.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.0 111.494 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 38' ' ' ILE . 1.1 t -161.83 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.798 -1.189 . . . . 0.0 111.051 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.06 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -140.59 123.96 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.565 0.698 . . . . 0.0 109.709 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.558 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 mtt180 -140.7 -56.59 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.6 Cg_endo -83.52 42.48 1.25 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.17 1.089 . . . . 0.0 111.712 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 38' ' ' ILE . 20.5 p -103.22 129.62 50.21 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 109.333 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -121.74 163.22 19.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.0 111.035 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -117.89 155.19 30.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.752 . . . . 0.0 109.958 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 27.0 mttt -159.79 118.64 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.947 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.8 m -119.72 148.83 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.634 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.947 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 0.8 OUTLIER -162.44 107.68 1.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.682 -0.893 . . . . 0.0 109.936 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.1 pp20? -126.87 177.26 6.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.817 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -161.96 171.89 16.89 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.216 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.501 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 26.8 mt-30 -130.28 125.29 34.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -121.49 75.11 1.16 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.842 -1.161 . . . . 0.0 109.738 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . 2.1 t80 -74.11 111.04 8.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.141 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.627 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 17.7 m -159.0 -154.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.784 0.802 . . . . 0.0 109.068 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 1.061 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.8 t80 -139.68 134.81 32.48 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.299 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -130.16 -126.65 0.21 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.361 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -103.14 -34.12 8.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.082 -1.011 . . . . 0.0 110.113 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 8.1 p-10 -132.65 0.83 3.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -114.38 104.09 11.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.845 . . . . 0.0 109.622 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.061 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 10.2 mt -100.58 66.61 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.461 -0.774 . . . . 0.0 109.852 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 167.68 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 31.4 ttm180 -121.26 148.09 44.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.127 -1.608 . . . . 0.0 112.909 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.756 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -113.93 107.52 15.81 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 13.8 t70 -88.57 165.92 14.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.957 -1.089 . . . . 0.0 110.639 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.817 HG22 ' CD1' ' A' ' 58' ' ' TYR . 3.2 tp -165.29 112.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.639 0.733 . . . . 0.0 109.301 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.5 p -108.76 162.44 14.17 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.652 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -170.12 117.72 0.56 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.781 . . . . 0.0 109.792 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.443 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.217 0.532 . . . . 0.0 110.222 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 5.0 tp -170.47 123.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -125.16 167.85 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.211 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 60.1 mtm180 -157.88 119.26 3.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.964 -1.085 . . . . 0.0 111.993 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 12.8 m-85 -107.43 71.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.71 -161.81 1.33 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.384 -1.326 . . . . 0.0 111.406 -179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.44 52.0 6.32 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 105.345 -3.102 . . . . 0.0 105.345 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.03 158.21 35.37 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.807 1.951 . . . . 0.0 112.08 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.282 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 45' ' ' THR . 4.7 pm0 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.549 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 26.4 p-90 -143.02 149.57 38.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 34.8 mt-10 -152.77 136.73 16.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 110.656 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -79.28 -174.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 110.664 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -114.2 -167.96 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.341 -0.849 . . . . 0.0 110.297 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 8' ' ' ILE . 33.9 t70 -137.12 49.27 2.04 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 111.16 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.715 ' C ' HG21 ' A' ' 12' ' ' THR . 17.8 tt 38.74 33.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.615 0.722 . . . . 0.0 109.911 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -138.11 -59.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.686 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 44.1 Cg_endo -84.88 -56.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.511 1.269 . . . . 0.0 111.57 -177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 9.2 m-85 -61.78 -27.21 68.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.959 -1.088 . . . . 0.0 109.695 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.982 HG22 HD12 ' A' ' 38' ' ' ILE . 10.8 p -65.44 -59.85 3.57 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.206 -0.934 . . . . 0.0 108.789 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 44.6 tt0 -59.67 -20.38 55.8 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.763 0.792 . . . . 0.0 109.175 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 3.5 m-20 -71.26 -56.22 6.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.748 0.785 . . . . 0.0 109.248 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.023 HD12 HD21 ' A' ' 60' ' ' LEU . 5.7 tt -43.1 -64.25 0.67 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 15' ' ' LEU . . . -41.11 -44.67 3.75 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.82 -79.78 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -1.167 . . . . 0.0 110.643 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -36.99 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.423 0.63 . . . . 0.0 111.086 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -77.4 -74.69 0.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 14.1 t -36.74 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.618 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' ALA . 34.9 t70 -93.05 -79.28 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.5 mt-10 -49.36 -25.8 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.805 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 33' ' ' THR . 11.6 tt0 -77.52 -63.18 1.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 72.6 m-20 -49.53 -48.43 48.3 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -55.01 -51.55 65.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.824 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -49.95 -25.13 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.442 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.85 21.7 5.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.508 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.428 -1.042 . . . . 0.0 109.657 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.54 0.686 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -161.24 54.02 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.619 -0.675 . . . . 0.0 109.577 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 2.6 p90 -161.53 32.56 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -18.04 20.83 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.802 -1.186 . . . . 0.0 109.09 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.759 ' HB3' ' CA ' ' A' ' 64' ' ' ALA 0.357 0.0 OUTLIER -66.55 -141.24 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 -178.124 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.638 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -161.12 -176.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 113.877 -1.511 . . . . 0.0 106.963 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.982 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -151.61 121.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.379 -1.451 . . . . 0.0 110.96 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.602 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -125.78 -57.16 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 110.126 179.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.8 Cg_endo -85.31 47.81 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.203 1.107 . . . . 0.0 110.89 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.749 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -85.38 129.77 34.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.867 . . . . 0.0 109.525 178.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 41.3 mtm -133.31 161.95 33.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.882 -1.136 . . . . 0.0 110.785 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 10.4 ttpt -129.12 156.31 44.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' CG ' ' HB3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -159.17 113.67 2.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.112 -0.993 . . . . 0.0 110.571 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.3 m -122.13 154.27 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -120.77 100.4 7.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.403 -1.057 . . . . 0.0 110.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 50.9 tt0 -123.05 173.83 7.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.352 -0.843 . . . . 0.0 109.225 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.36 173.37 14.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.081 -1.447 . . . . 0.0 113.179 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 2.6 pt20 -128.7 124.27 35.23 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.023 HD21 HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.11 72.58 0.87 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 108.593 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.625 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -71.56 106.42 4.0 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.567 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.713 HG23 ' HE2' ' A' ' 67' ' ' LYS . 17.8 m -163.52 -144.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.767 ' CD1' HD22 ' A' ' 68' ' ' LEU . 22.7 t80 -135.03 161.57 34.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -136.56 -140.31 0.16 Allowed 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.946 0.794 . . . . 0.0 108.924 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 24.3 t -86.91 -1.62 57.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.66 33.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.592 -0.693 . . . . 0.0 109.72 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.807 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -129.98 93.87 3.59 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.836 . . . . 0.0 109.701 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.767 HD22 ' CD1' ' A' ' 63' ' ' TYR . 1.4 mm? -88.46 74.8 8.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 171.52 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.571 -1.33 . . . . 0.0 110.59 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 59' ' ' GLN . 34.2 ttm180 -139.12 147.69 42.25 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.56 -1.338 . . . . 0.0 112.598 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -107.57 103.07 12.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 176.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -83.99 161.34 20.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 110.197 -178.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.693 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -163.01 108.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 121.939 0.875 . . . . 0.0 109.9 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.3 t -107.26 156.35 18.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 108.633 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 74' ' ' SER . 29.9 mt-10 -155.07 104.57 2.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.569 -1.332 . . . . 0.0 112.13 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 75' ' ' GLU . 1.6 p30 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.488 -0.758 . . . . 0.0 111.091 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -171.09 146.58 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.031 . . . . 0.0 110.304 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -137.62 158.34 44.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.9 . . . . 0.0 109.59 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -142.8 147.71 35.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.947 -1.096 . . . . 0.0 111.009 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.94 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 8.9 m-85 -119.55 85.56 2.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 109.348 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -168.94 -167.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.635 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 85.96 56.41 2.33 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.0 Cg_endo -61.87 151.37 81.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.508 1.794 . . . . 0.0 111.689 -176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.625 HG12 ' OH ' ' A' ' 61' ' ' TYR . 22.5 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 67.4 mm-40 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.2 p-90 -137.2 161.0 37.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.536 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 1.6 pm0 -172.47 173.03 4.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.724 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.7 173.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.737 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.17 -153.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.532 -0.73 . . . . 0.0 109.717 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -141.04 48.06 1.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.865 -1.147 . . . . 0.0 111.439 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.8 ' C ' HG21 ' A' ' 12' ' ' THR . 15.6 pt 40.17 36.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.932 0.873 . . . . 0.0 109.883 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.51 -59.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.954 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.8 Cg_endo -85.73 -66.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.596 1.314 . . . . 0.0 110.947 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.705 ' CE2' ' CE1' ' A' ' 58' ' ' TYR . 1.1 m-85 -47.42 -32.36 4.96 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.137 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.8 HG21 ' C ' ' A' ' 8' ' ' ILE . 23.6 p -59.9 -57.42 12.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.504 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.21 -26.13 68.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.549 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.532 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -76.83 -49.9 14.71 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.481 0.658 . . . . 0.0 109.832 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.772 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.4 tm? -42.94 -63.7 0.75 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.392 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.739 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -49.05 -41.84 30.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.583 ' O ' HG12 ' A' ' 20' ' ' VAL . 11.1 tptp -68.99 -68.52 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -1.16 . . . . 0.0 110.593 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CE2' ' OD1' ' A' ' 14' ' ' ASN . 18.0 m-30 -54.9 -36.11 64.84 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -58.68 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.815 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 17' ' ' LYS . 9.6 p -38.41 -27.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -87.17 -75.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.866 -1.146 . . . . 0.0 110.107 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.053 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.4 mm-40 -59.47 -36.98 77.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 26' ' ' ILE . 4.0 tt0 -62.62 -49.45 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.038 -1.039 . . . . 0.0 109.251 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 33.9 t-20 -70.63 -45.33 65.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 30.6 mmtt -58.61 -38.68 78.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 110.052 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.3 tp -71.68 -15.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.0 110.08 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.53 54.63 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 46.2 tp60 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.36 -1.082 . . . . 0.0 109.661 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.329 0.585 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -146.15 53.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.607 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 22.4 p90 178.98 114.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.82 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.4 t30 -150.28 -48.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.0 110.834 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 111.197 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 36' ' ' LYS . 17.0 t -158.31 172.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.633 -1.292 . . . . 0.0 111.361 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.016 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -133.26 99.94 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.757 . . . . 0.0 110.012 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.81 -54.18 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 110.492 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.1 Cg_endo -85.06 50.28 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.491 1.258 . . . . 0.0 111.362 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . 16.5 p -81.35 137.27 35.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' GLN . 6.2 mtp -130.95 169.29 16.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 110.959 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -151.92 138.65 18.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 109.946 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 45' ' ' THR . 8.3 ttmm -137.93 163.47 31.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.679 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 55' ' ' GLY . 5.1 m -163.25 148.67 11.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.075 -1.016 . . . . 0.0 110.879 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.512 ' CG1' ' HA3' ' A' ' 55' ' ' GLY . 25.3 pt . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.42 97.77 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.498 ' OE1' ' HA ' ' A' ' 45' ' ' THR . 4.3 pm0 -92.86 165.52 12.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.064 -1.022 . . . . 0.0 109.513 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.966 ' OH ' HD13 ' A' ' 60' ' ' LEU . 72.4 t80 -137.09 136.81 38.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.164 -0.96 . . . . 0.0 111.283 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.547 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 32.6 mt-30 -135.15 106.82 6.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.016 HD11 ' CD1' ' A' ' 38' ' ' ILE . 2.9 tp -119.41 80.16 1.53 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.01 -1.056 . . . . 0.0 110.076 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -74.4 110.37 8.64 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.747 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.3 m -160.33 -158.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.596 0.712 . . . . 0.0 109.656 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CE2' ' HD2' ' A' ' 36' ' ' LYS . 2.4 t80 -140.82 133.99 29.5 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.67 -0.644 . . . . 0.0 109.474 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -130.16 -124.4 0.21 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.738 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 t -97.73 -17.94 19.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.195 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.41 20.78 0.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.792 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.747 ' CD ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -118.61 81.03 1.62 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -0.791 . . . . 0.0 110.188 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -84.94 57.6 4.52 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.575 -0.703 . . . . 0.0 109.855 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.89 -117.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 110.368 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 21.5 ttp180 -122.96 148.26 45.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.158 -1.589 . . . . 0.0 113.122 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' A' ' 58' ' ' TYR . . . -109.94 105.35 14.48 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 66.2 m-20 -85.2 163.69 18.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.804 -1.185 . . . . 0.0 110.718 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.676 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -160.12 103.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -93.71 157.48 16.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.824 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.46 96.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.867 -1.146 . . . . 0.0 111.465 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 111.034 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.37 -167.74 0.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.095 -1.003 . . . . 0.0 109.979 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.053 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -171.25 171.74 5.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.211 -0.93 . . . . 0.0 109.757 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.542 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 30.3 mtt180 -144.77 175.41 10.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.002 -1.062 . . . . 0.0 110.986 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.806 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -151.63 69.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.519 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -155.06 -156.1 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.282 . . . . 0.0 111.105 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 87.68 52.79 2.89 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 106.711 -2.556 . . . . 0.0 106.711 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 39.6 Cg_endo -63.9 140.84 75.2 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.236 1.651 . . . . 0.0 111.276 -177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.343 -179.857 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.213 0.53 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 3' ' ' TRP . 5.9 p90 -124.18 170.4 10.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 110.318 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 176.66 111.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.105 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -92.32 178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.379 -0.825 . . . . 0.0 110.594 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.765 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.86 -166.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.65 41.46 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.15 . . . . 0.0 111.155 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 39' ' ' ARG . 4.1 mt 57.18 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.02 0.914 . . . . 0.0 110.291 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' C ' ' HG1' ' A' ' 12' ' ' THR . . . -153.5 -63.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HG2' HG22 ' A' ' 6' ' ' ILE . 44.0 Cg_endo -75.87 -76.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.59 1.31 . . . . 0.0 111.631 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -48.91 -26.65 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.023 -1.048 . . . . 0.0 110.46 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.82 HG22 HG21 ' A' ' 38' ' ' ILE . 26.9 p -57.6 -57.77 11.26 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.943 -1.098 . . . . 0.0 108.26 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.1 mm-40 -63.2 -24.8 68.04 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.77 0.795 . . . . 0.0 109.206 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' LEU . 4.6 t30 -72.14 -56.3 5.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.487 0.66 . . . . 0.0 109.37 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.2 tm? -42.66 -71.72 0.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.66 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.672 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -40.73 -37.82 1.4 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.826 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.7 mttp -76.78 -83.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -1.093 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -45.43 -28.33 0.87 Allowed 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.587 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -63.55 -72.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 17' ' ' LYS . 10.4 p -41.72 -25.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.52 -70.8 0.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 110.112 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.068 ' CB ' HD13 ' A' ' 85' ' ' LEU . 4.5 mm-40 -59.9 -38.5 82.46 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.718 -1.239 . . . . 0.0 109.324 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.855 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -63.58 -51.84 63.56 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.235 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 27.8 t-20 -67.15 -44.52 79.59 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.163 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -43.11 92.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.42 -0.8 . . . . 0.0 110.092 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -66.6 -21.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.6 36.02 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 3.3 mm100 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.324 0.583 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -154.24 49.05 0.62 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.776 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 3.4 t80 179.8 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.547 -0.721 . . . . 0.0 110.228 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -154.22 -48.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 110.579 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.3 mmpt? -69.61 -100.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.7 t -157.89 171.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.605 -1.309 . . . . 0.0 111.669 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.82 HG21 HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -135.41 92.93 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.682 -0.636 . . . . 0.0 109.829 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.77 ' HG2' HD11 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -105.1 -53.26 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.635 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.5 Cg_endo -84.7 50.78 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.538 1.283 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 38' ' ' ILE . 20.6 p -104.12 118.32 36.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.598 ' HB3' HG22 ' A' ' 5' ' ' ILE . 66.4 mtm -126.66 175.6 7.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 58' ' ' TYR . 10.9 tmtt? -152.71 140.68 20.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.038 -1.039 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 13.6 mttt -137.93 121.99 17.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 0.0 109.778 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 55' ' ' GLY . 6.5 m -108.42 154.12 22.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.896 . . . . 0.0 110.746 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.0 tt . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 45' ' ' THR . 18.4 m-85 -133.25 119.36 19.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.987 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' OE2' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -124.31 163.75 21.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 0.0 109.623 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.785 ' HE2' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -157.54 165.89 34.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.448 -1.301 . . . . 0.0 112.681 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 5.5 pt20 -124.47 120.41 31.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.785 HD13 ' HE2' ' A' ' 58' ' ' TYR . 2.9 tp -114.43 67.77 0.69 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.7 t80 -68.79 108.65 3.51 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' CD ' ' A' ' 67' ' ' LYS . 27.4 m -159.56 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.596 0.712 . . . . 0.0 109.585 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 1.9 t80 -148.46 130.94 15.75 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.951 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -126.83 -123.74 0.24 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.829 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.0 p -91.53 -32.84 15.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.056 . . . . 0.0 109.551 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.36 14.26 1.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.674 ' CD ' HG23 ' A' ' 62' ' ' VAL . 4.7 ttmt -107.98 78.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.756 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -89.94 68.53 7.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.624 -0.673 . . . . 0.0 109.287 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 173.31 -119.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.28 -0.887 . . . . 0.0 109.863 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 16.4 ttm180 -135.32 124.93 25.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.571 -1.33 . . . . 0.0 111.702 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.44 104.27 12.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.6 t70 -89.39 157.1 18.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 110.167 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.739 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.09 117.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 57' ' ' GLU . 2.1 t -116.66 144.98 43.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.011 -1.056 . . . . 0.0 111.085 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -129.43 159.85 34.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.068 -1.02 . . . . 0.0 111.732 -178.672 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.36 0.6 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 tp -171.32 128.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.197 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.068 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -130.31 171.96 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.981 -1.075 . . . . 0.0 111.099 -179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.552 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -146.45 -179.0 6.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.851 . . . . 0.0 110.564 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 5.2 m-85 -153.44 67.6 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.528 -0.732 . . . . 0.0 109.199 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.596 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.06 -158.7 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.72 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.622 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.06 48.9 44.33 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 44.5 Cg_endo -69.03 -173.79 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.446 1.761 . . . . 0.0 111.823 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.585 HG12 ' OH ' ' A' ' 61' ' ' TYR . 27.4 m . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.311 0.577 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -119.35 -176.5 3.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.476 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER 176.33 112.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 110.105 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.739 HG22 ' SD ' ' A' ' 42' ' ' MET . 1.2 pp -85.68 -179.06 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 110.638 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.103 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -135.24 -161.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.989 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.17 -157.11 0.79 Allowed 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.988 -1.07 . . . . 0.0 109.505 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.864 ' C ' HG21 ' A' ' 12' ' ' THR . 0.9 OUTLIER -101.08 36.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.18 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -128.4 -57.42 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.906 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.6 Cg_endo -82.51 -77.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.369 1.194 . . . . 0.0 111.253 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.0 m-85 -43.63 -29.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.937 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.939 HG22 HD12 ' A' ' 38' ' ' ILE . 24.3 p -62.15 -58.91 6.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -62.47 -15.54 50.42 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.259 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.2 t30 -83.14 -59.13 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.624 0.726 . . . . 0.0 110.052 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 60' ' ' LEU . 1.3 pp -42.57 -31.54 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.649 -0.657 . . . . 0.0 109.704 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.96 -56.64 5.7 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -69.63 -67.15 0.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -1.142 . . . . 0.0 110.525 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.88 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -39.05 -49.27 1.73 Allowed 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.468 0.651 . . . . 0.0 110.424 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.632 ' N ' ' CD1' ' A' ' 18' ' ' PHE . . . -53.74 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.834 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' CG ' ' A' ' 24' ' ' ASN . 2.7 t -37.86 -26.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.46 -0.775 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.7 m-20 -89.76 -73.51 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.616 -1.303 . . . . 0.0 110.039 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.112 ' HB2' HD13 ' A' ' 85' ' ' LEU . 1.8 mt-10 -59.13 -32.91 70.29 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.255 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.848 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -63.69 -56.65 14.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 108.339 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 2.3 m120 -62.57 -47.11 85.29 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.757 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.92 -41.19 74.19 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.404 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.9 tp -72.62 -10.91 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.835 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.47 51.31 1.33 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 11.2 tp60 . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.487 -1.008 . . . . 0.0 109.346 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.29 0.567 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -41.86 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 110.68 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 32' ' ' LEU . 1.6 t80 164.12 115.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 109.203 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -165.34 -59.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.394 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.738 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.8 tppp? -69.54 -103.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.982 -1.074 . . . . 0.0 111.139 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 36' ' ' LYS . 15.8 t -158.59 172.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.213 . . . . 0.0 111.524 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.972 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -123.8 117.49 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.521 0.677 . . . . 0.0 109.797 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -124.3 -56.27 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.6 Cg_endo -86.61 48.14 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.174 1.091 . . . . 0.0 110.537 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.675 ' C ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -89.18 117.87 28.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 109.675 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.739 ' SD ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -127.57 179.6 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 110.641 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -158.11 134.77 9.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 109.773 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 2.4 tttt -141.34 122.81 15.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 55' ' ' GLY . 17.9 m -101.65 150.47 23.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.9 . . . . 0.0 109.68 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.738 HG22 ' OE2' ' A' ' 57' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.842 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.579 ' HA ' HG23 ' A' ' 45' ' ' THR . 0.3 OUTLIER -123.32 108.3 12.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.545 -0.973 . . . . 0.0 110.028 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.738 ' OE2' HG22 ' A' ' 46' ' ' ILE . 3.0 mp0 -114.73 163.62 15.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.842 . . . . 0.0 108.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -150.8 163.48 38.51 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.916 -179.408 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 95.8 mt-30 -128.11 121.84 30.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -116.33 69.57 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.355 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 1.031 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.88 109.37 4.99 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.505 -0.747 . . . . 0.0 109.27 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG23 ' CE ' ' A' ' 67' ' ' LYS . 18.3 m -161.51 -163.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.5 t80 -135.19 138.01 43.23 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.887 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 67' ' ' LYS . . . -135.21 -136.22 0.16 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.421 -0.799 . . . . 0.0 110.102 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.535 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -82.82 -37.61 24.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.801 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -138.15 7.42 2.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.689 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -105.44 94.82 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.837 0.827 . . . . 0.0 109.737 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -101.31 64.53 1.02 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.364 -0.835 . . . . 0.0 108.775 178.48 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 173.08 -123.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.305 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 36.8 ttp180 -130.44 122.71 28.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.526 -1.359 . . . . 0.0 111.944 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -83.01 106.31 14.72 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 22.6 t70 -88.89 170.96 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.762 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -169.94 119.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.565 -0.709 . . . . 0.0 110.17 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.508 ' OG ' ' CG ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -110.89 156.71 20.78 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.016 -1.052 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.5 111.81 4.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.489 -1.382 . . . . 0.0 112.138 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.216 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' SER . 13.7 mtmm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 1.5 tt -171.9 130.81 0.65 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 0.0 109.829 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.112 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -117.1 168.28 10.42 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.0 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 10.8 mtt180 -137.04 -172.07 3.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.488 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 60.1 m-85 -158.32 64.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -154.31 -160.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.728 -1.233 . . . . 0.0 111.71 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.19 50.88 30.7 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -177.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.7 Cg_endo -67.95 -173.86 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 124.564 1.823 . . . . 0.0 111.851 -176.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.031 HG12 ' OH ' ' A' ' 61' ' ' TYR . 25.0 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.38 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.154 0.502 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 2.9 p-90 -131.97 170.84 14.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.8 tp10 178.67 160.47 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.731 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.603 HD12 ' SD ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -117.67 173.3 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.039 -1.038 . . . . 0.0 110.444 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.082 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -103.84 -160.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.503 -0.748 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.659 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.9 p30 -132.0 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.977 -1.077 . . . . 0.0 111.644 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.754 ' C ' HG21 ' A' ' 12' ' ' THR . 14.9 tt 41.14 46.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.974 0.892 . . . . 0.0 109.909 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.524 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.66 -62.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD2' HD13 ' A' ' 6' ' ' ILE . 44.1 Cg_endo -84.01 -68.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.733 1.386 . . . . 0.0 111.062 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.082 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -44.58 -29.52 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.4 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.754 HG21 ' C ' ' A' ' 8' ' ' ILE . 17.5 p -64.43 -58.77 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.508 ' N ' ' OG1' ' A' ' 12' ' ' THR . 3.8 tt0 -65.74 -26.72 67.86 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.844 0.831 . . . . 0.0 109.052 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -74.12 -55.16 6.42 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.584 0.707 . . . . 0.0 109.495 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.045 HD11 ' HE3' ' A' ' 67' ' ' LYS . 2.7 tt -37.99 -53.9 1.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.394 0.616 . . . . 0.0 109.924 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.874 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -56.04 -46.59 84.4 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 tttp -73.15 -72.46 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -1.185 . . . . 0.0 111.016 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -39.88 -48.08 2.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.593 0.711 . . . . 0.0 110.868 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 33' ' ' THR . . . -55.34 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.712 -0.618 . . . . 0.0 110.604 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 17' ' ' LYS . 15.0 m -43.89 -23.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 120.952 -1.092 . . . . 0.0 110.546 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -88.73 -73.78 0.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.072 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.04 ' HB2' HD13 ' A' ' 85' ' ' LEU . 20.6 mm-40 -57.69 -37.53 73.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.693 -1.255 . . . . 0.0 109.232 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -64.71 -50.06 68.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.974 -1.078 . . . . 0.0 109.155 178.514 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 55.1 t-20 -66.02 -46.53 77.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.573 -1.329 . . . . 0.0 107.739 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 4.2 tttp -59.4 -41.54 89.69 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.032 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -73.77 -12.93 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.05 81.44 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.532 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.426 ' C ' ' OG1' ' A' ' 33' ' ' THR . 16.6 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.553 0.692 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' OE2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -164.13 51.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.781 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -176.19 123.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.363 -0.836 . . . . 0.0 109.833 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -158.67 -58.86 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.042 -1.036 . . . . 0.0 111.318 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.772 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.61 -97.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.957 -1.09 . . . . 0.0 111.38 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.7 t -160.48 173.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.521 -1.362 . . . . 0.0 111.617 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.825 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -126.79 109.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.795 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -117.24 -59.4 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.999 . . . . 0.0 110.926 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.6 Cg_endo -83.98 46.84 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.117 1.062 . . . . 0.0 111.119 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' CB ' HD11 ' A' ' 38' ' ' ILE . 18.6 p -88.97 98.0 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.509 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.603 ' SD ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -97.52 -177.58 3.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 0.0 111.013 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -161.86 155.78 21.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.708 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.1 OUTLIER -170.68 126.96 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 110.817 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 55' ' ' GLY . 19.2 m -112.58 152.11 29.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.1 mt . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.916 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.494 2.521 0 CA-C-O 121.845 0.691 . . . . 0.0 111.992 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.57 ' CG ' ' OG1' ' A' ' 45' ' ' THR . 2.0 t80 -126.91 102.06 6.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.146 -0.62 . . . . 0.0 109.808 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.5 pt-20 -104.08 152.23 22.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 109.558 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -141.94 154.93 45.43 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.14 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 6.1 pt20 -126.05 125.24 42.28 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 15' ' ' LEU . 1.2 tp -121.44 69.54 0.92 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.919 -1.113 . . . . 0.0 109.179 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' C ' HG13 ' A' ' 62' ' ' VAL . 23.0 t80 -69.21 110.52 4.62 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' CD ' ' A' ' 67' ' ' LYS . 31.2 m -159.5 -161.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -142.56 126.62 17.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -119.95 -131.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.632 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 85.1 p -85.69 -25.29 26.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.007 -1.058 . . . . 0.0 109.175 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.59 17.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 1.045 ' HE3' HD11 ' A' ' 15' ' ' LEU . 1.1 ttmm -110.7 74.5 0.88 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.053 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mt -85.73 66.48 9.66 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 175.31 -119.92 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.455 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 19.6 ttp85 -137.73 125.65 22.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.55 -1.344 . . . . 0.0 111.918 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.69 110.71 17.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.5 t70 -92.03 165.58 13.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 111.032 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.736 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.78 118.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.28 142.06 51.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.861 -1.15 . . . . 0.0 110.771 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 74' ' ' SER . 21.7 mt-10 -152.99 132.29 12.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.315 -0.866 . . . . 0.0 109.824 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' C ' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 0.0 110.723 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -172.2 155.8 3.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.971 -1.081 . . . . 0.0 109.602 -179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -142.72 166.24 25.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 11.1 mmt180 -135.32 -174.08 3.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 111.168 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 20.6 m-85 -157.69 61.08 0.48 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -152.27 -157.0 0.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 111.765 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.62 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 68.91 49.3 42.71 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -68.69 -169.26 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 124.436 1.756 . . . . 0.0 112.009 -176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.429 HG12 ' OH ' ' A' ' 61' ' ' TYR . 19.0 m . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.285 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.186 0.517 . . . . 2.7200000000000002 110.279 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.1 p90 -125.19 156.51 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 3.5299999999999998 110.214 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 5.6 pt-20 -166.36 129.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 2.4300000000000002 110.183 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.877 HG22 ' HG2' ' A' ' 42' ' ' MET . 10.8 pt -75.45 176.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.18 -0.95 . . . . 1.3100000000000001 110.42 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.07 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -111.15 -162.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 2.4100000000000001 109.891 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -137.48 49.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.853 -1.154 . . . . 2.1600000000000001 111.597 -179.173 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 7' ' ' ASP . 10.6 tt 40.08 43.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.826 0.822 . . . . 1.6899999999999999 110.038 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.434 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.04 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.061 -1.066 . . . . 0.85999999999999999 110.933 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.7 Cg_endo -86.35 -59.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.558 1.294 . . . . 0.90000000000000002 111.131 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 1.07 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.3 m-30 -52.28 -32.7 38.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.957 -1.09 . . . . 1.46 109.318 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.726 HG22 ' CG2' ' A' ' 38' ' ' ILE . 8.5 p -59.19 -57.91 10.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.113 -1.439 . . . . 0.65000000000000002 107.113 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.532 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -66.8 -18.47 65.39 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.672 0.749 . . . . 2.1899999999999999 109.141 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 13.6 t-20 -78.02 -63.73 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 1.71 109.833 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.825 HD22 HD21 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -40.22 -63.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.328 0.585 . . . . 2.02 109.573 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -46.16 -46.18 15.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.246 -1.542 . . . . 0.52000000000000002 109.246 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -70.78 -84.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 2.6499999999999999 110.538 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' ALA . 2.5 m-85 -38.71 -64.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.401 0.619 . . . . 2.5899999999999999 111.045 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -43.37 -70.61 0.1 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.602 -0.686 . . . . 0.54000000000000004 109.919 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 42.4 t -40.89 -27.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.353 -0.842 . . . . 1.3400000000000001 110.46 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -92.6 -66.27 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 1.72 110.336 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.022 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.4 mt-10 -60.82 -31.66 71.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.045 -1.062 . . . . 1.95 109.874 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -73.69 -60.19 2.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.891 -1.151 . . . . 1.6100000000000001 107.891 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.5 t-20 -52.02 -48.57 64.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.228 -1.397 . . . . 2.1899999999999999 107.228 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 42.5 tttt -56.85 -47.26 80.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.954 -1.128 . . . . 2.6800000000000002 107.954 177.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.565 HG13 ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -50.48 -24.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.56 -0.904 . . . . 1.3200000000000001 108.56 178.609 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.67 24.99 2.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.384 -1.486 . . . . 0.87 109.384 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 34.6 tp60 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 2.1600000000000001 109.79 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 32' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.266 0.555 . . . . 2.25 109.961 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -146.9 50.12 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.266 -0.896 . . . . 0.68000000000000005 109.91 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 11.3 t80 174.96 79.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.73 . . . . 3.46 109.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -120.94 -44.36 2.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.5800000000000001 110.627 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -96.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 3.3599999999999999 110.955 -179.406 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 36' ' ' LYS . 28.1 t -157.57 171.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.621 -1.3 . . . . 0.70999999999999996 111.679 -179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.726 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.88 88.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.168 -0.678 . . . . 1.55 109.168 179.611 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -105.02 -53.55 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.979 -1.075 . . . . 2.98 110.979 -179.274 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.6 Cg_endo -84.02 50.92 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.395 1.208 . . . . 0.57999999999999996 110.941 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.846 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.0 p -103.52 120.82 41.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.399 -0.813 . . . . 1.5700000000000001 109.807 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.877 ' HG2' HG22 ' A' ' 5' ' ' ILE . 27.5 mtm -119.03 177.29 4.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 1.9099999999999999 110.649 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -140.62 154.28 46.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.229 -0.919 . . . . 1.47 110.41 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -151.75 100.63 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.144 -0.973 . . . . 2.46 110.354 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -97.88 148.88 22.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.60999999999999999 110.265 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.521 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.359 -0.978 . . . . 1.8400000000000001 108.359 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.897 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 110.611 -0.996 . . . . 0.63 110.611 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' GLU . 3.7 t80 -155.85 78.02 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.554 -0.968 . . . . 2.9900000000000002 110.231 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 14.9 pt-20 -99.35 167.39 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 2.4300000000000002 109.0 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.44 170.63 18.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.996 -1.481 . . . . 1.74 112.977 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -133.82 123.76 25.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.787 -1.19 . . . . 1.9099999999999999 107.787 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.846 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -121.07 74.78 1.11 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.034 -1.041 . . . . 0.66000000000000003 109.399 -179.06 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.947 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -69.25 112.28 5.73 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.198 -1.038 . . . . 1.51 108.198 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.667 HG23 ' CD ' ' A' ' 67' ' ' LYS . 33.2 m -158.19 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.779 0.799 . . . . 0.63 109.851 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.716 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.4 t80 -147.28 130.44 16.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.141 -0.688 . . . . 1.22 109.141 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -124.17 -126.07 0.25 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.388 -0.82 . . . . 0.59999999999999998 109.721 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 t -95.15 -24.71 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.912 -1.117 . . . . 1.3899999999999999 108.726 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.02 18.4 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.503 0.668 . . . . 1.52 109.446 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.863 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.3 ttmm -115.23 78.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 1.3700000000000001 110.229 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.716 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 9.0 mt -88.17 64.86 7.89 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.895 -0.78 . . . . 1.8 108.895 178.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 178.7 -123.83 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.047 -1.061 . . . . 1.8500000000000001 110.534 -179.085 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 25.3 ttm180 -131.02 123.63 29.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.328 -1.483 . . . . 1.6899999999999999 112.194 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.863 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -80.48 107.9 13.66 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.651 -1.611 . . . . 0.46999999999999997 106.651 176.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.8 t70 -89.64 162.2 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.002 -1.061 . . . . 1.71 110.404 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.713 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.2 110.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.73 0.776 . . . . 1.0900000000000001 109.294 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -110.71 122.47 47.89 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.247 -0.908 . . . . 1.25 109.955 -179.211 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.636 ' OE1' HD12 ' A' ' 73' ' ' ILE . 22.9 mt-10 -144.96 122.86 11.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 2.02 110.066 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.562 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 2.1400000000000001 110.104 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.976 -0.75 . . . . 3.2999999999999998 108.976 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 11.8 tp -170.59 173.95 5.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.145 . . . . 2.1899999999999999 110.423 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.022 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -154.01 171.64 18.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.97999999999999998 109.928 179.487 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.543 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 10.6 mtt180 -140.08 -177.9 5.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 2.71 110.989 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.763 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 23.7 m-85 -153.27 63.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.706 -0.621 . . . . 0.68000000000000005 109.398 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -153.3 -156.5 0.7 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.194 . . . . 1.8300000000000001 111.388 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.98 52.32 29.07 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 105.323 -3.111 . . . . 1.28 105.323 -177.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.6 Cg_endo -68.33 -178.02 1.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 124.598 1.841 . . . . 2.23 111.938 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.947 HG12 ' OH ' ' A' ' 61' ' ' TYR . 30.1 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.966 -1.016 . . . . 2.2200000000000002 110.45 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.56 178.18 8.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -1.129 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CB ' ' HE2' ' A' ' 44' ' ' LYS . 6.8 p90 -165.2 150.07 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 10.4 pt-20 -171.02 132.37 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' CG ' ' A' ' 42' ' ' MET . 21.5 pt -83.63 -177.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.266 -0.897 . . . . 0.0 110.486 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.768 HD11 ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -121.63 -154.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -138.77 50.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.837 -1.164 . . . . 0.0 111.53 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.623 ' C ' HG21 ' A' ' 12' ' ' THR . 19.2 tt 40.44 51.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.159 0.98 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -139.51 -65.43 0.04 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 46.2 Cg_endo -82.4 -58.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.83 1.437 . . . . 0.0 111.275 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 6' ' ' ILE . 2.6 m-30 -54.33 -22.07 11.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.834 -1.166 . . . . 0.0 109.687 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.893 HG22 ' CG1' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.12 -61.26 1.87 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.577 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -55.3 -25.09 32.11 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.676 0.751 . . . . 0.0 110.001 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -80.72 -44.1 19.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.797 0.808 . . . . 0.0 109.871 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.04 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -46.82 -47.21 21.1 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.479 0.656 . . . . 0.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 1.04 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -64.74 -51.13 54.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -67.73 -79.74 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.24 . . . . 0.0 110.592 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -33.84 -62.55 0.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.447 0.641 . . . . 0.0 111.1 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.39 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.411 -0.806 . . . . 0.0 109.917 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 26.2 t -41.62 -25.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.553 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' ALA . 2.6 t70 -87.66 -70.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.983 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.001 ' HB3' HD13 ' A' ' 85' ' ' LEU . 4.1 tt0 -61.88 -37.4 84.45 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.32 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 1.054 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -58.79 -53.22 60.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.938 -1.101 . . . . 0.0 108.778 177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 10.0 t-20 -68.68 -47.05 67.46 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.36 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -57.1 -35.84 69.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 110.322 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.054 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -68.63 -21.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.0 110.005 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.5 10.47 6.54 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 18.0 mm-40 -107.73 58.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 109.562 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 30' ' ' GLY . 33.1 p90 -82.61 12.75 4.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 31' ' ' ARG . . . -42.06 -66.86 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -145.57 -162.48 1.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.749 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.864 HD13 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.28 -177.78 1.19 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.186 -0.946 . . . . 0.0 109.74 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.572 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -136.94 52.12 1.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 109.943 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 13.9 p90 -169.7 123.11 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.881 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HB2' ' N ' ' A' ' 65' ' ' SER . 1.8 t-20 -155.14 -65.06 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -0.937 . . . . 0.0 110.71 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.82 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -69.14 -98.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.954 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.84 172.35 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.687 -1.258 . . . . 0.0 111.719 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.893 ' CG1' HG22 ' A' ' 12' ' ' THR . 0.3 OUTLIER -120.17 113.22 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -120.49 -59.92 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.92 -1.113 . . . . 0.0 110.707 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.1 Cg_endo -82.73 47.65 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.091 1.048 . . . . 0.0 111.081 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.563 ' HB3' HD13 ' A' ' 38' ' ' ILE . 27.8 p -84.18 122.18 28.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.751 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -123.23 164.15 19.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 111.25 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.23 137.46 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.864 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.527 ' HE2' ' CB ' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -145.58 134.2 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.069 -1.019 . . . . 0.0 110.291 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 55' ' ' GLY . 15.7 m -126.75 155.11 43.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.459 ' O ' ' CG1' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -116.27 56.1 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 49' ' ' ASN . 10.8 p90 -103.79 -179.3 3.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.686 0.755 . . . . 0.0 111.598 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -69.2 -100.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.648 -0.657 . . . . 0.0 110.089 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.596 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 8.4 t30 -178.89 -43.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.884 -1.135 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 50' ' ' GLU . 22.9 tt0 -154.98 17.47 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.809 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 -29.83 2.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.468 -0.77 . . . . 0.0 109.832 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.622 ' O ' HD13 ' A' ' 53' ' ' ILE . 8.3 pt-20 -170.63 178.33 3.64 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.456 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 52' ' ' GLU . 16.3 mm -125.45 126.71 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.527 -0.733 . . . . 0.0 109.412 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.46 -59.63 1.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.076 -1.015 . . . . 0.0 112.509 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.722 ' O ' HG23 ' A' ' 45' ' ' THR . . . -142.73 127.67 3.23 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.253 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.535 ' CE2' ' HE3' ' A' ' 43' ' ' LYS . 35.4 t80 -113.76 104.1 11.87 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.386 -1.067 . . . . 0.0 110.019 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.2 pt-20 -119.52 175.99 5.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.455 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.872 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -153.51 162.75 40.96 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.573 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.6 tt0 -126.22 120.98 31.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' LEU . 2.3 tp -118.66 71.5 0.85 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 109.566 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -70.16 110.97 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.803 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.1 m -159.74 -165.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.601 -0.687 . . . . 0.0 109.795 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.961 ' CE1' HD12 ' A' ' 68' ' ' LEU . 2.5 t80 -138.93 130.02 26.68 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.053 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -124.05 -131.4 0.26 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.632 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.542 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 79.8 p -81.73 -28.93 33.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.237 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.88 18.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.602 -0.686 . . . . 0.0 109.655 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.803 ' CD ' HG23 ' A' ' 62' ' ' VAL . 1.8 ttmm -105.18 73.63 1.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.961 HD12 ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.77 64.54 8.63 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 177.25 -127.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.517 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 14.0 ttm180 -132.46 127.02 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.49 -1.381 . . . . 0.0 111.987 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.668 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -83.79 102.75 12.54 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -86.55 172.83 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.497 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.872 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -168.51 131.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.877 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.511 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -122.25 159.73 26.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 2.3 mt-10 -152.59 108.51 3.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.829 -1.169 . . . . 0.0 111.785 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.523 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -42.62 168.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -158.19 -56.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.594 -1.316 . . . . 0.0 111.281 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 9.0 tptp -134.55 -37.16 0.85 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.934 -1.104 . . . . 0.0 109.342 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 1.042 HG22 ' HD2' ' A' ' 80' ' ' ARG . 17.6 m -75.25 -62.29 1.61 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 1.042 ' HD2' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 151.58 47.52 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.577 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -62.75 -137.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 8.2 ptm85 -172.43 172.56 4.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.403 -1.645 . . . . 0.0 111.082 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -99.09 127.7 45.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.3 tp -171.2 -169.44 0.74 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.954 -1.092 . . . . 0.0 109.791 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' HB3' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.69 166.16 8.04 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.3 mtt-85 -145.91 143.7 29.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.724 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.964 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.5 m-85 -115.22 73.81 0.85 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -159.71 -164.9 1.41 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.911 -1.118 . . . . 0.0 111.759 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.594 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 70.79 52.06 16.86 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.392 -3.483 . . . . 0.0 104.392 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.2 Cg_endo -64.46 -174.14 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.714 1.902 . . . . 0.0 112.742 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 1.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.105 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.56 173.79 10.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 110.209 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -161.77 149.0 14.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -177.18 159.23 1.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.45 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 3.1 pt -95.03 -175.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.621 HG21 ' CB ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.7 -165.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.217 -0.927 . . . . 0.0 110.468 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 8' ' ' ILE . 24.1 t70 -139.94 51.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.074 -1.016 . . . . 0.0 111.167 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 8' ' ' ILE . 4.6 tt 39.52 40.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.836 0.827 . . . . 0.0 110.098 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.505 ' N ' HG21 ' A' ' 12' ' ' THR . . . -147.25 -65.9 0.01 OUTLIER Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' THR . 44.7 Cg_endo -75.13 -85.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.61 1.321 . . . . 0.0 111.386 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.621 ' CB ' HG21 ' A' ' 6' ' ' ILE . 66.2 m-85 -39.05 -27.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.398 -0.814 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.822 HG22 ' CG2' ' A' ' 38' ' ' ILE . 18.6 p -60.47 -58.31 9.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.076 -1.015 . . . . 0.0 108.648 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.7 pt20 -59.15 -15.97 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.446 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -76.19 -60.04 2.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 110.065 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 pp -43.68 -34.81 1.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.409 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -62.51 -54.43 34.2 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -72.96 -66.45 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -1.022 . . . . 0.0 110.131 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 21' ' ' ASP . 2.0 m-30 -40.5 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.484 0.659 . . . . 0.0 110.44 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -39.92 -68.2 0.19 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.808 -0.558 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t -41.98 -26.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.104 -0.997 . . . . 0.0 110.024 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 18' ' ' PHE . 6.0 m-20 -95.3 -66.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.826 ' CG ' HD11 ' A' ' 73' ' ' ILE . 14.6 mm-40 -59.08 -26.83 64.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.825 -1.172 . . . . 0.0 109.23 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -76.79 -61.54 1.94 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 25.3 t-20 -54.22 -43.12 70.53 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.615 -1.234 . . . . 0.0 107.815 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 18.5 tptp -56.28 -59.21 5.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.211 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -55.32 -20.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.629 0.728 . . . . 0.0 109.622 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 60.72 2.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -119.35 -45.88 2.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -1.14 . . . . 0.0 109.892 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -140.34 -73.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.392 -0.818 . . . . 0.0 110.066 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.41 43.27 7.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -117.92 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -170.53 50.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -36.5 90.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.751 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' LEU . 7.7 t80 165.82 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 0.0 109.617 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -155.66 -64.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.94 -1.1 . . . . 0.0 111.382 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.52 -99.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 111.453 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 36' ' ' LYS . 13.9 t -159.22 172.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.536 -1.352 . . . . 0.0 111.727 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.822 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -127.79 99.08 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.626 . . . . 0.0 110.01 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.549 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -108.49 -54.76 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.488 -0.758 . . . . 0.0 110.159 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 41.7 Cg_endo -84.88 51.37 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.412 1.217 . . . . 0.0 111.306 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.9 t -104.42 106.37 16.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.536 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 10.2 mtt -96.96 157.08 16.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.056 -1.028 . . . . 0.0 110.158 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 2.6 tmtt? -137.11 154.71 50.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 110.978 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 13.3 tttt -160.33 158.9 30.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.627 -0.671 . . . . 0.0 109.603 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.4 m -159.48 151.05 20.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -118.48 62.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.483 ' CD1' ' OE2' ' A' ' 48' ' ' GLU . 12.3 p90 -68.1 -157.1 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.567 0.699 . . . . 0.0 111.215 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 52' ' ' GLU . 3.1 pm0 -66.88 -164.86 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.32 1.057 . . . . 0.0 111.884 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.455 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 16.0 t-20 -168.83 -36.72 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 -43.63 3.2 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.761 -0.587 . . . . 0.0 109.462 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 26.6 ttt85 -173.5 20.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.536 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 48' ' ' GLU . 12.8 pt-20 -147.85 120.86 8.8 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.137 -1.602 . . . . 0.0 111.926 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.842 HD12 ' CE1' ' A' ' 77' ' ' TYR . 7.8 mt -68.33 138.83 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -104.78 -77.27 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.118 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.96 ' O ' HG23 ' A' ' 45' ' ' THR . . . -171.12 174.97 44.88 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.878 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CD2' ' OG1' ' A' ' 45' ' ' THR . 2.4 m-85 -116.95 173.48 6.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 122.133 -0.628 . . . . 0.0 109.898 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 178.72 130.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.499 -0.751 . . . . 0.0 109.206 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' HB ' ' A' ' 73' ' ' ILE . 3.4 p90 -150.6 171.73 16.65 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.1 -1.44 . . . . 0.0 113.606 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.537 ' HB3' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -124.34 112.35 16.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 60' ' ' LEU . 0.4 OUTLIER -104.36 68.28 0.87 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 109.67 -178.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.852 ' OH ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.81 109.7 4.56 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG23 ' HD3' ' A' ' 67' ' ' LYS . 34.8 m -159.41 -162.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.574 0.702 . . . . 0.0 109.634 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.624 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -137.94 124.6 20.96 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -122.86 -127.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.477 -0.765 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.543 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 t -84.57 -52.56 6.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.019 -1.051 . . . . 0.0 109.389 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 29' ' ' TYR . 7.0 t0 -128.65 30.23 5.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.359 -0.838 . . . . 0.0 109.256 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.752 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -125.46 80.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.703 0.763 . . . . 0.0 110.046 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 6.3 mp -90.07 59.66 4.58 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 p90 176.98 -142.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.407 -0.808 . . . . 0.0 109.581 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.537 ' NH1' ' HB3' ' A' ' 59' ' ' GLN . 4.8 ttm180 -113.26 140.77 47.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.531 -1.356 . . . . 0.0 112.236 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -99.44 103.45 15.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' N ' ' A' ' 86' ' ' ARG . 9.9 t70 -77.24 157.58 30.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.769 -1.207 . . . . 0.0 109.927 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.826 HD11 ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -162.62 101.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.672 0.748 . . . . 0.0 109.156 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -113.37 134.96 54.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 mt-10 -157.9 136.53 11.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.936 -1.102 . . . . 0.0 111.28 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.638 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -60.13 -144.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.227 -0.92 . . . . 0.0 109.826 178.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.842 ' CE1' HD12 ' A' ' 53' ' ' ILE . 6.2 t80 -161.26 -56.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.68 -1.262 . . . . 0.0 111.36 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 1.7 ttmm -74.49 -58.43 3.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.113 -0.992 . . . . 0.0 109.722 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.598 ' O ' HG22 ' A' ' 79' ' ' THR . 52.6 m -93.75 9.52 36.77 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.137 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' C ' ' A' ' 81' ' ' GLY . 27.3 mmm-85 59.65 15.85 4.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.472 -0.768 . . . . 0.0 109.755 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.638 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . 4.09 -72.37 0.0 OUTLIER Glycine 0 N--CA 1.499 2.882 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.58 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 80' ' ' ARG . 3.2 mtt180 -161.07 -174.64 4.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.768 -1.43 . . . . 0.0 111.515 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -170.47 160.43 7.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 0.0 109.514 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.02 175.21 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.04 -1.038 . . . . 0.0 110.399 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 72' ' ' ASP . 6.0 mtt180 -157.5 131.67 8.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.0 110.704 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 84.2 m-85 -107.98 64.92 0.63 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -152.63 -158.76 0.93 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.998 -1.064 . . . . 0.0 111.148 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.17 52.82 29.53 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 104.876 -3.29 . . . . 0.0 104.876 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -65.64 -171.78 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.728 1.909 . . . . 0.0 112.585 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.852 HG13 ' OH ' ' A' ' 61' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.139 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.58 -1.408 . . . . 3.6000000000000001 109.58 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' HG2' ' C ' ' A' ' 1' ' ' GLY . 3.4 mt-10 -137.34 129.92 29.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 2.8300000000000001 110.218 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 23.5 p90 -79.99 167.96 19.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 3.6000000000000001 110.225 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.86 119.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 2.7200000000000002 110.167 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG22 ' CG ' ' A' ' 42' ' ' MET . 1.2 pt -80.35 -176.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.219 -0.926 . . . . 1.3700000000000001 110.396 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.739 HD12 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.21 -164.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.287 -0.883 . . . . 2.4300000000000002 109.881 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 8' ' ' ILE . 42.2 t0 -144.35 61.77 1.34 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 3.5 111.592 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.69 ' C ' HG21 ' A' ' 12' ' ' THR . 14.0 tt 40.53 45.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.002 0.906 . . . . 1.76 109.953 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -138.41 -65.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 120.138 -1.03 . . . . 0.85999999999999999 111.434 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.6 Cg_endo -82.17 -72.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.596 1.314 . . . . 0.93999999999999995 111.416 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.739 ' CD2' HD12 ' A' ' 6' ' ' ILE . 1.9 m-30 -44.5 -32.05 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 1.53 109.583 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.733 HG22 HG21 ' A' ' 38' ' ' ILE . 25.0 p -57.59 -57.69 11.59 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.52 -1.289 . . . . 0.90000000000000002 107.52 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -72.99 -17.67 61.43 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.749 0.785 . . . . 2.3599999999999999 109.455 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.545 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 2.7 t-20 -79.4 -58.65 3.1 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.643 0.735 . . . . 1.5600000000000001 109.371 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.839 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 2.6 tp -42.04 -56.13 2.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.212 -0.662 . . . . 2.0499999999999998 109.212 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -49.53 -57.48 9.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.57999999999999996 109.535 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -68.75 -77.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.129 . . . . 2.4500000000000002 110.665 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 3.3 m-85 -37.77 -72.57 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.418 0.628 . . . . 2.2799999999999998 111.221 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -41.42 -69.23 0.14 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.56000000000000005 110.342 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 55.4 t -42.34 -27.95 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 1.4299999999999999 110.356 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' LYS . 2.2 m-20 -93.49 -62.54 1.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.233 -0.917 . . . . 1.9099999999999999 110.353 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.0 mt-10 -61.96 -31.57 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.008 -1.057 . . . . 2.1699999999999999 109.81 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' OE2' ' CD2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -75.42 -59.59 2.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.181 -1.044 . . . . 1.6399999999999999 108.181 178.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 36.8 t-20 -53.25 -46.56 69.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.223 -1.399 . . . . 2.27 107.223 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 13.7 tttt -58.2 -48.56 79.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.867 -1.16 . . . . 2.8799999999999999 107.867 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.604 HD11 ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -48.46 -26.54 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.527 -0.916 . . . . 1.6299999999999999 108.527 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 27.89 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.223 -1.551 . . . . 1.01 109.223 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 24.8 tp60 -128.91 68.52 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -1.041 . . . . 2.3500000000000001 109.671 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.503 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 35.1 p90 -90.45 23.62 2.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 5.4900000000000002 109.766 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -40.44 -55.74 3.05 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.893 -1.283 . . . . 2.3100000000000001 109.893 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.949 ' HB3' HD12 ' A' ' 32' ' ' LEU . 13.1 mtt180 -161.07 -89.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -1.178 . . . . 3.7000000000000002 110.001 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.949 HD12 ' HB3' ' A' ' 31' ' ' ARG . 3.4 mp -133.26 -178.2 4.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.313 -0.867 . . . . 2.6000000000000001 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.621 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -144.9 50.65 1.25 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.345 -0.847 . . . . 0.94999999999999996 109.769 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.622 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 9.6 t80 -179.88 74.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 3.48 110.279 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.32 -45.86 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 2.52 110.561 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 3.5099999999999998 111.002 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LYS . 23.1 t -158.55 172.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.694 -1.254 . . . . 1.1200000000000001 111.622 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.39 85.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.675 -0.641 . . . . 1.6599999999999999 109.361 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -103.25 -54.22 0.12 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 3.0299999999999998 110.817 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.9 Cg_endo -83.5 52.15 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.335 1.177 . . . . 0.56999999999999995 110.324 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.552 ' C ' HD11 ' A' ' 6' ' ' ILE . 21.2 p -104.03 113.1 26.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.835 . . . . 1.6399999999999999 110.408 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.813 ' CG ' HG22 ' A' ' 5' ' ' ILE . 8.3 mtm -113.91 176.97 4.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.846 . . . . 2.1000000000000001 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.23 159.32 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.027 . . . . 1.6299999999999999 110.985 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -154.17 128.59 9.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.503 -0.748 . . . . 2.5099999999999998 109.93 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -118.57 148.84 42.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.62 110.084 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.532 ' HA ' ' CA ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -115.51 43.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.404 -0.962 . . . . 2.0 108.404 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.793 ' HB2' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.88 -176.82 6.08 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.624 -0.672 . . . . 2.8799999999999999 110.915 -178.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.541 ' CG ' ' HG2' ' A' ' 52' ' ' GLU . 9.7 tp10 -69.4 -101.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 4.0099999999999998 109.648 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.4 -59.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.773 -1.204 . . . . 4.1699999999999999 110.637 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -146.84 12.24 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 4.3600000000000003 110.059 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -122.7 -22.58 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.352 -0.842 . . . . 5.2699999999999996 109.828 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.541 ' HG2' ' CG ' ' A' ' 48' ' ' GLU . 15.4 pt-20 -170.14 -163.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.111 -1.036 . . . . 3.2799999999999998 111.107 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 47' ' ' TYR . 9.9 tp -131.57 157.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.742 -0.599 . . . . 2.02 109.539 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 2.9 tttt -136.36 -64.56 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.917 -1.115 . . . . 2.96 111.572 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.9 ' O ' HG23 ' A' ' 45' ' ' THR . . . -134.21 164.19 24.54 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.631 -1.747 . . . . 0.60999999999999999 110.625 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' GLU . 36.6 t80 -156.84 92.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -1.057 . . . . 3.9100000000000001 110.418 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.7 pt-20 -126.47 171.83 10.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 2.6299999999999999 108.85 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 1.7 p90 -163.05 166.02 24.11 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 117.876 -1.53 . . . . 1.8200000000000001 113.419 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 70' ' ' ARG . 92.6 mt-30 -119.82 107.53 13.27 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.742 -1.207 . . . . 2.1699999999999999 107.742 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.714 HD21 HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -105.77 73.72 1.02 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.289 -0.882 . . . . 0.70999999999999996 109.14 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.08 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -69.61 112.34 6.03 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.031 -1.1 . . . . 1.73 108.031 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.621 HG23 ' CD ' ' A' ' 67' ' ' LYS . 22.7 m -157.84 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.769 0.795 . . . . 0.41999999999999998 109.496 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.658 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.5 t80 -149.19 129.47 13.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 1.28 109.272 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.622 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -123.53 -118.09 0.29 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.77000000000000002 109.685 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -102.15 -25.21 13.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.754 -1.216 . . . . 1.4099999999999999 108.804 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.8 16.19 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 1.99 109.603 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.832 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -113.93 78.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 1.3700000000000001 110.338 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.9 mt -86.16 63.19 7.88 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.501 -0.926 . . . . 1.79 108.501 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 176.06 -122.69 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.539 -0.864 . . . . 1.8799999999999999 109.912 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 5.9 tmm_? -133.73 144.61 49.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.166 -1.583 . . . . 1.8799999999999999 112.416 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -92.08 92.33 8.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.241 -1.763 . . . . 0.47999999999999998 106.241 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 4.7 t0 -80.99 82.96 6.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.011 . . . . 1.73 110.741 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -76.19 138.92 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.692 -0.803 . . . . 1.1799999999999999 109.577 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -131.54 121.65 24.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 1.26 109.518 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 1.1 mt-10 -151.81 119.16 5.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.937 -1.102 . . . . 2.2999999999999998 110.477 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.567 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 3.2 t0 -61.33 -137.83 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.17 -0.956 . . . . 2.2599999999999998 109.895 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.717 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.21 -60.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 3.2200000000000002 110.76 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 tttt -87.06 -55.23 3.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.184 -0.948 . . . . 4.1900000000000004 109.587 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 1.81 18.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.309 -0.869 . . . . 3.6099999999999999 109.602 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 81' ' ' GLY . 12.9 mmt85 55.3 29.07 12.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.335 -0.853 . . . . 6.2800000000000002 109.935 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -24.92 -70.49 0.03 OUTLIER Glycine 0 N--CA 1.501 3.03 0 CA-C-N 116.216 -0.447 . . . . 2.4199999999999999 112.102 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -162.97 -178.08 5.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.653 -1.498 . . . . 5.0899999999999999 111.212 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 10.8 mtpt -148.58 105.29 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.655 -0.653 . . . . 3.5299999999999998 109.325 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.0 tp -170.1 179.12 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 2.4100000000000001 110.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 1.2 pt? -153.68 -179.19 7.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 1.24 110.509 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.538 ' C ' ' CD2' ' A' ' 87' ' ' PHE . 3.0 mtt180 -134.66 -177.06 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 2.71 110.49 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 69.4 m-85 -154.17 62.6 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.055 -0.72 . . . . 0.76000000000000001 109.055 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 3.0 m-80 -152.37 -157.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 1.9099999999999999 111.488 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 66.71 52.59 33.01 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 104.855 -3.298 . . . . 1.21 104.855 -176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.0 Cg_endo -67.77 -171.17 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 124.499 1.789 . . . . 2.1499999999999999 111.899 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.08 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.6 m . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 117.945 -1.026 . . . . 2.29 110.4 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.32 159.71 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 0.0 110.245 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 42.2 p-90 -150.58 142.32 23.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.156 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 21.2 mt-10 -158.36 -176.99 6.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.42 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.039 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -133.38 168.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.039 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -148.66 -170.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.7 OUTLIER 174.5 143.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.03 -1.044 . . . . 0.0 111.319 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.7 tp 43.06 25.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.317 0.58 . . . . 0.0 110.636 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.625 ' N ' HG21 ' A' ' 12' ' ' THR . . . -127.75 -103.21 1.19 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.311 -1.423 . . . . 0.0 112.421 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.723 ' CG ' HG21 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -81.66 -64.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.844 1.696 . . . . 0.0 111.984 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.711 ' CD1' ' CZ ' ' A' ' 58' ' ' TYR . 2.2 m-85 -42.91 -25.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 38' ' ' ILE . 2.6 p -69.59 -62.08 1.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.573 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.8 tt0 -66.64 -18.0 65.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 109.357 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.7 m-80 -79.21 -60.83 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.664 -0.647 . . . . 0.0 110.053 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -39.91 -50.66 2.48 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.425 0.631 . . . . 0.0 109.39 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -53.32 -57.31 15.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' PHE . 6.0 tttp -69.36 -69.25 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -1.175 . . . . 0.0 110.62 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-30 -38.72 -63.33 0.52 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.996 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -44.19 -72.79 0.05 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.589 -0.694 . . . . 0.0 110.273 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 11.0 t -40.74 -26.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 0.0 110.616 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.5 m-20 -92.19 -70.92 0.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.943 -1.098 . . . . 0.0 109.783 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.863 ' CB ' HD13 ' A' ' 85' ' ' LEU . 8.9 mm-40 -56.42 -34.61 66.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.911 -1.118 . . . . 0.0 109.52 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.801 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -67.17 -56.63 9.1 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.9 m120 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.914 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -55.35 -51.07 67.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.489 -0.757 . . . . 0.0 109.757 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -62.91 -16.57 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.469 -0.77 . . . . 0.0 110.021 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.26 50.89 0.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -152.16 78.18 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -1.106 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 30' ' ' GLY . 29.4 p90 -107.66 29.14 7.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.57 -53.95 4.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -168.53 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -1.135 . . . . 0.0 109.897 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -146.34 153.13 40.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 109.813 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.917 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -112.83 52.88 0.77 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.262 -0.899 . . . . 0.0 110.094 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.64 98.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.1 t-20 -134.2 -64.83 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.935 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -70.41 -106.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 111.237 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 36' ' ' LYS . 11.0 t -158.85 173.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.485 -1.384 . . . . 0.0 111.829 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.9 132.53 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.596 0.712 . . . . 0.0 110.259 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.629 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -136.63 -61.54 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.536 -0.727 . . . . 0.0 109.709 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.0 Cg_endo -81.48 46.16 2.17 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.062 1.033 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.855 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.9 p -80.34 80.18 6.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.078 -1.014 . . . . 0.0 109.098 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.509 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -83.18 138.13 33.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.131 -0.981 . . . . 0.0 111.066 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.38 157.61 17.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.801 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 4.5 mttt -160.09 103.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -0.78 . . . . 0.0 109.214 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.4 m -124.27 153.89 41.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.866 -1.146 . . . . 0.0 111.213 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -128.74 60.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -88.57 -153.55 0.25 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.933 0.873 . . . . 0.0 112.528 -177.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' HG2' ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -68.55 -145.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.759 0.79 . . . . 0.0 111.891 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.61 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -113.79 -49.26 2.88 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -167.99 25.66 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -31.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.144 -1.022 . . . . 0.0 112.005 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.746 ' O ' HD13 ' A' ' 53' ' ' ILE . 1.7 mt-10 -107.89 -156.6 0.59 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.511 -1.368 . . . . 0.0 111.919 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.756 HG22 ' CG ' ' A' ' 77' ' ' TYR . 30.4 mm -152.91 131.28 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -119.89 -65.9 1.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.715 -1.241 . . . . 0.0 111.815 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.846 ' O ' HG23 ' A' ' 45' ' ' THR . . . -144.01 164.68 27.49 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.164 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -150.35 86.74 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.267 -1.137 . . . . 0.0 111.153 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 7.1 pt-20 -95.16 149.27 21.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CZ ' ' CD1' ' A' ' 11' ' ' PHE . 2.3 t80 -144.97 139.64 27.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.914 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 28.2 mt-30 -99.19 107.03 19.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 25.0 tp -98.92 62.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.605 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.4 t80 -71.9 104.86 3.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.779 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG23 ' CE ' ' A' ' 67' ' ' LYS . 33.6 m -161.64 -165.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.7 t80 -131.26 134.6 46.57 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.248 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -130.68 -132.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.331 -0.856 . . . . 0.0 109.977 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.0 -29.73 13.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.595 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -136.18 3.88 2.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.427 -0.796 . . . . 0.0 110.12 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.634 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -113.19 100.7 8.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' HG ' ' CE2' ' A' ' 63' ' ' TYR . 6.8 mp -100.88 59.31 0.92 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.366 -0.834 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.24 -115.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.012 . . . . 0.0 110.156 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.9 ttp85 -124.35 157.83 34.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.332 -1.48 . . . . 0.0 112.807 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -118.37 91.88 3.68 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 30.5 t0 -69.15 81.27 0.34 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 110.906 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 22' ' ' GLU . 2.6 mm -68.38 114.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.394 -0.817 . . . . 0.0 108.903 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -118.36 118.17 31.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.372 -0.83 . . . . 0.0 110.675 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 40.3 mt-10 -153.38 120.19 5.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.031 -1.043 . . . . 0.0 110.794 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t0 -72.4 -140.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.153 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.756 ' CG ' HG22 ' A' ' 53' ' ' ILE . 0.3 OUTLIER 179.72 -65.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.965 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 5.7 tttt -77.68 -55.79 5.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 0.0 109.169 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -72.26 -6.23 41.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.362 -0.836 . . . . 0.0 109.012 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER 63.02 27.43 15.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.334 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -33.03 -78.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 5.4 mtt85 -170.16 -168.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.657 -1.496 . . . . 0.0 111.436 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -149.43 104.16 3.35 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.4 tp -169.97 -174.13 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 110.221 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.981 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -165.43 179.1 6.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 110.645 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mtt85 -142.84 128.65 19.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.981 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 4.5 m-85 -104.77 85.13 2.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.635 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -153.59 -156.98 0.74 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.734 -1.229 . . . . 0.0 110.784 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.05 51.49 6.88 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.1 Cg_endo -66.49 138.64 50.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.459 1.768 . . . . 0.0 111.203 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.2 m . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.323 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -154.06 161.41 41.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.268 -1.137 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -132.37 178.16 7.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 43' ' ' LYS . 1.1 tt0 176.99 119.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.767 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 16.4 pt -75.59 178.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.248 -0.908 . . . . 0.0 110.829 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.706 HG13 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.84 -164.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.328 -0.857 . . . . 0.0 110.712 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.699 ' O ' HG22 ' A' ' 8' ' ' ILE . 39.6 t0 -156.75 46.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.797 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 7' ' ' ASP . 17.9 tt 40.27 37.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.656 0.741 . . . . 0.0 109.83 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -143.52 -65.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.207 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 46.1 Cg_endo -78.7 -79.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.665 1.35 . . . . 0.0 111.427 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 43' ' ' LYS . 97.1 m-85 -40.19 -29.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.04 HG22 HD12 ' A' ' 38' ' ' ILE . 16.9 p -61.15 -59.11 5.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -67.35 -12.36 59.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 16.4 m120 -84.61 -69.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.0 pp -42.04 -28.22 0.17 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.695 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -74.66 -46.15 19.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -80.87 -41.89 22.39 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.201 -1.176 . . . . 0.0 110.253 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -35.85 82.46 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.595 0.712 . . . . 0.0 109.916 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -65.87 -71.79 0.18 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.5 p -34.52 -33.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.775 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 19' ' ' ALA . 87.1 m-20 -93.15 -73.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.079 ' HB2' HD13 ' A' ' 85' ' ' LEU . 6.9 mm-40 -57.2 -23.42 47.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.107 . . . . 0.0 110.206 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 1.4 tt0 -80.93 -63.36 1.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 49.1 m-20 -52.23 -46.89 65.9 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 11.0 ttpt -55.35 -50.67 69.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -50.18 -24.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.7 0.762 . . . . 0.0 109.05 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.04 36.12 1.06 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -139.26 73.51 1.43 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.503 -0.998 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 46.8 t80 -92.95 25.47 3.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.414 -0.804 . . . . 0.0 109.697 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.7 -66.47 0.65 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 35.6 mtp180 -161.67 -91.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -1.206 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -138.06 159.39 42.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.91 . . . . 0.0 110.062 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -116.6 57.81 0.77 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 2.4 t80 -158.5 109.69 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -152.02 -70.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.923 . . . . 0.0 111.281 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -69.47 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.926 -1.109 . . . . 0.0 111.265 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 36' ' ' LYS . 4.6 t -160.57 156.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.443 -1.411 . . . . 0.0 112.273 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.04 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -106.12 140.74 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.713 0.768 . . . . 0.0 109.546 178.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.585 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.47 -61.92 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.679 -0.638 . . . . 0.0 110.09 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 52.1 Cg_endo -77.91 39.95 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.307 1.161 . . . . 0.0 111.687 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.635 ' HB3' HG21 ' A' ' 6' ' ' ILE . 85.3 m -93.49 148.45 22.07 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.938 -1.101 . . . . 0.0 109.945 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.512 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 5.2 mtm -138.48 161.93 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.028 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 2.7 tmtt? -152.03 131.72 13.16 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.955 -1.091 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -148.81 130.54 15.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.884 . . . . 0.0 110.348 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.5 m -108.21 154.09 22.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.977 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 12.9 pt -120.67 41.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.807 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -69.93 -148.27 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 122.12 0.962 . . . . 0.0 111.673 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.2 pt-20 -69.12 -153.0 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.962 0.887 . . . . 0.0 112.608 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 3.5 t30 -156.35 -35.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.303 0.573 . . . . 0.0 109.574 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.46 -29.94 1.17 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 51' ' ' ARG . 4.0 ppt_? -171.37 20.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.739 -1.225 . . . . 0.0 112.089 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 5.1 mt-10 -114.97 -147.13 0.41 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.974 -1.079 . . . . 0.0 110.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG12 ' CG ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -170.66 140.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' TYR . 7.7 mttt -131.64 -78.12 0.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 112.091 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 45' ' ' THR . . . -163.14 -163.62 16.25 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 117.757 -2.163 . . . . 0.0 111.326 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.3 t80 -160.85 107.73 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.786 -0.832 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.9 pt-20 -117.74 142.84 46.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.233 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -144.35 170.64 15.62 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.027 -1.469 . . . . 0.0 113.425 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -135.11 128.72 32.69 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.925 HD23 ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.8 85.61 2.35 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 109.104 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 1.8 t80 -77.52 108.94 11.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.624 HG11 HD21 ' A' ' 60' ' ' LEU . 1.3 p -153.46 173.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.0 t80 -128.57 127.23 41.91 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.765 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -127.67 -126.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.856 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.607 ' OG ' HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -96.96 -40.21 9.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.45 31.94 4.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 109.861 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -143.85 92.23 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.753 0.787 . . . . 0.0 109.357 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 68' ' ' LEU . 1.6 mp -100.58 63.58 1.09 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.715 -0.616 . . . . 0.0 110.761 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 168.86 -109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.034 -1.041 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 1.4 ttp-105 -130.4 141.52 50.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.906 -1.121 . . . . 0.0 112.779 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.925 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -107.26 113.41 26.79 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 3.1 t70 -93.35 168.69 10.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.076 . . . . 0.0 111.34 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 58' ' ' TYR . 4.3 tp -158.99 116.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -126.69 131.51 51.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.92 -1.113 . . . . 0.0 109.814 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 16.1 mt-10 -149.82 132.05 15.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.93 -1.106 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.574 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -74.87 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.168 -0.958 . . . . 0.0 110.079 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.602 ' CG ' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -173.08 -46.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.586 -1.321 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -66.39 -61.56 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.128 . . . . 0.0 108.123 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.412 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 11.5 t -90.86 14.33 13.98 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 81' ' ' GLY . 30.0 mmt180 48.53 42.42 18.79 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.513 0.673 . . . . 0.0 109.227 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -33.35 -79.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 3.6 mtm180 -171.12 -160.73 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.677 -1.484 . . . . 0.0 112.446 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 21.0 mttt -148.35 139.8 23.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -170.73 151.29 3.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 110.832 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.079 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -136.1 175.93 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.42 -0.8 . . . . 0.0 109.506 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.5 mtm180 -147.79 178.75 8.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.042 -1.036 . . . . 0.0 110.949 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.787 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -155.63 84.26 1.04 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.622 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -153.42 -154.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 62.34 53.39 42.39 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.8 Cg_endo -64.43 154.78 69.75 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.582 1.833 . . . . 0.0 111.549 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.188 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' C ' ' CG ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' CG ' ' C ' ' A' ' 1' ' ' GLY . 21.7 mt-10 -148.98 130.98 15.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.262 -1.14 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 28.1 p90 -107.65 155.37 20.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.888 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.546 ' HG2' ' CD ' ' A' ' 43' ' ' LYS . 12.3 pt-20 -177.34 137.76 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.712 ' C ' HD13 ' A' ' 6' ' ' ILE . 4.9 pt -89.3 -178.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.712 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -125.73 -147.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.18 -0.95 . . . . 0.0 109.656 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -134.79 -152.12 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.76 -1.213 . . . . 0.0 110.295 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.774 ' C ' HG21 ' A' ' 12' ' ' THR . 2.0 tt -104.35 39.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' N ' HG21 ' A' ' 12' ' ' THR . . . -144.69 -63.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.272 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 6' ' ' ILE . 41.9 Cg_endo -68.72 -93.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.293 1.154 . . . . 0.0 112.498 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.696 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.7 m-85 -43.33 -26.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 0.0 111.013 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.047 HG22 HD12 ' A' ' 38' ' ' ILE . 22.4 p -54.41 -56.34 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.825 -1.172 . . . . 0.0 108.391 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' A' ' 12' ' ' THR . 7.4 tt0 -58.24 -22.43 52.17 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.762 0.791 . . . . 0.0 109.233 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 5.4 t-20 -72.26 -56.81 4.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.538 0.685 . . . . 0.0 109.801 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -42.32 -56.09 3.1 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.588 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.973 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.41 -38.38 41.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -79.81 -80.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -1.056 . . . . 0.0 110.676 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CD2' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -37.59 -36.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.283 0.563 . . . . 0.0 111.004 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.695 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -66.71 -69.6 0.3 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.393 -0.817 . . . . 0.0 109.738 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 19' ' ' ALA . 9.5 t -39.35 -27.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 110.198 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 19' ' ' ALA . 5.6 m-20 -93.32 -69.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 110.122 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.839 ' CB ' HD13 ' A' ' 85' ' ' LEU . 6.3 mp0 -57.27 -32.51 66.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.502 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.98 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -69.68 -59.88 2.67 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 23.4 m-20 -55.94 -44.71 78.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -52.8 63.02 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.453 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.98 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -54.51 -22.48 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.489 -0.757 . . . . 0.0 109.711 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 19.83 3.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 50.9 mm-40 -114.88 60.44 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.946 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 61.2 t80 -84.16 13.8 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -43.35 -53.04 5.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HG2' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.26 -147.2 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.06 -174.23 0.59 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.668 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -147.3 53.58 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 110.065 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 22.5 t80 -175.64 97.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.2 t-20 -129.68 -52.55 1.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.824 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -69.72 -99.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 111.183 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.46 173.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.558 -1.339 . . . . 0.0 111.825 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.047 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -126.92 121.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.437 0.637 . . . . 0.0 109.576 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.605 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -129.36 -58.27 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.467 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.2 Cg_endo -84.91 45.68 1.7 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.178 1.094 . . . . 0.0 110.965 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.752 ' SG ' HD11 ' A' ' 38' ' ' ILE . 24.0 p -80.06 88.6 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 109.496 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 5' ' ' ILE . 17.0 mtm -88.93 135.38 33.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.426 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CD ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.428 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' GLU . 19.5 mttt -142.97 121.09 12.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 5.7 m -125.87 150.12 48.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -115.4 45.11 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.921 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.9 m-30 -75.61 176.64 7.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -99.65 -77.9 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.528 -0.732 . . . . 0.0 109.446 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.615 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 1.3 t30 87.78 -18.97 0.25 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.656 0.741 . . . . 0.0 109.28 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 0.2 43.19 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.516 ' CB ' ' OE1' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -170.19 -29.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.888 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' CD ' ' HD3' ' A' ' 78' ' ' LYS . 15.3 pt-20 -169.05 -166.18 0.61 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.95 -1.094 . . . . 0.0 111.108 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.791 HG21 ' CD2' ' A' ' 77' ' ' TYR . 39.9 mm -117.47 113.83 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.632 -0.667 . . . . 0.0 109.556 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.7 OUTLIER -80.86 -75.77 0.26 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.302 -0.874 . . . . 0.0 111.969 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . -153.33 -177.61 27.04 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 118.006 -2.045 . . . . 0.0 111.163 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -159.45 88.39 0.86 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.967 . . . . 0.0 110.565 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' LYS . 12.6 pt-20 -87.99 155.45 19.82 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 60' ' ' LEU . 2.6 t80 -142.24 124.98 15.93 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.493 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 70' ' ' ARG . 10.7 mt-30 -96.78 96.22 8.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.903 ' CD2' HD23 ' A' ' 15' ' ' LEU . 7.8 tp -97.04 69.32 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 108.978 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -72.96 110.45 7.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.096 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.609 HG13 ' C ' ' A' ' 61' ' ' TYR . 22.9 m -160.96 -163.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.744 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.72 130.05 23.75 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.85 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 36' ' ' LYS . . . -125.44 -116.31 0.28 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.409 -0.807 . . . . 0.0 109.945 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -46.32 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.25 -1.42 5.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 110.021 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -94.53 92.32 7.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.781 . . . . 0.0 109.734 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.744 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.1 mt -96.35 61.92 2.05 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.657 ' N ' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 167.59 -113.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.019 . . . . 0.0 110.473 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.25 149.61 52.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.43 -1.419 . . . . 0.0 113.626 -178.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -101.89 92.66 4.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -70.78 79.84 0.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.903 . . . . 0.0 110.64 -177.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -68.59 107.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.54 0.686 . . . . 0.0 109.571 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -103.18 114.86 29.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.472 -0.768 . . . . 0.0 110.31 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HG23 ' A' ' 73' ' ' ILE . 11.3 mt-10 -145.94 112.04 5.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.072 -1.018 . . . . 0.0 110.748 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.583 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.8 m-20 -81.99 -149.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.997 . . . . 0.0 109.513 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.791 ' CD2' HG21 ' A' ' 53' ' ' ILE . 1.1 t80 -176.4 -58.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.348 -1.47 . . . . 0.0 111.091 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -66.37 -58.46 5.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.928 -1.107 . . . . 0.0 108.584 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.43 2.15 29.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 81' ' ' GLY . 26.6 mmt180 55.71 38.8 30.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.571 -0.706 . . . . 0.0 109.743 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -37.73 -85.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 mtt180 -155.21 -169.14 3.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.892 -1.358 . . . . 0.0 111.753 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 16.1 mtmt -151.21 97.33 2.42 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.8 tp -169.88 -172.07 1.3 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.152 -0.968 . . . . 0.0 109.979 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.963 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -150.94 -179.72 7.53 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 72' ' ' ASP . 21.1 mtm180 -146.01 126.78 14.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.127 . . . . 0.0 111.55 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.6 m-85 -104.77 89.6 3.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.419 -0.801 . . . . 0.0 108.933 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.614 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 1.5 m120 -153.44 -143.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.52 -1.362 . . . . 0.0 111.268 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 51.37 50.33 41.46 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.2 Cg_endo -68.91 158.02 59.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.332 1.701 . . . . 0.0 111.111 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.5 m . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.13 178.84 6.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -133.41 169.11 17.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.464 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 6.5 tp10 -168.28 116.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.916 HG22 ' HG2' ' A' ' 42' ' ' MET . 20.9 pt -110.14 144.15 18.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.988 -1.07 . . . . 0.0 111.512 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.805 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.38 -175.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.639 ' HA ' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER 172.74 34.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.655 -1.278 . . . . 0.0 112.145 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 7' ' ' ASP . 6.7 tp 177.92 18.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.502 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -158.47 -64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.524 -1.798 . . . . 0.0 111.906 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.747 ' HG3' HG21 ' A' ' 6' ' ' ILE . 46.3 Cg_endo -74.66 -86.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.69 1.363 . . . . 0.0 112.199 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.652 ' HD2' HD12 ' A' ' 60' ' ' LEU . 3.9 m-85 -45.78 -22.43 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.961 HG22 HD12 ' A' ' 38' ' ' ILE . 27.6 p -66.14 -59.89 3.33 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.972 -1.08 . . . . 0.0 109.177 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' N ' ' OG1' ' A' ' 12' ' ' THR . 29.1 tt0 -72.15 -19.89 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.495 0.664 . . . . 0.0 109.924 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 8.2 m120 -79.25 -51.38 9.53 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.0 109.294 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.0 HD12 HD21 ' A' ' 60' ' ' LEU . 1.6 tt -44.98 -55.55 5.41 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.4 0.619 . . . . 0.0 109.521 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.985 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -52.31 -55.37 22.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' PHE . 4.3 mttm -69.89 -79.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -1.124 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -33.03 -66.64 0.14 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.451 0.643 . . . . 0.0 111.232 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -42.35 -70.28 0.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.601 -0.687 . . . . 0.0 109.849 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 24.8 t -43.62 -25.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.214 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 19' ' ' ALA . 7.6 t0 -91.18 -69.48 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.23 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.071 ' CB ' HD13 ' A' ' 85' ' ' LEU . 77.4 mm-40 -59.55 -34.86 73.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.767 -1.208 . . . . 0.0 109.345 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.913 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -66.6 -54.75 20.04 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 109.017 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.5 m120 -64.7 -43.7 92.64 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.041 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.1 tttm -57.65 -46.0 84.78 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.913 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -64.26 -17.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.466 -0.771 . . . . 0.0 110.016 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.98 37.47 1.37 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.464 ' HB3' ' OE2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -138.99 72.09 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.134 . . . . 0.0 110.066 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 29' ' ' TYR . 41.8 p90 -109.72 30.75 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.857 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.41 -48.53 5.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 72.2 mtt-85 -157.76 -89.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.989 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -141.0 152.57 45.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.919 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.7 55.5 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 110.458 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 5.5 p90 -177.33 119.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.103 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB3' ' C ' ' A' ' 64' ' ' ALA . 45.6 t30 -157.37 -56.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.818 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.29 -97.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.7 t -160.14 172.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.659 -1.276 . . . . 0.0 111.476 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.971 HD11 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.17 121.1 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.687 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.5 ttm180 -130.91 -57.37 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 110.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.9 Cg_endo -86.5 45.19 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.07 1.037 . . . . 0.0 110.965 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.971 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.1 p -85.11 79.27 9.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.487 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.916 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.8 mtp -82.47 163.0 21.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.171 -0.956 . . . . 0.0 110.685 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 3.4 ttpp -138.51 140.86 39.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.211 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 57' ' ' GLU . 6.0 ttmm -142.75 128.79 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.978 HG21 ' CE1' ' A' ' 47' ' ' TYR . 1.4 m -114.44 160.26 19.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 110.213 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.786 ' O ' HG23 ' A' ' 46' ' ' ILE . 1.3 tt -131.5 82.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.978 ' CE1' HG21 ' A' ' 45' ' ' THR . 23.7 m-85 -68.78 -164.75 0.05 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' N ' ' HB2' ' A' ' 54' ' ' LYS . 2.5 tp10 -66.99 -99.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.758 -0.589 . . . . 0.0 110.032 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 26.4 m-20 -127.83 -78.05 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.694 -1.254 . . . . 0.0 109.748 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.73 18.78 1.15 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -145.13 -29.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.143 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 2.7 mm-40 -118.54 -159.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG12 ' CD2' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -126.04 169.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' HB2' ' N ' ' A' ' 48' ' ' GLU . 18.0 tttt -156.97 -49.56 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.801 -1.187 . . . . 0.0 113.245 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.854 ' O ' HG23 ' A' ' 45' ' ' THR . . . -143.08 172.17 24.68 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 117.54 -2.267 . . . . 0.0 111.277 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 1.2 t80 -161.25 91.44 0.86 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.842 -0.799 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.3 mt-10 -123.87 -179.44 4.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -164.08 167.01 20.81 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.557 -1.257 . . . . 0.0 112.943 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 49.6 mt-30 -120.72 107.89 13.32 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 15' ' ' LEU . 1.3 tp -98.6 71.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.027 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.606 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -72.78 111.48 7.96 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.628 0.728 . . . . 0.0 109.082 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 15' ' ' LEU . 17.2 m -160.1 -163.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.574 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.2 t80 -138.85 126.88 22.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.714 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -122.58 -130.41 0.27 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.461 -0.774 . . . . 0.0 109.886 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.573 ' CB ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.87 -18.51 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 25.4 t70 -151.02 38.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.891 ' HE2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -150.31 88.69 1.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.553 0.692 . . . . 0.0 109.514 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 7.7 mt -92.44 60.04 3.51 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.618 -0.676 . . . . 0.0 109.596 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 170.45 -122.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.188 -0.945 . . . . 0.0 109.851 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 2.6 tmm_? -122.53 147.88 45.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.21 -1.556 . . . . 0.0 113.246 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 86' ' ' ARG . . . -102.05 98.09 8.33 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -68.78 152.37 45.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 110.133 -177.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.77 127.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 34.2 t -129.98 155.34 46.26 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.222 -0.923 . . . . 0.0 109.24 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' OE2' HG23 ' A' ' 73' ' ' ILE . 3.5 mp0 -156.33 116.79 3.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.607 -1.308 . . . . 0.0 112.46 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.625 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 2.7 p30 -39.89 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.412 0.625 . . . . 0.0 111.643 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.602 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.93 -61.42 0.23 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 178.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HB2' ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -126.42 -38.94 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.271 -0.893 . . . . 0.0 108.653 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 37.3 p -90.87 30.16 1.24 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER 39.98 57.92 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.643 . . . . 0.0 111.49 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.625 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -53.4 -108.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -173.82 155.64 2.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.498 -1.59 . . . . 0.0 112.094 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -103.17 126.54 50.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.8 tp -171.22 179.51 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 0.0 109.864 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.071 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.03 167.5 8.9 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.035 -1.041 . . . . 0.0 110.455 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.566 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 1.1 mtt180 -143.44 -174.86 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 10.7 m-85 -155.01 83.52 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.606 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -168.68 -164.06 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.503 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 86.82 54.83 2.54 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 39.5 Cg_endo -63.21 144.68 92.37 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 124.407 1.741 . . . . 0.0 111.472 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' H ' HG13 ' A' ' 91' ' ' VAL . 4.7 m . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 0.5 OUTLIER 175.83 178.21 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -1.146 . . . . 0.0 110.168 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 m-90 -83.28 -176.81 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HG2' ' CE ' ' A' ' 43' ' ' LYS . 20.7 tp10 174.31 163.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -139.29 173.43 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.931 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 7' ' ' ASP . 1.2 pp -136.82 -159.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 t70 -113.21 -143.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 109.617 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.823 ' C ' HG21 ' A' ' 12' ' ' THR . 0.8 OUTLIER -108.38 38.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.647 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -129.91 -56.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.702 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.5 Cg_endo -75.7 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 122.963 0.98 . . . . 0.0 111.853 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.7 ' CE1' ' CD2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -40.4 -34.96 0.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.136 -0.978 . . . . 0.0 110.447 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.133 HG22 HD12 ' A' ' 38' ' ' ILE . 44.5 p -50.19 -54.22 22.38 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.4 OUTLIER -63.78 -25.98 68.43 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.751 0.786 . . . . 0.0 109.36 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 11.6 m120 -72.26 -52.4 16.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 0.0 109.86 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -42.9 -58.4 2.41 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.257 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 1.02 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -45.72 -45.97 13.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -83.52 -80.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.053 . . . . 0.0 111.154 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 2.5 m-85 -35.69 -29.58 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 111.592 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.787 ' HB1' ' OE1' ' A' ' 23' ' ' GLU . . . -84.02 -72.49 0.46 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.749 HG23 ' OG1' ' A' ' 33' ' ' THR . 24.3 t -43.64 -26.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 109.833 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -86.64 -62.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.667 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.067 ' HB2' HD13 ' A' ' 85' ' ' LEU . 25.3 mm-40 -62.12 -43.21 99.32 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.464 -1.294 . . . . 0.0 108.998 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.888 ' CD ' HG21 ' A' ' 33' ' ' THR . 55.4 mt-10 -58.83 -51.86 68.2 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 108.877 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 35.0 t-20 -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.383 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -57.66 -42.11 82.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.966 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.2 tp -69.57 -16.48 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.393 -0.817 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.07 52.72 0.26 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.422 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -158.34 81.83 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -1.12 . . . . 0.0 109.878 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 39.4 p90 -105.5 29.18 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.15 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -41.16 -51.73 4.27 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.901 ' HB3' HD23 ' A' ' 32' ' ' LEU . 7.6 mtm180 -179.62 -81.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -141.49 164.68 29.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.44 -0.787 . . . . 0.0 109.782 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.888 HG21 ' CD ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -130.04 52.5 2.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.751 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.522 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 38.9 t80 -163.85 112.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.415 -0.803 . . . . 0.0 110.015 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.9 t-20 -150.4 -55.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.546 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.749 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.6 mttt -69.46 -103.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 111.049 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.2 t -159.59 172.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.755 -1.216 . . . . 0.0 111.536 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.133 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.65 129.12 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.615 -0.678 . . . . 0.0 109.846 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -132.1 -58.13 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.375 -0.828 . . . . 0.0 110.057 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 44.9 Cg_endo -87.44 46.42 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.174 1.091 . . . . 0.0 110.81 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 1.001 ' HB2' HD12 ' A' ' 60' ' ' LEU . 22.6 p -87.46 111.61 21.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.482 ' HB3' ' CE ' ' A' ' 44' ' ' LYS . 27.1 mtm -109.66 179.81 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.703 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' CE ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -152.54 142.38 22.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 110.107 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -137.96 105.69 5.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.772 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.9 m -124.17 154.19 40.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 25.8 pt -122.2 39.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.801 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -75.75 -150.19 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.274 1.035 . . . . 0.0 111.696 -178.16 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.4 pt-20 -68.73 -155.99 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.077 0.941 . . . . 0.0 112.745 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.583 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 1.7 m-20 -155.99 -35.41 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.433 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HG3' ' HG2' ' A' ' 51' ' ' ARG . 15.7 pt-20 -131.29 -30.78 1.69 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 110.819 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.453 ' HG2' ' HG3' ' A' ' 50' ' ' GLU . 1.6 ptt85 -171.31 18.57 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.719 -1.238 . . . . 0.0 112.358 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 40.3 mm-40 -111.71 -148.33 0.43 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.836 -1.165 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.592 HG12 ' CG ' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -171.15 142.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 1.8 mtmt -141.3 -75.09 0.31 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.754 -1.216 . . . . 0.0 112.463 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . -141.06 167.61 25.62 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' GLU . 86.5 t80 -152.29 90.83 1.54 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.259 -1.142 . . . . 0.0 110.809 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.9 tt0 -112.08 159.61 18.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.704 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -156.35 169.16 25.22 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 117.859 -1.536 . . . . 0.0 113.45 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 13.3 mt-30 -137.93 120.97 16.67 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -121.98 83.85 2.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 109.436 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.65 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -75.18 110.32 9.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.756 HG23 ' HD3' ' A' ' 67' ' ' LYS . 35.6 m -160.33 -161.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.462 -0.774 . . . . 0.0 109.697 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 1.109 ' CE1' HD22 ' A' ' 68' ' ' LEU . 2.0 t80 -135.09 135.2 41.04 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.506 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -133.15 -127.74 0.18 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -40.01 9.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.992 . . . . 0.0 108.982 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' OD1' HG22 ' A' ' 33' ' ' THR . 2.5 p30 -127.67 -2.39 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -104.5 88.87 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.109 HD22 ' CE1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -100.25 60.9 1.05 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 108.788 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER 172.3 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 7.3 ttp180 -152.94 156.27 38.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.972 -1.705 . . . . 0.0 112.643 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -119.2 115.52 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' OD1' ' NH1' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -93.07 166.34 12.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.992 -1.067 . . . . 0.0 110.235 -178.064 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.704 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.69 114.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.618 -0.676 . . . . 0.0 109.179 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -109.84 144.57 38.11 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.3 mt-10 -167.72 104.17 0.5 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.694 -1.254 . . . . 0.0 111.726 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.618 ' HB3' ' CA ' ' A' ' 81' ' ' GLY . 16.1 p-10 -61.8 -148.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.657 0.741 . . . . 0.0 112.149 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.592 ' CG ' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 175.97 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.389 0.614 . . . . 0.0 109.505 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.3 ttpt -119.85 -32.12 4.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 109.06 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -69.48 -15.98 63.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 79' ' ' THR . 7.6 mmt180 74.02 104.11 0.07 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.23 1.014 . . . . 0.0 110.343 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.618 ' CA ' ' HB3' ' A' ' 76' ' ' ASP . . . -143.01 -95.09 0.21 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -171.6 -157.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.408 -1.643 . . . . 0.0 112.041 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.785 ' C ' HD23 ' A' ' 84' ' ' LEU . 6.8 mttt -146.8 117.74 7.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.785 HD23 ' C ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -170.86 -169.56 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.528 -1.357 . . . . 0.0 111.75 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.37 175.95 4.63 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 13.0 mtt180 -150.35 152.15 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 13.4 m-85 -103.69 97.39 7.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 1.5 t-20 -66.79 125.86 27.19 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . -8.09 99.35 0.01 OUTLIER Glycine 0 N--CA 1.503 3.108 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.45 ' C ' ' HB2' ' A' ' 68' ' ' LEU . 47.3 Cg_endo -74.95 79.07 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.553 . . . . 0.0 109.941 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 68' ' ' LEU . 2.1 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.239 -0.913 . . . . 0.0 110.336 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' CA ' HD12 ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -123.87 162.13 23.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.356 -1.085 . . . . 0.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CB ' ' HG2' ' A' ' 44' ' ' LYS . 4.8 p90 -115.77 177.81 4.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.51 121.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.206 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 18.4 pt -85.17 170.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.075 -1.016 . . . . 0.0 110.499 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.777 HG22 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -89.4 -166.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.256 -0.902 . . . . 0.0 110.509 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 m-20 -137.16 49.56 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.141 -0.975 . . . . 0.0 110.705 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 7' ' ' ASP . 5.1 tt 39.9 46.01 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.963 0.887 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -156.1 -62.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.346 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.1 Cg_endo -72.7 -84.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 0.0 111.535 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.777 ' CD2' HG22 ' A' ' 6' ' ' ILE . 6.3 m-85 -41.42 -29.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.243 -0.911 . . . . 0.0 110.568 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.599 ' HA ' HG21 ' A' ' 38' ' ' ILE . 11.4 p -55.33 -58.0 9.52 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.535 ' N ' ' OG1' ' A' ' 12' ' ' THR . 9.6 mt-30 -68.19 -17.7 64.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.694 0.759 . . . . 0.0 109.394 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 7.2 t-20 -80.82 -57.28 3.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.55 0.69 . . . . 0.0 109.352 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -39.14 -46.49 1.45 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 1.011 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -65.24 -40.45 96.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.74 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.44 -69.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -1.054 . . . . 0.0 110.241 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 1.7 m-30 -40.86 -47.3 2.91 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.686 0.755 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -57.69 -77.56 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.526 -0.734 . . . . 0.0 110.01 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.0 p -38.33 -27.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.0 110.967 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.11 -77.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.915 -1.115 . . . . 0.0 110.213 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.1 mm-40 -56.06 -36.31 67.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.671 -1.268 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.812 ' O ' HG22 ' A' ' 26' ' ' ILE . 30.6 tt0 -64.77 -52.37 57.28 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -66.64 -44.19 82.62 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.015 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.8 ttmt -59.72 -41.72 91.46 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.127 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.4 tp -69.39 -17.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.389 -0.819 . . . . 0.0 110.194 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . 115.58 52.13 0.4 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 36.5 mm-40 -156.36 82.32 0.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.122 . . . . 0.0 109.736 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' A' ' 29' ' ' TYR . 50.9 p90 -104.02 30.37 5.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.889 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 31' ' ' ARG . . . -38.67 -48.81 2.43 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 171.37 -82.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -1.235 . . . . 0.0 110.341 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.914 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -131.91 158.89 40.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.723 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -129.98 52.71 1.98 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.835 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 6.3 p90 -172.7 62.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -106.06 -26.16 11.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.102 -0.999 . . . . 0.0 111.218 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.761 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -96.39 -89.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 36' ' ' LYS . 10.0 t -160.29 172.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.482 -1.386 . . . . 0.0 111.342 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -135.6 82.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.573 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.577 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -102.04 -58.02 0.1 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.026 -1.046 . . . . 0.0 111.494 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 61' ' ' TYR . 39.3 Cg_endo -79.19 48.04 2.7 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.292 1.154 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . 20.8 p -104.74 121.62 43.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.799 -1.188 . . . . 0.0 109.789 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 2.3 mpt? -117.65 157.66 26.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.111 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.53 129.8 46.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 110.215 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 15.0 mttm -130.93 125.43 33.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.1 m -125.1 164.65 19.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.984 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -127.55 51.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 2' ' ' GLU . 3.8 p90 -69.47 -159.79 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.989 0.899 . . . . 0.0 111.322 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.594 ' HB3' ' C ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -67.46 -147.47 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.693 0.758 . . . . 0.0 112.237 -178.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.589 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 1.1 t30 -156.75 -35.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.592 -0.692 . . . . 0.0 109.827 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.52 -31.75 1.78 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.293 -0.879 . . . . 0.0 110.796 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.97 20.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.801 -1.187 . . . . 0.0 112.222 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.691 ' C ' HD12 ' A' ' 53' ' ' ILE . 13.1 mt-10 -111.92 -151.27 0.48 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 0.0 110.516 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.716 HG22 ' HB3' ' A' ' 77' ' ' TYR . 1.2 mp -164.19 132.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -123.72 -76.51 0.59 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.557 -1.34 . . . . 0.0 113.095 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 45' ' ' THR . . . -155.43 -174.09 24.9 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.303 -1.903 . . . . 0.0 109.913 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.73 ' HA ' HG23 ' A' ' 45' ' ' THR . 13.7 t80 -162.2 109.51 1.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.902 -0.764 . . . . 0.0 110.617 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -126.04 177.85 6.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.351 -0.843 . . . . 0.0 108.831 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 1.089 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -165.38 175.18 9.34 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.168 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.517 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.8 tt0 -127.69 125.06 39.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 41' ' ' CYS . 21.1 tp -119.52 67.62 0.81 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.726 -1.234 . . . . 0.0 109.842 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 2.5 t80 -69.5 108.78 3.93 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 15' ' ' LEU . 34.9 m -160.42 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.695 ' CE1' HD12 ' A' ' 68' ' ' LEU . 1.4 t80 -154.2 117.34 4.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.971 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.91 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -104.46 -102.62 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.559 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.512 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 22.9 t -120.03 -26.74 5.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.75 5.62 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.959 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.91 ' NZ ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -109.07 86.35 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 110.109 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 63' ' ' TYR . 1.2 tp -88.78 61.96 6.21 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.717 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 169.73 -113.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.0 110.213 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 17.5 ttm180 -127.0 146.21 50.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.557 -1.34 . . . . 0.0 112.963 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -106.59 102.42 11.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.3 t70 -84.68 154.88 22.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.089 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -156.18 142.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.842 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.1 t -128.49 159.2 36.2 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -167.65 105.04 0.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.677 -1.264 . . . . 0.0 111.917 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.602 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 56.9 p-10 -55.56 -165.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.716 ' HB3' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -160.61 -53.34 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.496 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.1 tptm -135.11 -39.78 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.133 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.613 ' C ' ' HG3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.7 -61.71 1.88 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.613 ' HG3' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 152.06 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.794 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -21.19 -96.42 0.01 OUTLIER Glycine 0 N--CA 1.505 3.271 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 1.5 mtt180 -165.12 -165.29 0.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.946 -1.326 . . . . 0.0 110.786 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -166.76 88.73 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -171.2 -167.78 0.57 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.81 172.4 5.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.295 -0.878 . . . . 0.0 109.704 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 19.6 mtp180 -148.51 178.6 8.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.909 -1.12 . . . . 0.0 111.244 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 3.2 m-85 -155.36 80.86 1.05 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -155.79 -163.31 1.47 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.765 -1.209 . . . . 0.0 111.209 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 77.74 53.21 5.08 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.14 119.66 6.93 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.834 1.965 . . . . 0.0 111.697 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.449 ' H ' HG12 ' A' ' 91' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -172.5 170.01 5.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -1.168 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 7.5 p90 -159.36 165.58 32.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -0.901 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 43' ' ' LYS . 8.2 pt-20 -172.94 158.71 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.823 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.05 171.81 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.163 -0.96 . . . . 0.0 110.44 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.823 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -150.84 -176.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.868 -0.52 . . . . 0.0 109.784 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.78 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.8 p30 -179.32 126.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER 43.21 25.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.691 -0.631 . . . . 0.0 110.13 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.66 ' N ' HG21 ' A' ' 12' ' ' THR . . . -118.02 -107.63 2.38 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.161 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . 48.7 Cg_endo -80.65 -72.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.72 1.613 . . . . 0.0 112.752 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 6' ' ' ILE . 59.6 m-85 -40.09 -27.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.286 -0.883 . . . . 0.0 109.9 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.829 HG22 HG21 ' A' ' 38' ' ' ILE . 2.1 p -65.69 -61.81 1.87 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.582 ' N ' ' OG1' ' A' ' 12' ' ' THR . 5.3 mt-30 -59.89 -26.35 65.83 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.924 0.868 . . . . 0.0 108.767 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 1.7 t-20 -74.45 -47.0 36.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.604 0.716 . . . . 0.0 109.202 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 60' ' ' LEU . 3.4 tm? -44.03 -70.4 0.11 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . . . -44.27 -37.39 4.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 18.1 mttp -71.24 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -40.54 -41.3 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.579 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -59.63 -68.27 0.3 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.438 -0.789 . . . . 0.0 109.316 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' GLY . 23.3 t -38.5 -28.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.479 -0.763 . . . . 0.0 110.288 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.17 -73.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 110.341 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 14.0 mm-40 -54.86 -27.98 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.897 -1.127 . . . . 0.0 109.827 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -76.76 -61.11 2.08 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 6.6 m-20 -51.76 -47.17 64.22 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 20.7 mmmt -55.25 -51.69 65.8 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.653 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -51.77 -22.39 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.101 178.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.2 67.41 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -127.49 -71.64 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -1.169 . . . . 0.0 110.304 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -102.25 -75.37 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA2' ' ND2' ' A' ' 24' ' ' ASN . . . 100.8 36.41 3.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.078 ' O ' HD23 ' A' ' 32' ' ' LEU . 72.1 mtt180 -153.56 -82.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -1.18 . . . . 0.0 110.437 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.078 HD23 ' O ' ' A' ' 31' ' ' ARG . 7.0 mt -131.08 166.17 21.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.905 . . . . 0.0 110.38 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.533 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -154.35 62.32 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.1 t80 176.94 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.315 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 t-20 -117.12 -56.37 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 110.734 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.51 -101.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.019 -1.051 . . . . 0.0 111.263 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' LYS . 2.4 t -163.43 174.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.696 -1.253 . . . . 0.0 111.527 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.004 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -121.36 112.16 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.739 -0.601 . . . . 0.0 109.768 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.604 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -119.23 -57.07 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.1 Cg_endo -86.93 48.29 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.901 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 60' ' ' LEU . 23.6 p -96.41 122.13 38.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' GLN . 12.1 mtm -121.1 165.14 15.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -143.17 144.5 32.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLU . 18.5 mttt -148.43 157.44 43.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.6 m -149.1 152.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -122.39 43.91 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.732 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -72.74 -147.27 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.06 0.933 . . . . 0.0 111.721 -178.157 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.587 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.2 pt-20 -68.54 -153.9 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 122.043 0.925 . . . . 0.0 112.724 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.587 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 11.1 m-80 -157.16 -36.04 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.538 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -137.71 -27.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 111.252 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.34 23.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.685 -1.259 . . . . 0.0 111.83 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.3 mt-10 -121.67 -147.11 0.38 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.109 . . . . 0.0 110.445 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.881 HD12 ' CG ' ' A' ' 77' ' ' TYR . 0.2 OUTLIER -170.94 145.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -137.89 -76.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.556 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.881 ' O ' HG23 ' A' ' 45' ' ' THR . . . -158.82 -173.12 26.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 118.12 -1.991 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -157.84 107.42 2.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.705 -0.88 . . . . 0.0 110.234 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' LYS . 17.1 pt-20 -117.14 134.65 54.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.41 164.22 26.18 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.49 -1.284 . . . . 0.0 112.534 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 11.5 mt-30 -132.12 124.12 28.5 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.004 HD11 ' CD1' ' A' ' 38' ' ' ILE . 1.8 tp -120.69 78.15 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.747 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -73.28 113.0 9.86 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 38' ' ' ILE . 32.9 m -159.63 -162.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 2.8 t80 -136.01 141.58 44.37 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -138.98 -115.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.845 . . . . 0.0 110.043 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -111.8 -39.0 4.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.268 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 29' ' ' TYR . 3.5 p-10 -127.54 -0.98 6.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.602 -0.687 . . . . 0.0 109.641 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -106.25 97.68 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 109.736 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' CZ ' ' A' ' 63' ' ' TYR . 6.5 mp -100.2 60.09 1.03 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.428 -0.795 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 168.17 -115.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 110.237 -179.233 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 3.1 ttm180 -122.46 145.35 48.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.184 -1.572 . . . . 0.0 113.142 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.37 108.31 19.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' CB ' ' HG3' ' A' ' 86' ' ' ARG . 1.4 t70 -90.33 162.37 15.19 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.917 -1.114 . . . . 0.0 111.247 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -155.78 101.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.26 150.52 22.01 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.656 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.06 119.9 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.104 -0.998 . . . . 0.0 110.675 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.604 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -61.47 -152.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.584 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.881 ' CG ' HD12 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -166.37 -50.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.864 -1.148 . . . . 0.0 110.928 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' CA ' HG22 ' A' ' 53' ' ' ILE . 11.1 ttmt -67.8 -57.91 5.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.095 . . . . 0.0 108.521 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 79' ' ' THR . 86.2 m -99.06 10.81 40.7 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 81' ' ' GLY . 24.3 mmt85 58.88 18.49 6.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.536 -0.727 . . . . 0.0 109.789 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.604 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -0.36 -69.68 0.0 OUTLIER Glycine 0 N--CA 1.501 3.03 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.315 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -170.05 -173.14 1.47 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.736 -1.449 . . . . 0.0 111.371 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -146.23 137.2 24.38 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.8 tt -171.25 163.65 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.17 . . . . 0.0 110.516 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -149.43 160.86 43.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.596 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HG3' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -150.53 147.9 28.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 111.269 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.932 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -124.7 89.82 3.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.638 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 2.1 m120 -153.52 -146.43 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.685 -1.26 . . . . 0.0 110.929 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 60.35 52.8 50.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -67.01 136.6 41.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.408 1.741 . . . . 0.0 111.253 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.279 -179.756 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER 173.6 148.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -1.149 . . . . 0.0 110.413 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -66.3 -176.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 174.78 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.937 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.965 HG22 ' HG2' ' A' ' 42' ' ' MET . 1.1 pp -89.37 167.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 120.979 -1.076 . . . . 0.0 110.324 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.149 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -115.11 -160.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.995 -1.065 . . . . 0.0 110.672 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 40.3 t0 -135.46 52.74 2.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.844 -1.16 . . . . 0.0 112.123 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.908 HG22 ' O ' ' A' ' 38' ' ' ILE . 29.8 pt 39.83 46.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.168 0.985 . . . . 0.0 110.314 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -134.02 -69.15 0.07 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.785 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 45.7 Cg_endo -79.28 -63.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.845 1.445 . . . . 0.0 111.28 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.149 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.5 m-85 -47.39 -36.02 9.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.025 -1.047 . . . . 0.0 109.212 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.909 HG22 HG13 ' A' ' 38' ' ' ILE . 1.7 p -52.3 -57.66 9.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.602 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -64.87 -15.97 62.62 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.059 179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.56 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 5.7 m120 -82.82 -68.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.271 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 3.0 pp -40.93 -28.76 0.09 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.456 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 20' ' ' VAL . . . -71.42 -53.34 10.35 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -76.58 -42.49 42.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -1.127 . . . . 0.0 110.837 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' ALA . 7.6 m-85 -63.63 -64.86 0.78 Allowed 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.44 -0.788 . . . . 0.0 110.065 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.42 -66.22 0.42 Allowed 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.625 -0.672 . . . . 0.0 110.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 16' ' ' GLY . 30.5 m -42.43 -26.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 120.961 -1.087 . . . . 0.0 110.149 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -94.77 -69.86 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.969 ' HB2' HD13 ' A' ' 85' ' ' LEU . 22.7 mm-40 -55.37 -35.01 64.79 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.247 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -69.69 -59.66 2.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.057 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 61.7 t-20 -51.38 -45.32 62.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -54.46 46.67 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.703 -0.799 . . . . 0.0 108.965 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -57.06 -19.1 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.636 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.66 70.91 1.33 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -126.74 -74.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.4 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -106.75 -71.36 0.76 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.12 18.01 9.63 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -135.96 -140.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -1.159 . . . . 0.0 110.287 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 32' ' ' LEU . 2.7 mm? -83.24 152.38 25.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.295 -0.878 . . . . 0.0 110.799 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.97 50.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.633 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 6.5 p90 -162.85 123.0 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.74 -59.26 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.992 -1.068 . . . . 0.0 111.314 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 mmmt -69.09 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.993 -1.067 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.4 t -161.13 173.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.7 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -123.96 103.35 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.959 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.652 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -101.74 -60.48 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.953 -1.092 . . . . 0.0 110.185 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.4 Cg_endo -86.76 54.43 3.07 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.176 1.092 . . . . 0.0 110.336 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 1.071 ' SG ' HD12 ' A' ' 60' ' ' LEU . 4.5 t -102.67 110.55 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.965 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.0 mtt -113.75 175.75 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 110.628 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 2.3 ttpt -147.68 120.7 8.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -114.78 160.98 18.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.1 m -163.53 153.42 15.21 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.87 -1.144 . . . . 0.0 110.364 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -122.13 41.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.833 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.81 -144.42 0.06 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.02 0.914 . . . . 0.0 111.92 -177.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 47' ' ' TYR . 2.0 pt-20 -68.81 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.291 1.043 . . . . 0.0 112.939 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 3.1 p30 -163.47 -46.41 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HB3' ' CD ' ' A' ' 51' ' ' ARG . 2.7 mp0 -107.53 -41.11 5.14 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.508 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.512 ' CD ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -171.88 14.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.758 -1.214 . . . . 0.0 112.828 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.639 ' O ' HD12 ' A' ' 53' ' ' ILE . 12.3 pt-20 -105.71 -145.39 0.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.511 -1.368 . . . . 0.0 110.494 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.694 HG23 ' CG ' ' A' ' 77' ' ' TYR . 0.7 OUTLIER -170.06 143.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -139.38 -76.89 0.35 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.799 -1.188 . . . . 0.0 112.551 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 45' ' ' THR . . . -144.98 175.1 24.77 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.409 -1.853 . . . . 0.0 110.735 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -152.87 110.21 3.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.427 -1.043 . . . . 0.0 111.018 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.0 pm0 -124.8 124.46 42.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.51 169.67 10.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.566 -1.334 . . . . 0.0 113.267 -177.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' HB3' ' NE ' ' A' ' 70' ' ' ARG . 6.7 mp0 -133.66 123.08 24.39 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.071 HD12 ' SG ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -121.24 72.59 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 0.0 109.888 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.621 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -68.23 107.13 2.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.8 m -158.29 -160.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.346 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.99 129.24 22.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.515 -0.741 . . . . 0.0 109.932 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -122.0 -130.27 0.27 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 -18.76 30.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 108.744 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 9.6 p-10 -162.4 23.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.565 -0.71 . . . . 0.0 109.735 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -117.07 71.47 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.384 -0.823 . . . . 0.0 110.32 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.876 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 4.6 mt -81.73 52.6 1.95 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -168.62 -153.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.547 -0.721 . . . . 0.0 109.81 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 ttm180 -106.52 119.64 39.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 111.321 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.753 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -80.6 107.19 13.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t70 -87.64 160.37 18.18 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.732 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.73 112.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.905 0.86 . . . . 0.0 109.745 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -103.12 144.17 31.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.005 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.5 mt-10 -153.58 105.75 2.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.461 -1.399 . . . . 0.0 112.335 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.626 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 1.7 p-10 -50.66 173.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.521 0.677 . . . . 0.0 111.03 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.694 ' CG ' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.17 -72.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.138 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.0 tppt? -120.2 -34.34 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.644 ' O ' HG22 ' A' ' 79' ' ' THR . 3.2 m -90.43 9.33 29.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.364 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.544 ' HA ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER 66.33 55.38 0.86 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.496 -0.752 . . . . 0.0 111.057 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.626 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -51.33 -99.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -158.21 -165.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.279 . . . . 0.0 111.052 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 79.4 mttt -158.18 97.93 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -171.17 -172.99 1.19 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 110.605 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.969 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -170.3 167.67 8.36 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.646 -0.659 . . . . 0.0 109.329 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.9 mtm180 -143.45 -176.21 4.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.933 -1.105 . . . . 0.0 111.198 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.843 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 17.3 m-85 -155.98 66.79 0.6 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -154.16 -161.41 1.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.81 -1.182 . . . . 0.0 111.624 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 73.05 54.7 6.82 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -176.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.1 Cg_endo -62.57 177.12 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.82 1.958 . . . . 0.0 112.065 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.461 HG13 ' OH ' ' A' ' 61' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.196 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER 71.29 -148.55 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.318 -1.107 . . . . 0.0 110.128 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.526 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 7.0 p-90 -144.03 169.27 18.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.783 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 177.28 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.063 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.0 HG22 ' HG3' ' A' ' 42' ' ' MET . 6.9 pt -69.89 -172.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mm -131.1 -138.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.535 ' O ' HD11 ' A' ' 38' ' ' ILE . 19.3 m-20 -142.07 -146.83 0.2 Allowed 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.791 -1.193 . . . . 0.0 110.221 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt -113.62 47.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.611 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -157.39 -60.9 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.357 -1.402 . . . . 0.0 111.777 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.815 ' HG2' HG22 ' A' ' 6' ' ' ILE . 38.6 Cg_endo -64.92 -68.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.527 1.277 . . . . 0.0 112.527 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.659 ' HD1' HG21 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -65.36 -23.53 67.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.483 -1.385 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' N ' ' A' ' 9' ' ' GLY . 10.0 p -48.62 -53.36 18.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.4 tp60 -64.02 -29.78 70.9 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.072 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 3.8 m120 -66.02 -58.73 4.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.605 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.833 HD13 ' CD2' ' A' ' 60' ' ' LEU . 9.0 tp -41.03 -66.99 0.28 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -43.46 -29.31 1.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 20' ' ' VAL . 70.5 mmtt -88.67 -82.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 110.418 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -41.6 -27.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.486 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 15' ' ' LEU . . . -81.2 -70.5 0.53 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 17' ' ' LYS . 4.4 p -41.57 -25.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.324 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ALA . 59.3 t0 -92.7 -72.5 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.085 -1.01 . . . . 0.0 110.516 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.974 ' HB2' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -57.83 -28.96 64.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.452 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.3 tt0 -72.43 -58.97 2.97 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 17.0 m-20 -54.14 -51.82 63.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -51.45 -48.62 62.69 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.456 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.054 HD11 HD11 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -53.75 -20.44 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.529 0.68 . . . . 0.0 109.294 178.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.68 22.86 5.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 1.5 tp60 -120.96 65.19 0.86 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.443 -1.033 . . . . 0.0 109.664 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 7.0 t80 -89.98 23.11 2.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.439 -0.788 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.69 -58.71 1.75 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.846 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -168.32 -96.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -1.229 . . . . 0.0 110.5 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.846 HD12 ' HB3' ' A' ' 31' ' ' ARG . 1.9 mp -112.11 -175.39 2.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -155.35 49.67 0.55 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.302 -0.874 . . . . 0.0 110.088 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.669 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 43.5 p90 179.65 55.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.471 -0.768 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 20.9 t-20 -85.77 -54.24 4.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.454 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.806 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.54 -105.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.021 -1.049 . . . . 0.0 110.962 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.7 t -161.06 172.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.53 -1.356 . . . . 0.0 111.775 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.56 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.2 pp -121.37 97.62 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.611 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -96.04 -55.56 0.21 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.863 -1.148 . . . . 0.0 109.866 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.2 Cg_endo -86.87 54.18 2.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.554 1.292 . . . . 0.0 110.362 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 60' ' ' LEU . 7.5 t -91.25 92.94 8.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 1.0 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -90.68 126.4 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.155 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -123.63 155.78 37.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 1.4 ptpp? -164.54 173.5 11.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.4 m -157.86 158.07 34.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.8 pt -118.74 48.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -116.45 164.07 15.1 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -178.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -90.43 -125.87 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.884 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 170.96 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.865 -1.147 . . . . 0.0 110.553 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 49' ' ' ASN . 14.8 mp0 -129.26 -3.23 4.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' NE ' ' HA ' ' A' ' 51' ' ' ARG . 5.7 tpm_? -128.83 -30.94 2.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.288 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 17.2 pt-20 -170.28 -165.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.701 HD13 ' CE1' ' A' ' 77' ' ' TYR . 7.6 tt -152.6 107.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.731 0.776 . . . . 0.0 109.566 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -82.77 -76.43 0.27 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.86 -1.15 . . . . 0.0 112.103 -178.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 45' ' ' THR . . . -172.28 173.22 45.23 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 117.772 -2.156 . . . . 0.0 111.237 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HA ' HG23 ' A' ' 45' ' ' THR . 11.3 m-85 -115.65 -179.19 3.58 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.82 -0.812 . . . . 0.0 110.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 7.4 pt-20 171.34 137.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.807 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -151.06 171.78 16.79 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 117.432 -1.707 . . . . 0.0 113.974 -178.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.553 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt-30 -129.24 124.82 35.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.833 ' CD2' HD13 ' A' ' 15' ' ' LEU . 23.7 tp -117.67 71.76 0.83 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.871 -1.143 . . . . 0.0 109.83 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -69.53 107.01 3.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' CD ' ' A' ' 67' ' ' LYS . 13.0 m -158.2 -160.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.343 -0.848 . . . . 0.0 109.685 -177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -141.32 139.1 33.53 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.473 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.669 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -132.98 -113.08 0.22 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.374 -0.829 . . . . 0.0 109.508 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -30.6 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.125 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -143.18 12.82 1.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.652 -0.655 . . . . 0.0 109.51 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HZ3' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.16 87.71 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.525 -0.735 . . . . 0.0 110.03 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 1.5 mt -93.57 63.21 3.42 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.657 -0.652 . . . . 0.0 109.773 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.62 -118.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.573 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 48.0 ttp85 -123.76 146.08 48.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.402 -1.436 . . . . 0.0 112.807 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -109.48 106.56 16.36 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 6.1 t70 -84.74 159.88 20.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 110.753 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.807 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -160.11 119.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.503 0.668 . . . . 0.0 109.577 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HB3' ' CB ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -108.75 153.39 23.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.046 . . . . 0.0 109.528 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 2.5 mt-10 -152.19 104.75 2.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.641 -1.287 . . . . 0.0 112.206 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 3.2 p30 -63.96 170.51 3.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.499 0.666 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.701 ' CE1' HD13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -149.03 -75.14 0.17 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.563 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 10.9 tttm -117.26 -34.4 4.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.307 -0.871 . . . . 0.0 108.871 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.679 ' O ' HG22 ' A' ' 79' ' ' THR . 4.5 m -87.91 12.32 13.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.483 -0.76 . . . . 0.0 109.159 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.553 ' NH2' ' HA ' ' A' ' 79' ' ' THR . 0.7 OUTLIER 59.57 55.29 4.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.732 -0.605 . . . . 0.0 111.411 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.624 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -53.71 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.514 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 1.7 mtm-85 -155.65 -169.45 3.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.235 . . . . 0.0 110.715 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -162.29 82.22 0.54 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 HD11 ' A' ' 26' ' ' ILE . 10.5 tp -171.17 178.72 3.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.353 -0.842 . . . . 0.0 109.639 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.974 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -154.58 167.99 28.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 6.5 mtt-85 -139.48 -177.7 5.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.772 -1.205 . . . . 0.0 111.45 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.693 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 11.0 m-85 -156.19 82.89 0.99 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.669 -0.644 . . . . 0.0 109.399 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -161.21 -164.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.615 -1.303 . . . . 0.0 111.371 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.555 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 80.6 53.72 3.95 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.2 Cg_endo -60.09 149.67 83.37 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.828 1.962 . . . . 0.0 111.828 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 91' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.109 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.505 ' CA ' HD12 ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.561 -1.416 . . . . 3.5699999999999998 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HG2' ' C ' ' A' ' 1' ' ' GLY . 13.6 mm-40 -136.19 135.99 39.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -1.146 . . . . 2.79 110.2 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -115.53 152.59 32.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 3.5800000000000001 110.202 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 3.8 pt-20 -163.69 134.08 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.92 . . . . 2.7000000000000002 110.177 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' A' ' 42' ' ' MET . 16.7 pt -82.34 175.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.055 -1.028 . . . . 1.3600000000000001 110.491 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.083 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.35 -162.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.251 -0.906 . . . . 2.4100000000000001 109.881 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -136.36 50.17 2.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.14 . . . . 2.4300000000000002 111.515 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 7' ' ' ASP . 11.5 tt 40.18 43.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.936 0.874 . . . . 1.72 110.043 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.81 -62.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.295 -0.955 . . . . 0.84999999999999998 110.804 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.9 Cg_endo -86.34 -61.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.503 1.265 . . . . 0.93000000000000005 110.896 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.1 m-85 -50.06 -31.89 14.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.993 -1.067 . . . . 1.3899999999999999 109.387 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.716 HG22 ' CG2' ' A' ' 38' ' ' ILE . 7.2 p -60.2 -58.67 7.53 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.124 -1.436 . . . . 0.89000000000000001 107.124 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.9 tt0 -66.73 -19.47 65.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.766 0.793 . . . . 2.3100000000000001 109.18 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 9.9 t-20 -78.19 -56.43 4.47 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.502 0.668 . . . . 1.55 109.547 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 60' ' ' LEU . 7.1 tp -41.55 -66.13 0.37 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.402 0.62 . . . . 2.0800000000000001 109.357 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.67 -43.61 16.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.323 -1.511 . . . . 0.56999999999999995 109.323 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -69.64 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -1.16 . . . . 2.3999999999999999 110.939 -179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.1 m-85 -37.69 -53.71 1.23 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.414 0.626 . . . . 2.25 111.238 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.667 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -43.9 -70.06 0.12 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.475 -0.766 . . . . 0.55000000000000004 110.001 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 32' ' ' LEU . 16.2 t -42.77 -26.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.032 . . . . 1.3999999999999999 110.358 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -91.9 -66.28 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.8100000000000001 109.896 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.109 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.3 mm-40 -60.16 -41.09 92.06 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.581 -1.247 . . . . 2.1699999999999999 108.981 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.827 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -61.46 -53.22 59.3 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.6799999999999999 108.711 178.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -61.86 -46.58 88.82 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.687 -1.205 . . . . 2.2799999999999998 107.824 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -56.92 -48.18 78.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 2.8199999999999998 109.842 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -60.85 -20.18 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.925 -0.71 . . . . 1.6000000000000001 109.844 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.67 28.54 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.572 -1.411 . . . . 0.98999999999999999 109.572 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.521 ' CG ' ' OE2' ' A' ' 23' ' ' GLU . 8.6 tp60 -126.77 65.95 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.152 . . . . 2.3100000000000001 110.019 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 37.4 p90 -88.14 19.15 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 5.4000000000000004 109.961 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.52 -62.62 2.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 2.2599999999999998 109.594 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.931 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.9 mtt180 -168.04 -88.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -1.212 . . . . 3.6099999999999999 109.989 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.931 HD12 ' HB3' ' A' ' 31' ' ' ARG . 2.7 mp -121.83 -177.65 3.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 2.5499999999999998 110.026 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.667 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -140.44 52.43 1.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.298 -0.876 . . . . 0.93000000000000005 109.848 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 32' ' ' LEU . 38.4 p90 -167.86 129.08 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.83 . . . . 3.4399999999999999 110.036 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB2' ' N ' ' A' ' 65' ' ' SER . 7.7 t30 -153.67 -64.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 2.46 110.678 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.98 -94.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.964 . . . . 3.4399999999999999 111.329 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.4 t -157.97 172.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.693 -1.254 . . . . 1.1000000000000001 111.822 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.716 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -129.22 86.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.201 -0.666 . . . . 1.6399999999999999 109.201 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -102.73 -52.14 0.14 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 3.02 110.533 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.3 Cg_endo -85.59 52.8 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.53 1.279 . . . . 0.56999999999999995 110.789 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.5 p -104.2 120.39 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 1.6200000000000001 109.781 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.854 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.7 mtm -119.04 178.02 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 2.0600000000000001 110.631 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -138.61 151.58 47.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 1.6100000000000001 110.461 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 1.9 mttt -148.39 106.21 3.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.362 -0.837 . . . . 2.48 109.889 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.831 HG22 ' H ' ' A' ' 47' ' ' TYR . 2.6 m -112.8 152.55 29.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.62 110.173 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.36 41.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.769 -1.567 . . . . 1.96 106.769 178.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.831 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.88 -153.09 0.1 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.402 1.096 . . . . 2.8300000000000001 112.462 -177.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.576 ' OE2' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -68.84 -164.52 0.05 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.38 1.086 . . . . 3.6499999999999999 112.84 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.511 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 13.1 t30 -126.91 -41.12 1.83 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.893 -1.151 . . . . 4.0899999999999999 107.893 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 16.4 tt0 -175.28 28.63 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.84 -0.538 . . . . 4.2400000000000002 109.637 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -171.05 -24.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.927 -1.108 . . . . 5.1600000000000001 112.62 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 22.9 pm0 -115.07 -146.23 0.4 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.272 -1.518 . . . . 2.8799999999999999 111.61 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.11 HD11 ' CE1' ' A' ' 77' ' ' TYR . 10.7 tt -169.42 143.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 109.633 -0.506 . . . . 1.99 109.633 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -139.52 -73.88 0.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.647 -1.221 . . . . 2.8799999999999999 112.752 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.803 ' O ' HG23 ' A' ' 45' ' ' THR . . . -149.57 173.67 29.3 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.263 -1.923 . . . . 0.59999999999999998 110.172 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CZ ' ' HE3' ' A' ' 43' ' ' LYS . 7.5 t80 -150.53 98.31 2.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.29 -1.124 . . . . 3.8300000000000001 110.87 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 15.8 pt-20 -120.0 174.01 6.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 2.5299999999999998 108.914 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 1.107 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -159.6 177.64 10.69 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 117.952 -1.499 . . . . 1.79 113.45 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -135.45 117.24 15.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.589 -1.263 . . . . 2.1400000000000001 107.589 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 41' ' ' CYS . 2.2 tp -116.0 72.41 0.81 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.69999999999999996 109.513 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.061 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.63 111.74 5.64 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.117 -1.068 . . . . 1.6100000000000001 108.117 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.697 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.6 m -158.13 -158.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.789 0.804 . . . . 0.41999999999999998 109.813 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.0 t80 -143.61 126.21 15.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.699 -0.626 . . . . 1.26 109.535 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -121.44 -136.45 0.32 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.393 -0.817 . . . . 0.75 109.884 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -87.34 -25.73 23.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 1.3899999999999999 108.964 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 15.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 1.78 109.567 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.912 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -118.29 79.2 1.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.3600000000000001 110.11 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mp -89.73 57.67 3.98 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.622 -0.881 . . . . 1.75 108.622 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -173.09 -121.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.074 -1.05 . . . . 1.8500000000000001 110.023 -178.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 30.5 ttm180 -133.84 124.76 27.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.325 -1.484 . . . . 1.9099999999999999 112.215 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -81.79 103.35 11.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.984 -1.487 . . . . 0.46999999999999997 106.984 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.45 156.04 19.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 1.75 110.15 -178.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.107 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -159.22 141.74 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.513 -0.742 . . . . 1.1699999999999999 109.863 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -127.96 153.32 46.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.238 -0.914 . . . . 1.23 109.049 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -157.67 106.42 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.635 -1.291 . . . . 2.2999999999999998 111.772 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 1.4 p30 -48.79 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.502 0.667 . . . . 1.74 111.224 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 1.11 ' CE1' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.31 -38.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 3.1400000000000001 109.487 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.053 ' HB2' HG23 ' A' ' 53' ' ' ILE . 1.5 ttpt -150.55 -42.92 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.939 -0.763 . . . . 4.0899999999999999 108.939 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -90.98 18.02 7.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.816 -0.809 . . . . 3.5499999999999998 108.816 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' CD ' ' N ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER 58.43 52.33 7.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 6.1600000000000001 110.823 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.585 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -44.72 -93.06 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.215 -1.554 . . . . 2.4399999999999999 109.215 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -161.33 -167.44 1.76 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.169 -1.194 . . . . 5.0199999999999996 110.796 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -165.25 86.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.395 -0.965 . . . . 3.4500000000000002 108.395 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.643 HD11 HG12 ' A' ' 26' ' ' ILE . 10.0 tp -171.25 179.74 2.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.318 -0.864 . . . . 2.4199999999999999 109.338 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.109 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -155.65 172.28 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.103 -0.998 . . . . 1.22 110.094 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.533 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 3.9 mtt180 -142.33 -176.67 4.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -0.894 . . . . 2.6200000000000001 110.905 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 48.5 m-85 -154.93 64.63 0.65 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.73999999999999999 108.954 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.87 -157.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 1.9299999999999999 111.26 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.46 52.5 30.33 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.193 -3.163 . . . . 1.21 105.193 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.4 Cg_endo -67.55 -175.03 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.582 1.833 . . . . 2.1400000000000001 111.933 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.061 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.1 m . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 117.966 -1.016 . . . . 2.25 110.387 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.63 ' CA ' ' CE1' ' A' ' 47' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 45' ' ' THR . 6.2 mt-10 63.05 -121.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -1.157 . . . . 0.0 109.823 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.512 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 51.2 p-90 -118.59 169.98 9.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.807 -1.183 . . . . 0.0 110.036 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 1.4 tt0 175.79 115.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 42' ' ' MET . 15.2 pt -82.77 -176.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.742 HG21 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -116.39 -165.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.089 -1.007 . . . . 0.0 110.543 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.658 ' O ' HG22 ' A' ' 8' ' ' ILE . 25.3 m-20 -136.66 49.99 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.945 -1.097 . . . . 0.0 111.461 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt 39.7 42.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -145.47 -68.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.975 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 43.8 Cg_endo -73.77 -84.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.689 1.363 . . . . 0.0 111.392 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 24.7 m-85 -39.68 -31.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.012 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.029 HG22 HD12 ' A' ' 38' ' ' ILE . 11.7 p -55.97 -56.89 15.28 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.85 -1.156 . . . . 0.0 108.21 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.516 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -57.34 -17.83 14.24 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.41 179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.57 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -79.86 -60.56 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.702 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 12' ' ' THR . 1.2 pp -41.57 -30.68 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.66 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.41 -49.28 20.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' PHE . 10.4 tptt -71.62 -69.36 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -1.05 . . . . 0.0 110.21 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-85 -39.75 -62.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.483 0.659 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.12 -72.45 0.06 Allowed 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 15.7 t -38.52 -26.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.756 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 19' ' ' ALA . 9.4 m-20 -95.09 -70.73 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 110.26 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.822 ' CD ' HD11 ' A' ' 73' ' ' ILE . 1.8 mt-10 -57.96 -26.87 62.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.579 -1.249 . . . . 0.0 109.062 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.9 tt0 -74.34 -58.91 2.99 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.1 m120 -56.81 -44.73 82.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.461 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.94 -52.68 63.28 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.793 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 85' ' ' LEU . 7.3 tp -63.68 -12.87 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.264 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.64 59.48 0.43 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -159.12 80.29 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 109.991 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.464 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 51.7 p90 -103.73 28.07 6.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -41.56 -53.41 4.32 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.959 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER 173.02 -69.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -1.209 . . . . 0.0 110.427 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.959 HD23 ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -135.2 164.76 26.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.324 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -135.13 55.27 1.9 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 11.3 p90 -174.4 60.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.886 . . . . 0.0 110.262 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.637 ' OD1' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -90.1 -56.05 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.63 -106.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.079 . . . . 0.0 111.115 -178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.1 t -160.03 173.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.732 -1.23 . . . . 0.0 111.431 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.029 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.53 118.07 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.498 -0.751 . . . . 0.0 110.162 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.607 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -123.49 -56.87 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.896 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.4 Cg_endo -87.33 48.89 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.212 1.111 . . . . 0.0 110.354 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 6' ' ' ILE . 2.7 t -91.27 128.81 37.24 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.537 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.2 mtm -122.96 162.98 21.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -145.19 115.87 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.481 -0.762 . . . . 0.0 109.237 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 1.3 mttp -124.93 152.12 44.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.034 -1.041 . . . . 0.0 110.313 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.3 m -147.41 152.51 38.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -122.81 41.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.796 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.07 -143.35 0.07 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.929 0.871 . . . . 0.0 111.704 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 3.0 pt-20 -65.96 -163.97 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 112.62 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 2.1 p-10 -159.89 -46.35 0.05 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -115.66 -36.54 4.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.855 -0.528 . . . . 0.0 111.029 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -171.89 20.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.721 -1.237 . . . . 0.0 112.344 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 7.5 pt-20 -117.53 -142.16 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.748 -1.22 . . . . 0.0 110.583 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.793 HG23 ' HB2' ' A' ' 78' ' ' LYS . 7.7 tp -172.52 156.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 2.7 mttt -153.28 -73.01 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.081 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 45' ' ' THR . . . -149.42 175.21 28.71 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.612 -1.756 . . . . 0.0 110.224 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -155.37 104.37 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 110.113 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 44' ' ' LYS . 2.1 pt-20 -105.15 152.31 22.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CB ' HG22 ' A' ' 73' ' ' ILE . 13.5 t80 -128.27 148.74 50.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.644 -1.285 . . . . 0.0 112.673 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.489 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 21.9 mt-30 -134.41 109.9 9.07 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -116.0 71.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.973 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -72.98 108.44 5.89 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.684 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 61' ' ' TYR . 33.6 m -159.86 -159.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.593 -0.692 . . . . 0.0 109.371 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 3.6 t80 -135.69 142.07 45.04 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.527 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -137.08 -118.99 0.15 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -99.42 -28.97 13.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.018 -1.051 . . . . 0.0 109.222 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -148.99 18.28 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.736 0.779 . . . . 0.0 109.143 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.64 ' NZ ' HD13 ' A' ' 15' ' ' LEU . 7.0 ttmt -109.18 79.15 1.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.511 0.672 . . . . 0.0 110.104 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.7 mp -85.89 57.59 4.56 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 109.263 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.52 -124.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 7.6 ttm180 -127.19 144.42 51.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.199 -1.563 . . . . 0.0 113.486 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -112.39 111.59 22.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -99.04 170.06 8.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.774 -1.204 . . . . 0.0 110.369 -177.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.85 HD12 ' O ' ' A' ' 84' ' ' LEU . 3.1 tp -151.62 113.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.768 0.794 . . . . 0.0 109.237 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 21.9 t -97.85 151.45 20.21 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.08 . . . . 0.0 109.5 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -148.8 110.08 4.4 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.387 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -54.0 156.88 2.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.417 -0.802 . . . . 0.0 111.218 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.13 -68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.114 -0.991 . . . . 0.0 108.801 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.793 ' HB2' HG23 ' A' ' 53' ' ' ILE . 39.0 tttm -124.9 -37.2 2.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.1 t -75.69 -2.84 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' GLY . 5.7 mmm180 73.62 46.03 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.094 0.473 . . . . 0.0 111.206 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -63.4 -130.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.684 ' NH1' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -174.04 174.16 3.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.419 -1.636 . . . . 0.0 111.518 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 74' ' ' SER . 11.8 tttt -103.08 125.63 49.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.85 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.7 tp -171.18 -170.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.969 -1.082 . . . . 0.0 110.037 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -171.21 -179.96 2.83 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.229 -0.92 . . . . 0.0 110.695 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 5.8 ptm85 -170.25 112.8 0.45 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.125 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.72 ' HE2' HG21 ' A' ' 26' ' ' ILE . 6.8 m-85 -90.85 86.66 6.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.525 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.619 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -160.78 -171.34 3.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.818 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . 91.9 59.65 1.31 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 37.1 Cg_endo -59.43 125.16 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.502 1.791 . . . . 0.0 112.116 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 2.6 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.211 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.46 162.46 18.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -1.144 . . . . 0.0 110.206 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 29.6 p90 -154.22 146.85 24.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 48.4 mt-10 -157.6 -174.54 4.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' CG1' HD13 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -121.85 171.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 110.035 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.941 HG13 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -81.1 -164.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.329 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.1 t0 -147.43 46.7 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.439 -0.788 . . . . 0.0 110.658 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.9 tt 39.88 40.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.657 0.741 . . . . 0.0 109.84 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -146.54 -61.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.628 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.4 Cg_endo -83.87 -77.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.574 1.302 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.737 ' CG ' HG22 ' A' ' 6' ' ' ILE . 86.1 m-85 -39.89 -35.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 110.284 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 1.06 HG22 HD12 ' A' ' 38' ' ' ILE . 9.7 p -61.61 -59.95 4.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' N ' ' OG1' ' A' ' 12' ' ' THR . 35.5 tt0 -66.73 -15.27 63.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.52 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 43.8 m-20 -78.4 -57.72 3.63 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.548 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -42.31 -50.73 4.98 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 1.021 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.64 -56.34 16.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -67.4 -77.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -1.081 . . . . 0.0 110.696 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 14' ' ' ASN . 16.8 m-30 -33.69 -63.99 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.569 0.699 . . . . 0.0 111.355 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 33' ' ' THR . . . -42.2 -71.89 0.07 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 12.5 t -39.86 -27.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 1.6 t70 -92.3 -71.0 0.67 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 2.8 pt-20 -54.35 -29.01 46.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.38 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -72.53 -60.18 2.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -59.3 -39.14 82.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.306 -1.358 . . . . 0.0 107.916 178.132 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -60.46 -48.94 79.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.37 -32.74 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.417 -0.802 . . . . 0.0 110.606 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.41 42.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.493 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -149.67 79.49 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -1.073 . . . . 0.0 108.889 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 31' ' ' ARG . 20.3 p90 -83.27 17.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 110.811 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 31' ' ' ARG . . . -43.1 -25.71 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.846 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER 76.84 -4.93 2.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.722 -0.87 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 31' ' ' ARG . 15.2 mt -121.08 130.04 53.59 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.755 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -163.44 42.79 0.11 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.552 0.692 . . . . 0.0 109.789 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 31.0 p90 -174.42 99.23 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.687 -0.633 . . . . 0.0 109.895 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.8 t-20 -141.58 -52.42 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.903 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -70.51 -98.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.0 111.494 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 38' ' ' ILE . 1.1 t -161.83 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.798 -1.189 . . . . 0.0 111.051 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.06 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -140.59 123.96 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.565 0.698 . . . . 0.0 109.709 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.558 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 mtt180 -140.7 -56.59 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.6 Cg_endo -83.52 42.48 1.25 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.17 1.089 . . . . 0.0 111.712 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 38' ' ' ILE . 20.5 p -103.22 129.62 50.21 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 109.333 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -121.74 163.22 19.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.0 111.035 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -117.89 155.19 30.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.752 . . . . 0.0 109.958 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 27.0 mttt -159.79 118.64 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.947 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.8 m -119.72 148.83 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.634 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -109.02 48.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.753 ' HD2' HD12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -107.42 169.55 8.51 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.486 -0.759 . . . . 0.0 110.884 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 2.8 tp10 -74.33 -102.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 109.802 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.509 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 7.3 t-20 179.64 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.016 . . . . 0.0 110.288 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -149.23 12.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 109.864 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.44 -25.01 4.85 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 48' ' ' GLU . 12.1 pt-20 -170.11 179.94 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.92 . . . . 0.0 110.956 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.753 HD12 ' HD2' ' A' ' 47' ' ' TYR . 1.8 tp -138.3 116.07 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.444 -0.785 . . . . 0.0 109.353 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -94.72 -71.6 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.075 -1.015 . . . . 0.0 112.157 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.947 ' O ' HG23 ' A' ' 45' ' ' THR . . . -149.3 -176.62 22.7 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.481 -1.819 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 0.8 OUTLIER -162.44 107.68 1.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.682 -0.893 . . . . 0.0 109.936 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.1 pp20? -126.87 177.26 6.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.817 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -161.96 171.89 16.89 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.216 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.501 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 26.8 mt-30 -130.28 125.29 34.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -121.49 75.11 1.16 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.842 -1.161 . . . . 0.0 109.738 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . 2.1 t80 -74.11 111.04 8.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.141 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.627 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 17.7 m -159.0 -154.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.784 0.802 . . . . 0.0 109.068 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 1.061 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.8 t80 -139.68 134.81 32.48 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.299 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -130.16 -126.65 0.21 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.361 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -103.14 -34.12 8.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.082 -1.011 . . . . 0.0 110.113 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 8.1 p-10 -132.65 0.83 3.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -114.38 104.09 11.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.845 . . . . 0.0 109.622 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.061 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 10.2 mt -100.58 66.61 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.461 -0.774 . . . . 0.0 109.852 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 167.68 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 31.4 ttm180 -121.26 148.09 44.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.127 -1.608 . . . . 0.0 112.909 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.756 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -113.93 107.52 15.81 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 13.8 t70 -88.57 165.92 14.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.957 -1.089 . . . . 0.0 110.639 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.817 HG22 ' CD1' ' A' ' 58' ' ' TYR . 3.2 tp -165.29 112.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.639 0.733 . . . . 0.0 109.301 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.5 p -108.76 162.44 14.17 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.652 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -170.12 117.72 0.56 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.781 . . . . 0.0 109.792 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -58.33 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.443 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CG ' ' CG1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -167.81 -59.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.931 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -54.22 -46.62 72.57 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -107.35 -8.39 16.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER 56.41 31.68 19.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.572 -0.705 . . . . 0.0 110.324 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' ARG . . . -126.42 80.66 0.36 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.23 -1.462 . . . . 0.0 111.548 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.593 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 21.3 mtt180 -170.09 78.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.924 . . . . 0.0 108.644 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -100.65 146.98 26.5 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.222 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 5.0 tp -170.47 123.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -125.16 167.85 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.211 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 60.1 mtm180 -157.88 119.26 3.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.964 -1.085 . . . . 0.0 111.993 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 12.8 m-85 -107.43 71.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.71 -161.81 1.33 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.384 -1.326 . . . . 0.0 111.406 -179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.44 52.0 6.32 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 105.345 -3.102 . . . . 0.0 105.345 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.03 158.21 35.37 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.807 1.951 . . . . 0.0 112.08 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.282 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 47' ' ' TYR . 4.7 pm0 -148.71 176.57 10.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -1.158 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.549 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 26.4 p-90 -143.02 149.57 38.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 34.8 mt-10 -152.77 136.73 16.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 110.656 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -79.28 -174.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 110.664 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -114.2 -167.96 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.341 -0.849 . . . . 0.0 110.297 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 8' ' ' ILE . 33.9 t70 -137.12 49.27 2.04 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 111.16 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.715 ' C ' HG21 ' A' ' 12' ' ' THR . 17.8 tt 38.74 33.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.615 0.722 . . . . 0.0 109.911 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -138.11 -59.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.686 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 44.1 Cg_endo -84.88 -56.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.511 1.269 . . . . 0.0 111.57 -177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 9.2 m-85 -61.78 -27.21 68.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.959 -1.088 . . . . 0.0 109.695 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.982 HG22 HD12 ' A' ' 38' ' ' ILE . 10.8 p -65.44 -59.85 3.57 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.206 -0.934 . . . . 0.0 108.789 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 44.6 tt0 -59.67 -20.38 55.8 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.763 0.792 . . . . 0.0 109.175 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 3.5 m-20 -71.26 -56.22 6.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.748 0.785 . . . . 0.0 109.248 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.023 HD12 HD21 ' A' ' 60' ' ' LEU . 5.7 tt -43.1 -64.25 0.67 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 15' ' ' LEU . . . -41.11 -44.67 3.75 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.82 -79.78 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -1.167 . . . . 0.0 110.643 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -36.99 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.423 0.63 . . . . 0.0 111.086 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -77.4 -74.69 0.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 14.1 t -36.74 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.618 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' ALA . 34.9 t70 -93.05 -79.28 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.5 mt-10 -49.36 -25.8 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.805 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 33' ' ' THR . 11.6 tt0 -77.52 -63.18 1.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 72.6 m-20 -49.53 -48.43 48.3 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -55.01 -51.55 65.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.824 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -49.95 -25.13 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.442 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.85 21.7 5.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.508 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -113.44 62.12 0.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.428 -1.042 . . . . 0.0 109.657 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 29' ' ' TYR . 34.4 p90 -88.8 22.7 2.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.865 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -36.67 -49.56 1.37 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.903 ' HB3' HD12 ' A' ' 32' ' ' LEU . 3.2 mtp180 -178.52 -83.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -1.214 . . . . 0.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' A' ' 31' ' ' ARG . 1.7 mp -123.47 -179.44 4.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 110.524 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -161.24 54.02 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.619 -0.675 . . . . 0.0 109.577 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 34' ' ' PHE . 2.6 p90 -161.53 32.56 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -18.04 20.83 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.802 -1.186 . . . . 0.0 109.09 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.759 ' HB3' ' CA ' ' A' ' 64' ' ' ALA 0.357 0.0 OUTLIER -66.55 -141.24 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 -178.124 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.638 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -161.12 -176.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 113.877 -1.511 . . . . 0.0 106.963 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.982 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -151.61 121.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.379 -1.451 . . . . 0.0 110.96 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.602 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -125.78 -57.16 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 110.126 179.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.8 Cg_endo -85.31 47.81 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.203 1.107 . . . . 0.0 110.89 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.749 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -85.38 129.77 34.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.867 . . . . 0.0 109.525 178.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 41.3 mtm -133.31 161.95 33.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.882 -1.136 . . . . 0.0 110.785 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 10.4 ttpt -129.12 156.31 44.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' CG ' ' HB3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -159.17 113.67 2.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.112 -0.993 . . . . 0.0 110.571 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.3 m -122.13 154.27 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -122.76 64.3 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.595 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 32.1 p90 -101.96 -179.31 3.97 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.688 0.756 . . . . 0.0 111.67 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' CB ' ' HG2' ' A' ' 52' ' ' GLU . 46.1 tp10 -68.94 -97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.649 -0.657 . . . . 0.0 109.974 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -162.22 -61.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.984 -1.073 . . . . 0.0 110.786 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 14.61 0.69 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.795 . . . . 0.0 109.52 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -22.95 5.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.5 -0.75 . . . . 0.0 109.665 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 6.6 pt-20 -163.97 169.05 18.56 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.619 HG21 ' CE2' ' A' ' 77' ' ' TYR . 18.0 mm -122.6 134.53 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.692 ' CG ' HG23 ' A' ' 79' ' ' THR . 0.0 OUTLIER -105.58 -57.24 2.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.096 -1.002 . . . . 0.0 112.203 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 45' ' ' THR . . . -147.43 130.23 3.48 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.843 -1.646 . . . . 0.0 110.003 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -120.77 100.4 7.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.403 -1.057 . . . . 0.0 110.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 50.9 tt0 -123.05 173.83 7.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.352 -0.843 . . . . 0.0 109.225 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.36 173.37 14.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.081 -1.447 . . . . 0.0 113.179 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 2.6 pt20 -128.7 124.27 35.23 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.023 HD21 HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.11 72.58 0.87 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 108.593 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.625 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -71.56 106.42 4.0 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.567 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.713 HG23 ' HE2' ' A' ' 67' ' ' LYS . 17.8 m -163.52 -144.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.767 ' CD1' HD22 ' A' ' 68' ' ' LEU . 22.7 t80 -135.03 161.57 34.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -136.56 -140.31 0.16 Allowed 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.946 0.794 . . . . 0.0 108.924 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 24.3 t -86.91 -1.62 57.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.66 33.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.592 -0.693 . . . . 0.0 109.72 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.807 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -129.98 93.87 3.59 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.836 . . . . 0.0 109.701 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.767 HD22 ' CD1' ' A' ' 63' ' ' TYR . 1.4 mm? -88.46 74.8 8.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 171.52 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.571 -1.33 . . . . 0.0 110.59 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 59' ' ' GLN . 34.2 ttm180 -139.12 147.69 42.25 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.56 -1.338 . . . . 0.0 112.598 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -107.57 103.07 12.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 176.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -83.99 161.34 20.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 110.197 -178.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.693 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -163.01 108.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 121.939 0.875 . . . . 0.0 109.9 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.3 t -107.26 156.35 18.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 108.633 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 29.9 mt-10 -155.07 104.57 2.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.569 -1.332 . . . . 0.0 112.13 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.557 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 1.6 p30 -40.05 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.488 -0.758 . . . . 0.0 111.091 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CE2' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.86 -75.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 178.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 31.8 tptt -115.88 -35.04 4.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 108.988 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.692 HG23 ' CG ' ' A' ' 54' ' ' LYS . 1.2 p -86.13 7.29 25.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 0.0 109.237 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER 66.45 51.7 1.14 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.623 -0.673 . . . . 0.0 111.013 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -60.46 -117.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 10.7 ptm85 -173.52 158.09 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.422 -1.634 . . . . 0.0 112.133 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -103.33 118.23 36.3 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -171.09 146.58 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.031 . . . . 0.0 110.304 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -137.62 158.34 44.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.9 . . . . 0.0 109.59 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -142.8 147.71 35.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.947 -1.096 . . . . 0.0 111.009 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.94 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 8.9 m-85 -119.55 85.56 2.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 109.348 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -168.94 -167.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.635 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 85.96 56.41 2.33 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.0 Cg_endo -61.87 151.37 81.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.508 1.794 . . . . 0.0 111.689 -176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.625 HG12 ' OH ' ' A' ' 61' ' ' TYR . 22.5 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 67.4 mm-40 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -1.133 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.2 p-90 -137.2 161.0 37.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.536 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 1.6 pm0 -172.47 173.03 4.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.724 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.7 173.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.737 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.17 -153.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.532 -0.73 . . . . 0.0 109.717 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -141.04 48.06 1.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.865 -1.147 . . . . 0.0 111.439 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.8 ' C ' HG21 ' A' ' 12' ' ' THR . 15.6 pt 40.17 36.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.932 0.873 . . . . 0.0 109.883 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.51 -59.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.954 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.8 Cg_endo -85.73 -66.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.596 1.314 . . . . 0.0 110.947 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.705 ' CE2' ' CE1' ' A' ' 58' ' ' TYR . 1.1 m-85 -47.42 -32.36 4.96 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.137 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.8 HG21 ' C ' ' A' ' 8' ' ' ILE . 23.6 p -59.9 -57.42 12.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.504 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.21 -26.13 68.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.549 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.532 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -76.83 -49.9 14.71 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.481 0.658 . . . . 0.0 109.832 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.772 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.4 tm? -42.94 -63.7 0.75 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.392 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.739 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -49.05 -41.84 30.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.583 ' O ' HG12 ' A' ' 20' ' ' VAL . 11.1 tptp -68.99 -68.52 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -1.16 . . . . 0.0 110.593 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CE2' ' OD1' ' A' ' 14' ' ' ASN . 18.0 m-30 -54.9 -36.11 64.84 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -58.68 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.815 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 17' ' ' LYS . 9.6 p -38.41 -27.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -87.17 -75.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.866 -1.146 . . . . 0.0 110.107 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.053 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.4 mm-40 -59.47 -36.98 77.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 26' ' ' ILE . 4.0 tt0 -62.62 -49.45 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.038 -1.039 . . . . 0.0 109.251 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.544 ' CB ' ' HB3' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -70.63 -45.33 65.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 30.6 mmtt -58.61 -38.68 78.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 110.052 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.3 tp -71.68 -15.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.0 110.08 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.53 54.63 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 46.2 tp60 -170.2 88.81 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -1.082 . . . . 0.0 109.661 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.544 ' HB3' ' CB ' ' A' ' 24' ' ' ASN . 35.3 p90 -142.83 51.03 1.43 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.09 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -39.24 -29.4 0.11 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.867 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER 174.15 -67.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -1.152 . . . . 0.0 110.016 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 31' ' ' ARG . 2.2 mp -132.62 177.62 7.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.126 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -146.15 53.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.607 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 22.4 p90 178.98 114.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.82 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.4 t30 -150.28 -48.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.0 110.834 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 111.197 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 36' ' ' LYS . 17.0 t -158.31 172.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.633 -1.292 . . . . 0.0 111.361 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.016 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -133.26 99.94 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.757 . . . . 0.0 110.012 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.81 -54.18 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 110.492 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.1 Cg_endo -85.06 50.28 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.491 1.258 . . . . 0.0 111.362 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . 16.5 p -81.35 137.27 35.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' GLN . 6.2 mtp -130.95 169.29 16.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 110.959 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -151.92 138.65 18.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 109.946 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 45' ' ' THR . 8.3 ttmm -137.93 163.47 31.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.679 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.818 HG22 ' H ' ' A' ' 47' ' ' TYR . 5.1 m -163.25 148.67 11.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.075 -1.016 . . . . 0.0 110.879 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 25.3 pt -118.87 40.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.818 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -75.45 -160.09 0.12 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.102 0.953 . . . . 0.0 112.406 -177.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.599 ' HG2' ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.76 -144.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.615 0.721 . . . . 0.0 111.816 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.599 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -118.41 -40.82 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 1.2 mt-10 -174.79 26.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -157.83 -29.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.05 . . . . 0.0 111.832 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.74 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -109.61 -155.34 0.56 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.445 -1.409 . . . . 0.0 111.988 -178.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.789 HG22 ' CG ' ' A' ' 77' ' ' TYR . 37.5 mm -151.92 135.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 1.7 mptt -130.97 -65.52 0.78 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.849 -1.157 . . . . 0.0 112.044 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 45' ' ' THR . . . -141.04 171.07 24.31 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.064 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.42 97.77 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.498 ' OE1' ' HA ' ' A' ' 45' ' ' THR . 4.3 pm0 -92.86 165.52 12.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.064 -1.022 . . . . 0.0 109.513 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.966 ' OH ' HD13 ' A' ' 60' ' ' LEU . 72.4 t80 -137.09 136.81 38.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.164 -0.96 . . . . 0.0 111.283 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.547 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 32.6 mt-30 -135.15 106.82 6.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.016 HD11 ' CD1' ' A' ' 38' ' ' ILE . 2.9 tp -119.41 80.16 1.53 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.01 -1.056 . . . . 0.0 110.076 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -74.4 110.37 8.64 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.747 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.3 m -160.33 -158.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.596 0.712 . . . . 0.0 109.656 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CE2' ' HD2' ' A' ' 36' ' ' LYS . 2.4 t80 -140.82 133.99 29.5 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.67 -0.644 . . . . 0.0 109.474 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -130.16 -124.4 0.21 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.738 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 t -97.73 -17.94 19.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.195 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.41 20.78 0.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.792 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.747 ' CD ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -118.61 81.03 1.62 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -0.791 . . . . 0.0 110.188 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -84.94 57.6 4.52 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.575 -0.703 . . . . 0.0 109.855 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.89 -117.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 110.368 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 21.5 ttp180 -122.96 148.26 45.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.158 -1.589 . . . . 0.0 113.122 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' A' ' 58' ' ' TYR . . . -109.94 105.35 14.48 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 66.2 m-20 -85.2 163.69 18.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.804 -1.185 . . . . 0.0 110.718 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.676 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -160.12 103.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -93.71 157.48 16.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.824 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' CA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -161.46 96.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.867 -1.146 . . . . 0.0 111.465 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 11.6 p-10 -57.21 173.21 0.25 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 111.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.789 ' CG ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -157.65 -73.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.485 -0.759 . . . . 0.0 109.312 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 15.8 tptt -119.0 -33.12 4.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 0.0 109.087 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.545 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -89.26 6.46 40.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 109.579 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' THR . 27.5 mmm-85 67.75 52.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 110.975 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -57.12 -106.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mtm180 -170.05 148.68 3.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.886 -1.361 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.41 95.66 5.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.853 . . . . 0.0 108.796 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.37 -167.74 0.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.095 -1.003 . . . . 0.0 109.979 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.053 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -171.25 171.74 5.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.211 -0.93 . . . . 0.0 109.757 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 30.3 mtt180 -144.77 175.41 10.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.002 -1.062 . . . . 0.0 110.986 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.806 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -151.63 69.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.519 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -155.06 -156.1 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.282 . . . . 0.0 111.105 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 87.68 52.79 2.89 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 106.711 -2.556 . . . . 0.0 106.711 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 39.6 Cg_endo -63.9 140.84 75.2 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.236 1.651 . . . . 0.0 111.276 -177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.343 -179.857 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -86.87 161.78 18.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.262 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 3' ' ' TRP . 5.9 p90 -124.18 170.4 10.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 110.318 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 176.66 111.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.105 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -92.32 178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.379 -0.825 . . . . 0.0 110.594 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.765 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.86 -166.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.65 41.46 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.15 . . . . 0.0 111.155 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 39' ' ' ARG . 4.1 mt 57.18 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.02 0.914 . . . . 0.0 110.291 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' C ' ' HG1' ' A' ' 12' ' ' THR . . . -153.5 -63.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HG2' HG22 ' A' ' 6' ' ' ILE . 44.0 Cg_endo -75.87 -76.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.59 1.31 . . . . 0.0 111.631 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -48.91 -26.65 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.023 -1.048 . . . . 0.0 110.46 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.82 HG22 HG21 ' A' ' 38' ' ' ILE . 26.9 p -57.6 -57.77 11.26 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.943 -1.098 . . . . 0.0 108.26 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.1 mm-40 -63.2 -24.8 68.04 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.77 0.795 . . . . 0.0 109.206 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' LEU . 4.6 t30 -72.14 -56.3 5.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.487 0.66 . . . . 0.0 109.37 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.2 tm? -42.66 -71.72 0.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.66 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.672 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -40.73 -37.82 1.4 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.826 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.7 mttp -76.78 -83.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -1.093 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -45.43 -28.33 0.87 Allowed 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.587 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -63.55 -72.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 17' ' ' LYS . 10.4 p -41.72 -25.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.52 -70.8 0.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 110.112 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.068 ' CB ' HD13 ' A' ' 85' ' ' LEU . 4.5 mm-40 -59.9 -38.5 82.46 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.718 -1.239 . . . . 0.0 109.324 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.855 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -63.58 -51.84 63.56 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.235 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t-20 -67.15 -44.52 79.59 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.163 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -43.11 92.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.42 -0.8 . . . . 0.0 110.092 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -66.6 -21.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.6 36.02 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 3.3 mm100 -134.58 71.55 1.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 24' ' ' ASN . 5.7 t80 -100.66 28.53 5.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.956 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.64 -39.55 0.85 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.74 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.4 mmt180 169.65 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -1.078 . . . . 0.0 110.015 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 31' ' ' ARG . 1.3 mp -120.64 -177.73 3.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.054 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -154.24 49.05 0.62 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.776 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 3.4 t80 179.8 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.547 -0.721 . . . . 0.0 110.228 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -154.22 -48.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 110.579 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.3 mmpt? -69.61 -100.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.7 t -157.89 171.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.605 -1.309 . . . . 0.0 111.669 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.82 HG21 HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -135.41 92.93 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.682 -0.636 . . . . 0.0 109.829 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.77 ' HG2' HD11 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -105.1 -53.26 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.635 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.5 Cg_endo -84.7 50.78 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.538 1.283 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 38' ' ' ILE . 20.6 p -104.12 118.32 36.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.598 ' HB3' HG22 ' A' ' 5' ' ' ILE . 66.4 mtm -126.66 175.6 7.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 58' ' ' TYR . 10.9 tmtt? -152.71 140.68 20.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.038 -1.039 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 13.6 mttt -137.93 121.99 17.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 0.0 109.778 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 55' ' ' GLY . 6.5 m -108.42 154.12 22.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.896 . . . . 0.0 110.746 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 46' ' ' ILE . 3.0 tt -118.68 102.07 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 2' ' ' GLU . 8.7 p90 -110.21 -173.93 2.37 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.281 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.58 ' HB3' ' C ' ' A' ' 52' ' ' GLU . 16.7 pm0 -69.62 -141.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.01 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.551 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 17.8 t30 -141.03 -40.64 0.4 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.741 0.782 . . . . 0.0 109.161 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' GLU . 2.4 tm-20 178.72 32.4 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -165.05 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 111.855 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' C ' ' HB3' ' A' ' 48' ' ' GLU . 24.1 pt-20 -129.09 -152.1 0.5 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.447 -1.408 . . . . 0.0 111.02 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.642 HG22 ' CG ' ' A' ' 77' ' ' TYR . 4.0 mt -160.01 125.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.77 -0.581 . . . . 0.0 109.552 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 18.8 mttm -91.08 -77.5 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 112.036 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 45' ' ' THR . . . -178.49 179.23 48.71 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.059 -2.019 . . . . 0.0 110.085 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 45' ' ' THR . 18.4 m-85 -133.25 119.36 19.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.987 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' OE2' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -124.31 163.75 21.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 0.0 109.623 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.785 ' HE2' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -157.54 165.89 34.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.448 -1.301 . . . . 0.0 112.681 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 5.5 pt20 -124.47 120.41 31.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.785 HD13 ' HE2' ' A' ' 58' ' ' TYR . 2.9 tp -114.43 67.77 0.69 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.7 t80 -68.79 108.65 3.51 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' CD ' ' A' ' 67' ' ' LYS . 27.4 m -159.56 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.596 0.712 . . . . 0.0 109.585 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 1.9 t80 -148.46 130.94 15.75 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.951 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -126.83 -123.74 0.24 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.829 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.0 p -91.53 -32.84 15.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.056 . . . . 0.0 109.551 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.36 14.26 1.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.674 ' CD ' HG23 ' A' ' 62' ' ' VAL . 4.7 ttmt -107.98 78.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.756 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -89.94 68.53 7.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.624 -0.673 . . . . 0.0 109.287 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 173.31 -119.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.28 -0.887 . . . . 0.0 109.863 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 16.4 ttm180 -135.32 124.93 25.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.571 -1.33 . . . . 0.0 111.702 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.44 104.27 12.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.6 t70 -89.39 157.1 18.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 110.167 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.739 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.09 117.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 57' ' ' GLU . 2.1 t -116.66 144.98 43.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.011 -1.056 . . . . 0.0 111.085 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -129.43 159.85 34.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 39.8 m-20 -128.23 -161.09 1.07 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.068 -1.02 . . . . 0.0 111.732 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' CG ' HG22 ' A' ' 53' ' ' ILE . 5.3 t80 166.06 -52.62 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 11.0 tmtt? -87.37 -47.99 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 79.1 p -69.26 -48.7 61.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.639 ' HB3' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 167.38 88.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 176.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 76' ' ' ASP . . . -29.95 109.92 0.03 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -157.61 175.86 13.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.696 -0.884 . . . . 0.0 108.864 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -130.57 151.77 50.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 tp -171.32 128.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.197 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.068 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -130.31 171.96 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.981 -1.075 . . . . 0.0 111.099 -179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.552 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -146.45 -179.0 6.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.851 . . . . 0.0 110.564 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 5.2 m-85 -153.44 67.6 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.528 -0.732 . . . . 0.0 109.199 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.596 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.06 -158.7 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.72 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.622 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.06 48.9 44.33 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 44.5 Cg_endo -69.03 -173.79 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.446 1.761 . . . . 0.0 111.823 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.585 HG12 ' OH ' ' A' ' 61' ' ' TYR . 27.4 m . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -176.07 171.67 2.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -1.157 . . . . 0.0 110.335 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -119.35 -176.5 3.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.476 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER 176.33 112.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 110.105 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.739 HG22 ' SD ' ' A' ' 42' ' ' MET . 1.2 pp -85.68 -179.06 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 110.638 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.103 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -135.24 -161.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.989 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.17 -157.11 0.79 Allowed 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.988 -1.07 . . . . 0.0 109.505 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.864 ' C ' HG21 ' A' ' 12' ' ' THR . 0.9 OUTLIER -101.08 36.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.545 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -128.4 -57.42 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.906 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.6 Cg_endo -82.51 -77.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.369 1.194 . . . . 0.0 111.253 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.0 m-85 -43.63 -29.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.937 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.939 HG22 HD12 ' A' ' 38' ' ' ILE . 24.3 p -62.15 -58.91 6.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -62.47 -15.54 50.42 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.259 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.2 t30 -83.14 -59.13 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.624 0.726 . . . . 0.0 110.052 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 60' ' ' LEU . 1.3 pp -42.57 -31.54 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.649 -0.657 . . . . 0.0 109.704 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.96 -56.64 5.7 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -69.63 -67.15 0.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -1.142 . . . . 0.0 110.525 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.88 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -39.05 -49.27 1.73 Allowed 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.468 0.651 . . . . 0.0 110.424 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.632 ' N ' ' CD1' ' A' ' 18' ' ' PHE . . . -53.74 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.834 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' CG ' ' A' ' 24' ' ' ASN . 2.7 t -37.86 -26.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.46 -0.775 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.7 m-20 -89.76 -73.51 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.616 -1.303 . . . . 0.0 110.039 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.112 ' HB2' HD13 ' A' ' 85' ' ' LEU . 1.8 mt-10 -59.13 -32.91 70.29 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.255 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.848 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -63.69 -56.65 14.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 108.339 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 29' ' ' TYR . 2.3 m120 -62.57 -47.11 85.29 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.757 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.92 -41.19 74.19 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.404 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.9 tp -72.62 -10.91 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.835 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.47 51.31 1.33 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 11.2 tp60 -170.18 90.46 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.487 -1.008 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 31' ' ' ARG . 1.4 t80 -69.35 -33.79 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.883 . . . . 0.0 110.23 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 41.6 27.12 0.29 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 4.1 mtt180 64.52 -143.76 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 110.323 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.773 ' H ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -86.68 75.32 9.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.33 -0.856 . . . . 0.0 110.831 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -41.86 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 110.68 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 32' ' ' LEU . 1.6 t80 164.12 115.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 109.203 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -165.34 -59.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.394 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.738 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.8 tppp? -69.54 -103.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.982 -1.074 . . . . 0.0 111.139 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 36' ' ' LYS . 15.8 t -158.59 172.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.213 . . . . 0.0 111.524 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.972 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -123.8 117.49 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.521 0.677 . . . . 0.0 109.797 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -124.3 -56.27 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.6 Cg_endo -86.61 48.14 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.174 1.091 . . . . 0.0 110.537 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.675 ' C ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -89.18 117.87 28.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 109.675 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.739 ' SD ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -127.57 179.6 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 110.641 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -158.11 134.77 9.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 109.773 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 2.4 tttt -141.34 122.81 15.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 55' ' ' GLY . 17.9 m -101.65 150.47 23.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.9 . . . . 0.0 109.68 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.738 HG22 ' OE2' ' A' ' 57' ' ' GLU . 0.8 OUTLIER -107.21 45.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.882 ' HD2' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -110.3 169.78 8.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.487 0.66 . . . . 0.0 111.095 -178.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.565 ' CB ' ' HG2' ' A' ' 52' ' ' GLU . 20.5 tp10 -86.44 -89.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.559 -0.713 . . . . 0.0 109.792 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 30.2 t30 -175.99 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.414 -0.804 . . . . 0.0 110.492 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 14.09 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.839 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -23.8 3.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 110.109 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.565 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 7.3 pt-20 -168.45 79.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.028 -1.045 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.882 HG23 ' HD2' ' A' ' 47' ' ' TYR . 2.8 mp -68.97 86.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.502 -0.749 . . . . 0.0 109.084 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -56.26 -71.19 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.842 ' O ' HG23 ' A' ' 45' ' ' THR . . . -161.83 162.76 34.3 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.477 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.579 ' HA ' HG23 ' A' ' 45' ' ' THR . 0.3 OUTLIER -123.32 108.3 12.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.545 -0.973 . . . . 0.0 110.028 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.738 ' OE2' HG22 ' A' ' 46' ' ' ILE . 3.0 mp0 -114.73 163.62 15.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.842 . . . . 0.0 108.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -150.8 163.48 38.51 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.916 -179.408 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 95.8 mt-30 -128.11 121.84 30.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -116.33 69.57 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.355 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.031 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.88 109.37 4.99 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.505 -0.747 . . . . 0.0 109.27 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG23 ' CE ' ' A' ' 67' ' ' LYS . 18.3 m -161.51 -163.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.5 t80 -135.19 138.01 43.23 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.887 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 67' ' ' LYS . . . -135.21 -136.22 0.16 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.421 -0.799 . . . . 0.0 110.102 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.535 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -82.82 -37.61 24.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.801 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -138.15 7.42 2.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.689 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -105.44 94.82 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.837 0.827 . . . . 0.0 109.737 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -101.31 64.53 1.02 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.364 -0.835 . . . . 0.0 108.775 178.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 173.08 -123.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.305 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 36.8 ttp180 -130.44 122.71 28.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.526 -1.359 . . . . 0.0 111.944 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -83.01 106.31 14.72 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 22.6 t70 -88.89 170.96 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.762 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -169.94 119.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.565 -0.709 . . . . 0.0 110.17 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.508 ' OG ' ' CG ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -110.89 156.71 20.78 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.016 -1.052 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -148.5 111.81 4.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.489 -1.382 . . . . 0.0 112.138 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.541 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -48.66 150.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.216 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CZ ' HG21 ' A' ' 53' ' ' ILE . 1.7 t80 -147.88 -73.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.933 -1.105 . . . . 0.0 109.932 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 9.7 tmtt? -109.91 -38.17 5.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.791 -1.193 . . . . 0.0 109.547 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.539 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 1.2 m -86.23 8.44 21.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 108.815 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 65.55 49.27 1.84 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.665 -0.647 . . . . 0.0 111.044 179.304 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -62.25 -125.26 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptp180 -173.76 168.01 4.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.397 -1.649 . . . . 0.0 111.9 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' SER . 13.7 mtmm -100.36 120.13 39.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 1.5 tt -171.9 130.81 0.65 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 0.0 109.829 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.112 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -117.1 168.28 10.42 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.0 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 10.8 mtt180 -137.04 -172.07 3.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.488 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 60.1 m-85 -158.32 64.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -154.31 -160.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.728 -1.233 . . . . 0.0 111.71 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.19 50.88 30.7 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -177.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.7 Cg_endo -67.95 -173.86 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 124.564 1.823 . . . . 0.0 111.851 -176.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.031 HG12 ' OH ' ' A' ' 61' ' ' TYR . 25.0 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.38 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.501 ' HA2' HG12 ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -168.05 157.57 9.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -1.194 . . . . 0.0 110.366 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 2.9 p-90 -131.97 170.84 14.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.8 tp10 178.67 160.47 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.731 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.603 HD12 ' SD ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -117.67 173.3 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.039 -1.038 . . . . 0.0 110.444 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.082 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -103.84 -160.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.503 -0.748 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.659 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.9 p30 -132.0 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.977 -1.077 . . . . 0.0 111.644 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.754 ' C ' HG21 ' A' ' 12' ' ' THR . 14.9 tt 41.14 46.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.974 0.892 . . . . 0.0 109.909 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.524 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.66 -62.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD2' HD13 ' A' ' 6' ' ' ILE . 44.1 Cg_endo -84.01 -68.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.733 1.386 . . . . 0.0 111.062 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.082 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -44.58 -29.52 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.4 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.754 HG21 ' C ' ' A' ' 8' ' ' ILE . 17.5 p -64.43 -58.77 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.508 ' N ' ' OG1' ' A' ' 12' ' ' THR . 3.8 tt0 -65.74 -26.72 67.86 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.844 0.831 . . . . 0.0 109.052 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -74.12 -55.16 6.42 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.584 0.707 . . . . 0.0 109.495 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.045 HD11 ' HE3' ' A' ' 67' ' ' LYS . 2.7 tt -37.99 -53.9 1.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.394 0.616 . . . . 0.0 109.924 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.874 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -56.04 -46.59 84.4 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 tttp -73.15 -72.46 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -1.185 . . . . 0.0 111.016 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -39.88 -48.08 2.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.593 0.711 . . . . 0.0 110.868 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 33' ' ' THR . . . -55.34 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.712 -0.618 . . . . 0.0 110.604 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 17' ' ' LYS . 15.0 m -43.89 -23.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 120.952 -1.092 . . . . 0.0 110.546 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -88.73 -73.78 0.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.072 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.04 ' HB2' HD13 ' A' ' 85' ' ' LEU . 20.6 mm-40 -57.69 -37.53 73.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.693 -1.255 . . . . 0.0 109.232 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -64.71 -50.06 68.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.974 -1.078 . . . . 0.0 109.155 178.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 55.1 t-20 -66.02 -46.53 77.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.573 -1.329 . . . . 0.0 107.739 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 4.2 tttp -59.4 -41.54 89.69 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.032 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -73.77 -12.93 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.05 81.44 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.532 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -140.47 -72.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.171 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.465 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.26 -23.25 7.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.937 . . . . 0.0 110.138 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' HA2' ' CB ' ' A' ' 24' ' ' ASN . . . 40.37 28.85 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.981 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.8 mtt-85 -141.91 -68.29 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -1.197 . . . . 0.0 110.586 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 31' ' ' ARG . 16.6 mt -138.2 160.35 39.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 110.702 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' OE2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -164.13 51.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.781 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -176.19 123.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.363 -0.836 . . . . 0.0 109.833 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.4 OUTLIER -158.67 -58.86 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.042 -1.036 . . . . 0.0 111.318 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.772 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.61 -97.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.957 -1.09 . . . . 0.0 111.38 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.7 t -160.48 173.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.521 -1.362 . . . . 0.0 111.617 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.825 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -126.79 109.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.795 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -117.24 -59.4 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.999 . . . . 0.0 110.926 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.6 Cg_endo -83.98 46.84 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.117 1.062 . . . . 0.0 111.119 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' CB ' HD11 ' A' ' 38' ' ' ILE . 18.6 p -88.97 98.0 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.509 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.603 ' SD ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -97.52 -177.58 3.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 0.0 111.013 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -161.86 155.78 21.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.708 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.1 OUTLIER -170.68 126.96 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 110.817 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 55' ' ' GLY . 19.2 m -112.58 152.11 29.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 2.1 mt -123.37 126.25 72.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.889 ' HB2' HD12 ' A' ' 53' ' ' ILE . 11.1 p90 -149.36 162.62 39.71 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.399 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 6.9 tp10 -69.58 -129.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.211 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER 166.41 -19.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.842 -1.161 . . . . 0.0 110.908 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.42 21.65 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.058 . . . . 0.0 109.755 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.33 -32.2 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.934 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.2 pt-20 -171.31 -161.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.623 -1.298 . . . . 0.0 112.449 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.889 HD12 ' HB2' ' A' ' 47' ' ' TYR . 9.8 tp -123.27 157.12 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.9 -63.48 1.45 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.344 -1.473 . . . . 0.0 113.227 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.916 ' O ' HG23 ' A' ' 45' ' ' THR . . . -170.52 166.63 39.83 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 117.409 -2.329 . . . . 0.0 111.992 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.57 ' CG ' ' OG1' ' A' ' 45' ' ' THR . 2.0 t80 -126.91 102.06 6.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.146 -0.62 . . . . 0.0 109.808 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.5 pt-20 -104.08 152.23 22.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 109.558 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -141.94 154.93 45.43 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.14 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 6.1 pt20 -126.05 125.24 42.28 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 15' ' ' LEU . 1.2 tp -121.44 69.54 0.92 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.919 -1.113 . . . . 0.0 109.179 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' C ' HG13 ' A' ' 62' ' ' VAL . 23.0 t80 -69.21 110.52 4.62 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' CD ' ' A' ' 67' ' ' LYS . 31.2 m -159.5 -161.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -142.56 126.62 17.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -119.95 -131.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.632 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 85.1 p -85.69 -25.29 26.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.007 -1.058 . . . . 0.0 109.175 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.59 17.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.045 ' HE3' HD11 ' A' ' 15' ' ' LEU . 1.1 ttmm -110.7 74.5 0.88 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.053 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mt -85.73 66.48 9.66 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 175.31 -119.92 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.455 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 19.6 ttp85 -137.73 125.65 22.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.55 -1.344 . . . . 0.0 111.918 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.69 110.71 17.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.5 t70 -92.03 165.58 13.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 111.032 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.736 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.78 118.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.28 142.06 51.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.861 -1.15 . . . . 0.0 110.771 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 21.7 mt-10 -152.99 132.29 12.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.315 -0.866 . . . . 0.0 109.824 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.611 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -58.07 -154.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 0.0 110.723 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.846 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -160.75 -48.7 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.032 -1.043 . . . . 0.0 111.301 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 53' ' ' ILE . 8.2 pttp -52.47 -42.0 63.84 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.029 -1.044 . . . . 0.0 108.52 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 11.8 t -135.22 14.3 3.52 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 82' ' ' ARG . 2.6 mmm180 67.21 14.65 9.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.754 -0.591 . . . . 0.0 109.443 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . 11.17 -75.72 0.0 OUTLIER Glycine 0 N--CA 1.5 2.956 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.553 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -153.22 -171.8 4.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.845 -1.385 . . . . 0.0 111.44 -178.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -144.13 144.8 31.75 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -172.2 155.8 3.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.971 -1.081 . . . . 0.0 109.602 -179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -142.72 166.24 25.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 11.1 mmt180 -135.32 -174.08 3.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 111.168 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 20.6 m-85 -157.69 61.08 0.48 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -152.27 -157.0 0.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 111.765 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.62 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 68.91 49.3 42.71 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -68.69 -169.26 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 124.436 1.756 . . . . 0.0 112.009 -176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.429 HG12 ' OH ' ' A' ' 61' ' ' TYR . 19.0 m . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.285 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.484 -1.446 . . . . 3.2799999999999998 109.484 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -136.72 151.07 48.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -1.191 . . . . 2.7200000000000002 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.1 p90 -125.19 156.51 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 3.5299999999999998 110.214 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 5.6 pt-20 -166.36 129.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 2.4300000000000002 110.183 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.877 HG22 ' HG2' ' A' ' 42' ' ' MET . 10.8 pt -75.45 176.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.18 -0.95 . . . . 1.3100000000000001 110.42 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.07 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -111.15 -162.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 2.4100000000000001 109.891 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -137.48 49.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.853 -1.154 . . . . 2.1600000000000001 111.597 -179.173 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 7' ' ' ASP . 10.6 tt 40.08 43.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.826 0.822 . . . . 1.6899999999999999 110.038 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.04 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.061 -1.066 . . . . 0.85999999999999999 110.933 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.7 Cg_endo -86.35 -59.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.558 1.294 . . . . 0.90000000000000002 111.131 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 1.07 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.3 m-30 -52.28 -32.7 38.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.957 -1.09 . . . . 1.46 109.318 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.726 HG22 ' CG2' ' A' ' 38' ' ' ILE . 8.5 p -59.19 -57.91 10.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.113 -1.439 . . . . 0.65000000000000002 107.113 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -66.8 -18.47 65.39 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.672 0.749 . . . . 2.1899999999999999 109.141 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 13.6 t-20 -78.02 -63.73 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 1.71 109.833 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.825 HD22 HD21 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -40.22 -63.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.328 0.585 . . . . 2.02 109.573 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -46.16 -46.18 15.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.246 -1.542 . . . . 0.52000000000000002 109.246 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -70.78 -84.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 2.6499999999999999 110.538 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' ALA . 2.5 m-85 -38.71 -64.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.401 0.619 . . . . 2.5899999999999999 111.045 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -43.37 -70.61 0.1 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.602 -0.686 . . . . 0.54000000000000004 109.919 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 42.4 t -40.89 -27.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.353 -0.842 . . . . 1.3400000000000001 110.46 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -92.6 -66.27 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 1.72 110.336 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.022 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.4 mt-10 -60.82 -31.66 71.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.045 -1.062 . . . . 1.95 109.874 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -73.69 -60.19 2.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.891 -1.151 . . . . 1.6100000000000001 107.891 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.5 t-20 -52.02 -48.57 64.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.228 -1.397 . . . . 2.1899999999999999 107.228 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 42.5 tttt -56.85 -47.26 80.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.954 -1.128 . . . . 2.6800000000000002 107.954 177.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.565 HG13 ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -50.48 -24.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.56 -0.904 . . . . 1.3200000000000001 108.56 178.609 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.67 24.99 2.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.384 -1.486 . . . . 0.87 109.384 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 34.6 tp60 -125.47 66.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 2.1600000000000001 109.79 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 38.5 p90 -90.76 22.69 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 5.4699999999999998 109.831 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -41.32 -55.55 3.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.818 -1.313 . . . . 2.23 109.818 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.953 ' HB3' HD12 ' A' ' 32' ' ' LEU . 9.4 mtt180 -162.6 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -1.208 . . . . 3.4900000000000002 110.069 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.953 HD12 ' HB3' ' A' ' 31' ' ' ARG . 3.9 mp -126.9 -177.31 3.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 2.25 109.961 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -146.9 50.12 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.266 -0.896 . . . . 0.68000000000000005 109.91 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 11.3 t80 174.96 79.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.73 . . . . 3.46 109.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -120.94 -44.36 2.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.5800000000000001 110.627 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -96.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 3.3599999999999999 110.955 -179.406 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 36' ' ' LYS . 28.1 t -157.57 171.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.621 -1.3 . . . . 0.70999999999999996 111.679 -179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.726 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.88 88.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.168 -0.678 . . . . 1.55 109.168 179.611 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -105.02 -53.55 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.979 -1.075 . . . . 2.98 110.979 -179.274 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.6 Cg_endo -84.02 50.92 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.395 1.208 . . . . 0.57999999999999996 110.941 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.846 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.0 p -103.52 120.82 41.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.399 -0.813 . . . . 1.5700000000000001 109.807 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.877 ' HG2' HG22 ' A' ' 5' ' ' ILE . 27.5 mtm -119.03 177.29 4.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 1.9099999999999999 110.649 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -140.62 154.28 46.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.229 -0.919 . . . . 1.47 110.41 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -151.75 100.63 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.144 -0.973 . . . . 2.46 110.354 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -97.88 148.88 22.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.60999999999999999 110.265 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.521 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -114.39 43.39 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.359 -0.978 . . . . 1.8400000000000001 108.359 178.79 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.748 ' HB2' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.12 -177.13 6.5 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.495 0.664 . . . . 2.8599999999999999 110.987 -178.801 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' CB ' ' HG3' ' A' ' 52' ' ' GLU . 2.2 tp10 -69.38 -101.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 3.5800000000000001 109.789 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 65.1 t30 -176.1 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.751 -1.218 . . . . 4.1500000000000004 110.938 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -149.19 14.15 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 4.4800000000000004 110.079 -179.684 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.88 -27.83 3.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.421 -0.799 . . . . 5.1699999999999999 109.626 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.54 ' HG3' ' CB ' ' A' ' 48' ' ' GLU . 2.9 pt-20 -170.58 -165.17 0.43 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.046 -1.061 . . . . 2.8199999999999998 111.269 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.748 HD12 ' HB2' ' A' ' 47' ' ' TYR . 9.6 tp -126.47 152.7 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.658 -0.651 . . . . 2.1099999999999999 109.54 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.86 -65.93 0.77 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.999 -1.063 . . . . 2.8100000000000001 111.705 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.897 ' O ' HG23 ' A' ' 45' ' ' THR . . . -135.2 173.91 21.43 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.689 -1.72 . . . . 0.63 110.611 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' GLU . 3.7 t80 -155.85 78.02 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.554 -0.968 . . . . 2.9900000000000002 110.231 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 14.9 pt-20 -99.35 167.39 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 2.4300000000000002 109.0 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.44 170.63 18.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.996 -1.481 . . . . 1.74 112.977 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -133.82 123.76 25.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.787 -1.19 . . . . 1.9099999999999999 107.787 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.846 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -121.07 74.78 1.11 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.034 -1.041 . . . . 0.66000000000000003 109.399 -179.06 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.947 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -69.25 112.28 5.73 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.198 -1.038 . . . . 1.51 108.198 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.667 HG23 ' CD ' ' A' ' 67' ' ' LYS . 33.2 m -158.19 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.779 0.799 . . . . 0.63 109.851 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.716 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.4 t80 -147.28 130.44 16.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.141 -0.688 . . . . 1.22 109.141 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -124.17 -126.07 0.25 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.388 -0.82 . . . . 0.59999999999999998 109.721 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 t -95.15 -24.71 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.912 -1.117 . . . . 1.3899999999999999 108.726 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.02 18.4 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.503 0.668 . . . . 1.52 109.446 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.863 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.3 ttmm -115.23 78.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 1.3700000000000001 110.229 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.716 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 9.0 mt -88.17 64.86 7.89 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.895 -0.78 . . . . 1.8 108.895 178.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 178.7 -123.83 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.047 -1.061 . . . . 1.8500000000000001 110.534 -179.085 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 25.3 ttm180 -131.02 123.63 29.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.328 -1.483 . . . . 1.6899999999999999 112.194 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.863 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -80.48 107.9 13.66 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.651 -1.611 . . . . 0.46999999999999997 106.651 176.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.8 t70 -89.64 162.2 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.002 -1.061 . . . . 1.71 110.404 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.713 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.2 110.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.73 0.776 . . . . 1.0900000000000001 109.294 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -110.71 122.47 47.89 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.247 -0.908 . . . . 1.25 109.955 -179.211 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.636 ' OE1' HD12 ' A' ' 73' ' ' ILE . 22.9 mt-10 -144.96 122.86 11.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 2.02 110.066 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.578 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER -60.88 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 2.1400000000000001 110.104 179.694 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.718 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -171.28 -60.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.85 -1.157 . . . . 2.73 110.715 -179.699 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 12.9 tttt -83.48 -56.7 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 4.0199999999999996 109.596 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.82 0.54 23.45 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.333 -0.854 . . . . 3.3199999999999998 109.619 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 81' ' ' GLY . 9.1 mmt85 57.01 28.54 14.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 5.9000000000000004 109.916 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.578 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -24.29 -70.25 0.02 OUTLIER Glycine 0 N--CA 1.502 3.071 0 CA-C-N 116.104 -0.498 . . . . 2.0600000000000001 112.287 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -168.49 -172.52 1.7 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.591 -1.535 . . . . 4.79 111.831 -179.196 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -149.93 125.63 10.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.976 -0.75 . . . . 3.2999999999999998 108.976 179.54 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 11.8 tp -170.59 173.95 5.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.145 . . . . 2.1899999999999999 110.423 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.022 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -154.01 171.64 18.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.97999999999999998 109.928 179.487 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.543 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 10.6 mtt180 -140.08 -177.9 5.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 2.71 110.989 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.763 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 23.7 m-85 -153.27 63.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.706 -0.621 . . . . 0.68000000000000005 109.398 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -153.3 -156.5 0.7 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.194 . . . . 1.8300000000000001 111.388 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.98 52.32 29.07 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 105.323 -3.111 . . . . 1.28 105.323 -177.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.6 Cg_endo -68.33 -178.02 1.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 124.598 1.841 . . . . 2.23 111.938 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.947 HG12 ' OH ' ' A' ' 61' ' ' TYR . 30.1 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.966 -1.016 . . . . 2.2200000000000002 110.45 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.311 0.577 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CB ' ' HE2' ' A' ' 44' ' ' LYS . 6.8 p90 -165.2 150.07 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 10.4 pt-20 -171.02 132.37 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' CG ' ' A' ' 42' ' ' MET . 21.5 pt -83.63 -177.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.266 -0.897 . . . . 0.0 110.486 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.768 HD11 ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -121.63 -154.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -138.77 50.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.837 -1.164 . . . . 0.0 111.53 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.623 ' C ' HG21 ' A' ' 12' ' ' THR . 19.2 tt 40.44 51.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.159 0.98 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -139.51 -65.43 0.04 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 46.2 Cg_endo -82.4 -58.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.83 1.437 . . . . 0.0 111.275 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 6' ' ' ILE . 2.6 m-30 -54.33 -22.07 11.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.834 -1.166 . . . . 0.0 109.687 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.893 HG22 ' CG1' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.12 -61.26 1.87 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.577 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -55.3 -25.09 32.11 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.676 0.751 . . . . 0.0 110.001 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -80.72 -44.1 19.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.797 0.808 . . . . 0.0 109.871 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.04 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -46.82 -47.21 21.1 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.479 0.656 . . . . 0.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 1.04 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -64.74 -51.13 54.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -67.73 -79.74 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.24 . . . . 0.0 110.592 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -33.84 -62.55 0.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.447 0.641 . . . . 0.0 111.1 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.39 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.411 -0.806 . . . . 0.0 109.917 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 26.2 t -41.62 -25.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.553 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' ALA . 2.6 t70 -87.66 -70.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.983 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.001 ' HB3' HD13 ' A' ' 85' ' ' LEU . 4.1 tt0 -61.88 -37.4 84.45 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.32 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 1.054 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -58.79 -53.22 60.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.938 -1.101 . . . . 0.0 108.778 177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 10.0 t-20 -68.68 -47.05 67.46 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.36 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -57.1 -35.84 69.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 110.322 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.054 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -68.63 -21.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.0 110.005 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.5 10.47 6.54 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 18.0 mm-40 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 109.562 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.864 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.406 0.622 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.572 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -136.94 52.12 1.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 109.943 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 13.9 p90 -169.7 123.11 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.881 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HB2' ' N ' ' A' ' 65' ' ' SER . 1.8 t-20 -155.14 -65.06 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -0.937 . . . . 0.0 110.71 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.82 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -69.14 -98.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.954 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.84 172.35 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.687 -1.258 . . . . 0.0 111.719 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.893 ' CG1' HG22 ' A' ' 12' ' ' THR . 0.3 OUTLIER -120.17 113.22 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -120.49 -59.92 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.92 -1.113 . . . . 0.0 110.707 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.1 Cg_endo -82.73 47.65 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.091 1.048 . . . . 0.0 111.081 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.563 ' HB3' HD13 ' A' ' 38' ' ' ILE . 27.8 p -84.18 122.18 28.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.751 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -123.23 164.15 19.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 111.25 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.23 137.46 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.864 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.527 ' HE2' ' CB ' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -145.58 134.2 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.069 -1.019 . . . . 0.0 110.291 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 55' ' ' GLY . 15.7 m -126.75 155.11 43.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.722 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.535 ' CE2' ' HE3' ' A' ' 43' ' ' LYS . 35.4 t80 -113.76 104.1 11.87 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.386 -1.067 . . . . 0.0 110.019 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.2 pt-20 -119.52 175.99 5.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.455 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.872 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -153.51 162.75 40.96 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.573 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.6 tt0 -126.22 120.98 31.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' LEU . 2.3 tp -118.66 71.5 0.85 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 109.566 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.64 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -70.16 110.97 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.803 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.1 m -159.74 -165.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.601 -0.687 . . . . 0.0 109.795 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.961 ' CE1' HD12 ' A' ' 68' ' ' LEU . 2.5 t80 -138.93 130.02 26.68 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.053 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -124.05 -131.4 0.26 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.632 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.542 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 79.8 p -81.73 -28.93 33.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.237 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.88 18.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.602 -0.686 . . . . 0.0 109.655 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.803 ' CD ' HG23 ' A' ' 62' ' ' VAL . 1.8 ttmm -105.18 73.63 1.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.961 HD12 ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.77 64.54 8.63 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 177.25 -127.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.517 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 14.0 ttm180 -132.46 127.02 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.49 -1.381 . . . . 0.0 111.987 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.668 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -83.79 102.75 12.54 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -86.55 172.83 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.497 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.872 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -168.51 131.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.877 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.511 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -122.25 159.73 26.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 76' ' ' ASP . 2.3 mt-10 -152.59 108.51 3.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.829 -1.169 . . . . 0.0 111.785 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.069 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.3 tp -171.2 -169.44 0.74 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.954 -1.092 . . . . 0.0 109.791 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' HB3' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.69 166.16 8.04 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.3 mtt-85 -145.91 143.7 29.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.724 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.964 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.5 m-85 -115.22 73.81 0.85 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -159.71 -164.9 1.41 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.911 -1.118 . . . . 0.0 111.759 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.594 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 70.79 52.06 16.86 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.392 -3.483 . . . . 0.0 104.392 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.2 Cg_endo -64.46 -174.14 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.714 1.902 . . . . 0.0 112.742 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 1.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.105 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.161 0.505 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -161.77 149.0 14.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -177.18 159.23 1.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.45 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.452 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 3.1 pt -95.03 -175.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.621 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.7 -165.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.217 -0.927 . . . . 0.0 110.468 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 8' ' ' ILE . 24.1 t70 -139.94 51.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.074 -1.016 . . . . 0.0 111.167 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 8' ' ' ILE . 4.6 tt 39.52 40.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.836 0.827 . . . . 0.0 110.098 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.505 ' N ' HG21 ' A' ' 12' ' ' THR . . . -147.25 -65.9 0.01 OUTLIER Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' THR . 44.7 Cg_endo -75.13 -85.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.61 1.321 . . . . 0.0 111.386 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.621 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 66.2 m-85 -39.05 -27.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.398 -0.814 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.822 HG22 ' CG2' ' A' ' 38' ' ' ILE . 18.6 p -60.47 -58.31 9.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.076 -1.015 . . . . 0.0 108.648 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.7 pt20 -59.15 -15.97 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.446 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -76.19 -60.04 2.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 110.065 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 pp -43.68 -34.81 1.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.409 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -62.51 -54.43 34.2 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -72.96 -66.45 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -1.022 . . . . 0.0 110.131 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 21' ' ' ASP . 2.0 m-30 -40.5 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.484 0.659 . . . . 0.0 110.44 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -39.92 -68.2 0.19 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.808 -0.558 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t -41.98 -26.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.104 -0.997 . . . . 0.0 110.024 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 18' ' ' PHE . 6.0 m-20 -95.3 -66.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.826 ' CG ' HD11 ' A' ' 73' ' ' ILE . 14.6 mm-40 -59.08 -26.83 64.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.825 -1.172 . . . . 0.0 109.23 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -76.79 -61.54 1.94 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 25.3 t-20 -54.22 -43.12 70.53 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.615 -1.234 . . . . 0.0 107.815 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 18.5 tptp -56.28 -59.21 5.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.211 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -55.32 -20.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.629 0.728 . . . . 0.0 109.622 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 60.72 2.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -1.14 . . . . 0.0 109.892 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.031 0.443 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -36.5 90.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.751 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' LEU . 7.7 t80 165.82 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 0.0 109.617 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -155.66 -64.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.94 -1.1 . . . . 0.0 111.382 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.52 -99.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 111.453 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 36' ' ' LYS . 13.9 t -159.22 172.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.536 -1.352 . . . . 0.0 111.727 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.822 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -127.79 99.08 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.626 . . . . 0.0 110.01 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.549 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -108.49 -54.76 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.488 -0.758 . . . . 0.0 110.159 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 41.7 Cg_endo -84.88 51.37 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.412 1.217 . . . . 0.0 111.306 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.9 t -104.42 106.37 16.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.536 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 10.2 mtt -96.96 157.08 16.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.056 -1.028 . . . . 0.0 110.158 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 2.6 tmtt? -137.11 154.71 50.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 110.978 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 13.3 tttt -160.33 158.9 30.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.627 -0.671 . . . . 0.0 109.603 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.4 m -159.48 151.05 20.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.96 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 121.976 0.764 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CD2' ' OG1' ' A' ' 45' ' ' THR . 2.4 m-85 -116.95 173.48 6.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 122.133 -0.628 . . . . 0.0 109.898 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 178.72 130.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.499 -0.751 . . . . 0.0 109.206 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' HB ' ' A' ' 73' ' ' ILE . 3.4 p90 -150.6 171.73 16.65 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.1 -1.44 . . . . 0.0 113.606 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.537 ' HB3' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -124.34 112.35 16.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -104.36 68.28 0.87 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 109.67 -178.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.852 ' OH ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.81 109.7 4.56 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG23 ' HD3' ' A' ' 67' ' ' LYS . 34.8 m -159.41 -162.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.574 0.702 . . . . 0.0 109.634 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.624 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -137.94 124.6 20.96 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -122.86 -127.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.477 -0.765 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.543 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 t -84.57 -52.56 6.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.019 -1.051 . . . . 0.0 109.389 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -128.65 30.23 5.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.359 -0.838 . . . . 0.0 109.256 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.752 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -125.46 80.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.703 0.763 . . . . 0.0 110.046 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 6.3 mp -90.07 59.66 4.58 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 p90 176.98 -142.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.407 -0.808 . . . . 0.0 109.581 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.537 ' NH1' ' HB3' ' A' ' 59' ' ' GLN . 4.8 ttm180 -113.26 140.77 47.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.531 -1.356 . . . . 0.0 112.236 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -99.44 103.45 15.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' N ' ' A' ' 86' ' ' ARG . 9.9 t70 -77.24 157.58 30.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.769 -1.207 . . . . 0.0 109.927 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.826 HD11 ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -162.62 101.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.672 0.748 . . . . 0.0 109.156 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -113.37 134.96 54.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 74' ' ' SER . 18.4 mt-10 -157.9 136.53 11.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.936 -1.102 . . . . 0.0 111.28 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.63 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.227 -0.92 . . . . 0.0 109.826 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -170.47 160.43 7.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 0.0 109.514 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.02 175.21 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.04 -1.038 . . . . 0.0 110.399 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 72' ' ' ASP . 6.0 mtt180 -157.5 131.67 8.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.0 110.704 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 84.2 m-85 -107.98 64.92 0.63 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -152.63 -158.76 0.93 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.998 -1.064 . . . . 0.0 111.148 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.17 52.82 29.53 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 104.876 -3.29 . . . . 0.0 104.876 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -65.64 -171.78 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.728 1.909 . . . . 0.0 112.585 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.852 HG13 ' OH ' ' A' ' 61' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.139 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.336 0.588 . . . . 2.83 110.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 23.5 p90 -79.99 167.96 19.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 3.6 110.225 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.86 119.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 2.72 110.167 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.813 HG22 ' CG ' ' A' ' 42' ' ' MET . 1.2 pt -80.35 -176.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.219 -0.926 . . . . 1.37 110.396 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.739 HD12 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.21 -164.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.287 -0.883 . . . . 2.43 109.881 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 8' ' ' ILE . 42.2 t0 -144.35 61.77 1.34 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 3.5 111.592 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.69 ' C ' HG21 ' A' ' 12' ' ' THR . 14.0 tt 40.53 45.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.002 0.906 . . . . 1.76 109.953 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -138.41 -65.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 120.138 -1.03 . . . . 0.86 111.434 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.6 Cg_endo -82.17 -72.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.596 1.314 . . . . 0.94 111.416 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.739 ' CD2' HD12 ' A' ' 6' ' ' ILE . 1.9 m-30 -44.5 -32.05 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 1.53 109.583 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.733 HG22 HG21 ' A' ' 38' ' ' ILE . 25.0 p -57.59 -57.69 11.59 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.52 -1.289 . . . . 0.9 107.52 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -72.99 -17.67 61.43 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.749 0.785 . . . . 2.36 109.455 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.545 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 2.7 t-20 -79.4 -58.65 3.1 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.643 0.735 . . . . 1.56 109.371 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.839 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 2.6 tp -42.04 -56.13 2.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.212 -0.662 . . . . 2.05 109.212 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -49.53 -57.48 9.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.58 109.535 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -68.75 -77.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.129 . . . . 2.45 110.665 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 3.3 m-85 -37.77 -72.57 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.418 0.628 . . . . 2.28 111.221 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -41.42 -69.23 0.14 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.56 110.342 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 55.4 t -42.34 -27.95 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 1.43 110.356 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' LYS . 2.2 m-20 -93.49 -62.54 1.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.233 -0.917 . . . . 1.91 110.353 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.0 mt-10 -61.96 -31.57 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.008 -1.057 . . . . 2.17 109.81 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.575 ' OE2' ' CD2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -75.42 -59.59 2.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.181 -1.044 . . . . 1.64 108.181 178.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 36.8 t-20 -53.25 -46.56 69.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.223 -1.399 . . . . 2.27 107.223 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 13.7 tttt -58.2 -48.56 79.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.867 -1.16 . . . . 2.88 107.867 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.604 HD11 ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -48.46 -26.54 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.527 -0.916 . . . . 1.63 108.527 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 27.89 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.223 -1.551 . . . . 1.01 109.223 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 24.8 tp60 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.431 -1.041 . . . . 2.35 109.671 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 32' ' ' LEU . 3.4 mp . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.324 0.583 . . . . 2.6 109.873 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.621 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -144.9 50.65 1.25 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.345 -0.847 . . . . 0.95 109.769 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.622 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 9.6 t80 -179.88 74.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 3.48 110.279 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.32 -45.86 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 2.52 110.561 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 3.51 111.002 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LYS . 23.1 t -158.55 172.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.694 -1.254 . . . . 1.12 111.622 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.39 85.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.675 -0.641 . . . . 1.66 109.361 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -103.25 -54.22 0.12 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 3.03 110.817 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.9 Cg_endo -83.5 52.15 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.335 1.177 . . . . 0.57 110.324 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.552 ' C ' HD11 ' A' ' 6' ' ' ILE . 21.2 p -104.03 113.1 26.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.835 . . . . 1.64 110.408 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.813 ' CG ' HG22 ' A' ' 5' ' ' ILE . 8.3 mtm -113.91 176.97 4.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.846 . . . . 2.1 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.23 159.32 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.027 . . . . 1.63 110.985 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -154.17 128.59 9.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.503 -0.748 . . . . 2.51 109.93 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -118.57 148.84 42.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.62 110.084 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.525 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.404 -0.962 . . . . 2.0 108.404 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.9 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 110.625 -0.99 . . . . 0.61 110.625 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' GLU . 36.6 t80 -156.84 92.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -1.057 . . . . 3.91 110.418 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.7 pt-20 -126.47 171.83 10.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 2.63 108.85 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 1.7 p90 -163.05 166.02 24.11 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 117.876 -1.53 . . . . 1.82 113.419 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 70' ' ' ARG . 92.6 mt-30 -119.82 107.53 13.27 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.742 -1.207 . . . . 2.17 107.742 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.714 HD21 HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -105.77 73.72 1.02 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.289 -0.882 . . . . 0.71 109.14 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 1.08 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -69.61 112.34 6.03 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.031 -1.1 . . . . 1.73 108.031 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.621 HG23 ' CD ' ' A' ' 67' ' ' LYS . 22.7 m -157.84 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.769 0.795 . . . . 0.42 109.496 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.658 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.5 t80 -149.19 129.47 13.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 1.28 109.272 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.622 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -123.53 -118.09 0.29 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.77 109.685 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -102.15 -25.21 13.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.754 -1.216 . . . . 1.41 108.804 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.8 16.19 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 1.99 109.603 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.832 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -113.93 78.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 1.37 110.338 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.9 mt -86.16 63.19 7.88 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.501 -0.926 . . . . 1.79 108.501 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 176.06 -122.69 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.539 -0.864 . . . . 1.88 109.912 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 5.9 tmm_? -133.73 144.61 49.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.166 -1.583 . . . . 1.88 112.416 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -92.08 92.33 8.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.241 -1.763 . . . . 0.48 106.241 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 4.7 t0 -80.99 82.96 6.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.011 . . . . 1.73 110.741 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -76.19 138.92 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.692 -0.803 . . . . 1.18 109.577 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -131.54 121.65 24.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 1.26 109.518 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HG2' ' HG2' ' A' ' 83' ' ' LYS . 1.1 mt-10 -151.81 119.16 5.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.937 -1.102 . . . . 2.3 110.477 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.554 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.2 t0 . . . . . 0 C--N 1.303 -1.416 0 O-C-N 121.17 -0.956 . . . . 2.26 109.895 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.47 ' HG2' ' HG2' ' A' ' 75' ' ' GLU . 10.8 mtpt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.325 -0.62 . . . . 3.53 109.325 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.0 tp -170.1 179.12 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 2.41 110.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 1.2 pt? -153.68 -179.19 7.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 1.24 110.509 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.538 ' C ' ' CD2' ' A' ' 87' ' ' PHE . 3.0 mtt180 -134.66 -177.06 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 2.71 110.49 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 69.4 m-85 -154.17 62.6 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.055 -0.72 . . . . 0.76 109.055 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 3.0 m-80 -152.37 -157.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 1.91 111.488 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 66.71 52.59 33.01 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 104.855 -3.298 . . . . 1.21 104.855 -176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.0 Cg_endo -67.77 -171.17 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 124.499 1.789 . . . . 2.15 111.899 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.08 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.6 m . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 117.945 -1.026 . . . . 2.29 110.4 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.267 0.555 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 42.2 p-90 -150.58 142.32 23.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.156 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 21.2 mt-10 -158.36 -176.99 6.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.42 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.039 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -133.38 168.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.039 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -148.66 -170.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.7 OUTLIER 174.5 143.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.03 -1.044 . . . . 0.0 111.319 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.7 tp 43.06 25.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.317 0.58 . . . . 0.0 110.636 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.625 ' N ' HG21 ' A' ' 12' ' ' THR . . . -127.75 -103.21 1.19 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.311 -1.423 . . . . 0.0 112.421 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.723 ' CG ' HG21 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -81.66 -64.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.844 1.696 . . . . 0.0 111.984 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.711 ' CD1' ' CZ ' ' A' ' 58' ' ' TYR . 2.2 m-85 -42.91 -25.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 38' ' ' ILE . 2.6 p -69.59 -62.08 1.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.573 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.8 tt0 -66.64 -18.0 65.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 109.357 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.7 m-80 -79.21 -60.83 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.664 -0.647 . . . . 0.0 110.053 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -39.91 -50.66 2.48 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.425 0.631 . . . . 0.0 109.39 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -53.32 -57.31 15.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' PHE . 6.0 tttp -69.36 -69.25 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -1.175 . . . . 0.0 110.62 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-30 -38.72 -63.33 0.52 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.996 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -44.19 -72.79 0.05 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.589 -0.694 . . . . 0.0 110.273 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 11.0 t -40.74 -26.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 0.0 110.616 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.5 m-20 -92.19 -70.92 0.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.943 -1.098 . . . . 0.0 109.783 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.863 ' CB ' HD13 ' A' ' 85' ' ' LEU . 8.9 mm-40 -56.42 -34.61 66.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.911 -1.118 . . . . 0.0 109.52 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.801 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -67.17 -56.63 9.1 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.9 m120 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.914 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -55.35 -51.07 67.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.489 -0.757 . . . . 0.0 109.757 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -62.91 -16.57 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.469 -0.77 . . . . 0.0 110.021 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.26 50.89 0.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.32 -1.106 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.813 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.917 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -112.83 52.88 0.77 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.262 -0.899 . . . . 0.0 110.094 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.64 98.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.1 t-20 -134.2 -64.83 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.935 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -70.41 -106.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 111.237 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 36' ' ' LYS . 11.0 t -158.85 173.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.485 -1.384 . . . . 0.0 111.829 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.9 132.53 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.596 0.712 . . . . 0.0 110.259 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.629 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -136.63 -61.54 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.536 -0.727 . . . . 0.0 109.709 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.0 Cg_endo -81.48 46.16 2.17 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.062 1.033 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.855 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.9 p -80.34 80.18 6.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.078 -1.014 . . . . 0.0 109.098 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.509 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -83.18 138.13 33.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.131 -0.981 . . . . 0.0 111.066 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.38 157.61 17.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.801 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 4.5 mttt -160.09 103.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -0.78 . . . . 0.0 109.214 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.4 m -124.27 153.89 41.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.866 -1.146 . . . . 0.0 111.213 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.846 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -150.35 86.74 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.267 -1.137 . . . . 0.0 111.153 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 7.1 pt-20 -95.16 149.27 21.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CZ ' ' CD1' ' A' ' 11' ' ' PHE . 2.3 t80 -144.97 139.64 27.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.914 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 28.2 mt-30 -99.19 107.03 19.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 25.0 tp -98.92 62.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.605 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.4 t80 -71.9 104.86 3.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.779 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG23 ' CE ' ' A' ' 67' ' ' LYS . 33.6 m -161.64 -165.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.7 t80 -131.26 134.6 46.57 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.248 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -130.68 -132.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.331 -0.856 . . . . 0.0 109.977 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.0 -29.73 13.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.595 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -136.18 3.88 2.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.427 -0.796 . . . . 0.0 110.12 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.634 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -113.19 100.7 8.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.582 ' HG ' ' CE2' ' A' ' 63' ' ' TYR . 6.8 mp -100.88 59.31 0.92 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.366 -0.834 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.24 -115.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.012 . . . . 0.0 110.156 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.9 ttp85 -124.35 157.83 34.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.332 -1.48 . . . . 0.0 112.807 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -118.37 91.88 3.68 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 30.5 t0 -69.15 81.27 0.34 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 110.906 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 22' ' ' GLU . 2.6 mm -68.38 114.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.394 -0.817 . . . . 0.0 108.903 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -118.36 118.17 31.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.372 -0.83 . . . . 0.0 110.675 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 40.3 mt-10 -153.38 120.19 5.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.031 -1.043 . . . . 0.0 110.794 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.153 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.4 tp -169.97 -174.13 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 110.221 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.981 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -165.43 179.1 6.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 110.645 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mtt85 -142.84 128.65 19.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.981 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 4.5 m-85 -104.77 85.13 2.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.635 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -153.59 -156.98 0.74 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.734 -1.229 . . . . 0.0 110.784 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.05 51.49 6.88 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.1 Cg_endo -66.49 138.64 50.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.459 1.768 . . . . 0.0 111.203 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.2 m . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.323 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.289 0.566 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -132.37 178.16 7.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 43' ' ' LYS . 1.1 tt0 176.99 119.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.767 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 16.4 pt -75.59 178.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.248 -0.908 . . . . 0.0 110.829 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.706 HG13 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.84 -164.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.328 -0.857 . . . . 0.0 110.712 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.699 ' O ' HG22 ' A' ' 8' ' ' ILE . 39.6 t0 -156.75 46.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.797 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 7' ' ' ASP . 17.9 tt 40.27 37.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.656 0.741 . . . . 0.0 109.83 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -143.52 -65.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.207 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 46.1 Cg_endo -78.7 -79.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.665 1.35 . . . . 0.0 111.427 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 43' ' ' LYS . 97.1 m-85 -40.19 -29.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.04 HG22 HD12 ' A' ' 38' ' ' ILE . 16.9 p -61.15 -59.11 5.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -67.35 -12.36 59.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 16.4 m120 -84.61 -69.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 15' ' ' LEU . 4.0 pp -42.04 -28.22 0.17 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.695 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -74.66 -46.15 19.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -80.87 -41.89 22.39 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.201 -1.176 . . . . 0.0 110.253 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -35.85 82.46 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.595 0.712 . . . . 0.0 109.916 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -65.87 -71.79 0.18 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.5 p -34.52 -33.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.775 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 19' ' ' ALA . 87.1 m-20 -93.15 -73.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.079 ' HB2' HD13 ' A' ' 85' ' ' LEU . 6.9 mm-40 -57.2 -23.42 47.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.107 . . . . 0.0 110.206 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 1.4 tt0 -80.93 -63.36 1.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 49.1 m-20 -52.23 -46.89 65.9 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 11.0 ttpt -55.35 -50.67 69.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -50.18 -24.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.7 0.762 . . . . 0.0 109.05 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.04 36.12 1.06 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.503 -0.998 . . . . 0.0 109.828 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.235 0.541 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -116.6 57.81 0.77 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 2.4 t80 -158.5 109.69 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -152.02 -70.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.923 . . . . 0.0 111.281 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -69.47 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.926 -1.109 . . . . 0.0 111.265 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 36' ' ' LYS . 4.6 t -160.57 156.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.443 -1.411 . . . . 0.0 112.273 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.04 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -106.12 140.74 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.713 0.768 . . . . 0.0 109.546 178.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.585 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.47 -61.92 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.679 -0.638 . . . . 0.0 110.09 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 52.1 Cg_endo -77.91 39.95 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.307 1.161 . . . . 0.0 111.687 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.635 ' HB3' HG21 ' A' ' 6' ' ' ILE . 85.3 m -93.49 148.45 22.07 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.938 -1.101 . . . . 0.0 109.945 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.512 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 5.2 mtm -138.48 161.93 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.028 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 2.7 tmtt? -152.03 131.72 13.16 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.955 -1.091 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -148.81 130.54 15.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.884 . . . . 0.0 110.348 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.5 m -108.21 154.09 22.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.977 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 46' ' ' ILE . 12.9 pt . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.483 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.3 t80 -160.85 107.73 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.786 -0.832 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.9 pt-20 -117.74 142.84 46.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.233 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -144.35 170.64 15.62 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.027 -1.469 . . . . 0.0 113.425 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -135.11 128.72 32.69 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.925 HD23 ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.8 85.61 2.35 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 109.104 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 1.8 t80 -77.52 108.94 11.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.624 HG11 HD21 ' A' ' 60' ' ' LEU . 1.3 p -153.46 173.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.0 t80 -128.57 127.23 41.91 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.765 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -127.67 -126.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.856 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.607 ' OG ' HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -96.96 -40.21 9.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.45 31.94 4.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 109.861 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -143.85 92.23 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.753 0.787 . . . . 0.0 109.357 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 68' ' ' LEU . 1.6 mp -100.58 63.58 1.09 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.715 -0.616 . . . . 0.0 110.761 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 168.86 -109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.034 -1.041 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 1.4 ttp-105 -130.4 141.52 50.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.906 -1.121 . . . . 0.0 112.779 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.925 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -107.26 113.41 26.79 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 3.1 t70 -93.35 168.69 10.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.076 . . . . 0.0 111.34 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 58' ' ' TYR . 4.3 tp -158.99 116.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -126.69 131.51 51.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.92 -1.113 . . . . 0.0 109.814 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 16.1 mt-10 -149.82 132.05 15.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.93 -1.106 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.168 -0.958 . . . . 0.0 110.079 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 21.0 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -170.73 151.29 3.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 110.832 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.079 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -136.1 175.93 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.42 -0.8 . . . . 0.0 109.506 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.5 mtm180 -147.79 178.75 8.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.042 -1.036 . . . . 0.0 110.949 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.787 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -155.63 84.26 1.04 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.622 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -153.42 -154.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 62.34 53.39 42.39 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.58 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.8 Cg_endo -64.43 154.78 69.75 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.582 1.833 . . . . 0.0 111.549 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.188 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.27 0.557 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 28.1 p90 -107.65 155.37 20.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.888 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.546 ' HG2' ' CD ' ' A' ' 43' ' ' LYS . 12.3 pt-20 -177.34 137.76 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.712 ' C ' HD13 ' A' ' 6' ' ' ILE . 4.9 pt -89.3 -178.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.712 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -125.73 -147.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.18 -0.95 . . . . 0.0 109.656 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -134.79 -152.12 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.76 -1.213 . . . . 0.0 110.295 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.774 ' C ' HG21 ' A' ' 12' ' ' THR . 2.0 tt -104.35 39.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.606 ' N ' HG21 ' A' ' 12' ' ' THR . . . -144.69 -63.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.272 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 6' ' ' ILE . 41.9 Cg_endo -68.72 -93.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.293 1.154 . . . . 0.0 112.498 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.696 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.7 m-85 -43.33 -26.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 0.0 111.013 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.047 HG22 HD12 ' A' ' 38' ' ' ILE . 22.4 p -54.41 -56.34 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.825 -1.172 . . . . 0.0 108.391 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' A' ' 12' ' ' THR . 7.4 tt0 -58.24 -22.43 52.17 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.762 0.791 . . . . 0.0 109.233 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 5.4 t-20 -72.26 -56.81 4.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.538 0.685 . . . . 0.0 109.801 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -42.32 -56.09 3.1 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.588 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.973 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.41 -38.38 41.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -79.81 -80.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -1.056 . . . . 0.0 110.676 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CD2' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -37.59 -36.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.283 0.563 . . . . 0.0 111.004 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.695 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -66.71 -69.6 0.3 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.393 -0.817 . . . . 0.0 109.738 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 19' ' ' ALA . 9.5 t -39.35 -27.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 110.198 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 19' ' ' ALA . 5.6 m-20 -93.32 -69.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 110.122 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.839 ' CB ' HD13 ' A' ' 85' ' ' LEU . 6.3 mp0 -57.27 -32.51 66.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.502 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.98 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -69.68 -59.88 2.67 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.8 m120 -55.94 -44.71 78.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -52.8 63.02 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.453 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.98 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -54.51 -22.48 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.489 -0.757 . . . . 0.0 109.711 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 19.83 3.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 50.9 mm-40 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.946 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.858 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.233 0.54 . . . . 0.0 110.055 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.668 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -147.3 53.58 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 110.065 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 22.5 t80 -175.64 97.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.2 t-20 -129.68 -52.55 1.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.824 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -69.72 -99.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 111.183 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.46 173.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.558 -1.339 . . . . 0.0 111.825 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.047 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -126.92 121.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.437 0.637 . . . . 0.0 109.576 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.605 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -129.36 -58.27 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.467 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.2 Cg_endo -84.91 45.68 1.7 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.178 1.094 . . . . 0.0 110.965 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.752 ' SG ' HD11 ' A' ' 38' ' ' ILE . 24.0 p -80.06 88.6 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 109.496 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 5' ' ' ILE . 17.0 mtm -88.93 135.38 33.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.426 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CD ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.428 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' GLU . 19.5 mttt -142.97 121.09 12.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 5.7 m -125.87 150.12 48.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -159.45 88.39 0.86 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.967 . . . . 0.0 110.565 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' LYS . 12.6 pt-20 -87.99 155.45 19.82 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 60' ' ' LEU . 2.6 t80 -142.24 124.98 15.93 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.493 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 70' ' ' ARG . 10.7 mt-30 -96.78 96.22 8.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.903 ' CD2' HD23 ' A' ' 15' ' ' LEU . 7.8 tp -97.04 69.32 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 108.978 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -72.96 110.45 7.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.096 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.609 HG13 ' C ' ' A' ' 61' ' ' TYR . 22.9 m -160.96 -163.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.744 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.72 130.05 23.75 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.85 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 36' ' ' LYS . . . -125.44 -116.31 0.28 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.409 -0.807 . . . . 0.0 109.945 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -46.32 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.25 -1.42 5.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 110.021 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -94.53 92.32 7.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.781 . . . . 0.0 109.734 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.744 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.1 mt -96.35 61.92 2.05 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 167.59 -113.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.019 . . . . 0.0 110.473 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.25 149.61 52.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.43 -1.419 . . . . 0.0 113.626 -178.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -101.89 92.66 4.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -70.78 79.84 0.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.903 . . . . 0.0 110.64 -177.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -68.59 107.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.54 0.686 . . . . 0.0 109.571 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -103.18 114.86 29.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.472 -0.768 . . . . 0.0 110.31 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HG23 ' A' ' 73' ' ' ILE . 11.3 mt-10 -145.94 112.04 5.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.072 -1.018 . . . . 0.0 110.748 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.583 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.8 m-20 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.997 . . . . 0.0 109.513 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 16.1 mtmt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.8 tp -169.88 -172.07 1.3 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.152 -0.968 . . . . 0.0 109.979 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.963 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -150.94 -179.72 7.53 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 72' ' ' ASP . 21.1 mtm180 -146.01 126.78 14.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.127 . . . . 0.0 111.55 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.6 m-85 -104.77 89.6 3.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.419 -0.801 . . . . 0.0 108.933 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.614 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.44 -143.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.52 -1.362 . . . . 0.0 111.268 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 51.37 50.33 41.46 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.2 Cg_endo -68.91 158.02 59.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.332 1.701 . . . . 0.0 111.111 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.5 m . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.227 0.537 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -133.41 169.11 17.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.464 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 6.5 tp10 -168.28 116.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.916 HG22 ' HG2' ' A' ' 42' ' ' MET . 20.9 pt -110.14 144.15 18.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.988 -1.07 . . . . 0.0 111.512 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.805 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.38 -175.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.639 ' HA ' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER 172.74 34.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.655 -1.278 . . . . 0.0 112.145 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 7' ' ' ASP . 6.7 tp 177.92 18.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.502 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -158.47 -64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.524 -1.798 . . . . 0.0 111.906 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.747 ' HG3' HG21 ' A' ' 6' ' ' ILE . 46.3 Cg_endo -74.66 -86.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.69 1.363 . . . . 0.0 112.199 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.652 ' HD2' HD12 ' A' ' 60' ' ' LEU . 3.9 m-85 -45.78 -22.43 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.961 HG22 HD12 ' A' ' 38' ' ' ILE . 27.6 p -66.14 -59.89 3.33 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.972 -1.08 . . . . 0.0 109.177 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.484 ' N ' ' OG1' ' A' ' 12' ' ' THR . 29.1 tt0 -72.15 -19.89 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.495 0.664 . . . . 0.0 109.924 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 8.2 m120 -79.25 -51.38 9.53 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.0 109.294 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.0 HD12 HD21 ' A' ' 60' ' ' LEU . 1.6 tt -44.98 -55.55 5.41 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.4 0.619 . . . . 0.0 109.521 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.985 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -52.31 -55.37 22.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' PHE . 4.3 mttm -69.89 -79.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -1.124 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -33.03 -66.64 0.14 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.451 0.643 . . . . 0.0 111.232 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -42.35 -70.28 0.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.601 -0.687 . . . . 0.0 109.849 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 24.8 t -43.62 -25.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.214 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 19' ' ' ALA . 7.6 t0 -91.18 -69.48 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.23 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.071 ' CB ' HD13 ' A' ' 85' ' ' LEU . 77.4 mm-40 -59.55 -34.86 73.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.767 -1.208 . . . . 0.0 109.345 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.913 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -66.6 -54.75 20.04 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 109.017 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.5 m120 -64.7 -43.7 92.64 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.041 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.1 tttm -57.65 -46.0 84.78 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.913 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -64.26 -17.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.466 -0.771 . . . . 0.0 110.016 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.98 37.47 1.37 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.464 ' HB3' ' OE2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.134 . . . . 0.0 110.066 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.989 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.275 0.559 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.7 55.5 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 110.458 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 5.5 p90 -177.33 119.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.103 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB3' ' C ' ' A' ' 64' ' ' ALA . 45.6 t30 -157.37 -56.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.818 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.29 -97.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.7 t -160.14 172.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.659 -1.276 . . . . 0.0 111.476 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.971 HD11 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.17 121.1 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.687 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.557 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.5 ttm180 -130.91 -57.37 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 110.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.9 Cg_endo -86.5 45.19 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.07 1.037 . . . . 0.0 110.965 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.971 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.1 p -85.11 79.27 9.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.487 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.916 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.8 mtp -82.47 163.0 21.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.171 -0.956 . . . . 0.0 110.685 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 3.4 ttpp -138.51 140.86 39.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.211 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 57' ' ' GLU . 6.0 ttmm -142.75 128.79 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.854 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.4 m -114.44 160.26 19.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 110.213 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 46' ' ' ILE . 1.3 tt . . . . . 0 C--N 1.306 -1.283 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.854 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 1.2 t80 -161.25 91.44 0.86 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.842 -0.799 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.3 mt-10 -123.87 -179.44 4.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -164.08 167.01 20.81 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.557 -1.257 . . . . 0.0 112.943 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 49.6 mt-30 -120.72 107.89 13.32 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 15' ' ' LEU . 1.3 tp -98.6 71.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.027 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.606 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -72.78 111.48 7.96 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.628 0.728 . . . . 0.0 109.082 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 15' ' ' LEU . 17.2 m -160.1 -163.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.574 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.2 t80 -138.85 126.88 22.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.714 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -122.58 -130.41 0.27 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.461 -0.774 . . . . 0.0 109.886 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.573 ' CB ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.87 -18.51 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 25.4 t70 -151.02 38.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.891 ' HE2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -150.31 88.69 1.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.553 0.692 . . . . 0.0 109.514 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 7.7 mt -92.44 60.04 3.51 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.618 -0.676 . . . . 0.0 109.596 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 170.45 -122.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.188 -0.945 . . . . 0.0 109.851 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 2.6 tmm_? -122.53 147.88 45.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.21 -1.556 . . . . 0.0 113.246 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 86' ' ' ARG . . . -102.05 98.09 8.33 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -68.78 152.37 45.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 110.133 -177.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.77 127.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 34.2 t -129.98 155.34 46.26 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.222 -0.923 . . . . 0.0 109.24 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' OE2' HG23 ' A' ' 73' ' ' ILE . 3.5 mp0 -156.33 116.79 3.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.607 -1.308 . . . . 0.0 112.46 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 75' ' ' GLU . 2.7 p30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.412 0.625 . . . . 0.0 111.643 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.8 tp -171.22 179.51 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 0.0 109.864 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.071 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.03 167.5 8.9 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.035 -1.041 . . . . 0.0 110.455 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.566 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 1.1 mtt180 -143.44 -174.86 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 10.7 m-85 -155.01 83.52 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.606 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -168.68 -164.06 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.503 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 86.82 54.83 2.54 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 39.5 Cg_endo -63.21 144.68 92.37 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 124.407 1.741 . . . . 0.0 111.472 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' H ' HG13 ' A' ' 91' ' ' VAL . 4.7 m . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.309 0.576 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 m-90 -83.28 -176.81 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HG2' ' CE ' ' A' ' 43' ' ' LYS . 20.7 tp10 174.31 163.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -139.29 173.43 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.931 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 7' ' ' ASP . 1.2 pp -136.82 -159.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 t70 -113.21 -143.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 109.617 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.823 ' C ' HG21 ' A' ' 12' ' ' THR . 0.8 OUTLIER -108.38 38.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.647 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -129.91 -56.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.702 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.5 Cg_endo -75.7 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 122.963 0.98 . . . . 0.0 111.853 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.7 ' CE1' ' CD2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -40.4 -34.96 0.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.136 -0.978 . . . . 0.0 110.447 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.133 HG22 HD12 ' A' ' 38' ' ' ILE . 44.5 p -50.19 -54.22 22.38 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.4 OUTLIER -63.78 -25.98 68.43 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.751 0.786 . . . . 0.0 109.36 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 11.6 m120 -72.26 -52.4 16.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 0.0 109.86 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -42.9 -58.4 2.41 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.257 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 1.02 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -45.72 -45.97 13.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -83.52 -80.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.053 . . . . 0.0 111.154 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 2.5 m-85 -35.69 -29.58 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 111.592 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.787 ' HB1' ' OE1' ' A' ' 23' ' ' GLU . . . -84.02 -72.49 0.46 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.749 HG23 ' OG1' ' A' ' 33' ' ' THR . 24.3 t -43.64 -26.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 109.833 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -86.64 -62.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.667 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.067 ' HB2' HD13 ' A' ' 85' ' ' LEU . 25.3 mm-40 -62.12 -43.21 99.32 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.464 -1.294 . . . . 0.0 108.998 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.888 ' CD ' HG21 ' A' ' 33' ' ' THR . 55.4 mt-10 -58.83 -51.86 68.2 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 108.877 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.0 t-20 -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.383 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -57.66 -42.11 82.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.966 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.2 tp -69.57 -16.48 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.393 -0.817 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.07 52.72 0.26 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.422 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.297 -1.12 . . . . 0.0 109.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' HA ' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.227 0.537 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.888 HG21 ' CD ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -130.04 52.5 2.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.751 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.522 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 38.9 t80 -163.85 112.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.415 -0.803 . . . . 0.0 110.015 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.9 t-20 -150.4 -55.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.546 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.749 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.6 mttt -69.46 -103.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 111.049 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.2 t -159.59 172.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.755 -1.216 . . . . 0.0 111.536 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.133 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.65 129.12 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.615 -0.678 . . . . 0.0 109.846 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -132.1 -58.13 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.375 -0.828 . . . . 0.0 110.057 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 44.9 Cg_endo -87.44 46.42 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.174 1.091 . . . . 0.0 110.81 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 1.001 ' HB2' HD12 ' A' ' 60' ' ' LEU . 22.6 p -87.46 111.61 21.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.482 ' HB3' ' CE ' ' A' ' 44' ' ' LYS . 27.1 mtm -109.66 179.81 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.703 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' CE ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -152.54 142.38 22.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 110.107 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -137.96 105.69 5.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.772 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.9 m -124.17 154.19 40.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 46' ' ' ILE . 25.8 pt . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' GLU . 86.5 t80 -152.29 90.83 1.54 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.259 -1.142 . . . . 0.0 110.809 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.9 tt0 -112.08 159.61 18.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.704 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -156.35 169.16 25.22 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 117.859 -1.536 . . . . 0.0 113.45 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.542 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 13.3 mt-30 -137.93 120.97 16.67 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -121.98 83.85 2.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 109.436 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.65 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -75.18 110.32 9.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.756 HG23 ' HD3' ' A' ' 67' ' ' LYS . 35.6 m -160.33 -161.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.462 -0.774 . . . . 0.0 109.697 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 1.109 ' CE1' HD22 ' A' ' 68' ' ' LEU . 2.0 t80 -135.09 135.2 41.04 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.506 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -133.15 -127.74 0.18 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -40.01 9.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.992 . . . . 0.0 108.982 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' OD1' HG22 ' A' ' 33' ' ' THR . 2.5 p30 -127.67 -2.39 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -104.5 88.87 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.109 HD22 ' CE1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -100.25 60.9 1.05 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 108.788 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER 172.3 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 7.3 ttp180 -152.94 156.27 38.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.972 -1.705 . . . . 0.0 112.643 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -119.2 115.52 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' OD1' ' NH1' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -93.07 166.34 12.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.992 -1.067 . . . . 0.0 110.235 -178.064 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.704 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.69 114.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.618 -0.676 . . . . 0.0 109.179 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -109.84 144.57 38.11 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 83' ' ' LYS . 3.3 mt-10 -167.72 104.17 0.5 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.694 -1.254 . . . . 0.0 111.726 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.598 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 16.1 p-10 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.657 0.741 . . . . 0.0 112.149 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.785 ' C ' HD23 ' A' ' 84' ' ' LEU . 6.8 mttt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.785 HD23 ' C ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -170.86 -169.56 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.528 -1.357 . . . . 0.0 111.75 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.37 175.95 4.63 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 13.0 mtt180 -150.35 152.15 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 13.4 m-85 -103.69 97.39 7.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 1.5 t-20 -66.79 125.86 27.19 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . -8.09 99.35 0.01 OUTLIER Glycine 0 N--CA 1.503 3.108 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.45 ' C ' ' HB2' ' A' ' 68' ' ' LEU . 47.3 Cg_endo -74.95 79.07 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.553 . . . . 0.0 109.941 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 68' ' ' LEU . 2.1 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.239 -0.913 . . . . 0.0 110.336 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.284 0.564 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CB ' ' HG2' ' A' ' 44' ' ' LYS . 4.8 p90 -115.77 177.81 4.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.51 121.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.206 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 18.4 pt -85.17 170.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.075 -1.016 . . . . 0.0 110.499 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.777 HG22 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -89.4 -166.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.256 -0.902 . . . . 0.0 110.509 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 m-20 -137.16 49.56 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.141 -0.975 . . . . 0.0 110.705 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 7' ' ' ASP . 5.1 tt 39.9 46.01 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.963 0.887 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -156.1 -62.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.346 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.1 Cg_endo -72.7 -84.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 0.0 111.535 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.777 ' CD2' HG22 ' A' ' 6' ' ' ILE . 6.3 m-85 -41.42 -29.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.243 -0.911 . . . . 0.0 110.568 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.599 ' HA ' HG21 ' A' ' 38' ' ' ILE . 11.4 p -55.33 -58.0 9.52 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.535 ' N ' ' OG1' ' A' ' 12' ' ' THR . 9.6 mt-30 -68.19 -17.7 64.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.694 0.759 . . . . 0.0 109.394 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.555 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 7.2 t-20 -80.82 -57.28 3.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.55 0.69 . . . . 0.0 109.352 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -39.14 -46.49 1.45 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 1.011 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -65.24 -40.45 96.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.74 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.44 -69.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -1.054 . . . . 0.0 110.241 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 1.7 m-30 -40.86 -47.3 2.91 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.686 0.755 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -57.69 -77.56 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.526 -0.734 . . . . 0.0 110.01 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.0 p -38.33 -27.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.0 110.967 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.11 -77.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.915 -1.115 . . . . 0.0 110.213 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.1 mm-40 -56.06 -36.31 67.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.671 -1.268 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.812 ' O ' HG22 ' A' ' 26' ' ' ILE . 30.6 tt0 -64.77 -52.37 57.28 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 18.8 t-20 -66.64 -44.19 82.62 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.015 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.8 ttmt -59.72 -41.72 91.46 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.127 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.4 tp -69.39 -17.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.389 -0.819 . . . . 0.0 110.194 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . 115.58 52.13 0.4 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 36.5 mm-40 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.122 . . . . 0.0 109.736 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.914 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.29 0.567 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.723 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -129.98 52.71 1.98 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.835 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 6.3 p90 -172.7 62.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 -26.16 11.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.102 -0.999 . . . . 0.0 111.218 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.761 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -96.39 -89.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 36' ' ' LYS . 10.0 t -160.29 172.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.482 -1.386 . . . . 0.0 111.342 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -135.6 82.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.573 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.577 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -102.04 -58.02 0.1 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.026 -1.046 . . . . 0.0 111.494 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 61' ' ' TYR . 39.3 Cg_endo -79.19 48.04 2.7 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.292 1.154 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . 20.8 p -104.74 121.62 43.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.799 -1.188 . . . . 0.0 109.789 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 2.3 mpt? -117.65 157.66 26.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.111 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.53 129.8 46.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 110.215 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 15.0 mttm -130.93 125.43 33.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.1 m -125.1 164.65 19.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.984 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.491 ' N ' HG22 ' A' ' 45' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.367 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.73 ' HA ' HG23 ' A' ' 45' ' ' THR . 13.7 t80 -162.2 109.51 1.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.902 -0.764 . . . . 0.0 110.617 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -126.04 177.85 6.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.351 -0.843 . . . . 0.0 108.831 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 1.089 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -165.38 175.18 9.34 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.168 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.517 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.8 tt0 -127.69 125.06 39.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 41' ' ' CYS . 21.1 tp -119.52 67.62 0.81 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.726 -1.234 . . . . 0.0 109.842 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 2.5 t80 -69.5 108.78 3.93 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 15' ' ' LEU . 34.9 m -160.42 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.695 ' CE1' HD12 ' A' ' 68' ' ' LEU . 1.4 t80 -154.2 117.34 4.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.971 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.91 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -104.46 -102.62 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.559 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.512 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 22.9 t -120.03 -26.74 5.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.75 5.62 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.959 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.91 ' NZ ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -109.07 86.35 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 110.109 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 63' ' ' TYR . 1.2 tp -88.78 61.96 6.21 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.717 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 169.73 -113.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.0 110.213 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 17.5 ttm180 -127.0 146.21 50.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.557 -1.34 . . . . 0.0 112.963 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -106.59 102.42 11.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.3 t70 -84.68 154.88 22.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.089 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -156.18 142.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.842 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.1 t -128.49 159.2 36.2 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -167.65 105.04 0.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.677 -1.264 . . . . 0.0 111.917 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' GLU . 56.9 p-10 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -171.2 -167.78 0.57 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.81 172.4 5.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.295 -0.878 . . . . 0.0 109.704 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 19.6 mtp180 -148.51 178.6 8.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.909 -1.12 . . . . 0.0 111.244 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 3.2 m-85 -155.36 80.86 1.05 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -155.79 -163.31 1.47 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.765 -1.209 . . . . 0.0 111.209 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 77.74 53.21 5.08 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.14 119.66 6.93 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.834 1.965 . . . . 0.0 111.697 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.449 ' H ' HG12 ' A' ' 91' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.216 0.531 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 7.5 p90 -159.36 165.58 32.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -0.901 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 43' ' ' LYS . 8.2 pt-20 -172.94 158.71 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.823 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.05 171.81 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.163 -0.96 . . . . 0.0 110.44 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.823 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -150.84 -176.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.868 -0.52 . . . . 0.0 109.784 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.78 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.8 p30 -179.32 126.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER 43.21 25.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.691 -0.631 . . . . 0.0 110.13 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.66 ' N ' HG21 ' A' ' 12' ' ' THR . . . -118.02 -107.63 2.38 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.161 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . 48.7 Cg_endo -80.65 -72.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.72 1.613 . . . . 0.0 112.752 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 6' ' ' ILE . 59.6 m-85 -40.09 -27.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.286 -0.883 . . . . 0.0 109.9 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.829 HG22 HG21 ' A' ' 38' ' ' ILE . 2.1 p -65.69 -61.81 1.87 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.582 ' N ' ' OG1' ' A' ' 12' ' ' THR . 5.3 mt-30 -59.89 -26.35 65.83 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.924 0.868 . . . . 0.0 108.767 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 1.7 t-20 -74.45 -47.0 36.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.604 0.716 . . . . 0.0 109.202 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 60' ' ' LEU . 3.4 tm? -44.03 -70.4 0.11 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . . . -44.27 -37.39 4.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 18.1 mttp -71.24 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -40.54 -41.3 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.579 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -59.63 -68.27 0.3 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.438 -0.789 . . . . 0.0 109.316 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' GLY . 23.3 t -38.5 -28.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.479 -0.763 . . . . 0.0 110.288 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.17 -73.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 110.341 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 14.0 mm-40 -54.86 -27.98 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.897 -1.127 . . . . 0.0 109.827 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -76.76 -61.11 2.08 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 6.6 m-20 -51.76 -47.17 64.22 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 20.7 mmmt -55.25 -51.69 65.8 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.653 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -51.77 -22.39 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.101 178.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.2 67.41 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.213 -1.169 . . . . 0.0 110.304 -179.898 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.329 0.585 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.533 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -154.35 62.32 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.1 t80 176.94 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.315 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 t-20 -117.12 -56.37 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 110.734 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.51 -101.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.019 -1.051 . . . . 0.0 111.263 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' LYS . 2.4 t -163.43 174.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.696 -1.253 . . . . 0.0 111.527 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.004 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -121.36 112.16 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.739 -0.601 . . . . 0.0 109.768 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.604 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -119.23 -57.07 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.1 Cg_endo -86.93 48.29 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.901 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 60' ' ' LEU . 23.6 p -96.41 122.13 38.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' GLN . 12.1 mtm -121.1 165.14 15.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -143.17 144.5 32.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLU . 18.5 mttt -148.43 157.44 43.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.6 m -149.1 152.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.564 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.881 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.495 2.595 0 CA-C-O 121.736 0.631 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -157.84 107.42 2.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.705 -0.88 . . . . 0.0 110.234 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' LYS . 17.1 pt-20 -117.14 134.65 54.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.41 164.22 26.18 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.49 -1.284 . . . . 0.0 112.534 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 11.5 mt-30 -132.12 124.12 28.5 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.004 HD11 ' CD1' ' A' ' 38' ' ' ILE . 1.8 tp -120.69 78.15 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.747 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -73.28 113.0 9.86 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 38' ' ' ILE . 32.9 m -159.63 -162.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 2.8 t80 -136.01 141.58 44.37 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -138.98 -115.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.845 . . . . 0.0 110.043 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -111.8 -39.0 4.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.268 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 3.5 p-10 -127.54 -0.98 6.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.602 -0.687 . . . . 0.0 109.641 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -106.25 97.68 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 109.736 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' CZ ' ' A' ' 63' ' ' TYR . 6.5 mp -100.2 60.09 1.03 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.428 -0.795 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 168.17 -115.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 110.237 -179.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 3.1 ttm180 -122.46 145.35 48.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.184 -1.572 . . . . 0.0 113.142 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.37 108.31 19.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' CB ' ' HG3' ' A' ' 86' ' ' ARG . 1.4 t70 -90.33 162.37 15.19 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.917 -1.114 . . . . 0.0 111.247 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -155.78 101.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.26 150.52 22.01 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.656 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -169.06 119.9 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.104 -0.998 . . . . 0.0 110.675 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.473 ' C ' ' HA2' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.584 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.8 tt -171.25 163.65 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.17 . . . . 0.0 110.516 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -149.43 160.86 43.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.596 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HG3' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -150.53 147.9 28.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 111.269 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.932 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -124.7 89.82 3.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.638 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.52 -146.43 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.685 -1.26 . . . . 0.0 110.929 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 60.35 52.8 50.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -67.01 136.6 41.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.408 1.741 . . . . 0.0 111.253 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.279 -179.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.279 0.562 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -66.3 -176.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 174.78 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.937 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.965 HG22 ' HG2' ' A' ' 42' ' ' MET . 1.1 pp -89.37 167.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 120.979 -1.076 . . . . 0.0 110.324 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.149 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -115.11 -160.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.995 -1.065 . . . . 0.0 110.672 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 40.3 t0 -135.46 52.74 2.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.844 -1.16 . . . . 0.0 112.123 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.908 HG22 ' O ' ' A' ' 38' ' ' ILE . 29.8 pt 39.83 46.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.168 0.985 . . . . 0.0 110.314 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -134.02 -69.15 0.07 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.785 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 45.7 Cg_endo -79.28 -63.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.845 1.445 . . . . 0.0 111.28 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.149 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.5 m-85 -47.39 -36.02 9.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.025 -1.047 . . . . 0.0 109.212 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.909 HG22 HG13 ' A' ' 38' ' ' ILE . 1.7 p -52.3 -57.66 9.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.602 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.87 -15.97 62.62 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.059 179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.56 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 5.7 m120 -82.82 -68.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.271 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 3.0 pp -40.93 -28.76 0.09 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.456 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 20' ' ' VAL . . . -71.42 -53.34 10.35 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -76.58 -42.49 42.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -1.127 . . . . 0.0 110.837 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' ALA . 7.6 m-85 -63.63 -64.86 0.78 Allowed 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.44 -0.788 . . . . 0.0 110.065 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.42 -66.22 0.42 Allowed 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.625 -0.672 . . . . 0.0 110.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 16' ' ' GLY . 30.5 m -42.43 -26.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 120.961 -1.087 . . . . 0.0 110.149 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -94.77 -69.86 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.969 ' HB2' HD13 ' A' ' 85' ' ' LEU . 22.7 mm-40 -55.37 -35.01 64.79 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.247 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -69.69 -59.66 2.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 61.7 t-20 -51.38 -45.32 62.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -54.46 46.67 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.703 -0.799 . . . . 0.0 108.965 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -57.06 -19.1 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.636 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.66 70.91 1.33 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 32' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.336 0.589 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.97 50.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.633 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.552 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 6.5 p90 -162.85 123.0 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.74 -59.26 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.992 -1.068 . . . . 0.0 111.314 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 mmmt -69.09 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.993 -1.067 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.4 t -161.13 173.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.7 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -123.96 103.35 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.959 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.652 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -101.74 -60.48 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.953 -1.092 . . . . 0.0 110.185 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.4 Cg_endo -86.76 54.43 3.07 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.176 1.092 . . . . 0.0 110.336 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 1.071 ' SG ' HD12 ' A' ' 60' ' ' LEU . 4.5 t -102.67 110.55 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.965 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.0 mtt -113.75 175.75 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 110.628 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 2.3 ttpt -147.68 120.7 8.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -114.78 160.98 18.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.1 m -163.53 153.42 15.21 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.87 -1.144 . . . . 0.0 110.364 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -152.87 110.21 3.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.427 -1.043 . . . . 0.0 111.018 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.0 pm0 -124.8 124.46 42.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.51 169.67 10.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.566 -1.334 . . . . 0.0 113.267 -177.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' HB3' ' NE ' ' A' ' 70' ' ' ARG . 6.7 mp0 -133.66 123.08 24.39 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.071 HD12 ' SG ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -121.24 72.59 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 0.0 109.888 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.621 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -68.23 107.13 2.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.8 m -158.29 -160.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.346 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.99 129.24 22.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.515 -0.741 . . . . 0.0 109.932 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -122.0 -130.27 0.27 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 -18.76 30.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 108.744 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 9.6 p-10 -162.4 23.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.565 -0.71 . . . . 0.0 109.735 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -117.07 71.47 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.384 -0.823 . . . . 0.0 110.32 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.876 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 4.6 mt -81.73 52.6 1.95 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -168.62 -153.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.547 -0.721 . . . . 0.0 109.81 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 ttm180 -106.52 119.64 39.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 111.321 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.753 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -80.6 107.19 13.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t70 -87.64 160.37 18.18 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.732 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.73 112.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.905 0.86 . . . . 0.0 109.745 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -103.12 144.17 31.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.005 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -153.58 105.75 2.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.461 -1.399 . . . . 0.0 112.335 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' CG ' ' A' ' 83' ' ' LYS . 1.7 p-10 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.521 0.677 . . . . 0.0 111.03 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' CG ' ' OD1' ' A' ' 76' ' ' ASP . 79.4 mttt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -171.17 -172.99 1.19 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 110.605 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.969 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -170.3 167.67 8.36 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.646 -0.659 . . . . 0.0 109.329 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.9 mtm180 -143.45 -176.21 4.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.933 -1.105 . . . . 0.0 111.198 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.843 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 17.3 m-85 -155.98 66.79 0.6 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -154.16 -161.41 1.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.81 -1.182 . . . . 0.0 111.624 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 73.05 54.7 6.82 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -176.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.1 Cg_endo -62.57 177.12 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.82 1.958 . . . . 0.0 112.065 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.461 HG13 ' OH ' ' A' ' 61' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.196 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.12 0.486 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.526 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 7.0 p-90 -144.03 169.27 18.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.783 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 177.28 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.063 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.0 HG22 ' HG3' ' A' ' 42' ' ' MET . 6.9 pt -69.89 -172.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mm -131.1 -138.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.535 ' O ' HD11 ' A' ' 38' ' ' ILE . 19.3 m-20 -142.07 -146.83 0.2 Allowed 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.791 -1.193 . . . . 0.0 110.221 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt -113.62 47.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.611 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -157.39 -60.9 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.357 -1.402 . . . . 0.0 111.777 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.815 ' HG2' HG22 ' A' ' 6' ' ' ILE . 38.6 Cg_endo -64.92 -68.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.527 1.277 . . . . 0.0 112.527 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.659 ' HD1' HG21 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -65.36 -23.53 67.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.483 -1.385 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' N ' ' A' ' 9' ' ' GLY . 10.0 p -48.62 -53.36 18.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -64.02 -29.78 70.9 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.072 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 2.0 m-80 -66.02 -58.73 4.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.605 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.833 HD13 ' CD2' ' A' ' 60' ' ' LEU . 9.0 tp -41.03 -66.99 0.28 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -43.46 -29.31 1.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 20' ' ' VAL . 70.5 mmtt -88.67 -82.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 110.418 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -41.6 -27.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.486 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 15' ' ' LEU . . . -81.2 -70.5 0.53 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 17' ' ' LYS . 4.4 p -41.57 -25.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.324 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ALA . 59.3 t0 -92.7 -72.5 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.085 -1.01 . . . . 0.0 110.516 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.974 ' HB2' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -57.83 -28.96 64.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.452 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.3 tt0 -72.43 -58.97 2.97 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.5 m120 -54.14 -51.82 63.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -51.45 -48.62 62.69 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.456 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.054 HD11 HD11 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -53.75 -20.44 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.529 0.68 . . . . 0.0 109.294 178.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.68 22.86 5.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 1.5 tp60 . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.443 -1.033 . . . . 0.0 109.664 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' N ' ' A' ' 32' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.37 0.605 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -155.35 49.67 0.55 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.302 -0.874 . . . . 0.0 110.088 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.669 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 43.5 p90 179.65 55.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.471 -0.768 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 20.9 t-20 -85.77 -54.24 4.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.454 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.806 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.54 -105.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.021 -1.049 . . . . 0.0 110.962 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.7 t -161.06 172.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.53 -1.356 . . . . 0.0 111.775 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.56 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.2 pp -121.37 97.62 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.611 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -96.04 -55.56 0.21 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.863 -1.148 . . . . 0.0 109.866 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.2 Cg_endo -86.87 54.18 2.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.554 1.292 . . . . 0.0 110.362 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 60' ' ' LEU . 7.5 t -91.25 92.94 8.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 1.0 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -90.68 126.4 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.155 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -123.63 155.78 37.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 1.4 ptpp? -164.54 173.5 11.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.4 m -157.86 158.07 34.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 46' ' ' ILE . 6.8 pt . . . . . 0 C--N 1.299 -1.605 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HA ' HG23 ' A' ' 45' ' ' THR . 11.3 m-85 -115.65 -179.19 3.58 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.82 -0.812 . . . . 0.0 110.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 7.4 pt-20 171.34 137.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.807 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -151.06 171.78 16.79 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 117.432 -1.707 . . . . 0.0 113.974 -178.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.553 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt-30 -129.24 124.82 35.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.833 ' CD2' HD13 ' A' ' 15' ' ' LEU . 23.7 tp -117.67 71.76 0.83 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.871 -1.143 . . . . 0.0 109.83 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -69.53 107.01 3.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' CD ' ' A' ' 67' ' ' LYS . 13.0 m -158.2 -160.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.343 -0.848 . . . . 0.0 109.685 -177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -141.32 139.1 33.53 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.473 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.669 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -132.98 -113.08 0.22 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.374 -0.829 . . . . 0.0 109.508 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -30.6 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.125 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -143.18 12.82 1.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.652 -0.655 . . . . 0.0 109.51 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HZ3' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.16 87.71 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.525 -0.735 . . . . 0.0 110.03 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 1.5 mt -93.57 63.21 3.42 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.657 -0.652 . . . . 0.0 109.773 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.62 -118.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.573 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 48.0 ttp85 -123.76 146.08 48.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.402 -1.436 . . . . 0.0 112.807 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -109.48 106.56 16.36 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 6.1 t70 -84.74 159.88 20.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 110.753 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.807 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -160.11 119.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.503 0.668 . . . . 0.0 109.577 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -108.75 153.39 23.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.046 . . . . 0.0 109.528 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -152.19 104.75 2.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.641 -1.287 . . . . 0.0 112.206 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 76' ' ' ASP . 3.2 p30 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.499 0.666 . . . . 0.0 111.494 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 HD11 ' A' ' 26' ' ' ILE . 10.5 tp -171.17 178.72 3.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.353 -0.842 . . . . 0.0 109.639 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.974 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -154.58 167.99 28.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.558 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 6.5 mtt-85 -139.48 -177.7 5.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.772 -1.205 . . . . 0.0 111.45 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.693 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 11.0 m-85 -156.19 82.89 0.99 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.669 -0.644 . . . . 0.0 109.399 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -161.21 -164.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.615 -1.303 . . . . 0.0 111.371 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.555 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 80.6 53.72 3.95 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.2 Cg_endo -60.09 149.67 83.37 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.828 1.962 . . . . 0.0 111.828 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 91' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.109 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.341 0.591 . . . . 2.79 110.2 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -115.53 152.59 32.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 3.58 110.202 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 3.8 pt-20 -163.69 134.08 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.92 . . . . 2.7 110.177 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' A' ' 42' ' ' MET . 16.7 pt -82.34 175.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.055 -1.028 . . . . 1.36 110.491 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.083 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.35 -162.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.251 -0.906 . . . . 2.41 109.881 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -136.36 50.17 2.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.14 . . . . 2.43 111.515 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 7' ' ' ASP . 11.5 tt 40.18 43.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.936 0.874 . . . . 1.72 110.043 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.81 -62.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.295 -0.955 . . . . 0.85 110.804 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.9 Cg_endo -86.34 -61.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.503 1.265 . . . . 0.93 110.896 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.1 m-85 -50.06 -31.89 14.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.993 -1.067 . . . . 1.39 109.387 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.716 HG22 ' CG2' ' A' ' 38' ' ' ILE . 7.2 p -60.2 -58.67 7.53 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.124 -1.436 . . . . 0.89 107.124 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.9 tt0 -66.73 -19.47 65.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.766 0.793 . . . . 2.31 109.18 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 9.9 t-20 -78.19 -56.43 4.47 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.502 0.668 . . . . 1.55 109.547 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 60' ' ' LEU . 7.1 tp -41.55 -66.13 0.37 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.402 0.62 . . . . 2.08 109.357 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.67 -43.61 16.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.323 -1.511 . . . . 0.57 109.323 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -69.64 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -1.16 . . . . 2.4 110.939 -179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.1 m-85 -37.69 -53.71 1.23 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.414 0.626 . . . . 2.25 111.238 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.667 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -43.9 -70.06 0.12 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.475 -0.766 . . . . 0.55 110.001 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 32' ' ' LEU . 16.2 t -42.77 -26.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.032 . . . . 1.4 110.358 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -91.9 -66.28 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.81 109.896 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.109 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.3 mm-40 -60.16 -41.09 92.06 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.581 -1.247 . . . . 2.17 108.981 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.827 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -61.46 -53.22 59.3 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.68 108.711 178.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 27.4 t-20 -61.86 -46.58 88.82 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.687 -1.205 . . . . 2.28 107.824 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -56.92 -48.18 78.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 2.82 109.842 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -60.85 -20.18 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.925 -0.71 . . . . 1.6 109.844 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.67 28.54 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.572 -1.411 . . . . 0.99 109.572 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.521 ' CG ' ' OE2' ' A' ' 23' ' ' GLU . 8.6 tp60 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.152 . . . . 2.31 110.019 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.559 ' HA ' HG22 ' A' ' 20' ' ' VAL . 2.7 mp . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 2.55 110.026 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.667 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -140.44 52.43 1.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.298 -0.876 . . . . 0.93 109.848 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 32' ' ' LEU . 38.4 p90 -167.86 129.08 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.83 . . . . 3.44 110.036 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB2' ' N ' ' A' ' 65' ' ' SER . 7.7 t30 -153.67 -64.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 2.46 110.678 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.98 -94.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.964 . . . . 3.44 111.329 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.4 t -157.97 172.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.693 -1.254 . . . . 1.1 111.822 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.716 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -129.22 86.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.201 -0.666 . . . . 1.64 109.201 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -102.73 -52.14 0.14 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 3.02 110.533 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.3 Cg_endo -85.59 52.8 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.53 1.279 . . . . 0.57 110.789 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.5 p -104.2 120.39 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 1.62 109.781 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.854 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.7 mtm -119.04 178.02 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 2.06 110.631 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -138.61 151.58 47.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 1.61 110.461 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 1.9 mttt -148.39 106.21 3.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.362 -0.837 . . . . 2.48 109.889 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.6 m -112.8 152.55 29.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.62 110.173 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.473 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.305 -1.346 0 N-CA-C 106.769 -1.567 . . . . 1.96 106.769 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.803 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 110.172 -1.171 . . . . 0.6 110.172 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CZ ' ' HE3' ' A' ' 43' ' ' LYS . 7.5 t80 -150.53 98.31 2.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.29 -1.124 . . . . 3.83 110.87 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 15.8 pt-20 -120.0 174.01 6.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 2.53 108.914 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 1.107 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -159.6 177.64 10.69 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 117.952 -1.499 . . . . 1.79 113.45 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -135.45 117.24 15.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.589 -1.263 . . . . 2.14 107.589 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 41' ' ' CYS . 2.2 tp -116.0 72.41 0.81 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.7 109.513 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 1.061 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.63 111.74 5.64 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.117 -1.068 . . . . 1.61 108.117 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.697 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.6 m -158.13 -158.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.789 0.804 . . . . 0.42 109.813 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.0 t80 -143.61 126.21 15.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.699 -0.626 . . . . 1.26 109.535 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -121.44 -136.45 0.32 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.393 -0.817 . . . . 0.75 109.884 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -87.34 -25.73 23.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 1.39 108.964 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 15.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 1.78 109.567 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.912 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -118.29 79.2 1.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.36 110.11 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mp -89.73 57.67 3.98 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.622 -0.881 . . . . 1.75 108.622 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -173.09 -121.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.074 -1.05 . . . . 1.85 110.023 -178.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 30.5 ttm180 -133.84 124.76 27.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.325 -1.484 . . . . 1.91 112.215 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -81.79 103.35 11.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.984 -1.487 . . . . 0.47 106.984 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.45 156.04 19.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 1.75 110.15 -178.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.107 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -159.22 141.74 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.513 -0.742 . . . . 1.17 109.863 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -127.96 153.32 46.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.238 -0.914 . . . . 1.23 109.049 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -157.67 106.42 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.635 -1.291 . . . . 2.3 111.772 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' GLU . 1.4 p30 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.502 0.667 . . . . 1.74 111.224 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 mttt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 108.395 -0.965 . . . . 3.45 108.395 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.643 HD11 HG12 ' A' ' 26' ' ' ILE . 10.0 tp -171.25 179.74 2.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.318 -0.864 . . . . 2.42 109.338 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.109 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -155.65 172.28 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.103 -0.998 . . . . 1.22 110.094 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.533 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 3.9 mtt180 -142.33 -176.67 4.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -0.894 . . . . 2.62 110.905 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 48.5 m-85 -154.93 64.63 0.65 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.74 108.954 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.87 -157.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 1.93 111.26 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.46 52.5 30.33 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.193 -3.163 . . . . 1.21 105.193 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.4 Cg_endo -67.55 -175.03 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.582 1.833 . . . . 2.14 111.933 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.061 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.1 m . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 117.966 -1.016 . . . . 2.25 110.387 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 45' ' ' THR . 6.2 mt-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.512 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 51.2 p-90 -118.59 169.98 9.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.807 -1.183 . . . . 0.0 110.036 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 1.4 tt0 175.79 115.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 42' ' ' MET . 15.2 pt -82.77 -176.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.742 HG21 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -116.39 -165.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.089 -1.007 . . . . 0.0 110.543 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.658 ' O ' HG22 ' A' ' 8' ' ' ILE . 25.3 m-20 -136.66 49.99 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.945 -1.097 . . . . 0.0 111.461 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt 39.7 42.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.455 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -145.47 -68.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.975 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 43.8 Cg_endo -73.77 -84.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.689 1.363 . . . . 0.0 111.392 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 24.7 m-85 -39.68 -31.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.012 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.029 HG22 HD12 ' A' ' 38' ' ' ILE . 11.7 p -55.97 -56.89 15.28 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.85 -1.156 . . . . 0.0 108.21 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.516 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -57.34 -17.83 14.24 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.41 179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.57 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -79.86 -60.56 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.702 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 12' ' ' THR . 1.2 pp -41.57 -30.68 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.66 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.41 -49.28 20.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' PHE . 10.4 tptt -71.62 -69.36 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -1.05 . . . . 0.0 110.21 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-85 -39.75 -62.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.483 0.659 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.12 -72.45 0.06 Allowed 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 15.7 t -38.52 -26.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.756 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 19' ' ' ALA . 9.4 m-20 -95.09 -70.73 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 110.26 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.822 ' CD ' HD11 ' A' ' 73' ' ' ILE . 1.8 mt-10 -57.96 -26.87 62.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.579 -1.249 . . . . 0.0 109.062 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.9 tt0 -74.34 -58.91 2.99 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' GLN . 1.7 m-80 -56.81 -44.73 82.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.461 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.94 -52.68 63.28 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.793 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 85' ' ' LEU . 7.3 tp -63.68 -12.87 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.264 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.64 59.48 0.43 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 109.991 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.637 HD11 ' OD1' ' A' ' 35' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -135.13 55.27 1.9 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 11.3 p90 -174.4 60.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.886 . . . . 0.0 110.262 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.637 ' OD1' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -90.1 -56.05 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.63 -106.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.079 . . . . 0.0 111.115 -178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.1 t -160.03 173.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.732 -1.23 . . . . 0.0 111.431 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.029 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.53 118.07 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.498 -0.751 . . . . 0.0 110.162 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.607 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -123.49 -56.87 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.896 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.4 Cg_endo -87.33 48.89 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.212 1.111 . . . . 0.0 110.354 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 6' ' ' ILE . 2.7 t -91.27 128.81 37.24 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.537 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.2 mtm -122.96 162.98 21.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -145.19 115.87 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.481 -0.762 . . . . 0.0 109.237 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 1.3 mttp -124.93 152.12 44.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.034 -1.041 . . . . 0.0 110.313 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.3 m -147.41 152.51 38.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -155.37 104.37 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 110.113 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 44' ' ' LYS . 2.1 pt-20 -105.15 152.31 22.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CB ' HG22 ' A' ' 73' ' ' ILE . 13.5 t80 -128.27 148.74 50.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.644 -1.285 . . . . 0.0 112.673 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.489 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 21.9 mt-30 -134.41 109.9 9.07 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -116.0 71.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.973 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.62 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -72.98 108.44 5.89 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.684 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 61' ' ' TYR . 33.6 m -159.86 -159.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.593 -0.692 . . . . 0.0 109.371 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 3.6 t80 -135.69 142.07 45.04 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.527 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -137.08 -118.99 0.15 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -99.42 -28.97 13.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.018 -1.051 . . . . 0.0 109.222 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -148.99 18.28 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.736 0.779 . . . . 0.0 109.143 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.64 ' NZ ' HD13 ' A' ' 15' ' ' LEU . 7.0 ttmt -109.18 79.15 1.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.511 0.672 . . . . 0.0 110.104 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.7 mp -85.89 57.59 4.56 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 109.263 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.52 -124.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 7.6 ttm180 -127.19 144.42 51.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.199 -1.563 . . . . 0.0 113.486 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -112.39 111.59 22.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -99.04 170.06 8.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.774 -1.204 . . . . 0.0 110.369 -177.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.85 HD12 ' O ' ' A' ' 84' ' ' LEU . 3.1 tp -151.62 113.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.768 0.794 . . . . 0.0 109.237 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 21.9 t -97.85 151.45 20.21 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.08 . . . . 0.0 109.5 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.8 110.08 4.4 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.387 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 O-C-N 121.417 -0.802 . . . . 0.0 111.218 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 74' ' ' SER . 11.8 tttt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.85 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.7 tp -171.18 -170.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.969 -1.082 . . . . 0.0 110.037 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -171.21 -179.96 2.83 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.229 -0.92 . . . . 0.0 110.695 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 5.8 ptm85 -170.25 112.8 0.45 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.125 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.72 ' HE2' HG21 ' A' ' 26' ' ' ILE . 6.8 m-85 -90.85 86.66 6.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.525 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.619 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -160.78 -171.34 3.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.818 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . 91.9 59.65 1.31 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 37.1 Cg_endo -59.43 125.16 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.502 1.791 . . . . 0.0 112.116 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 2.6 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.211 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.214 0.53 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.524 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 29.6 p90 -154.22 146.85 24.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 48.4 mt-10 -157.6 -174.54 4.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' CG1' HD13 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -121.85 171.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 110.035 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.941 HG13 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -81.1 -164.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.329 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.1 t0 -147.43 46.7 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.439 -0.788 . . . . 0.0 110.658 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.9 tt 39.88 40.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.657 0.741 . . . . 0.0 109.84 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.459 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -146.54 -61.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.628 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.4 Cg_endo -83.87 -77.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.574 1.302 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.737 ' CG ' HG22 ' A' ' 6' ' ' ILE . 86.1 m-85 -39.89 -35.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 110.284 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 1.06 HG22 HD12 ' A' ' 38' ' ' ILE . 9.7 p -61.61 -59.95 4.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.537 ' N ' ' OG1' ' A' ' 12' ' ' THR . 35.5 tt0 -66.73 -15.27 63.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.52 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 43.8 m-20 -78.4 -57.72 3.63 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.548 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -42.31 -50.73 4.98 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 1.021 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.64 -56.34 16.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -67.4 -77.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -1.081 . . . . 0.0 110.696 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 14' ' ' ASN . 16.8 m-30 -33.69 -63.99 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.569 0.699 . . . . 0.0 111.355 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 33' ' ' THR . . . -42.2 -71.89 0.07 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 12.5 t -39.86 -27.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 1.6 t70 -92.3 -71.0 0.67 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 2.8 pt-20 -54.35 -29.01 46.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.38 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -72.53 -60.18 2.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -59.3 -39.14 82.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.306 -1.358 . . . . 0.0 107.916 178.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -60.46 -48.94 79.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.37 -32.74 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.417 -0.802 . . . . 0.0 110.606 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.41 42.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.493 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.376 -1.073 . . . . 0.0 108.889 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 121.873 0.844 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.755 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -163.44 42.79 0.11 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.552 0.692 . . . . 0.0 109.789 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 34' ' ' PHE . 31.0 p90 -174.42 99.23 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.687 -0.633 . . . . 0.0 109.895 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.8 t-20 -141.58 -52.42 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.903 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -70.51 -98.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.0 111.494 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 38' ' ' ILE . 1.1 t -161.83 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.798 -1.189 . . . . 0.0 111.051 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.06 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -140.59 123.96 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.565 0.698 . . . . 0.0 109.709 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.558 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 mtt180 -140.7 -56.59 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.6 Cg_endo -83.52 42.48 1.25 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.17 1.089 . . . . 0.0 111.712 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 38' ' ' ILE . 20.5 p -103.22 129.62 50.21 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 109.333 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -121.74 163.22 19.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.0 111.035 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -117.89 155.19 30.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.752 . . . . 0.0 109.958 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 27.0 mttt -159.79 118.64 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.947 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.8 m -119.72 148.83 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.947 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 0.8 OUTLIER -162.44 107.68 1.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.682 -0.893 . . . . 0.0 109.936 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.1 pp20? -126.87 177.26 6.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.817 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -161.96 171.89 16.89 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.216 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.501 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 26.8 mt-30 -130.28 125.29 34.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -121.49 75.11 1.16 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.842 -1.161 . . . . 0.0 109.738 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . 2.1 t80 -74.11 111.04 8.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.141 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.627 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 17.7 m -159.0 -154.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.784 0.802 . . . . 0.0 109.068 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 1.061 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.8 t80 -139.68 134.81 32.48 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.299 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -130.16 -126.65 0.21 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.361 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -103.14 -34.12 8.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.082 -1.011 . . . . 0.0 110.113 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.1 p-10 -132.65 0.83 3.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -114.38 104.09 11.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.845 . . . . 0.0 109.622 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.061 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 10.2 mt -100.58 66.61 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.461 -0.774 . . . . 0.0 109.852 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 167.68 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 31.4 ttm180 -121.26 148.09 44.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.127 -1.608 . . . . 0.0 112.909 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.756 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -113.93 107.52 15.81 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 13.8 t70 -88.57 165.92 14.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.957 -1.089 . . . . 0.0 110.639 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.817 HG22 ' CD1' ' A' ' 58' ' ' TYR . 3.2 tp -165.29 112.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.639 0.733 . . . . 0.0 109.301 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.5 p -108.76 162.44 14.17 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.652 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -170.12 117.72 0.56 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.781 . . . . 0.0 109.792 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.858 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.443 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.217 0.532 . . . . 0.0 110.222 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 5.0 tp -170.47 123.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -125.16 167.85 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.211 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 60.1 mtm180 -157.88 119.26 3.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.964 -1.085 . . . . 0.0 111.993 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 12.8 m-85 -107.43 71.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.71 -161.81 1.33 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.384 -1.326 . . . . 0.0 111.406 -179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.44 52.0 6.32 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 105.345 -3.102 . . . . 0.0 105.345 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.03 158.21 35.37 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.807 1.951 . . . . 0.0 112.08 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.282 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.454 ' OE2' ' O ' ' A' ' 45' ' ' THR . 4.7 pm0 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.191 0.52 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.549 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 26.4 p-90 -143.02 149.57 38.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 34.8 mt-10 -152.77 136.73 16.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 110.656 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -79.28 -174.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 110.664 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -114.2 -167.96 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.341 -0.849 . . . . 0.0 110.297 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 8' ' ' ILE . 33.9 t70 -137.12 49.27 2.04 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 111.16 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.715 ' C ' HG21 ' A' ' 12' ' ' THR . 17.8 tt 38.74 33.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.615 0.722 . . . . 0.0 109.911 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -138.11 -59.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.686 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 44.1 Cg_endo -84.88 -56.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.511 1.269 . . . . 0.0 111.57 -177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 9.2 m-85 -61.78 -27.21 68.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.959 -1.088 . . . . 0.0 109.695 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.982 HG22 HD12 ' A' ' 38' ' ' ILE . 10.8 p -65.44 -59.85 3.57 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.206 -0.934 . . . . 0.0 108.789 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 44.6 tt0 -59.67 -20.38 55.8 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.763 0.792 . . . . 0.0 109.175 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -71.26 -56.22 6.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.748 0.785 . . . . 0.0 109.248 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.023 HD12 HD21 ' A' ' 60' ' ' LEU . 5.7 tt -43.1 -64.25 0.67 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 15' ' ' LEU . . . -41.11 -44.67 3.75 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.82 -79.78 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -1.167 . . . . 0.0 110.643 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -36.99 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.423 0.63 . . . . 0.0 111.086 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -77.4 -74.69 0.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 14.1 t -36.74 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.618 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' ALA . 34.9 t70 -93.05 -79.28 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.5 mt-10 -49.36 -25.8 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.805 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 33' ' ' THR . 11.6 tt0 -77.52 -63.18 1.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 4.3 m120 -49.53 -48.43 48.3 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -55.01 -51.55 65.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.824 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -49.95 -25.13 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.442 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.85 21.7 5.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.508 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.428 -1.042 . . . . 0.0 109.657 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.54 0.686 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -161.24 54.02 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.619 -0.675 . . . . 0.0 109.577 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 2.6 p90 -161.53 32.56 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -18.04 20.83 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.802 -1.186 . . . . 0.0 109.09 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.759 ' HB3' ' CA ' ' A' ' 64' ' ' ALA 0.357 0.0 OUTLIER -66.55 -141.24 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 -178.124 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.638 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -161.12 -176.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 113.877 -1.511 . . . . 0.0 106.963 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.982 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -151.61 121.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.379 -1.451 . . . . 0.0 110.96 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.602 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -125.78 -57.16 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 110.126 179.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.8 Cg_endo -85.31 47.81 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.203 1.107 . . . . 0.0 110.89 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.749 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -85.38 129.77 34.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.867 . . . . 0.0 109.525 178.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 41.3 mtm -133.31 161.95 33.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.882 -1.136 . . . . 0.0 110.785 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 10.4 ttpt -129.12 156.31 44.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' CG ' ' HB3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -159.17 113.67 2.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.112 -0.993 . . . . 0.0 110.571 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.3 m -122.13 154.27 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -120.77 100.4 7.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.403 -1.057 . . . . 0.0 110.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 50.9 tt0 -123.05 173.83 7.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.352 -0.843 . . . . 0.0 109.225 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.36 173.37 14.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.081 -1.447 . . . . 0.0 113.179 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 2.6 pt20 -128.7 124.27 35.23 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.023 HD21 HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.11 72.58 0.87 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 108.593 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.625 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -71.56 106.42 4.0 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.567 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.713 HG23 ' HE2' ' A' ' 67' ' ' LYS . 17.8 m -163.52 -144.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.767 ' CD1' HD22 ' A' ' 68' ' ' LEU . 22.7 t80 -135.03 161.57 34.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -136.56 -140.31 0.16 Allowed 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.946 0.794 . . . . 0.0 108.924 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 24.3 t -86.91 -1.62 57.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.66 33.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.592 -0.693 . . . . 0.0 109.72 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.807 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -129.98 93.87 3.59 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.836 . . . . 0.0 109.701 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.767 HD22 ' CD1' ' A' ' 63' ' ' TYR . 1.4 mm? -88.46 74.8 8.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 171.52 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.571 -1.33 . . . . 0.0 110.59 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 59' ' ' GLN . 34.2 ttm180 -139.12 147.69 42.25 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.56 -1.338 . . . . 0.0 112.598 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -107.57 103.07 12.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 176.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -83.99 161.34 20.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 110.197 -178.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.693 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -163.01 108.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 121.939 0.875 . . . . 0.0 109.9 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.3 t -107.26 156.35 18.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 108.633 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 74' ' ' SER . 29.9 mt-10 -155.07 104.57 2.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.569 -1.332 . . . . 0.0 112.13 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 75' ' ' GLU . 1.6 p30 . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.488 -0.758 . . . . 0.0 111.091 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -171.09 146.58 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.031 . . . . 0.0 110.304 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -137.62 158.34 44.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.9 . . . . 0.0 109.59 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -142.8 147.71 35.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.947 -1.096 . . . . 0.0 111.009 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.94 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 8.9 m-85 -119.55 85.56 2.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 109.348 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -168.94 -167.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.635 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 85.96 56.41 2.33 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.0 Cg_endo -61.87 151.37 81.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.508 1.794 . . . . 0.0 111.689 -176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.625 HG12 ' OH ' ' A' ' 61' ' ' TYR . 22.5 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 67.4 mm-40 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.2 p-90 -137.2 161.0 37.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.536 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 1.6 pm0 -172.47 173.03 4.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.724 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.7 173.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.17 -153.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.532 -0.73 . . . . 0.0 109.717 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -141.04 48.06 1.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.865 -1.147 . . . . 0.0 111.439 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.8 ' C ' HG21 ' A' ' 12' ' ' THR . 15.6 pt 40.17 36.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.932 0.873 . . . . 0.0 109.883 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.51 -59.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.954 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.8 Cg_endo -85.73 -66.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.596 1.314 . . . . 0.0 110.947 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.705 ' CE2' ' CE1' ' A' ' 58' ' ' TYR . 1.1 m-85 -47.42 -32.36 4.96 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.137 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.8 HG21 ' C ' ' A' ' 8' ' ' ILE . 23.6 p -59.9 -57.42 12.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.504 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.21 -26.13 68.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.549 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.532 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -76.83 -49.9 14.71 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.481 0.658 . . . . 0.0 109.832 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.772 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.4 tm? -42.94 -63.7 0.75 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.392 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.739 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -49.05 -41.84 30.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.583 ' O ' HG12 ' A' ' 20' ' ' VAL . 11.1 tptp -68.99 -68.52 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -1.16 . . . . 0.0 110.593 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CE2' ' OD1' ' A' ' 14' ' ' ASN . 18.0 m-30 -54.9 -36.11 64.84 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -58.68 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.815 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 17' ' ' LYS . 9.6 p -38.41 -27.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -87.17 -75.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.866 -1.146 . . . . 0.0 110.107 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.053 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.4 mm-40 -59.47 -36.98 77.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 26' ' ' ILE . 4.0 tt0 -62.62 -49.45 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.038 -1.039 . . . . 0.0 109.251 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 33.9 t-20 -70.63 -45.33 65.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 30.6 mmtt -58.61 -38.68 78.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 110.052 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.3 tp -71.68 -15.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.0 110.08 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.53 54.63 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 46.2 tp60 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.36 -1.082 . . . . 0.0 109.661 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.329 0.585 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -146.15 53.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.607 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 22.4 p90 178.98 114.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.82 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.4 t30 -150.28 -48.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.0 110.834 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 111.197 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 36' ' ' LYS . 17.0 t -158.31 172.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.633 -1.292 . . . . 0.0 111.361 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.016 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -133.26 99.94 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.757 . . . . 0.0 110.012 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.81 -54.18 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 110.492 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.1 Cg_endo -85.06 50.28 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.491 1.258 . . . . 0.0 111.362 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . 16.5 p -81.35 137.27 35.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' GLN . 6.2 mtp -130.95 169.29 16.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 110.959 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -151.92 138.65 18.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 109.946 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 45' ' ' THR . 8.3 ttmm -137.93 163.47 31.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.679 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 55' ' ' GLY . 5.1 m -163.25 148.67 11.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.075 -1.016 . . . . 0.0 110.879 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.512 ' CG1' ' HA3' ' A' ' 55' ' ' GLY . 25.3 pt . . . . . 0 C--N 1.302 -1.487 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.42 97.77 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.498 ' OE1' ' HA ' ' A' ' 45' ' ' THR . 4.3 pm0 -92.86 165.52 12.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.064 -1.022 . . . . 0.0 109.513 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.966 ' OH ' HD13 ' A' ' 60' ' ' LEU . 72.4 t80 -137.09 136.81 38.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.164 -0.96 . . . . 0.0 111.283 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.547 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 18.0 mt-30 -135.15 106.82 6.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.016 HD11 ' CD1' ' A' ' 38' ' ' ILE . 2.9 tp -119.41 80.16 1.53 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.01 -1.056 . . . . 0.0 110.076 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -74.4 110.37 8.64 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.747 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.3 m -160.33 -158.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.596 0.712 . . . . 0.0 109.656 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CE2' ' HD2' ' A' ' 36' ' ' LYS . 2.4 t80 -140.82 133.99 29.5 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.67 -0.644 . . . . 0.0 109.474 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -130.16 -124.4 0.21 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.738 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 t -97.73 -17.94 19.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.195 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.41 20.78 0.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.792 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.747 ' CD ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -118.61 81.03 1.62 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -0.791 . . . . 0.0 110.188 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -84.94 57.6 4.52 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.575 -0.703 . . . . 0.0 109.855 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.89 -117.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 110.368 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 21.5 ttp180 -122.96 148.26 45.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.158 -1.589 . . . . 0.0 113.122 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' A' ' 58' ' ' TYR . . . -109.94 105.35 14.48 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 66.2 m-20 -85.2 163.69 18.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.804 -1.185 . . . . 0.0 110.718 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -160.12 103.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -93.71 157.48 16.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.824 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.46 96.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.867 -1.146 . . . . 0.0 111.465 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 111.034 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.37 -167.74 0.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.095 -1.003 . . . . 0.0 109.979 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.053 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -171.25 171.74 5.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.211 -0.93 . . . . 0.0 109.757 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.542 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 30.3 mtt180 -144.77 175.41 10.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.002 -1.062 . . . . 0.0 110.986 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.806 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -151.63 69.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.519 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -155.06 -156.1 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.282 . . . . 0.0 111.105 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 87.68 52.79 2.89 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 106.711 -2.556 . . . . 0.0 106.711 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 39.6 Cg_endo -63.9 140.84 75.2 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.236 1.651 . . . . 0.0 111.276 -177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.343 -179.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.213 0.53 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 3' ' ' TRP . 5.9 p90 -124.18 170.4 10.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 110.318 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 176.66 111.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.105 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -92.32 178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.379 -0.825 . . . . 0.0 110.594 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.765 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.86 -166.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.65 41.46 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.15 . . . . 0.0 111.155 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 39' ' ' ARG . 4.1 mt 57.18 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.02 0.914 . . . . 0.0 110.291 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.487 ' C ' ' HG1' ' A' ' 12' ' ' THR . . . -153.5 -63.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HG2' HG22 ' A' ' 6' ' ' ILE . 44.0 Cg_endo -75.87 -76.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.59 1.31 . . . . 0.0 111.631 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -48.91 -26.65 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.023 -1.048 . . . . 0.0 110.46 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.82 HG22 HG21 ' A' ' 38' ' ' ILE . 26.9 p -57.6 -57.77 11.26 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.943 -1.098 . . . . 0.0 108.26 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.1 mm-40 -63.2 -24.8 68.04 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.77 0.795 . . . . 0.0 109.206 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' LEU . 4.6 t30 -72.14 -56.3 5.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.487 0.66 . . . . 0.0 109.37 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.2 tm? -42.66 -71.72 0.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.66 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.672 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -40.73 -37.82 1.4 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.826 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.7 mttp -76.78 -83.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -1.093 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -45.43 -28.33 0.87 Allowed 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.587 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -63.55 -72.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 17' ' ' LYS . 10.4 p -41.72 -25.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.52 -70.8 0.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 110.112 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.068 ' CB ' HD13 ' A' ' 85' ' ' LEU . 4.5 mm-40 -59.9 -38.5 82.46 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.718 -1.239 . . . . 0.0 109.324 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.855 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -63.58 -51.84 63.56 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.235 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 27.8 t-20 -67.15 -44.52 79.59 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.163 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -43.11 92.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.42 -0.8 . . . . 0.0 110.092 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -66.6 -21.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.6 36.02 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 3.0 mm-40 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.324 0.583 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -154.24 49.05 0.62 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.776 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 3.4 t80 179.8 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.547 -0.721 . . . . 0.0 110.228 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -154.22 -48.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 110.579 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.3 mmpt? -69.61 -100.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.7 t -157.89 171.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.605 -1.309 . . . . 0.0 111.669 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.82 HG21 HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -135.41 92.93 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.682 -0.636 . . . . 0.0 109.829 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.77 ' HG2' HD11 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -105.1 -53.26 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.635 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.5 Cg_endo -84.7 50.78 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.538 1.283 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 38' ' ' ILE . 20.6 p -104.12 118.32 36.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.598 ' HB3' HG22 ' A' ' 5' ' ' ILE . 66.4 mtm -126.66 175.6 7.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 58' ' ' TYR . 10.9 tmtt? -152.71 140.68 20.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.038 -1.039 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 13.6 mttt -137.93 121.99 17.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 0.0 109.778 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 55' ' ' GLY . 6.5 m -108.42 154.12 22.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.896 . . . . 0.0 110.746 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 46' ' ' ILE . 3.0 tt . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 45' ' ' THR . 18.4 m-85 -133.25 119.36 19.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.987 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' OE2' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -124.31 163.75 21.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 0.0 109.623 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.785 ' HE2' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -157.54 165.89 34.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.448 -1.301 . . . . 0.0 112.681 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 5.5 pt20 -124.47 120.41 31.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.785 HD13 ' HE2' ' A' ' 58' ' ' TYR . 2.9 tp -114.43 67.77 0.69 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.7 t80 -68.79 108.65 3.51 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' CD ' ' A' ' 67' ' ' LYS . 27.4 m -159.56 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.596 0.712 . . . . 0.0 109.585 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 1.9 t80 -148.46 130.94 15.75 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.951 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -126.83 -123.74 0.24 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.829 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.0 p -91.53 -32.84 15.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.056 . . . . 0.0 109.551 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.36 14.26 1.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.674 ' CD ' HG23 ' A' ' 62' ' ' VAL . 4.7 ttmt -107.98 78.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.756 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -89.94 68.53 7.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.624 -0.673 . . . . 0.0 109.287 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 173.31 -119.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.28 -0.887 . . . . 0.0 109.863 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 16.4 ttm180 -135.32 124.93 25.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.571 -1.33 . . . . 0.0 111.702 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.44 104.27 12.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.6 t70 -89.39 157.1 18.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 110.167 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.739 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.09 117.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 57' ' ' GLU . 2.1 t -116.66 144.98 43.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.011 -1.056 . . . . 0.0 111.085 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -129.43 159.85 34.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.068 -1.02 . . . . 0.0 111.732 -178.672 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.36 0.6 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 tp -171.32 128.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.197 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.068 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -130.31 171.96 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.981 -1.075 . . . . 0.0 111.099 -179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.552 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -146.45 -179.0 6.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.851 . . . . 0.0 110.564 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 5.2 m-85 -153.44 67.6 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.528 -0.732 . . . . 0.0 109.199 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.596 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.06 -158.7 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.72 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.622 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.06 48.9 44.33 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 44.5 Cg_endo -69.03 -173.79 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.446 1.761 . . . . 0.0 111.823 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.585 HG12 ' OH ' ' A' ' 61' ' ' TYR . 27.4 m . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.311 0.577 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -119.35 -176.5 3.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.476 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER 176.33 112.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 110.105 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.739 HG22 ' SD ' ' A' ' 42' ' ' MET . 1.2 pp -85.68 -179.06 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 110.638 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.103 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -135.24 -161.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.989 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.17 -157.11 0.79 Allowed 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.988 -1.07 . . . . 0.0 109.505 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.864 ' C ' HG21 ' A' ' 12' ' ' THR . 0.9 OUTLIER -101.08 36.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -128.4 -57.42 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.906 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.6 Cg_endo -82.51 -77.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.369 1.194 . . . . 0.0 111.253 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.0 m-85 -43.63 -29.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.937 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.939 HG22 HD12 ' A' ' 38' ' ' ILE . 24.3 p -62.15 -58.91 6.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -62.47 -15.54 50.42 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.259 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.2 t30 -83.14 -59.13 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.624 0.726 . . . . 0.0 110.052 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 60' ' ' LEU . 1.3 pp -42.57 -31.54 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.649 -0.657 . . . . 0.0 109.704 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.96 -56.64 5.7 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -69.63 -67.15 0.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -1.142 . . . . 0.0 110.525 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.88 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -39.05 -49.27 1.73 Allowed 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.468 0.651 . . . . 0.0 110.424 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.632 ' N ' ' CD1' ' A' ' 18' ' ' PHE . . . -53.74 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.834 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' CG ' ' A' ' 24' ' ' ASN . 2.7 t -37.86 -26.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.46 -0.775 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.7 m-20 -89.76 -73.51 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.616 -1.303 . . . . 0.0 110.039 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.112 ' HB2' HD13 ' A' ' 85' ' ' LEU . 1.8 mt-10 -59.13 -32.91 70.29 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.255 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.848 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -63.69 -56.65 14.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 108.339 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 2.3 m120 -62.57 -47.11 85.29 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.757 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.92 -41.19 74.19 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.404 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.9 tp -72.62 -10.91 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.835 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.47 51.31 1.33 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 11.2 tp60 . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.487 -1.008 . . . . 0.0 109.346 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.744 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.29 0.567 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -41.86 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 110.68 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 32' ' ' LEU . 1.6 t80 164.12 115.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 109.203 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -165.34 -59.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.394 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.738 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.8 tppp? -69.54 -103.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.982 -1.074 . . . . 0.0 111.139 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 36' ' ' LYS . 15.8 t -158.59 172.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.213 . . . . 0.0 111.524 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.972 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -123.8 117.49 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.521 0.677 . . . . 0.0 109.797 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -124.3 -56.27 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.6 Cg_endo -86.61 48.14 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.174 1.091 . . . . 0.0 110.537 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.675 ' C ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -89.18 117.87 28.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 109.675 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.739 ' SD ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -127.57 179.6 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 110.641 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -158.11 134.77 9.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 109.773 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 2.4 tttt -141.34 122.81 15.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 55' ' ' GLY . 17.9 m -101.65 150.47 23.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.9 . . . . 0.0 109.68 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.738 HG22 ' OE2' ' A' ' 57' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.842 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.579 ' HA ' HG23 ' A' ' 45' ' ' THR . 0.3 OUTLIER -123.32 108.3 12.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.545 -0.973 . . . . 0.0 110.028 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.738 ' OE2' HG22 ' A' ' 46' ' ' ILE . 3.0 mp0 -114.73 163.62 15.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.842 . . . . 0.0 108.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -150.8 163.48 38.51 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.916 -179.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.554 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 26.8 mt-30 -128.11 121.84 30.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -116.33 69.57 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.355 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 1.031 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.88 109.37 4.99 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.505 -0.747 . . . . 0.0 109.27 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG23 ' CE ' ' A' ' 67' ' ' LYS . 18.3 m -161.51 -163.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.5 t80 -135.19 138.01 43.23 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.887 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 67' ' ' LYS . . . -135.21 -136.22 0.16 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.421 -0.799 . . . . 0.0 110.102 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.535 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -82.82 -37.61 24.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.801 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -138.15 7.42 2.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.689 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -105.44 94.82 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.837 0.827 . . . . 0.0 109.737 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -101.31 64.53 1.02 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.364 -0.835 . . . . 0.0 108.775 178.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 173.08 -123.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.305 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 36.8 ttp180 -130.44 122.71 28.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.526 -1.359 . . . . 0.0 111.944 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -83.01 106.31 14.72 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 22.6 t70 -88.89 170.96 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.762 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -169.94 119.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.565 -0.709 . . . . 0.0 110.17 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.508 ' OG ' ' CG ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -110.89 156.71 20.78 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.016 -1.052 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.5 111.81 4.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.489 -1.382 . . . . 0.0 112.138 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.216 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' SER . 13.7 mtmm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 1.5 tt -171.9 130.81 0.65 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 0.0 109.829 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.112 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -117.1 168.28 10.42 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.0 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 10.8 mtt180 -137.04 -172.07 3.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.488 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 60.1 m-85 -158.32 64.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -154.31 -160.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.728 -1.233 . . . . 0.0 111.71 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.19 50.88 30.7 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -177.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.7 Cg_endo -67.95 -173.86 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 124.564 1.823 . . . . 0.0 111.851 -176.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.031 HG12 ' OH ' ' A' ' 61' ' ' TYR . 25.0 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.38 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.154 0.502 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 2.9 p-90 -131.97 170.84 14.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.8 tp10 178.67 160.47 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.731 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.603 HD12 ' SD ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -117.67 173.3 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.039 -1.038 . . . . 0.0 110.444 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.082 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -103.84 -160.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.503 -0.748 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.659 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.9 p30 -132.0 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.977 -1.077 . . . . 0.0 111.644 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.754 ' C ' HG21 ' A' ' 12' ' ' THR . 14.9 tt 41.14 46.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.974 0.892 . . . . 0.0 109.909 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.524 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.66 -62.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD2' HD13 ' A' ' 6' ' ' ILE . 44.1 Cg_endo -84.01 -68.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.733 1.386 . . . . 0.0 111.062 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.082 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -44.58 -29.52 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.4 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.754 HG21 ' C ' ' A' ' 8' ' ' ILE . 17.5 p -64.43 -58.77 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.508 ' N ' ' OG1' ' A' ' 12' ' ' THR . 3.8 tt0 -65.74 -26.72 67.86 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.844 0.831 . . . . 0.0 109.052 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.486 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 1.2 t30 -74.12 -55.16 6.42 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.584 0.707 . . . . 0.0 109.495 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.045 HD11 ' HE3' ' A' ' 67' ' ' LYS . 2.7 tt -37.99 -53.9 1.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.394 0.616 . . . . 0.0 109.924 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.874 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -56.04 -46.59 84.4 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 tttp -73.15 -72.46 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -1.185 . . . . 0.0 111.016 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CD1' ' ND2' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -39.88 -48.08 2.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.593 0.711 . . . . 0.0 110.868 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 33' ' ' THR . . . -55.34 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.712 -0.618 . . . . 0.0 110.604 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 17' ' ' LYS . 15.0 m -43.89 -23.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 120.952 -1.092 . . . . 0.0 110.546 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -88.73 -73.78 0.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.072 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.04 ' HB2' HD13 ' A' ' 85' ' ' LEU . 20.6 mm-40 -57.69 -37.53 73.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.693 -1.255 . . . . 0.0 109.232 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -64.71 -50.06 68.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.974 -1.078 . . . . 0.0 109.155 178.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 55.1 t-20 -66.02 -46.53 77.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.573 -1.329 . . . . 0.0 107.739 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 4.2 tttp -59.4 -41.54 89.69 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.032 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -73.77 -12.93 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.05 81.44 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.532 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.426 ' C ' ' OG1' ' A' ' 33' ' ' THR . 16.6 mt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.553 0.692 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' OE2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -164.13 51.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.781 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -176.19 123.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.363 -0.836 . . . . 0.0 109.833 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -158.67 -58.86 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.042 -1.036 . . . . 0.0 111.318 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.772 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.61 -97.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.957 -1.09 . . . . 0.0 111.38 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.7 t -160.48 173.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.521 -1.362 . . . . 0.0 111.617 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.825 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -126.79 109.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.795 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -117.24 -59.4 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.999 . . . . 0.0 110.926 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.6 Cg_endo -83.98 46.84 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.117 1.062 . . . . 0.0 111.119 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' CB ' HD11 ' A' ' 38' ' ' ILE . 18.6 p -88.97 98.0 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.509 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.603 ' SD ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -97.52 -177.58 3.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 0.0 111.013 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -161.86 155.78 21.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.708 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.1 OUTLIER -170.68 126.96 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 110.817 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 55' ' ' GLY . 19.2 m -112.58 152.11 29.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 55' ' ' GLY . 2.1 mt . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.916 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.494 2.521 0 CA-C-O 121.845 0.691 . . . . 0.0 111.992 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.57 ' CG ' ' OG1' ' A' ' 45' ' ' THR . 2.0 t80 -126.91 102.06 6.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.146 -0.62 . . . . 0.0 109.808 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.5 pt-20 -104.08 152.23 22.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 109.558 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -141.94 154.93 45.43 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.14 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 6.1 pt20 -126.05 125.24 42.28 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 15' ' ' LEU . 1.2 tp -121.44 69.54 0.92 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.919 -1.113 . . . . 0.0 109.179 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.608 ' C ' HG13 ' A' ' 62' ' ' VAL . 23.0 t80 -69.21 110.52 4.62 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' CD ' ' A' ' 67' ' ' LYS . 31.2 m -159.5 -161.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -142.56 126.62 17.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -119.95 -131.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.632 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 85.1 p -85.69 -25.29 26.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.007 -1.058 . . . . 0.0 109.175 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.59 17.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 1.045 ' HE3' HD11 ' A' ' 15' ' ' LEU . 1.1 ttmm -110.7 74.5 0.88 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.053 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mt -85.73 66.48 9.66 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 175.31 -119.92 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.455 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 19.6 ttp85 -137.73 125.65 22.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.55 -1.344 . . . . 0.0 111.918 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.69 110.71 17.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.5 t70 -92.03 165.58 13.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 111.032 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.736 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.78 118.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.28 142.06 51.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.861 -1.15 . . . . 0.0 110.771 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 74' ' ' SER . 21.7 mt-10 -152.99 132.29 12.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.315 -0.866 . . . . 0.0 109.824 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' C ' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 0.0 110.723 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -172.2 155.8 3.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.971 -1.081 . . . . 0.0 109.602 -179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -142.72 166.24 25.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 11.1 mmt180 -135.32 -174.08 3.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 111.168 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 20.6 m-85 -157.69 61.08 0.48 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -152.27 -157.0 0.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 111.765 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.62 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 68.91 49.3 42.71 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -68.69 -169.26 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 124.436 1.756 . . . . 0.0 112.009 -176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.429 HG12 ' OH ' ' A' ' 61' ' ' TYR . 19.0 m . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.285 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.186 0.517 . . . . 2.72 110.279 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.1 p90 -125.19 156.51 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 3.53 110.214 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 5.6 pt-20 -166.36 129.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 2.43 110.183 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.877 HG22 ' HG2' ' A' ' 42' ' ' MET . 10.8 pt -75.45 176.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.18 -0.95 . . . . 1.31 110.42 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.07 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -111.15 -162.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 2.41 109.891 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -137.48 49.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.853 -1.154 . . . . 2.16 111.597 -179.173 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 7' ' ' ASP . 10.6 tt 40.08 43.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.826 0.822 . . . . 1.69 110.038 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.434 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.04 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.061 -1.066 . . . . 0.86 110.933 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.7 Cg_endo -86.35 -59.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.558 1.294 . . . . 0.9 111.131 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 1.07 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.3 m-30 -52.28 -32.7 38.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.957 -1.09 . . . . 1.46 109.318 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.726 HG22 ' CG2' ' A' ' 38' ' ' ILE . 8.5 p -59.19 -57.91 10.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.113 -1.439 . . . . 0.65 107.113 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.532 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -66.8 -18.47 65.39 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.672 0.749 . . . . 2.19 109.141 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 13.6 t-20 -78.02 -63.73 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 1.71 109.833 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.825 HD22 HD21 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -40.22 -63.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.328 0.585 . . . . 2.02 109.573 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -46.16 -46.18 15.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.246 -1.542 . . . . 0.52 109.246 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -70.78 -84.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 2.65 110.538 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' ALA . 2.5 m-85 -38.71 -64.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.401 0.619 . . . . 2.59 111.045 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -43.37 -70.61 0.1 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.602 -0.686 . . . . 0.54 109.919 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 42.4 t -40.89 -27.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.353 -0.842 . . . . 1.34 110.46 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -92.6 -66.27 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 1.72 110.336 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.022 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.4 mt-10 -60.82 -31.66 71.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.045 -1.062 . . . . 1.95 109.874 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -73.69 -60.19 2.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.891 -1.151 . . . . 1.61 107.891 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.5 t-20 -52.02 -48.57 64.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.228 -1.397 . . . . 2.19 107.228 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 42.5 tttt -56.85 -47.26 80.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.954 -1.128 . . . . 2.68 107.954 177.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.565 HG13 ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -50.48 -24.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.56 -0.904 . . . . 1.32 108.56 178.609 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.67 24.99 2.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.384 -1.486 . . . . 0.87 109.384 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 34.6 tp60 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 2.16 109.79 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 32' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.266 0.555 . . . . 2.25 109.961 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -146.9 50.12 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.266 -0.896 . . . . 0.68 109.91 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 11.3 t80 174.96 79.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.73 . . . . 3.46 109.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -120.94 -44.36 2.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.58 110.627 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -96.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 3.36 110.955 -179.406 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 36' ' ' LYS . 28.1 t -157.57 171.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.621 -1.3 . . . . 0.71 111.679 -179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.726 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.88 88.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.168 -0.678 . . . . 1.55 109.168 179.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -105.02 -53.55 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.979 -1.075 . . . . 2.98 110.979 -179.274 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.6 Cg_endo -84.02 50.92 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.395 1.208 . . . . 0.58 110.941 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.846 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.0 p -103.52 120.82 41.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.399 -0.813 . . . . 1.57 109.807 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.877 ' HG2' HG22 ' A' ' 5' ' ' ILE . 27.5 mtm -119.03 177.29 4.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 1.91 110.649 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -140.62 154.28 46.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.229 -0.919 . . . . 1.47 110.41 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -151.75 100.63 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.144 -0.973 . . . . 2.46 110.354 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -97.88 148.88 22.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.61 110.265 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.521 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.359 -0.978 . . . . 1.84 108.359 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.897 ' O ' HG23 ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 110.611 -0.996 . . . . 0.63 110.611 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' GLU . 3.7 t80 -155.85 78.02 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.554 -0.968 . . . . 2.99 110.231 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 14.9 pt-20 -99.35 167.39 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 2.43 109.0 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.44 170.63 18.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.996 -1.481 . . . . 1.74 112.977 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -133.82 123.76 25.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.787 -1.19 . . . . 1.91 107.787 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.846 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -121.07 74.78 1.11 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.034 -1.041 . . . . 0.66 109.399 -179.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.947 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -69.25 112.28 5.73 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.198 -1.038 . . . . 1.51 108.198 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.667 HG23 ' CD ' ' A' ' 67' ' ' LYS . 33.2 m -158.19 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.779 0.799 . . . . 0.63 109.851 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.716 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.4 t80 -147.28 130.44 16.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.141 -0.688 . . . . 1.22 109.141 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -124.17 -126.07 0.25 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.388 -0.82 . . . . 0.6 109.721 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 t -95.15 -24.71 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.912 -1.117 . . . . 1.39 108.726 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.02 18.4 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.503 0.668 . . . . 1.52 109.446 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.863 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.3 ttmm -115.23 78.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 1.37 110.229 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.716 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 9.0 mt -88.17 64.86 7.89 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.895 -0.78 . . . . 1.8 108.895 178.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 178.7 -123.83 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.047 -1.061 . . . . 1.85 110.534 -179.085 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 25.3 ttm180 -131.02 123.63 29.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.328 -1.483 . . . . 1.69 112.194 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.863 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -80.48 107.9 13.66 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.651 -1.611 . . . . 0.47 106.651 176.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.8 t70 -89.64 162.2 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.002 -1.061 . . . . 1.71 110.404 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.713 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.2 110.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.73 0.776 . . . . 1.09 109.294 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -110.71 122.47 47.89 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.247 -0.908 . . . . 1.25 109.955 -179.211 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.636 ' OE1' HD12 ' A' ' 73' ' ' ILE . 22.9 mt-10 -144.96 122.86 11.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 2.02 110.066 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.562 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 2.14 110.104 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.976 -0.75 . . . . 3.3 108.976 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 11.8 tp -170.59 173.95 5.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.145 . . . . 2.19 110.423 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.022 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -154.01 171.64 18.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.98 109.928 179.487 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.543 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 10.6 mtt180 -140.08 -177.9 5.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 2.71 110.989 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.763 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 23.7 m-85 -153.27 63.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.706 -0.621 . . . . 0.68 109.398 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -153.3 -156.5 0.7 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.194 . . . . 1.83 111.388 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.98 52.32 29.07 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 105.323 -3.111 . . . . 1.28 105.323 -177.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.6 Cg_endo -68.33 -178.02 1.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 124.598 1.841 . . . . 2.23 111.938 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.947 HG12 ' OH ' ' A' ' 61' ' ' TYR . 30.1 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.966 -1.016 . . . . 2.22 110.45 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.56 178.18 8.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -1.129 . . . . 0.0 110.174 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.527 ' CB ' ' HE2' ' A' ' 44' ' ' LYS . 6.8 p90 -165.2 150.07 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.176 -0.952 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 10.4 pt-20 -171.02 132.37 0.84 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.148 -0.97 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.751 HG22 ' CG ' ' A' ' 42' ' ' MET . 21.5 pt -83.63 -177.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.266 -0.897 . . . . 0.0 110.486 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.768 HD11 ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -121.63 -154.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -138.77 50.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.837 -1.164 . . . . 0.0 111.53 -179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.623 ' C ' HG21 ' A' ' 12' ' ' THR . 19.2 tt 40.44 51.97 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.159 0.98 . . . . 0.0 109.524 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -139.51 -65.43 0.04 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HG2' ' CG2' ' A' ' 6' ' ' ILE . 46.2 Cg_endo -82.4 -58.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.83 1.437 . . . . 0.0 111.275 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.768 ' CE2' HD11 ' A' ' 6' ' ' ILE . 2.6 m-30 -54.33 -22.07 11.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.834 -1.166 . . . . 0.0 109.687 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.893 HG22 ' CG1' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -69.12 -61.26 1.87 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.577 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -55.3 -25.09 32.11 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.676 0.751 . . . . 0.0 110.001 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -80.72 -44.1 19.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.797 0.808 . . . . 0.0 109.871 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.04 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -46.82 -47.21 21.1 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.479 0.656 . . . . 0.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 1.04 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -64.74 -51.13 54.52 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -67.73 -79.74 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.093 -1.24 . . . . 0.0 110.592 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.595 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -33.84 -62.55 0.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.447 0.641 . . . . 0.0 111.1 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.39 -74.05 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.411 -0.806 . . . . 0.0 109.917 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 26.2 t -41.62 -25.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.553 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 19' ' ' ALA . 2.6 t70 -87.66 -70.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.983 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.001 ' HB3' HD13 ' A' ' 85' ' ' LEU . 4.1 tt0 -61.88 -37.4 84.45 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.249 -1.381 . . . . 0.0 109.32 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 1.054 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -58.79 -53.22 60.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.938 -1.101 . . . . 0.0 108.778 177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 10.0 t-20 -68.68 -47.05 67.46 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.36 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -57.1 -35.84 69.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.371 -0.831 . . . . 0.0 110.322 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.054 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -68.63 -21.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.0 110.005 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.5 10.47 6.54 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 18.0 mm-40 -107.73 58.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 109.562 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 30' ' ' GLY . 33.1 p90 -82.61 12.75 4.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 31' ' ' ARG . . . -42.06 -66.86 0.95 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -145.57 -162.48 1.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.749 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.864 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.28 -177.78 1.19 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.186 -0.946 . . . . 0.0 109.74 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.572 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -136.94 52.12 1.95 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.213 -0.93 . . . . 0.0 109.943 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 13.9 p90 -169.7 123.11 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.881 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HB2' ' N ' ' A' ' 65' ' ' SER . 1.8 t-20 -155.14 -65.06 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -0.937 . . . . 0.0 110.71 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.82 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -69.14 -98.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.954 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.84 172.35 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.687 -1.258 . . . . 0.0 111.719 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.893 ' CG1' HG22 ' A' ' 12' ' ' THR . 0.3 OUTLIER -120.17 113.22 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -120.49 -59.92 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.92 -1.113 . . . . 0.0 110.707 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.1 Cg_endo -82.73 47.65 2.52 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.091 1.048 . . . . 0.0 111.081 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.563 ' HB3' HD13 ' A' ' 38' ' ' ILE . 27.8 p -84.18 122.18 28.5 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.751 ' CG ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -123.23 164.15 19.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 111.25 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -131.23 137.46 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.864 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.527 ' HE2' ' CB ' ' A' ' 3' ' ' TRP . 0.6 OUTLIER -145.58 134.2 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.069 -1.019 . . . . 0.0 110.291 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.722 HG23 ' O ' ' A' ' 55' ' ' GLY . 15.7 m -126.75 155.11 43.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.459 ' CG1' ' O ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -116.27 56.1 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 49' ' ' ASN . 10.8 p90 -103.79 -179.3 3.91 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.686 0.755 . . . . 0.0 111.598 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -69.2 -100.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.648 -0.657 . . . . 0.0 110.089 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.596 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 8.4 t30 -178.89 -43.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.884 -1.135 . . . . 0.0 110.735 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 22.9 tt0 -154.98 17.47 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.405 -0.809 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 -29.83 2.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.468 -0.77 . . . . 0.0 109.832 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.622 ' O ' HD13 ' A' ' 53' ' ' ILE . 8.3 pt-20 -170.63 178.33 3.64 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.456 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 52' ' ' GLU . 16.3 mm -125.45 126.71 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.527 -0.733 . . . . 0.0 109.412 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -100.46 -59.63 1.67 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.076 -1.015 . . . . 0.0 112.509 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.722 ' O ' HG23 ' A' ' 45' ' ' THR . . . -142.73 127.67 3.23 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.722 -1.704 . . . . 0.0 110.253 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.535 ' CE2' ' HE3' ' A' ' 43' ' ' LYS . 35.4 t80 -113.76 104.1 11.87 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.386 -1.067 . . . . 0.0 110.019 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.2 pt-20 -119.52 175.99 5.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.455 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.872 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -153.51 162.75 40.96 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 118.417 -1.313 . . . . 0.0 112.573 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.518 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.6 tt0 -126.22 120.98 31.43 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 15' ' ' LEU . 2.3 tp -118.66 71.5 0.85 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 109.566 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.64 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -70.16 110.97 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.803 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.1 m -159.74 -165.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.601 -0.687 . . . . 0.0 109.795 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.961 ' CE1' HD12 ' A' ' 68' ' ' LEU . 2.5 t80 -138.93 130.02 26.68 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.053 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -124.05 -131.4 0.26 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.404 -0.81 . . . . 0.0 109.632 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.542 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 79.8 p -81.73 -28.93 33.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.237 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.88 18.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.602 -0.686 . . . . 0.0 109.655 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.803 ' CD ' HG23 ' A' ' 62' ' ' VAL . 1.8 ttmm -105.18 73.63 1.06 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 110.389 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.961 HD12 ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -84.77 64.54 8.63 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 177.25 -127.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.517 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 14.0 ttm180 -132.46 127.02 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.49 -1.381 . . . . 0.0 111.987 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.668 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -83.79 102.75 12.54 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -86.55 172.83 9.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.497 -177.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.872 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -168.51 131.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.877 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.511 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -122.25 159.73 26.71 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.509 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 2.3 mt-10 -152.59 108.51 3.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.829 -1.169 . . . . 0.0 111.785 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.523 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -42.62 168.08 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -158.19 -56.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.594 -1.316 . . . . 0.0 111.281 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 9.0 tptp -134.55 -37.16 0.85 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.934 -1.104 . . . . 0.0 109.342 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 1.042 HG22 ' HD2' ' A' ' 80' ' ' ARG . 17.6 m -75.25 -62.29 1.61 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 1.042 ' HD2' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 151.58 47.52 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.577 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -62.75 -137.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 8.2 ptm85 -172.43 172.56 4.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.403 -1.645 . . . . 0.0 111.082 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -99.09 127.7 45.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.3 tp -171.2 -169.44 0.74 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.954 -1.092 . . . . 0.0 109.791 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.001 HD13 ' HB3' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.69 166.16 8.04 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.323 -0.861 . . . . 0.0 109.696 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.3 mtt-85 -145.91 143.7 29.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.09 -1.006 . . . . 0.0 110.724 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.964 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.5 m-85 -115.22 73.81 0.85 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -159.71 -164.9 1.41 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.911 -1.118 . . . . 0.0 111.759 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.594 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 70.79 52.06 16.86 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.392 -3.483 . . . . 0.0 104.392 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.2 Cg_endo -64.46 -174.14 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 124.714 1.902 . . . . 0.0 112.742 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 1.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.105 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -129.56 173.79 10.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 110.209 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -161.77 149.0 14.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -177.18 159.23 1.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 110.45 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' O ' ' OE2' ' A' ' 4' ' ' GLU . 3.1 pt -95.03 -175.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.621 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.7 -165.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.217 -0.927 . . . . 0.0 110.468 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 8' ' ' ILE . 24.1 t70 -139.94 51.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.074 -1.016 . . . . 0.0 111.167 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 8' ' ' ILE . 4.6 tt 39.52 40.34 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.836 0.827 . . . . 0.0 110.098 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.505 ' N ' HG21 ' A' ' 12' ' ' THR . . . -147.25 -65.9 0.01 OUTLIER Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.912 -1.137 . . . . 0.0 111.339 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 12' ' ' THR . 44.7 Cg_endo -75.13 -85.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.61 1.321 . . . . 0.0 111.386 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.621 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 66.2 m-85 -39.05 -27.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.398 -0.814 . . . . 0.0 110.705 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.822 HG22 ' CG2' ' A' ' 38' ' ' ILE . 18.6 p -60.47 -58.31 9.05 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.076 -1.015 . . . . 0.0 108.648 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.7 pt20 -59.15 -15.97 17.41 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.446 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -76.19 -60.04 2.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.582 -0.699 . . . . 0.0 110.065 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.779 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 1.1 pp -43.68 -34.81 1.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.409 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -62.51 -54.43 34.2 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -72.96 -66.45 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.463 -1.022 . . . . 0.0 110.131 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 21' ' ' ASP . 2.0 m-30 -40.5 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.484 0.659 . . . . 0.0 110.44 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -39.92 -68.2 0.19 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.808 -0.558 . . . . 0.0 110.059 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 4.1 t -41.98 -26.15 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.104 -0.997 . . . . 0.0 110.024 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 18' ' ' PHE . 6.0 m-20 -95.3 -66.54 0.91 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.826 ' CG ' HD11 ' A' ' 73' ' ' ILE . 14.6 mm-40 -59.08 -26.83 64.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.825 -1.172 . . . . 0.0 109.23 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.807 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -76.79 -61.54 1.94 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 25.3 t-20 -54.22 -43.12 70.53 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.615 -1.234 . . . . 0.0 107.815 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 18.5 tptp -56.28 -59.21 5.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.211 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -55.32 -20.01 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.629 0.728 . . . . 0.0 109.622 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 60.72 2.21 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' OE1' ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -119.35 -45.88 2.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -1.14 . . . . 0.0 109.892 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -140.34 -73.64 0.35 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.392 -0.818 . . . . 0.0 110.066 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.41 43.27 7.49 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -117.92 -76.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.146 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -170.53 50.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 0.0 110.487 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -36.5 90.21 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.751 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 32' ' ' LEU . 7.7 t80 165.82 108.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 0.0 109.617 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -155.66 -64.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.94 -1.1 . . . . 0.0 111.382 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.52 -99.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 111.453 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 36' ' ' LYS . 13.9 t -159.22 172.54 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.536 -1.352 . . . . 0.0 111.727 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.822 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -127.79 99.08 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.626 . . . . 0.0 110.01 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.549 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -108.49 -54.76 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.488 -0.758 . . . . 0.0 110.159 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 41.7 Cg_endo -84.88 51.37 3.14 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.412 1.217 . . . . 0.0 111.306 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.9 t -104.42 106.37 16.84 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.536 ' HB2' ' CG ' ' A' ' 59' ' ' GLN . 10.2 mtt -96.96 157.08 16.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.056 -1.028 . . . . 0.0 110.158 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 2.6 tmtt? -137.11 154.71 50.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.125 -0.984 . . . . 0.0 110.978 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 13.3 tttt -160.33 158.9 30.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.627 -0.671 . . . . 0.0 109.603 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.96 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.4 m -159.48 151.05 20.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.946 -1.096 . . . . 0.0 110.414 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -118.48 62.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.483 ' CD1' ' OE2' ' A' ' 48' ' ' GLU . 12.3 p90 -68.1 -157.1 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.567 0.699 . . . . 0.0 111.215 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 52' ' ' GLU . 3.1 pm0 -66.88 -164.86 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.32 1.057 . . . . 0.0 111.884 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.455 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 16.0 t-20 -168.83 -36.72 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.24 -43.63 3.2 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.761 -0.587 . . . . 0.0 109.462 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 26.6 ttt85 -173.5 20.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.895 -1.122 . . . . 0.0 112.536 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 48' ' ' GLU . 12.8 pt-20 -147.85 120.86 8.8 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.137 -1.602 . . . . 0.0 111.926 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.842 HD12 ' CE1' ' A' ' 77' ' ' TYR . 7.8 mt -68.33 138.83 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -104.78 -77.27 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.118 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.96 ' O ' HG23 ' A' ' 45' ' ' THR . . . -171.12 174.97 44.88 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 117.343 -2.36 . . . . 0.0 111.878 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.556 ' CD2' ' OG1' ' A' ' 45' ' ' THR . 2.4 m-85 -116.95 173.48 6.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 122.133 -0.628 . . . . 0.0 109.898 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 178.72 130.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.499 -0.751 . . . . 0.0 109.206 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.613 ' CE2' ' HB ' ' A' ' 73' ' ' ILE . 3.4 p90 -150.6 171.73 16.65 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 118.1 -1.44 . . . . 0.0 113.606 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.537 ' HB3' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -124.34 112.35 16.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -104.36 68.28 0.87 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.195 -0.941 . . . . 0.0 109.67 -178.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.852 ' OH ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.81 109.7 4.56 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG23 ' HD3' ' A' ' 67' ' ' LYS . 34.8 m -159.41 -162.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.574 0.702 . . . . 0.0 109.634 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.624 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -137.94 124.6 20.96 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -122.86 -127.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.477 -0.765 . . . . 0.0 109.557 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.543 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 2.8 t -84.57 -52.56 6.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.019 -1.051 . . . . 0.0 109.389 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 29' ' ' TYR . 7.0 t0 -128.65 30.23 5.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.359 -0.838 . . . . 0.0 109.256 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.752 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -125.46 80.26 1.88 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.703 0.763 . . . . 0.0 110.046 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 6.3 mp -90.07 59.66 4.58 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 p90 176.98 -142.67 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.407 -0.808 . . . . 0.0 109.581 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.537 ' NH1' ' HB3' ' A' ' 59' ' ' GLN . 4.8 ttm180 -113.26 140.77 47.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.531 -1.356 . . . . 0.0 112.236 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -99.44 103.45 15.22 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' HB3' ' N ' ' A' ' 86' ' ' ARG . 9.9 t70 -77.24 157.58 30.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.769 -1.207 . . . . 0.0 109.927 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.826 HD11 ' CG ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -162.62 101.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.672 0.748 . . . . 0.0 109.156 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -113.37 134.96 54.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 18.4 mt-10 -157.9 136.53 11.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.936 -1.102 . . . . 0.0 111.28 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.638 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -60.13 -144.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.227 -0.92 . . . . 0.0 109.826 178.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.842 ' CE1' HD12 ' A' ' 53' ' ' ILE . 6.2 t80 -161.26 -56.73 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.68 -1.262 . . . . 0.0 111.36 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 1.7 ttmm -74.49 -58.43 3.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.113 -0.992 . . . . 0.0 109.722 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 79' ' ' THR . 52.6 m -93.75 9.52 36.77 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.395 -0.815 . . . . 0.0 109.137 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' C ' ' A' ' 81' ' ' GLY . 27.3 mmm-85 59.65 15.85 4.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.472 -0.768 . . . . 0.0 109.755 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.638 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . 4.09 -72.37 0.0 OUTLIER Glycine 0 N--CA 1.499 2.882 0 CA-C-N 116.314 -0.403 . . . . 0.0 112.58 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 80' ' ' ARG . 3.2 mtt180 -161.07 -174.64 4.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.768 -1.43 . . . . 0.0 111.515 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -170.47 160.43 7.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.066 -1.021 . . . . 0.0 109.514 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -156.02 175.21 14.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.04 -1.038 . . . . 0.0 110.399 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 72' ' ' ASP . 6.0 mtt180 -157.5 131.67 8.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.0 110.704 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 84.2 m-85 -107.98 64.92 0.63 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.9 OUTLIER -152.63 -158.76 0.93 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.998 -1.064 . . . . 0.0 111.148 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.17 52.82 29.53 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 104.876 -3.29 . . . . 0.0 104.876 -177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -65.64 -171.78 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.728 1.909 . . . . 0.0 112.585 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.852 HG13 ' OH ' ' A' ' 61' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.139 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.58 -1.408 . . . . 3.6 109.58 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' HG2' ' C ' ' A' ' 1' ' ' GLY . 3.4 mt-10 -137.34 129.92 29.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 2.83 110.218 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 23.5 p90 -79.99 167.96 19.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 3.6 110.225 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.86 119.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 2.72 110.167 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.813 HG22 ' CG ' ' A' ' 42' ' ' MET . 1.2 pt -80.35 -176.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.219 -0.926 . . . . 1.37 110.396 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.739 HD12 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.21 -164.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.287 -0.883 . . . . 2.43 109.881 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 8' ' ' ILE . 42.2 t0 -144.35 61.77 1.34 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.951 -1.093 . . . . 3.5 111.592 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.69 ' C ' HG21 ' A' ' 12' ' ' THR . 14.0 tt 40.53 45.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.002 0.906 . . . . 1.76 109.953 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' OG1' ' A' ' 12' ' ' THR . . . -138.41 -65.18 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 120.138 -1.03 . . . . 0.86 111.434 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.6 Cg_endo -82.17 -72.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.596 1.314 . . . . 0.94 111.416 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.739 ' CD2' HD12 ' A' ' 6' ' ' ILE . 1.9 m-30 -44.5 -32.05 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 1.53 109.583 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.733 HG22 HG21 ' A' ' 38' ' ' ILE . 25.0 p -57.59 -57.69 11.59 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.52 -1.289 . . . . 0.9 107.52 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.0 OUTLIER -72.99 -17.67 61.43 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.749 0.785 . . . . 2.36 109.455 178.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.545 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 2.7 t-20 -79.4 -58.65 3.1 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.643 0.735 . . . . 1.56 109.371 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.839 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 2.6 tp -42.04 -56.13 2.93 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.212 -0.662 . . . . 2.05 109.212 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -49.53 -57.48 9.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.58 109.535 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -68.75 -77.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.129 . . . . 2.45 110.665 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 3.3 m-85 -37.77 -72.57 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.418 0.628 . . . . 2.28 111.221 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -41.42 -69.23 0.14 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.741 -0.6 . . . . 0.56 110.342 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 55.4 t -42.34 -27.95 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.278 -0.889 . . . . 1.43 110.356 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' LYS . 2.2 m-20 -93.49 -62.54 1.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.233 -0.917 . . . . 1.91 110.353 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.0 mt-10 -61.96 -31.57 71.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.008 -1.057 . . . . 2.17 109.81 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.575 ' OE2' ' CD2' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -75.42 -59.59 2.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.181 -1.044 . . . . 1.64 108.181 178.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 36.8 t-20 -53.25 -46.56 69.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.223 -1.399 . . . . 2.27 107.223 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 13.7 tttt -58.2 -48.56 79.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.867 -1.16 . . . . 2.88 107.867 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.604 HD11 ' HG ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -48.46 -26.54 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.527 -0.916 . . . . 1.63 108.527 178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 27.89 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.223 -1.551 . . . . 1.01 109.223 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 24.8 tp60 -128.91 68.52 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -1.041 . . . . 2.35 109.671 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.503 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 35.1 p90 -90.45 23.62 2.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.403 -0.811 . . . . 5.49 109.766 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -40.44 -55.74 3.05 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.893 -1.283 . . . . 2.31 109.893 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.949 ' HB3' HD12 ' A' ' 32' ' ' LEU . 13.1 mtt180 -161.07 -89.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.198 -1.178 . . . . 3.7 110.001 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.949 HD12 ' HB3' ' A' ' 31' ' ' ARG . 3.4 mp -133.26 -178.2 4.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.313 -0.867 . . . . 2.6 109.873 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.621 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -144.9 50.65 1.25 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.345 -0.847 . . . . 0.95 109.769 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.622 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 9.6 t80 -179.88 74.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 3.48 110.279 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.32 -45.86 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 2.52 110.561 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.24 -94.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.122 -0.986 . . . . 3.51 111.002 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LYS . 23.1 t -158.55 172.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.694 -1.254 . . . . 1.12 111.622 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.733 HG21 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.39 85.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.675 -0.641 . . . . 1.66 109.361 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.542 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -103.25 -54.22 0.12 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 3.03 110.817 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.9 Cg_endo -83.5 52.15 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.335 1.177 . . . . 0.57 110.324 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.552 ' C ' HD11 ' A' ' 6' ' ' ILE . 21.2 p -104.03 113.1 26.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.835 . . . . 1.64 110.408 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.813 ' CG ' HG22 ' A' ' 5' ' ' ILE . 8.3 mtm -113.91 176.97 4.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.846 . . . . 2.1 109.892 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -156.23 159.32 38.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.056 -1.027 . . . . 1.63 110.985 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -154.17 128.59 9.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.503 -0.748 . . . . 2.51 109.93 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -118.57 148.84 42.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.62 110.084 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.532 ' HA ' ' CA ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -115.51 43.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.404 -0.962 . . . . 2.0 108.404 178.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.793 ' HB2' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -80.88 -176.82 6.08 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.624 -0.672 . . . . 2.88 110.915 -178.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.541 ' CG ' ' HG2' ' A' ' 52' ' ' GLU . 9.7 tp10 -69.4 -101.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.37 -0.831 . . . . 4.01 109.648 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -172.4 -59.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.773 -1.204 . . . . 4.17 110.637 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -146.84 12.24 1.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 4.36 110.059 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -122.7 -22.58 5.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.352 -0.842 . . . . 5.27 109.828 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.541 ' HG2' ' CG ' ' A' ' 48' ' ' GLU . 15.4 pt-20 -170.14 -163.85 0.38 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.111 -1.036 . . . . 3.28 111.107 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 47' ' ' TYR . 9.9 tp -131.57 157.77 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.742 -0.599 . . . . 2.02 109.539 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 2.9 tttt -136.36 -64.56 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.917 -1.115 . . . . 2.96 111.572 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.9 ' O ' HG23 ' A' ' 45' ' ' THR . . . -134.21 164.19 24.54 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.631 -1.747 . . . . 0.61 110.625 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 75' ' ' GLU . 36.6 t80 -156.84 92.64 1.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -1.057 . . . . 3.91 110.418 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.7 pt-20 -126.47 171.83 10.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 2.63 108.85 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CE2' ' CG2' ' A' ' 73' ' ' ILE . 1.7 p90 -163.05 166.02 24.11 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 117.876 -1.53 . . . . 1.82 113.419 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 70' ' ' ARG . 92.6 mt-30 -119.82 107.53 13.27 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.742 -1.207 . . . . 2.17 107.742 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.714 HD21 HD22 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -105.77 73.72 1.02 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.289 -0.882 . . . . 0.71 109.14 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.08 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -69.61 112.34 6.03 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.031 -1.1 . . . . 1.73 108.031 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.621 HG23 ' CD ' ' A' ' 67' ' ' LYS . 22.7 m -157.84 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.769 0.795 . . . . 0.42 109.496 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.658 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.5 t80 -149.19 129.47 13.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.272 -0.64 . . . . 1.28 109.272 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.622 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -123.53 -118.09 0.29 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.328 -0.858 . . . . 0.77 109.685 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -102.15 -25.21 13.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.754 -1.216 . . . . 1.41 108.804 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -148.8 16.19 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 1.99 109.603 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.832 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -113.93 78.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 1.37 110.338 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.9 mt -86.16 63.19 7.88 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.501 -0.926 . . . . 1.79 108.501 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 176.06 -122.69 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.539 -0.864 . . . . 1.88 109.912 -179.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 5.9 tmm_? -133.73 144.61 49.21 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.166 -1.583 . . . . 1.88 112.416 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -92.08 92.33 8.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.241 -1.763 . . . . 0.48 106.241 175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 4.7 t0 -80.99 82.96 6.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.011 . . . . 1.73 110.741 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -76.19 138.92 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.692 -0.803 . . . . 1.18 109.577 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -131.54 121.65 24.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.372 -0.83 . . . . 1.26 109.518 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 1.1 mt-10 -151.81 119.16 5.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.937 -1.102 . . . . 2.3 110.477 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.567 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 3.2 t0 -61.33 -137.83 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.17 -0.956 . . . . 2.26 109.895 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.717 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.21 -60.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.828 -1.17 . . . . 3.22 110.76 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 3.7 tttt -87.06 -55.23 3.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.184 -0.948 . . . . 4.19 109.587 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 1.81 18.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.309 -0.869 . . . . 3.61 109.602 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 81' ' ' GLY . 12.9 mmt85 55.3 29.07 12.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.335 -0.853 . . . . 6.28 109.935 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -24.92 -70.49 0.03 OUTLIER Glycine 0 N--CA 1.501 3.03 0 CA-C-N 116.216 -0.447 . . . . 2.42 112.102 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -162.97 -178.08 5.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.653 -1.498 . . . . 5.09 111.212 -179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 10.8 mtpt -148.58 105.29 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.655 -0.653 . . . . 3.53 109.325 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.854 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.0 tp -170.1 179.12 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 2.41 110.069 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 1.2 pt? -153.68 -179.19 7.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 1.24 110.509 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.538 ' C ' ' CD2' ' A' ' 87' ' ' PHE . 3.0 mtt180 -134.66 -177.06 4.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 2.71 110.49 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.877 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 69.4 m-85 -154.17 62.6 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.055 -0.72 . . . . 0.76 109.055 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 3.0 m-80 -152.37 -157.33 0.79 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.968 -1.082 . . . . 1.91 111.488 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 66.71 52.59 33.01 Favored Glycine 0 N--CA 1.481 1.696 0 N-CA-C 104.855 -3.298 . . . . 1.21 104.855 -176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.0 Cg_endo -67.77 -171.17 0.31 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 124.499 1.789 . . . . 2.15 111.899 -176.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.08 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.6 m . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 117.945 -1.026 . . . . 2.29 110.4 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.32 159.71 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 0.0 110.245 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.521 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 42.2 p-90 -150.58 142.32 23.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.156 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 21.2 mt-10 -158.36 -176.99 6.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.42 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.039 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -133.38 168.72 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 110.689 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.039 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -148.66 -170.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.7 OUTLIER 174.5 143.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.03 -1.044 . . . . 0.0 111.319 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.7 tp 43.06 25.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.317 0.58 . . . . 0.0 110.636 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.625 ' N ' HG21 ' A' ' 12' ' ' THR . . . -127.75 -103.21 1.19 Allowed Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.311 -1.423 . . . . 0.0 112.421 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.723 ' CG ' HG21 ' A' ' 6' ' ' ILE . 48.5 Cg_endo -81.66 -64.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.844 1.696 . . . . 0.0 111.984 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.711 ' CD1' ' CZ ' ' A' ' 58' ' ' TYR . 2.2 m-85 -42.91 -25.15 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.865 HG22 HD12 ' A' ' 38' ' ' ILE . 2.6 p -69.59 -62.08 1.53 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.573 ' N ' ' OG1' ' A' ' 12' ' ' THR . 1.8 tt0 -66.64 -18.0 65.14 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.755 0.788 . . . . 0.0 109.357 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.503 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.7 m-80 -79.21 -60.83 2.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.664 -0.647 . . . . 0.0 110.053 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.917 HD11 ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -39.91 -50.66 2.48 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.425 0.631 . . . . 0.0 109.39 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.498 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -53.32 -57.31 15.7 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 18' ' ' PHE . 6.0 tttp -69.36 -69.25 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -1.175 . . . . 0.0 110.62 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-30 -38.72 -63.33 0.52 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.618 0.723 . . . . 0.0 110.996 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -44.19 -72.79 0.05 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.589 -0.694 . . . . 0.0 110.273 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 11.0 t -40.74 -26.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 0.0 110.616 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' ALA . 1.5 m-20 -92.19 -70.92 0.67 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.943 -1.098 . . . . 0.0 109.783 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.863 ' CB ' HD13 ' A' ' 85' ' ' LEU . 8.9 mm-40 -56.42 -34.61 66.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.911 -1.118 . . . . 0.0 109.52 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.801 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -67.17 -56.63 9.1 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.9 m120 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.914 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -55.35 -51.07 67.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.489 -0.757 . . . . 0.0 109.757 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -62.91 -16.57 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.469 -0.77 . . . . 0.0 110.021 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.26 50.89 0.45 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -152.16 78.18 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -1.106 . . . . 0.0 110.209 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.434 ' O ' ' C ' ' A' ' 30' ' ' GLY . 29.4 p90 -107.66 29.14 7.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.57 -53.95 4.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -168.53 -78.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -1.135 . . . . 0.0 109.897 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -146.34 153.13 40.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 109.813 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.917 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -112.83 52.88 0.77 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.262 -0.899 . . . . 0.0 110.094 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.64 98.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.1 t-20 -134.2 -64.83 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.935 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -70.41 -106.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 111.237 -179.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 36' ' ' LYS . 11.0 t -158.85 173.04 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.485 -1.384 . . . . 0.0 111.829 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.865 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.9 132.53 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.596 0.712 . . . . 0.0 110.259 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.629 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -136.63 -61.54 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.536 -0.727 . . . . 0.0 109.709 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.0 Cg_endo -81.48 46.16 2.17 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.062 1.033 . . . . 0.0 111.163 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.855 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.9 p -80.34 80.18 6.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.078 -1.014 . . . . 0.0 109.098 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.509 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -83.18 138.13 33.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.131 -0.981 . . . . 0.0 111.066 -179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -104.38 157.61 17.03 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.422 -0.799 . . . . 0.0 110.801 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 4.5 mttt -160.09 103.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.453 -0.78 . . . . 0.0 109.214 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.4 m -124.27 153.89 41.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.866 -1.146 . . . . 0.0 111.213 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -128.74 60.65 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -88.57 -153.55 0.25 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.933 0.873 . . . . 0.0 112.528 -177.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' HG2' ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -68.55 -145.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.759 0.79 . . . . 0.0 111.891 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.61 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 0.9 OUTLIER -113.79 -49.26 2.88 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -167.99 25.66 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -31.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.144 -1.022 . . . . 0.0 112.005 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.746 ' O ' HD13 ' A' ' 53' ' ' ILE . 1.7 mt-10 -107.89 -156.6 0.59 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.511 -1.368 . . . . 0.0 111.919 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.756 HG22 ' CG ' ' A' ' 77' ' ' TYR . 30.4 mm -152.91 131.28 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -119.89 -65.9 1.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.715 -1.241 . . . . 0.0 111.815 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.846 ' O ' HG23 ' A' ' 45' ' ' THR . . . -144.01 164.68 27.49 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.364 -1.874 . . . . 0.0 110.164 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -150.35 86.74 1.42 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.267 -1.137 . . . . 0.0 111.153 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 7.1 pt-20 -95.16 149.27 21.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CZ ' ' CD1' ' A' ' 11' ' ' PHE . 2.3 t80 -144.97 139.64 27.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.914 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 28.2 mt-30 -99.19 107.03 19.26 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.912 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 25.0 tp -98.92 62.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.605 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.4 t80 -71.9 104.86 3.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.779 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG23 ' CE ' ' A' ' 67' ' ' LYS . 33.6 m -161.64 -165.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.7 t80 -131.26 134.6 46.57 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.248 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -130.68 -132.37 0.2 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.331 -0.856 . . . . 0.0 109.977 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.0 -29.73 13.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.595 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -136.18 3.88 2.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.427 -0.796 . . . . 0.0 110.12 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.634 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -113.19 100.7 8.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' HG ' ' CE2' ' A' ' 63' ' ' TYR . 6.8 mp -100.88 59.31 0.92 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.366 -0.834 . . . . 0.0 109.74 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.24 -115.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.012 . . . . 0.0 110.156 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 38.9 ttp85 -124.35 157.83 34.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.332 -1.48 . . . . 0.0 112.807 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -118.37 91.88 3.68 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 30.5 t0 -69.15 81.27 0.34 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 110.906 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.561 ' CD1' ' HG3' ' A' ' 22' ' ' GLU . 2.6 mm -68.38 114.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.394 -0.817 . . . . 0.0 108.903 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -118.36 118.17 31.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.372 -0.83 . . . . 0.0 110.675 -178.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 40.3 mt-10 -153.38 120.19 5.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.031 -1.043 . . . . 0.0 110.794 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 5.4 t0 -72.4 -140.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.153 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.756 ' CG ' HG22 ' A' ' 53' ' ' ILE . 0.3 OUTLIER 179.72 -65.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.155 -0.965 . . . . 0.0 110.631 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 5.7 tttt -77.68 -55.79 5.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 0.0 109.169 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -72.26 -6.23 41.59 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.362 -0.836 . . . . 0.0 109.012 178.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER 63.02 27.43 15.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.334 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -33.03 -78.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 5.4 mtt85 -170.16 -168.17 0.71 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.657 -1.496 . . . . 0.0 111.436 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -149.43 104.16 3.35 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.4 tp -169.97 -174.13 1.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 110.221 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.981 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -165.43 179.1 6.35 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 110.645 179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mtt85 -142.84 128.65 19.39 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.981 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 4.5 m-85 -104.77 85.13 2.26 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.323 -0.861 . . . . 0.0 109.979 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.635 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -153.59 -156.98 0.74 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.734 -1.229 . . . . 0.0 110.784 179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.58 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.05 51.49 6.88 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.1 Cg_endo -66.49 138.64 50.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.459 1.768 . . . . 0.0 111.203 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.2 m . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.323 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -154.06 161.41 41.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.268 -1.137 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -132.37 178.16 7.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.812 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 43' ' ' LYS . 1.1 tt0 176.99 119.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.424 -0.798 . . . . 0.0 109.767 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 16.4 pt -75.59 178.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.248 -0.908 . . . . 0.0 110.829 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.706 HG13 HD11 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -92.84 -164.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.328 -0.857 . . . . 0.0 110.712 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.699 ' O ' HG22 ' A' ' 8' ' ' ILE . 39.6 t0 -156.75 46.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.797 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 7' ' ' ASP . 17.9 tt 40.27 37.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.656 0.741 . . . . 0.0 109.83 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -143.52 -65.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.207 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 46.1 Cg_endo -78.7 -79.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.665 1.35 . . . . 0.0 111.427 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 43' ' ' LYS . 97.1 m-85 -40.19 -29.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.04 HG22 HD12 ' A' ' 38' ' ' ILE . 16.9 p -61.15 -59.11 5.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -67.35 -12.36 59.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 16.4 m120 -84.61 -69.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 15' ' ' LEU . 4.0 pp -42.04 -28.22 0.17 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.695 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -74.66 -46.15 19.67 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.507 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -80.87 -41.89 22.39 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.201 -1.176 . . . . 0.0 110.253 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -35.85 82.46 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.595 0.712 . . . . 0.0 109.916 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -65.87 -71.79 0.18 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.3 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.5 p -34.52 -33.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.775 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 19' ' ' ALA . 87.1 m-20 -93.15 -73.96 0.54 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 0.0 110.757 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.079 ' HB2' HD13 ' A' ' 85' ' ' LEU . 6.9 mm-40 -57.2 -23.42 47.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.107 . . . . 0.0 110.206 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 87' ' ' PHE . 1.4 tt0 -80.93 -63.36 1.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 49.1 m-20 -52.23 -46.89 65.9 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 11.0 ttpt -55.35 -50.67 69.06 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.624 HG13 HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -50.18 -24.84 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.7 0.762 . . . . 0.0 109.05 178.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.04 36.12 1.06 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -139.26 73.51 1.43 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.503 -0.998 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 46.8 t80 -92.95 25.47 3.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.414 -0.804 . . . . 0.0 109.697 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.7 -66.47 0.65 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 35.6 mtp180 -161.67 -91.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.15 -1.206 . . . . 0.0 110.521 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -138.06 159.39 42.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.245 -0.91 . . . . 0.0 110.062 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -116.6 57.81 0.77 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 2.4 t80 -158.5 109.69 2.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.223 -0.923 . . . . 0.0 110.119 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.1 OUTLIER -152.02 -70.72 0.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -0.923 . . . . 0.0 111.281 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.6 OUTLIER -69.47 -106.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.926 -1.109 . . . . 0.0 111.265 -178.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 36' ' ' LYS . 4.6 t -160.57 156.78 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.443 -1.411 . . . . 0.0 112.273 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.04 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -106.12 140.74 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 121.713 0.768 . . . . 0.0 109.546 178.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.585 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.47 -61.92 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.679 -0.638 . . . . 0.0 110.09 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 52.1 Cg_endo -77.91 39.95 0.82 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.307 1.161 . . . . 0.0 111.687 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.635 ' HB3' HG21 ' A' ' 6' ' ' ILE . 85.3 m -93.49 148.45 22.07 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.938 -1.101 . . . . 0.0 109.945 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.512 ' HB2' ' HG3' ' A' ' 59' ' ' GLN . 5.2 mtm -138.48 161.93 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.028 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 2.7 tmtt? -152.03 131.72 13.16 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.955 -1.091 . . . . 0.0 110.615 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -148.81 130.54 15.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.285 -0.884 . . . . 0.0 110.348 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.5 m -108.21 154.09 22.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.977 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 12.9 pt -120.67 41.88 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.807 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -69.93 -148.27 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 122.12 0.962 . . . . 0.0 111.673 -178.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.2 pt-20 -69.12 -153.0 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.962 0.887 . . . . 0.0 112.608 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 3.5 t30 -156.35 -35.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.303 0.573 . . . . 0.0 109.574 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -134.46 -29.94 1.17 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 51' ' ' ARG . 4.0 ppt_? -171.37 20.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.739 -1.225 . . . . 0.0 112.089 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 5.1 mt-10 -114.97 -147.13 0.41 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.974 -1.079 . . . . 0.0 110.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG12 ' CG ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -170.66 140.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 77' ' ' TYR . 7.7 mttt -131.64 -78.12 0.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 112.091 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.871 ' O ' HG23 ' A' ' 45' ' ' THR . . . -163.14 -163.62 16.25 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 117.757 -2.163 . . . . 0.0 111.326 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.3 t80 -160.85 107.73 1.49 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.786 -0.832 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 6.9 pt-20 -117.74 142.84 46.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.203 -0.936 . . . . 0.0 109.233 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -144.35 170.64 15.62 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.027 -1.469 . . . . 0.0 113.425 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HB2' ' NE ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -135.11 128.72 32.69 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.925 HD23 ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -128.8 85.61 2.35 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 109.104 -179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 1.8 t80 -77.52 108.94 11.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.624 HG11 HD21 ' A' ' 60' ' ' LEU . 1.3 p -153.46 173.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD2' ' HG2' ' A' ' 36' ' ' LYS . 2.0 t80 -128.57 127.23 41.91 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.765 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -127.67 -126.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.856 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.607 ' OG ' HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -96.96 -40.21 9.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.159 -0.963 . . . . 0.0 109.805 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.45 31.94 4.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.366 -0.834 . . . . 0.0 109.861 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -143.85 92.23 2.32 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.753 0.787 . . . . 0.0 109.357 -179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 68' ' ' LEU . 1.6 mp -100.58 63.58 1.09 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.715 -0.616 . . . . 0.0 110.761 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 168.86 -109.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.034 -1.041 . . . . 0.0 110.904 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 1.4 ttp-105 -130.4 141.52 50.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.906 -1.121 . . . . 0.0 112.779 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.925 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -107.26 113.41 26.79 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 3.1 t70 -93.35 168.69 10.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.978 -1.076 . . . . 0.0 111.34 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.85 HG22 ' CD1' ' A' ' 58' ' ' TYR . 4.3 tp -158.99 116.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -126.69 131.51 51.37 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.92 -1.113 . . . . 0.0 109.814 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 83' ' ' LYS . 16.1 mt-10 -149.82 132.05 15.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.93 -1.106 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.574 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -74.87 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.168 -0.958 . . . . 0.0 110.079 179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.602 ' CG ' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -173.08 -46.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.586 -1.321 . . . . 0.0 111.135 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -66.39 -61.56 1.93 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.896 -1.128 . . . . 0.0 108.123 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.412 ' N ' ' HG2' ' A' ' 78' ' ' LYS . 11.5 t -90.86 14.33 13.98 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 81' ' ' GLY . 30.0 mmt180 48.53 42.42 18.79 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.513 0.673 . . . . 0.0 109.227 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.574 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -33.35 -79.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 3.6 mtm180 -171.12 -160.73 0.19 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.677 -1.484 . . . . 0.0 112.446 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 21.0 mttt -148.35 139.8 23.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -170.73 151.29 3.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 110.832 -178.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.079 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -136.1 175.93 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.42 -0.8 . . . . 0.0 109.506 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.5 mtm180 -147.79 178.75 8.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.042 -1.036 . . . . 0.0 110.949 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.787 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -155.63 84.26 1.04 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.622 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -153.42 -154.55 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.419 -1.312 . . . . 0.0 111.236 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 62.34 53.39 42.39 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 38.8 Cg_endo -64.43 154.78 69.75 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.582 1.833 . . . . 0.0 111.549 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.188 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' C ' ' CG ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' CG ' ' C ' ' A' ' 1' ' ' GLY . 21.7 mt-10 -148.98 130.98 15.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.262 -1.14 . . . . 0.0 110.277 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' GLU . 28.1 p90 -107.65 155.37 20.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.888 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.546 ' HG2' ' CD ' ' A' ' 43' ' ' LYS . 12.3 pt-20 -177.34 137.76 0.22 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.712 ' C ' HD13 ' A' ' 6' ' ' ILE . 4.9 pt -89.3 -178.21 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.712 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -125.73 -147.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.18 -0.95 . . . . 0.0 109.656 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -134.79 -152.12 0.46 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.76 -1.213 . . . . 0.0 110.295 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.774 ' C ' HG21 ' A' ' 12' ' ' THR . 2.0 tt -104.35 39.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' N ' HG21 ' A' ' 12' ' ' THR . . . -144.69 -63.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.461 -1.352 . . . . 0.0 112.272 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HG2' HG22 ' A' ' 6' ' ' ILE . 41.9 Cg_endo -68.72 -93.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.293 1.154 . . . . 0.0 112.498 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.696 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.7 m-85 -43.33 -26.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.94 -1.1 . . . . 0.0 111.013 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.047 HG22 HD12 ' A' ' 38' ' ' ILE . 22.4 p -54.41 -56.34 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.825 -1.172 . . . . 0.0 108.391 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' A' ' 12' ' ' THR . 7.4 tt0 -58.24 -22.43 52.17 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.762 0.791 . . . . 0.0 109.233 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' OD1' ' CD2' ' A' ' 18' ' ' PHE . 5.4 t-20 -72.26 -56.81 4.9 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.538 0.685 . . . . 0.0 109.801 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -42.32 -56.09 3.1 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.588 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.973 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.41 -38.38 41.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -79.81 -80.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -1.056 . . . . 0.0 110.676 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CD2' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -37.59 -36.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.283 0.563 . . . . 0.0 111.004 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.695 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -66.71 -69.6 0.3 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.393 -0.817 . . . . 0.0 109.738 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 19' ' ' ALA . 9.5 t -39.35 -27.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 110.198 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 19' ' ' ALA . 5.6 m-20 -93.32 -69.83 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 110.122 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.839 ' CB ' HD13 ' A' ' 85' ' ' LEU . 6.3 mp0 -57.27 -32.51 66.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.502 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.98 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.8 OUTLIER -69.68 -59.88 2.67 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 29' ' ' TYR . 1.8 m120 -55.94 -44.71 78.63 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -52.8 63.02 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.453 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.98 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -54.51 -22.48 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.489 -0.757 . . . . 0.0 109.711 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.43 19.83 3.73 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 50.9 mm-40 -114.88 60.44 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 109.946 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 61.2 t80 -84.16 13.8 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -43.35 -53.04 5.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HG2' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.26 -147.2 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -1.169 . . . . 0.0 110.098 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.858 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -69.06 -174.23 0.59 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 110.055 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.668 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -147.3 53.58 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 110.065 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 22.5 t80 -175.64 97.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.173 -0.954 . . . . 0.0 110.338 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 12.2 t-20 -129.68 -52.55 1.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.641 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.824 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -69.72 -99.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.202 -0.937 . . . . 0.0 111.183 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.3 t -161.46 173.45 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.558 -1.339 . . . . 0.0 111.825 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.047 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -126.92 121.22 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.437 0.637 . . . . 0.0 109.576 179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.605 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -129.36 -58.27 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.467 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.2 Cg_endo -84.91 45.68 1.7 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.178 1.094 . . . . 0.0 110.965 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.752 ' SG ' HD11 ' A' ' 38' ' ' ILE . 24.0 p -80.06 88.6 5.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 109.496 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.488 ' HG2' HG22 ' A' ' 5' ' ' ILE . 17.0 mtm -88.93 135.38 33.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.426 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.546 ' CD ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -117.64 137.02 52.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.0 110.428 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' GLU . 19.5 mttt -142.97 121.09 12.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 5.7 m -125.87 150.12 48.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.508 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.545 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -115.4 45.11 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.921 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.9 m-30 -75.61 176.64 7.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.449 -0.782 . . . . 0.0 110.502 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.615 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -99.65 -77.9 0.52 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.528 -0.732 . . . . 0.0 109.446 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.615 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 1.3 t30 87.78 -18.97 0.25 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.656 0.741 . . . . 0.0 109.28 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.07 0.2 43.19 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.516 ' CB ' ' OE1' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -170.19 -29.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.888 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' CD ' ' HD3' ' A' ' 78' ' ' LYS . 15.3 pt-20 -169.05 -166.18 0.61 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.95 -1.094 . . . . 0.0 111.108 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.791 HG21 ' CD2' ' A' ' 77' ' ' TYR . 39.9 mm -117.47 113.83 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.632 -0.667 . . . . 0.0 109.556 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.7 OUTLIER -80.86 -75.77 0.26 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.302 -0.874 . . . . 0.0 111.969 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . -153.33 -177.61 27.04 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 118.006 -2.045 . . . . 0.0 111.163 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -159.45 88.39 0.86 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.967 . . . . 0.0 110.565 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 44' ' ' LYS . 12.6 pt-20 -87.99 155.45 19.82 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.664 ' OH ' HD12 ' A' ' 60' ' ' LEU . 2.6 t80 -142.24 124.98 15.93 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.81 -1.556 . . . . 0.0 113.493 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 70' ' ' ARG . 10.7 mt-30 -96.78 96.22 8.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.903 ' CD2' HD23 ' A' ' 15' ' ' LEU . 7.8 tp -97.04 69.32 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.868 . . . . 0.0 108.978 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -72.96 110.45 7.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.681 -0.808 . . . . 0.0 109.096 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.609 HG13 ' C ' ' A' ' 61' ' ' TYR . 22.9 m -160.96 -163.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.744 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.72 130.05 23.75 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.85 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 36' ' ' LYS . . . -125.44 -116.31 0.28 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.409 -0.807 . . . . 0.0 109.945 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -46.32 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 109.727 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.25 -1.42 5.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 110.021 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -94.53 92.32 7.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.781 . . . . 0.0 109.734 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.744 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 10.1 mt -96.35 61.92 2.05 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.245 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER 167.59 -113.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.019 . . . . 0.0 110.473 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.25 149.61 52.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.43 -1.419 . . . . 0.0 113.626 -178.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -101.89 92.66 4.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -70.78 79.84 0.62 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.903 . . . . 0.0 110.64 -177.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -68.59 107.84 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 121.54 0.686 . . . . 0.0 109.571 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -103.18 114.86 29.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.472 -0.768 . . . . 0.0 110.31 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' OE1' HG23 ' A' ' 73' ' ' ILE . 11.3 mt-10 -145.94 112.04 5.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.072 -1.018 . . . . 0.0 110.748 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.583 ' HA ' ' HA2' ' A' ' 55' ' ' GLY . 3.8 m-20 -81.99 -149.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.997 . . . . 0.0 109.513 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.791 ' CD2' HG21 ' A' ' 53' ' ' ILE . 1.1 t80 -176.4 -58.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.348 -1.47 . . . . 0.0 111.091 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -66.37 -58.46 5.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.928 -1.107 . . . . 0.0 108.584 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.43 2.15 29.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.455 ' O ' ' C ' ' A' ' 81' ' ' GLY . 26.6 mmt180 55.71 38.8 30.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.571 -0.706 . . . . 0.0 109.743 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -37.73 -85.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 mtt180 -155.21 -169.14 3.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.892 -1.358 . . . . 0.0 111.753 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . 16.1 mtmt -151.21 97.33 2.42 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 84' ' ' LEU . 7.8 tp -169.88 -172.07 1.3 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.152 -0.968 . . . . 0.0 109.979 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.963 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -150.94 -179.72 7.53 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.271 -0.893 . . . . 0.0 110.037 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 72' ' ' ASP . 21.1 mtm180 -146.01 126.78 14.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.127 . . . . 0.0 111.55 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 2.6 m-85 -104.77 89.6 3.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.419 -0.801 . . . . 0.0 108.933 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.614 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.44 -143.63 0.13 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.52 -1.362 . . . . 0.0 111.268 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.596 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 51.37 50.33 41.46 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 43.2 Cg_endo -68.91 158.02 59.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.332 1.701 . . . . 0.0 111.111 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 91' ' ' VAL . 19.5 m . . . . . 0 C--N 1.304 -1.376 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.339 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.13 178.84 6.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -133.41 169.11 17.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.464 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 6.5 tp10 -168.28 116.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.916 HG22 ' HG2' ' A' ' 42' ' ' MET . 20.9 pt -110.14 144.15 18.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.988 -1.07 . . . . 0.0 111.512 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.805 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.38 -175.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.639 ' HA ' HD11 ' A' ' 38' ' ' ILE . 0.6 OUTLIER 172.74 34.15 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.655 -1.278 . . . . 0.0 112.145 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 7' ' ' ASP . 6.7 tp 177.92 18.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.502 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -158.47 -64.1 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.524 -1.798 . . . . 0.0 111.906 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.747 ' HG3' HG21 ' A' ' 6' ' ' ILE . 46.3 Cg_endo -74.66 -86.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.69 1.363 . . . . 0.0 112.199 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.652 ' HD2' HD12 ' A' ' 60' ' ' LEU . 3.9 m-85 -45.78 -22.43 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.167 -0.958 . . . . 0.0 111.107 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.961 HG22 HD12 ' A' ' 38' ' ' ILE . 27.6 p -66.14 -59.89 3.33 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.972 -1.08 . . . . 0.0 109.177 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' N ' ' OG1' ' A' ' 12' ' ' THR . 29.1 tt0 -72.15 -19.89 61.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.495 0.664 . . . . 0.0 109.924 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 8.2 m120 -79.25 -51.38 9.53 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.0 109.294 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.0 HD12 HD21 ' A' ' 60' ' ' LEU . 1.6 tt -44.98 -55.55 5.41 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 121.4 0.619 . . . . 0.0 109.521 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.985 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -52.31 -55.37 22.37 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' PHE . 4.3 mttm -69.89 -79.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -1.124 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -33.03 -66.64 0.14 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.451 0.643 . . . . 0.0 111.232 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -42.35 -70.28 0.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.601 -0.687 . . . . 0.0 109.849 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 24.8 t -43.62 -25.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.214 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 19' ' ' ALA . 7.6 t0 -91.18 -69.48 0.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.23 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.071 ' CB ' HD13 ' A' ' 85' ' ' LEU . 77.4 mm-40 -59.55 -34.86 73.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.767 -1.208 . . . . 0.0 109.345 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.913 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -66.6 -54.75 20.04 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 109.017 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 3.5 m120 -64.7 -43.7 92.64 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.041 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.1 tttm -57.65 -46.0 84.78 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.913 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -64.26 -17.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.466 -0.771 . . . . 0.0 110.016 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.98 37.47 1.37 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.464 ' HB3' ' OE2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -138.99 72.09 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -1.134 . . . . 0.0 110.066 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 29' ' ' TYR . 41.8 p90 -109.72 30.75 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.857 . . . . 0.0 110.159 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.41 -48.53 5.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 72.2 mtt-85 -157.76 -89.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -1.151 . . . . 0.0 110.137 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.989 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -141.0 152.57 45.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.919 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.632 ' HB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -108.7 55.5 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 110.458 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 5.5 p90 -177.33 119.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.249 -0.907 . . . . 0.0 110.103 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB3' ' C ' ' A' ' 64' ' ' ALA . 45.6 t30 -157.37 -56.72 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.014 . . . . 0.0 110.818 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.29 -97.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.7 t -160.14 172.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.659 -1.276 . . . . 0.0 111.476 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.971 HD11 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.17 121.1 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.669 . . . . 0.0 109.687 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.5 ttm180 -130.91 -57.37 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 110.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.9 Cg_endo -86.5 45.19 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.07 1.037 . . . . 0.0 110.965 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.971 ' SG ' HD11 ' A' ' 38' ' ' ILE . 22.1 p -85.11 79.27 9.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 109.487 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.916 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.8 mtp -82.47 163.0 21.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.171 -0.956 . . . . 0.0 110.685 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 3.4 ttpp -138.51 140.86 39.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 110.211 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 57' ' ' GLU . 6.0 ttmm -142.75 128.79 19.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.241 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.978 HG21 ' CE1' ' A' ' 47' ' ' TYR . 1.4 m -114.44 160.26 19.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 110.213 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 46' ' ' ILE . 1.3 tt -131.5 82.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.978 ' CE1' HG21 ' A' ' 45' ' ' THR . 23.7 m-85 -68.78 -164.75 0.05 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.562 ' N ' ' HB2' ' A' ' 54' ' ' LYS . 2.5 tp10 -66.99 -99.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.758 -0.589 . . . . 0.0 110.032 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 2.8 m120 -127.83 -78.05 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.694 -1.254 . . . . 0.0 109.748 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.73 18.78 1.15 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -145.13 -29.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.143 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 2.7 mm-40 -118.54 -159.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.602 HG12 ' CD2' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -126.04 169.01 18.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.562 ' HB2' ' N ' ' A' ' 48' ' ' GLU . 18.0 tttt -156.97 -49.56 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.801 -1.187 . . . . 0.0 113.245 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.854 ' O ' HG23 ' A' ' 45' ' ' THR . . . -143.08 172.17 24.68 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 117.54 -2.267 . . . . 0.0 111.277 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 1.2 t80 -161.25 91.44 0.86 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.842 -0.799 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 11.3 mt-10 -123.87 -179.44 4.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -164.08 167.01 20.81 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.557 -1.257 . . . . 0.0 112.943 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 49.6 mt-30 -120.72 107.89 13.32 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 15' ' ' LEU . 1.3 tp -98.6 71.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 109.027 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.606 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -72.78 111.48 7.96 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.628 0.728 . . . . 0.0 109.082 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 15' ' ' LEU . 17.2 m -160.1 -163.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.574 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 2.2 t80 -138.85 126.88 22.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.903 . . . . 0.0 109.714 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -122.58 -130.41 0.27 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.461 -0.774 . . . . 0.0 109.886 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.573 ' CB ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.87 -18.51 17.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 66' ' ' ASP . 25.4 t70 -151.02 38.85 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.538 -0.726 . . . . 0.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.891 ' HE2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -150.31 88.69 1.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.553 0.692 . . . . 0.0 109.514 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 7.7 mt -92.44 60.04 3.51 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.618 -0.676 . . . . 0.0 109.596 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.606 ' CD2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 170.45 -122.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.188 -0.945 . . . . 0.0 109.851 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 2.6 tmm_? -122.53 147.88 45.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.21 -1.556 . . . . 0.0 113.246 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 86' ' ' ARG . . . -102.05 98.09 8.33 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -68.78 152.37 45.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 110.133 -177.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -155.77 127.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.534 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 34.2 t -129.98 155.34 46.26 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.222 -0.923 . . . . 0.0 109.24 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' OE2' HG23 ' A' ' 73' ' ' ILE . 3.5 mp0 -156.33 116.79 3.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.607 -1.308 . . . . 0.0 112.46 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.625 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 2.7 p30 -39.89 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.412 0.625 . . . . 0.0 111.643 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.602 ' CD2' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.93 -61.42 0.23 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 178.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HB2' ' CG2' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -126.42 -38.94 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.271 -0.893 . . . . 0.0 108.653 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 37.3 p -90.87 30.16 1.24 Allowed 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER 39.98 57.92 2.24 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.643 . . . . 0.0 111.49 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.625 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -53.4 -108.03 0.01 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -173.82 155.64 2.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.498 -1.59 . . . . 0.0 112.094 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -103.17 126.54 50.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 73' ' ' ILE . 9.8 tp -171.22 179.51 2.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 0.0 109.864 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.071 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.03 167.5 8.9 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.035 -1.041 . . . . 0.0 110.455 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.566 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 1.1 mtt180 -143.44 -174.86 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 10.7 m-85 -155.01 83.52 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.606 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -168.68 -164.06 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.528 -1.269 . . . . 0.0 111.503 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 86.82 54.83 2.54 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 39.5 Cg_endo -63.21 144.68 92.37 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 124.407 1.741 . . . . 0.0 111.472 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' H ' HG13 ' A' ' 91' ' ' VAL . 4.7 m . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 118.069 -0.967 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 0.5 OUTLIER 175.83 178.21 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.252 -1.146 . . . . 0.0 110.168 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 m-90 -83.28 -176.81 6.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.031 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HG2' ' CE ' ' A' ' 43' ' ' LYS . 20.7 tp10 174.31 163.02 0.2 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' CG1' ' N ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -139.29 173.43 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.931 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 7' ' ' ASP . 1.2 pp -136.82 -159.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.855 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.681 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 t70 -113.21 -143.38 0.39 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.339 -0.851 . . . . 0.0 109.617 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.823 ' C ' HG21 ' A' ' 12' ' ' THR . 0.8 OUTLIER -108.38 38.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.647 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -129.91 -56.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.743 -1.218 . . . . 0.0 112.702 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.5 Cg_endo -75.7 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 122.963 0.98 . . . . 0.0 111.853 -177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.7 ' CE1' ' CD2' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -40.4 -34.96 0.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.136 -0.978 . . . . 0.0 110.447 -178.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.133 HG22 HD12 ' A' ' 38' ' ' ILE . 44.5 p -50.19 -54.22 22.38 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.4 OUTLIER -63.78 -25.98 68.43 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.751 0.786 . . . . 0.0 109.36 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.533 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 11.6 m120 -72.26 -52.4 16.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 0.0 109.86 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -42.9 -58.4 2.41 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.257 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 1.02 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -45.72 -45.97 13.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -83.52 -80.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.411 -1.053 . . . . 0.0 111.154 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 2.5 m-85 -35.69 -29.58 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.207 0.527 . . . . 0.0 111.592 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.787 ' HB1' ' OE1' ' A' ' 23' ' ' GLU . . . -84.02 -72.49 0.46 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.749 HG23 ' OG1' ' A' ' 33' ' ' THR . 24.3 t -43.64 -26.49 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.951 -1.093 . . . . 0.0 109.833 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.8 OUTLIER -86.64 -62.59 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.667 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.067 ' HB2' HD13 ' A' ' 85' ' ' LEU . 25.3 mm-40 -62.12 -43.21 99.32 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.464 -1.294 . . . . 0.0 108.998 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.888 ' CD ' HG21 ' A' ' 33' ' ' THR . 55.4 mt-10 -58.83 -51.86 68.2 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 108.877 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.568 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 35.0 t-20 -64.55 -47.99 76.7 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.052 -1.059 . . . . 0.0 108.383 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -57.66 -42.11 82.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.966 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.2 tp -69.57 -16.48 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.393 -0.817 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.07 52.72 0.26 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.422 ' C ' ' HA ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -158.34 81.83 0.83 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -1.12 . . . . 0.0 109.878 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 39.4 p90 -105.5 29.18 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.15 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -41.16 -51.73 4.27 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.901 ' HB3' HD23 ' A' ' 32' ' ' LEU . 7.6 mtm180 -179.62 -81.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -141.49 164.68 29.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.44 -0.787 . . . . 0.0 109.782 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.888 HG21 ' CD ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -130.04 52.5 2.0 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.328 -0.857 . . . . 0.0 109.751 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.522 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . 38.9 t80 -163.85 112.41 1.2 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.415 -0.803 . . . . 0.0 110.015 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.9 t-20 -150.4 -55.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.546 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.749 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.6 mttt -69.46 -103.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 111.049 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 36' ' ' LYS . 9.2 t -159.59 172.56 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 120.755 -1.216 . . . . 0.0 111.536 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.133 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -128.65 129.12 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.615 -0.678 . . . . 0.0 109.846 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.603 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -132.1 -58.13 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.375 -0.828 . . . . 0.0 110.057 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 44.9 Cg_endo -87.44 46.42 1.34 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 123.174 1.091 . . . . 0.0 110.81 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 1.001 ' HB2' HD12 ' A' ' 60' ' ' LEU . 22.6 p -87.46 111.61 21.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.657 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.482 ' HB3' ' CE ' ' A' ' 44' ' ' LYS . 27.1 mtm -109.66 179.81 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.703 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' CE ' ' HG2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -152.54 142.38 22.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.405 -0.809 . . . . 0.0 110.107 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HE3' ' N ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -137.96 105.69 5.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.772 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.993 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.9 m -124.17 154.19 40.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 25.8 pt -122.2 39.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.801 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -75.75 -150.19 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 122.274 1.035 . . . . 0.0 111.696 -178.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.583 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.4 pt-20 -68.73 -155.99 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.077 0.941 . . . . 0.0 112.745 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.583 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 1.7 m-20 -155.99 -35.41 0.09 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.433 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HG3' ' HG2' ' A' ' 51' ' ' ARG . 15.7 pt-20 -131.29 -30.78 1.69 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 110.819 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.453 ' HG2' ' HG3' ' A' ' 50' ' ' GLU . 1.6 ptt85 -171.31 18.57 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.719 -1.238 . . . . 0.0 112.358 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' C ' ' CB ' ' A' ' 48' ' ' GLU . 40.3 mm-40 -111.71 -148.33 0.43 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.836 -1.165 . . . . 0.0 110.511 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.592 HG12 ' CG ' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -171.15 142.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.721 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 1.8 mtmt -141.3 -75.09 0.31 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.754 -1.216 . . . . 0.0 112.463 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.993 ' O ' HG23 ' A' ' 45' ' ' THR . . . -141.06 167.61 25.62 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' GLU . 86.5 t80 -152.29 90.83 1.54 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.259 -1.142 . . . . 0.0 110.809 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.9 tt0 -112.08 159.61 18.32 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.704 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -156.35 169.16 25.22 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 117.859 -1.536 . . . . 0.0 113.45 -179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.542 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 13.3 mt-30 -137.93 120.97 16.67 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.001 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.4 OUTLIER -121.98 83.85 2.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.889 -1.132 . . . . 0.0 109.436 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.65 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -75.18 110.32 9.4 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.756 HG23 ' HD3' ' A' ' 67' ' ' LYS . 35.6 m -160.33 -161.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.462 -0.774 . . . . 0.0 109.697 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 1.109 ' CE1' HD22 ' A' ' 68' ' ' LEU . 2.0 t80 -135.09 135.2 41.04 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.506 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -133.15 -127.74 0.18 Allowed 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.426 -0.796 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -40.01 9.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.114 -0.992 . . . . 0.0 108.982 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' OD1' HG22 ' A' ' 33' ' ' THR . 2.5 p30 -127.67 -2.39 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.436 -0.79 . . . . 0.0 109.733 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD3' HG23 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -104.5 88.87 3.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.109 HD22 ' CE1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -100.25 60.9 1.05 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 108.788 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.3 OUTLIER 172.3 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 7.3 ttp180 -152.94 156.27 38.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.972 -1.705 . . . . 0.0 112.643 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -119.2 115.52 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' OD1' ' NH1' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -93.07 166.34 12.4 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.992 -1.067 . . . . 0.0 110.235 -178.064 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.704 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.69 114.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.618 -0.676 . . . . 0.0 109.179 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -109.84 144.57 38.11 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.958 -179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.3 mt-10 -167.72 104.17 0.5 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.694 -1.254 . . . . 0.0 111.726 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.618 ' HB3' ' CA ' ' A' ' 81' ' ' GLY . 16.1 p-10 -61.8 -148.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.657 0.741 . . . . 0.0 112.149 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.592 ' CG ' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 175.97 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.389 0.614 . . . . 0.0 109.505 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.3 ttpt -119.85 -32.12 4.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.882 . . . . 0.0 109.06 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -69.48 -15.98 63.37 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 79' ' ' THR . 7.6 mmt180 74.02 104.11 0.07 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.23 1.014 . . . . 0.0 110.343 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.618 ' CA ' ' HB3' ' A' ' 76' ' ' ASP . . . -143.01 -95.09 0.21 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -171.6 -157.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.408 -1.643 . . . . 0.0 112.041 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.785 ' C ' HD23 ' A' ' 84' ' ' LEU . 6.8 mttt -146.8 117.74 7.69 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.785 HD23 ' C ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -170.86 -169.56 0.78 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.528 -1.357 . . . . 0.0 111.75 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -170.37 175.95 4.63 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.536 ' N ' ' HG ' ' A' ' 85' ' ' LEU . 13.0 mtt180 -150.35 152.15 33.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.939 -1.104 . . . . 0.0 111.031 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 23' ' ' GLU . 13.4 m-85 -103.69 97.39 7.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' OD1' ' CE2' ' A' ' 69' ' ' PHE . 1.5 t-20 -66.79 125.86 27.19 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.068 -1.02 . . . . 0.0 110.076 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . -8.09 99.35 0.01 OUTLIER Glycine 0 N--CA 1.503 3.108 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.45 ' C ' ' HB2' ' A' ' 68' ' ' LEU . 47.3 Cg_endo -74.95 79.07 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.553 . . . . 0.0 109.941 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 68' ' ' LEU . 2.1 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.239 -0.913 . . . . 0.0 110.336 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' CA ' HD12 ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -123.87 162.13 23.92 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.356 -1.085 . . . . 0.0 110.145 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.492 ' CB ' ' HG2' ' A' ' 44' ' ' LYS . 4.8 p90 -115.77 177.81 4.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 175.51 121.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.206 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 18.4 pt -85.17 170.25 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.075 -1.016 . . . . 0.0 110.499 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.777 HG22 ' CD2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -89.4 -166.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.256 -0.902 . . . . 0.0 110.509 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.651 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 m-20 -137.16 49.56 2.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.141 -0.975 . . . . 0.0 110.705 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 7' ' ' ASP . 5.1 tt 39.9 46.01 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.963 0.887 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -156.1 -62.21 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.002 -1.094 . . . . 0.0 111.346 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.1 Cg_endo -72.7 -84.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 0.0 111.535 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.777 ' CD2' HG22 ' A' ' 6' ' ' ILE . 6.3 m-85 -41.42 -29.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.243 -0.911 . . . . 0.0 110.568 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.599 ' HA ' HG21 ' A' ' 38' ' ' ILE . 11.4 p -55.33 -58.0 9.52 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.535 ' N ' ' OG1' ' A' ' 12' ' ' THR . 9.6 mt-30 -68.19 -17.7 64.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.694 0.759 . . . . 0.0 109.394 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.555 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 7.2 t-20 -80.82 -57.28 3.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.55 0.69 . . . . 0.0 109.352 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -39.14 -46.49 1.45 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 1.011 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -65.24 -40.45 96.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.74 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -77.44 -69.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -1.054 . . . . 0.0 110.241 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD1' ' OD1' ' A' ' 14' ' ' ASN . 1.7 m-30 -40.86 -47.3 2.91 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.686 0.755 . . . . 0.0 110.222 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -57.69 -77.56 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.526 -0.734 . . . . 0.0 110.01 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 17' ' ' LYS . 7.0 p -38.33 -27.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.0 110.967 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -89.11 -77.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.915 -1.115 . . . . 0.0 110.213 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.018 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.1 mm-40 -56.06 -36.31 67.92 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.671 -1.268 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.812 ' O ' HG22 ' A' ' 26' ' ' ILE . 30.6 tt0 -64.77 -52.37 57.28 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.578 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 18.8 t-20 -66.64 -44.19 82.62 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.852 -1.139 . . . . 0.0 108.015 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.8 ttmt -59.72 -41.72 91.46 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.127 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.4 tp -69.39 -17.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.389 -0.819 . . . . 0.0 110.194 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . 115.58 52.13 0.4 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 36.5 mm-40 -156.36 82.32 0.98 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.122 . . . . 0.0 109.736 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 50.9 p90 -104.02 30.37 5.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.412 -0.805 . . . . 0.0 109.889 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 31' ' ' ARG . . . -38.67 -48.81 2.43 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 171.37 -82.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -1.235 . . . . 0.0 110.341 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.914 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -131.91 158.89 40.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.723 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -129.98 52.71 1.98 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.835 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 6.3 p90 -172.7 62.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.342 -0.849 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.06 -26.16 11.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.102 -0.999 . . . . 0.0 111.218 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.761 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -96.39 -89.93 0.25 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.759 -1.213 . . . . 0.0 111.404 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 36' ' ' LYS . 10.0 t -160.29 172.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.482 -1.386 . . . . 0.0 111.342 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -135.6 82.49 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 109.573 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.577 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -102.04 -58.02 0.1 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.026 -1.046 . . . . 0.0 111.494 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 61' ' ' TYR . 39.3 Cg_endo -79.19 48.04 2.7 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.292 1.154 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . 20.8 p -104.74 121.62 43.99 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.799 -1.188 . . . . 0.0 109.789 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.499 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 2.3 mpt? -117.65 157.66 26.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.111 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -128.53 129.8 46.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.945 -1.097 . . . . 0.0 110.215 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 15.0 mttm -130.93 125.43 33.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 55' ' ' GLY . 21.1 m -125.1 164.65 19.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.984 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -127.55 51.2 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 2' ' ' GLU . 3.8 p90 -69.47 -159.79 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.989 0.899 . . . . 0.0 111.322 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.594 ' HB3' ' C ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -67.46 -147.47 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.693 0.758 . . . . 0.0 112.237 -178.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.589 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 1.1 t30 -156.75 -35.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.592 -0.692 . . . . 0.0 109.827 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.52 -31.75 1.78 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.293 -0.879 . . . . 0.0 110.796 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.97 20.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.801 -1.187 . . . . 0.0 112.222 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.691 ' C ' HD12 ' A' ' 53' ' ' ILE . 13.1 mt-10 -111.92 -151.27 0.48 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.878 -1.139 . . . . 0.0 110.516 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.716 HG22 ' HB3' ' A' ' 77' ' ' TYR . 1.2 mp -164.19 132.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -123.72 -76.51 0.59 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.557 -1.34 . . . . 0.0 113.095 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 45' ' ' THR . . . -155.43 -174.09 24.9 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 118.303 -1.903 . . . . 0.0 109.913 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.73 ' HA ' HG23 ' A' ' 45' ' ' THR . 13.7 t80 -162.2 109.51 1.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.902 -0.764 . . . . 0.0 110.617 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -126.04 177.85 6.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.351 -0.843 . . . . 0.0 108.831 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 1.089 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -165.38 175.18 9.34 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.168 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.517 ' HG3' ' CD ' ' A' ' 70' ' ' ARG . 2.8 tt0 -127.69 125.06 39.35 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 41' ' ' CYS . 21.1 tp -119.52 67.62 0.81 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.726 -1.234 . . . . 0.0 109.842 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 2.5 t80 -69.5 108.78 3.93 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.857 HG21 HD12 ' A' ' 15' ' ' LEU . 34.9 m -160.42 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.695 ' CE1' HD12 ' A' ' 68' ' ' LEU . 1.4 t80 -154.2 117.34 4.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.971 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.91 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -104.46 -102.62 0.31 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.559 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.512 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 22.9 t -120.03 -26.74 5.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 0.0 109.272 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.75 5.62 2.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 109.959 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.91 ' NZ ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -109.07 86.35 2.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 110.109 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 63' ' ' TYR . 1.2 tp -88.78 61.96 6.21 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.53 -0.731 . . . . 0.0 109.717 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 169.73 -113.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.0 110.213 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 17.5 ttm180 -127.0 146.21 50.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.557 -1.34 . . . . 0.0 112.963 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -106.59 102.42 11.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.3 t70 -84.68 154.88 22.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 110.302 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.089 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -156.18 142.74 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.842 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.1 t -128.49 159.2 36.2 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -167.65 105.04 0.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.677 -1.264 . . . . 0.0 111.917 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.602 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 56.9 p-10 -55.56 -165.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.716 ' HB3' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -160.61 -53.34 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.496 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.1 tptm -135.11 -39.78 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.133 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.613 ' C ' ' HG3' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -76.7 -61.71 1.88 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.613 ' HG3' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 152.06 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.794 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -21.19 -96.42 0.01 OUTLIER Glycine 0 N--CA 1.505 3.271 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 1.5 mtt180 -165.12 -165.29 0.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.946 -1.326 . . . . 0.0 110.786 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -166.76 88.73 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -171.2 -167.78 0.57 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 110.047 -178.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.018 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -170.81 172.4 5.68 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.295 -0.878 . . . . 0.0 109.704 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 19.6 mtp180 -148.51 178.6 8.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.909 -1.12 . . . . 0.0 111.244 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 3.2 m-85 -155.36 80.86 1.05 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.615 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -155.79 -163.31 1.47 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.765 -1.209 . . . . 0.0 111.209 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 77.74 53.21 5.08 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 105.19 -3.164 . . . . 0.0 105.19 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.14 119.66 6.93 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 124.834 1.965 . . . . 0.0 111.697 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.449 ' H ' HG12 ' A' ' 91' ' ' VAL . 2.6 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' N ' ' ND2' ' A' ' 49' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -172.5 170.01 5.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -1.168 . . . . 0.0 110.283 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.473 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 7.5 p90 -159.36 165.58 32.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -0.901 . . . . 0.0 110.316 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' CD ' ' HD2' ' A' ' 43' ' ' LYS . 8.2 pt-20 -172.94 158.71 3.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.823 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.05 171.81 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.163 -0.96 . . . . 0.0 110.44 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.823 HD13 ' C ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -150.84 -176.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.868 -0.52 . . . . 0.0 109.784 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.78 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.8 p30 -179.32 126.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.0 110.928 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER 43.21 25.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.691 -0.631 . . . . 0.0 110.13 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.66 ' N ' HG21 ' A' ' 12' ' ' THR . . . -118.02 -107.63 2.38 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.161 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' THR . 48.7 Cg_endo -80.65 -72.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.72 1.613 . . . . 0.0 112.752 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.714 ' CD1' HG21 ' A' ' 6' ' ' ILE . 59.6 m-85 -40.09 -27.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.286 -0.883 . . . . 0.0 109.9 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.829 HG22 HG21 ' A' ' 38' ' ' ILE . 2.1 p -65.69 -61.81 1.87 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.582 ' N ' ' OG1' ' A' ' 12' ' ' THR . 5.3 mt-30 -59.89 -26.35 65.83 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.924 0.868 . . . . 0.0 108.767 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 1.7 t-20 -74.45 -47.0 36.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.604 0.716 . . . . 0.0 109.202 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' CD2' ' A' ' 60' ' ' LEU . 3.4 tm? -44.03 -70.4 0.11 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 20' ' ' VAL . . . -44.27 -37.39 4.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' ASN . 18.1 mttp -71.24 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -40.54 -41.3 1.42 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.579 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -59.63 -68.27 0.3 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.438 -0.789 . . . . 0.0 109.316 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 16' ' ' GLY . 23.3 t -38.5 -28.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.479 -0.763 . . . . 0.0 110.288 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -95.17 -73.5 0.58 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 110.341 179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 14.0 mm-40 -54.86 -27.98 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.897 -1.127 . . . . 0.0 109.827 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.623 ' CG ' ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -76.76 -61.11 2.08 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 6.6 m-20 -51.76 -47.17 64.22 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 20.7 mmmt -55.25 -51.69 65.8 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.653 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -51.77 -22.39 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.101 178.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.2 67.41 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -127.49 -71.64 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.213 -1.169 . . . . 0.0 110.304 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -102.25 -75.37 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA2' ' ND2' ' A' ' 24' ' ' ASN . . . 100.8 36.41 3.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.078 ' O ' HD23 ' A' ' 32' ' ' LEU . 72.1 mtt180 -153.56 -82.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -1.18 . . . . 0.0 110.437 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.078 HD23 ' O ' ' A' ' 31' ' ' ARG . 7.0 mt -131.08 166.17 21.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.905 . . . . 0.0 110.38 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.533 HG21 ' HB1' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -154.35 62.32 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.1 t80 176.94 88.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -0.939 . . . . 0.0 110.315 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 3.7 t-20 -117.12 -56.37 2.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 110.734 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.51 -101.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.019 -1.051 . . . . 0.0 111.263 -179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' LYS . 2.4 t -163.43 174.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.696 -1.253 . . . . 0.0 111.527 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.004 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -121.36 112.16 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.739 -0.601 . . . . 0.0 109.768 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.604 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -119.23 -57.07 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 110.613 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.1 Cg_endo -86.93 48.29 1.78 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.209 1.11 . . . . 0.0 110.901 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.999 ' HB2' HD12 ' A' ' 60' ' ' LEU . 23.6 p -96.41 122.13 38.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.26 -0.9 . . . . 0.0 110.009 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' GLN . 12.1 mtm -121.1 165.14 15.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.182 -0.949 . . . . 0.0 110.263 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -143.17 144.5 32.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLU . 18.5 mttt -148.43 157.44 43.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.34 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.6 m -149.1 152.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.127 -0.983 . . . . 0.0 110.197 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -122.39 43.91 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.732 ' H ' HG22 ' A' ' 45' ' ' THR . 0.1 OUTLIER -72.74 -147.27 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.06 0.933 . . . . 0.0 111.721 -178.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.587 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 1.2 pt-20 -68.54 -153.9 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 122.043 0.925 . . . . 0.0 112.724 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.587 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 10.5 m120 -157.16 -36.04 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.538 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -137.71 -27.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 111.252 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.34 23.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.685 -1.259 . . . . 0.0 111.83 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.552 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 1.3 mt-10 -121.67 -147.11 0.38 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.925 -1.109 . . . . 0.0 110.445 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.881 HD12 ' CG ' ' A' ' 77' ' ' TYR . 0.2 OUTLIER -170.94 145.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -137.89 -76.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.556 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.881 ' O ' HG23 ' A' ' 45' ' ' THR . . . -158.82 -173.12 26.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 118.12 -1.991 . . . . 0.0 111.59 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -157.84 107.42 2.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.705 -0.88 . . . . 0.0 110.234 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' LYS . 17.1 pt-20 -117.14 134.65 54.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.917 . . . . 0.0 109.054 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.69 ' CE2' ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -131.41 164.22 26.18 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.49 -1.284 . . . . 0.0 112.534 -178.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 70' ' ' ARG . 11.5 mt-30 -132.12 124.12 28.5 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.004 HD11 ' CD1' ' A' ' 38' ' ' ILE . 1.8 tp -120.69 78.15 1.35 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.747 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -73.28 113.0 9.86 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 38' ' ' ILE . 32.9 m -159.63 -162.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 2.8 t80 -136.01 141.58 44.37 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.335 -0.853 . . . . 0.0 109.893 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' H ' ' A' ' 35' ' ' ASN . . . -138.98 -115.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.349 -0.845 . . . . 0.0 110.043 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -111.8 -39.0 4.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.268 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 29' ' ' TYR . 3.5 p-10 -127.54 -0.98 6.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.602 -0.687 . . . . 0.0 109.641 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -106.25 97.68 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 109.736 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' HG ' ' CZ ' ' A' ' 63' ' ' TYR . 6.5 mp -100.2 60.09 1.03 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.428 -0.795 . . . . 0.0 109.515 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 168.17 -115.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 110.237 -179.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 59' ' ' GLN . 3.1 ttm180 -122.46 145.35 48.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.184 -1.572 . . . . 0.0 113.142 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -107.37 108.31 19.62 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' CB ' ' HG3' ' A' ' 86' ' ' ARG . 1.4 t70 -90.33 162.37 15.19 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.917 -1.114 . . . . 0.0 111.247 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -155.78 101.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.26 150.52 22.01 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.656 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -169.06 119.9 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.104 -0.998 . . . . 0.0 110.675 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.604 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -61.47 -152.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.584 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.881 ' CG ' HD12 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -166.37 -50.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.864 -1.148 . . . . 0.0 110.928 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' CA ' HG22 ' A' ' 53' ' ' ILE . 11.1 ttmt -67.8 -57.91 5.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.095 . . . . 0.0 108.521 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 79' ' ' THR . 86.2 m -99.06 10.81 40.7 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 81' ' ' GLY . 24.3 mmt85 58.88 18.49 6.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.536 -0.727 . . . . 0.0 109.789 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.604 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -0.36 -69.68 0.0 OUTLIER Glycine 0 N--CA 1.501 3.03 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.315 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -170.05 -173.14 1.47 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.736 -1.449 . . . . 0.0 111.371 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -146.23 137.2 24.38 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.8 tt -171.25 163.65 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.17 . . . . 0.0 110.516 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -149.43 160.86 43.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.596 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HG3' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -150.53 147.9 28.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.02 -1.05 . . . . 0.0 111.269 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.932 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -124.7 89.82 3.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.638 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.52 -146.43 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.685 -1.26 . . . . 0.0 110.929 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 60.35 52.8 50.46 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 41.3 Cg_endo -67.01 136.6 41.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.408 1.741 . . . . 0.0 111.253 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.305 -1.344 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.279 -179.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER 173.6 148.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -1.149 . . . . 0.0 110.413 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 0.4 OUTLIER -66.3 -176.48 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.31 -0.869 . . . . 0.0 110.309 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 174.78 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.937 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.965 HG22 ' HG2' ' A' ' 42' ' ' MET . 1.1 pp -89.37 167.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 120.979 -1.076 . . . . 0.0 110.324 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.149 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -115.11 -160.54 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.995 -1.065 . . . . 0.0 110.672 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 40.3 t0 -135.46 52.74 2.0 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.844 -1.16 . . . . 0.0 112.123 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.908 HG22 ' O ' ' A' ' 38' ' ' ILE . 29.8 pt 39.83 46.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.168 0.985 . . . . 0.0 110.314 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -134.02 -69.15 0.07 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.785 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 45.7 Cg_endo -79.28 -63.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.845 1.445 . . . . 0.0 111.28 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.149 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.5 m-85 -47.39 -36.02 9.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.025 -1.047 . . . . 0.0 109.212 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.909 HG22 HG13 ' A' ' 38' ' ' ILE . 1.7 p -52.3 -57.66 9.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.602 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.87 -15.97 62.62 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.059 179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.56 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 5.7 m120 -82.82 -68.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.271 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 3.0 pp -40.93 -28.76 0.09 Allowed 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.456 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 20' ' ' VAL . . . -71.42 -53.34 10.35 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -76.58 -42.49 42.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -1.127 . . . . 0.0 110.837 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' ALA . 7.6 m-85 -63.63 -64.86 0.78 Allowed 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.44 -0.788 . . . . 0.0 110.065 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -44.42 -66.22 0.42 Allowed 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.625 -0.672 . . . . 0.0 110.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 16' ' ' GLY . 30.5 m -42.43 -26.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 O-C-N 120.961 -1.087 . . . . 0.0 110.149 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -94.77 -69.86 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.92 . . . . 0.0 110.078 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.969 ' HB2' HD13 ' A' ' 85' ' ' LEU . 22.7 mm-40 -55.37 -35.01 64.79 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.247 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.77 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -69.69 -59.66 2.81 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 61.7 t-20 -51.38 -45.32 62.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -54.46 46.67 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.703 -0.799 . . . . 0.0 108.965 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -57.06 -19.1 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.636 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.66 70.91 1.33 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -126.74 -74.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.4 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -106.75 -71.36 0.76 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.12 18.01 9.63 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -135.96 -140.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -1.159 . . . . 0.0 110.287 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.816 ' N ' HD22 ' A' ' 32' ' ' LEU . 2.7 mm? -83.24 152.38 25.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.295 -0.878 . . . . 0.0 110.799 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.534 ' OG1' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.97 50.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 109.633 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 6.5 p90 -162.85 123.0 2.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.532 -0.73 . . . . 0.0 109.819 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -157.74 -59.26 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.992 -1.068 . . . . 0.0 111.314 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.807 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.1 mmmt -69.09 -99.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.993 -1.067 . . . . 0.0 111.583 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.4 t -161.13 173.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.7 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -123.96 103.35 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.959 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.652 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -101.74 -60.48 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.953 -1.092 . . . . 0.0 110.185 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.652 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.4 Cg_endo -86.76 54.43 3.07 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 123.176 1.092 . . . . 0.0 110.336 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 1.071 ' SG ' HD12 ' A' ' 60' ' ' LEU . 4.5 t -102.67 110.55 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.338 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.965 ' HG2' HG22 ' A' ' 5' ' ' ILE . 2.0 mtt -113.75 175.75 5.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 110.628 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 2.3 ttpt -147.68 120.7 8.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 0.3 OUTLIER -114.78 160.98 18.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.165 -0.959 . . . . 0.0 109.574 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.1 m -163.53 153.42 15.21 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.87 -1.144 . . . . 0.0 110.364 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -122.13 41.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 178.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.833 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.81 -144.42 0.06 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 122.02 0.914 . . . . 0.0 111.92 -177.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' N ' ' CG ' ' A' ' 47' ' ' TYR . 2.0 pt-20 -68.81 -158.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.291 1.043 . . . . 0.0 112.939 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 3.1 p30 -163.47 -46.41 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HB3' ' CD ' ' A' ' 51' ' ' ARG . 2.7 mp0 -107.53 -41.11 5.14 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.508 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.512 ' CD ' ' HB3' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -171.88 14.24 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.758 -1.214 . . . . 0.0 112.828 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.639 ' O ' HD12 ' A' ' 53' ' ' ILE . 12.3 pt-20 -105.71 -145.39 0.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.511 -1.368 . . . . 0.0 110.494 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.694 HG23 ' CG ' ' A' ' 77' ' ' TYR . 0.7 OUTLIER -170.06 143.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -139.38 -76.89 0.35 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.799 -1.188 . . . . 0.0 112.551 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 45' ' ' THR . . . -144.98 175.1 24.77 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 118.409 -1.853 . . . . 0.0 110.735 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -152.87 110.21 3.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.427 -1.043 . . . . 0.0 111.018 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.0 pm0 -124.8 124.46 42.15 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.732 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.51 169.67 10.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.566 -1.334 . . . . 0.0 113.267 -177.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' HB3' ' NE ' ' A' ' 70' ' ' ARG . 6.7 mp0 -133.66 123.08 24.39 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.071 HD12 ' SG ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -121.24 72.59 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.899 -1.125 . . . . 0.0 109.888 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.621 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -68.23 107.13 2.67 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.8 m -158.29 -160.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.346 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.876 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.0 t80 -140.99 129.24 22.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.515 -0.741 . . . . 0.0 109.932 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -122.0 -130.27 0.27 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.367 -0.833 . . . . 0.0 109.489 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 -18.76 30.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.111 -0.993 . . . . 0.0 108.744 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 9.6 p-10 -162.4 23.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.565 -0.71 . . . . 0.0 109.735 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -117.07 71.47 0.8 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.384 -0.823 . . . . 0.0 110.32 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.876 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 4.6 mt -81.73 52.6 1.95 Allowed 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -168.62 -153.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.547 -0.721 . . . . 0.0 109.81 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 17.3 ttm180 -106.52 119.64 39.83 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.217 -0.927 . . . . 0.0 111.321 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.753 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -80.6 107.19 13.2 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.9 t70 -87.64 160.37 18.18 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 110.087 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.732 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.73 112.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.905 0.86 . . . . 0.0 109.745 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -103.12 144.17 31.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.005 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 3.5 mt-10 -153.58 105.75 2.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.461 -1.399 . . . . 0.0 112.335 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.626 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 1.7 p-10 -50.66 173.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.521 0.677 . . . . 0.0 111.03 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.694 ' CG ' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.17 -72.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.138 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 2.0 tppt? -120.2 -34.34 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.118 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 79' ' ' THR . 3.2 m -90.43 9.33 29.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.419 -0.801 . . . . 0.0 109.364 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.544 ' HA ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER 66.33 55.38 0.86 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.496 -0.752 . . . . 0.0 111.057 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.626 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -51.33 -99.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -158.21 -165.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.025 -1.279 . . . . 0.0 111.052 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 79.4 mttt -158.18 97.93 1.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -171.17 -172.99 1.19 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 110.605 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.969 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -170.3 167.67 8.36 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.646 -0.659 . . . . 0.0 109.329 179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 25.9 mtm180 -143.45 -176.21 4.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.933 -1.105 . . . . 0.0 111.198 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.843 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 17.3 m-85 -155.98 66.79 0.6 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -154.16 -161.41 1.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.81 -1.182 . . . . 0.0 111.624 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 73.05 54.7 6.82 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 104.517 -3.433 . . . . 0.0 104.517 -176.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.1 Cg_endo -62.57 177.12 1.37 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.82 1.958 . . . . 0.0 112.065 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.461 HG13 ' OH ' ' A' ' 61' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.196 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 45' ' ' THR . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER 71.29 -148.55 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.318 -1.107 . . . . 0.0 110.128 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.526 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 7.0 p-90 -144.03 169.27 18.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.783 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 177.28 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 110.063 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.0 HG22 ' HG3' ' A' ' 42' ' ' MET . 6.9 pt -69.89 -172.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.254 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mm -131.1 -138.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.535 ' O ' HD11 ' A' ' 38' ' ' ILE . 19.3 m-20 -142.07 -146.83 0.2 Allowed 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.791 -1.193 . . . . 0.0 110.221 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.548 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt -113.62 47.12 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.611 ' N ' ' CG2' ' A' ' 12' ' ' THR . . . -157.39 -60.9 0.01 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.357 -1.402 . . . . 0.0 111.777 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.815 ' HG2' HG22 ' A' ' 6' ' ' ILE . 38.6 Cg_endo -64.92 -68.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.527 1.277 . . . . 0.0 112.527 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.659 ' HD1' HG21 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -65.36 -23.53 67.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.483 -1.385 . . . . 0.0 110.627 -178.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' N ' ' A' ' 9' ' ' GLY . 10.0 p -48.62 -53.36 18.81 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -64.02 -29.78 70.9 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.072 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 2.0 m-80 -66.02 -58.73 4.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.364 -0.835 . . . . 0.0 109.605 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.833 HD13 ' CD2' ' A' ' 60' ' ' LEU . 9.0 tp -41.03 -66.99 0.28 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 34' ' ' PHE . . . -43.46 -29.31 1.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 20' ' ' VAL . 70.5 mmtt -88.67 -82.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -1.135 . . . . 0.0 110.418 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -41.6 -27.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.453 -0.779 . . . . 0.0 110.486 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB2' HD12 ' A' ' 15' ' ' LEU . . . -81.2 -70.5 0.53 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 17' ' ' LYS . 4.4 p -41.57 -25.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.324 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ALA . 59.3 t0 -92.7 -72.5 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.085 -1.01 . . . . 0.0 110.516 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.974 ' HB2' HD13 ' A' ' 85' ' ' LEU . 0.8 OUTLIER -57.83 -28.96 64.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.452 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 87' ' ' PHE . 1.3 tt0 -72.43 -58.97 2.97 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 29' ' ' TYR . 1.5 m120 -54.14 -51.82 63.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -51.45 -48.62 62.69 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.456 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.054 HD11 HD11 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -53.75 -20.44 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.529 0.68 . . . . 0.0 109.294 178.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.68 22.86 5.87 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 1.5 tp60 -120.96 65.19 0.86 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.443 -1.033 . . . . 0.0 109.664 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 7.0 t80 -89.98 23.11 2.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.439 -0.788 . . . . 0.0 109.795 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.69 -58.71 1.75 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.846 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -168.32 -96.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -1.229 . . . . 0.0 110.5 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.846 HD12 ' HB3' ' A' ' 31' ' ' ARG . 1.9 mp -112.11 -175.39 2.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -155.35 49.67 0.55 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.302 -0.874 . . . . 0.0 110.088 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.669 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 43.5 p90 179.65 55.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.471 -0.768 . . . . 0.0 110.207 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 20.9 t-20 -85.77 -54.24 4.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.454 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.806 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -69.54 -105.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.021 -1.049 . . . . 0.0 110.962 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 36' ' ' LYS . 3.7 t -161.06 172.7 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.53 -1.356 . . . . 0.0 111.775 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.56 ' N ' ' CG1' ' A' ' 37' ' ' VAL . 1.2 pp -121.37 97.62 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.611 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -96.04 -55.56 0.21 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.863 -1.148 . . . . 0.0 109.866 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 42.2 Cg_endo -86.87 54.18 2.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.554 1.292 . . . . 0.0 110.362 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.613 ' SG ' HD12 ' A' ' 60' ' ' LEU . 7.5 t -91.25 92.94 8.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.875 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 1.0 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -90.68 126.4 35.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.155 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -123.63 155.78 37.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 110.483 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 1.4 ptpp? -164.54 173.5 11.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.4 m -157.86 158.07 34.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 6.8 pt -118.74 48.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -116.45 164.07 15.1 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.376 0.607 . . . . 0.0 111.0 -178.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -90.43 -125.87 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.884 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER 170.96 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.865 -1.147 . . . . 0.0 110.553 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 49' ' ' ASN . 14.8 mp0 -129.26 -3.23 4.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.112 -0.992 . . . . 0.0 110.27 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 51' ' ' ARG . 5.7 tpm_? -128.83 -30.94 2.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.288 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 17.2 pt-20 -170.28 -165.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.701 HD13 ' CE1' ' A' ' 77' ' ' TYR . 7.6 tt -152.6 107.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.731 0.776 . . . . 0.0 109.566 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -82.77 -76.43 0.27 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.86 -1.15 . . . . 0.0 112.103 -178.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.776 ' O ' HG23 ' A' ' 45' ' ' THR . . . -172.28 173.22 45.23 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 117.772 -2.156 . . . . 0.0 111.237 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.539 ' HA ' HG23 ' A' ' 45' ' ' THR . 11.3 m-85 -115.65 -179.19 3.58 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.82 -0.812 . . . . 0.0 110.353 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 7.4 pt-20 171.34 137.81 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.807 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -151.06 171.78 16.79 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 117.432 -1.707 . . . . 0.0 113.974 -178.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.553 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt-30 -129.24 124.82 35.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.833 ' CD2' HD13 ' A' ' 15' ' ' LEU . 23.7 tp -117.67 71.76 0.83 Allowed 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.871 -1.143 . . . . 0.0 109.83 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.594 ' CG ' ' HG2' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -69.53 107.01 3.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' CD ' ' A' ' 67' ' ' LYS . 13.0 m -158.2 -160.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.343 -0.848 . . . . 0.0 109.685 -177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD2' ' HG3' ' A' ' 36' ' ' LYS . 2.4 t80 -141.32 139.1 33.53 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.473 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.669 ' HB1' ' N ' ' A' ' 34' ' ' PHE . . . -132.98 -113.08 0.22 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.374 -0.829 . . . . 0.0 109.508 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -30.6 8.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.125 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -143.18 12.82 1.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.652 -0.655 . . . . 0.0 109.51 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.642 ' HZ3' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -111.16 87.71 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.525 -0.735 . . . . 0.0 110.03 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 69' ' ' PHE . 1.5 mt -93.57 63.21 3.42 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.657 -0.652 . . . . 0.0 109.773 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.608 ' CE2' ' HA ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.62 -118.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 110.573 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.553 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 48.0 ttp85 -123.76 146.08 48.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.402 -1.436 . . . . 0.0 112.807 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.642 ' HB2' ' HZ3' ' A' ' 67' ' ' LYS . . . -109.48 106.56 16.36 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 6.1 t70 -84.74 159.88 20.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.102 -0.999 . . . . 0.0 110.753 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.807 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -160.11 119.77 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.503 0.668 . . . . 0.0 109.577 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HB3' ' CB ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -108.75 153.39 23.53 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.027 -1.046 . . . . 0.0 109.528 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 2.5 mt-10 -152.19 104.75 2.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.641 -1.287 . . . . 0.0 112.206 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 3.2 p30 -63.96 170.51 3.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.499 0.666 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.701 ' CE1' HD13 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -149.03 -75.14 0.17 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.563 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 10.9 tttm -117.26 -34.4 4.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.307 -0.871 . . . . 0.0 108.871 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 79' ' ' THR . 4.5 m -87.91 12.32 13.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.483 -0.76 . . . . 0.0 109.159 178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.553 ' NH2' ' HA ' ' A' ' 79' ' ' THR . 0.7 OUTLIER 59.57 55.29 4.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.732 -0.605 . . . . 0.0 111.411 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.624 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -53.71 -102.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 1.7 mtm-85 -155.65 -169.45 3.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.101 -1.235 . . . . 0.0 110.715 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -162.29 82.22 0.54 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.054 HD11 HD11 ' A' ' 26' ' ' ILE . 10.5 tp -171.17 178.72 3.24 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.353 -0.842 . . . . 0.0 109.639 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.974 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -154.58 167.99 28.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 6.5 mtt-85 -139.48 -177.7 5.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.772 -1.205 . . . . 0.0 111.45 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.693 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 11.0 m-85 -156.19 82.89 0.99 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.669 -0.644 . . . . 0.0 109.399 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.608 ' HA ' ' CE2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -161.21 -164.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.615 -1.303 . . . . 0.0 111.371 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.555 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 80.6 53.72 3.95 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 105.113 -3.195 . . . . 0.0 105.113 -177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.2 Cg_endo -60.09 149.67 83.37 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.828 1.962 . . . . 0.0 111.828 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 91' ' ' VAL . 1.6 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.109 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.505 ' CA ' HD12 ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.561 -1.416 . . . . 3.57 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HG2' ' C ' ' A' ' 1' ' ' GLY . 13.6 mm-40 -136.19 135.99 39.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -1.146 . . . . 2.79 110.2 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -115.53 152.59 32.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 3.58 110.202 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 3.8 pt-20 -163.69 134.08 4.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.92 . . . . 2.7 110.177 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' A' ' 42' ' ' MET . 16.7 pt -82.34 175.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.055 -1.028 . . . . 1.36 110.491 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.083 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -112.35 -162.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.251 -0.906 . . . . 2.41 109.881 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.653 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -136.36 50.17 2.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.14 . . . . 2.43 111.515 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 7' ' ' ASP . 11.5 tt 40.18 43.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.936 0.874 . . . . 1.72 110.043 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.445 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.81 -62.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.295 -0.955 . . . . 0.85 110.804 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.9 Cg_endo -86.34 -61.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.503 1.265 . . . . 0.93 110.896 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.083 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.1 m-85 -50.06 -31.89 14.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.993 -1.067 . . . . 1.39 109.387 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.716 HG22 ' CG2' ' A' ' 38' ' ' ILE . 7.2 p -60.2 -58.67 7.53 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.124 -1.436 . . . . 0.89 107.124 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' N ' ' OG1' ' A' ' 12' ' ' THR . 4.9 tt0 -66.73 -19.47 65.76 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.766 0.793 . . . . 2.31 109.18 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 9.9 t-20 -78.19 -56.43 4.47 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.502 0.668 . . . . 1.55 109.547 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 60' ' ' LEU . 7.1 tp -41.55 -66.13 0.37 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.402 0.62 . . . . 2.08 109.357 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -46.67 -43.61 16.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.323 -1.511 . . . . 0.57 109.323 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -69.64 -86.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -1.16 . . . . 2.4 110.939 -179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' GLU . 3.1 m-85 -37.69 -53.71 1.23 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.414 0.626 . . . . 2.25 111.238 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.667 ' HB1' ' CB ' ' A' ' 33' ' ' THR . . . -43.9 -70.06 0.12 Allowed 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.475 -0.766 . . . . 0.55 110.001 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 32' ' ' LEU . 16.2 t -42.77 -26.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.048 -1.032 . . . . 1.4 110.358 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -91.9 -66.28 0.94 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.81 109.896 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.109 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.3 mm-40 -60.16 -41.09 92.06 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.581 -1.247 . . . . 2.17 108.981 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.827 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -61.46 -53.22 59.3 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.68 108.711 178.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.572 ' ND2' ' CB ' ' A' ' 29' ' ' TYR . 27.4 t-20 -61.86 -46.58 88.82 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.687 -1.205 . . . . 2.28 107.824 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -56.92 -48.18 78.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 2.82 109.842 178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.827 HG22 ' O ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -60.85 -20.18 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 119.925 -0.71 . . . . 1.6 109.844 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.67 28.54 1.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.572 -1.411 . . . . 0.99 109.572 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.521 ' CG ' ' OE2' ' A' ' 23' ' ' GLU . 8.6 tp60 -126.77 65.95 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -1.152 . . . . 2.31 110.019 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.572 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 37.4 p90 -88.14 19.15 3.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 5.4 109.961 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -42.52 -62.62 2.13 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 2.26 109.594 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.931 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.9 mtt180 -168.04 -88.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -1.212 . . . . 3.61 109.989 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.931 HD12 ' HB3' ' A' ' 31' ' ' ARG . 2.7 mp -121.83 -177.65 3.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 2.55 110.026 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.667 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -140.44 52.43 1.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.298 -0.876 . . . . 0.93 109.848 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 32' ' ' LEU . 38.4 p90 -167.86 129.08 1.44 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.371 -0.83 . . . . 3.44 110.036 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB2' ' N ' ' A' ' 65' ' ' SER . 7.7 t30 -153.67 -64.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 2.46 110.678 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.98 -94.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.964 . . . . 3.44 111.329 -179.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.4 t -157.97 172.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.693 -1.254 . . . . 1.1 111.822 -178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.716 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -129.22 86.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.201 -0.666 . . . . 1.64 109.201 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.54 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -102.73 -52.14 0.14 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.12 -0.987 . . . . 3.02 110.533 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.3 Cg_endo -85.59 52.8 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.53 1.279 . . . . 0.57 110.789 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.827 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.5 p -104.2 120.39 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.282 -0.886 . . . . 1.62 109.781 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.854 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.7 mtm -119.04 178.02 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 2.06 110.631 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -138.61 151.58 47.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 1.61 110.461 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' N ' ' HG2' ' A' ' 43' ' ' LYS . 1.9 mttt -148.39 106.21 3.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.362 -0.837 . . . . 2.48 109.889 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.831 HG22 ' H ' ' A' ' 47' ' ' TYR . 2.6 m -112.8 152.55 29.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.62 110.173 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -120.36 41.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.769 -1.567 . . . . 1.96 106.769 178.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.831 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -81.88 -153.09 0.1 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.402 1.096 . . . . 2.83 112.462 -177.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.576 ' OE2' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -68.84 -164.52 0.05 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.38 1.086 . . . . 3.65 112.84 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.511 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 13.1 t30 -126.91 -41.12 1.83 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.893 -1.151 . . . . 4.09 107.893 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 16.4 tt0 -175.28 28.63 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.84 -0.538 . . . . 4.24 109.637 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -171.05 -24.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.927 -1.108 . . . . 5.16 112.62 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 22.9 pm0 -115.07 -146.23 0.4 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.272 -1.518 . . . . 2.88 111.61 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.11 HD11 ' CE1' ' A' ' 77' ' ' TYR . 10.7 tt -169.42 143.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 109.633 -0.506 . . . . 1.99 109.633 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -139.52 -73.88 0.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.647 -1.221 . . . . 2.88 112.752 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.803 ' O ' HG23 ' A' ' 45' ' ' THR . . . -149.57 173.67 29.3 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.263 -1.923 . . . . 0.6 110.172 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.558 ' CZ ' ' HE3' ' A' ' 43' ' ' LYS . 7.5 t80 -150.53 98.31 2.62 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.29 -1.124 . . . . 3.83 110.87 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' CB ' ' HA ' ' A' ' 74' ' ' SER . 15.8 pt-20 -120.0 174.01 6.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 2.53 108.914 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 1.107 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -159.6 177.64 10.69 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 117.952 -1.499 . . . . 1.79 113.45 -179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -135.45 117.24 15.09 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.589 -1.263 . . . . 2.14 107.589 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.827 HD12 ' HB2' ' A' ' 41' ' ' CYS . 2.2 tp -116.0 72.41 0.81 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.054 -1.029 . . . . 0.7 109.513 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.061 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -69.63 111.74 5.64 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.117 -1.068 . . . . 1.61 108.117 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.697 HG23 ' CD ' ' A' ' 67' ' ' LYS . 34.6 m -158.13 -158.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-O 121.789 0.804 . . . . 0.42 109.813 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.632 ' CD2' ' CD ' ' A' ' 36' ' ' LYS . 2.0 t80 -143.61 126.21 15.95 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.699 -0.626 . . . . 1.26 109.535 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -121.44 -136.45 0.32 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.393 -0.817 . . . . 0.75 109.884 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.54 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -87.34 -25.73 23.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.925 . . . . 1.39 108.964 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.98 15.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.568 -0.708 . . . . 1.78 109.567 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.912 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -118.29 79.2 1.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.36 110.11 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mp -89.73 57.67 3.98 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.622 -0.881 . . . . 1.75 108.622 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -173.09 -121.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.074 -1.05 . . . . 1.85 110.023 -178.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.54 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 30.5 ttm180 -133.84 124.76 27.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.325 -1.484 . . . . 1.91 112.215 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.912 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -81.79 103.35 11.4 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.984 -1.487 . . . . 0.47 106.984 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -88.45 156.04 19.33 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.179 -0.951 . . . . 1.75 110.15 -178.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.107 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -159.22 141.74 5.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.513 -0.742 . . . . 1.17 109.863 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.876 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -127.96 153.32 46.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.238 -0.914 . . . . 1.23 109.049 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -157.67 106.42 2.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.635 -1.291 . . . . 2.3 111.772 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 1.4 p30 -48.79 -175.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.502 0.667 . . . . 1.74 111.224 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 1.11 ' CE1' HD11 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.31 -38.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 3.14 109.487 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.053 ' HB2' HG23 ' A' ' 53' ' ' ILE . 1.5 ttpt -150.55 -42.92 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.939 -0.763 . . . . 4.09 108.939 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -90.98 18.02 7.2 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.816 -0.809 . . . . 3.55 108.816 178.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' N ' ' CD ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER 58.43 52.33 7.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.722 -0.611 . . . . 6.16 110.823 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.585 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -44.72 -93.06 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.215 -1.554 . . . . 2.44 109.215 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -161.33 -167.44 1.76 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.169 -1.194 . . . . 5.02 110.796 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -165.25 86.31 0.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.395 -0.965 . . . . 3.45 108.395 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.643 HD11 HG12 ' A' ' 26' ' ' ILE . 10.0 tp -171.25 179.74 2.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.318 -0.864 . . . . 2.42 109.338 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.109 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -155.65 172.28 18.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.103 -0.998 . . . . 1.22 110.094 179.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.533 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 3.9 mtt180 -142.33 -176.67 4.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -0.894 . . . . 2.62 110.905 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 48.5 m-85 -154.93 64.63 0.65 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.954 -0.758 . . . . 0.74 108.954 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.0 m-80 -153.87 -157.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 1.93 111.26 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.585 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.46 52.5 30.33 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 105.193 -3.163 . . . . 1.21 105.193 -177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.4 Cg_endo -67.55 -175.03 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.582 1.833 . . . . 2.14 111.933 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.061 HG12 ' OH ' ' A' ' 61' ' ' TYR . 31.1 m . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 117.966 -1.016 . . . . 2.25 110.387 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.63 ' CA ' ' CE1' ' A' ' 47' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 45' ' ' THR . 6.2 mt-10 63.05 -121.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -1.157 . . . . 0.0 109.823 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.512 ' HA ' ' CG ' ' A' ' 44' ' ' LYS . 51.2 p-90 -118.59 169.98 9.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.807 -1.183 . . . . 0.0 110.036 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 1.4 tt0 175.79 115.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.954 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 42' ' ' MET . 15.2 pt -82.77 -176.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 110.204 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.742 HG21 ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -116.39 -165.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.089 -1.007 . . . . 0.0 110.543 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.658 ' O ' HG22 ' A' ' 8' ' ' ILE . 25.3 m-20 -136.66 49.99 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.945 -1.097 . . . . 0.0 111.461 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 12' ' ' THR . 19.5 tt 39.7 42.83 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -145.47 -68.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.975 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 43.8 Cg_endo -73.77 -84.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.689 1.363 . . . . 0.0 111.392 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' A' ' 14' ' ' ASN . 24.7 m-85 -39.68 -31.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.856 . . . . 0.0 111.012 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.029 HG22 HD12 ' A' ' 38' ' ' ILE . 11.7 p -55.97 -56.89 15.28 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.85 -1.156 . . . . 0.0 108.21 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.516 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -57.34 -17.83 14.24 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.41 179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.57 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -79.86 -60.56 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.576 -0.702 . . . . 0.0 110.067 179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 12' ' ' THR . 1.2 pp -41.57 -30.68 0.22 Allowed 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.66 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.41 -49.28 20.52 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' PHE . 10.4 tptt -71.62 -69.36 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -1.05 . . . . 0.0 110.21 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 17' ' ' LYS . 1.9 m-85 -39.75 -62.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.483 0.659 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -43.12 -72.45 0.06 Allowed 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.599 -0.688 . . . . 0.0 109.694 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 15.7 t -38.52 -26.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.756 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 19' ' ' ALA . 9.4 m-20 -95.09 -70.73 0.7 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.963 -1.085 . . . . 0.0 110.26 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.822 ' CD ' HD11 ' A' ' 73' ' ' ILE . 1.8 mt-10 -57.96 -26.87 62.85 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.579 -1.249 . . . . 0.0 109.062 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.774 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.9 tt0 -74.34 -58.91 2.99 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 28' ' ' GLN . 1.7 m-80 -56.81 -44.73 82.26 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.308 -1.357 . . . . 0.0 107.461 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.94 -52.68 63.28 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.793 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 85' ' ' LEU . 7.3 tp -63.68 -12.87 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.264 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.64 59.48 0.43 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.516 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -159.12 80.29 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 109.991 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.446 ' O ' ' C ' ' A' ' 30' ' ' GLY . 51.7 p90 -103.73 28.07 6.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.932 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -41.56 -53.41 4.32 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.959 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER 173.02 -69.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.145 -1.209 . . . . 0.0 110.427 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.959 HD23 ' HB3' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -135.2 164.76 26.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.324 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -135.13 55.27 1.9 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.584 ' CG ' ' O ' ' A' ' 34' ' ' PHE . 11.3 p90 -174.4 60.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.283 -0.886 . . . . 0.0 110.262 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.637 ' OD1' HD11 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -90.1 -56.05 3.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.787 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -69.63 -106.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.079 . . . . 0.0 111.115 -178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.1 t -160.03 173.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.732 -1.23 . . . . 0.0 111.431 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.029 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -120.53 118.07 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.498 -0.751 . . . . 0.0 110.162 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.607 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -123.49 -56.87 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.543 -0.723 . . . . 0.0 109.896 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 43.4 Cg_endo -87.33 48.89 1.77 Allowed 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.212 1.111 . . . . 0.0 110.354 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.742 ' SG ' HG21 ' A' ' 6' ' ' ILE . 2.7 t -91.27 128.81 37.24 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.537 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 5' ' ' ILE . 14.2 mtm -122.96 162.98 21.26 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -145.19 115.87 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.481 -0.762 . . . . 0.0 109.237 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' CG ' ' HA ' ' A' ' 3' ' ' TRP . 1.3 mttp -124.93 152.12 44.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.034 -1.041 . . . . 0.0 110.313 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.859 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.3 m -147.41 152.51 38.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -122.81 41.29 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.796 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -83.07 -143.35 0.07 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.929 0.871 . . . . 0.0 111.704 -178.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HB3' ' O ' ' A' ' 52' ' ' GLU . 3.0 pt-20 -65.96 -163.97 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.221 1.01 . . . . 0.0 112.62 -178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 2.1 p-10 -159.89 -46.35 0.05 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -115.66 -36.54 4.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.855 -0.528 . . . . 0.0 111.029 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -171.89 20.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.721 -1.237 . . . . 0.0 112.344 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 7.5 pt-20 -117.53 -142.16 0.37 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.748 -1.22 . . . . 0.0 110.583 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.793 HG23 ' HB2' ' A' ' 78' ' ' LYS . 7.7 tp -172.52 156.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 2.7 mttt -153.28 -73.01 0.13 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.081 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 45' ' ' THR . . . -149.42 175.21 28.71 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 118.612 -1.756 . . . . 0.0 110.224 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -155.37 104.37 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 110.113 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' ' O ' ' A' ' 44' ' ' LYS . 2.1 pt-20 -105.15 152.31 22.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CB ' HG22 ' A' ' 73' ' ' ILE . 13.5 t80 -128.27 148.74 50.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.644 -1.285 . . . . 0.0 112.673 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.489 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 21.9 mt-30 -134.41 109.9 9.07 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -116.0 71.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -0.997 . . . . 0.0 109.973 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' C ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -72.98 108.44 5.89 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.684 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 61' ' ' TYR . 33.6 m -159.86 -159.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.593 -0.692 . . . . 0.0 109.371 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.606 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 3.6 t80 -135.69 142.07 45.04 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.527 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -137.08 -118.99 0.15 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.38 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 t -99.42 -28.97 13.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.018 -1.051 . . . . 0.0 109.222 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -148.99 18.28 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.736 0.779 . . . . 0.0 109.143 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.64 ' NZ ' HD13 ' A' ' 15' ' ' LEU . 7.0 ttmt -109.18 79.15 1.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.511 0.672 . . . . 0.0 110.104 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 68' ' ' LEU . 5.7 mp -85.89 57.59 4.56 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 109.263 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.619 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.52 -124.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 7.6 ttm180 -127.19 144.42 51.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.199 -1.563 . . . . 0.0 113.486 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 70' ' ' ARG . . . -112.39 111.59 22.55 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' HB3' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -99.04 170.06 8.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.774 -1.204 . . . . 0.0 110.369 -177.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.85 HD12 ' O ' ' A' ' 84' ' ' LEU . 3.1 tp -151.62 113.28 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.768 0.794 . . . . 0.0 109.237 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 21.9 t -97.85 151.45 20.21 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.971 -1.08 . . . . 0.0 109.5 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -148.8 110.08 4.4 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.863 -1.135 . . . . 0.0 112.387 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -54.0 156.88 2.73 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.417 -0.802 . . . . 0.0 111.218 179.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.602 ' CD1' HG12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.13 -68.86 0.23 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.114 -0.991 . . . . 0.0 108.801 178.036 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.793 ' HB2' HG23 ' A' ' 53' ' ' ILE . 39.0 tttm -124.9 -37.2 2.48 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.1 t -75.69 -2.84 31.46 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' GLY . 5.7 mmm180 73.62 46.03 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.094 0.473 . . . . 0.0 111.206 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -63.4 -130.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.684 ' NH1' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -174.04 174.16 3.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.419 -1.636 . . . . 0.0 111.518 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 74' ' ' SER . 11.8 tttt -103.08 125.63 49.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.85 ' O ' HD12 ' A' ' 73' ' ' ILE . 4.7 tp -171.18 -170.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.969 -1.082 . . . . 0.0 110.037 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -171.21 -179.96 2.83 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.229 -0.92 . . . . 0.0 110.695 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' ' HB3' ' A' ' 72' ' ' ASP . 5.8 ptm85 -170.25 112.8 0.45 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 111.125 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.72 ' HE2' HG21 ' A' ' 26' ' ' ILE . 6.8 m-85 -90.85 86.66 6.37 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.525 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.619 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -160.78 -171.34 3.07 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.818 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 69' ' ' PHE . . . 91.9 59.65 1.31 Allowed Glycine 0 N--CA 1.481 1.641 0 N-CA-C 104.748 -3.341 . . . . 0.0 104.748 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 37.1 Cg_endo -59.43 125.16 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.502 1.791 . . . . 0.0 112.116 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' HB ' ' OH ' ' A' ' 61' ' ' TYR . 2.6 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.211 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.46 162.46 18.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -1.144 . . . . 0.0 110.206 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.524 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 29.6 p90 -154.22 146.85 24.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 0.0 110.285 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 3' ' ' TRP . 48.4 mt-10 -157.6 -174.54 4.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' CG1' HD13 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -121.85 171.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 110.035 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.941 HG13 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -81.1 -164.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.329 -179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.1 t0 -147.43 46.7 1.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.439 -0.788 . . . . 0.0 110.658 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 7' ' ' ASP . 2.9 tt 39.88 40.96 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.657 0.741 . . . . 0.0 109.84 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.459 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -146.54 -61.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.628 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.4 Cg_endo -83.87 -77.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.574 1.302 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.737 ' CG ' HG22 ' A' ' 6' ' ' ILE . 86.1 m-85 -39.89 -35.13 0.32 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 110.284 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 1.06 HG22 HD12 ' A' ' 38' ' ' ILE . 9.7 p -61.61 -59.95 4.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' N ' ' OG1' ' A' ' 12' ' ' THR . 35.5 tt0 -66.73 -15.27 63.42 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.52 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.567 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 43.8 m-20 -78.4 -57.72 3.63 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.548 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -42.31 -50.73 4.98 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 1.021 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -51.64 -56.34 16.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -67.4 -77.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -1.081 . . . . 0.0 110.696 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 14' ' ' ASN . 16.8 m-30 -33.69 -63.99 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.569 0.699 . . . . 0.0 111.355 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 33' ' ' THR . . . -42.2 -71.89 0.07 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.274 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 12.5 t -39.86 -27.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.161 -0.962 . . . . 0.0 110.442 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' ' 24' ' ' ASN . 1.6 t70 -92.3 -71.0 0.67 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 2.8 pt-20 -54.35 -29.01 46.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.782 -1.199 . . . . 0.0 109.38 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.792 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -72.53 -60.18 2.36 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -59.3 -39.14 82.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.306 -1.358 . . . . 0.0 107.916 178.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -60.46 -48.94 79.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.507 -0.745 . . . . 0.0 109.792 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 85' ' ' LEU . 0.1 OUTLIER -64.37 -32.74 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.417 -0.802 . . . . 0.0 110.606 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.41 42.15 0.07 OUTLIER Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.493 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -149.67 79.49 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -1.073 . . . . 0.0 108.889 179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' O ' ' N ' ' A' ' 31' ' ' ARG . 20.3 p90 -83.27 17.74 1.98 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 110.811 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 31' ' ' ARG . . . -43.1 -25.71 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.846 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER 76.84 -4.93 2.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.722 -0.87 . . . . 0.0 110.21 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 31' ' ' ARG . 15.2 mt -121.08 130.04 53.59 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.755 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -163.44 42.79 0.11 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.552 0.692 . . . . 0.0 109.789 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' O ' ' A' ' 34' ' ' PHE . 31.0 p90 -174.42 99.23 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.687 -0.633 . . . . 0.0 109.895 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.8 t-20 -141.58 -52.42 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.903 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -70.51 -98.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.0 111.494 -178.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.62 HG13 ' N ' ' A' ' 38' ' ' ILE . 1.1 t -161.83 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.798 -1.189 . . . . 0.0 111.051 -178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.06 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -140.59 123.96 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.565 0.698 . . . . 0.0 109.709 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.558 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 mtt180 -140.7 -56.59 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.427 -0.796 . . . . 0.0 111.08 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 40.6 Cg_endo -83.52 42.48 1.25 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.17 1.089 . . . . 0.0 111.712 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 38' ' ' ILE . 20.5 p -103.22 129.62 50.21 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.09 -1.006 . . . . 0.0 109.333 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 0.9 OUTLIER -121.74 163.22 19.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.944 -1.097 . . . . 0.0 111.035 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -117.89 155.19 30.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.752 . . . . 0.0 109.958 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' CB ' ' A' ' 3' ' ' TRP . 27.0 mttt -159.79 118.64 2.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.34 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.947 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.8 m -119.72 148.83 42.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 110.241 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -109.02 48.94 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.753 ' HD2' HD12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -107.42 169.55 8.51 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.486 -0.759 . . . . 0.0 110.884 -178.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' HB2' ' CG ' ' A' ' 52' ' ' GLU . 2.8 tp10 -74.33 -102.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 109.802 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.509 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.2 OUTLIER 179.64 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.016 . . . . 0.0 110.288 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -149.23 12.05 0.82 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.375 -0.828 . . . . 0.0 109.864 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.44 -25.01 4.85 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.592 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 48' ' ' GLU . 12.1 pt-20 -170.11 179.94 3.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.92 . . . . 0.0 110.956 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.753 HD12 ' HD2' ' A' ' 47' ' ' TYR . 1.8 tp -138.3 116.07 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.444 -0.785 . . . . 0.0 109.353 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -94.72 -71.6 0.66 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.075 -1.015 . . . . 0.0 112.157 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.947 ' O ' HG23 ' A' ' 45' ' ' THR . . . -149.3 -176.62 22.7 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.481 -1.819 . . . . 0.0 111.008 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CD1' ' OG1' ' A' ' 45' ' ' THR . 0.8 OUTLIER -162.44 107.68 1.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.682 -0.893 . . . . 0.0 109.936 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.1 pp20? -126.87 177.26 6.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.444 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.817 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -161.96 171.89 16.89 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.216 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.501 ' CB ' ' HD3' ' A' ' 70' ' ' ARG . 26.8 mt-30 -130.28 125.29 34.41 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' ' CE2' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -121.49 75.11 1.16 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.842 -1.161 . . . . 0.0 109.738 -178.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' C ' HG13 ' A' ' 62' ' ' VAL . 2.1 t80 -74.11 111.04 8.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.141 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.627 ' CG2' ' HE3' ' A' ' 67' ' ' LYS . 17.7 m -159.0 -154.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.784 0.802 . . . . 0.0 109.068 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 1.061 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.8 t80 -139.68 134.81 32.48 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.299 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 67' ' ' LYS . . . -130.16 -126.65 0.21 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.361 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -103.14 -34.12 8.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.082 -1.011 . . . . 0.0 110.113 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.1 p-10 -132.65 0.83 3.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.0 110.218 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HZ2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -114.38 104.09 11.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.845 . . . . 0.0 109.622 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.061 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 10.2 mt -100.58 66.61 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.461 -0.774 . . . . 0.0 109.852 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 167.68 -117.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.283 -179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 31.4 ttm180 -121.26 148.09 44.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.127 -1.608 . . . . 0.0 112.909 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.756 ' HB2' ' HZ2' ' A' ' 67' ' ' LYS . . . -113.93 107.52 15.81 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 13.8 t70 -88.57 165.92 14.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.957 -1.089 . . . . 0.0 110.639 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.817 HG22 ' CD1' ' A' ' 58' ' ' TYR . 3.2 tp -165.29 112.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.639 0.733 . . . . 0.0 109.301 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.5 p -108.76 162.44 14.17 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.029 -1.044 . . . . 0.0 109.652 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -170.12 117.72 0.56 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.451 -0.781 . . . . 0.0 109.792 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -58.33 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.443 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.625 ' CG ' ' CG1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -167.81 -59.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.931 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -54.22 -46.62 72.57 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -107.35 -8.39 16.35 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' CD ' ' O ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER 56.41 31.68 19.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.572 -0.705 . . . . 0.0 110.324 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' ARG . . . -126.42 80.66 0.36 Allowed Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.23 -1.462 . . . . 0.0 111.548 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.593 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 21.3 mtt180 -170.09 78.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.924 . . . . 0.0 108.644 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.4 OUTLIER -100.65 146.98 26.5 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.222 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 5.0 tp -170.47 123.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -125.16 167.85 14.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.874 . . . . 0.0 110.211 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 85' ' ' LEU . 60.1 mtm180 -157.88 119.26 3.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.964 -1.085 . . . . 0.0 111.993 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CZ ' ' CD1' ' A' ' 85' ' ' LEU . 12.8 m-85 -107.43 71.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.64 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -153.71 -161.81 1.33 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.384 -1.326 . . . . 0.0 111.406 -179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.583 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 76.44 52.0 6.32 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 105.345 -3.102 . . . . 0.0 105.345 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 37.4 Cg_endo -61.03 158.21 35.37 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.807 1.951 . . . . 0.0 112.08 -176.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 91' ' ' VAL . 3.0 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.282 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' OE2' ' CD1' ' A' ' 47' ' ' TYR . 4.7 pm0 -148.71 176.57 10.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -1.158 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.549 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 26.4 p-90 -143.02 149.57 38.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 34.8 mt-10 -152.77 136.73 16.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 110.656 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -79.28 -174.86 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 110.664 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CG2' ' CG ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -114.2 -167.96 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.341 -0.849 . . . . 0.0 110.297 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 8' ' ' ILE . 33.9 t70 -137.12 49.27 2.04 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 0.0 111.16 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.715 ' C ' HG21 ' A' ' 12' ' ' THR . 17.8 tt 38.74 33.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.615 0.722 . . . . 0.0 109.911 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -138.11 -59.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.692 -1.242 . . . . 0.0 111.686 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 44.1 Cg_endo -84.88 -56.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.511 1.269 . . . . 0.0 111.57 -177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.661 ' CG ' ' CG2' ' A' ' 6' ' ' ILE . 9.2 m-85 -61.78 -27.21 68.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.959 -1.088 . . . . 0.0 109.695 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.982 HG22 HD12 ' A' ' 38' ' ' ILE . 10.8 p -65.44 -59.85 3.57 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.206 -0.934 . . . . 0.0 108.789 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 44.6 tt0 -59.67 -20.38 55.8 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.763 0.792 . . . . 0.0 109.175 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -71.26 -56.22 6.48 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.748 0.785 . . . . 0.0 109.248 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.023 HD12 HD21 ' A' ' 60' ' ' LEU . 5.7 tt -43.1 -64.25 0.67 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 15' ' ' LEU . . . -41.11 -44.67 3.75 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.82 -79.78 0.17 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -1.167 . . . . 0.0 110.643 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 17' ' ' LYS . 3.1 m-85 -36.99 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.423 0.63 . . . . 0.0 111.086 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' CB ' ' A' ' 23' ' ' GLU . . . -77.4 -74.69 0.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.28 -0.887 . . . . 0.0 109.629 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 14.1 t -36.74 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.618 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' ALA . 34.9 t70 -93.05 -79.28 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.964 -1.085 . . . . 0.0 110.034 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.058 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.5 mt-10 -49.36 -25.8 2.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.016 -1.052 . . . . 0.0 109.805 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 33' ' ' THR . 11.6 tt0 -77.52 -63.18 1.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 29' ' ' TYR . 4.3 m120 -49.53 -48.43 48.3 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -55.01 -51.55 65.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.824 HG13 HD23 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -49.95 -25.13 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.442 179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.85 21.7 5.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.508 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -113.44 62.12 0.65 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.428 -1.042 . . . . 0.0 109.657 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 34.4 p90 -88.8 22.7 2.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.865 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 29' ' ' TYR . . . -36.67 -49.56 1.37 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.903 ' HB3' HD12 ' A' ' 32' ' ' LEU . 3.2 mtp180 -178.52 -83.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -1.214 . . . . 0.0 110.408 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' A' ' 31' ' ' ARG . 1.7 mp -123.47 -179.44 4.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.19 -0.944 . . . . 0.0 110.524 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -161.24 54.02 0.28 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.619 -0.675 . . . . 0.0 109.577 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 34' ' ' PHE . 2.6 p90 -161.53 32.56 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.188 -0.945 . . . . 0.0 111.413 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -18.04 20.83 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.802 -1.186 . . . . 0.0 109.09 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.759 ' HB3' ' CA ' ' A' ' 64' ' ' ALA 0.357 0.0 OUTLIER -66.55 -141.24 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 117.943 2.572 . . . . 0.0 117.943 -178.124 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.638 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -161.12 -176.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 113.877 -1.511 . . . . 0.0 106.963 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.982 HD12 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -151.61 121.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.379 -1.451 . . . . 0.0 110.96 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.602 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -125.78 -57.16 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.721 . . . . 0.0 110.126 179.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.8 Cg_endo -85.31 47.81 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 O-C-N 123.203 1.107 . . . . 0.0 110.89 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.749 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -85.38 129.77 34.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.867 . . . . 0.0 109.525 178.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 5' ' ' ILE . 41.3 mtm -133.31 161.95 33.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.882 -1.136 . . . . 0.0 110.785 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 10.4 ttpt -129.12 156.31 44.09 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.919 -1.113 . . . . 0.0 110.133 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' CG ' ' HB3' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -159.17 113.67 2.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.112 -0.993 . . . . 0.0 110.571 -179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 55' ' ' GLY . 18.3 m -122.13 154.27 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.481 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -122.76 64.3 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.595 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 32.1 p90 -101.96 -179.31 3.97 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.688 0.756 . . . . 0.0 111.67 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' CB ' ' HG2' ' A' ' 52' ' ' GLU . 46.1 tp10 -68.94 -97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.649 -0.657 . . . . 0.0 109.974 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -162.22 -61.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.984 -1.073 . . . . 0.0 110.786 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.34 14.61 0.69 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.427 -0.795 . . . . 0.0 109.52 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -22.95 5.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.5 -0.75 . . . . 0.0 109.665 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.548 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 6.6 pt-20 -163.97 169.05 18.56 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.404 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.619 HG21 ' CE2' ' A' ' 77' ' ' TYR . 18.0 mm -122.6 134.53 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.447 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.692 ' CG ' HG23 ' A' ' 79' ' ' THR . 0.0 OUTLIER -105.58 -57.24 2.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.096 -1.002 . . . . 0.0 112.203 -178.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.739 ' O ' HG23 ' A' ' 45' ' ' THR . . . -147.43 130.23 3.48 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.843 -1.646 . . . . 0.0 110.003 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -120.77 100.4 7.08 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.403 -1.057 . . . . 0.0 110.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 50.9 tt0 -123.05 173.83 7.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.352 -0.843 . . . . 0.0 109.225 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.693 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.36 173.37 14.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.081 -1.447 . . . . 0.0 113.179 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 2.6 pt20 -128.7 124.27 35.23 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.023 HD21 HD12 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.11 72.58 0.87 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.06 -1.025 . . . . 0.0 108.593 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.625 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -71.56 106.42 4.0 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.021 -0.671 . . . . 0.0 109.567 -178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.713 HG23 ' HE2' ' A' ' 67' ' ' LYS . 17.8 m -163.52 -144.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.767 ' CD1' HD22 ' A' ' 68' ' ' LEU . 22.7 t80 -135.03 161.57 34.91 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -136.56 -140.31 0.16 Allowed 'General case' 0 N--CA 1.513 2.725 0 CA-C-N 118.946 0.794 . . . . 0.0 108.924 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.548 ' CB ' ' HA ' ' A' ' 33' ' ' THR . 24.3 t -86.91 -1.62 57.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 177.66 33.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.592 -0.693 . . . . 0.0 109.72 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.807 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -129.98 93.87 3.59 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.836 . . . . 0.0 109.701 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.767 HD22 ' CD1' ' A' ' 63' ' ' TYR . 1.4 mm? -88.46 74.8 8.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.198 -0.939 . . . . 0.0 110.636 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER 171.52 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.571 -1.33 . . . . 0.0 110.59 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 59' ' ' GLN . 34.2 ttm180 -139.12 147.69 42.25 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.56 -1.338 . . . . 0.0 112.598 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -107.57 103.07 12.3 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 176.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -83.99 161.34 20.79 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.088 -1.008 . . . . 0.0 110.197 -178.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.693 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -163.01 108.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 CA-C-O 121.939 0.875 . . . . 0.0 109.9 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 83' ' ' LYS . 1.3 t -107.26 156.35 18.96 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 108.633 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 29.9 mt-10 -155.07 104.57 2.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.569 -1.332 . . . . 0.0 112.13 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.557 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 1.6 p30 -40.05 162.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.488 -0.758 . . . . 0.0 111.091 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CE2' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -148.86 -75.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 178.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 31.8 tptt -115.88 -35.04 4.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.129 -0.982 . . . . 0.0 108.988 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.692 HG23 ' CG ' ' A' ' 54' ' ' LYS . 1.2 p -86.13 7.29 25.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 0.0 109.237 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER 66.45 51.7 1.14 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.623 -0.673 . . . . 0.0 111.013 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -60.46 -117.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 10.7 ptm85 -173.52 158.09 3.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.422 -1.634 . . . . 0.0 112.133 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -103.33 118.23 36.3 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -171.09 146.58 2.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.051 -1.031 . . . . 0.0 110.304 -179.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.058 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -137.62 158.34 44.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.9 . . . . 0.0 109.59 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -142.8 147.71 35.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.947 -1.096 . . . . 0.0 111.009 -179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.94 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 8.9 m-85 -119.55 85.56 2.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.5 -0.75 . . . . 0.0 109.348 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -168.94 -167.67 0.77 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.635 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 85.96 56.41 2.33 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 104.964 -3.254 . . . . 0.0 104.964 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 38.0 Cg_endo -61.87 151.37 81.47 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.508 1.794 . . . . 0.0 111.689 -176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.625 HG12 ' OH ' ' A' ' 61' ' ' TYR . 22.5 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.367 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 67.4 mm-40 -110.78 147.2 34.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.274 -1.133 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 66.2 p-90 -137.2 161.0 37.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.873 . . . . 0.0 110.218 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.536 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 1.6 pm0 -172.47 173.03 4.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.724 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.7 173.94 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.09 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.17 -153.59 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.532 -0.73 . . . . 0.0 109.717 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -141.04 48.06 1.7 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.865 -1.147 . . . . 0.0 111.439 -179.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.8 ' C ' HG21 ' A' ' 12' ' ' THR . 15.6 pt 40.17 36.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.932 0.873 . . . . 0.0 109.883 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -132.51 -59.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.954 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 6' ' ' ILE . 43.8 Cg_endo -85.73 -66.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.596 1.314 . . . . 0.0 110.947 -178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.705 ' CE2' ' CE1' ' A' ' 58' ' ' TYR . 1.1 m-85 -47.42 -32.36 4.96 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.137 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.8 HG21 ' C ' ' A' ' 8' ' ' ILE . 23.6 p -59.9 -57.42 12.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.504 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -62.21 -26.13 68.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.549 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.532 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -76.83 -49.9 14.71 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.481 0.658 . . . . 0.0 109.832 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.772 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.4 tm? -42.94 -63.7 0.75 Allowed 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.392 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.739 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -49.05 -41.84 30.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.583 ' O ' HG12 ' A' ' 20' ' ' VAL . 11.1 tptp -68.99 -68.52 0.39 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.228 -1.16 . . . . 0.0 110.593 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CE2' ' OD1' ' A' ' 14' ' ' ASN . 18.0 m-30 -54.9 -36.11 64.84 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -58.68 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.469 -0.769 . . . . 0.0 109.815 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 17' ' ' LYS . 9.6 p -38.41 -27.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -87.17 -75.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.866 -1.146 . . . . 0.0 110.107 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.053 ' HB2' HD13 ' A' ' 85' ' ' LEU . 5.4 mm-40 -59.47 -36.98 77.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 26' ' ' ILE . 4.0 tt0 -62.62 -49.45 75.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.038 -1.039 . . . . 0.0 109.251 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.628 ' ND2' ' CG ' ' A' ' 29' ' ' TYR . 33.9 t-20 -70.63 -45.33 65.4 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 30.6 mmtt -58.61 -38.68 78.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 110.052 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.3 tp -71.68 -15.69 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.0 110.08 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.53 54.63 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 46.2 tp60 -170.2 88.81 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -1.082 . . . . 0.0 109.661 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.628 ' CG ' ' ND2' ' A' ' 24' ' ' ASN . 35.3 p90 -142.83 51.03 1.43 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.09 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -39.24 -29.4 0.11 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.867 ' HB3' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER 174.15 -67.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -1.152 . . . . 0.0 110.016 179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.867 HD12 ' HB3' ' A' ' 31' ' ' ARG . 2.2 mp -132.62 177.62 7.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 110.126 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.585 ' O ' HD11 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -146.15 53.23 1.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.607 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 22.4 p90 178.98 114.89 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.389 -0.82 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' H ' ' HA ' ' A' ' 64' ' ' ALA . 5.4 t30 -150.28 -48.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.0 110.834 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.727 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 111.197 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 36' ' ' LYS . 17.0 t -158.31 172.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.633 -1.292 . . . . 0.0 111.361 -178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.016 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -133.26 99.94 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.488 -0.757 . . . . 0.0 110.012 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.579 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -107.81 -54.18 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.377 -0.827 . . . . 0.0 110.492 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 39.1 Cg_endo -85.06 50.28 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.491 1.258 . . . . 0.0 111.362 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 38' ' ' ILE . 16.5 p -81.35 137.27 35.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.856 . . . . 0.0 109.578 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' ' O ' ' A' ' 59' ' ' GLN . 6.2 mtp -130.95 169.29 16.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 110.959 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -151.92 138.65 18.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 109.946 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 45' ' ' THR . 8.3 ttmm -137.93 163.47 31.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.679 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.818 HG22 ' H ' ' A' ' 47' ' ' TYR . 5.1 m -163.25 148.67 11.52 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.075 -1.016 . . . . 0.0 110.879 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 25.3 pt -118.87 40.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.818 ' H ' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -75.45 -160.09 0.12 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 122.102 0.953 . . . . 0.0 112.406 -177.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.599 ' HG2' ' N ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.76 -144.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.615 0.721 . . . . 0.0 111.816 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.599 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 0.8 OUTLIER -118.41 -40.82 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 1.2 mt-10 -174.79 26.61 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -157.83 -29.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.05 . . . . 0.0 111.832 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.74 ' O ' HD13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -109.61 -155.34 0.56 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.445 -1.409 . . . . 0.0 111.988 -178.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.789 HG22 ' CG ' ' A' ' 77' ' ' TYR . 37.5 mm -151.92 135.99 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 47' ' ' TYR . 1.7 mptt -130.97 -65.52 0.78 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.849 -1.157 . . . . 0.0 112.044 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.81 ' O ' HG23 ' A' ' 45' ' ' THR . . . -141.04 171.07 24.31 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.064 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.42 97.77 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 110.774 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.498 ' OE1' ' HA ' ' A' ' 45' ' ' THR . 4.3 pm0 -92.86 165.52 12.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.064 -1.022 . . . . 0.0 109.513 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.966 ' OH ' HD13 ' A' ' 60' ' ' LEU . 72.4 t80 -137.09 136.81 38.66 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.164 -0.96 . . . . 0.0 111.283 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.547 ' CA ' ' HD2' ' A' ' 70' ' ' ARG . 18.0 mt-30 -135.15 106.82 6.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.016 HD11 ' CD1' ' A' ' 38' ' ' ILE . 2.9 tp -119.41 80.16 1.53 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.01 -1.056 . . . . 0.0 110.076 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -74.4 110.37 8.64 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.747 HG23 ' CD ' ' A' ' 67' ' ' LYS . 29.3 m -160.33 -158.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.596 0.712 . . . . 0.0 109.656 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CE2' ' HD2' ' A' ' 36' ' ' LYS . 2.4 t80 -140.82 133.99 29.5 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.67 -0.644 . . . . 0.0 109.474 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 34' ' ' PHE . . . -130.16 -124.4 0.21 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.738 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 t -97.73 -17.94 19.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.195 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.41 20.78 0.29 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.54 -0.725 . . . . 0.0 109.792 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.747 ' CD ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -118.61 81.03 1.62 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -0.791 . . . . 0.0 110.188 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.5 mt -84.94 57.6 4.52 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.575 -0.703 . . . . 0.0 109.855 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 0.1 OUTLIER 169.89 -117.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.935 . . . . 0.0 110.368 -179.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' HD2' ' CA ' ' A' ' 59' ' ' GLN . 21.5 ttp180 -122.96 148.26 45.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.158 -1.589 . . . . 0.0 113.122 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' A' ' 58' ' ' TYR . . . -109.94 105.35 14.48 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 66.2 m-20 -85.2 163.69 18.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.804 -1.185 . . . . 0.0 110.718 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 73' ' ' ILE . 0.5 OUTLIER -160.12 103.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -93.71 157.48 16.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.824 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' CA ' ' O ' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -161.46 96.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.867 -1.146 . . . . 0.0 111.465 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 11.6 p-10 -57.21 173.21 0.25 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 111.034 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.789 ' CG ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -157.65 -73.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.485 -0.759 . . . . 0.0 109.312 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 15.8 tptt -119.0 -33.12 4.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.335 -0.853 . . . . 0.0 109.087 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.545 ' CG2' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -89.26 6.46 40.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 109.579 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' THR . 27.5 mmm-85 67.75 52.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.532 -0.73 . . . . 0.0 110.975 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -57.12 -106.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' N ' ' HB3' ' A' ' 76' ' ' ASP . 2.0 mtm180 -170.05 148.68 3.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.886 -1.361 . . . . 0.0 111.131 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.41 95.66 5.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.853 . . . . 0.0 108.796 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -171.37 -167.74 0.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.095 -1.003 . . . . 0.0 109.979 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.053 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -171.25 171.74 5.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.211 -0.93 . . . . 0.0 109.757 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 30.3 mtt180 -144.77 175.41 10.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.002 -1.062 . . . . 0.0 110.986 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.806 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 1.9 m-85 -151.63 69.79 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.519 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -155.06 -156.1 0.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.649 -1.282 . . . . 0.0 111.105 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.536 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 87.68 52.79 2.89 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 106.711 -2.556 . . . . 0.0 106.711 -178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HA ' ' HB3' ' A' ' 69' ' ' PHE . 39.6 Cg_endo -63.9 140.84 75.2 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.236 1.651 . . . . 0.0 111.276 -177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.343 -179.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -86.87 161.78 18.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -1.184 . . . . 0.0 110.262 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 3' ' ' TRP . 5.9 p90 -124.18 170.4 10.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 110.318 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 176.66 111.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.105 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -92.32 178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.379 -0.825 . . . . 0.0 110.594 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.765 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -116.86 -166.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.65 41.46 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.15 . . . . 0.0 111.155 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 39' ' ' ARG . 4.1 mt 57.18 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.02 0.914 . . . . 0.0 110.291 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.487 ' C ' ' HG1' ' A' ' 12' ' ' THR . . . -153.5 -63.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HG2' HG22 ' A' ' 6' ' ' ILE . 44.0 Cg_endo -75.87 -76.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.59 1.31 . . . . 0.0 111.631 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -48.91 -26.65 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.023 -1.048 . . . . 0.0 110.46 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.82 HG22 HG21 ' A' ' 38' ' ' ILE . 26.9 p -57.6 -57.77 11.26 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.943 -1.098 . . . . 0.0 108.26 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.1 mm-40 -63.2 -24.8 68.04 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.77 0.795 . . . . 0.0 109.206 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 15' ' ' LEU . 4.6 t30 -72.14 -56.3 5.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.487 0.66 . . . . 0.0 109.37 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.2 tm? -42.66 -71.72 0.08 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.66 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.672 ' N ' HD13 ' A' ' 15' ' ' LEU . . . -40.73 -37.82 1.4 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.826 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.7 mttp -76.78 -83.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -1.093 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -45.43 -28.33 0.87 Allowed 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.587 -179.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -63.55 -72.23 0.15 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 17' ' ' LYS . 10.4 p -41.72 -25.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -89.52 -70.8 0.64 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.015 -1.053 . . . . 0.0 110.112 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.068 ' CB ' HD13 ' A' ' 85' ' ' LEU . 4.5 mm-40 -59.9 -38.5 82.46 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.718 -1.239 . . . . 0.0 109.324 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.855 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.2 tt0 -63.58 -51.84 63.56 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.315 -0.866 . . . . 0.0 109.235 178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t-20 -67.15 -44.52 79.59 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.163 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -43.11 92.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.42 -0.8 . . . . 0.0 110.092 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -66.6 -21.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.6 36.02 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.529 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 3.0 mm-40 -134.58 71.55 1.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -1.088 . . . . 0.0 109.598 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 24' ' ' ASN . 5.7 t80 -100.66 28.53 5.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.956 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -38.64 -39.55 0.85 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.74 ' HB3' HD12 ' A' ' 32' ' ' LEU . 2.4 mmt180 169.65 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -1.078 . . . . 0.0 110.015 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 31' ' ' ARG . 1.3 mp -120.64 -177.73 3.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.321 -0.862 . . . . 0.0 110.054 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -154.24 49.05 0.62 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.374 -0.829 . . . . 0.0 109.776 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CA ' ' HB1' ' A' ' 64' ' ' ALA . 3.4 t80 179.8 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.547 -0.721 . . . . 0.0 110.228 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -154.22 -48.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.96 . . . . 0.0 110.579 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.701 ' O ' HG23 ' A' ' 37' ' ' VAL . 1.3 mmpt? -69.61 -100.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.2 -0.937 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 36' ' ' LYS . 24.7 t -157.89 171.88 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.605 -1.309 . . . . 0.0 111.669 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.82 HG21 HG22 ' A' ' 12' ' ' THR . 0.2 OUTLIER -135.41 92.93 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.682 -0.636 . . . . 0.0 109.829 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.77 ' HG2' HD11 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -105.1 -53.26 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.635 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 38.5 Cg_endo -84.7 50.78 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.538 1.283 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 38' ' ' ILE . 20.6 p -104.12 118.32 36.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.598 ' HB3' HG22 ' A' ' 5' ' ' ILE . 66.4 mtm -126.66 175.6 7.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.52 ' CB ' ' HB2' ' A' ' 58' ' ' TYR . 10.9 tmtt? -152.71 140.68 20.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.038 -1.039 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 3' ' ' TRP . 13.6 mttt -137.93 121.99 17.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 0.0 109.778 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 55' ' ' GLY . 6.5 m -108.42 154.12 22.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.896 . . . . 0.0 110.746 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 46' ' ' ILE . 3.0 tt -118.68 102.07 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 2' ' ' GLU . 8.7 p90 -110.21 -173.93 2.37 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.281 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.58 ' HB3' ' C ' ' A' ' 52' ' ' GLU . 16.7 pm0 -69.62 -141.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.01 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.551 ' N ' ' HG2' ' A' ' 48' ' ' GLU . 17.8 t30 -141.03 -40.64 0.4 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.741 0.782 . . . . 0.0 109.161 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.4 tm-20 178.72 32.4 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -165.05 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 111.855 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.58 ' C ' ' HB3' ' A' ' 48' ' ' GLU . 24.1 pt-20 -129.09 -152.1 0.5 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.447 -1.408 . . . . 0.0 111.02 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.642 HG22 ' CG ' ' A' ' 77' ' ' TYR . 4.0 mt -160.01 125.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.77 -0.581 . . . . 0.0 109.552 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 18.8 mttm -91.08 -77.5 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.145 -0.972 . . . . 0.0 112.036 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.855 ' O ' HG23 ' A' ' 45' ' ' THR . . . -178.49 179.23 48.71 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.059 -2.019 . . . . 0.0 110.085 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.721 ' CD2' HG21 ' A' ' 45' ' ' THR . 18.4 m-85 -133.25 119.36 19.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.987 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' OE2' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -124.31 163.75 21.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.309 -0.869 . . . . 0.0 109.623 179.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.785 ' HE2' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -157.54 165.89 34.38 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.448 -1.301 . . . . 0.0 112.681 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 5.5 pt20 -124.47 120.41 31.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.785 HD13 ' HE2' ' A' ' 58' ' ' TYR . 2.9 tp -114.43 67.77 0.69 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' C ' HG13 ' A' ' 62' ' ' VAL . 1.7 t80 -68.79 108.65 3.51 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' CD ' ' A' ' 67' ' ' LYS . 27.4 m -159.56 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.596 0.712 . . . . 0.0 109.585 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.598 ' CE2' ' HG3' ' A' ' 36' ' ' LYS . 1.9 t80 -148.46 130.94 15.75 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.951 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.575 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -126.83 -123.74 0.24 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.44 -0.788 . . . . 0.0 109.829 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.0 p -91.53 -32.84 15.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.056 . . . . 0.0 109.551 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.36 14.26 1.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.677 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.674 ' CD ' HG23 ' A' ' 62' ' ' VAL . 4.7 ttmt -107.98 78.06 1.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.491 -0.756 . . . . 0.0 110.075 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -89.94 68.53 7.34 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.624 -0.673 . . . . 0.0 109.287 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CE1' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 173.31 -119.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.28 -0.887 . . . . 0.0 109.863 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 16.4 ttm180 -135.32 124.93 25.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.571 -1.33 . . . . 0.0 111.702 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.44 104.27 12.6 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.6 t70 -89.39 157.1 18.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.109 -0.994 . . . . 0.0 110.167 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.739 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -159.09 117.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 57' ' ' GLU . 2.1 t -116.66 144.98 43.75 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.011 -1.056 . . . . 0.0 111.085 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.8 OUTLIER -129.43 159.85 34.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 39.8 m-20 -128.23 -161.09 1.07 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.068 -1.02 . . . . 0.0 111.732 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' CG ' HG22 ' A' ' 53' ' ' ILE . 5.3 t80 166.06 -52.62 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 11.0 tmtt? -87.37 -47.99 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 79.1 p -69.26 -48.7 61.01 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.639 ' HB3' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 167.38 88.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 176.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 76' ' ' ASP . . . -29.95 109.92 0.03 OUTLIER Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -157.61 175.86 13.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.696 -0.884 . . . . 0.0 108.864 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -130.57 151.77 50.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 2.5 tp -171.32 128.21 0.69 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.197 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.068 HD13 ' CB ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -130.31 171.96 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.981 -1.075 . . . . 0.0 111.099 -179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.552 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -146.45 -179.0 6.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.851 . . . . 0.0 110.564 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 5.2 m-85 -153.44 67.6 0.78 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.528 -0.732 . . . . 0.0 109.199 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.596 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -153.06 -158.7 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.72 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.622 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.06 48.9 44.33 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 105.377 -3.089 . . . . 0.0 105.377 -176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 44.5 Cg_endo -69.03 -173.79 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.446 1.761 . . . . 0.0 111.823 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.585 HG12 ' OH ' ' A' ' 61' ' ' TYR . 27.4 m . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.285 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -176.07 171.67 2.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -1.157 . . . . 0.0 110.335 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 59.0 p-90 -119.35 -176.5 3.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.476 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 43' ' ' LYS . 0.6 OUTLIER 176.33 112.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.389 -0.819 . . . . 0.0 110.105 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.739 HG22 ' SD ' ' A' ' 42' ' ' MET . 1.2 pp -85.68 -179.06 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.313 -0.867 . . . . 0.0 110.638 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.103 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -135.24 -161.3 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 109.989 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.17 -157.11 0.79 Allowed 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.988 -1.07 . . . . 0.0 109.505 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.864 ' C ' HG21 ' A' ' 12' ' ' THR . 0.9 OUTLIER -101.08 36.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.545 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -128.4 -57.42 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.725 -1.226 . . . . 0.0 111.906 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 9' ' ' GLY . 43.6 Cg_endo -82.51 -77.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.369 1.194 . . . . 0.0 111.253 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.103 ' CD1' HG21 ' A' ' 6' ' ' ILE . 2.0 m-85 -43.63 -29.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.937 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.939 HG22 HD12 ' A' ' 38' ' ' ILE . 24.3 p -62.15 -58.91 6.03 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -62.47 -15.54 50.42 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.259 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 1.2 t30 -83.14 -59.13 2.57 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.624 0.726 . . . . 0.0 110.052 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 60' ' ' LEU . 1.3 pp -42.57 -31.54 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.649 -0.657 . . . . 0.0 109.704 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' N ' ' HG ' ' A' ' 15' ' ' LEU . . . -72.96 -56.64 5.7 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -69.63 -67.15 0.5 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -1.142 . . . . 0.0 110.525 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.88 ' CZ ' HD12 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -39.05 -49.27 1.73 Allowed 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.468 0.651 . . . . 0.0 110.424 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.632 ' N ' ' CD1' ' A' ' 18' ' ' PHE . . . -53.74 -77.53 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.834 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' CG ' ' A' ' 24' ' ' ASN . 2.7 t -37.86 -26.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.46 -0.775 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.7 m-20 -89.76 -73.51 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.616 -1.303 . . . . 0.0 110.039 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.112 ' HB2' HD13 ' A' ' 85' ' ' LEU . 1.8 mt-10 -59.13 -32.91 70.29 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.376 -1.329 . . . . 0.0 109.255 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.848 ' O ' HG22 ' A' ' 26' ' ' ILE . 2.3 tt0 -63.69 -56.65 14.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 108.339 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 29' ' ' TYR . 2.3 m120 -62.57 -47.11 85.29 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.757 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -55.92 -41.19 74.19 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.404 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 23' ' ' GLU . 4.9 tp -72.62 -10.91 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.835 . . . . 0.0 110.322 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.47 51.31 1.33 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 23' ' ' GLU . 11.2 tp60 -170.18 90.46 0.18 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.487 -1.008 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 31' ' ' ARG . 1.4 t80 -69.35 -33.79 73.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.883 . . . . 0.0 110.23 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' ARG . . . 41.6 27.12 0.29 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 4.1 mtt180 64.52 -143.76 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 110.323 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.773 ' H ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -86.68 75.32 9.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.33 -0.856 . . . . 0.0 110.831 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -41.86 89.13 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 110.68 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 32' ' ' LEU . 1.6 t80 164.12 115.46 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.55 -0.719 . . . . 0.0 109.203 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -165.34 -59.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.394 -179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.738 ' O ' HG23 ' A' ' 37' ' ' VAL . 3.8 tppp? -69.54 -103.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.982 -1.074 . . . . 0.0 111.139 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 36' ' ' LYS . 15.8 t -158.59 172.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.213 . . . . 0.0 111.524 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.972 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -123.8 117.49 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.521 0.677 . . . . 0.0 109.797 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -124.3 -56.27 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 40.6 Cg_endo -86.61 48.14 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.174 1.091 . . . . 0.0 110.537 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.675 ' C ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -89.18 117.87 28.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.333 -0.854 . . . . 0.0 109.675 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.739 ' SD ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -127.57 179.6 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 110.641 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -158.11 134.77 9.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 109.773 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 2.4 tttt -141.34 122.81 15.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 110.954 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 55' ' ' GLY . 17.9 m -101.65 150.47 23.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.9 . . . . 0.0 109.68 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.738 HG22 ' OE2' ' A' ' 57' ' ' GLU . 0.8 OUTLIER -107.21 45.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.882 ' HD2' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -110.3 169.78 8.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.487 0.66 . . . . 0.0 111.095 -178.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.565 ' CB ' ' HG2' ' A' ' 52' ' ' GLU . 20.5 tp10 -86.44 -89.29 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.559 -0.713 . . . . 0.0 109.792 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 3.2 t-20 -175.99 -52.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.414 -0.804 . . . . 0.0 110.492 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.33 14.09 0.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.839 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -23.8 3.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.363 -0.836 . . . . 0.0 110.109 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.565 ' HG2' ' CB ' ' A' ' 48' ' ' GLU . 7.3 pt-20 -168.45 79.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.028 -1.045 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.882 HG23 ' HD2' ' A' ' 47' ' ' TYR . 2.8 mp -68.97 86.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 O-C-N 121.502 -0.749 . . . . 0.0 109.084 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -56.26 -71.19 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.842 ' O ' HG23 ' A' ' 45' ' ' THR . . . -161.83 162.76 34.3 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.477 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.579 ' HA ' HG23 ' A' ' 45' ' ' THR . 0.3 OUTLIER -123.32 108.3 12.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.545 -0.973 . . . . 0.0 110.028 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.738 ' OE2' HG22 ' A' ' 46' ' ' ILE . 3.0 mp0 -114.73 163.62 15.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.842 . . . . 0.0 108.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.83 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -150.8 163.48 38.51 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 118.133 -1.427 . . . . 0.0 112.916 -179.408 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.554 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 26.8 mt-30 -128.11 121.84 30.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -116.33 69.57 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 0.0 109.355 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.031 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -70.88 109.37 4.99 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.505 -0.747 . . . . 0.0 109.27 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG23 ' CE ' ' A' ' 67' ' ' LYS . 18.3 m -161.51 -163.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.58 -0.7 . . . . 0.0 109.497 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.536 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 2.5 t80 -135.19 138.01 43.23 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.887 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 67' ' ' LYS . . . -135.21 -136.22 0.16 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.421 -0.799 . . . . 0.0 110.102 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.535 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -82.82 -37.61 24.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 0.0 109.801 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -138.15 7.42 2.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.376 -0.828 . . . . 0.0 109.954 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.689 ' CE ' HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -105.44 94.82 5.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.837 0.827 . . . . 0.0 109.737 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' N ' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -101.31 64.53 1.02 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.364 -0.835 . . . . 0.0 108.775 178.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 173.08 -123.57 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.305 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 59' ' ' GLN . 36.8 ttp180 -130.44 122.71 28.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.526 -1.359 . . . . 0.0 111.944 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.823 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -83.01 106.31 14.72 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 22.6 t70 -88.89 170.96 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.762 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.83 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -169.94 119.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.565 -0.709 . . . . 0.0 110.17 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.508 ' OG ' ' CG ' ' A' ' 57' ' ' GLU . 0.3 OUTLIER -110.89 156.71 20.78 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.016 -1.052 . . . . 0.0 109.109 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -148.5 111.81 4.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.489 -1.382 . . . . 0.0 112.138 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.541 ' HB2' ' N ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER -48.66 150.78 1.31 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.476 -0.765 . . . . 0.0 111.216 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CZ ' HG21 ' A' ' 53' ' ' ILE . 1.7 t80 -147.88 -73.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.933 -1.105 . . . . 0.0 109.932 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' ' 53' ' ' ILE . 9.7 tmtt? -109.91 -38.17 5.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.791 -1.193 . . . . 0.0 109.547 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.539 ' OG1' ' CG ' ' A' ' 54' ' ' LYS . 1.2 m -86.23 8.44 21.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.856 . . . . 0.0 108.815 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 65.55 49.27 1.84 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.665 -0.647 . . . . 0.0 111.044 179.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' HB2' ' A' ' 76' ' ' ASP . . . -62.25 -125.26 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 8.0 ptp180 -173.76 168.01 4.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.397 -1.649 . . . . 0.0 111.9 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 74' ' ' SER . 13.7 mtmm -100.36 120.13 39.48 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 1.5 tt -171.9 130.81 0.65 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 0.0 109.829 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.112 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -117.1 168.28 10.42 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 110.0 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 10.8 mtt180 -137.04 -172.07 3.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.488 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 60.1 m-85 -158.32 64.92 0.44 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.559 -0.713 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.597 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.7 OUTLIER -154.31 -160.86 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.728 -1.233 . . . . 0.0 111.71 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.603 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 69.19 50.88 30.7 Favored Glycine 0 N--CA 1.481 1.68 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -177.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 46.7 Cg_endo -67.95 -173.86 0.55 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 124.564 1.823 . . . . 0.0 111.851 -176.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.031 HG12 ' OH ' ' A' ' 61' ' ' TYR . 25.0 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.38 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.501 ' HA2' HG12 ' A' ' 46' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -168.05 157.57 9.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.171 -1.194 . . . . 0.0 110.366 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.52 ' HA ' ' CB ' ' A' ' 44' ' ' LYS . 2.9 p-90 -131.97 170.84 14.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.104 -0.998 . . . . 0.0 110.792 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 43' ' ' LYS . 1.8 tp10 178.67 160.47 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.731 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.603 HD12 ' SD ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -117.67 173.3 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.039 -1.038 . . . . 0.0 110.444 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.082 HG21 ' CD1' ' A' ' 11' ' ' PHE . 1.2 pp -103.84 -160.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.503 -0.748 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.659 ' O ' HG22 ' A' ' 8' ' ' ILE . 12.9 p30 -132.0 56.97 1.8 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.977 -1.077 . . . . 0.0 111.644 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.754 ' C ' HG21 ' A' ' 12' ' ' THR . 14.9 tt 41.14 46.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.974 0.892 . . . . 0.0 109.909 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.524 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.66 -62.51 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HD2' HD13 ' A' ' 6' ' ' ILE . 44.1 Cg_endo -84.01 -68.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.733 1.386 . . . . 0.0 111.062 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.082 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.2 m-85 -44.58 -29.52 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.4 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.754 HG21 ' C ' ' A' ' 8' ' ' ILE . 17.5 p -64.43 -58.77 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.508 ' N ' ' OG1' ' A' ' 12' ' ' THR . 3.8 tt0 -65.74 -26.72 67.86 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.844 0.831 . . . . 0.0 109.052 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.486 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 1.2 t30 -74.12 -55.16 6.42 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.584 0.707 . . . . 0.0 109.495 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.045 HD11 ' HE3' ' A' ' 67' ' ' LYS . 2.7 tt -37.99 -53.9 1.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.394 0.616 . . . . 0.0 109.924 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.874 ' N ' HD23 ' A' ' 15' ' ' LEU . . . -56.04 -46.59 84.4 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 tttp -73.15 -72.46 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -1.185 . . . . 0.0 111.016 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' CD1' ' ND2' ' A' ' 14' ' ' ASN . 0.4 OUTLIER -39.88 -48.08 2.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.593 0.711 . . . . 0.0 110.868 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 33' ' ' THR . . . -55.34 -74.88 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.712 -0.618 . . . . 0.0 110.604 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 17' ' ' LYS . 15.0 m -43.89 -23.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 120.952 -1.092 . . . . 0.0 110.546 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -88.73 -73.78 0.49 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.974 -1.079 . . . . 0.0 110.072 179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.04 ' HB2' HD13 ' A' ' 85' ' ' LEU . 20.6 mm-40 -57.69 -37.53 73.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.693 -1.255 . . . . 0.0 109.232 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -64.71 -50.06 68.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.974 -1.078 . . . . 0.0 109.155 178.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 55.1 t-20 -66.02 -46.53 77.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.573 -1.329 . . . . 0.0 107.739 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 4.2 tttp -59.4 -41.54 89.69 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.032 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 23' ' ' GLU . 5.6 tp -73.77 -12.93 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.05 81.44 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.532 ' CB ' ' HG2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -140.47 -72.86 0.36 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 110.171 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.465 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.26 -23.25 7.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.937 . . . . 0.0 110.138 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.484 ' HA2' ' CB ' ' A' ' 24' ' ' ASN . . . 40.37 28.85 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.981 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.8 mtt-85 -141.91 -68.29 0.38 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -1.197 . . . . 0.0 110.586 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 31' ' ' ARG . 16.6 mt -138.2 160.35 39.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 110.702 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' OE2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -164.13 51.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.781 179.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.568 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -176.19 123.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.363 -0.836 . . . . 0.0 109.833 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB2' ' N ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -158.67 -58.86 0.07 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.042 -1.036 . . . . 0.0 111.318 -179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.772 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.61 -97.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.957 -1.09 . . . . 0.0 111.38 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 36' ' ' LYS . 6.7 t -160.48 173.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.521 -1.362 . . . . 0.0 111.617 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.825 ' CD1' HD11 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -126.79 109.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.7 -0.625 . . . . 0.0 109.795 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -117.24 -59.4 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.999 . . . . 0.0 110.926 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 39' ' ' ARG . 41.6 Cg_endo -83.98 46.84 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.117 1.062 . . . . 0.0 111.119 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' CB ' HD11 ' A' ' 38' ' ' ILE . 18.6 p -88.97 98.0 11.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.368 -0.832 . . . . 0.0 109.509 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.603 ' SD ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -97.52 -177.58 3.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 0.0 111.013 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -161.86 155.78 21.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 109.708 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 3' ' ' TRP . 0.1 OUTLIER -170.68 126.96 0.75 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 110.817 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 55' ' ' GLY . 19.2 m -112.58 152.11 29.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 110.151 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 54' ' ' LYS . 2.1 mt -123.37 126.25 72.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.889 ' HB2' HD12 ' A' ' 53' ' ' ILE . 11.1 p90 -149.36 162.62 39.71 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.399 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 6.9 tp10 -69.58 -129.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.211 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 48' ' ' GLU . 0.1 OUTLIER 166.41 -19.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.842 -1.161 . . . . 0.0 110.908 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.42 21.65 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.008 -1.058 . . . . 0.0 109.755 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.33 -32.2 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.283 -0.886 . . . . 0.0 110.934 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.2 pt-20 -171.31 -161.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.623 -1.298 . . . . 0.0 112.449 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.889 HD12 ' HB2' ' A' ' 47' ' ' TYR . 9.8 tp -123.27 157.12 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.9 -63.48 1.45 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.344 -1.473 . . . . 0.0 113.227 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.916 ' O ' HG23 ' A' ' 45' ' ' THR . . . -170.52 166.63 39.83 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 117.409 -2.329 . . . . 0.0 111.992 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.57 ' CG ' ' OG1' ' A' ' 45' ' ' THR . 2.0 t80 -126.91 102.06 6.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.146 -0.62 . . . . 0.0 109.808 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 12.5 pt-20 -104.08 152.23 22.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 109.558 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -141.94 154.93 45.43 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.14 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 70' ' ' ARG . 6.1 pt20 -126.05 125.24 42.28 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 15' ' ' LEU . 1.2 tp -121.44 69.54 0.92 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.919 -1.113 . . . . 0.0 109.179 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.608 ' C ' HG13 ' A' ' 62' ' ' VAL . 23.0 t80 -69.21 110.52 4.62 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' CD ' ' A' ' 67' ' ' LYS . 31.2 m -159.5 -161.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.402 -0.811 . . . . 0.0 109.808 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.647 ' CE2' ' CD ' ' A' ' 36' ' ' LYS . 2.1 t80 -142.56 126.62 17.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.488 -0.758 . . . . 0.0 110.124 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' CA ' ' A' ' 34' ' ' PHE . . . -119.95 -131.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.457 -0.777 . . . . 0.0 109.632 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 35' ' ' ASN . 85.1 p -85.69 -25.29 26.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.007 -1.058 . . . . 0.0 109.175 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.59 17.88 0.61 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.489 -0.757 . . . . 0.0 109.92 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.045 ' HE3' HD11 ' A' ' 15' ' ' LEU . 1.1 ttmm -110.7 74.5 0.88 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.306 -0.871 . . . . 0.0 110.053 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.599 ' HG ' ' CE1' ' A' ' 63' ' ' TYR . 1.7 mt -85.73 66.48 9.66 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 175.31 -119.92 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.455 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 19.6 ttp85 -137.73 125.65 22.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.55 -1.344 . . . . 0.0 111.918 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.63 ' O ' ' CE1' ' A' ' 58' ' ' TYR . . . -82.69 110.71 17.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.5 t70 -92.03 165.58 13.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.054 -1.029 . . . . 0.0 111.032 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.736 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.78 118.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -125.28 142.06 51.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.861 -1.15 . . . . 0.0 110.771 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 82' ' ' ARG . 21.7 mt-10 -152.99 132.29 12.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.315 -0.866 . . . . 0.0 109.824 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.611 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -58.07 -154.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 0.0 110.723 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.846 ' HB3' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -160.75 -48.7 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.032 -1.043 . . . . 0.0 111.301 -179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 53' ' ' ILE . 8.2 pttp -52.47 -42.0 63.84 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.029 -1.044 . . . . 0.0 108.52 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.544 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 11.8 t -135.22 14.3 3.52 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 82' ' ' ARG . 2.6 mmm180 67.21 14.65 9.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.754 -0.591 . . . . 0.0 109.443 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . 11.17 -75.72 0.0 OUTLIER Glycine 0 N--CA 1.5 2.956 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.553 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' N ' ' O ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -153.22 -171.8 4.03 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.845 -1.385 . . . . 0.0 111.44 -178.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' N ' ' CD ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -144.13 144.8 31.75 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 0.6 OUTLIER -172.2 155.8 3.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.971 -1.081 . . . . 0.0 109.602 -179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.04 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -142.72 166.24 25.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.791 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 11.1 mmt180 -135.32 -174.08 3.52 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 111.168 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 20.6 m-85 -157.69 61.08 0.48 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -152.27 -157.0 0.76 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.841 -1.162 . . . . 0.0 111.765 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.62 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 68.91 49.3 42.71 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 45.3 Cg_endo -68.69 -169.26 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 124.436 1.756 . . . . 0.0 112.009 -176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.429 HG12 ' OH ' ' A' ' 61' ' ' TYR . 19.0 m . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.285 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.484 -1.446 . . . . 3.28 109.484 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -136.72 151.07 48.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -1.191 . . . . 2.72 110.279 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' LYS . 2.1 p90 -125.19 156.51 38.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 3.53 110.214 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CG ' ' HD2' ' A' ' 43' ' ' LYS . 5.6 pt-20 -166.36 129.17 1.94 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 2.43 110.183 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.877 HG22 ' HG2' ' A' ' 42' ' ' MET . 10.8 pt -75.45 176.67 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.18 -0.95 . . . . 1.31 110.42 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.07 HG21 ' CD1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -111.15 -162.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.193 -0.942 . . . . 2.41 109.891 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -137.48 49.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.853 -1.154 . . . . 2.16 111.597 -179.173 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 7' ' ' ASP . 10.6 tt 40.08 43.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.826 0.822 . . . . 1.69 110.038 179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' H ' ' HD2' ' A' ' 10' ' ' PRO . . . -133.04 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.061 -1.066 . . . . 0.86 110.933 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 14' ' ' ASN . 42.7 Cg_endo -86.35 -59.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.558 1.294 . . . . 0.9 111.131 -178.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 1.07 ' CD1' HG21 ' A' ' 6' ' ' ILE . 3.3 m-30 -52.28 -32.7 38.7 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.957 -1.09 . . . . 1.46 109.318 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.726 HG22 ' CG2' ' A' ' 38' ' ' ILE . 8.5 p -59.19 -57.91 10.95 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.113 -1.439 . . . . 0.65 107.113 177.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.532 ' N ' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -66.8 -18.47 65.39 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.672 0.749 . . . . 2.19 109.141 178.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' CB ' ' HA ' ' A' ' 11' ' ' PHE . 13.6 t-20 -78.02 -63.73 1.32 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.471 0.653 . . . . 1.71 109.833 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.825 HD22 HD21 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -40.22 -63.9 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.328 0.585 . . . . 2.02 109.573 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 20' ' ' VAL . . . -46.16 -46.18 15.5 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.246 -1.542 . . . . 0.52 109.246 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -70.78 -84.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 2.65 110.538 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' ALA . 2.5 m-85 -38.71 -64.12 0.46 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.401 0.619 . . . . 2.59 111.045 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -43.37 -70.61 0.1 Allowed 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.602 -0.686 . . . . 0.54 109.919 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.525 ' CG2' ' OG1' ' A' ' 33' ' ' THR . 42.4 t -40.89 -27.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.353 -0.842 . . . . 1.34 110.46 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -92.6 -66.27 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 1.72 110.336 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.022 ' HB2' HD13 ' A' ' 85' ' ' LEU . 2.4 mt-10 -60.82 -31.66 71.06 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.045 -1.062 . . . . 1.95 109.874 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -73.69 -60.19 2.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.891 -1.151 . . . . 1.61 107.891 177.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 35.5 t-20 -52.02 -48.57 64.46 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.228 -1.397 . . . . 2.19 107.228 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 42.5 tttt -56.85 -47.26 80.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.954 -1.128 . . . . 2.68 107.954 177.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.565 HG13 ' CD2' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -50.48 -24.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.56 -0.904 . . . . 1.32 108.56 178.609 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.67 24.99 2.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.384 -1.486 . . . . 0.87 109.384 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 34.6 tp60 -125.47 66.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 2.16 109.79 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.511 ' CB ' ' ND2' ' A' ' 24' ' ' ASN . 38.5 p90 -90.76 22.69 3.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 5.47 109.831 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 31' ' ' ARG . . . -41.32 -55.55 3.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.818 -1.313 . . . . 2.23 109.818 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.953 ' HB3' HD12 ' A' ' 32' ' ' LEU . 9.4 mtt180 -162.6 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -1.208 . . . . 3.49 110.069 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.953 HD12 ' HB3' ' A' ' 31' ' ' ARG . 3.9 mp -126.9 -177.31 3.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 2.25 109.961 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -146.9 50.12 1.12 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.266 -0.896 . . . . 0.68 109.91 179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 11.3 t80 174.96 79.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.73 . . . . 3.46 109.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -120.94 -44.36 2.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.58 110.627 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -68.91 -96.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 3.36 110.955 -179.406 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 36' ' ' LYS . 28.1 t -157.57 171.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.621 -1.3 . . . . 0.71 111.679 -179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.726 ' CG2' HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -134.88 88.15 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.168 -0.678 . . . . 1.55 109.168 179.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.539 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -105.02 -53.55 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.979 -1.075 . . . . 2.98 110.979 -179.274 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HB2' ' CD2' ' A' ' 61' ' ' TYR . 38.6 Cg_endo -84.02 50.92 3.24 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.395 1.208 . . . . 0.58 110.941 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.846 ' HB2' HD12 ' A' ' 60' ' ' LEU . 21.0 p -103.52 120.82 41.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.399 -0.813 . . . . 1.57 109.807 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.877 ' HG2' HG22 ' A' ' 5' ' ' ILE . 27.5 mtm -119.03 177.29 4.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 1.91 110.649 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -140.62 154.28 46.39 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.229 -0.919 . . . . 1.47 110.41 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -151.75 100.63 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.144 -0.973 . . . . 2.46 110.354 179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.0 m -97.88 148.88 22.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.186 -0.946 . . . . 0.61 110.265 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.521 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -114.39 43.39 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.359 -0.978 . . . . 1.84 108.359 178.79 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.748 ' HB2' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.12 -177.13 6.5 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.495 0.664 . . . . 2.86 110.987 -178.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' CB ' ' HG3' ' A' ' 52' ' ' GLU . 2.2 tp10 -69.38 -101.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 3.58 109.789 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 65.1 t30 -176.1 -53.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.751 -1.218 . . . . 4.15 110.938 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -149.19 14.15 0.88 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 4.48 110.079 -179.684 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.88 -27.83 3.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.421 -0.799 . . . . 5.17 109.626 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.54 ' HG3' ' CB ' ' A' ' 48' ' ' GLU . 2.9 pt-20 -170.58 -165.17 0.43 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.046 -1.061 . . . . 2.82 111.269 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.748 HD12 ' HB2' ' A' ' 47' ' ' TYR . 9.6 tp -126.47 152.7 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.658 -0.651 . . . . 2.11 109.54 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' CB ' ' HA ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -130.86 -65.93 0.77 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.999 -1.063 . . . . 2.81 111.705 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.897 ' O ' HG23 ' A' ' 45' ' ' THR . . . -135.2 173.91 21.43 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.689 -1.72 . . . . 0.63 110.611 -179.007 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 75' ' ' GLU . 3.7 t80 -155.85 78.02 0.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.554 -0.968 . . . . 2.99 110.231 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' LYS . 14.9 pt-20 -99.35 167.39 10.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 2.43 109.0 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CD1' HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -162.44 170.63 18.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 117.996 -1.481 . . . . 1.74 112.977 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CG ' ' HD3' ' A' ' 70' ' ' ARG . 2.5 mt-30 -133.82 123.76 25.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.787 -1.19 . . . . 1.91 107.787 178.036 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.846 HD12 ' HB2' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -121.07 74.78 1.11 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.034 -1.041 . . . . 0.66 109.399 -179.06 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.947 ' OH ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -69.25 112.28 5.73 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.198 -1.038 . . . . 1.51 108.198 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.667 HG23 ' CD ' ' A' ' 67' ' ' LYS . 33.2 m -158.19 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.779 0.799 . . . . 0.63 109.851 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.716 ' CZ ' HD21 ' A' ' 68' ' ' LEU . 2.4 t80 -147.28 130.44 16.45 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.141 -0.688 . . . . 1.22 109.141 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . . . -124.17 -126.07 0.25 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.388 -0.82 . . . . 0.6 109.721 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.4 t -95.15 -24.71 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.912 -1.117 . . . . 1.39 108.726 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.02 18.4 0.77 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.503 0.668 . . . . 1.52 109.446 179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.863 ' NZ ' ' HB2' ' A' ' 71' ' ' ALA . 1.3 ttmm -115.23 78.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.389 -0.82 . . . . 1.37 110.229 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.716 HD21 ' CZ ' ' A' ' 63' ' ' TYR . 9.0 mt -88.17 64.86 7.89 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.895 -0.78 . . . . 1.8 108.895 178.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER 178.7 -123.83 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.047 -1.061 . . . . 1.85 110.534 -179.085 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 25.3 ttm180 -131.02 123.63 29.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.328 -1.483 . . . . 1.69 112.194 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.863 ' HB2' ' NZ ' ' A' ' 67' ' ' LYS . . . -80.48 107.9 13.66 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.651 -1.611 . . . . 0.47 106.651 176.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.8 t70 -89.64 162.2 15.74 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.002 -1.061 . . . . 1.71 110.404 -178.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.713 HG22 ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -160.2 110.34 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.73 0.776 . . . . 1.09 109.294 179.345 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -110.71 122.47 47.89 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.247 -0.908 . . . . 1.25 109.955 -179.211 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.636 ' OE1' HD12 ' A' ' 73' ' ' ILE . 22.9 mt-10 -144.96 122.86 11.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 2.02 110.066 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.578 ' CB ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER -60.88 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 2.14 110.104 179.694 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.718 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -171.28 -60.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.85 -1.157 . . . . 2.73 110.715 -179.699 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 12.9 tttt -83.48 -56.7 3.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 4.02 109.596 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.82 0.54 23.45 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.333 -0.854 . . . . 3.32 109.619 179.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' O ' ' C ' ' A' ' 81' ' ' GLY . 9.1 mmt85 57.01 28.54 14.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 5.9 109.916 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.578 ' N ' ' CB ' ' A' ' 76' ' ' ASP . . . -24.29 -70.25 0.02 OUTLIER Glycine 0 N--CA 1.502 3.071 0 CA-C-N 116.104 -0.498 . . . . 2.06 112.287 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -168.49 -172.52 1.7 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.591 -1.535 . . . . 4.79 111.831 -179.196 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.538 ' CG ' ' HG2' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -149.93 125.63 10.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.976 -0.75 . . . . 3.3 108.976 179.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 11.8 tp -170.59 173.95 5.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.868 -1.145 . . . . 2.19 110.423 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.022 HD13 ' HB2' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -154.01 171.64 18.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.98 109.928 179.487 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.543 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 10.6 mtt180 -140.08 -177.9 5.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -0.97 . . . . 2.71 110.989 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.763 ' CZ ' HD11 ' A' ' 85' ' ' LEU . 23.7 m-85 -153.27 63.28 0.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.706 -0.621 . . . . 0.68 109.398 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 2.3 m-80 -153.3 -156.5 0.7 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.789 -1.194 . . . . 1.83 111.388 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 90' ' ' PRO . . . 67.98 52.32 29.07 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 105.323 -3.111 . . . . 1.28 105.323 -177.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 89' ' ' GLY . 42.6 Cg_endo -68.33 -178.02 1.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 124.598 1.841 . . . . 2.23 111.938 -176.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.947 HG12 ' OH ' ' A' ' 61' ' ' TYR . 30.1 m . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.966 -1.016 . . . . 2.22 110.45 -179.844 . . . . . . . . 1 1 . 1 stop_ save_